Clustering O 0 7.18771673291485e-08
of O 0 7.069792234276617e-12
missense O 0 1.8554422354100097e-07
mutations O 0 5.099855115986429e-07
in O 0 5.155356141983702e-10
the O 0 3.0069236345298123e-06
ataxia B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999954700469971
telangiectasia I-Disease 1 0.999998927116394
gene O 0 1.20664517453406e-05
in O 0 7.682642022555086e-11
a O 0 1.5397091934765683e-10
sporadic B-Disease 0 7.044741323625203e-07
T I-Disease 1 0.7202596068382263
- I-Disease 0 0.002426024293527007
cell I-Disease 1 0.7283188104629517
leukaemia I-Disease 1 0.9959868788719177
. O 0 1.1656690723782503e-08

Ataxia B-Disease 1 0.9999645948410034
- I-Disease 1 0.999941349029541
telangiectasia I-Disease 1 0.9999951124191284
( O 0 0.00084064737893641
A B-Disease 1 0.9999964237213135
- I-Disease 1 0.9999934434890747
T I-Disease 1 0.9999995231628418
) O 0 2.3173189755976153e-10
is O 0 3.438724999194065e-13
a O 0 1.800422332921825e-13
recessive B-Disease 0 1.8169724853578373e-06
multi I-Disease 0 0.00016978995699901134
- I-Disease 1 0.9995937943458557
system I-Disease 1 0.9964277148246765
disorder I-Disease 1 0.9998332262039185
caused O 0 9.407346368561775e-08
by O 0 3.0776181841711547e-13
mutations O 0 1.0839475983459579e-09
in O 0 7.980279577348565e-14
the O 0 1.463470593624991e-13
ATM O 0 1.7499824878086656e-07
gene O 0 9.801157219158085e-09
at O 0 1.1608455530165429e-08
11q22 O 0 2.994915249132646e-08
- O 0 6.961831331864232e-06
q23 O 0 4.924523864247021e-07
( O 0 1.5051021410097953e-12
ref O 0 9.727743588427984e-08
. O 0 4.294921623210213e-12
3 O 0 1.9041095089544768e-11
) O 0 7.99088833297601e-12
. O 0 5.404423783494927e-11

The O 0 2.1961895413369348e-08
risk O 0 5.09261838033126e-07
of O 0 1.8234686330331762e-11
cancer B-Disease 0 8.014645231924078e-07
, O 0 9.048446020232248e-11
especially O 0 1.0669114029748794e-11
lymphoid B-Disease 0 7.471588681084995e-09
neoplasias I-Disease 0 2.38342408920289e-06
, O 0 3.278440886822498e-12
is O 0 2.767164752545681e-13
substantially O 0 1.3931381048770675e-10
elevated O 0 6.172099801915465e-06
in O 0 2.2254154075085353e-08
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
patients O 0 9.491511718806578e-07
and O 0 3.269310377973511e-09
has O 0 1.8378079502667788e-08
long O 0 2.4094755080028563e-09
been O 0 6.575865962865635e-10
associated O 0 1.7297652199488311e-10
with O 0 3.2158569140960935e-09
chromosomal O 1 0.9999958276748657
instability O 1 0.9999785423278809
. O 0 7.320414141531728e-08

By O 0 1.5328759095378786e-10
analysing O 0 4.0504090748072485e-07
tumour B-Disease 1 0.9999799728393555
DNA O 0 5.417587999545503e-06
from O 0 1.4038844739494571e-11
patients O 0 4.746913799535957e-12
with O 0 3.7338898249347774e-13
sporadic B-Disease 0 1.530718307662937e-08
T I-Disease 0 0.06296076625585556
- I-Disease 0 0.00022690746118314564
cell I-Disease 0 0.23351290822029114
prolymphocytic I-Disease 0 0.2891000211238861
leukaemia I-Disease 1 0.9369192123413086
( O 0 4.4500475526731975e-10
T B-Disease 0 4.371468457975425e-05
- I-Disease 0 1.95578263628704e-06
PLL I-Disease 0 5.178924311621813e-06
) O 0 4.570995925518018e-12
, O 0 1.5697566944222752e-14
a O 0 3.814721636990169e-14
rare O 0 3.925496733225842e-11
clonal B-Disease 0 1.5025659605427677e-09
malignancy I-Disease 0 3.339271415825351e-06
with O 0 1.85245178571658e-12
similarities O 0 1.0972278641219191e-11
to O 0 1.6183216875950701e-12
a O 0 1.5570617711846424e-11
mature B-Disease 0 3.852989927111139e-09
T I-Disease 0 0.00011952834756812081
- I-Disease 0 8.967736562226492e-07
cell I-Disease 0 0.00022118953347671777
leukaemia I-Disease 0 0.03167261183261871
seen O 0 3.6384963664204406e-07
in O 0 8.84052483995923e-11
A B-Disease 1 0.9999935626983643
- I-Disease 1 0.9999740123748779
T I-Disease 1 0.9999998807907104
, O 0 3.9848048472013176e-11
we O 0 3.572504434206508e-13
demonstrate O 0 1.7507357868117024e-14
a O 0 3.0975615833845867e-15
high O 0 2.859158005838469e-12
frequency O 0 1.6602563768230993e-10
of O 0 1.2416091849857917e-14
ATM O 0 4.6594004743383266e-07
mutations O 0 1.4926378355539782e-08
in O 0 1.0322775273463591e-10
T B-Disease 0 0.0030335162300616503
- I-Disease 0 1.7923508494277485e-05
PLL I-Disease 0 0.00010463553189765662
. O 0 1.881188760322061e-09

In O 0 2.2032527191573337e-10
marked O 0 2.139584731608579e-09
contrast O 0 2.694725519114538e-12
to O 0 1.275006084733429e-14
the O 0 2.434189943050489e-15
ATM O 0 9.573678738661329e-08
mutation O 0 1.4622298927235988e-08
pattern O 0 3.761724428841262e-06
in O 0 3.717335061992344e-08
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999985694885254
T I-Disease 1 0.9999998807907104
, O 0 1.292598927199462e-11
the O 0 1.4808443023995254e-15
most O 0 3.4557888103769346e-16
frequent O 0 2.485944630215616e-14
nucleotide O 0 1.959783463983955e-12
changes O 0 3.2935690307857313e-13
in O 0 7.607402799066423e-14
this O 0 3.999826511669191e-12
leukaemia B-Disease 0 2.1789734091726132e-05
were O 0 1.9759287261944536e-10
missense O 0 4.933582076205312e-08
mutations O 0 1.4266670689266903e-07
. O 0 5.521259005547563e-09

These O 0 3.8263156532103437e-10
clustered O 0 3.835372552885019e-08
in O 0 1.218906659633534e-11
the O 0 3.919030464732964e-12
region O 0 5.7266687052137666e-12
corresponding O 0 3.419848226219463e-13
to O 0 1.4153580380187741e-13
the O 0 2.946203190808995e-14
kinase O 0 2.559830925008555e-08
domain O 0 1.50389922737304e-09
, O 0 7.873096272148494e-12
which O 0 2.7468262039920255e-12
is O 0 6.8290951405370216e-15
highly O 0 1.844135992323066e-15
conserved O 0 1.2752602793209e-12
in O 0 4.5506878972555176e-14
ATM O 0 1.6441869377104013e-07
- O 0 3.046270435902443e-08
related O 0 3.661275796429386e-11
proteins O 0 4.917150887850941e-12
in O 0 1.6795423287817995e-13
mouse O 0 9.205442097481864e-08
, O 0 2.99857713529153e-13
yeast O 0 1.2441536689777877e-09
and O 0 2.3044342475908586e-11
Drosophila O 0 6.178420552949149e-10
. O 0 8.374016757795033e-11

The O 0 6.851445105704457e-11
resulting O 0 1.2295409135276714e-10
amino O 0 7.093856613238358e-10
- O 0 1.2291253881357989e-07
acid O 0 1.0408446327048182e-09
substitutions O 0 3.9932598894232285e-10
are O 0 4.577039702108321e-13
predicted O 0 3.9445374050428583e-11
to O 0 5.221762150280085e-13
interfere O 0 1.5201819802967975e-09
with O 0 1.0957117158039154e-11
ATP O 0 3.2495236723661947e-08
binding O 0 1.066436983165886e-08
or O 0 3.1445854253853156e-10
substrate O 0 2.0971786796053493e-07
recognition O 0 6.399835661419218e-10
. O 0 2.537835941396338e-09

Two O 0 7.578301701449686e-12
of O 0 1.1995321457045766e-13
seventeen O 0 5.785230627886051e-11
mutated O 0 2.7597090479503095e-07
T B-Disease 0 0.0007459979970008135
- I-Disease 0 5.512708867172478e-06
PLL I-Disease 0 7.758201718388591e-06
samples O 0 1.356746626157701e-08
had O 0 2.2983788205976907e-09
a O 0 7.745680724417781e-13
previously O 0 1.6755142828728253e-09
reported O 0 4.457766067389457e-07
A B-Disease 1 0.9999011754989624
- I-Disease 1 0.9997822642326355
T I-Disease 1 0.9999908208847046
allele O 0 1.4818117961112875e-05
. O 0 1.2211138766815566e-09

In O 0 8.126463391100458e-10
contrast O 0 1.2054127696004002e-09
, O 0 3.218072943539374e-12
no O 0 1.4645939626009574e-12
mutations O 0 1.4727472019693266e-10
were O 0 1.0245412157550149e-10
detected O 0 6.325665324879992e-09
in O 0 9.402726400221592e-14
the O 0 3.596774299837596e-14
p53 O 0 6.021471082168217e-12
gene O 0 5.210915587916531e-10
, O 0 3.70518806608322e-12
suggesting O 0 3.302971091079243e-11
that O 0 1.024153938739003e-11
this O 0 3.1024873642371276e-11
tumour B-Disease 1 0.9999996423721313
suppressor O 0 0.05852106213569641
is O 0 8.4406845957119e-09
not O 0 1.473207805746668e-10
frequently O 0 4.227712402382622e-09
altered O 0 1.4015461147209862e-07
in O 0 5.839597555512555e-11
this O 0 2.2372586006014217e-09
leukaemia B-Disease 0 0.18248139321804047
. O 0 9.709352433162621e-09

Occasional O 0 1.5674838778068079e-06
missense O 0 1.5186445807557902e-06
mutations O 0 4.5012544092060125e-07
in O 0 3.2684282363915074e-11
ATM O 0 4.457257091416977e-06
were O 0 6.362063942333407e-08
also O 0 3.1157385560476314e-09
found O 0 2.5915949386501325e-09
in O 0 8.829688369349498e-11
tumour B-Disease 1 0.9999995231628418
DNA O 0 1.1226155947952066e-05
from O 0 1.855684876594932e-11
patients O 0 5.695471004540931e-12
with O 0 1.0232336896190408e-12
B B-Disease 0 2.944122456938203e-08
- I-Disease 0 1.7055327816706267e-07
cell I-Disease 0 0.0003303643024992198
non I-Disease 0 3.6853623441857053e-07
- I-Disease 1 0.9886264204978943
Hodgkins I-Disease 1 0.9999703168869019
lymphomas I-Disease 1 0.9421516060829163
( O 0 1.1949569805880245e-11
B B-Disease 0 1.2167483021130465e-08
- I-Disease 0 3.4181354635620664e-08
NHL I-Disease 0 5.212213238792174e-08
) O 0 7.625555568935294e-12
and O 0 7.205104026429543e-13
a O 0 3.649505177227841e-12
B B-Disease 0 6.054532875054974e-09
- I-Disease 0 5.297048133456883e-09
NHL I-Disease 0 3.995654473953891e-09
cell O 0 4.5800553039043734e-07
line O 0 6.058173767087283e-07
. O 0 1.4957768357248824e-10

The O 0 7.840117444146699e-11
evidence O 0 7.032941069795573e-12
of O 0 3.0700812934768154e-15
a O 0 7.718761881828767e-14
significant O 0 5.1405094644938615e-14
proportion O 0 2.9854131319839716e-12
of O 0 1.7286157314583273e-12
loss O 0 3.104232249029337e-08
- O 0 1.9775708182123708e-08
of O 0 1.2479145321264706e-11
- O 0 3.808873714206129e-07
function O 0 4.404190345752568e-09
mutations O 0 4.0301739723247465e-09
and O 0 5.851281958957344e-11
a O 0 6.6708583101871e-12
complete O 0 2.6319435519894796e-10
absence O 0 8.706768639399343e-11
of O 0 8.070187720128283e-15
the O 0 4.2718638956079635e-13
normal O 0 1.1355820797587235e-12
copy O 0 7.017391112640325e-10
of O 0 1.5235918741376107e-14
ATM O 0 6.423419449674839e-07
in O 0 4.197607105654866e-12
the O 0 1.6980654729548128e-11
majority O 0 6.334795101675672e-12
of O 0 1.3302813711701944e-12
mutated O 0 2.426469472993631e-05
tumours B-Disease 1 0.999997615814209
establishes O 0 2.460784571667318e-07
somatic O 0 5.389433965774515e-08
inactivation O 0 1.623522985028103e-05
of O 0 2.0008766778850662e-13
this O 0 1.6791570981973883e-14
gene O 0 9.793891392329002e-12
in O 0 1.7273525275071644e-13
the O 0 2.2459248003037224e-13
pathogenesis O 0 6.523373508038333e-10
of O 0 2.084419469710122e-13
sporadic B-Disease 0 6.787434614352605e-08
T I-Disease 0 0.04286883771419525
- I-Disease 0 6.448161002481356e-05
PLL I-Disease 0 0.000302353611914441
and O 0 1.5781453921448474e-09
suggests O 0 9.006393721089356e-12
that O 0 4.594778333852356e-13
ATM O 0 4.985695056802797e-08
acts O 0 1.7077747549443245e-10
as O 0 3.9368165845321546e-12
a O 0 7.164633331058212e-10
tumour B-Disease 1 0.9999929666519165
suppressor O 0 0.0576702319085598
. O 0 1.0586147425328818e-07

As O 0 7.353275627286493e-11
constitutional O 0 2.444574273910427e-12
DNA O 0 8.200047307838076e-10
was O 0 3.714652196951107e-10
not O 0 2.4878666834982077e-13
available O 0 2.1079997149968735e-14
, O 0 1.1855610148659747e-14
a O 0 1.180546003835825e-12
putative O 0 1.0450653462612536e-06
hereditary O 0 0.16976600885391235
predisposition O 0 3.114058927167207e-05
to O 0 5.278442927192373e-08
T B-Disease 0 0.041899848729372025
- I-Disease 0 1.9812666778307175e-06
PLL I-Disease 0 1.404526187798183e-06
will O 0 3.54165004615159e-12
require O 0 1.0102334321797466e-15
further O 0 1.8830495329528758e-15
investigation O 0 3.1936632158280354e-12
. O 0 1.2620677072860964e-12
. O 0 1.4732801784100857e-11

Myotonic B-Disease 1 0.999763548374176
dystrophy I-Disease 1 0.9997076392173767
protein O 0 5.0901408030767925e-06
kinase O 0 0.0003874521644320339
is O 0 3.982117136036578e-10
involved O 0 1.7097570104498971e-13
in O 0 7.18730833854618e-15
the O 0 7.164041190518052e-15
modulation O 0 2.1083045032010972e-11
of O 0 9.748625856760042e-15
the O 0 5.0208986274169476e-12
Ca2 O 0 1.4584413747797953e-06
+ O 0 4.903663466393482e-06
homeostasis O 0 0.0031161087099462748
in O 0 2.314743396958363e-10
skeletal O 0 0.00011280760372756049
muscle O 0 3.416646734422102e-07
cells O 0 2.6205140279955685e-09
. O 0 2.1003064565316976e-10

Myotonic B-Disease 1 0.9997124075889587
dystrophy I-Disease 1 0.9999163150787354
( O 0 1.0465370905876625e-05
DM B-Disease 1 0.9999810457229614
) O 0 1.020812678831362e-08
, O 0 1.253723253685779e-12
the O 0 1.4464923941796826e-13
most O 0 4.423001201403487e-11
prevalent O 0 5.745856469729915e-05
muscular B-Disease 0 0.0057535539381206036
disorder I-Disease 0 0.0012269761646166444
in O 0 5.990155593771362e-11
adults O 0 7.705943261271386e-08
, O 0 1.0184118826028765e-10
is O 0 8.638785797820958e-10
caused O 0 9.607773243658357e-09
by O 0 6.0394718739975595e-12
( O 0 7.344630817158332e-14
CTG O 0 1.1078915562734437e-08
) O 0 2.810165121436281e-11
n O 0 4.589552204947722e-08
- O 0 1.7179212363771512e-07
repeat O 0 1.4544383475367795e-06
expansion O 0 1.131507214313654e-11
in O 0 3.0748634297387764e-15
a O 0 1.7794713001379657e-16
gene O 0 1.0871768674929668e-14
encoding O 0 9.338651407080414e-14
a O 0 3.76057068514693e-13
protein O 0 1.908957991680893e-10
kinase O 0 1.0948494946205756e-06
( O 0 1.582329536495286e-12
DM B-Disease 1 0.9999798536300659
protein O 0 4.4066045035151546e-08
kinase O 0 1.4412752534553874e-05
; O 0 8.912700438790111e-11
DMPK O 0 1.1838906743832922e-07
) O 0 2.0619436876239544e-13
and O 0 1.8885285655721902e-14
involves O 0 2.2679021289114193e-15
changes O 0 1.0226805601638248e-14
in O 0 4.46842710673679e-14
cytoarchitecture O 0 5.660890778358407e-08
and O 0 4.357519553521705e-11
ion O 0 2.9629842401845963e-07
homeostasis O 0 0.0011999094858765602
. O 0 1.4722543184575443e-08

To O 0 7.685363630216546e-12
obtain O 0 8.931563713447666e-13
clues O 0 7.471741003683974e-10
to O 0 1.670106761220147e-12
the O 0 1.5678124488764655e-13
normal O 0 1.6327572974206284e-12
biological O 0 1.4008271972953956e-11
role O 0 5.709128374047079e-13
of O 0 3.3229847909779786e-14
DMPK O 0 5.29928421144632e-08
in O 0 4.14801859852619e-14
cellular O 0 8.988915167762457e-10
ion O 0 3.870958664720092e-07
homeostasis O 0 9.632940782466903e-05
, O 0 2.1430173607894787e-11
we O 0 4.850880547940806e-12
have O 0 1.9523206835903029e-13
compared O 0 4.211317980538226e-13
the O 0 1.313100832494446e-13
resting O 0 6.23736866600666e-08
[ O 0 1.0295117622988181e-12
Ca2 O 0 9.253050547997077e-10
+ O 0 8.758929581631492e-09
] O 0 2.308928603866889e-09
i O 0 2.173144303396768e-10
, O 0 1.947855388472592e-15
the O 0 2.126242432988479e-15
amplitude O 0 3.0793829292052877e-11
and O 0 1.2314255171119726e-10
shape O 0 1.4894652178298884e-10
of O 0 3.5491643989932686e-15
depolarization O 0 2.2401738797306336e-10
- O 0 5.404214675763797e-07
induced O 0 5.925544883211842e-06
Ca2 O 0 7.178092005233339e-07
+ O 0 2.8959536280126486e-07
transients O 0 1.5926766536722425e-06
, O 0 5.676207117180643e-13
and O 0 4.3377434755026076e-14
the O 0 1.3383264562218979e-15
content O 0 4.556683264218819e-13
of O 0 1.7316258764886981e-15
ATP O 0 3.2242081227096264e-10
- O 0 1.1737387062282778e-08
driven O 0 3.769367928896372e-09
ion O 0 1.1609917471844255e-08
pumps O 0 8.974925691518365e-08
in O 0 1.2583804441176905e-12
cultured O 0 3.262690029259829e-08
skeletal O 0 1.1624357284745201e-05
muscle O 0 5.131852720552388e-09
cells O 0 1.2083996130118901e-11
of O 0 1.879996572101087e-14
wild O 0 9.205135542700305e-10
- O 0 3.8087064240244217e-06
type O 0 7.09739538251597e-08
and O 0 1.0564156660564095e-08
DMPK O 0 4.178000835963758e-06
[ O 0 4.9907206839394647e-11
- O 0 6.109008410248862e-08
/ O 0 9.175833781682741e-08
- O 0 1.097183599085838e-06
] O 0 2.987424352340895e-08
knockout O 0 2.2810718292021193e-06
mice O 0 5.417848569777561e-07
. O 0 1.4624236543969715e-10

In O 0 9.921181931549228e-11
vitro O 0 5.279165105065431e-09
- O 0 3.0948504559091816e-07
differentiated O 0 1.824895008439853e-07
DMPK O 0 9.534151467960328e-05
[ O 0 3.6474645526141103e-09
- O 0 4.5393147729555494e-07
/ O 0 1.2042664820910431e-06
- O 0 1.4748084140592255e-06
] O 0 7.137916036015213e-09
myotubes O 0 3.841352125277808e-09
exhibit O 0 6.695584299672153e-13
a O 0 5.167632137091302e-14
higher O 0 2.9706944369711774e-13
resting O 0 2.2048722847500812e-09
[ O 0 6.185226484635431e-13
Ca2 O 0 3.3838960522558637e-09
+ O 0 2.3489162614964698e-08
] O 0 2.3932795745196245e-09
i O 0 1.3770283524561222e-10
than O 0 4.939269767522585e-15
do O 0 3.0778236404828407e-13
wild O 0 3.35995467559691e-11
- O 0 1.1968806575168855e-05
type O 0 6.860863095425884e-07
myotubes O 0 3.181192369083874e-05
because O 0 9.136719159030804e-11
of O 0 9.477059894090261e-16
an O 0 1.0623941911749521e-13
altered O 0 1.014302641877407e-09
open O 0 1.6753248788248243e-10
probability O 0 1.016650999496882e-11
of O 0 4.336039584025911e-14
voltage O 0 1.0736664535215823e-07
- O 0 1.1474370467112749e-06
dependent O 0 2.887882999402791e-08
l O 0 3.593710289351293e-07
- O 0 4.352058269319059e-09
type O 0 5.737670408234585e-11
Ca2 O 0 4.605694048365194e-09
+ O 0 1.1039006153623632e-08
and O 0 1.5454877655418642e-10
Na O 0 5.492856836042392e-09
+ O 0 1.1346441564086263e-09
channels O 0 3.249629187962455e-08
. O 0 6.649130690483673e-10

The O 0 5.28764497464973e-11
mutant O 0 6.602251545473337e-08
myotubes O 0 7.163382775843274e-08
exhibit O 0 3.628400011002064e-11
smaller O 0 7.660377865890966e-13
and O 0 5.469544955838401e-12
slower O 0 1.4636990230965097e-10
Ca2 O 0 1.750243683318331e-08
+ O 0 2.2033431079648835e-08
responses O 0 6.8228821030469344e-12
upon O 0 4.70209862799692e-13
triggering O 0 7.202857754684544e-11
by O 0 4.878305333473609e-13
acetylcholine O 0 6.286252869358577e-07
or O 0 8.726612321652283e-09
high O 0 2.1577573505737746e-08
external O 0 5.349319280867348e-07
K O 0 7.665796033506922e-07
+ O 0 8.00142814227911e-08
. O 0 7.314029937255384e-10

In O 0 2.937673021508047e-11
addition O 0 6.166484965881847e-13
, O 0 5.654474487921078e-14
we O 0 1.734648259451091e-14
observed O 0 5.3524333809519195e-15
that O 0 6.662608697171821e-15
these O 0 2.213205103397415e-14
Ca2 O 0 2.395432261437236e-07
+ O 0 2.691246845643036e-05
transients O 0 0.00021586006914731115
partially O 0 4.255969543009996e-06
result O 0 1.675966483649649e-11
from O 0 3.970117115647317e-15
an O 0 7.638626762842822e-16
influx O 0 1.7054819928134573e-15
of O 0 1.8284930672625123e-16
extracellular O 0 1.7669493646010892e-10
Ca2 O 0 2.103266893982436e-08
+ O 0 1.5034746780884234e-09
through O 0 3.6735432404344515e-12
the O 0 2.6406363207165384e-11
l O 0 1.800836173515563e-07
- O 0 3.0469080591899456e-09
type O 0 1.4220710720103114e-10
Ca2 O 0 2.7267141433640063e-08
+ O 0 1.040541430796793e-08
channel O 0 2.987210336868884e-06
. O 0 1.1776848385380845e-09

Neither O 0 1.656424331031303e-08
the O 0 2.9870819359678613e-12
content O 0 2.470227841722128e-11
nor O 0 2.9620674402847103e-12
the O 0 3.3293017509403644e-15
activity O 0 1.563953637819318e-13
of O 0 5.466001440937408e-15
Na O 0 3.387641500651739e-09
+ O 0 6.243317418608285e-09
/ O 0 3.1631870456294564e-09
K O 0 1.1825670442888736e-09
+ O 0 2.7082799891609e-10
ATPase O 0 2.7258092671900158e-08
and O 0 9.913956461327089e-11
sarcoplasmic O 0 2.371496776731874e-08
reticulum O 0 3.0830025821160234e-07
Ca2 O 0 1.1178464092154172e-06
+ O 0 3.2286934583680704e-06
- O 0 6.75274975492357e-07
ATPase O 0 1.9432259250606876e-06
are O 0 1.0337902409118804e-11
affected O 0 1.8255025041515743e-13
by O 0 1.2344667660053182e-13
DMPK O 0 6.870729976071743e-07
absence O 0 5.279464643237475e-10
. O 0 7.406564077327982e-12

In O 0 4.1926323524066333e-11
conclusion O 0 6.311698993316517e-12
, O 0 8.017922805726718e-13
our O 0 6.610577428338427e-13
data O 0 5.742706657430041e-11
suggest O 0 9.042281680360365e-12
that O 0 6.350631392287864e-12
DMPK O 0 1.026823710503777e-07
is O 0 2.0941229436285957e-13
involved O 0 2.177687487259737e-14
in O 0 4.650860131180179e-15
modulating O 0 1.699372031982449e-10
the O 0 1.3438940715468362e-13
initial O 0 1.5964036733165377e-13
events O 0 1.2979983028075376e-13
of O 0 6.664946931622716e-15
excitation O 0 6.9896506360578314e-09
- O 0 3.603610093705356e-05
contraction O 0 1.5512712252530036e-06
coupling O 0 7.452945993691173e-08
in O 0 3.1277390399875316e-11
skeletal O 0 5.3849438700126484e-05
muscle O 0 1.9751777813326044e-07
. O 0 9.082781401992257e-12
. O 0 4.5411306659470796e-11

Constitutional O 0 2.032049906119937e-08
RB1 O 0 0.00038107496220618486
- O 0 5.399055680754827e-06
gene O 0 1.6024213209675509e-06
mutations O 0 1.2755952411680482e-05
in O 0 1.6242854283810004e-10
patients O 0 4.039714673886863e-10
with O 0 2.271907141582208e-11
isolated O 0 6.672283348052588e-07
unilateral B-Disease 0 3.2654784263286274e-06
retinoblastoma I-Disease 0 0.0010887006064876914
. O 0 4.87646616420534e-08

In O 0 1.2045893449386114e-10
most O 0 2.2505055544824737e-12
patients O 0 7.533050572217093e-12
with O 0 6.879723028242746e-13
isolated O 0 1.0715915266246157e-08
unilateral B-Disease 0 1.706937098333583e-07
retinoblastoma I-Disease 0 0.000591710617300123
, O 0 3.66046748467852e-10
tumor B-Disease 0 1.2914333069602435e-07
development O 0 3.871043839209082e-13
is O 0 5.077908308680906e-14
initiated O 0 1.6868106846208708e-13
by O 0 3.229402219273071e-14
somatic O 0 9.242974441381335e-11
inactivation O 0 1.6180090369743994e-06
of O 0 5.1476424983492794e-14
both O 0 6.278161584355457e-13
alleles O 0 1.8157361031390096e-11
of O 0 4.0389820801052176e-14
the O 0 2.0329384009531992e-11
RB1 O 0 3.759874061870505e-06
gene O 0 4.581120904845193e-08
. O 0 8.101191384390916e-10

However O 0 5.7598139591164e-09
, O 0 2.355641506510131e-12
some O 0 1.924874828748211e-16
of O 0 4.510259332320425e-16
these O 0 5.674649118658781e-13
patients O 0 6.465001277378146e-12
can O 0 3.5891456473535754e-11
transmit O 0 2.4368886442971416e-05
retinoblastoma B-Disease 0 2.1013134755776264e-05
predisposition O 0 5.437207164504798e-07
to O 0 2.0625486041314645e-10
their O 0 1.463214105434929e-09
offspring O 0 8.272269269582466e-08
. O 0 1.0669898298232283e-09

To O 0 1.5123836211161645e-11
determine O 0 2.1131547033037545e-12
the O 0 6.064480108413164e-14
frequency O 0 8.604569501358128e-09
and O 0 8.001263540613479e-11
nature O 0 5.857082397212054e-13
of O 0 2.1768560397187123e-15
constitutional O 0 1.3012022015423952e-11
RB1 O 0 5.614123438135721e-06
- O 0 2.1173669040308596e-08
gene O 0 1.0414667350744367e-08
mutations O 0 7.598797679975178e-08
in O 0 1.7324875258364902e-12
patients O 0 5.1764764349981895e-12
with O 0 9.367575075011625e-13
isolated O 0 3.252990410373968e-08
unilateral B-Disease 0 9.733646066933943e-08
retinoblastoma I-Disease 0 1.138401057687588e-05
, O 0 4.776515641347068e-11
we O 0 1.510267605420168e-11
analyzed O 0 7.648253558256712e-11
DNA O 0 1.8392060496807972e-07
from O 0 6.50085124620503e-11
peripheral O 0 0.00014267570804804564
blood O 0 0.12452924996614456
and O 0 7.084519637601261e-08
from O 0 1.2831154194703487e-10
tumor B-Disease 0 4.68951984657906e-05
tissue O 0 4.357217767392285e-05
. O 0 2.4745132165548966e-08

The O 0 1.8952261982008167e-10
analysis O 0 7.867189677490671e-10
of O 0 9.936224065754118e-10
tumors B-Disease 1 0.9999985694885254
from O 0 2.7413975534074098e-09
54 O 0 4.3515768766155816e-09
( O 0 1.6083792284127263e-12
71 O 0 3.513584756476007e-09
% O 0 1.0708394891298378e-12
) O 0 1.8186666094540532e-13
of O 0 8.033635707355418e-15
76 O 0 6.520732565018506e-11
informative O 0 2.090451811653793e-09
patients O 0 3.170942841634883e-09
showed O 0 7.749540600343607e-07
loss O 0 1.988759734672385e-08
of O 0 6.632969997907856e-13
constitutional O 0 7.537865798212806e-08
heterozygosity O 0 0.001087442273274064
( O 0 2.83491630170829e-09
LOH O 0 0.02977750264108181
) O 0 2.5062321107327534e-09
at O 0 4.429810296358028e-09
intragenic O 0 5.557723170568352e-07
loci O 0 1.5793567342825554e-08
. O 0 1.55616075581122e-09

Three O 0 4.749744486609586e-10
of O 0 1.9746797513126024e-12
13 O 0 6.330864166237404e-10
uninformative O 0 9.405618584423792e-06
patients O 0 1.981749875312744e-09
had O 0 8.539916551697502e-10
constitutional O 0 5.7444812795459654e-11
deletions O 0 3.0394224381780077e-07
. O 0 1.865204701800849e-08

For O 0 1.0936462239291567e-12
39 O 0 1.2969850020361218e-11
randomly O 0 3.2526456528181313e-10
selected O 0 1.579251396321979e-08
tumors B-Disease 1 0.9999916553497314
, O 0 1.099590085651414e-09
SSCP O 0 1.3301669241627678e-05
, O 0 4.867473438197045e-11
hetero O 0 5.475412123701062e-08
- O 0 8.016551333867028e-08
duplex O 0 2.479134536770289e-06
analysis O 0 6.135913391963621e-12
, O 0 7.385702936550925e-15
sequencing O 0 3.605026650463361e-12
, O 0 2.929362481751685e-12
and O 0 1.3996974586316657e-11
Southern O 0 1.1038105325600345e-11
blot O 0 0.00013439016765914857
analysis O 0 5.2567131203495876e-11
were O 0 6.204438547131874e-13
used O 0 4.966974639745991e-13
to O 0 2.1821834703811271e-13
identify O 0 6.71564970300409e-10
mutations O 0 4.62393430211705e-08
. O 0 1.6495849131104023e-09

Mutations O 0 3.344509877933888e-07
were O 0 1.945147598547692e-09
detected O 0 8.565177012087588e-08
in O 0 3.3040424562980064e-11
21 O 0 8.865553846604257e-10
( O 0 1.0084464730289455e-12
91 O 0 7.106573107762415e-10
% O 0 1.138644517215126e-12
) O 0 1.878489551410123e-12
of O 0 7.743750085609236e-12
23 O 0 6.800302344345255e-06
tumors B-Disease 1 0.999998927116394
with O 0 6.901247161295032e-06
LOH O 1 0.6529279351234436
. O 0 1.0611497458512531e-07

In O 0 8.303925880248642e-10
6 O 0 3.2932991889111918e-09
( O 0 1.0209411441253202e-12
38 O 0 9.165868064542337e-11
% O 0 3.2208654146548277e-13
) O 0 7.232558735942307e-13
of O 0 5.739930015666306e-13
16 O 0 2.75118992476564e-07
tumors B-Disease 1 0.9999996423721313
without O 0 1.8961831926844752e-07
LOH O 0 0.0005337563925422728
, O 0 1.2990696192372031e-11
one O 0 4.378177941716244e-12
mutation O 0 2.3100021895317013e-10
was O 0 2.951487942937092e-08
detected O 0 1.0949386819447682e-07
, O 0 2.7347310180281248e-11
and O 0 7.461967849176077e-11
in O 0 8.627283783202433e-12
9 O 0 3.5750882254603766e-09
( O 0 9.815968025385369e-14
56 O 0 2.4413240873322195e-10
% O 0 8.26795500553229e-14
) O 0 4.5296470567446345e-13
of O 0 3.6828651022932646e-13
the O 0 5.876976956642466e-06
tumors B-Disease 1 0.9999998807907104
without O 0 2.180470119128586e-06
LOH O 0 0.0009846123866736889
, O 0 3.384641178438841e-11
both O 0 6.057526442254657e-12
mutations O 0 1.4201155806858878e-08
were O 0 4.125634001095335e-10
found O 0 8.371006998686426e-09
. O 0 1.2191543330430932e-09

Thus O 0 1.7164040855277563e-08
, O 0 2.519716206517142e-12
a O 0 2.8330346423834085e-13
total O 0 2.2073589158767837e-13
of O 0 2.273126077558668e-14
45 O 0 8.472620933834552e-13
mutations O 0 1.140062627635885e-10
were O 0 6.106553457341235e-11
identified O 0 2.1210047052022674e-08
in O 0 5.926836799119428e-09
tumors B-Disease 1 0.9999996423721313
of O 0 5.561957491795333e-11
36 O 0 4.63336924383384e-09
patients O 0 9.651739407701143e-10
. O 0 3.731752684643652e-10

Thirty O 0 6.38516155504476e-08
- O 0 1.598459107299277e-07
nine O 0 2.457119840926225e-09
of O 0 8.961933842602243e-14
the O 0 9.757713300556636e-13
mutations O 0 1.7935633533916473e-10
- O 0 1.7388861461853367e-09
including O 0 4.972756689931856e-13
34 O 0 6.897776620717888e-13
small O 0 5.029721281937967e-14
mutations O 0 5.310689388249301e-11
, O 0 2.1695668807504565e-13
2 O 0 1.0730251322893514e-12
large O 0 1.0973758794025068e-12
structural O 0 3.1428659674759274e-09
alterations O 0 3.122888336815066e-10
, O 0 1.233914121052948e-12
and O 0 8.486485819636513e-12
hypermethylation O 0 7.911980048902478e-08
in O 0 7.125384726691664e-10
3 O 0 1.0254932021780405e-05
tumors O 1 0.9999998807907104
- O 0 0.0001793772098608315
were O 0 3.082872268578285e-08
not O 0 4.121355756669942e-10
detected O 0 2.4767137674075457e-08
in O 0 1.2923905381208994e-13
the O 0 7.003474948412414e-13
corresponding O 0 1.407204075487556e-10
peripheral O 0 1.3349630307857296e-06
blood O 0 1.0019501132774167e-05
DNA O 0 8.851401616993826e-06
. O 0 1.1303203706347631e-08

In O 0 8.082007285636905e-10
6 O 0 5.211434839225149e-09
( O 0 3.126103325853946e-12
17 O 0 2.582480063129111e-10
% O 0 1.897559800262405e-13
) O 0 6.371821608753062e-14
of O 0 3.774205171210975e-15
the O 0 6.5243617800025966e-12
36 O 0 4.7674135472686174e-11
patients O 0 9.43008583546845e-13
, O 0 1.0809037414856015e-14
a O 0 2.7463323499024583e-13
mutation O 0 9.37779159881913e-11
was O 0 5.2807386907716136e-08
detected O 0 8.006340479482787e-09
in O 0 1.1246402030137825e-13
constitutional O 0 5.835037856539993e-13
DNA O 0 9.97097515664791e-08
, O 0 3.635153983383432e-11
and O 0 1.3696174402944017e-11
1 O 0 2.440376676779432e-12
of O 0 1.0772324465823171e-13
these O 0 3.8373935973279316e-11
mutations O 0 1.0029064245742347e-09
is O 0 9.367507637636496e-12
known O 0 2.1780223024431278e-12
to O 0 1.1639232112836684e-11
be O 0 1.1413810868665664e-10
associated O 0 1.833184125332732e-11
with O 0 1.665628572566913e-11
reduced O 0 3.840707307745106e-09
expressivity O 0 0.00012079146836185828
. O 0 8.292407649435063e-09

The O 0 9.273647821883557e-11
presence O 0 6.768249589256259e-12
of O 0 1.5643317872082903e-14
a O 0 1.4668137581289042e-12
constitutional O 0 2.1074713155155855e-12
mutation O 0 8.947673157955194e-10
was O 0 1.8452374206390232e-07
not O 0 2.2743103234024176e-10
associated O 0 6.7776283717291275e-12
with O 0 1.7517253923446385e-13
an O 0 2.939418727952031e-13
early O 0 6.431234989001666e-10
age O 0 4.1499662040145324e-10
at O 0 1.7905622817782074e-10
treatment O 0 1.6016123149942274e-10
. O 0 2.3806477622567712e-11

In O 0 1.3359274797508647e-10
1 O 0 1.0245529424857125e-10
patient O 0 5.974594152746704e-10
, O 0 7.625027996158162e-13
somatic O 0 2.2986758330123536e-10
mosaicism O 0 2.764700866464409e-06
was O 0 1.309936408233625e-07
demonstrated O 0 3.2357946183614317e-11
by O 0 3.4261648388983403e-15
molecular O 0 1.1916998637895304e-11
analysis O 0 3.796984428261485e-12
of O 0 9.991006028682754e-15
DNA O 0 7.134448765100387e-08
and O 0 7.968549431414118e-11
RNA O 0 7.516960920384008e-08
from O 0 9.081395357934952e-12
peripheral O 0 2.3027914721751586e-06
blood O 0 4.374371201265603e-05
. O 0 3.7349874304482e-09

In O 0 5.595489072085513e-10
2 O 0 1.4564395245386663e-09
patients O 0 1.4216391952537322e-11
without O 0 6.65628956033476e-13
a O 0 2.2460158732862112e-12
detectable O 0 2.4881815718913458e-08
mutation O 0 9.142480550394794e-09
in O 0 1.4750017873765842e-10
peripheral O 0 0.0011081198463216424
blood O 1 0.6312355995178223
, O 0 4.079554916103234e-09
mosaicism O 0 1.460304929423728e-06
was O 0 5.6806953807608807e-08
suggested O 0 4.727634256296298e-11
because O 0 7.4961532207235e-13
1 O 0 1.4121377542785848e-14
of O 0 3.5044580000371866e-15
the O 0 1.2470871557646035e-10
patients O 0 1.1641115627014642e-08
showed O 0 2.9022763555985875e-05
multifocal O 1 0.8938218355178833
tumors B-Disease 1 0.9999998807907104
and O 0 2.0809450163028487e-08
the O 0 7.677301719702379e-13
other O 0 1.2428780877746237e-12
later O 0 8.149653174527316e-10
developed O 0 4.8094441623680595e-11
bilateral B-Disease 0 1.6417410764191231e-09
retinoblastoma I-Disease 0 3.832476977549959e-06
. O 0 3.948868176895104e-10

In O 0 6.316700634778627e-11
conclusion O 0 8.355489043709863e-12
, O 0 9.462155451528398e-13
our O 0 3.59168424168832e-12
results O 0 1.82742208409796e-13
emphasize O 0 1.6549485577516815e-13
that O 0 9.843434254546216e-14
the O 0 1.9749599769166085e-14
manifestation O 0 1.6453413284600593e-11
and O 0 1.8743603891202554e-11
transmissibility O 0 4.14943768234366e-09
of O 0 1.5092920945154742e-14
retinoblastoma B-Disease 0 1.962098039598459e-09
depend O 0 1.1182750688995546e-12
on O 0 3.028279849104365e-10
the O 0 1.8886142649776616e-11
nature O 0 1.580659214628355e-11
of O 0 4.601799135842263e-15
the O 0 7.978928932492191e-13
first O 0 3.588214794736366e-11
mutation O 0 6.217926867835288e-11
, O 0 1.5153096876233119e-13
its O 0 2.9579729507803187e-13
time O 0 2.9673884877068346e-12
in O 0 4.1358999287432335e-14
development O 0 2.3686324304933795e-14
, O 0 1.2587519459920926e-13
and O 0 3.966041904612805e-13
the O 0 1.9119173475315443e-13
number O 0 1.5458399534387657e-12
and O 0 2.187875575154763e-10
types O 0 1.7735054744227874e-11
of O 0 1.0486238749074853e-13
cells O 0 4.1172543152612207e-10
that O 0 1.4535797045189813e-11
are O 0 4.9694924960036815e-14
affected O 0 6.072350738559051e-14
. O 0 2.860416439300073e-13
. O 0 2.6533589561617e-11

Hereditary B-Disease 1 0.9999173879623413
deficiency I-Disease 1 0.9999595880508423
of I-Disease 0 8.670884323047634e-12
the I-Disease 0 1.0551555289228798e-11
fifth I-Disease 0 8.967184217389956e-10
component I-Disease 0 1.2657881687250239e-11
of I-Disease 0 1.622554290903709e-14
complement I-Disease 0 1.52037184925069e-11
in O 0 8.176331139919668e-12
man O 0 4.273716740499367e-07
. O 0 5.018462312378347e-10

I O 0 5.685404539690353e-05
. O 0 1.9523106686847314e-08

Clinical O 0 4.1885780888151203e-07
, O 0 4.191261115948919e-09
immunochemical O 0 3.5125704016536474e-05
, O 0 3.486007316144679e-10
and O 0 1.544597783009749e-10
family O 0 2.2707573599234365e-09
studies O 0 1.2915152280967845e-10
. O 0 3.497640718719275e-11

The O 0 8.205425922058751e-11
first O 0 9.531031519571798e-11
recognized O 0 2.321486197720546e-10
human O 0 1.911476532612255e-09
kindred O 0 5.09038072777912e-05
with O 0 9.502579700892966e-07
hereditary B-Disease 1 0.9999788999557495
deficiency I-Disease 1 0.9997639060020447
of I-Disease 0 2.5348606135129625e-13
the I-Disease 0 4.3081063889893745e-12
fifth I-Disease 0 8.12546030459771e-09
component I-Disease 0 1.0255813559512106e-10
of I-Disease 0 3.9082720892057166e-13
complement I-Disease 0 5.782685441602098e-10
( O 0 9.55060249635542e-13
C5 O 0 1.555082417326048e-05
) O 0 1.2460148191006937e-10
is O 0 4.156774750796455e-12
described O 0 2.7902358201714605e-09
. O 0 5.395599522728389e-10

The O 0 3.5721964275481355e-10
proband O 0 4.897504481959913e-07
, O 0 4.666868562604176e-13
a O 0 5.6025788121218806e-14
20 O 0 1.9787807731350832e-13
- O 0 7.937365764654203e-10
year O 0 1.4376763668444426e-10
- O 0 1.970582985677538e-07
old O 0 7.900722266640514e-06
black O 0 7.307761507036048e-08
female O 0 1.3752133654065801e-08
with O 0 5.219744139139948e-07
systemic B-Disease 1 0.9999978542327881
lupus I-Disease 1 0.9999443292617798
erythematosus I-Disease 1 0.9999927282333374
since O 0 2.0218210750044818e-07
age O 0 2.5928695301935534e-10
11 O 0 1.467402241384086e-11
, O 0 2.610407007740123e-13
lacked O 0 7.590011952274267e-10
serum O 0 9.593893537385156e-07
hemolytic O 0 6.664346301477053e-07
complement O 0 5.405369294525508e-12
activity O 0 2.8459995471408206e-10
, O 0 7.815713137446223e-13
even O 0 3.848797582722829e-12
during O 0 7.745526442448636e-11
remission O 0 1.6166225691449654e-07
. O 0 3.3462574378084753e-10

C5 O 0 0.004507900681346655
was O 0 5.1642073231050745e-06
undetectable O 0 8.953159522206988e-06
in O 0 6.156517518007831e-10
her O 0 3.6819403703702847e-07
serum O 0 3.388102811641147e-07
by O 0 1.5784652231121132e-12
both O 0 2.3880104491058596e-11
immunodiffusion O 0 6.929018127266318e-06
and O 0 4.471738090927602e-09
hemolytic O 0 3.725890564965084e-05
assays O 0 1.249338623665608e-07
. O 0 5.256735602365836e-10

Other O 0 3.824267020679367e-13
complement O 0 9.009997067009612e-13
components O 0 3.4857061681492496e-11
were O 0 9.573217869471295e-13
normal O 0 1.4756240934027387e-13
during O 0 5.204096268501823e-12
remission O 0 2.217114714042623e-09
of O 0 4.4828561435866776e-13
lupus O 0 7.875063801066062e-08
, O 0 1.5920593836316055e-12
but O 0 3.093671152587518e-11
C1 O 0 6.337864988381625e-08
, O 0 9.245944938493511e-13
C4 O 0 1.8170522935179179e-06
, O 0 7.308071509060099e-11
C2 O 0 1.742601057230786e-06
, O 0 5.707770627666475e-12
and O 0 4.69806034353315e-11
C3 O 0 2.079087971651461e-05
levels O 0 4.800999153786734e-09
fell O 0 3.4004333429038525e-06
during O 0 6.549180087134232e-10
exacerbations O 0 2.8401020244928077e-05
. O 0 3.417460481269785e-10

A O 0 6.644468530936365e-09
younger O 0 4.3126615167921045e-08
half O 0 3.4843670171369467e-09
- O 0 1.4313758356365724e-06
sister O 0 7.743007154203951e-05
, O 0 1.3026232870139154e-10
who O 0 1.0389068494376374e-09
had O 0 1.8107246546605893e-07
no O 0 2.96859892223722e-09
underlying O 0 9.83743461802078e-07
disease O 0 1.604214844519447e-06
, O 0 6.960477767076201e-12
was O 0 8.228946768440437e-08
also O 0 1.2480776412360228e-09
found O 0 7.719734296252057e-10
to O 0 2.2467551430427335e-10
lack O 0 4.494661032250491e-10
immunochemically O 0 2.892850488933618e-06
detectable O 0 1.0440422784085968e-06
C5 O 0 9.581143240211532e-05
. O 0 1.667515125980401e-09

By O 0 1.826234163893048e-09
hemolytic O 0 0.0001522470120107755
assay O 0 3.4427746413712157e-06
, O 0 3.240411716731728e-09
she O 0 1.2148467121164686e-08
exhibited O 0 6.062546298313265e-11
1 O 0 6.904199434387692e-13
- O 0 9.45656264406125e-09
2 O 0 1.144080052917218e-09
% O 0 9.12506645901279e-15
of O 0 1.6214079376887188e-16
the O 0 1.5211243993996232e-13
normal O 0 2.880188448850518e-11
serum O 0 4.2082774598384276e-08
C5 O 0 5.925222694713739e-07
level O 0 8.404595075450771e-11
and O 0 3.9591134190497534e-12
normal O 0 1.7999632817219946e-12
concentrations O 0 6.24748031086142e-11
of O 0 3.77053381278022e-16
other O 0 6.823626695829548e-15
complement O 0 2.2609691896491313e-12
components O 0 1.2990956088643202e-09
. O 0 7.575761545863813e-11

C5 O 0 0.057180218398571014
levels O 0 1.1222258535781293e-06
of O 0 1.7947901194761973e-12
other O 0 4.820443957193055e-12
family O 0 3.729231853877302e-11
members O 0 3.551155138177553e-15
were O 0 6.40321739316281e-14
either O 0 1.0958876696192353e-14
normal O 0 2.2349296350220038e-13
or O 0 3.2829839107656467e-12
approximately O 0 2.9376197654973346e-13
half O 0 1.4923515201381576e-10
- O 0 1.4705850048812863e-07
normal O 0 6.121160023297989e-09
, O 0 3.2942256561474537e-11
consistent O 0 3.998444686459379e-09
with O 0 1.227884571797233e-09
autosomal O 0 0.03383661061525345
codominant O 0 0.00034531671553850174
inheritance O 0 3.862461639414505e-08
of O 0 5.752301033504909e-14
the O 0 1.0065305793699464e-12
gene O 0 9.715506621432723e-08
determining O 0 4.389945388538763e-06
C5 B-Disease 1 0.9999916553497314
deficiency I-Disease 1 0.9999908208847046
. O 0 6.7743840759249e-08

Normal O 0 1.156661483037169e-06
hemolytic O 0 0.033850666135549545
titers O 0 6.150065928522963e-06
were O 0 3.626234382214655e-11
restored O 0 1.6270326752554354e-10
to O 0 3.575367270042956e-13
both O 0 1.2622248732330199e-11
homozygous O 0 0.00011307058593956754
C5 B-Disease 1 0.999998927116394
- I-Disease 1 0.999996542930603
deficient I-Disease 1 0.9999996423721313
( O 0 1.6459704283988685e-06
C5D B-Disease 1 0.9999992847442627
) O 0 7.758504239063768e-08
sera O 0 1.1993537896159978e-07
by O 0 2.8131105978728213e-14
addition O 0 1.2529186841942364e-14
of O 0 3.1502442798467256e-15
highly O 0 1.0894370475189596e-11
purified O 0 1.3738311599453823e-09
human O 0 3.659762493057883e-10
C5 O 0 2.8163241950096563e-05
. O 0 4.484316806774302e-10

In O 0 6.363471815457045e-12
specific O 0 1.133807978059842e-11
C5 O 0 3.3000073017319664e-05
titrations O 0 1.34560775677528e-06
, O 0 4.8079859538141534e-11
however O 0 2.6136676156696126e-11
, O 0 2.602249199543799e-13
it O 0 7.290484188571256e-12
was O 0 1.5814418663495644e-09
noted O 0 1.2066830824483676e-12
that O 0 6.132108167598849e-13
when O 0 1.5980162072076753e-12
limited O 0 3.517689448766687e-16
amounts O 0 6.854957173999063e-16
of O 0 8.797373658038217e-16
C5 O 0 8.265755724323753e-08
were O 0 3.5134185057822398e-12
assayed O 0 5.913802780810329e-10
in O 0 4.9401580509743706e-14
the O 0 3.601490579287908e-14
presence O 0 3.622207514399761e-13
of O 0 1.3476666038279763e-14
low O 0 2.351648320519928e-10
dilutions O 0 1.2867954701789586e-08
of O 0 2.4373659015565485e-13
either O 0 2.894443573708827e-09
C5D B-Disease 1 0.9999966621398926
serum O 0 2.711924935283605e-05
, O 0 4.763627643386559e-13
curving O 0 4.126671226956091e-11
rather O 0 6.218866432016953e-14
than O 0 5.825010108763157e-16
linear O 0 1.4715101966794597e-12
dose O 0 2.04919289870098e-10
- O 0 2.7770328259180133e-08
response O 0 1.2651057978985136e-10
plots O 0 3.7683275166955355e-08
were O 0 4.121371299792287e-10
consistently O 0 4.8646193739898536e-09
obtained O 0 1.5069003987330798e-12
, O 0 1.124356531679747e-14
suggesting O 0 9.800272166059568e-14
some O 0 4.0674409630588195e-17
inhibitory O 0 5.7157042987476814e-11
effect O 0 1.0831595342875033e-10
. O 0 1.8555229575056842e-10

Further O 0 4.2375897929547435e-11
studies O 0 3.4662327261930637e-12
suggested O 0 1.3828674533603036e-12
that O 0 1.6338250468251464e-13
low O 0 1.7885415370955116e-10
dilutions O 0 2.2415187572732975e-07
of O 0 1.9291994390879807e-10
C5D B-Disease 1 0.9999988079071045
serum O 0 0.0023502022959291935
contain O 0 1.9721719812793026e-09
a O 0 3.3547806893574617e-11
factor O 0 2.342685767597885e-10
( O 0 6.238349545056518e-14
or O 0 1.5459175606302722e-11
factors O 0 1.4439000342592045e-11
) O 0 4.75999448190656e-13
interfering O 0 9.217903523817128e-11
at O 0 6.789013795582832e-12
some O 0 2.0402362163017145e-16
step O 0 3.5080883510618666e-12
in O 0 3.2391613940781563e-14
the O 0 2.6834519849250338e-12
hemolytic O 0 6.990465521994338e-07
assay O 0 1.5681633769304426e-08
of O 0 5.381972536903923e-13
C5 O 0 3.1569918519380735e-06
, O 0 7.527919260175153e-13
rather O 0 9.40848029503229e-15
than O 0 4.552679801110104e-16
a O 0 4.777537550683733e-14
true O 0 1.315592079720318e-10
C5 O 0 9.699404017737834e-07
inhibitor O 0 6.594181645169783e-09
or O 0 5.07202335686685e-10
inactivator O 0 1.2755502211803105e-05
. O 0 2.900755191603821e-09

Of O 0 3.967280948202756e-10
clinical O 0 6.384087480881817e-09
interest O 0 2.102976903728404e-09
are O 0 6.699232835138957e-11
( O 0 6.964374687839711e-14
a O 0 2.7961877605009455e-12
) O 0 4.54040749225601e-13
the O 0 1.0089327241507781e-13
documentation O 0 7.118154676799548e-11
of O 0 2.84123983021467e-12
membranous O 0 0.21947389841079712
glomerulonephritis B-Disease 1 0.9999986886978149
, O 0 2.151898115698714e-06
vasculitis B-Disease 1 0.9999967813491821
, O 0 3.3821558531599294e-07
and O 0 0.00349644897505641
arthritis B-Disease 1 0.9999998807907104
in O 0 1.577061259361301e-10
an O 0 4.2603302830013234e-11
individual O 0 1.6245899070455039e-09
lacking O 0 7.866416495971862e-08
C5 O 0 0.00017736555309966207
( O 0 7.523483789087515e-13
and O 0 6.655299141650195e-13
its O 0 8.260850228695993e-13
biologic O 0 2.003622823210094e-09
functions O 0 6.616093090050512e-12
) O 0 5.250347899499186e-12
, O 0 4.65360042167795e-12
and O 0 1.6054046980684689e-10
( O 0 4.4461867320473233e-14
b O 0 1.3421848354955301e-10
) O 0 1.1110029725629883e-14
a O 0 1.4373115734709827e-14
remarkable O 0 5.068012524402088e-13
propensity O 0 2.328751635971571e-09
to O 0 7.10570546846867e-10
bacterial B-Disease 1 0.9999995231628418
infections I-Disease 1 0.9999997615814209
in O 0 2.3123020859161514e-11
the O 0 1.888978036490574e-11
proband O 0 1.8040486793324817e-06
, O 0 5.163516099068732e-13
even O 0 8.089999481951382e-13
during O 0 1.1476056650111532e-12
periods O 0 1.0732221535081354e-11
of O 0 4.741280813596281e-14
low O 0 9.583577487148887e-09
- O 0 2.3463369913656607e-08
dose O 0 1.8150375646897032e-10
or O 0 5.988321275483821e-13
alternate O 0 1.1011603955057847e-12
- O 0 3.7281207454498144e-08
day O 0 1.3419397815184197e-09
corticosteroid O 0 9.767568087681866e-08
therapy O 0 3.521253066907093e-09
. O 0 1.7687119130416207e-11

Other O 0 2.5725576183188714e-11
observations O 0 3.6724398522203217e-10
indicate O 0 1.972686458628914e-10
that O 0 5.080955621517003e-12
the O 0 1.4520702695808296e-10
C5D B-Disease 1 0.9999983310699463
state O 0 4.385534990714035e-11
is O 0 2.4563651893766414e-13
compatible O 0 1.593312565217886e-10
with O 0 1.1965192725504892e-11
normal O 0 1.7375647795581095e-11
coagulation O 0 1.9435300657733023e-07
function O 0 4.851616886014654e-10
and O 0 8.05758758326558e-12
the O 0 1.7443604069869445e-13
capacity O 0 6.356468628364309e-13
to O 0 1.5374822996769982e-13
mount O 0 2.279540334271246e-09
a O 0 6.242254491084509e-10
neutrophilic O 0 0.0006148286629468203
leukocytosis O 0 0.0006478812429122627
during O 0 3.644835544491798e-09
pyogenic B-Disease 0 0.0016334118554368615
infection I-Disease 0 0.00016935469466261566
. O 0 5.218730655953685e-11
. O 0 5.215986531581507e-10

Susceptibility O 0 0.000393511465517804
to O 0 8.363899542018771e-05
ankylosing B-Disease 1 0.9999352693557739
spondylitis I-Disease 1 0.9999991655349731
in O 0 3.2334605748474132e-06
twins O 0 3.07870504911989e-05
: O 0 1.7635738789462119e-12
the O 0 1.3626737406643649e-14
role O 0 1.3417477578211295e-13
of O 0 2.7176596832445077e-15
genes O 0 1.797919105261947e-11
, O 0 7.062726597138747e-13
HLA O 0 7.340863472649062e-10
, O 0 2.1458670344115527e-12
and O 0 1.4537737333397693e-11
the O 0 8.534077958199937e-12
environment O 0 8.936693163263953e-09
. O 0 2.730260462158185e-10

OBJECTIVE O 0 1.5633782046720057e-09
To O 0 6.0923570875670574e-12
determine O 0 2.1554258378131408e-11
the O 0 1.9042829379339876e-12
relative O 0 9.446101678634022e-10
effects O 0 1.2673517790773303e-10
of O 0 5.442822807852268e-15
genetic O 0 1.014360706541595e-09
and O 0 3.901140868678432e-11
environmental O 0 7.556791021927356e-13
factors O 0 8.799228300203701e-14
in O 0 1.8387177766693644e-14
susceptibility O 0 2.941493733032985e-07
to O 0 3.6495268886937993e-06
ankylosing B-Disease 1 0.9999986886978149
spondylitis I-Disease 1 0.9999998807907104
( O 0 2.680455395420722e-07
AS B-Disease 1 0.9996851682662964
) O 0 3.1029696589968125e-09
. O 0 6.285552078821866e-10

METHODS O 0 1.7682701525245648e-07
Twins O 0 1.0545561053731944e-05
with O 0 1.6703004535045807e-09
AS B-Disease 1 0.9775382876396179
were O 0 1.2092141177255655e-10
identified O 0 8.511844007408342e-11
from O 0 2.7556564885858337e-13
the O 0 1.344423444099574e-11
Royal O 0 1.3509906970909924e-08
National O 0 1.2283413175495639e-09
Hospital O 0 2.3971823637225498e-08
for O 0 8.603407916640826e-12
Rheumatic B-Disease 1 0.8237350583076477
Diseases I-Disease 0 1.3904649676987901e-05
database O 0 2.4472182058588032e-09
. O 0 1.932408011384723e-09

Clinical O 0 5.631114277093729e-07
and O 0 1.6205026653892673e-08
radiographic O 0 4.032539436593652e-06
examinations O 0 1.1068544303327599e-08
were O 0 2.9858646805047684e-11
performed O 0 1.3192073301804275e-11
to O 0 1.21995214494644e-13
establish O 0 1.2084595477079851e-11
diagnoses O 0 3.0515327580360463e-06
, O 0 6.562884680150205e-10
and O 0 1.1031055180410476e-07
disease O 0 4.29095734943985e-06
severity O 0 1.3690245737052464e-07
was O 0 2.3599082688008366e-09
assessed O 0 2.2768004495632432e-11
using O 0 1.6676746789068275e-12
a O 0 1.8159300452236238e-11
combination O 0 5.850277901009449e-11
of O 0 9.226191859112998e-14
validated O 0 1.3582768687570024e-08
scoring O 0 1.1381017905875979e-08
systems O 0 7.951114184834296e-07
. O 0 4.920479135250844e-09

HLA O 0 2.8313681355029985e-07
typing O 0 9.274509693568689e-08
for O 0 1.189008852313378e-12
HLA O 0 2.5206345455330847e-08
- O 0 5.63305952994142e-08
B27 O 0 2.2163197943569912e-09
, O 0 4.726213994818429e-13
HLA O 0 6.585129108671595e-10
- O 0 2.710917046400141e-09
B60 O 0 4.100013939467573e-10
, O 0 1.3849149962680968e-13
and O 0 1.25110989276922e-12
HLA O 0 3.944107263009755e-08
- O 0 1.55479610839393e-05
DR1 O 1 0.8206170201301575
was O 0 1.4023906480531423e-08
performed O 0 5.238794207468311e-12
by O 0 1.9122800046879112e-15
polymerase O 0 9.685948709758918e-10
chain O 0 8.327817546671668e-09
reaction O 0 1.6461776332268169e-13
with O 0 1.7489526765786137e-15
sequence O 0 5.458494984136864e-13
- O 0 2.2065739860299693e-11
specific O 0 6.902830629144929e-13
primers O 0 4.1851242826851376e-07
, O 0 8.919667955631372e-12
and O 0 6.376608963076791e-11
zygosity O 0 3.835043571598362e-08
was O 0 5.706078942679937e-10
assessed O 0 1.1779847063075888e-11
using O 0 3.0748621964588052e-12
microsatellite O 0 9.337787196272984e-05
markers O 0 0.00014126297901384532
. O 0 1.6068034014438126e-08

Genetic O 0 1.7740954945111298e-06
and O 0 1.4131382730653286e-09
environmental O 0 4.049052326066116e-12
variance O 0 9.248960104735193e-13
components O 0 2.0851713689040707e-09
were O 0 2.3592667749983143e-11
assessed O 0 1.7171840338559008e-11
with O 0 2.099598300124919e-13
the O 0 1.9987103064191686e-13
program O 0 1.4285575500316838e-10
Mx O 0 1.5511892215158696e-08
, O 0 2.9651887566953423e-15
using O 0 1.0705423262550185e-14
data O 0 4.70437300226223e-11
from O 0 3.016854344464748e-13
this O 0 9.23866452090527e-13
and O 0 4.766722433435788e-11
previous O 0 3.4921363023521224e-10
studies O 0 4.887910822620745e-12
of O 0 1.0889325973860355e-14
twins O 0 3.6045439966159165e-09
with O 0 6.691489810167761e-12
AS B-Disease 1 0.8797571659088135
. O 0 6.514271344570943e-10

RESULTS O 0 1.7461255552575494e-08
Six O 0 1.0448321374756375e-10
of O 0 7.005331644632795e-13
8 O 0 1.995080545214023e-09
monozygotic O 0 1.7561130505328038e-07
( O 0 2.4996034755919716e-11
MZ O 1 0.6835572123527527
) O 0 1.2226830214956408e-08
twin O 0 0.000695390161126852
pairs O 0 9.009706900542369e-07
were O 0 8.174148291573147e-08
disease O 0 2.3428449935636309e-07
concordant O 0 7.140639635139223e-09
, O 0 3.805555870428634e-11
compared O 0 1.3547741921360323e-11
with O 0 6.974241605235687e-13
4 O 0 1.5615378781697054e-11
of O 0 1.5849897349456965e-13
15 O 0 2.4184083555200964e-12
B27 O 0 3.350990041006696e-10
- O 0 6.092287208048219e-08
positive O 0 3.645556634346292e-10
dizygotic O 0 9.452578275670476e-09
( O 0 5.5246817320595e-13
DZ O 0 5.749035699409433e-05
) O 0 1.2519759673423891e-09
twin O 0 0.00018552479741629213
pairs O 0 7.768855425638321e-08
( O 0 6.320441674374788e-13
27 O 0 2.0240949194505475e-10
% O 0 3.440179930746905e-14
) O 0 5.779828926664315e-14
and O 0 4.3191863388809815e-13
4 O 0 1.5841474182778925e-12
of O 0 1.525479775051769e-13
32 O 0 1.5427848998328386e-09
DZ O 1 0.7748709917068481
twin O 0 0.13443036377429962
pairs O 0 2.701293055906717e-07
overall O 0 2.7282800019179376e-08
( O 0 9.781093984881015e-14
12 O 0 2.3325709853222465e-12
. O 0 5.678839017954351e-13
5 O 0 1.952795737614199e-11
% O 0 1.2056404052190883e-13
) O 0 6.09522762123893e-12
. O 0 8.814948077029428e-11

Nonsignificant O 0 2.4388225938309915e-05
increases O 0 1.2466507826047746e-08
in O 0 6.676506678245098e-13
similarity O 0 3.826779171323125e-12
with O 0 4.1955398573725877e-13
regard O 0 2.8946089232137484e-13
to O 0 2.3591406606016108e-11
age O 0 2.692344402976943e-10
at O 0 3.302062978605136e-08
disease O 0 1.3477213656187814e-07
onset O 0 1.0182802379077316e-09
and O 0 1.8599654802442522e-11
all O 0 7.340470868947777e-14
of O 0 4.201944104080188e-14
the O 0 1.1019795076450123e-09
disease O 0 3.6606988942367025e-06
severity O 0 4.3167105445718335e-08
scores O 0 2.586640623913894e-10
assessed O 0 4.89560336713879e-10
were O 0 5.4218619177648364e-11
noted O 0 1.3680202803900698e-10
in O 0 6.074236946762568e-11
disease O 0 4.698347038356587e-05
- O 0 0.00016006996156647801
concordant O 0 0.06989917159080505
MZ O 1 0.9996389150619507
twins O 0 2.5813511456362903e-05
compared O 0 4.842353185097181e-10
with O 0 9.353087054853049e-11
concordant O 0 8.335086022270843e-05
DZ O 1 0.9743353128433228
twins O 0 7.700586866121739e-05
. O 0 1.9508916704324974e-09

HLA O 0 3.661582377390005e-05
- O 0 6.5033855207730085e-06
B27 O 0 4.1736495859368006e-07
and O 0 8.252704630784535e-10
B60 O 0 1.8224864950511233e-09
were O 0 4.3551016959408884e-11
associated O 0 5.0808875336205706e-12
with O 0 2.504441098949428e-12
the O 0 4.1867206923562605e-10
disease O 0 2.174760282969146e-07
in O 0 2.835274116180786e-12
probands O 0 5.53199186015263e-07
, O 0 4.3605436102212014e-12
and O 0 2.261443636519811e-12
the O 0 3.929427529886231e-12
rate O 0 8.358036041045125e-09
of O 0 5.657141421977485e-13
disease O 0 1.2774092894574096e-09
concordance O 0 2.402671638035425e-11
was O 0 9.683191748433018e-11
significantly O 0 6.835986637865332e-12
increased O 0 6.418248094455792e-13
among O 0 2.970402743218692e-11
DZ O 1 0.8968519568443298
twin O 0 0.21318145096302032
pairs O 0 5.4214879696701246e-08
in O 0 1.4079255990229189e-11
which O 0 1.8148021974084827e-10
the O 0 2.8447551606025634e-11
co O 0 8.154602255672216e-06
- O 0 1.9522905859048478e-05
twin O 0 0.0005637319991365075
was O 0 4.784507456889742e-09
positive O 0 7.42278858008056e-15
for O 0 1.5119123856438494e-16
both O 0 2.2226808609783488e-14
B27 O 0 2.929885223323936e-10
and O 0 1.6816027736954453e-10
DR1 O 0 0.003302915021777153
. O 0 4.145520038356665e-10

Additive O 0 3.532333536782062e-08
genetic O 0 2.916769403782382e-07
effects O 0 2.1025369889571266e-08
were O 0 1.0525645459391608e-11
estimated O 0 2.594864156445914e-13
to O 0 2.976513350030907e-13
contribute O 0 3.3234808134718907e-13
97 O 0 6.164319055201872e-10
% O 0 2.2345332236026888e-13
of O 0 2.245836708877208e-15
the O 0 2.0099507995474664e-12
population O 0 6.991765700474842e-14
variance O 0 8.773762966152177e-12
. O 0 2.588848024842605e-09

CONCLUSION O 0 5.160169624929267e-09
Susceptibility O 0 7.630654295098793e-07
to O 0 1.6766914967547564e-08
AS B-Disease 1 0.9989153146743774
is O 0 4.5672771120663924e-11
largely O 0 7.098866850255292e-13
genetically O 0 1.3943469642785367e-11
determined O 0 1.6168987260201106e-09
, O 0 3.2145642484687764e-12
and O 0 3.30949191662544e-11
the O 0 1.6699707588996304e-11
environmental O 0 4.421383814623425e-10
trigger O 0 8.756924962938228e-09
for O 0 8.190156452342334e-13
the O 0 1.16244458503445e-09
disease O 0 7.385558546957327e-07
is O 0 1.3441157908911094e-11
probably O 0 4.0366646136824613e-10
ubiquitous O 0 2.5927532121272634e-08
. O 0 1.124590975898343e-09

HLA O 0 6.492283137049526e-05
- O 0 4.132883077545557e-06
B27 O 0 3.682459848164399e-08
accounts O 0 2.0905853437280797e-11
for O 0 7.397520232011248e-14
a O 0 1.442539447268909e-12
minority O 0 5.409979755843786e-12
of O 0 4.458277449743021e-15
the O 0 5.585307607039458e-13
overall O 0 4.29213123376293e-11
genetic O 0 3.332639442188423e-10
susceptibility O 0 5.290353932707603e-09
to O 0 4.3586520503957615e-10
AS B-Disease 1 0.9987319111824036
. O 0 1.552414552463688e-08

Cell O 0 0.0003652081941254437
cycle O 0 0.0003646021941676736
- O 0 7.480598014808493e-06
dependent O 0 1.2923696601774282e-07
colocalization O 0 4.534768777375575e-06
of O 0 1.1307866101817332e-11
BARD1 O 0 7.2785464908520225e-06
and O 0 6.128758611723129e-11
BRCA1 O 0 4.1226139169125986e-10
proteins O 0 4.280071089213244e-12
in O 0 7.16002540731512e-15
discrete O 0 7.177626826226913e-10
nuclear O 0 5.506282832357101e-06
domains O 0 1.5746673298622227e-08
. O 0 4.660000163525524e-10

Germ O 0 0.0017848245333880186
- O 0 0.005747848190367222
line O 0 6.007840420352295e-05
mutations O 0 4.9821682779338516e-08
of O 0 3.117004267541579e-13
the O 0 5.734122811990039e-12
BRCA1 O 0 6.100810878706397e-08
gene O 0 3.5769571749000306e-09
predispose O 0 3.996052555521601e-08
women O 0 7.220650401380813e-13
to O 0 1.1116903567403441e-13
early O 0 2.833211998343188e-10
- O 0 0.07329541444778442
onset O 0 0.33961471915245056
breast B-Disease 1 0.9999793767929077
and I-Disease 1 0.9999344348907471
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999990463256836
by O 0 6.027912058392815e-10
compromising O 0 1.0371808230047463e-06
the O 0 3.5853684604569835e-11
genes O 0 1.2777297797583742e-07
presumptive O 0 0.004769469611346722
function O 0 1.7574685040600002e-09
as O 0 1.3960821214353825e-11
a O 0 4.615336238189549e-11
tumor B-Disease 0 1.846501254476607e-05
suppressor O 0 0.0005250055692158639
. O 0 1.2109514102576213e-07

Although O 0 3.7534533814387316e-10
the O 0 1.2482638620664455e-12
biochemical O 0 7.327605633378198e-09
properties O 0 1.2201197829853072e-09
of O 0 1.1747442211704207e-12
BRCA1 O 0 3.350412498548394e-07
polypeptides O 0 1.6500043997780267e-08
are O 0 2.069814805660819e-11
not O 0 5.116373470726021e-12
understood O 0 1.6366961605451813e-11
, O 0 4.044424775011095e-14
their O 0 2.618291868039524e-12
expression O 0 4.375959664071338e-11
pattern O 0 1.9404829743052687e-08
and O 0 3.252048630386639e-11
subcellular O 0 3.271425130790817e-09
localization O 0 7.443197613810071e-09
suggest O 0 3.973350294617095e-12
a O 0 1.8477705259964394e-14
role O 0 3.043731933161098e-12
in O 0 7.95431320636808e-13
cell O 0 1.937149363584467e-06
- O 0 2.678722694327007e-06
cycle O 0 3.877545168506913e-06
regulation O 0 1.6603529218173207e-08
. O 0 1.8252581390765243e-10

When O 0 3.225103029080856e-08
resting O 0 2.476780593951844e-07
cells O 0 1.4783597679368654e-09
are O 0 5.03204574363314e-13
induced O 0 5.379571454966481e-09
to O 0 7.242529492801353e-12
proliferate O 0 9.47521741068158e-08
, O 0 5.088284936623222e-13
the O 0 4.3568420355841186e-13
steady O 0 2.1572798658553438e-08
- O 0 8.10659006589276e-09
state O 0 4.696606818732629e-12
levels O 0 5.269517461270468e-13
of O 0 8.891736966480388e-17
BRCA1 O 0 4.3738235255830205e-11
increase O 0 1.0909865675798325e-14
in O 0 2.821298187747571e-15
late O 0 1.285623257157864e-11
G1 O 0 4.3769097146650893e-07
and O 0 1.951867487082204e-12
reach O 0 4.807183297261819e-13
a O 0 1.3749870924999186e-13
maximum O 0 2.671390018915698e-12
during O 0 9.283646767999088e-11
S O 0 3.5654757084557787e-06
phase O 0 4.1988923449309823e-10
. O 0 1.2981264674305493e-10

Moreover O 0 1.9886762459009333e-08
, O 0 1.2273658651917874e-11
in O 0 2.9158373307004715e-13
S O 0 3.679875959505807e-08
phase O 0 5.971877072713516e-12
cells O 0 3.071881915506225e-10
, O 0 9.982521536819333e-13
BRCA1 O 0 1.8526002065755165e-08
polypeptides O 0 9.407647105774686e-09
are O 0 6.262628870351561e-12
hyperphosphorylated O 0 2.3856793518461927e-07
and O 0 9.810872947380034e-11
accumulate O 0 1.1282612177865303e-08
into O 0 3.6092441969143296e-12
discrete O 0 7.761612863532719e-08
subnuclear O 0 0.0003633213636931032
foci O 0 5.21371875947807e-05
termed O 0 9.505301079570927e-08
" O 0 1.7223323878212682e-09
BRCA1 O 0 4.897439112028223e-07
nuclear O 0 3.5435130030236905e-06
dots O 0 6.401504833775107e-06
. O 0 3.637543377621455e-09

" O 0 8.067058274718875e-07
BRCA1 O 0 5.1659109885804355e-05
associates O 0 6.258337089093402e-05
in O 0 1.9893257180436663e-11
vivo O 0 5.675377678926452e-08
with O 0 3.9996457534829943e-11
a O 0 3.4719050551190733e-11
structurally O 0 3.8883666775291204e-07
related O 0 1.6897340471278e-10
protein O 0 6.599844226684581e-09
termed O 0 1.9256360417330143e-07
BARD1 O 0 0.0001924798561958596
. O 0 2.7393434187672483e-09

Here O 0 3.869649045640244e-09
we O 0 1.1414871652071223e-11
show O 0 5.10787115728939e-12
that O 0 2.0892108301608786e-14
the O 0 2.836769752748939e-14
steady O 0 3.57141982654241e-10
- O 0 1.5336253378350762e-09
state O 0 9.377232497442822e-12
levels O 0 1.0604435732308737e-11
of O 0 1.6400905834173043e-14
BARD1 O 0 3.737419262961339e-08
, O 0 3.939892100177263e-14
unlike O 0 1.6861762908246952e-14
those O 0 1.1711902538828582e-14
of O 0 9.468609469891979e-15
BRCA1 O 0 1.4336142939441743e-08
, O 0 5.068614365028035e-12
remain O 0 1.791832134057092e-11
relatively O 0 8.812395935588538e-14
constant O 0 1.992396699013188e-12
during O 0 4.4653985370457505e-12
cell O 0 2.8784850201191148e-06
cycle O 0 1.9908563899662113e-06
progression O 0 2.0170614334347192e-06
. O 0 2.0635884112607528e-09

However O 0 4.6197115466384275e-08
, O 0 1.1432155916368814e-10
immunostaining O 0 3.8637702459709544e-07
revealed O 0 6.007097397286998e-08
that O 0 9.330208827762476e-11
BARD1 O 0 7.155080083975918e-07
resides O 0 5.700335203862039e-10
within O 0 1.651066605754415e-14
BRCA1 O 0 5.038855999117686e-09
nuclear O 0 5.808003606944112e-07
dots O 0 1.1050260440015336e-07
during O 0 2.1972776931278304e-09
S O 0 2.0377028704388067e-06
phase O 0 3.536130416259553e-11
of O 0 4.975534212609857e-14
the O 0 2.013330908240407e-12
cell O 0 1.6682419072822086e-06
cycle O 0 1.3810310406370263e-07
, O 0 5.21093747578999e-13
but O 0 1.157797680428549e-13
not O 0 7.13494137361513e-15
during O 0 6.631318876583773e-15
the O 0 4.064136248133239e-14
G1 O 0 2.491506734259019e-07
phase O 0 2.6786070583817434e-10
. O 0 4.9892739245605e-11

Nevertheless O 0 8.589616413701151e-07
, O 0 2.553927069826045e-10
BARD1 O 0 9.757994803294423e-07
polypeptides O 0 2.0273926537583975e-08
are O 0 4.761050494822561e-12
found O 0 2.6248521585447993e-12
exclusively O 0 5.053379047680051e-13
in O 0 1.2893515194314226e-14
the O 0 4.9377182572730993e-14
nuclear O 0 4.853023538586854e-10
fractions O 0 4.1869360355075574e-14
of O 0 2.352449993091028e-15
both O 0 6.193513583940824e-13
G1 O 0 6.513706694022403e-07
- O 0 4.4998895987191645e-07
and O 0 4.929120667185316e-09
S O 0 1.6054927982622758e-06
- O 0 3.282004390481319e-10
phase O 0 1.5822397211873174e-11
cells O 0 1.7157182619076394e-10
. O 0 5.18521206874234e-12

Therefore O 0 5.405715319817261e-10
, O 0 1.7097838986637748e-12
progression O 0 3.325389741348772e-09
to O 0 9.8210628518558e-10
S O 0 4.3842268496518955e-05
phase O 0 1.0549371376455952e-09
is O 0 1.0248944921908976e-11
accompanied O 0 4.985789558986653e-12
by O 0 1.2425324297224752e-15
the O 0 5.000505590927861e-15
aggregation O 0 1.2270388871638005e-10
of O 0 2.1087688886756162e-13
nuclear O 0 1.7630333104534657e-07
BARD1 O 0 1.3261741704795327e-09
polypeptides O 0 2.0098740380336544e-12
into O 0 1.033580664631939e-12
BRCA1 O 0 2.433129395740252e-07
nuclear O 0 2.2420799723477103e-06
dots O 0 5.407957814895781e-07
. O 0 5.480505493871135e-10

This O 0 2.2082875458795392e-11
cell O 0 8.479357234136842e-07
cycle O 0 1.324139884673059e-05
- O 0 1.1212244999114773e-06
dependent O 0 1.725420872844552e-08
colocalization O 0 5.131375928613124e-07
of O 0 2.5833590908824755e-12
BARD1 O 0 8.438532859145198e-06
and O 0 1.5562788557854645e-10
BRCA1 O 0 2.86032975083117e-09
indicates O 0 3.3558496259633586e-11
a O 0 2.5324093001636086e-14
role O 0 6.419864639894968e-13
for O 0 1.0519512913748433e-13
BARD1 O 0 1.7257257240999024e-06
in O 0 6.196884585335516e-12
BRCA1 O 0 3.985993316746317e-06
- O 0 6.917555765539873e-06
mediated O 0 0.00022441164765041322
tumor B-Disease 0 0.0029254381079226732
suppression O 0 6.599556741093693e-07
. O 0 1.0728425925421448e-09

Ethnic O 0 4.840204237410717e-09
differences O 0 2.5960192218121847e-08
in O 0 6.927561280699324e-13
the O 0 3.134043588884361e-12
HFE O 0 1.038838854583446e-05
codon O 0 2.8115957562135918e-08
282 O 0 6.168865525069123e-07
( O 0 7.306054095046477e-10
Cys O 0 0.04074271023273468
/ O 0 1.687870462774299e-05
Tyr O 0 1.5079922377481125e-06
) O 0 1.1031017765894546e-10
polymorphism O 0 2.0694505664664575e-08
. O 0 1.905136048918621e-09

Recent O 0 3.845968543636502e-10
studies O 0 6.184502215900167e-11
have O 0 1.3031246220984727e-11
shown O 0 6.075552061446388e-09
that O 0 7.275342568391352e-07
hereditary B-Disease 1 0.9999998807907104
hemochromatosis I-Disease 1 1.0
( O 0 7.75184673784679e-07
HH B-Disease 1 0.9981591105461121
) O 0 2.6475732717301526e-09
is O 0 6.978746053265539e-11
likely O 0 3.61606751486665e-11
to O 0 2.5275233295207755e-12
be O 0 1.707331775957499e-10
caused O 0 2.545654520513807e-10
by O 0 2.1489582303305804e-13
homozygosity O 0 1.452218523212423e-08
for O 0 2.9633247759916145e-14
a O 0 2.4489854588694016e-11
Cys282Tyr O 0 3.2763102808530675e-07
mutation O 0 3.313997409826186e-10
in O 0 1.7837897229189964e-13
the O 0 1.7337138669137886e-12
HFE O 0 2.4061017711574095e-07
gene O 0 2.015454914072734e-09
located O 0 4.017033095049527e-10
4 O 0 1.7579981914650489e-09
. O 0 1.983334163568884e-09

5 O 0 1.8342012353400605e-08
Mb O 0 6.515280256280676e-05
telomeric O 0 2.811161357385572e-05
to O 0 5.477516218377332e-10
HLA O 0 1.1373432471373235e-06
- O 0 3.5603143260232173e-06
A O 0 5.6440075724140115e-08
. O 0 2.2069088778664536e-09

Population O 0 1.534198768027295e-09
studies O 0 5.1207010853815405e-11
of O 0 2.8045921569288743e-14
this O 0 1.8247019563724654e-13
polymorphism O 0 1.952986661279965e-10
are O 0 3.563472013670167e-14
facilitated O 0 1.3620098972266792e-12
by O 0 1.0709988668491932e-12
the O 0 5.303436726236677e-13
fact O 0 2.5905928877772988e-12
that O 0 5.81032726272579e-13
the O 0 9.156162156589986e-13
Cys282Tyr O 0 4.872682666245964e-07
mutation O 0 6.949447128867803e-10
creates O 0 9.678796653034283e-11
a O 0 1.1534061032658638e-11
Rsal O 0 1.4889248234339902e-07
restriction O 0 1.4934165015745293e-10
site O 0 5.1072648332706194e-09
. O 0 2.410636967820068e-10

We O 0 1.4306906770400474e-09
have O 0 2.514406217957177e-12
studied O 0 2.867468632331005e-13
the O 0 1.3667872714694107e-13
codon O 0 4.559332633657931e-10
282 O 0 6.514675021662697e-08
( O 0 6.787217315951111e-11
Cys O 0 0.00041380117181688547
/ O 0 9.257142323804146e-07
Tyr O 0 1.1918795905785373e-07
) O 0 1.015679988031204e-11
polymorphism O 0 2.0287174717914525e-10
in O 0 1.831587622725967e-14
different O 0 2.321282102895738e-14
ethnic O 0 3.6430144382919305e-13
groups O 0 7.095604485918283e-13
. O 0 3.023141806335339e-11

In O 0 1.9462809836001682e-11
agreement O 0 2.949855637535137e-12
with O 0 5.597166610402105e-13
previous O 0 5.922702866340002e-12
observations O 0 1.4768080855431798e-11
the O 0 2.140120112376076e-12
Tyr O 0 7.1818764268982704e-09
allele O 0 3.1544583833920115e-08
appeared O 0 6.726883050589549e-09
to O 0 5.666785400301744e-13
be O 0 2.003665679553568e-12
rare O 0 1.1826809497017532e-11
or O 0 6.373131189452153e-11
absent O 0 2.8169460097871024e-09
in O 0 1.2907118082661206e-11
Asiatic O 0 6.585567575712048e-07
( O 0 1.34570496022543e-13
Indian O 0 2.3283217801678413e-12
, O 0 7.628297407809292e-14
Chinese O 0 1.0604177414364879e-14
) O 0 1.0707020936095296e-13
populations O 0 2.5870316089013357e-13
. O 0 5.751539002007977e-12

The O 0 7.659362727396868e-11
highest O 0 5.309466755143433e-10
allele O 0 4.605289927184231e-09
frequency O 0 1.207171607120472e-07
( O 0 2.358266576810153e-12
7 O 0 6.712009420484222e-11
. O 0 7.77950186908738e-12
5 O 0 9.547952706245866e-11
% O 0 5.909215716574934e-13
) O 0 2.5863764255285027e-12
was O 0 4.293994493309583e-09
found O 0 2.2781351805001293e-10
in O 0 2.664926656084643e-12
Swedes O 0 3.2391642434959067e-06
. O 0 3.5147088017772887e-10

Saamis O 0 0.00010596921492833644
( O 0 3.7476088898813487e-10
2 O 0 2.3277613170336053e-09
% O 0 4.661773137654146e-12
) O 0 7.727416796721176e-12
and O 0 9.230254754966083e-11
Mordvinians O 0 2.344082439265094e-08
( O 0 3.058299065180508e-15
1 O 0 3.077499735083811e-14
. O 0 1.1898454769197764e-13
8 O 0 1.1248450955403388e-11
% O 0 9.212225302252311e-15
) O 0 2.475402796967268e-14
had O 0 9.095406372505721e-11
significantly O 0 2.105293587031931e-12
lower O 0 2.5447040850369584e-13
frequencies O 0 9.456013055908485e-11
of O 0 1.947945555129827e-14
the O 0 1.2066100722740725e-11
Tyr O 0 8.120025540847564e-08
allele O 0 9.452166693790787e-08
. O 0 9.026351888152817e-10

Comparisons O 0 6.027679050335522e-11
with O 0 9.688225699119868e-13
allele O 0 6.460862400636813e-11
frequencies O 0 9.62537133331054e-11
based O 0 1.6668288927920716e-12
on O 0 8.290336417360322e-09
prevalence O 0 7.445357823598897e-07
estimates O 0 2.3779986313421375e-10
of O 0 3.933176267317817e-12
HH B-Disease 1 0.7646105885505676
showed O 0 1.2917080027818884e-07
some O 0 9.552888401110834e-15
disagreements O 0 1.1562789614671942e-10
with O 0 2.544044076964458e-13
the O 0 1.4174112458829186e-13
RFLP O 0 8.518377669908261e-10
data O 0 9.319879312741364e-10
, O 0 1.0581033662096506e-12
particularly O 0 1.06551779118641e-12
in O 0 7.718250951554984e-13
Finns O 0 3.491774123176583e-07
. O 0 5.125960766960702e-10

The O 0 1.8062173978705687e-10
newly O 0 2.9025484238331956e-09
described O 0 8.28690627230344e-09
HFE O 0 1.9812875962088583e-06
marker O 0 8.546834351363941e-08
provides O 0 1.0949500719092606e-13
a O 0 8.239979878976733e-14
new O 0 3.0103063054440216e-14
approach O 0 4.588096395863328e-13
to O 0 1.0194437084591872e-14
the O 0 2.8325997248463113e-15
screening O 0 9.881023950442103e-13
of O 0 8.622027652385386e-14
HH B-Disease 0 6.208613194758072e-05
as O 0 1.192177346426293e-11
well O 0 1.172908341631751e-12
as O 0 1.1265171738147894e-12
studies O 0 1.5137216567012723e-12
of O 0 3.3712588927078957e-15
the O 0 6.704018308371917e-13
relationship O 0 1.8056008077582675e-10
between O 0 1.6634941037499407e-12
the O 0 1.7989954144426168e-12
HFE O 0 6.940114758435811e-07
Tyr O 0 6.015350439980693e-09
allele O 0 3.262018211103168e-08
and O 0 6.031868338141066e-10
different O 0 5.918203149768431e-10
disorders O 0 0.0019039841135963798
including O 0 7.366924847929113e-10
cancer B-Disease 0 0.0009304879931733012

Autosomal B-Disease 1 0.999221682548523
dominant I-Disease 1 0.998683512210846
neurohypophyseal I-Disease 1 0.9997348189353943
diabetes I-Disease 1 0.9999403953552246
insipidus I-Disease 1 0.9989336133003235
associated O 0 9.450163247493037e-07
with O 0 4.4553447736683793e-11
a O 0 3.735758230538622e-12
missense O 0 2.0231309960649924e-09
mutation O 0 4.758074836908044e-11
encoding O 0 3.328929354395882e-10
Gly23 O 0 2.9511518732761033e-05
- O 0 5.123077062307857e-05
- O 0 0.0005866056890226901
> O 0 1.1194985205520425e-07
Val O 0 2.770706851151772e-05
in O 0 4.188542013228158e-10
neurophysin O 0 3.7368579796748236e-05
II O 0 0.0002312287106178701
. O 0 2.2536319477239886e-09

Autosomal B-Disease 1 0.998759388923645
dominant I-Disease 1 0.9990027546882629
neurohypophyseal I-Disease 1 0.99972003698349
diabetes I-Disease 1 0.9999516010284424
insipidus I-Disease 1 0.9994650483131409
( O 0 1.3932782394476817e-07
ADNDI B-Disease 0 0.0036417783703655005
) O 0 2.825329303846047e-09
is O 0 1.873443622457671e-09
an O 0 1.9471515599889244e-07
inherited B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999998807907104
caused O 0 0.005307089537382126
by O 0 2.2955441991712178e-09
progressive O 0 1.2883521094408934e-06
degeneration O 0 0.012958426959812641
of O 0 8.314615489168897e-12
the O 0 8.674809481856727e-11
magnocellular O 0 1.0869438256122521e-06
neurons O 0 4.1716276655279216e-08
of O 0 7.648056450301755e-13
the O 0 7.164110277235736e-11
hypothalamus O 0 2.084921746359214e-08
leading O 0 1.538680294288497e-08
to O 0 9.963546654390143e-11
decreased O 0 3.0918572146987344e-09
ability O 0 8.603936313411609e-11
to O 0 2.4947819417947548e-12
produce O 0 6.855389086263264e-12
the O 0 5.158442076269587e-11
hormone O 0 8.075940804985748e-09
arginine O 0 2.2519646147856065e-09
vasopressin O 0 2.057029879765082e-09
( O 0 2.256164818772305e-13
AVP O 0 2.6305961853267945e-08
) O 0 2.4648059634979624e-11
. O 0 4.101678025003608e-11

Affected O 0 9.600555905819874e-09
individuals O 0 9.743713648424634e-12
are O 0 6.255056693958705e-13
not O 0 1.6707352515354934e-11
symptomatic O 0 1.188552173347901e-10
at O 0 9.418127389082542e-10
birth O 0 5.780603995475531e-09
, O 0 1.5549605006381917e-11
but O 0 4.3782830139171836e-10
usually O 0 3.6784917334387046e-09
develop O 0 5.4230905988106315e-08
diabetes B-Disease 0 0.10298974812030792
insipidus I-Disease 0 4.043832450406626e-05
at O 0 6.14843465029935e-09
1 O 0 1.130436189100692e-09
- O 0 4.5942881115479395e-05
6 O 0 1.83493114036537e-06
yr O 0 0.1436447948217392
of O 0 7.640142858644783e-12
age O 0 5.323998464312751e-10
. O 0 1.2442098740184093e-10

The O 0 2.3808172100459046e-10
genetic O 0 2.321408842931305e-08
locus O 0 6.1732707763439976e-06
of O 0 3.208784904451534e-10
the O 0 1.8970579773736063e-08
disease O 0 2.65746598415717e-06
is O 0 2.852817157852905e-12
the O 0 4.987910692116904e-12
AVP O 0 1.2786267689079978e-05
- O 0 0.010208168998360634
neurophysin O 0 0.004215652123093605
II O 0 0.00935106910765171
( O 0 2.11922124813968e-12
NPII O 0 5.8197919372560136e-08
) O 0 1.2283201528389548e-13
gene O 0 1.0178713774622317e-11
, O 0 1.9309610334306004e-12
and O 0 1.4394838619702366e-11
mutations O 0 6.320503231904695e-09
that O 0 3.782331337021105e-09
cause O 0 1.3552491573420866e-08
ADNDI B-Disease 0 3.2399362680735067e-05
have O 0 1.106670310946356e-09
been O 0 1.051586373534974e-09
found O 0 3.7781330841646366e-10
in O 0 7.94607503168572e-14
both O 0 8.231088065909636e-14
the O 0 2.4332548779690266e-13
signal O 0 1.2341519806113865e-08
peptide O 0 1.4672959028350085e-11
of O 0 3.8067225013582718e-16
the O 0 8.014421374810676e-13
prepro O 0 5.341917130863294e-07
- O 0 2.91206362135199e-07
AVP O 0 1.2030361176584847e-05
- O 0 1.325480297964532e-06
NPII O 0 1.211988205795933e-06
precursor O 0 1.1524808884999516e-10
and O 0 1.5365576866432917e-11
within O 0 4.156524503382518e-14
NPII O 0 2.671834238299198e-07
itself O 0 1.6473997721533351e-09
. O 0 1.0123307053744313e-10

An O 0 4.252335983334632e-10
affected O 0 2.8555109388150868e-09
girl O 0 5.465102503876551e-07
who O 0 1.5256566843202535e-10
presented O 0 2.964492150023257e-12
at O 0 4.937151382167215e-11
9 O 0 2.0847159068471122e-11
months O 0 4.1632593206220037e-11
of O 0 1.5972474536572745e-13
age O 0 2.1738739974797028e-10
and O 0 1.6449623607694974e-10
her O 0 5.172558914523506e-08
similarly O 0 1.973500252105964e-09
affected O 0 4.53340013098491e-12
younger O 0 4.874610715077665e-10
brother O 0 1.244029022018367e-07
and O 0 2.2065330118614668e-10
father O 0 3.779864421460388e-09
were O 0 1.107090764548846e-12
all O 0 3.4176930271181396e-15
found O 0 1.557839360982749e-12
to O 0 1.501637491652455e-13
have O 0 1.2220300726201172e-12
a O 0 6.758016455471472e-13
novel O 0 2.3334589815959816e-10
missense O 0 5.0990720978916215e-08
mutation O 0 3.0606717160708286e-09
( O 0 4.595292991071108e-14
G1758 O 0 1.3699263945454732e-10
- O 0 6.645408348049386e-07
- O 0 3.426411421969533e-05
> O 0 4.2579624270899785e-09
T O 0 2.8280588537654694e-08
) O 0 1.6139666473679714e-15
encoding O 0 2.6537635411101428e-15
the O 0 1.4184861603391374e-15
amino O 0 1.5946842641962472e-13
acid O 0 1.907312537617091e-14
substitution O 0 2.331389916461913e-14
Gly23 O 0 6.557057563583157e-09
- O 0 1.0691420726516299e-07
- O 0 2.225565594926593e-06
> O 0 3.7001579578088695e-09
Val O 0 1.743073084981006e-06
within O 0 1.1616101310008009e-11
NPII O 0 1.1916666153410915e-05
. O 0 2.0383909837828895e-10

The O 0 5.633623012535338e-10
mutation O 0 3.199559728273016e-08
was O 0 8.737704781935918e-09
confirmed O 0 4.260720248838723e-11
by O 0 3.5256594464651986e-14
restriction O 0 8.276183557920369e-12
endonuclease O 0 3.8572940752601426e-07
analysis O 0 1.5877010817177961e-09
. O 0 4.585680168922579e-10

A O 0 7.2130941219938904e-09
T1 O 0 6.864939496153966e-05
- O 0 5.145263415329282e-08
weighted O 0 3.978404827797988e-10
magnetic O 0 8.668482820439749e-09
resonance O 0 5.2349491852510255e-08
imaging O 0 1.052907350640453e-06
of O 0 1.606016535038446e-11
the O 0 6.835709775998566e-09
fathers O 0 9.364464858663268e-06
pituitary O 0 1.5200546840787865e-05
gland O 0 9.304104082730191e-07
demonstrates O 0 4.206579806709243e-10
an O 0 9.212028709293385e-12
attenuated O 0 0.009855703450739384
posterior O 0 0.13764815032482147
pituitary O 0 0.09562090784311295
bright O 0 2.067998593702214e-06
spot O 0 2.429083178867586e-05
. O 0 1.989882747466254e-08

This O 0 6.017791265300332e-10
mutation O 0 2.4315164992572136e-08
may O 0 2.5858956642643705e-10
be O 0 1.7218640335298291e-15
valuable O 0 2.6204459236463685e-15
for O 0 1.02629105927732e-15
developing O 0 9.861141851003064e-13
models O 0 3.5583765101154796e-11
of O 0 4.119292580651024e-12
dominantly B-Disease 0 0.0006494610570371151
inherited I-Disease 1 0.9998875856399536
neurodegeneration I-Disease 1 0.9999994039535522
, O 0 1.557089457371319e-10
as O 0 1.4928844564634364e-13
the O 0 2.577166724384433e-13
early O 0 1.9370704693044694e-11
age O 0 1.5882144557832767e-11
of O 0 7.344672152366158e-14
onset O 0 6.663976037657449e-09
of O 0 9.245720508643807e-12
symptoms O 0 4.445519508067264e-09
suggests O 0 1.3265845670226706e-12
that O 0 4.99172480693949e-13
this O 0 4.710177560485196e-13
mutation O 0 1.7854340228495857e-09
may O 0 1.101561286631636e-09
be O 0 2.4054870942369355e-11
particularly O 0 1.1017150733372283e-12
deleterious O 0 1.6537834990337785e-10
to O 0 5.757355963503796e-12
the O 0 7.927130306339958e-12
magnocellular O 0 2.313552300847732e-07
neuron O 0 5.79188565552613e-07
. O 0 2.833855095030202e-10
. O 0 3.6255445867716674e-10

Frequent O 0 9.791926913749194e-07
inactivation O 0 4.5173128455644473e-05
of O 0 2.5360635813598265e-10
PTEN O 0 0.00015642293146811426
/ O 0 2.7679810955305584e-05
MMAC1 O 0 0.0008047650917433202
in O 0 4.632706662732744e-09
primary O 0 0.0002934609947260469
prostate B-Disease 1 0.999985933303833
cancer I-Disease 1 0.9999769926071167
. O 0 1.6956330455286661e-06

Sporadic B-Disease 0 0.3556469976902008
prostate I-Disease 1 0.9998859167098999
carcinoma I-Disease 1 0.9999972581863403
is O 0 1.1150195859954692e-06
the O 0 3.925385849701257e-10
most O 0 5.418287485348117e-10
common O 0 5.5515897656732704e-08
male B-Disease 0 6.033174599906488e-07
cancer I-Disease 0 4.363023720088677e-07
in O 0 3.7238779768133945e-12
the O 0 3.065547121705592e-11
Western O 0 3.0228164416001846e-09
world O 0 2.593000658634992e-08
, O 0 2.589654185536361e-12
yet O 0 1.3811540886671247e-12
many O 0 9.108750910382778e-16
of O 0 1.9493781684232979e-16
the O 0 4.428464092285332e-14
major O 0 1.9354879027613792e-13
genetic O 0 1.1056484894300667e-10
events O 0 3.0062638576439094e-12
involved O 0 4.1739092108798725e-13
in O 0 4.245203431949181e-14
the O 0 1.7246341074000915e-12
progression O 0 2.1106250969182838e-08
of O 0 5.630843014081677e-13
this O 0 8.198639545042852e-10
often O 0 1.20291570055997e-05
fatal O 0 0.03513248637318611
cancer B-Disease 0 7.910808199085295e-05
remain O 0 7.625621800677607e-10
to O 0 1.5965720499139247e-12
be O 0 7.92051493836432e-11
elucidated O 0 5.532622708415147e-06
. O 0 2.7874642594127863e-09

Numerous O 0 2.2139494681994165e-09
cytogenetic O 0 3.2162017305381596e-05
and O 0 3.4600304843479535e-08
allelotype O 0 7.041859589662636e-06
studies O 0 2.1161343788378417e-09
have O 0 4.1791233668098116e-11
reported O 0 2.355869499481855e-09
frequent O 0 6.867610036209726e-09
loss O 0 3.808277426742279e-08
of O 0 3.5115741694666247e-13
heterozygosity O 0 2.839648232111358e-07
on O 0 4.0586334648651246e-07
chromosomal O 1 0.9722193479537964
arm O 1 0.6769317388534546
10q O 0 3.388988147889904e-07
in O 0 6.050220741071755e-11
sporadic B-Disease 0 4.274522507330403e-05
prostate I-Disease 1 0.9999971389770508
cancer I-Disease 1 0.9999889135360718
. O 0 1.5560391375402105e-06

Deletion O 0 2.6181627617916092e-05
mapping O 0 9.204278285324108e-06
studies O 0 7.253561307152268e-08
have O 0 4.6456410940365345e-10
unambiguously O 0 7.005535280768527e-07
identified O 0 1.0598906197145652e-09
a O 0 4.0068382639590894e-11
region O 0 1.1218717621552798e-10
of O 0 5.131920821459246e-13
chromosome O 0 9.873717317532282e-06
10q23 O 0 1.1833319879528403e-09
to O 0 4.742724008660604e-12
be O 0 3.845590946377486e-12
the O 0 3.3304609070583524e-13
minimal O 0 3.025120431932038e-11
area O 0 4.6775135847942906e-11
of O 0 2.7537730776239222e-11
loss O 0 3.4939503166242503e-06
. O 0 8.223039471566551e-10

A O 0 2.217684369476558e-10
new O 0 6.788871114576933e-12
tumor B-Disease 0 7.2302013265357346e-09
suppressor O 0 6.734177304679179e-08
gene O 0 2.7488599840808092e-08
, O 0 7.817453906433514e-10
PTEN O 0 2.082810715364758e-05
/ O 0 2.11078513530083e-05
MMAC1 O 0 0.00106760673224926
, O 0 5.691371818272728e-10
was O 0 8.314723132230029e-09
isolated O 0 4.4953147870785415e-09
recently O 0 3.9882834812488e-09
at O 0 3.5274289045261753e-10
this O 0 2.0479901411893375e-13
region O 0 3.1320655704408784e-12
of O 0 5.758473667523412e-13
chromosome O 0 3.548041058820672e-05
10q23 O 0 1.777131330982229e-08
and O 0 4.276142218095913e-10
found O 0 5.465123579379005e-12
to O 0 1.4411052646351452e-14
be O 0 8.266231801704396e-15
inactivated O 0 5.815241951173666e-12
by O 0 5.258306844688285e-15
mutation O 0 4.943181627914406e-11
in O 0 2.166050498686456e-11
three O 0 2.231914322692319e-06
prostate B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999970197677612
cell O 0 0.012484713457524776
lines O 0 6.135965122666676e-06
. O 0 3.700851536336813e-08

We O 0 7.866757911756395e-09
screened O 0 8.443474541763862e-08
80 O 0 6.018483045266976e-09
prostate B-Disease 0 0.42783623933792114
tumors I-Disease 1 0.9999979734420776
by O 0 1.5800820651890035e-09
microsatellite O 0 9.052935638464987e-05
analysis O 0 7.0113350680856e-09
and O 0 2.05595496183264e-09
found O 0 1.4429351047340333e-09
chromosome O 0 6.850506224509445e-07
10q23 O 0 5.057108620754036e-10
to O 0 2.6992626883659554e-12
be O 0 2.435638062764367e-12
deleted O 0 1.0430685204454448e-09
in O 0 6.749463184532734e-13
23 O 0 3.451127578157909e-11
cases O 0 1.1915612593837999e-11
. O 0 1.2182657660453344e-10

We O 0 1.085426748481666e-09
then O 0 1.8589900452337105e-11
proceeded O 0 4.175687573493292e-12
with O 0 2.1606251943834254e-14
sequence O 0 1.998417707357869e-12
analysis O 0 2.3754747626413e-13
of O 0 6.566145408764949e-16
the O 0 8.064528862414266e-14
entire O 0 5.722511006722719e-11
PTEN O 0 1.6169971104318392e-06
/ O 0 2.217200290033361e-08
MMAC1 O 0 1.439164293515205e-06
coding O 0 3.300164462416433e-05
region O 0 1.8711330262988213e-09
and O 0 3.000204945591278e-11
tested O 0 1.0464595856518599e-10
for O 0 1.512380397816987e-15
homozygous O 0 4.156596455917594e-10
deletion O 0 2.7966506888077447e-09
with O 0 1.2623669470857024e-11
new O 0 2.550738509299322e-10
intragenic O 0 1.154608980868943e-05
markers O 0 3.0364433314389316e-06
in O 0 1.1298309293347741e-12
these O 0 9.360229063191949e-14
23 O 0 1.1421138557468624e-12
cases O 0 3.9915862498976495e-13
with O 0 1.616138473048423e-11
10q23 O 0 1.3016713751312636e-07
loss O 0 1.035753953715357e-07
of O 0 1.969767014428636e-12
heterozygosity O 0 2.6187872208538465e-06
. O 0 2.7122100121346193e-09

The O 0 1.2690389104147437e-12
identification O 0 5.147019529333496e-12
of O 0 4.951742751187378e-14
the O 0 3.609973648135978e-12
second O 0 7.783180322462613e-09
mutational O 0 8.205082622225746e-07
event O 0 5.161262084385498e-09
in O 0 1.0738338386898083e-12
10 O 0 1.2414263193816222e-11
( O 0 2.311116860495739e-14
43 O 0 3.8972661903224903e-11
% O 0 2.614888123739223e-12
) O 0 3.4814173766051226e-09
tumors B-Disease 1 0.9999963045120239
establishes O 0 6.709215085720643e-07
PTEN O 0 0.00026170455384999514
/ O 0 2.77633205314487e-07
MMAC1 O 0 7.480473982468538e-07
as O 0 1.4700991075519698e-12
a O 0 1.188724818449241e-13
main O 0 6.553162873457197e-11
inactivation O 0 5.105280820316693e-07
target O 0 2.134037613288342e-09
of O 0 1.641026995281153e-13
10q O 0 2.0651409471383886e-08
loss O 0 3.9192329381876334e-08
in O 0 9.231130616849104e-12
sporadic B-Disease 0 0.00019685983716044575
prostate I-Disease 1 0.9999986886978149
cancer I-Disease 1 0.9999947547912598
. O 0 1.3034049395344027e-08
. O 0 2.336256965662642e-09

Risk O 0 8.329042202603887e-07
reversals O 0 3.2908207714399396e-08
in O 0 3.990551107873469e-13
predictive O 0 4.84506046394273e-10
testing O 0 2.4897943706747583e-09
for O 0 2.375234675611182e-09
Huntington B-Disease 1 0.9999797344207764
disease I-Disease 1 0.9999847412109375
. O 0 7.737342144764625e-08

The O 0 1.3582586661300966e-12
first O 0 1.037020621284801e-12
predictive O 0 2.841253621266304e-10
testing O 0 3.837661299854744e-09
for O 0 2.075553950930953e-08
Huntington B-Disease 1 0.9999984502792358
disease I-Disease 1 0.9999985694885254
( O 0 2.128749433671917e-12
HD B-Disease 0 3.095774445682764e-05
) O 0 3.0828578578834254e-10
was O 0 1.5772095851573908e-09
based O 0 8.488808343320303e-14
on O 0 2.162629381130543e-10
analysis O 0 1.335063309904072e-11
of O 0 2.4333372773341355e-14
linked O 0 1.1938562138880116e-08
polymorphic O 0 5.10837261380459e-10
DNA O 0 7.312474537002345e-08
markers O 0 2.1124500904079468e-07
to O 0 4.94361279343436e-12
estimate O 0 5.162179711470927e-12
the O 0 1.1623920142395106e-12
likelihood O 0 2.66500935902636e-11
of O 0 7.8520028749373e-14
inheriting O 0 2.947143862286339e-09
the O 0 2.5864591501542633e-13
mutation O 0 4.339055590524277e-12
for O 0 1.3804343952650289e-13
HD B-Disease 0 0.00026304915081709623
. O 0 1.9615599811118045e-08

Limits O 0 2.6738905534173796e-10
to O 0 3.709975469196047e-12
accuracy O 0 7.371113164289511e-10
included O 0 2.5699740255282107e-14
recombination O 0 6.667707358465336e-11
between O 0 6.838855436813729e-12
the O 0 6.711029843821381e-13
DNA O 0 2.4468322479265225e-08
markers O 0 7.002582833592896e-07
and O 0 3.5591096042564274e-11
the O 0 9.888640470703813e-13
mutation O 0 2.7614446285184613e-09
, O 0 2.236933277499631e-10
pedigree O 0 1.455695496588305e-06
structure O 0 5.566651029020875e-10
, O 0 3.93686168734253e-12
and O 0 5.706015629609873e-13
whether O 0 8.350796860652834e-14
DNA O 0 1.5507150008531312e-09
samples O 0 2.6152996435158116e-10
were O 0 2.7365243317895027e-12
available O 0 1.3708915187933546e-13
from O 0 5.005565596348169e-14
family O 0 4.945530096556183e-11
members O 0 1.1552763682764339e-13
. O 0 4.698443890893689e-12

With O 0 1.5946920867149217e-11
direct O 0 1.072170022035912e-12
tests O 0 1.0057328234114316e-11
for O 0 1.1211180917883334e-15
the O 0 1.307509364721713e-14
HD B-Disease 0 6.608512421735213e-07
mutation O 0 9.553933200123765e-10
, O 0 1.956534110073016e-12
we O 0 1.1469820319215396e-12
have O 0 1.642732987399559e-14
assessed O 0 3.8036509163695553e-13
the O 0 2.4242034161320314e-13
accuracy O 0 1.1137905886471344e-07
of O 0 1.197861363051722e-12
results O 0 1.4164830766660863e-11
obtained O 0 2.2607050508948595e-13
by O 0 3.0616255753226126e-15
linkage O 0 4.60602320173642e-11
approaches O 0 6.465494372526193e-12
when O 0 7.1426176605216e-12
requested O 0 7.092759810468224e-14
to O 0 1.6945572549331711e-12
do O 0 1.9059944594834732e-12
so O 0 9.788204318253446e-14
by O 0 9.237703206272773e-15
the O 0 5.71771579735425e-13
test O 0 4.778978324182503e-10
individuals O 0 2.8187930031027715e-14
. O 0 2.4004992871945463e-12

For O 0 3.8750072595128415e-11
six O 0 2.6956830864732773e-11
such O 0 2.1016244368160693e-14
individuals O 0 3.364772653211001e-14
, O 0 4.610200093316426e-14
there O 0 2.125157044969867e-14
was O 0 7.832898218929074e-11
significant O 0 1.323134581499713e-13
disparity O 0 8.61118901879232e-12
between O 0 1.0930246508236707e-12
the O 0 3.037997631238909e-11
tests O 0 1.343700084532884e-08
. O 0 1.391254819682608e-11

Three O 0 1.6262090341001567e-08
went O 0 4.5497468903477056e-08
from O 0 4.4605782283969886e-13
a O 0 5.0817110935907905e-12
decreased O 0 1.3553622668638354e-09
risk O 0 3.0485208107888795e-11
to O 0 2.1979985919459016e-13
an O 0 3.8917285193063034e-13
increased O 0 1.6511926548279376e-10
risk O 0 4.094865779791235e-09
, O 0 2.5968855971864047e-12
while O 0 9.534626560503412e-12
in O 0 1.881682506479302e-14
another O 0 4.675368165535376e-13
three O 0 6.969165695924762e-12
the O 0 3.7125486018751985e-10
risk O 0 2.416910227509561e-08
was O 0 3.362222855685104e-08
decreased O 0 2.3220807499058083e-09
. O 0 1.5213415249792916e-10

Knowledge O 0 4.173565382181721e-10
of O 0 2.8740391685468103e-13
the O 0 1.8235990517125045e-13
potential O 0 2.7003117623880524e-13
reasons O 0 3.3915378779047003e-14
for O 0 1.0820907443411261e-16
these O 0 9.599317665081632e-15
changes O 0 7.388411578509654e-14
in O 0 2.385599855679599e-13
results O 0 5.7506423234432447e-11
and O 0 1.7709914090779932e-10
impact O 0 1.0973528943164501e-12
of O 0 2.5358943325217917e-14
these O 0 6.312951463666172e-12
risk O 0 6.791529838512389e-11
reversals O 0 2.1160939667197454e-09
on O 0 1.1020908630143822e-09
both O 0 2.0284959476035702e-11
patients O 0 6.4314734093962045e-12
and O 0 6.372735997760282e-13
the O 0 2.615625272796296e-13
counseling O 0 4.76837735963187e-11
team O 0 1.476717402873473e-12
can O 0 1.9611801061174966e-14
assist O 0 7.90064628303222e-14
in O 0 2.4311614190992287e-14
the O 0 1.121401487836661e-13
development O 0 1.7554095028564148e-15
of O 0 1.5870051651403934e-16
strategies O 0 3.8833790783759925e-13
for O 0 2.268783572572156e-16
the O 0 2.1342155541209835e-14
prevention O 0 7.145632696659021e-11
and O 0 1.927318114131049e-12
, O 0 1.1880957397848095e-15
where O 0 5.1034518577547806e-15
necessary O 0 4.8701030052255775e-14
, O 0 5.1590249270944827e-14
management O 0 5.544591478653937e-13
of O 0 4.562589557197388e-16
a O 0 6.89571490186669e-12
risk O 0 9.251616833738652e-11
reversal O 0 1.011340143575179e-11
in O 0 2.77915692219313e-16
any O 0 8.835916304116248e-16
predictive O 0 7.275648399723833e-12
testing O 0 1.6377985773141646e-11
program O 0 3.596203543287935e-11
. O 0 1.9605976185003288e-13
. O 0 3.5814365795944214e-12

A O 0 2.23634555318597e-09
novel O 0 3.8563408022440626e-10
common O 0 1.1474098754460371e-10
missense O 0 1.3376166840828319e-08
mutation O 0 3.3805800381259132e-09
G301C O 0 2.011050659334046e-09
in O 0 1.4732345118145806e-12
the O 0 1.7803382032499648e-11
N O 0 5.119525667396374e-06
- O 0 4.0794670894683804e-06
acetylgalactosamine O 0 6.798126560170203e-05
- O 0 3.7717651935054164e-07
6 O 0 7.642938726348802e-09
- O 0 1.3071111482076958e-07
sulfate O 0 6.899188065290218e-08
sulfatase O 0 2.651931296782095e-08
gene O 0 1.150219586243395e-09
in O 0 1.136470952067814e-11
mucopolysaccharidosis B-Disease 0 5.9070216593681835e-06
IVA I-Disease 0 0.0003433592210058123
. O 0 5.616363374372213e-09

Mucopolysaccharidosis B-Disease 0 0.07225321978330612
IVA I-Disease 1 0.9872139692306519
( O 0 4.3081745388917625e-06
MPS B-Disease 1 0.9999533891677856
IVA I-Disease 1 0.9999878406524658
) O 0 1.790368173715251e-06
is O 0 2.7686590797770805e-09
an O 0 3.0544549112221375e-09
autosomal B-Disease 1 0.9999485015869141
recessive I-Disease 1 0.9999896287918091
lysosomal I-Disease 1 0.9999892711639404
storage I-Disease 1 0.9999749660491943
disorder I-Disease 1 0.9999886751174927
caused O 0 1.0609044238663046e-06
by O 0 7.1074738976217855e-12
a O 0 1.642036195903529e-08
genetic B-Disease 1 0.9999979734420776
defect I-Disease 1 0.9999980926513672
in O 0 2.013453181959335e-09
N O 0 1.0692929208744317e-05
- O 0 2.136847615474835e-05
acetylgalactosamine O 0 0.009852037765085697
- O 0 4.717828051070683e-05
6 O 0 7.182248396020441e-07
- O 0 0.0001784214546205476
sulfate O 0 0.00011675868154270574
sulfatase O 0 4.945064938510768e-05
( O 0 6.135199553253257e-12
GALNS O 0 3.096834575444518e-07
) O 0 7.708398155892304e-12
. O 0 1.1733026009097536e-11

In O 0 4.005510922944211e-10
previous O 0 2.687743583251745e-09
studies O 0 1.414329348081722e-10
, O 0 1.8164765481706868e-12
we O 0 5.207800336803903e-12
have O 0 3.2929534750023026e-13
found O 0 1.0001464717177e-12
two O 0 1.0878334908218101e-12
common O 0 3.804683564728739e-12
mutations O 0 2.3374457924774106e-10
in O 0 4.117570271289922e-13
Caucasians O 0 1.194547516458755e-10
and O 0 9.69494016317407e-12
Japanese O 0 2.732636339430883e-10
, O 0 4.941385842172075e-13
respectively O 0 1.1005185478196733e-11
. O 0 3.224661510037308e-11

To O 0 2.14839188106275e-10
characterize O 0 2.1994077670228762e-09
the O 0 8.782034995047372e-12
mutational O 0 2.628019331041287e-07
spectrum O 0 3.4819087613158217e-09
in O 0 1.556121327443965e-14
various O 0 1.1198144022033906e-15
ethnic O 0 3.759629258848034e-14
groups O 0 5.198456343668244e-14
, O 0 7.98685797403012e-14
mutations O 0 3.279716775939079e-12
in O 0 1.092002583600064e-14
the O 0 6.65397966760628e-13
GALNS O 0 2.6582057444102247e-08
gene O 0 2.2167837010478308e-10
in O 0 3.801760121990849e-12
Colombian O 0 2.0342001789686037e-06
MPS B-Disease 1 0.9999969005584717
IVA I-Disease 1 0.9999988079071045
patients O 0 4.596349967300739e-08
were O 0 2.2655375839231162e-11
investigated O 0 1.5945719189502938e-09
, O 0 1.7642342448054293e-11
and O 0 1.0314665788158095e-10
genetic O 0 8.344511748248351e-09
backgrounds O 0 3.602906029076536e-10
were O 0 1.2466536483679569e-11
extensively O 0 4.532815095492637e-11
analyzed O 0 1.5143190035260545e-09
to O 0 1.5577688444734505e-11
identify O 0 7.70007335670897e-10
racial O 0 7.320794664922303e-11
origin O 0 2.9848738064552904e-11
, O 0 2.3357308925539555e-13
based O 0 1.3139351260661736e-13
on O 0 4.941377085287968e-09
mitochondrial O 0 2.5852134513115743e-06
DNA O 0 4.810479367733933e-06
( O 0 1.313893221652207e-12
mtDNA O 0 3.7059760815694176e-10
) O 0 1.3384517452696976e-11
lineages O 0 1.589118947542545e-09
. O 0 6.711782241097808e-10

Three O 0 7.07862746196497e-09
novel O 0 8.064829870590984e-08
missense O 0 4.139032171224244e-06
mutations O 0 6.647083409916377e-06
never O 0 1.1053797379645403e-06
identified O 0 1.6402418312466693e-09
previously O 0 6.7022933869509416e-09
in O 0 7.476733533511026e-13
other O 0 7.91054634990962e-12
populations O 0 2.638437246460512e-10
and O 0 3.102017087641684e-09
found O 0 4.33025659773989e-09
in O 0 6.771551635392781e-13
16 O 0 1.7455328632162703e-12
out O 0 3.393547162028332e-12
of O 0 4.091800174783975e-15
19 O 0 1.9516674734654238e-11
Colombian O 0 6.095169879927198e-08
MPS B-Disease 1 0.9999345541000366
IVA I-Disease 1 0.999982476234436
unrelated O 0 3.739693710258507e-08
alleles O 0 1.2995169385021654e-09
account O 0 5.4970437923795856e-11
for O 0 8.797537893491525e-13
84 O 0 1.901578228213907e-09
. O 0 1.283916639671645e-09

2 O 0 2.9702835036005126e-07
% O 0 2.6006094847041972e-11
of O 0 2.958016589917761e-14
the O 0 7.446760764452665e-13
alleles O 0 3.224427669312746e-11
in O 0 5.212557815936769e-13
this O 0 4.2428422429054147e-13
study O 0 2.329752059673784e-12
. O 0 6.816303771417509e-11

The O 0 5.182507756273935e-10
G301C O 0 6.542194341818686e-08
and O 0 7.283958436410387e-10
S162F O 0 1.1479796002689113e-09
mutations O 0 1.1248526554652472e-09
account O 0 1.3836808435141457e-11
for O 0 1.8112514797458817e-13
68 O 0 5.148146353661787e-09
. O 0 4.0748168728121925e-10

4 O 0 3.0265249506555847e-07
% O 0 1.6570167460372431e-10
and O 0 7.789513478684285e-11
10 O 0 5.04414947311016e-11
. O 0 1.2105016988783746e-10

5 O 0 6.960052445492693e-08
% O 0 3.1826340174401224e-11
of O 0 1.3828509463822275e-13
mutations O 0 1.6967267590928259e-09
, O 0 2.204226731694625e-11
respectively O 0 1.4709447548888477e-10
, O 0 2.7091660078498725e-12
whereas O 0 4.750980858725384e-12
the O 0 1.0408693872088204e-11
remaining O 0 2.203339022344153e-08
F69V O 0 5.221554602030665e-06
is O 0 6.496580075114611e-13
limited O 0 2.0281085838513846e-15
to O 0 1.888741170841951e-14
a O 0 1.5748495986022543e-13
single O 0 4.2517439569067506e-10
allele O 0 1.992641955439467e-06
. O 0 3.1524236554503204e-09

The O 0 2.9168545356839104e-10
skewed O 0 4.047685919772448e-08
prevalence O 0 2.8308438686508453e-06
of O 0 7.40499187575766e-13
G301C O 0 1.966975471390242e-10
in O 0 5.5523565346132786e-14
only O 0 7.050945520807247e-14
Colombian O 0 2.14214784799438e-10
patients O 0 4.393620883780258e-12
and O 0 7.927883067908315e-13
haplotype O 0 3.833812822762184e-09
analysis O 0 3.869936597740431e-13
by O 0 6.171785715006423e-15
restriction O 0 5.161579497148239e-12
fragment O 0 4.1672354456068206e-09
length O 0 8.984424315627848e-10
polymorphisms O 0 6.5815162209048594e-09
in O 0 3.1077330379242207e-12
the O 0 9.24251127021325e-12
GALNS O 0 1.5390140788440476e-06
gene O 0 2.471559179539895e-09
suggest O 0 2.0198256955872296e-10
that O 0 1.3291559693151545e-11
G301C O 0 8.077784552362743e-10
originated O 0 1.4336401510384178e-10
from O 0 4.4517534325766786e-14
a O 0 2.298159492569729e-13
common O 0 1.6903681579472085e-11
ancestor O 0 8.891229974494763e-09
. O 0 5.310655026846689e-09

Investigation O 0 7.626435594154657e-10
of O 0 1.170896604500704e-12
the O 0 7.492980303065722e-13
genetic O 0 2.826486544815765e-10
background O 0 3.669917147952617e-11
by O 0 1.367415566628366e-13
means O 0 5.774971429881037e-13
of O 0 1.682834745847777e-14
mtDNA O 0 6.394955121002965e-10
lineages O 0 3.6518152946030114e-09
indicate O 0 3.0432023567783517e-09
that O 0 3.113038299362714e-11
all O 0 2.721663172611244e-12
our O 0 2.6046675927204888e-09
patients O 0 1.4475758265686256e-11
are O 0 2.3659053232163996e-14
probably O 0 9.499410806579345e-12
of O 0 1.1229762914921962e-14
native O 0 1.3314623709126394e-11
American O 0 2.3929795034405288e-08
descent O 0 0.0016019066097214818

Low O 0 3.8605762142651656e-08
frequency O 0 1.8732766449147675e-08
of O 0 1.9988025991291014e-12
BRCA1 O 0 3.9645092897444556e-07
germline O 0 2.4162970291286e-08
mutations O 0 1.7295104726144928e-07
in O 0 2.6619015325302087e-10
45 O 0 2.8272713947785633e-08
German O 1 0.9990193843841553
breast B-Disease 1 0.9999872446060181
/ I-Disease 1 0.9999918937683105
ovarian I-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999953508377075
families O 0 9.109426741815696e-07
. O 0 2.0723804894373643e-09

In O 0 3.517134847252912e-11
this O 0 2.0222549763221354e-13
study O 0 5.0250415943109764e-14
we O 0 4.627548886616817e-13
investigated O 0 7.346617064696304e-11
45 O 0 3.229242429014789e-10
German O 0 0.16670109331607819
breast B-Disease 1 0.999954104423523
/ I-Disease 1 0.9999898672103882
ovarian I-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999977350234985
families O 0 1.0668759209409018e-09
for O 0 1.5929606537925384e-13
germline O 0 2.060249526536495e-09
mutations O 0 6.323698453769566e-09
in O 0 6.973829608410143e-13
the O 0 3.832586158158957e-12
BRCA1 O 0 7.690993584219541e-07
gene O 0 1.1257052392465994e-06
. O 0 7.834552917529436e-08

We O 0 6.929038454117631e-10
identified O 0 7.981083155472746e-11
four O 0 1.7841046348610057e-11
germline O 0 3.815240567917044e-09
mutations O 0 2.779065653157886e-07
in O 0 1.570616414703352e-10
three O 0 5.664854541009845e-08
breast B-Disease 0 0.0651271715760231
cancer I-Disease 0 0.00036128266947343946
families O 0 2.5924934421439616e-10
and O 0 1.8184499045448277e-11
in O 0 1.0785946788494094e-11
one O 0 1.2375919141049962e-05
breast B-Disease 1 0.9999972581863403
- I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
family O 0 7.699764864810277e-06
. O 0 1.913370286862892e-12
among O 0 1.0201595360029118e-14
these O 0 1.1200798623290601e-14
were O 0 2.1649589673072844e-12
one O 0 3.2922095605236734e-11
frameshift O 0 4.378663334136945e-07
mutation O 0 1.3674027465881977e-09
, O 0 1.856938214306325e-11
one O 0 3.6105493594895677e-10
nonsense O 0 3.2446735076518962e-06
mutation O 0 1.4758727573394026e-08
, O 0 3.829365644025806e-11
one O 0 2.627357879869674e-11
novel O 0 3.619008981381455e-10
splice O 0 0.001957354135811329
site O 0 3.1738138204673305e-05
mutation O 0 1.8490106867830036e-07
, O 0 2.589813606623803e-11
and O 0 3.403700238324703e-11
one O 0 1.0162889974019151e-10
missense O 0 4.6517993723682594e-07
mutation O 0 1.5854375590151903e-07
. O 0 1.0984398279845209e-08

The O 0 1.0110982051614315e-09
missense O 0 7.741814442852046e-07
mutation O 0 3.9711770227768284e-07
was O 0 1.7579507129994454e-06
also O 0 5.875220310258555e-09
found O 0 2.550300526316107e-10
in O 0 2.7807639003951667e-12
2 O 0 1.5388820218120713e-09
. O 0 4.49203840791057e-10

8 O 0 2.2754586836981616e-07
% O 0 2.50665998374755e-11
of O 0 9.560653152138315e-15
the O 0 1.8583287578026464e-13
general O 0 1.8263976485702327e-13
population O 0 2.98665877185994e-13
, O 0 8.262788240079311e-13
suggesting O 0 6.703846505695665e-11
that O 0 1.6605564145955043e-11
it O 0 5.334855335270561e-10
is O 0 1.8209567187454923e-10
not O 0 2.8275342067729525e-09
disease O 0 9.184676486029275e-08
associated O 0 7.156438774913454e-10
. O 0 5.177044348769755e-10

The O 0 2.4154467315185e-10
average O 0 2.2731677873366607e-08
age O 0 8.718039623545337e-10
of O 0 4.133130296346543e-11
disease O 0 2.2075928427511826e-05
onset O 0 2.2442482361384464e-07
in O 0 3.274605586689461e-11
those O 0 2.4451596303265433e-10
families O 0 3.6201392578094627e-11
harbouring O 0 3.3025846732925856e-06
causative O 0 1.3067135284927645e-07
mutations O 0 2.611619436265755e-07
was O 0 2.9426470860016707e-07
between O 0 4.33987096259969e-10
32 O 0 5.026051574930079e-09
. O 0 4.369833384032518e-09

3 O 0 5.0338055501697454e-08
and O 0 8.130385809046459e-10
37 O 0 1.08126108067097e-09
. O 0 2.999016313065539e-10

4 O 0 4.876596548797352e-08
years O 0 2.868519199950015e-09
, O 0 4.148149271993029e-12
whereas O 0 2.905235730807365e-12
the O 0 1.0822147214831213e-12
family O 0 2.3456110387343188e-09
harbouring O 0 1.9866536149493186e-06
the O 0 1.7819620778958267e-11
missense O 0 1.4054299057875141e-08
mutation O 0 2.6720767820620495e-09
had O 0 7.384739042493038e-09
an O 0 4.033258969859954e-12
average O 0 8.787963245993069e-09
age O 0 1.2017604689162908e-09
of O 0 4.966371064396569e-12
onset O 0 9.637104625426218e-08
of O 0 1.003320603681912e-11
51 O 0 7.231376741856366e-08
. O 0 3.6270129122328854e-09

2 O 0 1.1734514515637784e-07
years O 0 6.1745129009693756e-09
. O 0 3.3288274914333726e-10

These O 0 1.9396891037803954e-10
findings O 0 7.837890059203545e-11
show O 0 1.673840399618598e-09
that O 0 1.1765745495939672e-11
BRCA1 O 0 5.056621787957738e-08
is O 0 7.693008036158133e-11
implicated O 0 5.846067185899528e-09
in O 0 2.357046849366107e-13
a O 0 7.234131913294584e-13
small O 0 3.7044792147028494e-13
fraction O 0 4.4326542436579075e-11
of O 0 4.3422740958476425e-09
breast B-Disease 1 0.9999895095825195
/ I-Disease 1 0.9999973773956299
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999996423721313
families O 0 6.645269223781725e-08
suggesting O 0 8.549385088763017e-10
the O 0 1.4467573460855837e-13
involvement O 0 1.434848507370079e-11
of O 0 6.0944549103506e-14
another O 0 1.3563331881238927e-11
susceptibility O 0 1.6310487183091027e-08
gene O 0 5.442955171020003e-07
( O 0 7.210064212337386e-10
s O 0 7.923522207420319e-05
) O 0 2.152274092281914e-08

Paternal O 0 0.034237075597047806
transmission O 1 0.9412932991981506
of O 0 3.464141991571523e-05
congenital B-Disease 1 0.9999457597732544
myotonic I-Disease 1 0.9999604225158691
dystrophy I-Disease 1 0.9998918771743774
. O 0 4.995937160856556e-06

We O 0 2.210714100669975e-08
report O 0 1.4877779563882143e-11
a O 0 1.340438041596767e-13
rare O 0 9.493357705850358e-13
case O 0 3.4008434089682904e-12
of O 0 1.196247701590325e-11
paternally O 1 0.9883989095687866
transmitted O 1 0.9999697208404541
congenital B-Disease 1 0.999996542930603
myotonic I-Disease 1 0.9999973773956299
dystrophy I-Disease 1 0.9999951124191284
( O 0 4.121818619751139e-06
DM B-Disease 1 0.9999788999557495
) O 0 5.492203740686818e-07
. O 0 5.440036865422826e-09

The O 0 1.8253355493769163e-09
proband O 0 5.853852599102538e-06
is O 0 2.381179108057463e-11
a O 0 5.187227058479904e-13
23 O 0 1.6331755392506864e-11
year O 0 1.0201746565574599e-11
old O 0 3.9290083009291266e-07
, O 0 2.5242992141016884e-09
mentally B-Disease 1 0.9999949932098389
retarded I-Disease 1 0.9999947547912598
male O 0 5.7568642660044134e-05
who O 0 8.424069528700784e-05
suffers O 1 0.9953108429908752
severe O 0 0.01971764676272869
muscular B-Disease 0 0.05032495781779289
weakness I-Disease 0 0.0035481383092701435
. O 0 1.9008684404298037e-08

He O 0 5.4732609555685485e-08
presented O 0 3.358382016926953e-09
with O 0 7.418281100513013e-09
respiratory O 0 0.0028905400540679693
and O 0 1.1633080276851615e-08
feeding O 0 3.6430208183446666e-06
difficulties O 0 3.515684809940467e-08
at O 0 8.89977702644984e-10
birth O 0 2.1093693902685118e-08
. O 0 1.0193801358582277e-09

His O 0 1.1707949170158827e-06
two O 0 7.052915975691576e-07
sibs O 1 0.9724383354187012
suffer O 0 0.00025508084218017757
from O 0 2.3071357324599973e-10
childhood O 0 1.7307662346865982e-05
onset O 0 0.0026403164956718683
DM B-Disease 1 0.9999409914016724
. O 0 1.5274233646778157e-06

Their O 0 1.461964216353806e-09
late O 0 1.5691170585085956e-09
father O 0 1.6974205152564537e-08
had O 0 7.424813541767605e-11
the O 0 1.787081801171795e-14
adult O 0 1.5467344419151097e-11
type O 0 2.4955305183427257e-11
of O 0 1.478465440352128e-11
DM B-Disease 1 0.9999995231628418
, O 0 3.211742261033379e-10
with O 0 3.7273972103291086e-11
onset O 0 5.536645364401238e-09
around O 0 3.6168124051272343e-11
30 O 0 3.658007056983603e-12
years O 0 8.585854943676807e-11
. O 0 1.6732833868493557e-11

Only O 0 2.7135214214490944e-11
six O 0 7.665756592868667e-13
other O 0 8.017196491915107e-15
cases O 0 6.022843356857932e-14
of O 0 5.557102968436513e-14
paternal O 0 5.294846232573036e-06
transmission O 1 0.540724515914917
of O 0 1.1291162138604705e-07
congenital B-Disease 1 0.9999959468841553
DM I-Disease 1 0.9999995231628418
have O 0 4.0810752466313716e-07
been O 0 1.2381414116191536e-08
reported O 0 1.93201472598048e-08
recently O 0 8.622805580671411e-09
. O 0 4.3710066122137903e-10

We O 0 5.354673371371632e-10
review O 0 4.882597147773393e-13
the O 0 5.091592634163568e-14
sex O 0 6.544802894081769e-12
related O 0 3.958637237455598e-12
effects O 0 8.262272810366511e-12
on O 0 2.0602367034605606e-10
transmission O 0 5.694264837075025e-05
of O 0 3.0859832467200476e-09
congenital B-Disease 1 0.9999531507492065
DM I-Disease 1 0.9999874830245972
. O 0 4.1628376834523806e-07

Decreased O 0 1.244912164111156e-05
fertility O 0 2.322601858395501e-06
of O 0 6.969108450050054e-13
males O 0 3.829320107534562e-12
with O 0 3.854233772415672e-12
adult O 0 1.27702193708501e-07
onset O 0 3.516062497510575e-05
DM B-Disease 1 0.9999992847442627
and O 0 3.2034545256465208e-06
contraction O 0 8.17275758180358e-09
of O 0 1.518309099052175e-14
the O 0 3.2349168916506743e-12
repeat O 0 9.621750507449178e-08
upon O 0 2.155984939189448e-11
male O 0 5.304142680628843e-10
transmission O 0 1.9696056341445e-08
contribute O 0 4.8057874547273796e-14
to O 0 3.5433711086801933e-13
the O 0 6.202569382586509e-13
almost O 0 7.355993418556306e-12
absent O 0 5.074362804946553e-11
occurrence O 0 1.4801751838100508e-11
of O 0 2.4875202809040986e-13
paternal O 0 3.1765997846378013e-05
transmission O 0 0.31823548674583435
of O 0 1.41678029308423e-07
congenital B-Disease 1 0.999968409538269
DM I-Disease 1 0.9999911785125732
. O 0 1.7810560848374735e-06

Also O 0 1.0878604683739468e-08
the O 0 9.045851741273925e-12
fathers O 0 5.743903130905892e-10
of O 0 1.4492311905113346e-14
the O 0 4.1200015621356556e-11
reported O 0 1.3755681038674084e-07
congenitally O 0 1.844188773247879e-05
affected O 0 1.6129521329677488e-10
children O 0 8.753308494702239e-11
showed O 0 4.80686046522294e-10
, O 0 4.916974166284957e-15
on O 0 4.117053920005276e-12
average O 0 4.585351629643464e-12
, O 0 7.898566647740121e-14
shorter O 0 2.4853330504726046e-10
CTG O 0 7.71626744722198e-08
repeat O 0 8.497611929669802e-07
lengths O 0 3.857477622659644e-06
and O 0 1.191848286730135e-10
hence O 0 4.3807197452894187e-11
less O 0 1.8642773089161402e-11
severe O 0 2.819538380549602e-08
clinical O 0 5.0659860306723203e-08
symptoms O 0 1.5063565683703928e-07
than O 0 2.1137460542736825e-13
the O 0 2.3643031976661177e-11
mothers O 0 1.207979760664557e-08
of O 0 5.199658520589623e-13
children O 0 7.4165131813686e-09
with O 0 4.0546257196183433e-07
congenital B-Disease 1 0.9999687671661377
DM I-Disease 1 0.9999877214431763
. O 0 9.456113048145198e-07

We O 0 2.7071178632098736e-10
conclude O 0 1.3514042662698955e-10
that O 0 6.762533241722046e-12
paternal O 0 1.9931880501644628e-07
transmission O 0 0.00651953648775816
of O 0 9.105087173111315e-08
congenital B-Disease 1 0.999991774559021
DM I-Disease 1 0.9999992847442627
is O 0 2.9384898070361487e-08
rare O 0 8.799477119181276e-11
and O 0 3.391411934269839e-12
preferentially O 0 1.4736807329995827e-09
occurs O 0 8.43634676006566e-11
with O 0 5.7568949607400555e-12
onset O 0 6.942194374914834e-08
of O 0 3.672005477461937e-10
DM B-Disease 1 0.9999992847442627
past O 0 6.387685971276369e-06
30 O 0 2.2764803930819255e-10
years O 0 1.4143887450135395e-10
in O 0 6.370521243772437e-14
the O 0 8.879162596148182e-13
father O 0 1.2395638293583033e-08
. O 0 9.196540013897692e-13
. O 0 4.240207143735297e-12

The O 0 3.147225258182118e-10
RB1 O 0 3.784083446589648e-06
gene O 0 3.600333542408407e-08
mutation O 0 1.7518976846986334e-07
in O 0 1.789888723346955e-11
a O 0 7.384974298751956e-10
child O 0 1.1730676305887755e-05
with O 0 1.0318690328858793e-06
ectopic B-Disease 1 0.9999432563781738
intracranial I-Disease 1 0.9998948574066162
retinoblastoma I-Disease 1 0.9876761436462402
. O 0 2.2159695163281867e-06

The O 0 7.87469534024865e-10
RB1 O 0 8.080432053247932e-06
gene O 0 5.271209246870967e-08
mutation O 0 1.5228533811750822e-07
was O 0 3.704573359186725e-08
investigated O 0 4.459821401070485e-09
in O 0 2.872999364453288e-12
a O 0 9.1764207343914e-10
child O 0 3.3953896490857005e-05
with O 0 1.2092427823517937e-06
ectopic B-Disease 1 0.9999513626098633
intracranial I-Disease 1 0.9995599389076233
retinoblastoma I-Disease 0 3.210523573216051e-05
using O 0 1.8874449225769752e-10
DNA O 0 1.629643975320505e-07
obtained O 0 6.334547886233111e-10
from O 0 4.2663594011782546e-13
both O 0 8.165978743895907e-13
the O 0 1.4132662054522349e-11
pineal B-Disease 0 2.8148797355243005e-06
and I-Disease 0 5.871212351848953e-07
retinal I-Disease 0 0.037281304597854614
tumours I-Disease 1 0.9999988079071045
of O 0 2.454678127428167e-10
the O 0 1.144138894737523e-09
patient O 0 6.081479568820214e-07
. O 0 7.27404980693791e-09

A O 0 1.0180438714257889e-08
nonsense O 0 2.2288313061835652e-07
mutation O 0 1.309474417787726e-09
in O 0 1.8621876610169785e-11
exon O 0 1.2388882453251426e-07
17 O 0 5.327224172901879e-08
( O 0 5.939454115165554e-13
codon O 0 7.635718446419304e-11
556 O 0 4.948592202680402e-09
) O 0 2.2366932958539643e-11
of O 0 2.0802839499297655e-14
the O 0 8.209631759126257e-12
RB1 O 0 1.6413399634984671e-06
gene O 0 2.3427986217683383e-09
was O 0 2.7734861518524667e-08
found O 0 1.9021203015445742e-11
to O 0 1.3847512817400515e-13
be O 0 6.535147423214482e-12
present O 0 2.103102414441338e-12
homozygously O 0 8.906170023692539e-08
in O 0 3.2657202137832686e-13
both O 0 2.5097862698698903e-13
the O 0 3.2271455473187327e-12
retinal B-Disease 0 5.319111906487706e-08
and I-Disease 0 2.0523074351075365e-09
the I-Disease 0 4.064417691296285e-09
pineal I-Disease 0 0.08226747065782547
tumours I-Disease 1 0.9999867677688599
. O 0 4.458021010123048e-07

The O 0 2.561228486241962e-11
same O 0 1.2048576546186407e-11
mutation O 0 3.1693572766222644e-10
was O 0 1.23642802662971e-08
present O 0 1.4373850200366523e-11
heterozygously O 0 1.4539597259499715e-07
in O 0 3.852710522573438e-13
the O 0 5.31449396209277e-13
DNA O 0 2.1500872193769283e-08
from O 0 1.7584818150229165e-12
the O 0 1.07802377864296e-13
constitutional O 0 1.0306336947069061e-12
cells O 0 1.1372305180890052e-10
of O 0 4.176566996980449e-14
the O 0 2.4392330169598075e-11
patient O 0 1.0031570019108926e-09
, O 0 1.842936176929544e-12
proving O 0 1.0598300015374207e-09
it O 0 4.679411805957878e-12
to O 0 6.74018783494712e-13
be O 0 3.928932700014709e-12
of O 0 8.83855570113154e-14
germline O 0 3.696151607002207e-09
origin O 0 2.2460781845534683e-10
. O 0 7.140949498385396e-10

The O 0 1.623277900986153e-11
initial O 0 3.8628756443559453e-11
mutation O 0 7.242924038308729e-10
was O 0 3.385349955919992e-08
shown O 0 5.570804373355998e-10
to O 0 1.0244972188308554e-12
have O 0 3.538557467874792e-12
occurred O 0 1.2413529405785884e-11
in O 0 3.4549487972152307e-14
the O 0 4.444351570792593e-12
paternally O 0 7.462319331352774e-07
derived O 0 1.1298514901447732e-10
RB1 O 0 5.481971129484009e-06
allele O 0 6.942709660506807e-07
. O 0 1.5197645364395385e-09

The O 0 8.465703693616433e-10
mutation O 0 1.3895680694986368e-07
is O 0 1.0043881282228995e-09
in O 0 8.010676540506911e-13
an O 0 9.348886682164492e-13
area O 0 6.693434001503462e-11
of O 0 1.0293208071911891e-13
the O 0 1.2380065505732119e-12
gene O 0 2.5007385051623032e-11
that O 0 1.5347875964924484e-12
encodes O 0 1.1158042372005905e-11
the O 0 2.7242550663247878e-12
protein O 0 3.349546195963171e-10
- O 0 4.4857393355357544e-09
binding O 0 1.4372932843897956e-09
region O 0 8.21798271793961e-12
known O 0 1.9133412302446695e-12
as O 0 3.0508228322095876e-12
the O 0 3.757556071848356e-11
pocket O 0 0.05205589532852173
region O 0 5.9095238924555815e-08
and O 0 4.072052917081237e-09
has O 0 7.11938374919896e-09
been O 0 7.710257987625369e-10
detected O 0 1.414413697276018e-09
in O 0 8.820396331181944e-15
other O 0 2.396635509136196e-14
cases O 0 6.958771395487034e-14
of O 0 2.157425612128467e-14
retinoblastoma B-Disease 0 3.189201791542473e-08
. O 0 7.447049053810328e-12
. O 0 7.51848444613401e-11

Low O 0 5.9200428950134665e-06
levels O 0 1.0142934492307631e-08
of O 0 4.4535902743447764e-13
beta O 0 2.902829365769577e-10
hexosaminidase O 0 6.664855050075857e-07
A O 0 1.899446600006627e-09
in O 0 5.028403041174023e-12
healthy O 0 2.2771230734353054e-10
individuals O 0 2.5777860748754655e-13
with O 0 3.4097644152630835e-10
apparent O 0 0.000934619689360261
deficiency O 0 0.001263893791474402
of O 0 1.5783843814405943e-15
this O 0 1.4078973718193583e-13
enzyme O 0 2.465419646213718e-09
. O 0 2.8576888078113427e-10

Appreciable O 0 5.078921105905465e-08
beta O 0 1.3916130114921543e-07
hexosaminidase O 0 3.388829645700753e-05
A O 0 1.1434396895992904e-07
( O 0 1.0478872110308846e-11
hex O 0 1.0976189059874741e-06
A O 0 6.391113749337762e-10
) O 0 1.975572483381427e-12
activity O 0 4.721585102063219e-12
has O 0 2.443161775320113e-12
been O 0 2.6188313670405527e-12
detected O 0 9.787420873763608e-10
in O 0 2.3464609704045014e-13
cultured O 0 4.926989731757203e-07
skin O 0 0.0002803248062264174
fibroblasts O 0 2.5473923415120225e-06
and O 0 0.00016819698794279248
melanoma B-Disease 1 0.9998955726623535
tissue O 0 0.03761220723390579
from O 0 6.554241038791986e-10
healthy O 0 1.0675781370039772e-09
individuals O 0 2.8283159234782085e-13
previously O 0 1.616237976787005e-10
reported O 0 6.830991328143909e-09
as O 0 1.0424276025711166e-10
having O 0 4.386508010156831e-07
deficiency B-Disease 0 0.0016610712045803666
of I-Disease 0 2.3784564880222243e-14
hex I-Disease 0 2.372239805481513e-06
A I-Disease 0 1.2145351391268377e-10
activity O 0 6.07500438842834e-10
indistinguishable O 0 5.103484301827166e-10
from O 0 1.0512252147324569e-13
that O 0 1.0630635911487718e-12
of O 0 1.8232930356493204e-13
patients O 0 1.1332339511227474e-09
with O 0 2.884992909457651e-06
Tay B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999994039535522
Sachs I-Disease 1 0.9999996423721313
disease I-Disease 1 0.9845237731933594
( O 0 2.8364872950437103e-11
TSD B-Disease 0 2.1595087673631497e-06
) O 0 2.937747267672819e-10
. O 0 7.903100396333684e-11

Identification O 0 3.922065339168057e-09
and O 0 8.1987183708776e-10
quantitation O 0 9.019988738145912e-07
of O 0 6.6121066955027175e-12
hex O 0 1.0549644684942905e-05
A O 0 3.6954095339325477e-10
, O 0 6.136050868799092e-13
amounting O 0 7.530001470447412e-13
to O 0 4.678320990152141e-13
3 O 0 7.086942144240993e-11
. O 0 2.738218818354454e-10

5 O 0 2.3772761892359995e-07
% O 0 2.9590382921718117e-10
- O 0 2.943504568975186e-06
6 O 0 1.1989111214916193e-07
. O 0 2.2075108407904054e-09

9 O 0 3.014854996763461e-07
% O 0 2.3735293244731004e-11
of O 0 3.2567363112941464e-14
total O 0 3.2125644917717355e-13
beta O 0 2.7141426259258417e-11
hexosaminidase O 0 1.3362377160319738e-07
activity O 0 1.2055945131095314e-09
, O 0 1.4694738481590974e-12
has O 0 2.963372819700383e-12
been O 0 6.683781674822475e-13
obtained O 0 1.1032831820443484e-13
by O 0 6.866963866026393e-14
cellulose O 0 2.238075467175804e-07
acetate O 0 2.2725309634097357e-07
gel O 0 8.866338134794205e-07
electrophoresis O 0 3.818234972641221e-07
, O 0 3.103280479810344e-11
DEAE O 0 2.573794404270302e-07
- O 0 1.9438131104720924e-08
cellulose O 0 1.0089738680107985e-06
ion O 0 3.5663450859146906e-08
- O 0 1.334823362952875e-08
exchange O 0 5.626908314293466e-11
chromatography O 0 6.574217081833922e-08
, O 0 5.390965018142735e-12
radial O 0 6.636516758362632e-08
immunodiffusion O 0 2.5837321118160617e-06
, O 0 1.5636450467759744e-11
and O 0 5.709635195194629e-11
radioimmunoassay O 0 3.4661848076211754e-06
. O 0 4.504977502151064e-10

Previous O 0 9.129064437729539e-07
family O 0 1.7169091393043345e-07
studies O 0 1.3056529468702394e-10
suggested O 0 4.1518007781737865e-11
that O 0 5.1787181314100206e-12
these O 0 1.874751574685099e-13
individuals O 0 2.2015260437140832e-14
may O 0 2.525470717967826e-12
be O 0 6.711743384376148e-14
compound O 0 4.180558677013835e-11
heterozygotes O 0 1.2557861651593671e-12
for O 0 3.178210025512392e-16
the O 0 5.757207725961763e-14
common O 0 1.297222485679983e-11
mutant O 0 8.175021548595396e-08
TSD B-Disease 0 3.713763163659678e-08
gene O 0 1.7009554875713206e-09
and O 0 6.698146898242996e-11
a O 0 8.658853148379997e-12
rare O 0 6.715137335078225e-10
( O 0 5.435521892066704e-14
allelic O 0 9.381589949342128e-10
) O 0 2.0380322429680575e-11
mutant O 0 7.1672476842365995e-09
gene O 0 1.1738846694697713e-07
. O 0 8.665424822140722e-09

Thus O 0 6.0796900847037705e-09
, O 0 3.798505780749917e-12
the O 0 2.6020691203392128e-14
postulated O 0 6.173305616696823e-11
rate O 0 1.1840454172684645e-09
mutant O 0 1.712573749479418e-09
gene O 0 9.698001290914249e-10
appears O 0 1.5322518365223914e-08
to O 0 3.174470777390914e-13
code O 0 5.022581742869514e-13
for O 0 3.0001778242739335e-14
the O 0 1.5549063772657412e-12
expression O 0 2.5930658661965644e-11
of O 0 2.835570049163766e-13
low O 0 3.587438346386307e-09
amounts O 0 7.204770769786775e-14
of O 0 5.975015810897807e-14
hex O 0 5.2082659749430604e-06
A O 0 4.2584007431401005e-09
. O 0 6.792401086030964e-10

Heterozygotes O 0 6.332488311500128e-08
for O 0 3.5911226249629724e-12
the O 0 2.277707319628397e-12
rare O 0 6.403397950771605e-11
mutant O 0 2.2841729219180706e-07
may O 0 5.114497714231447e-09
be O 0 1.0986351585418053e-11
indistinguishable O 0 1.359486523355713e-09
from O 0 3.9961417963758905e-13
heterozygotes O 0 1.5640657172188988e-11
for O 0 4.6365647561293685e-15
the O 0 1.5286902603148245e-12
common O 0 2.4116578178912107e-10
TSD B-Disease 0 2.826939862643485e-06
mutant O 0 1.2869105603385833e-06
. O 0 1.4757762789585627e-09

However O 0 9.715418747280324e-11
, O 0 3.441203485360367e-14
direct O 0 2.978170214238372e-14
visualization O 0 1.3912143437266877e-08
and O 0 6.384708761686397e-09
quantitation O 0 1.01557679954567e-06
of O 0 4.5612068809430806e-12
hex O 0 4.504201115196338e-06
A O 0 1.3625561616492643e-11
by O 0 1.3537595659274607e-14
the O 0 3.991927028192989e-14
methods O 0 6.955384879159254e-11
described O 0 4.2174033154651624e-09
may O 0 4.293531502552739e-11
prevent O 0 4.03245882865666e-12
false O 0 3.597934172816508e-10
- O 0 3.0721760690965993e-09
positive O 0 2.0224074151475868e-11
prenatal O 0 2.44731634957418e-09
diagnosis O 0 3.8573009675246794e-08
of O 0 3.2546887277287717e-13
TSD B-Disease 0 1.59526848619862e-06
in O 0 1.1219053464017748e-11
fetuses O 0 3.29914797703168e-08
having O 0 2.8297973339586058e-11
the O 0 8.929315078141931e-13
incomplete O 0 1.6719626216854522e-07
hex B-Disease 0 0.2134152352809906
A I-Disease 0 0.00017770596605259925
deficiency I-Disease 1 0.8930425047874451
of O 0 3.6287352246297533e-13
the O 0 2.8429233966953404e-10
type O 0 6.509036154511705e-08
described O 0 1.6151123816143809e-07
in O 0 3.08685564089084e-12
the O 0 4.729429348149239e-11
four O 0 3.3861233816878666e-09
healthy O 0 1.2512795244390418e-08
individuals O 0 6.026793647473383e-11

The O 0 5.325075380646638e-10
tumor B-Disease 0 1.0374023986514658e-06
suppressor O 0 8.888375305105e-06
gene O 0 9.014734132506419e-06
Smad4 O 0 0.0016662401612848043
/ O 0 9.438306733500212e-06
Dpc4 O 0 3.393371343918261e-06
is O 0 2.2366238635468383e-12
required O 0 4.067197255798027e-15
for O 0 7.676601896846192e-16
gastrulation O 0 4.067380210415195e-09
and O 0 7.014872016597451e-11
later O 0 8.350924396438586e-10
for O 0 6.943077297989764e-13
anterior O 0 5.668667313329934e-09
development O 0 2.405379226962795e-13
of O 0 1.5628496489571847e-14
the O 0 5.025746312170565e-12
mouse O 0 1.1937808039874653e-06
embryo O 0 3.021193037966441e-07
. O 0 9.174133452916067e-09

Mutations O 0 3.396646945930115e-07
in O 0 7.873715568429418e-11
the O 0 4.488150406878333e-10
SMAD4 O 0 0.001286426093429327
/ O 0 7.797425496391952e-06
DPC4 O 0 2.9992828785907477e-05
tumor B-Disease 0 4.595631537540612e-07
suppressor O 0 1.3566359768901748e-07
gene O 0 3.0104629900051805e-09
, O 0 1.1521126934421755e-12
a O 0 3.3642336014433685e-14
key O 0 1.0641885289652819e-10
signal O 0 1.5680353726565954e-07
transducer O 0 3.798010084210546e-07
in O 0 8.224940910642187e-13
most O 0 1.6188032902000882e-12
TGFbeta O 0 8.719060815565172e-07
- O 0 1.1111933417851105e-07
related O 0 8.14246003955077e-10
pathways O 0 3.864399644726291e-08
, O 0 6.904963254818208e-13
are O 0 1.948687598343269e-15
involved O 0 8.055178296302937e-15
in O 0 3.7808863976923276e-14
50 O 0 1.4312022920959233e-11
% O 0 6.823945705378143e-13
of O 0 1.261202808855444e-10
pancreatic B-Disease 1 0.9925905466079712
cancers I-Disease 0 0.06980247795581818
. O 0 6.088222193056936e-08

Homozygous O 0 7.35750472813379e-06
Smad4 O 0 0.0002351512957829982
mutant O 0 0.0006542780320160091
mice O 0 0.012706941924989223
die O 0 4.956688644597307e-05
before O 0 4.084450000441109e-10
day O 0 3.228318445902545e-10
7 O 0 4.393709007732838e-10
. O 0 9.838775627546426e-11

5 O 0 2.6243205386577984e-09
of O 0 4.336407968819067e-12
embryogenesis O 0 3.737255838132114e-07
. O 0 7.51191375769622e-09

Mutant O 0 4.879415982372848e-08
embryos O 0 4.326071501026263e-09
have O 0 4.391983166041058e-10
reduced O 0 3.3535587501409836e-11
size O 0 1.832969220849634e-09
, O 0 1.5083596871523497e-10
fail O 0 1.4183606822371075e-07
to O 0 8.880526869425864e-11
gastrulate O 0 1.2903643437311985e-05
or O 0 5.012304349349961e-09
express O 0 3.710318996485995e-10
a O 0 9.036225001764209e-13
mesodermal O 0 4.482557436347179e-09
marker O 0 4.958106728736311e-05
, O 0 2.6301957140040244e-11
and O 0 4.3582509129391767e-11
show O 0 5.198538932660313e-09
abnormal O 0 1.4022970340477059e-08
visceral O 0 6.226121396224471e-09
endoderm O 0 2.238582283098367e-06
development O 0 2.9600485951242206e-10
. O 0 8.332961543011663e-10

Growth B-Disease 1 0.999955415725708
retardation I-Disease 1 0.9999845027923584
of O 0 2.9786971500467274e-11
the O 0 1.0469513034294664e-09
Smad4 O 0 0.0014677953440696
- O 0 0.0012093455297872424
deficient O 0 0.001844395068474114
embryos O 0 7.46028518960884e-08
results O 0 6.404891061961848e-10
from O 0 4.2696645915010767e-13
reduced O 0 1.5354061771999383e-11
cell O 0 1.7079695169286424e-07
proliferation O 0 1.2223523526699864e-07
rather O 0 5.88078847771345e-14
than O 0 5.535580009477547e-16
increased O 0 1.0598879223279803e-14
apoptosis O 0 6.032121468990681e-10
. O 0 4.5067649612207106e-10

Aggregation O 0 2.5173243045628624e-08
of O 0 1.0295242089397583e-11
mutant O 0 2.57135798165109e-06
Smad4 O 0 7.598718639201252e-06
ES O 0 2.248862429610199e-08
cells O 0 1.5260612218348513e-10
with O 0 1.6853910628222835e-11
wild O 0 2.8190312306719534e-09
- O 0 6.655164270341629e-06
type O 0 1.551923674014688e-07
tetraploid O 0 4.6870372898411006e-06
morulae O 0 6.495392881333828e-05
rescues O 0 2.4759967800491722e-06
the O 0 4.7067606756545644e-11
gastrulation B-Disease 0 1.0568837751634419e-05
defect I-Disease 0 2.3350354240392335e-05
. O 0 3.5608357928929024e-10

These O 0 5.251845625053875e-10
results O 0 2.628070816523831e-10
indicate O 0 2.2155789702882345e-10
that O 0 5.291185892208894e-11
Smad4 O 0 1.9106251158973464e-07
is O 0 4.93464427306356e-12
initially O 0 7.421865205747835e-12
required O 0 2.5461484286779575e-15
for O 0 1.3517377935735712e-16
the O 0 9.612876121468331e-15
differentiation O 0 5.883719618286765e-13
of O 0 1.7285182820118115e-14
the O 0 2.951566508563319e-12
visceral O 0 1.316927678018942e-10
endoderm O 0 4.231263872611635e-08
and O 0 3.975088314067676e-11
that O 0 1.1012949449953902e-12
the O 0 4.0146678299476934e-13
gastrulation B-Disease 0 1.0077778256345482e-07
defect I-Disease 0 5.480254117173899e-07
in O 0 8.47198694661419e-14
the O 0 1.2369780547083487e-11
epiblast O 0 3.501874380162917e-05
is O 0 1.5221658655750758e-10
secondary O 0 8.805083745455633e-11
and O 0 6.718134937244713e-10
non O 0 4.3038458213962016e-11
- O 0 2.8860446832368325e-07
cell O 0 2.6523050109972246e-05
autonomous O 0 8.28883450765261e-09
. O 0 3.327229602945181e-09

Rescued O 0 2.061288250843063e-05
embryos O 0 3.1997722089727176e-06
show O 0 0.0002378719364060089
severe O 0 4.318021092331037e-05
anterior O 0 8.716268894204404e-06
truncations O 0 2.1232324343145592e-06
, O 0 3.157617056714912e-09
indicating O 0 1.4273109361084835e-09
a O 0 3.5555727199293452e-12
second O 0 5.677101150292074e-11
important O 0 4.4174318608418417e-13
role O 0 2.1856180060231267e-11
for O 0 2.3597426096477747e-12
Smad4 O 0 2.3067721031111432e-06
in O 0 1.4037613953188366e-11
anterior O 0 2.418515236968233e-07
patterning O 0 4.354379143478582e-06
during O 0 4.4122119291500894e-09
embryogenesis O 0 2.1745870526501676e-06
. O 0 5.1306781045923344e-09

Prevalence O 0 4.9123333155876026e-05
of O 0 4.412045381818608e-12
p16 O 0 5.4377751190770596e-09
and O 0 2.8963642595414285e-10
CDK4 O 0 5.900507744627248e-07
germline O 0 1.4128256342615941e-09
mutations O 0 1.2888956568701815e-08
in O 0 2.969111415063175e-11
48 O 0 4.951115428752928e-08
melanoma B-Disease 1 0.9998887777328491
- O 1 0.9985595345497131
prone O 1 0.9999555349349976
families O 0 1.5830187294341158e-07
in O 0 1.282242090283603e-10
France O 0 3.5261146535958687e-07
. O 0 3.1034788072759056e-09

The O 0 3.086473299163117e-08
French O 0 1.4775599993299693e-05
Familial B-Disease 0 0.13649551570415497
Melanoma I-Disease 1 0.9426645636558533
Study O 0 2.82509771132311e-09
Group O 0 2.0963610847246628e-09
. O 0 1.9605593537530552e-10

Germline O 0 5.559812166211486e-07
mutations O 0 3.5657947705658444e-07
in O 0 1.386523448138055e-11
the O 0 2.944891509468195e-12
p16 O 0 1.3861387593294694e-09
and O 0 3.733881259737615e-10
CDK4 O 0 7.439453497681825e-08
genes O 0 1.2371019764145785e-09
have O 0 1.2317449837873085e-10
been O 0 2.4106874829676883e-10
reported O 0 4.4113682151625255e-10
in O 0 2.1222717542899875e-15
a O 0 3.15618950245955e-13
subset O 0 2.494716759560145e-11
of O 0 2.0872155392925862e-10
melanoma B-Disease 0 0.23750945925712585
pedigrees O 0 2.730964524744195e-06
, O 0 1.988074115055749e-11
but O 0 3.509241161547827e-11
their O 0 5.847670125902482e-10
prevalence O 0 6.435947170757572e-07
is O 0 1.0201260843001325e-11
not O 0 5.786750852804223e-12
well O 0 2.201813818075715e-12
known O 0 1.9216084279349843e-10
. O 0 5.380205170268937e-10

We O 0 4.331417169378682e-11
searched O 0 8.177458710179053e-11
for O 0 2.701586597795647e-15
such O 0 1.7938734807494694e-15
germline O 0 7.572579716064176e-12
mutations O 0 2.013409855505799e-10
in O 0 4.246860241946537e-12
48 O 0 7.4350534617906305e-09
French O 0 0.00011289788380963728
melanoma B-Disease 1 0.9999923706054688
- O 1 0.9377104640007019
prone O 1 0.9926669001579285
families O 0 5.0427547554354746e-11
selected O 0 3.160561479957462e-14
according O 0 2.995214550016202e-14
to O 0 8.354588180124745e-14
two O 0 5.960528294893241e-13
major O 0 4.1667446402937625e-12
criteria O 0 9.130069478224812e-10
families O 0 4.513470326650282e-12
with O 0 1.661859940025462e-13
at O 0 9.739942359587861e-12
least O 0 1.1349437870698917e-15
three O 0 1.3496995676046813e-13
affected O 0 1.7084432284673878e-13
members O 0 1.0165699797790376e-14
( O 0 7.91334093521931e-15
n O 0 4.6000685927083396e-08
= O 0 3.6101393874332643e-08
20 O 0 1.9110735563487857e-11
) O 0 6.854404739110864e-13
or O 0 6.977292008047975e-12
families O 0 1.4473348734778124e-12
with O 0 3.2610082711416466e-13
two O 0 1.0565229247028185e-11
affected O 0 2.062636086236358e-13
members O 0 3.061275327198923e-15
, O 0 9.082455619568216e-15
one O 0 2.9568263392202795e-14
of O 0 9.151450900045052e-16
them O 0 6.301362968745561e-13
affected O 0 4.015293617889125e-14
before O 0 5.214984260398792e-13
the O 0 2.4182503330534566e-13
age O 0 2.636477841599927e-12
of O 0 7.361681082166793e-15
50 O 0 5.632464438430629e-13
( O 0 9.873665707466669e-15
n O 0 2.0871061323646245e-08
= O 0 6.211060821215142e-08
28 O 0 7.488277220524253e-10
) O 0 1.3821555662138496e-12
, O 0 4.0465698012467216e-14
and O 0 2.973141549037113e-14
one O 0 3.764082703974813e-15
additional O 0 4.564872734506712e-15
minor O 0 1.0835433245093284e-11
criterion O 0 9.909372877814349e-09
. O 0 6.288382037311635e-10

Sixteen O 0 5.264461644394203e-10
different O 0 2.357853062101567e-12
p16 O 0 2.556916234297546e-09
germline O 0 9.765403596873057e-09
mutations O 0 3.1272424649841923e-08
were O 0 1.1523187959383563e-09
found O 0 2.3911794766462435e-10
in O 0 2.1911797734325972e-13
21 O 0 2.4043678506502353e-11
families O 0 2.478036439240716e-12
, O 0 2.504725214128728e-14
while O 0 1.1376888472101887e-13
one O 0 3.5439389595680326e-13
germline O 0 2.6350727155843856e-10
mutation O 0 4.686671939424514e-09
, O 0 5.24460544437666e-11
Arg24His O 0 8.935749065130949e-07
, O 0 4.462914413028152e-11
was O 0 8.003882001617058e-09
detected O 0 1.6357654786247622e-08
in O 0 5.013976972327583e-13
the O 0 1.2709048223535913e-11
CDK4 O 0 7.56626604925259e-06
gene O 0 7.400181800676364e-08
. O 0 3.349419852582969e-09

The O 0 3.69931993024486e-12
frequency O 0 7.431462667462085e-10
of O 0 7.866453257017458e-14
p16 O 0 1.283518690636809e-11
gene O 0 2.1276354289501143e-10
mutation O 0 7.60604024208078e-10
in O 0 3.4253663273864365e-12
our O 0 2.112656993791262e-10
sample O 0 3.1238653330767363e-10
( O 0 2.6251312863941056e-13
44 O 0 1.7474056923649783e-11
% O 0 2.2101603587652147e-13
) O 0 5.869674863344387e-13
is O 0 5.577451478097628e-13
among O 0 2.7232442985206974e-14
the O 0 2.0428337840772137e-12
highest O 0 9.132128830913189e-09
rates O 0 3.648078816809175e-08
yet O 0 1.1817728740037836e-10
reported O 0 5.437253425277788e-10
and O 0 3.535406993201984e-12
the O 0 4.1161822214585975e-12
CDK4 O 0 1.7370113710057922e-05
mutation O 0 4.228363492675413e-10
is O 0 1.3184444855318667e-12
the O 0 4.2052578324951184e-13
second O 0 2.6579254353009674e-09
mutation O 0 9.519554033943223e-10
detected O 0 7.2851018551034485e-09
in O 0 2.6187883648718865e-14
this O 0 1.9996853768667298e-14
gene O 0 6.987820322379434e-10
worldwide O 0 2.121566033963518e-09
. O 0 3.1975552761132064e-10

In O 0 1.1499688701288591e-10
summary O 0 4.171760714655193e-09
, O 0 1.2115242836729934e-11
our O 0 1.921304365604115e-10
results O 0 7.886491459885292e-11
show O 0 1.044332620381283e-09
frequent O 0 7.532820721356526e-12
involvement O 0 2.3987049325990828e-12
of O 0 1.0570488372953733e-15
the O 0 5.579034006693642e-14
p16 O 0 8.91439526362614e-12
gene O 0 3.738506171302447e-10
in O 0 2.212887512120787e-11
familial B-Disease 0 0.00029453227762132883
melanoma I-Disease 1 0.9702646136283875
and O 0 3.2831766194618694e-09
confirm O 0 1.034013985545812e-09
the O 0 7.569456671706332e-13
role O 0 1.9305824300319685e-11
of O 0 2.195998476106891e-14
the O 0 2.449479421379186e-12
CDK4 O 0 8.975919030262958e-08
gene O 0 7.233711546428268e-11
as O 0 1.9167052927454575e-12
a O 0 1.2423247153225958e-10
melanoma B-Disease 0 0.005682982970029116
- O 0 3.555661862719717e-07
predisposing O 0 6.152085774147054e-08
gene O 0 2.4727487613063204e-08
. O 0 1.4291708094749112e-10
. O 0 2.3058027709410567e-10

Progression O 0 1.2835961342716473e-06
of O 0 5.9389468169690485e-12
somatic O 0 8.280589014475481e-08
CTG O 0 9.580613550497219e-05
repeat O 0 0.0005472108605317771
length O 0 3.8255649315033224e-07
heterogeneity O 0 1.0893705137959842e-07
in O 0 4.1204966522156994e-11
the O 0 1.6179682593708833e-10
blood O 0 5.958843303233152e-06
cells O 0 5.491287424774782e-07
of O 0 7.099128396248489e-08
myotonic B-Disease 1 0.9999958276748657
dystrophy I-Disease 1 0.9999897480010986
patients O 0 4.3622745238280913e-07
. O 0 2.3271620186449127e-09

The O 0 1.1554186427065183e-11
genetic O 0 3.6400399361369296e-10
basis O 0 3.363861689198444e-10
of O 0 1.077578772878951e-07
myotonic B-Disease 1 0.9999958276748657
dystrophy I-Disease 1 0.9999966621398926
( O 0 3.7669735775125446e-07
DM B-Disease 1 0.999998927116394
) O 0 1.592846032849593e-08
is O 0 4.679661606138419e-12
the O 0 5.579172242470634e-14
expansion O 0 2.890169440578072e-12
of O 0 6.476411204200949e-14
an O 0 2.0994402397112033e-11
unstable O 0 0.00012039692228427157
CTG O 0 2.6755469662020914e-07
repeat O 0 2.582453646482463e-07
in O 0 2.008343849297517e-13
the O 0 5.111094381927972e-13
34 O 0 2.4523590623493075e-12
UTR O 0 1.2917678482438077e-08
of O 0 1.3423153037771078e-14
the O 0 7.773068994021415e-11
DM B-Disease 1 0.999983549118042
protein O 0 2.780268237856376e-10
kinase O 0 5.220309073905582e-09
gene O 0 1.7804681340383155e-10
on O 0 1.343079314430895e-09
chromosome O 0 8.159238859661855e-06
19 O 0 1.2958388806438847e-09
. O 0 2.0431084601924e-10

One O 0 8.515420590882172e-10
of O 0 1.7569253614891506e-13
the O 0 5.343686647688028e-13
principal O 0 2.811285752801762e-11
features O 0 6.3372970066089e-12
of O 0 8.740182649890141e-14
the O 0 9.143278911771802e-10
DM B-Disease 1 0.9999991655349731
mutation O 0 3.3845239499896707e-08
is O 0 4.42993862079244e-12
an O 0 1.5833097636794302e-13
extraordinarily O 0 7.580311489618907e-08
high O 0 1.8308806915001696e-08
level O 0 2.938184417988765e-10
of O 0 2.1627786909485247e-13
somatic O 0 1.7181564615498246e-08
mosaicism O 0 1.6479636542499065e-05
, O 0 3.255350156106118e-11
due O 0 1.892240704404191e-12
to O 0 3.632945994817144e-13
an O 0 2.6445902759353324e-13
extremely O 0 2.875514493183573e-09
high O 0 2.680601740578936e-09
degree O 0 3.7148770171135936e-11
of O 0 3.791258214487503e-13
somatic O 0 9.061892001227534e-07
instability O 0 5.543649876926793e-06
both O 0 5.571332978293597e-11
within O 0 2.99679486955029e-12
and O 0 4.329172853534402e-10
between O 0 3.1198505584528746e-11
different O 0 1.4401539856490064e-11
tissues O 0 7.7248813568076e-07
. O 0 3.2783835646199577e-09

This O 0 6.921539341675498e-09
instability O 0 1.244434088221169e-06
appears O 0 2.3550834615804206e-09
to O 0 1.2564396138087242e-13
be O 0 6.208248026990174e-14
biased O 0 6.026641425488366e-12
towards O 0 1.6472360855977058e-13
further O 0 1.9458957353974717e-14
expansion O 0 6.624271985979091e-13
and O 0 2.907076055574942e-12
continuous O 0 3.808371586838666e-12
throughout O 0 9.273195275896762e-13
the O 0 1.050983779171677e-11
life O 0 2.0429409552935596e-10
of O 0 2.224878233850116e-14
an O 0 1.2610378236424524e-12
individual O 0 2.5854494326710276e-12
, O 0 1.0359036762067064e-12
features O 0 1.0789367316244025e-10
that O 0 7.74589947738491e-10
could O 0 2.643294472193247e-09
be O 0 1.1802703259178315e-10
associated O 0 2.349136683788e-11
with O 0 1.1116661410848216e-11
the O 0 4.0521469513166153e-10
progressive O 0 2.810834409672225e-08
nature O 0 1.0016332208095946e-09
of O 0 8.278579102620476e-13
the O 0 3.053342245706858e-09
disease O 0 1.181589141197037e-06
. O 0 2.8463903456454887e-10

Although O 0 1.2373822799727208e-10
increasing O 0 1.3471675164300478e-11
measured O 0 8.6557125911213e-09
allele O 0 1.8145276214909245e-07
size O 0 1.232327093703134e-07
between O 0 5.966239058352585e-09
patients O 0 3.8421560377699393e-10
clearly O 0 5.763218235976808e-10
correlates O 0 4.520951321640432e-11
with O 0 1.4321238693635469e-13
an O 0 2.3813676724993016e-13
increased O 0 2.8276947450223133e-10
severity O 0 1.0565082675384474e-06
of O 0 6.13183392950134e-11
symptoms O 0 1.3352770622532262e-07
and O 0 6.117053478332801e-12
an O 0 8.755336950230785e-13
earlier O 0 3.876107612654778e-08
age O 0 6.21701690128873e-10
of O 0 4.687538877022612e-13
onset O 0 1.0440895925611926e-09
, O 0 2.2351811699260205e-13
this O 0 2.3557006937843534e-15
correlation O 0 3.3432746588540896e-12
is O 0 7.072256734234894e-13
not O 0 2.003309220984309e-13
precise O 0 5.64662872015731e-10
and O 0 1.4882448606812204e-09
measured O 0 1.5703820110957167e-07
allele O 0 1.4365548395289807e-06
length O 0 8.334096150974801e-07
cannot O 0 1.117013237461606e-08
be O 0 1.846011191131147e-12
used O 0 4.084586401748025e-12
as O 0 6.757719926177297e-13
an O 0 1.4559514618234237e-12
accurate O 0 3.301014714907069e-07
predictor O 0 2.2981159418122843e-05
of O 0 1.9886694721527043e-11
age O 0 1.6609666975142545e-09
of O 0 2.9130040393732237e-12
onset O 0 2.7151571657668683e-07
. O 0 3.342980114950933e-09

In O 0 5.108153483535105e-12
order O 0 2.032754390160485e-13
to O 0 1.0793462173021903e-14
further O 0 2.298981461812074e-15
characterize O 0 5.609267824530084e-12
the O 0 5.624756845186429e-13
dynamics O 0 1.6756740439660689e-09
of O 0 2.409895720478783e-11
DM B-Disease 1 0.9999887943267822
CTG O 0 1.3017800483794417e-05
repeat O 0 3.467728220130084e-07
somatic O 0 2.708499735604164e-08
instability O 0 6.00140594997356e-07
, O 0 1.894414746600459e-12
we O 0 6.041695355812893e-12
have O 0 1.1758829587121822e-12
studied O 0 5.5331004535086326e-12
repeat O 0 7.235981591691143e-09
length O 0 1.5731707603272582e-10
changes O 0 1.5236992779153226e-14
over O 0 6.536303616411221e-13
time O 0 7.359782921989577e-12
in O 0 3.837172333348571e-12
111 O 0 3.827193359029479e-05
myotonic B-Disease 1 0.9999972581863403
dystrophy I-Disease 1 0.9999958276748657
patients O 0 9.743612583434924e-10
with O 0 1.8284620779268623e-12
varying O 0 2.7511586758732776e-11
clinical O 0 2.7020083948059437e-08
severity O 0 9.923872312356252e-06
and O 0 4.396653707772202e-09
CTG O 0 2.5284650746471016e-06
repeat O 0 1.7238078271475388e-06
size O 0 8.749040381061945e-10
over O 0 9.079079155149827e-11
time O 0 4.9078206776353994e-11
intervals O 0 5.364189648027207e-10
of O 0 4.6015027590140187e-14
1 O 0 1.109748924699172e-11
- O 0 9.208356743783952e-08
7 O 0 1.8609644936162795e-09
years O 0 1.9456510014226325e-10
. O 0 1.8657428033086454e-11

We O 0 8.58054338692682e-09
have O 0 2.3684599420592534e-11
found O 0 6.253220055478514e-13
a O 0 7.514039439488265e-15
direct O 0 2.7273262858187874e-13
progression O 0 4.7346986775664845e-08
of O 0 2.9955359481977084e-13
the O 0 1.0060915642262636e-11
size O 0 1.0558868362986473e-10
heterogeneity O 0 8.019200581355079e-11
over O 0 1.177286133163813e-11
time O 0 9.178717898586375e-13
related O 0 3.205487091040293e-14
to O 0 2.3868092493216884e-14
initial O 0 4.671214587012584e-13
CTG O 0 3.6591989438505834e-09
repeat O 0 3.730589170913845e-08
size O 0 1.5413899323579727e-10
and O 0 1.2202768309710343e-11
the O 0 1.4314874426882979e-13
time O 0 4.708152270826993e-11
interval O 0 3.577980800528735e-09
and O 0 1.0248103581023127e-11
always O 0 3.6788441216961676e-12
biased O 0 3.2143435049064584e-12
towards O 0 6.920650169476086e-14
further O 0 4.6078260293718615e-14
expansion O 0 7.130842791247538e-12
. O 0 2.1964877833235974e-11

Attempts O 0 1.2112304936806595e-08
to O 0 3.643386287111028e-11
mathematically O 0 7.580148952968102e-09
model O 0 2.9988506122791136e-10
the O 0 1.1088543971915499e-10
dynamics O 0 4.0413219437596126e-08
have O 0 1.962846551961661e-09
proved O 0 1.110453879960005e-07
only O 0 6.940433037311289e-12
partially O 0 8.259196881965636e-09
successful O 0 1.0865695843076395e-10
suggesting O 0 2.4961552269608944e-10
that O 0 7.513828020064631e-14
individual O 0 1.7433366099103013e-16
specific O 0 1.0405820085809814e-14
genetic O 0 1.3717659008705141e-08
and O 0 3.594357522729297e-08
/ O 0 1.5474958559025254e-07
or O 0 1.2311819341803698e-09
environmental O 0 8.676844659438743e-11
factors O 0 1.3308251202437393e-11
also O 0 4.014633764315434e-11
play O 0 1.1561394203107866e-11
a O 0 7.784837227978181e-14
role O 0 3.460663830154309e-12
in O 0 2.833699258315142e-13
somatic O 0 2.1812419925826276e-10
mosaicism O 0 2.2127859722331777e-07
. O 0 5.7004917279612766e-12
. O 0 2.953927727422645e-11

Aspartylglucosaminuria B-Disease 1 0.9994257688522339
among O 0 5.688463589059722e-10
Palestinian O 0 6.385465667335666e-08
Arabs O 0 1.139218639423234e-07
. O 0 2.4280579768998223e-09

Aspartylglucosaminuria B-Disease 1 0.9999278783798218
( O 0 1.1605902727751527e-05
AGU B-Disease 1 0.9999353885650635
) O 0 1.2403773119729067e-08
is O 0 3.3396816562225595e-11
a O 0 1.9492641875618055e-11
rare O 0 2.6995307322863482e-08
disorder B-Disease 0 0.0012358290841802955
of I-Disease 0 1.5018530039392908e-12
glycoprotein I-Disease 0 1.5877549230935983e-05
metabolism I-Disease 0 0.01993429847061634
caused O 0 5.038945118940319e-07
by O 0 6.142040348544597e-11
the O 0 3.720654717653815e-08
deficiency B-Disease 0 0.1831466555595398
of I-Disease 0 1.160698734391577e-13
the I-Disease 0 1.2121767478667778e-10
lysosomal I-Disease 0 0.00040667172288522124
enzyme I-Disease 0 2.7006410164176486e-05
aspartylglucosaminidase I-Disease 0 6.61960439174436e-05
( O 0 2.56367583412187e-12
AGA O 0 8.32772570902307e-08
) O 0 2.58411569920014e-10
. O 0 7.430055876112007e-11

AGU B-Disease 1 0.9998612403869629
is O 0 6.342149390548002e-06
inherited O 0 0.0004398779128678143
as O 0 8.206555990319941e-10
an O 0 1.0068778033556214e-09
autosomal O 1 0.9871578812599182
recessive O 1 0.983141303062439
trait O 0 0.24068157374858856
and O 0 2.9323433636818663e-07
occurs O 0 7.218816100440506e-10
with O 0 7.214427623011832e-13
a O 0 9.91565336783129e-12
high O 0 4.5065697840129815e-09
frequency O 0 1.1017824590453529e-06
in O 0 1.1786938092228638e-09
Finland O 0 5.910216714255512e-06
because O 0 8.910065740774797e-11
of O 0 5.029200526081995e-15
a O 0 2.607616596608797e-12
founder O 0 7.807072321952546e-09
effect O 0 4.099693362569212e-10
. O 0 2.625193812333393e-11

While O 0 3.888261934648085e-10
very O 0 3.230754856350937e-12
few O 0 8.228365905305068e-12
patients O 0 3.3325994741595366e-11
with O 0 9.849013826723763e-10
AGU B-Disease 1 0.9999973773956299
have O 0 2.1696666685500077e-09
been O 0 9.171486903269965e-10
reported O 0 2.4936153142363082e-09
from O 0 1.3431047723652667e-13
non O 0 1.909077063100284e-11
- O 0 1.3718165519094327e-06
Finnish O 0 5.628474809782347e-06
origin O 0 8.888546565444244e-10
, O 0 4.968438854779933e-11
we O 0 1.7268355634314503e-09
diagnosed O 0 4.4269154386711307e-07
the O 0 4.6039352885607343e-10
disorder O 0 4.824671123060398e-05
in O 0 1.5305284166780564e-12
8 O 0 3.0287072849688457e-10
patients O 0 9.152185086180875e-12
originating O 0 2.829596366243914e-12
from O 0 7.683234473990219e-13
3 O 0 1.8219563011068196e-11
unrelated O 0 3.58888030405069e-10
families O 0 2.9527616463020934e-11
, O 0 5.796333871861334e-14
all O 0 1.6040669497969368e-14
Palestinian O 0 1.9331352518747735e-08
Arabs O 0 3.727011588239293e-08
from O 0 3.1892622223694822e-12
the O 0 3.191363145971238e-11
region O 0 2.8407659558027376e-10
of O 0 8.188656458636701e-13
Jerusalem O 0 1.0146620297746267e-05
. O 0 1.586007059017902e-08

The O 0 3.9097763915307837e-10
clinical O 0 1.566767160454674e-08
diagnosis O 0 3.998025931650773e-05
of O 0 2.9694216863163092e-08
AGU B-Disease 1 0.9999964237213135
is O 0 9.699971315058065e-08
often O 0 1.3031091761206426e-08
difficult O 0 2.4147386312733943e-09
, O 0 6.069678722304961e-13
in O 0 2.193863444860042e-14
particular O 0 2.144241815354997e-13
early O 0 1.1851829413711545e-11
in O 0 1.6672548758256411e-12
the O 0 3.974004458839886e-11
course O 0 5.9489018156000384e-08
of O 0 8.647295661641519e-13
the O 0 4.7179464779389946e-09
disease O 0 2.78233528661076e-07
, O 0 1.4200097261246603e-12
and O 0 2.796177135319655e-12
most O 0 1.5829866714320295e-13
of O 0 5.01504525028066e-14
the O 0 2.8302898913423746e-10
patients O 0 2.2158114232340154e-10
are O 0 5.822844810488004e-12
diagnosed O 0 6.19391897771493e-08
after O 0 8.940201356999466e-10
the O 0 1.2164679853710059e-11
age O 0 9.519313115546879e-11
of O 0 5.806957020272618e-14
5 O 0 7.361709852826692e-11
years O 0 3.6569711148182193e-10
. O 0 4.4787926839484626e-11

However O 0 6.226193338676467e-09
, O 0 3.7312791745236495e-12
since O 0 1.9595516615594777e-12
these O 0 7.113095377465906e-14
patients O 0 1.3759052762147422e-13
excrete O 0 3.887316250145156e-12
early O 0 1.5241040580201565e-13
large O 0 2.6879059145546585e-14
amounts O 0 1.0112755495202477e-13
of O 0 4.0361041332009906e-13
aspartylglucosamine O 0 2.3737109131616307e-06
in O 0 2.1969318725334475e-11
urine O 0 7.531338219735062e-09
, O 0 2.5722054491244574e-14
biochemical O 0 3.976026539259658e-12
screening O 0 1.6378391698435024e-11
is O 0 4.245742646347139e-12
easy O 0 4.667819464287959e-10
by O 0 3.479183607879577e-11
urine O 0 7.809933890712273e-07
chromatography O 0 1.260450858353579e-06
. O 0 3.2554556272934576e-11
. O 0 4.81651281358797e-11

Detection O 0 3.628592182280954e-08
of O 0 1.363798288710194e-12
heterozygous O 0 1.944928440522631e-09
carriers O 0 1.217975303946517e-10
of O 0 5.9996773174586515e-12
the O 0 5.487390353664523e-06
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999984502792358
telangiectasia I-Disease 1 0.9999996423721313
( O 0 4.763528238527215e-09
ATM O 0 4.779594291903777e-06
) O 0 3.3228359300196963e-12
gene O 0 2.170275677920719e-12
by O 0 2.0266182124400317e-13
G2 O 0 2.6872764919971814e-06
phase O 0 2.6928095309131095e-08
chromosomal O 0 0.0026688522193580866
radiosensitivity O 0 4.9277132347924635e-05
of O 0 1.1962705999402079e-11
peripheral O 0 3.203681990271434e-05
blood O 0 0.00112721708137542
lymphocytes O 0 3.0482862712233327e-05
. O 0 8.76429329110806e-09

In O 0 5.954360858595464e-06
ataxia B-Disease 1 0.9999842643737793
- I-Disease 1 0.9999699592590332
telangiectasia I-Disease 1 0.9999986886978149
( O 0 0.00037347665056586266
A B-Disease 1 0.9999977350234985
- I-Disease 1 0.999996542930603
T I-Disease 1 0.9999995231628418
) O 0 4.3732960364195606e-08
patients O 0 2.311928287701548e-10
, O 0 2.6585995232565607e-13
mutations O 0 5.4176031716313133e-11
in O 0 3.181028845281736e-13
a O 0 1.4522820879908638e-12
single O 0 1.013576930719573e-10
gene O 0 2.328049752975403e-09
, O 0 9.451626113710088e-12
ATM O 0 1.3399792919699394e-07
, O 0 1.8613459731864346e-11
result O 0 7.585449629532448e-11
in O 0 4.88753315597279e-10
an O 0 0.008424019441008568
autosomal B-Disease 1 1.0
recessive I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
that O 0 9.883761720175244e-08
embraces O 0 1.6971282157385303e-09
a O 0 9.278490302466746e-12
variety O 0 7.591694200365096e-13
of O 0 2.0068429069149823e-13
clinical O 0 1.243903730019369e-10
features O 0 1.509944347333203e-08
and O 0 2.7432296434426462e-08
manifests O 0 1.1340528089931468e-06
extreme O 0 8.436149556700911e-08
radiosensitivity O 0 1.749720104271546e-05
and O 0 1.1004650524171211e-09
a O 0 3.107296017712535e-11
strong O 0 7.613787378346615e-11
pre O 0 1.2738072996398841e-07
- O 0 1.9420996977714822e-05
disposition O 0 6.811296202613448e-07
to O 0 6.2610139295316e-09
malignancy B-Disease 0 0.0006208351696841419
. O 0 3.024160033504586e-09

Heterozygotes O 0 4.901859540495934e-08
for O 0 7.086421835618417e-13
the O 0 2.292914122459244e-13
ATM O 0 4.089427463327411e-08
gene O 0 7.480115193914116e-09
have O 0 6.629439219807409e-10
no O 0 1.1456548600422e-12
clinical O 0 6.2118778003383834e-12
expression O 0 4.384263785350839e-11
of O 0 1.2955911343759396e-10
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999991655349731
T I-Disease 1 1.0
but O 0 7.123866907932097e-06
may O 0 6.036705357814753e-09
be O 0 1.1293694868186321e-09
cancer B-Disease 0 3.1205895538732875e-06
prone O 0 2.6223007807857357e-05
with O 0 4.337624009975727e-12
a O 0 2.428796573583636e-11
moderate O 0 7.792151812680004e-09
increase O 0 1.806821944665138e-12
in O 0 1.4581301660890333e-12
in O 0 1.1593236787232897e-11
vitro O 0 5.248535899227136e-07
radiosensitivity O 0 4.522092785919085e-05
. O 0 6.937938556994538e-10

We O 0 3.0726113209311734e-08
performed O 0 1.576902830535687e-09
a O 0 1.8249996999730733e-11
blind O 0 2.640312857238314e-08
chromosomal O 0 5.121939850027957e-08
analysis O 0 5.686103497770656e-12
on O 0 1.965557994143552e-10
G2 O 0 1.3863742651665234e-06
- O 0 7.654610278962082e-09
phase O 0 1.6079451659045674e-10
lymphocytes O 0 2.233480955737832e-09
from O 0 3.1232050908165665e-13
7 O 0 1.808119105828343e-11
unrelated O 0 7.025044368447197e-08
A B-Disease 1 0.9999951124191284
- I-Disease 1 0.9999914169311523
T I-Disease 1 0.9999995231628418
patients O 0 1.750779521358936e-10
, O 0 7.471964771899302e-15
13 O 0 4.5827765546161206e-14
obligate O 0 4.905074124650355e-09
A B-Disease 1 0.9999978542327881
- I-Disease 1 0.9999988079071045
T I-Disease 1 0.9999998807907104
heterozygotes O 0 3.315008507343009e-05
( O 0 1.7782907308153129e-12
parents O 0 2.6298835071464355e-12
of O 0 2.5123986126528467e-15
the O 0 4.446157851611954e-12
patients O 0 6.989213461455757e-12
) O 0 5.476753084246791e-14
, O 0 1.767363721192662e-14
and O 0 8.164530791894553e-13
14 O 0 2.1109057156323136e-13
normal O 0 1.552463805296403e-13
controls O 0 2.3154134859426634e-11
following O 0 1.7399617987731708e-12
X O 0 2.7337547336969692e-08
- O 0 1.9468945899880907e-10
irradiation O 0 4.431952374539527e-11
with O 0 3.8528958669348246e-12
1 O 0 1.217888203480788e-12
Gy O 0 9.985210575047532e-12
in O 0 4.0602810200254585e-16
order O 0 1.5050481629881986e-15
to O 0 1.625570681108e-15
evaluate O 0 1.4485376399341228e-14
this O 0 7.156035035100605e-16
cytogenetic O 0 5.080151143505018e-12
method O 0 2.170175389219764e-13
as O 0 9.104483558394511e-15
a O 0 1.1007808307247576e-15
tool O 0 9.558042725343885e-12
for O 0 1.3306846573206676e-16
detection O 0 1.3427602779669812e-11
of O 0 4.265101845242784e-15
ATM O 0 1.0683517075449345e-06
carriers O 0 1.4956036409330409e-09
. O 0 4.838651146421569e-10

Both O 0 9.61650314934559e-08
A B-Disease 1 0.9997804760932922
- I-Disease 1 0.9999443292617798
T I-Disease 1 0.9999977350234985
homozygotes O 0 8.658052138343919e-06
and O 0 7.240378435691142e-11
heterozygotes O 0 6.729519719250732e-11
showed O 0 1.5868880862135448e-11
significantly O 0 3.160707372912297e-13
increased O 0 1.775848619631898e-14
levels O 0 4.337259718045772e-12
of O 0 4.847567659782559e-13
radiation O 0 6.526952347485349e-05
- O 0 0.01828537881374359
induced O 1 0.9294887185096741
chromatid O 1 0.5948402285575867
damage O 0 9.23749539651908e-05
relative O 0 8.368543635839387e-10
to O 0 9.753787404490066e-13
that O 0 1.4068162867281186e-12
of O 0 1.0582315493996245e-14
normal O 0 6.906314409249603e-11
controls O 0 6.1803831385987e-08
. O 0 4.782235940581359e-09

These O 0 2.207829613576351e-10
results O 0 2.0031622194327525e-11
show O 0 2.5077693394104372e-11
that O 0 1.4132963259438393e-14
the O 0 1.8061827329455583e-14
G2 O 0 1.6505904909536184e-07
- O 0 9.753363627851286e-08
phase O 0 3.2844418296207323e-09
chromosomal O 0 5.22987284057308e-05
radiosensitivity O 0 3.865162852889625e-06
assay O 0 3.925854628050729e-07
can O 0 1.2225389103837081e-11
be O 0 1.9480531283141284e-14
used O 0 2.8720434233978076e-14
for O 0 8.470713284347228e-17
the O 0 1.4662836578054582e-14
detection O 0 4.4431125445498765e-09
of O 0 2.8475130239846713e-11
A B-Disease 1 0.9999948740005493
- I-Disease 1 0.9999724626541138
T I-Disease 1 0.9999971389770508
heterozygotes O 0 1.3438534551823977e-06
. O 0 1.4390316716017537e-10

In O 0 1.3504715401513323e-10
combination O 0 1.2217934997060809e-10
with O 0 3.473658426872417e-12
molecular O 0 1.8679230384677226e-10
genetic O 0 3.1218299056945398e-09
analyses O 0 5.445092376987759e-09
, O 0 1.3490188133236103e-11
this O 0 3.8962093100447515e-12
test O 0 5.21993070989879e-09
may O 0 1.9522109623304473e-11
be O 0 3.445953917179112e-13
of O 0 1.0669539347014467e-15
value O 0 1.6235374589862461e-12
in O 0 1.8915468150138004e-13
studies O 0 1.2124282480763249e-11
of O 0 3.230344797536776e-14
familial B-Disease 0 3.221623785520933e-07
and I-Disease 0 1.9537411688475004e-08
sporadic I-Disease 0 3.252320937008335e-07
cancers I-Disease 0 6.663927342742682e-05
aimed O 0 9.4378627579772e-08
at O 0 1.4750995092072117e-07
determination O 0 2.856600511691454e-09
of O 0 3.521007329760641e-15
the O 0 1.4842505479881196e-13
potential O 0 2.270272945331664e-12
involvement O 0 1.9694551978838293e-12
of O 0 6.784718660913895e-15
ATM O 0 7.933988854347263e-06
mutations O 0 6.917845780662901e-07
in O 0 1.2564344009646788e-10
tumor B-Disease 0 0.0007451510755345225
risk O 0 2.4121344921468335e-08
or O 0 1.2869505808255077e-11
development O 0 3.284848521661887e-13
. O 0 1.540075532380225e-11
. O 0 2.6549448750579074e-10

Ataxia B-Disease 1 0.999976396560669
- I-Disease 1 0.9999282360076904
telangiectasia I-Disease 1 0.9999922513961792
: O 0 1.5181247370321671e-09
identification O 0 7.374062471754428e-11
and O 0 1.3357356887233607e-11
detection O 0 1.479730782349975e-09
of O 0 2.41016001644237e-13
founder O 0 1.507498481601033e-08
- O 0 3.243347634906968e-07
effect O 0 6.955839237932082e-10
mutations O 0 2.6411764442180186e-10
in O 0 1.2640805455599747e-14
the O 0 4.395393215519093e-14
ATM O 0 3.7097631633287165e-08
gene O 0 2.7213820086302576e-09
in O 0 3.5620143987169506e-12
ethnic O 0 7.423086451074923e-11
populations O 0 2.9387687838777765e-09
. O 0 2.3522910286288834e-09

To O 0 3.2579947854133318e-12
facilitate O 0 1.6803305437611965e-13
the O 0 7.006183556489826e-14
evaluation O 0 4.822719982156172e-14
of O 0 5.216587401541577e-16
ATM O 0 1.2180533026651119e-08
heterozygotes O 0 4.9363884507824807e-11
for O 0 8.453742026336922e-15
susceptibility O 0 6.189070922424378e-10
to O 0 3.4166568879667736e-11
other O 0 2.2944399158397744e-10
diseases O 0 3.209320880159794e-07
, O 0 6.537388360684793e-13
such O 0 8.796531211774372e-13
as O 0 3.743005194678517e-08
breast B-Disease 0 0.0001646862510824576
cancer I-Disease 0 6.752261015208205e-06
, O 0 6.179357373015115e-12
we O 0 1.2547189849609897e-11
have O 0 1.3093974689237786e-12
attempted O 0 8.916462013175419e-10
to O 0 8.598666050019244e-12
define O 0 1.1442845282427783e-10
the O 0 1.7873121602521302e-12
most O 0 1.2438955030932841e-12
common O 0 1.5180848115040058e-12
mutations O 0 2.567929896502008e-11
and O 0 3.940202385286501e-13
their O 0 5.678763123802277e-13
frequencies O 0 1.5050412116579537e-07
in O 0 1.5800503661012044e-07
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999984502792358
telangiectasia I-Disease 1 0.9999997615814209
( O 0 7.418336736009223e-06
A B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999986886978149
T I-Disease 1 0.9999998807907104
) O 0 6.2685661106343105e-09
homozygotes O 0 2.883544292231477e-09
from O 0 3.9494320628555984e-14
10 O 0 1.623979271371534e-13
ethnic O 0 6.612279625749229e-13
populations O 0 1.7245964378798107e-10
. O 0 2.1448708087401513e-10

Both O 0 6.331198759701451e-11
genomic O 0 3.91447407821488e-08
mutations O 0 1.2994713642910938e-06
and O 0 4.7969805905268e-09
their O 0 8.632473208480818e-11
effects O 0 7.425947357031504e-11
on O 0 1.9481751281635873e-11
cDNA O 0 1.8338303320319937e-08
were O 0 1.6026643345767866e-09
characterized O 0 4.638453621197414e-09
. O 0 8.148375030270216e-11

Protein O 0 7.476381824744749e-08
- O 0 9.640451281711648e-08
truncation O 0 6.547911368670611e-08
testing O 0 7.703407911563431e-10
of O 0 4.2289572553175486e-15
the O 0 6.077213639412533e-15
entire O 0 7.476843851082077e-14
ATM O 0 7.243770028253493e-09
cDNA O 0 7.588756290033416e-09
detected O 0 9.866411119219265e-07
92 O 0 5.129278779492097e-09
( O 0 5.146467019906398e-13
66 O 0 1.109874858684634e-09
% O 0 5.667553015439863e-13
) O 0 1.4171786845169204e-13
truncating O 0 7.607302565659779e-10
mutations O 0 2.658584463688385e-09
in O 0 1.4056621535155078e-13
140 O 0 1.2711853054556133e-12
mutant O 0 1.4739653941830966e-08
alleles O 0 1.1048358672383074e-08
screened O 0 3.0575570235669147e-06
. O 0 2.2293367152315113e-08

The O 0 7.150994241200692e-10
haplotyping O 0 4.92964045406552e-06
of O 0 1.4604857254130188e-11
patients O 0 1.9291773734053663e-10
with O 0 5.212165074541808e-11
identical O 0 1.2716576236471155e-07
mutations O 0 5.572063059844368e-07
indicates O 0 1.9458497035884648e-08
that O 0 2.8041699517977747e-10
almost O 0 1.261890245074504e-11
all O 0 1.2581405101769194e-12
of O 0 1.0631420873860598e-13
these O 0 2.1810079783857184e-11
represent O 0 4.0472359079564424e-13
common O 0 1.5700001299023825e-09
ancestry O 0 3.216423749563546e-07
and O 0 3.808318993492321e-09
that O 0 6.220346460139581e-11
very O 0 7.921522812703863e-12
few O 0 3.61464712328452e-11
spontaneously O 0 1.8102708221334751e-09
recurring O 0 5.238232070325921e-09
ATM O 0 0.0001719478750601411
mutations O 0 8.73679164214991e-06
exist O 0 1.6202955421817933e-08
. O 0 7.49325312909832e-09

Assays O 0 4.045840995559047e-08
requiring O 0 1.4096164513421883e-10
minimal O 0 1.121693536665358e-11
amounts O 0 1.0844230109155126e-13
of O 0 2.793816415532142e-15
genomic O 0 2.519491559827003e-11
DNA O 0 5.933943469926817e-08
were O 0 9.07270855665665e-11
designed O 0 1.4474709625345028e-11
to O 0 1.0220447772336157e-14
allow O 0 2.0992837036179794e-15
rapid O 0 7.0308918463744124e-15
screening O 0 1.4260237413653287e-13
for O 0 6.905720705560961e-15
common O 0 1.8310097361917688e-12
ethnic O 0 2.965408300859007e-12
mutations O 0 7.029762372212645e-08
. O 0 9.559656399815708e-10

These O 0 3.35666910933341e-11
rapid O 0 1.9213693136510557e-11
assays O 0 3.136960913252551e-09
detected O 0 2.0184026894298768e-08
mutations O 0 2.3427895179395364e-09
in O 0 6.692217092985064e-12
76 O 0 1.2113575920125186e-08
% O 0 9.304063595949597e-12
of O 0 8.457593132782382e-12
Costa O 0 7.723172643636644e-07
Rican O 0 3.821826410899121e-08
patients O 0 2.5915147805477545e-10
( O 0 1.3582772585032888e-15
3 O 0 1.0702861123410012e-12
) O 0 2.6925046935945274e-13
, O 0 6.064144683366052e-14
50 O 0 2.0245357311172302e-13
% O 0 1.1537629745095746e-14
of O 0 6.98068339244351e-13
Norwegian O 0 0.0012023882009088993
patients O 0 3.0530261652117474e-10
( O 0 2.400696989766633e-15
1 O 0 1.7132892056025834e-13
) O 0 2.639037534508948e-13
, O 0 3.3091476607516324e-13
25 O 0 4.073181028574346e-12
% O 0 3.7396111597989834e-14
of O 0 1.7317333819103636e-13
Polish O 0 6.802754342061235e-06
patients O 0 8.665433648413767e-11
( O 0 1.5043594193229625e-15
4 O 0 1.430194721332989e-12
) O 0 7.58937780242358e-13
, O 0 1.4329927218795224e-13
and O 0 1.1063609230144156e-11
14 O 0 1.7499474092019796e-11
% O 0 5.5152351462932694e-14
of O 0 9.644364300231967e-13
Italian O 0 6.885161383252125e-06
patients O 0 1.1106111863501411e-10
( O 0 3.1159667622954754e-15
1 O 0 1.0100172651364425e-12
) O 0 1.1217486358197637e-12
, O 0 7.347166494989232e-14
as O 0 9.176315171046875e-14
well O 0 1.7701175269481395e-13
as O 0 5.934754640848916e-13
in O 0 1.9862830455928682e-13
patients O 0 5.841530059148836e-13
of O 0 1.5911500361644876e-14
Amish O 0 2.140402557415655e-07
/ O 0 1.406774146062162e-07
Mennonite O 0 4.070355146268412e-07
and O 0 3.841559248485282e-08
Irish O 0 5.103859379573805e-08
English O 0 4.547078824579387e-10
backgrounds O 0 7.936090673510421e-11
. O 0 9.179549481652671e-11

Additional O 0 1.577460731483349e-11
mutations O 0 2.0577517467756934e-09
were O 0 2.5988591487169366e-11
observed O 0 3.465593090279384e-11
in O 0 1.6915695190064528e-13
Japanese O 0 2.647107255615566e-10
, O 0 3.187199039845351e-13
Utah O 0 4.975741346724405e-11
Mormon O 0 3.8549874403770445e-10
, O 0 2.159902248374812e-12
and O 0 9.295035227618875e-12
African O 0 3.2541609923213144e-13
American O 0 1.2817033892553731e-11
patients O 0 1.7292464335461055e-11
. O 0 9.369240626388997e-12

These O 0 2.45382837313346e-12
assays O 0 2.70086036868733e-11
should O 0 2.4525251146882872e-14
facilitate O 0 1.1036482490094503e-15
screening O 0 2.2297066536863808e-12
for O 0 3.585819835505433e-11
A B-Disease 1 0.9999845027923584
- I-Disease 1 0.9999732971191406
T I-Disease 1 0.9999992847442627
heterozygotes O 0 9.761924957274459e-08
in O 0 1.0742450630213049e-13
the O 0 2.3888191229802513e-13
populations O 0 8.008614387974844e-13
studied O 0 1.7801267187741998e-12
. O 0 3.621958690001176e-13
. O 0 2.4270137982673745e-11

The O 0 1.0240776759928849e-07
von B-Disease 1 0.9988219141960144
Hippel I-Disease 1 0.999273955821991
- I-Disease 1 0.9996616840362549
Lindau I-Disease 1 0.9996198415756226
tumor I-Disease 0 0.05034707859158516
suppressor O 0 3.1369349017040804e-05
gene O 0 1.508583551412812e-07
is O 0 4.473328998888526e-11
required O 0 1.8378209381848115e-13
for O 0 3.446339893152517e-14
cell O 0 1.7597286614545737e-06
cycle O 0 1.1061474651796743e-06
exit O 0 1.381288594615171e-08
upon O 0 6.497503923785786e-11
serum O 0 4.5224069822324964e-07
withdrawal O 0 9.330521244521606e-09
. O 0 1.688378437059157e-09

The O 0 1.418903883276812e-10
inactivation O 0 5.740929509556736e-07
of O 0 4.897821731519869e-12
the O 0 5.535019109714767e-09
von B-Disease 1 0.9995473027229309
Hippel I-Disease 1 0.999782383441925
- I-Disease 1 0.999947190284729
Lindau I-Disease 1 0.9999282360076904
( I-Disease 0 2.064132864632029e-08
VHL I-Disease 0 0.00011737017484847456
) I-Disease 0 3.131710446524494e-10
tumor I-Disease 0 2.7900358645638335e-07
suppressor O 0 3.647978473964031e-06
gene O 0 2.843663878593361e-06
predisposes O 0 6.993402348598465e-05
affected O 0 1.8993044637038992e-10
individuals O 0 5.619327702807708e-14
to O 0 2.217022572470473e-12
the O 0 9.413889667797548e-10
human O 0 0.0002691081608645618
VHL B-Disease 1 0.9999902248382568
cancer I-Disease 1 0.9999983310699463
syndrome I-Disease 1 0.9999973773956299
and O 0 6.668706031831562e-09
is O 0 1.0701320385386737e-10
associated O 0 2.369324181294985e-10
with O 0 3.571760387455214e-10
sporadic B-Disease 0 0.0036539568100124598
renal I-Disease 1 0.9999858140945435
cell I-Disease 1 0.9999921321868896
carcinomas I-Disease 1 0.9999994039535522
( O 0 1.402076890144599e-07
RCC B-Disease 0 0.3891199231147766
) O 0 1.047203852522216e-07
and O 0 1.1236829067229337e-07
brain B-Disease 0 0.014625513926148415
hemangioblastomas I-Disease 0 0.002515177708119154
. O 0 6.03318497383043e-08

VHL O 0 0.006733008194714785
- O 0 2.8296693926677108e-05
negative O 0 8.042924548590236e-08
786 O 0 8.82087931586284e-07
- O 0 2.0334675355115905e-05
0 O 0 9.459178329507267e-09
RCC B-Disease 0 1.3768769804300973e-06
cells O 0 8.79515660301422e-09
are O 0 1.7401883753431768e-11
tumorigenic O 0 2.592516693766811e-06
in O 0 5.086189247549555e-09
nude O 0 0.03714346885681152
mice O 0 0.004232149571180344
which O 0 6.025443699542166e-09
is O 0 6.4056667956058355e-12
suppressed O 0 1.2853928858802544e-11
by O 0 1.2959641362440474e-14
the O 0 6.864357715054281e-14
reintroduction O 0 2.3876258747890233e-09
of O 0 1.01728911752752e-11
VHL B-Disease 0 1.43855768328649e-05
. O 0 5.893062149375794e-10

Remarkably O 0 3.2203828936872014e-07
, O 0 1.8545031829630965e-11
this O 0 5.367804725014969e-13
occurs O 0 2.9723621567528946e-12
without O 0 8.491707228878986e-14
affecting O 0 7.668824207390443e-14
the O 0 2.3669909348517093e-12
growth O 0 4.261236252744993e-09
rate O 0 9.69632285574562e-09
and O 0 9.87948819974882e-11
cell O 0 3.198653939762153e-05
cycle O 0 1.7501688489574008e-06
profile O 0 4.6979038437200416e-09
of O 0 1.7470198532720978e-14
these O 0 4.841773683372796e-13
cells O 0 2.6599260988247053e-11
in O 0 1.617450612464641e-13
culture O 0 3.1208535755666844e-09
. O 0 1.016880912807494e-09

The O 0 1.7880777414269744e-10
786 O 0 2.7673353386603594e-08
- O 0 3.319119969091844e-06
0 O 0 4.8590274026594216e-09
cell O 0 3.7553440961346496e-06
line O 0 2.8763925001840107e-05
, O 0 2.603135415557567e-11
like O 0 4.856398269637019e-12
many O 0 2.0790235310229332e-13
cancer B-Disease 0 2.9973594717347396e-09
cells O 0 8.873386470042988e-10
, O 0 5.118816481797239e-11
fails O 0 5.710667849712081e-08
to O 0 6.660763520599522e-12
exit O 0 8.353557845452997e-09
the O 0 2.276331380335339e-11
cell O 0 4.0216859815700445e-06
cycle O 0 5.231644806258373e-08
upon O 0 1.941346215728057e-11
serum O 0 2.6182428314314166e-07
withdrawal O 0 2.2146009470702666e-08
. O 0 8.008535501424774e-10

Here O 0 8.454380306943676e-09
, O 0 6.543180060269993e-12
it O 0 1.063160952503861e-12
is O 0 2.1500559172675862e-14
shown O 0 1.3091272315322866e-13
that O 0 2.003379668714532e-15
reintroduction O 0 1.658396727236e-12
of O 0 5.273973354322464e-16
the O 0 1.5225264083339185e-13
wild O 0 7.448534011800234e-10
- O 0 1.017218892229721e-06
type O 0 1.9071428880579333e-09
VHL B-Disease 0 1.6000690550299623e-08
gene O 0 3.4384203817516834e-11
restores O 0 2.4870843162716483e-09
the O 0 1.7539096260413278e-12
ability O 0 5.172267059094793e-10
of O 0 8.118708830218146e-12
VHL O 0 0.010146068409085274
- O 0 0.00882852915674448
negative O 0 7.3183873610105366e-06
RCC B-Disease 0 0.0027145566418766975
cancer I-Disease 0 7.497765750485996e-07
cells O 0 1.0307762976502488e-10
to O 0 2.3861197306213056e-12
exit O 0 1.4284602389835754e-09
the O 0 5.3993003644448034e-12
cell O 0 2.4723653950786684e-06
cycle O 0 2.615013556805934e-07
and O 0 2.009599084362712e-11
enter O 0 1.0899524338636724e-11
G0 O 0 2.0586614937201375e-06
/ O 0 1.7376842720295826e-07
quiescence O 0 1.1802172821262502e-06
in O 0 4.439634423980543e-11
low O 0 1.935080007342549e-07
serum O 0 1.9102765236311825e-06
. O 0 5.582611040111374e-10

Both O 0 3.850462615417882e-09
VHL O 0 0.00017519544053357095
- O 0 5.9186768339714035e-06
positive O 0 9.547926005382124e-09
and O 0 1.1975736846636664e-08
VHL O 0 7.833787094568834e-05
- O 0 9.584351573721506e-06
negative O 0 3.821491034727842e-08
RCC B-Disease 0 3.4271879485459067e-06
cells O 0 8.84014550450729e-09
exit O 0 3.743590681892783e-08
the O 0 4.355525315413722e-11
cell O 0 6.584672064491315e-06
cycle O 0 2.058373809177283e-07
by O 0 3.9390604493483306e-13
contact O 0 4.544009890583567e-10
inhibition O 0 6.503226401832762e-09
. O 0 2.3653203840012793e-09

The O 0 9.852094695617097e-10
cyclin O 0 7.318833922909107e-06
- O 0 2.06706793903777e-08
dependent O 0 1.723478304516135e-10
kinase O 0 3.829911676689335e-08
inhibitor O 0 4.988174762132758e-09
, O 0 8.913485590898371e-14
p27 O 0 8.431870653080598e-12
, O 0 1.3802362064960303e-14
accumulates O 0 1.676382123394493e-11
upon O 0 8.348985023297339e-13
serum O 0 4.934796038469358e-08
withdrawal O 0 6.655906381602961e-10
, O 0 1.7536485501581933e-12
only O 0 4.354073254286134e-14
in O 0 9.27831758906067e-15
the O 0 2.162040349269062e-13
presence O 0 3.961492592297056e-12
of O 0 5.488132734723927e-13
VHL B-Disease 0 5.290488047648978e-07
, O 0 9.016254539848112e-13
as O 0 5.328358739474515e-13
a O 0 5.708304055135338e-12
result O 0 8.535869060188883e-12
of O 0 3.9520753138708e-15
the O 0 1.1338938685559463e-12
stabilization O 0 4.323714129783607e-12
of O 0 1.0922560793853535e-15
the O 0 1.423270952049388e-13
protein O 0 1.562077966976716e-10
. O 0 1.0907052171160725e-11

We O 0 7.29027949120109e-11
propose O 0 5.2113278969923016e-12
that O 0 4.2783407025459574e-12
the O 0 4.0336744361324506e-12
loss O 0 7.853965811044361e-10
of O 0 1.1213582044530563e-14
wild O 0 5.0016750741121996e-09
- O 0 0.00011766781972255558
type O 0 9.783212107095096e-08
VHL B-Disease 0 1.6169724403880537e-06
gene O 0 2.563728562776646e-09
results O 0 3.1038012437978324e-11
in O 0 2.269096445367048e-15
a O 0 1.3956532225755953e-15
specific O 0 2.56677512089961e-14
cellular O 0 2.895641841860197e-07
defect O 0 9.088506089938164e-07
in O 0 1.1598500805620748e-11
serum O 0 6.013763595547061e-06
- O 0 3.2477831268806767e-07
dependent O 0 4.2879893413783066e-08
growth O 0 3.3140683530774595e-09
control O 0 9.155414915085203e-08
, O 0 1.68546496204236e-11
which O 0 4.407169421072332e-11
may O 0 8.145666433034826e-12
initiate O 0 7.30911338397977e-12
tumor B-Disease 0 4.535831124030665e-07
formation O 0 1.6419665627154245e-09
. O 0 2.863528303365115e-09

This O 0 2.5289245697557305e-10
is O 0 1.1086423445938465e-11
corrected O 0 1.2144847350015198e-09
by O 0 3.205950248655852e-15
the O 0 4.87283231478822e-15
reintroduction O 0 3.1314041637475754e-11
of O 0 7.54037403263158e-14
wild O 0 3.5883276350290316e-09
- O 0 5.8171874115942046e-05
type O 0 1.849832642619731e-07
VHL B-Disease 0 0.00045345837133936584
, O 0 3.529488090681099e-10
implicating O 0 5.576528678830073e-07
VHL B-Disease 0 3.745019228063029e-07
as O 0 1.0409562751709234e-12
the O 0 1.2756756642782335e-13
first O 0 5.290930887857925e-12
tumor B-Disease 0 1.3995287595491845e-08
suppressor O 0 2.5034145423319387e-08
involved O 0 6.197251045669816e-12
in O 0 8.793859466570825e-14
the O 0 5.659926195257514e-13
regulation O 0 4.745929690908035e-11
of O 0 1.9048413020528177e-13
cell O 0 4.7505320253549144e-05
cycle O 0 3.727202056325041e-05
exit O 0 1.989156089621247e-06
, O 0 5.348038678576472e-10
which O 0 2.5036892004060007e-10
is O 0 7.647155478296419e-12
consistent O 0 3.035072887458412e-11
with O 0 5.102609957827187e-13
its O 0 2.757999210956097e-11
gatekeeper O 0 4.60738363017299e-07
function O 0 1.576289321292279e-09
in O 0 8.004571831754514e-12
the O 0 1.1449946546449041e-09
kidney O 0 1.1973168511758558e-05
. O 0 6.543395686398057e-11
. O 0 3.7472230873802914e-10

Piebaldism B-Disease 1 0.9998828172683716
with O 0 0.2948410212993622
deafness B-Disease 1 0.9999969005584717
: O 0 2.11877582145803e-09
molecular O 0 1.781657044119811e-10
evidence O 0 1.0737545401429127e-11
for O 0 1.2732229279135282e-13
an O 0 2.967559878386261e-11
expanded O 0 1.2532529581221752e-05
syndrome O 1 0.9998537302017212
. O 0 1.4021953376186502e-08

In O 0 4.302056627603079e-11
a O 0 5.333987071476365e-11
South O 0 2.9997487827060354e-10
African O 0 7.182933501465039e-12
girl O 0 9.150710744698642e-10
of O 0 4.0064729555895975e-14
Xhosa O 0 5.32030641764436e-09
stock O 0 1.5494783234260012e-10
with O 0 4.926456118048428e-11
severe O 0 3.844417761911245e-08
piebaldism B-Disease 0 6.8510307755786926e-06
and O 0 8.115841332312357e-09
profound O 0 5.873093869013246e-07
congenital O 1 0.9999712705612183
sensorineural B-Disease 1 0.9998037219047546
deafness I-Disease 1 0.9999995231628418
we O 0 1.7026247078888446e-08
identified O 0 1.7111298489247417e-10
a O 0 1.901647892973979e-12
novel O 0 5.7775562112283296e-11
missense O 0 1.0489460411378104e-09
substitution O 0 2.165100564111011e-11
at O 0 2.7698304760903625e-10
a O 0 1.513120547911792e-13
highly O 0 9.01708015980246e-13
conserved O 0 2.9171548510120715e-10
residue O 0 4.0125041067540224e-08
in O 0 2.6312741810858306e-15
the O 0 1.9011806967053277e-15
intracellular O 0 1.1835441515728462e-09
kinase O 0 1.812571639447924e-07
domain O 0 2.0546132850629562e-10
of O 0 1.856496151199285e-14
the O 0 5.338045977465455e-12
KIT O 0 9.778862022358226e-07
proto O 0 1.290153051058951e-07
- O 0 7.126995171802264e-08
oncogene O 0 6.983262892390485e-07
, O 0 2.891317740782995e-11
R796G O 0 3.564507133901884e-09
. O 0 8.537338891390078e-11

Though O 0 1.0965981545041359e-07
auditory B-Disease 0 1.6277925169561058e-05
anomalies I-Disease 0 5.589376814896241e-05
have O 0 9.51644985036637e-10
been O 0 5.909582545537972e-11
observed O 0 1.6022479176758253e-10
in O 0 2.3958929458445244e-12
mice O 0 1.1950568534757622e-08
with O 0 1.3016689288936067e-11
dominant O 0 2.0845806147917756e-07
white O 0 2.8258104975975584e-06
spotting O 0 0.0003511063987389207
( O 0 3.554037064645854e-10
W O 0 0.003935336135327816
) O 0 4.572216737164236e-12
due O 0 3.3472239736875853e-12
to O 0 1.1384626748267568e-11
KIT O 0 5.697661435988266e-06
mutations O 0 1.7731499610817991e-06
, O 0 6.547187325622872e-08
deafness B-Disease 1 0.9999997615814209
is O 0 6.679475195170426e-09
not O 0 1.235903324126042e-10
typical O 0 2.1706587916003883e-10
in O 0 2.7515940914657477e-11
human O 0 7.946065139208258e-09
piebaldism B-Disease 0 0.00018051840015687048
. O 0 1.3251584718432241e-08

Thus O 0 3.665443726319495e-09
, O 0 8.068717677507664e-13
the O 0 4.754121833076656e-14
occurrence O 0 2.631101558847604e-09
of O 0 9.107250509288178e-10
sensorineural B-Disease 1 0.9996700286865234
deafness I-Disease 1 0.9999997615814209
in O 0 2.805043308740096e-09
this O 0 6.040128033152348e-12
patient O 0 1.2935713611383903e-10
extends O 0 3.6644406259389584e-11
considerably O 0 4.8844553401927726e-11
the O 0 1.0753356348815538e-13
phenotypic O 0 4.348815578480991e-12
range O 0 1.790617765173863e-09
of O 0 3.5187165681183075e-12
piebaldism B-Disease 0 1.7328846979580703e-06
due O 0 1.4391187894147173e-11
to O 0 2.1624486869122744e-13
KIT O 0 1.2215518596647712e-09
gene O 0 4.5546628968384795e-11
mutation O 0 2.4719634672543123e-10
in O 0 2.8897048057370534e-13
humans O 0 1.9021529143459226e-11
and O 0 5.664770388880136e-11
tightens O 0 5.565453102462925e-05
the O 0 7.255734207900488e-12
clinical O 0 9.527123534525117e-11
similarity O 0 3.1212210593878353e-10
between O 0 3.832100192724397e-10
piebaldism B-Disease 0 7.168765932874521e-06
and O 0 8.683567059852848e-11
the O 0 5.925759150949075e-14
various O 0 1.180309105661137e-13
forms O 0 2.8403379648267446e-10
of O 0 1.0912275882901668e-07
Waardenburg B-Disease 1 0.9999769926071167
syndrome I-Disease 1 0.9995452761650085
. O 0 2.757972843159262e-11
. O 0 2.2195166538008237e-10

Cycloheximide O 0 8.288037633974454e-07
facilitates O 0 2.428288403688583e-10
the O 0 7.099896300218067e-13
identification O 0 3.2040127495580606e-11
of O 0 1.4341110764204412e-13
aberrant O 0 6.038654021267575e-08
transcripts O 0 1.6678870906616794e-06
resulting O 0 3.6072538289744216e-09
from O 0 1.1675514071177173e-12
a O 0 2.6680292090214275e-12
novel O 0 1.4159245997902303e-10
splice O 0 0.002939219120889902
- O 0 2.1846995878149755e-05
site O 0 2.9583411560452078e-06
mutation O 0 3.3146838518405275e-07
in O 0 7.136397722762311e-11
COL17A1 O 0 6.399833364412189e-05
in O 0 3.579784038643119e-12
a O 0 1.5499801095386623e-11
patient O 0 3.317603747277076e-09
with O 0 1.5950517295859612e-10
generalized O 0 1.770269250300771e-06
atrophic B-Disease 1 0.8545379638671875
benign I-Disease 1 0.9959194660186768
epidermolysis I-Disease 1 0.9910919070243835
bullosa I-Disease 1 0.9391321539878845
. O 0 1.0347168881708058e-06

Patients O 0 2.8886469749522803e-07
with O 0 1.2261294202176032e-09
generalized O 0 3.290480890427716e-06
atrophic B-Disease 0 0.38128671050071716
benign I-Disease 1 0.9862439036369324
epidermolysis I-Disease 1 0.9482607841491699
bullosa I-Disease 1 0.614144504070282
often O 0 3.4355655316176126e-06
show O 0 2.6532117658462084e-07
decreased O 0 6.947662001266508e-09
expression O 0 1.4413466080387405e-11
of O 0 1.5343455672667261e-12
type O 0 2.6943352438024704e-08
XVII O 0 9.892745765682776e-06
collagen O 0 4.2349583395662194e-07
, O 0 8.560950559566294e-11
a O 0 1.5786375678894515e-11
transmembrane O 0 2.3977403174058054e-08
hemidesmosomal O 0 2.8266997631476443e-08
protein O 0 1.7667530632925477e-11
encoded O 0 6.561366727719786e-11
by O 0 1.5371908607120233e-11
COL17A1 O 0 2.021882937697228e-05
. O 0 1.283747663727297e-09

This O 0 1.5095137639864475e-10
report O 0 7.2225133859737944e-12
documents O 0 1.2700607709623113e-12
a O 0 3.4109236160366485e-13
novel O 0 5.905838752068293e-12
splice O 0 5.868671723874286e-05
- O 0 2.9375819394772407e-06
site O 0 2.3494230561027507e-07
mutation O 0 4.3731628096566055e-08
in O 0 1.3227825952644157e-11
COL17A1 O 0 4.493200776778394e-06
in O 0 6.835330912391413e-13
a O 0 4.0646440206681955e-12
patient O 0 7.847810734595839e-10
with O 0 8.77229608398089e-11
generalized O 0 1.999577676770059e-07
atrophic B-Disease 0 0.06820271164178848
benign I-Disease 1 0.5238045454025269
epidermolysis I-Disease 0 0.1412351429462433
bullosa I-Disease 0 0.03239067271351814
, O 0 9.375650256160384e-10
and O 0 5.645718701569047e-12
applies O 0 2.276051255020034e-13
a O 0 4.4072130520782585e-14
new O 0 2.4507200874776883e-14
methodology O 0 1.8363966597378933e-11
to O 0 2.4523310899332573e-12
define O 0 1.92770979734469e-10
and O 0 5.208289702296476e-11
characterize O 0 2.5789997915026674e-10
the O 0 5.589271992283151e-13
resulting O 0 5.918118425873864e-12
mRNA O 0 2.455450842653306e-10
splice O 0 0.0001437213650206104
variants O 0 3.7140048902983835e-07
. O 0 7.80471953731876e-09

Mutational O 0 2.401411984465085e-05
analysis O 0 3.1876250528029004e-09
of O 0 9.78224185682608e-12
COL17A1 O 0 8.244844025284692e-07
identified O 0 1.0237252157097032e-09
a O 0 5.618939688534219e-11
maternally O 0 8.90859701030422e-06
inherited O 0 0.0014934457140043378
G O 0 5.286323357722722e-05
- O 0 1.421685311697729e-07
to O 0 5.754027476712054e-09
- O 0 0.0001313171087531373
T O 0 0.0001078142668120563
transversion O 0 6.216654924173781e-08
at O 0 1.809651040129978e-11
the O 0 6.798479558174989e-14
- O 0 9.855622568055722e-11
1 O 0 4.742196761144124e-13
position O 0 2.0394089195185927e-11
of O 0 1.145950874340343e-14
exon O 0 5.206842179639182e-10
32 O 0 4.520298302335135e-10
. O 0 9.750039664524479e-11

This O 0 1.5242510378876695e-11
acceptor O 0 3.674723858537732e-10
splice O 0 0.00011390732834115624
- O 0 1.1825092769868206e-05
site O 0 6.9656431378462e-07
mutation O 0 2.545006516641024e-08
led O 0 1.7035356458805495e-10
to O 0 1.6189854361650657e-12
the O 0 3.22843694052638e-13
formation O 0 5.245773433693035e-12
of O 0 7.323102627770917e-14
aberrant O 0 6.622642878539864e-09
transcripts O 0 1.922237302665053e-08
present O 0 1.0692093911635059e-11
at O 0 4.5610895615944003e-10
extremely O 0 9.799581146552327e-10
low O 0 4.604642356298427e-08
levels O 0 1.4958575489387727e-09
. O 0 1.633998908401324e-10

Based O 0 7.297249610127565e-11
on O 0 2.2689419787447207e-10
our O 0 9.45130172042008e-12
recent O 0 4.846982055084145e-14
finding O 0 6.550515745063976e-14
that O 0 4.919680656780001e-13
cycloheximide O 0 1.4403127579498687e-08
stabilized O 0 2.845905555659556e-07
mutant O 0 2.2578323211064344e-08
COL17A1 O 0 1.672256075835321e-07
transcripts O 0 2.9387294819827048e-09
in O 0 1.3362821591443586e-13
keratinocytes O 0 2.530043952120309e-10
homozygous O 0 1.725524306772641e-10
for O 0 8.634551542730309e-14
a O 0 8.302180470876053e-11
frameshift O 0 3.604089670261601e-06
mutation O 0 1.3971741452678543e-07
, O 0 2.6494714755465054e-10
the O 0 4.4397617526836797e-11
effects O 0 2.4808066712012078e-09
of O 0 3.0741671686561334e-14
the O 0 5.975910738476031e-12
splice O 0 0.00027029329794459045
- O 0 2.243713197458419e-07
site O 0 1.0364768598947194e-08
mutation O 0 3.606796111776944e-11
on O 0 8.934225755041769e-12
splicing O 0 5.768774347103545e-09
of O 0 1.0564035540436278e-12
COL17A1 O 0 1.0855146825861084e-07
transcripts O 0 5.857180851442934e-10
were O 0 1.6645754598917234e-13
determined O 0 6.841823250525528e-14
using O 0 3.2784501703036e-14
reverse O 0 1.738041355281439e-08
transcriptase O 0 2.0164716829640383e-07
polymerase O 0 4.084106876689475e-06
chain O 0 1.0428949508423102e-06
reaction O 0 2.8119720094088585e-11
of O 0 2.29763997338186e-15
total O 0 1.4552864596446662e-14
RNA O 0 3.2537086358530587e-09
from O 0 1.4546709377425554e-13
keratinocytes O 0 5.2224748831042334e-11
incubated O 0 3.5223729488720323e-10
for O 0 2.048325058016682e-14
2 O 0 1.810652322520312e-11
. O 0 2.5271826298300937e-11

5 O 0 5.7959528731998944e-08
h O 0 1.9328717826283537e-06
in O 0 1.4766335723614965e-11
the O 0 1.9924689068778756e-12
presence O 0 2.3698473738953396e-11
or O 0 9.68097546572011e-11
absence O 0 3.71479062788449e-12
of O 0 4.171898998408131e-15
10 O 0 7.881465445558344e-12
microg O 0 1.0162671770785892e-07
cycloheximide O 0 7.075674091083783e-08
per O 0 1.7350015521500062e-11
ml O 0 2.0227234642788972e-07
. O 0 1.003813587807656e-09

Using O 0 5.8014079651336203e-11
this O 0 3.437900571862107e-12
approach O 0 3.120149694169072e-10
, O 0 3.5235117774867764e-12
an O 0 1.0078446324029988e-12
abnormally O 0 5.2698596846312284e-06
spliced O 0 0.1760949343442917
transcript O 0 0.025546029210090637
was O 0 2.5624595423323626e-07
identified O 0 2.5089955113521967e-10
that O 0 1.6217197940440742e-13
contains O 0 7.527089464348376e-16
an O 0 1.148790287598217e-16
extra O 0 2.5188293291400488e-14
264 O 0 1.337267102607953e-12
bases O 0 4.4018239574172835e-12
upstream O 0 5.088147125853482e-10
from O 0 2.6252227388473548e-12
exon O 0 3.5505698381399498e-09
32 O 0 2.149922018190864e-09
, O 0 1.1191291816869953e-11
resulting O 0 1.2814883702805258e-11
in O 0 8.153710589738419e-14
a O 0 9.444057515184401e-12
premature O 0 8.21970402853367e-09
termination O 0 1.1591473614291914e-10
codon O 0 1.9682479257543406e-10
27 O 0 1.6873547004081502e-09
bp O 0 3.415033589249106e-08
downstream O 0 6.7952297122531036e-09
from O 0 7.019161185443934e-13
the O 0 1.8281342151899027e-12
cryptic O 0 3.425275352242352e-08
splice O 0 1.557787982164882e-05
site O 0 2.604620249258005e-06
. O 0 1.1416479317460926e-08

Three O 0 2.566710559370744e-11
other O 0 3.129949912531599e-13
splice O 0 1.3283668067742838e-06
variants O 0 4.7028734684317897e-08
, O 0 2.459621221972963e-11
including O 0 4.210239605952418e-14
one O 0 4.586766621898775e-13
derived O 0 1.8449261215969237e-13
from O 0 1.7512634883378418e-14
the O 0 2.9796928406643566e-14
skipping O 0 5.634404401377857e-11
of O 0 2.527660833461301e-14
exon O 0 2.2807928878876282e-09
32 O 0 6.179493028390937e-10
, O 0 2.3883145894992852e-12
were O 0 3.012210056038689e-12
also O 0 1.2054828489593827e-11
identified O 0 4.952244170297604e-10
. O 0 2.369739959817707e-10

These O 0 4.838097700243793e-10
results O 0 6.50216477882104e-11
indicate O 0 1.0277623370413824e-11
the O 0 1.191857891677181e-13
usefulness O 0 3.6803776692906354e-10
of O 0 3.3324243971927237e-13
cycloheximide O 0 1.4701588213483774e-07
treatment O 0 5.753330103996923e-11
in O 0 1.6895394563175921e-15
evaluating O 0 3.343692374846094e-14
the O 0 6.093176229413425e-14
abnormal O 0 6.008326475237524e-11
processing O 0 5.757902292978512e-13
of O 0 2.5057929203345657e-16
mRNA O 0 3.425988659433443e-11
due O 0 3.755055641430083e-11
to O 0 1.5580473109594317e-12
splice O 0 5.281963967718184e-05
- O 0 1.3338875760382507e-05
site O 0 2.139146772606182e-06
mutations O 0 1.6391531971748918e-06
, O 0 1.483822370529353e-10
because O 0 1.8490718678432216e-10
( O 0 4.1233760383983104e-14
i O 0 1.5906109762653386e-09
) O 0 3.1898552674053046e-14
aberrant O 0 4.676969575512224e-11
splicing O 0 7.0951862163326496e-09
often O 0 2.5131718928150804e-10
generates O 0 1.5665937514244832e-12
a O 0 2.546433766972833e-12
premature O 0 7.634619159091471e-09
termination O 0 3.388428149175837e-10
codon O 0 1.0868188571322435e-09
, O 0 6.564963017652303e-10
( O 0 1.2939475879658602e-12
ii O 0 7.000599566708843e-07
) O 0 4.034736086899748e-12
transcripts O 0 4.274260501091476e-09
with O 0 7.445515558257565e-12
premature O 0 1.3075551752450565e-09
termination O 0 3.659361008656603e-12
codons O 0 8.284337105202155e-11
can O 0 1.8658220801714975e-10
occur O 0 2.516259423046563e-11
at O 0 2.2318413783750657e-09
low O 0 1.7729628609686188e-07
or O 0 1.4144387883163745e-08
undetectable O 0 6.3692309595353436e-06
levels O 0 1.7436753152466622e-09
due O 0 2.194686966883186e-11
to O 0 4.3523774861942144e-11
nonsense O 0 8.139548413055309e-08
- O 0 1.1863557913827094e-09
mediated O 0 4.795071362195813e-08
mRNA O 0 1.0197077671136867e-07
decay O 0 1.0374913472332992e-05
, O 0 1.48020918439018e-11
and O 0 6.390964840674584e-11
( O 0 2.4887151055794955e-14
iii O 0 1.0544150796931717e-07
) O 0 1.6969807503652845e-11
the O 0 2.389007177847069e-12
levels O 0 1.2527533697903603e-11
of O 0 5.136025568532629e-16
these O 0 1.5003605725438102e-13
transcripts O 0 5.254771062723762e-10
can O 0 1.2578285852118953e-12
be O 0 1.0089153769160183e-13
increased O 0 3.1178113882963585e-14
by O 0 1.037527052119569e-12
cycloheximide O 0 2.225565594926593e-06
. O 0 3.829163375268507e-10

A O 0 5.160080807087297e-09
deletion O 0 5.213227609601745e-07
mutation O 0 1.7072235891646415e-07
in O 0 5.62243751556224e-10
COL17A1 O 0 4.100509249838069e-05
in O 0 1.5230421090972612e-11
five O 0 1.7287658804487904e-10
Austrian O 0 5.654746018990409e-06
families O 0 7.118114431214906e-11
with O 0 2.2388016787666665e-11
generalized O 0 1.0755644552773447e-07
atrophic B-Disease 0 0.04600781947374344
benign I-Disease 1 0.970708429813385
epidermolysis I-Disease 1 0.9894266128540039
bullosa I-Disease 1 0.755255401134491
represents O 0 6.142281350207668e-09
propagation O 0 1.1269421662518653e-07
of O 0 6.179401066362666e-13
an O 0 4.275966733469083e-12
ancestral O 0 8.306210474984255e-06
allele O 0 0.00011732967686839402
. O 0 8.078578161985206e-08

Patients O 0 3.9520372752122057e-07
with O 0 1.6437400329749607e-09
generalized O 0 3.1621500511391787e-06
atrophic B-Disease 1 0.5096891522407532
benign I-Disease 1 0.9737103581428528
epidermolysis I-Disease 1 0.9512999057769775
bullosa I-Disease 0 0.03524705022573471
, O 0 2.2501045471301495e-10
a O 0 1.8554042850726926e-12
usually O 0 2.86750310996009e-12
nonlethal O 0 1.0563420971276827e-10
form O 0 3.8559856696540606e-11
of O 0 5.5867730580638764e-11
junctional B-Disease 0 0.20285870134830475
epidermolysis I-Disease 0 0.015011772513389587
bullosa I-Disease 0 0.0008314204169437289
, O 0 4.713291909541617e-11
have O 0 7.323654703517146e-12
generalized O 0 3.2298583252377e-10
blistering B-Disease 0 0.0010484931990504265
, O 0 2.7533263846635236e-07
nail B-Disease 1 0.9999935626983643
dystrophy I-Disease 1 0.8874363899230957
, O 0 1.9844362597609688e-08
patchy B-Disease 0 0.04538062587380409
alopecia I-Disease 1 0.9996984004974365
, O 0 1.0621739932048513e-08
and O 0 6.693557708103981e-08
dental B-Disease 0 0.0011964781442657113
abnormalities I-Disease 1 0.9534332752227783
. O 0 1.0580817644267881e-07

Skin B-Disease 1 0.9995922446250916
fragility I-Disease 0 0.3282639682292938
in O 0 1.0567854230592033e-10
most O 0 2.7129923741570083e-12
cases O 0 6.612434558239677e-12
is O 0 9.298421407843982e-12
due O 0 2.0975511258458646e-11
to O 0 5.326309272107865e-12
mutations O 0 5.012518872193894e-11
in O 0 5.0341717624494305e-15
the O 0 2.0080929835495287e-15
gene O 0 2.6422131843562013e-11
encoding O 0 1.8450846406281585e-09
type O 0 1.2482358613397082e-07
XVII O 0 3.713531623361632e-05
collagen O 0 6.9689394877059385e-06
( O 0 2.808478727356345e-10
COL17A1 O 0 3.2450512662762776e-05
) O 0 2.4158150480069196e-10
. O 0 2.2316488934581713e-10

Recently O 0 2.606901432500308e-07
, O 0 3.908387849471673e-11
we O 0 2.096107315496809e-11
reported O 0 2.3888774292046833e-10
five O 0 4.242553357236556e-12
Austrian O 0 3.3545046562721836e-07
families O 0 1.9686859781264943e-11
with O 0 5.2792479589280905e-12
generalized O 0 1.134475979824856e-08
atrophic B-Disease 0 0.0018790657632052898
benign I-Disease 0 0.357262521982193
epidermolysis I-Disease 0 0.40140315890312195
bullosa I-Disease 0 0.07194767147302628
who O 0 1.3547663968438428e-07
share O 0 6.468840740847526e-11
the O 0 5.670908187482837e-12
same O 0 1.5842153977541074e-10
COL17A1 O 0 1.0556376764725428e-05
mutation O 0 4.047917556704306e-08
. O 0 1.1671658084466685e-09

Affected O 0 2.4311825441714063e-08
individuals O 0 3.5968465619123924e-12
in O 0 1.804475622743662e-13
three O 0 3.3298654632252234e-12
families O 0 1.6686930700074432e-12
are O 0 6.13402075105309e-15
homozygous O 0 5.10629299260712e-12
for O 0 2.433988340738713e-13
4003delTC O 0 6.524175688582545e-08
, O 0 5.984217288368399e-11
whereas O 0 4.355888479773418e-12
those O 0 4.493008612729832e-13
in O 0 5.148408554946776e-14
two O 0 1.530067912647315e-11
others O 0 2.069522504755117e-11
are O 0 3.675382345474584e-14
compound O 0 2.763793360838207e-10
heterozygotes O 0 1.0348565337992e-09
. O 0 5.779407161177197e-11

To O 0 8.390148298342837e-11
determine O 0 3.0824801044992967e-11
if O 0 3.5151343641404154e-12
the O 0 1.4224622727539854e-13
occurrence O 0 2.2537555155466293e-10
of O 0 1.0791867616558037e-12
4003delTC O 0 3.144360505302757e-08
in O 0 3.1348670404343637e-13
these O 0 1.6940070765407433e-13
unrelated O 0 1.397259478258528e-11
families O 0 1.7025562817213347e-12
signifies O 0 1.4373356671537607e-11
propagation O 0 2.0623480700976415e-10
of O 0 6.645906054484913e-15
an O 0 2.505362182905063e-13
ancestral O 0 7.893018505455984e-08
allele O 0 1.693348167464137e-06
or O 0 7.641448029893638e-10
a O 0 1.2497063106575723e-10
mutational O 0 2.25316034629941e-05
hot O 0 5.540025813388638e-05
spot O 0 7.420370820909739e-05
, O 0 7.653492423154162e-11
haplotypes O 0 4.070616288487372e-09
were O 0 7.146314096040385e-11
determined O 0 7.322876333093475e-11
for O 0 1.0339981908885632e-13
polymorphisms O 0 1.8168336168855603e-08
both O 0 9.023558983356494e-11
within O 0 1.8601348759916814e-12
and O 0 2.633737672397274e-09
flanking O 0 0.00011674955749185756
COL17A1 O 0 0.03665905445814133
. O 0 2.309467106442753e-08

Five O 0 3.583391716688311e-08
intragenic O 0 1.496970639891515e-06
polymorphisms O 0 1.0092244195902822e-07
were O 0 1.090880580312259e-10
chosen O 0 1.8152296072521112e-12
based O 0 2.427960447710237e-13
on O 0 8.51001435986376e-10
their O 0 2.75231082369487e-09
informativeness O 0 3.027592356374953e-06
. O 0 1.7118644002334094e-10

One O 0 9.906099274203939e-10
of O 0 5.578919487839173e-13
these O 0 4.1687560521641576e-12
, O 0 2.599262764659688e-13
not O 0 1.8242748891367233e-12
previously O 0 2.2832771784386807e-10
reported O 0 3.1812354972515777e-09
, O 0 1.5583170062498375e-13
was O 0 5.442794548393692e-10
2988 O 0 3.5172975643149584e-10
A O 0 3.646709670346304e-11
or O 0 4.4347851779757974e-11
C O 0 3.837631989966894e-09
that O 0 2.566179419568465e-13
introduces O 0 1.0713011424148822e-12
a O 0 8.092912597663579e-14
new O 0 3.480479386685012e-14
restriction O 0 3.7038858850639567e-13
site O 0 2.0333457140253586e-11
for O 0 3.189289449396539e-14
Eco0109 O 0 2.970143575531381e-10
I O 0 3.5714098345351886e-08
. O 0 2.7602989338681994e-11

All O 0 1.7283034378645645e-11
the O 0 1.1170386447420522e-12
4003delTC O 0 8.046803223749066e-09
alleles O 0 2.3625292833173717e-09
showed O 0 1.4894497191164646e-08
the O 0 6.977138457915297e-14
same O 0 1.1811384119028712e-12
haplotype O 0 2.1407928763039763e-09
for O 0 5.498269584579534e-15
these O 0 4.427053951834743e-14
five O 0 7.146756602315063e-13
polymorphic O 0 3.3623943629379482e-09
markers O 0 8.890409844752867e-06
. O 0 4.0065062378857874e-09

Fourteen O 0 5.987388362882484e-08
microsatellite O 0 6.76751460559899e-06
polymorphisms O 0 4.169985743374127e-07
were O 0 6.453103329473464e-11
selected O 0 7.19658504338451e-14
based O 0 1.2975676034945177e-13
on O 0 2.0454569149563895e-09
their O 0 4.624046479051458e-09
high O 0 8.776559212719803e-08
heterozygosity O 0 7.083570618959811e-09
and O 0 1.5042009521640254e-12
their O 0 1.8765403727444285e-13
location O 0 8.15978621476754e-12
within O 0 6.876584127428129e-14
10q23 O 0 2.7461024565411662e-09
- O 0 8.197675924748182e-07
q25 O 0 1.7824957865286706e-07
near O 0 7.642009336450428e-08
COL17A1 O 0 3.618052141973749e-05
. O 0 4.583257939838603e-10

Three O 0 3.9044056876491595e-09
families O 0 5.658499779848114e-10
shared O 0 6.000773655756575e-09
microsatellite O 0 1.6919542758842e-05
polymorphisms O 0 5.470794803841272e-06
covering O 0 9.531295752651658e-09
at O 0 9.35568333915171e-09
most O 0 8.153454474080224e-12
19 O 0 1.1039085201502985e-09
cM O 0 5.251690282648269e-08
, O 0 8.240250929519854e-13
whereas O 0 9.15174511693928e-13
the O 0 1.6243922439790337e-12
others O 0 4.0963712977237776e-10
shared O 0 4.3674230898460564e-10
smaller O 0 3.118993605055742e-11
regions O 0 1.9022219563402665e-11
consistent O 0 1.1637513175344338e-09
with O 0 2.74191919169553e-10
cross O 0 7.514510258488372e-08
- O 0 1.2220206144775148e-06
over O 0 1.1150144807459128e-08
events O 0 7.889786046710867e-11
during O 0 1.3817950256234113e-11
passage O 0 3.883994092058335e-13
of O 0 4.859207789831635e-15
this O 0 2.1117905262490154e-14
mutation O 0 3.9556766607933003e-13
through O 0 8.351019799724552e-14
several O 0 2.8631691201957965e-12
generations O 0 5.375651035421924e-10
. O 0 2.1561330845742965e-11

These O 0 7.608869645459038e-10
results O 0 3.548537297337617e-10
indicate O 0 4.712548129504057e-10
that O 0 4.07940313473798e-11
4003delTC O 0 1.220418823777436e-07
occurs O 0 2.0575977033310267e-10
on O 0 6.034074628846753e-11
a O 0 1.8173532340473586e-12
single O 0 3.6220176163892503e-11
ancestral O 0 1.4346871068937617e-07
allele O 0 3.4769007584145584e-07
. O 0 6.977841221500469e-11
. O 0 7.810877639125025e-11

The O 0 4.735199454763972e-10
haptoglobin O 0 3.990229743067175e-06
- O 0 1.346484168607276e-07
gene O 0 1.3676596211098513e-07
deletion O 0 1.9457179405435454e-06
responsible O 0 2.842176494155524e-09
for O 0 4.842616325301252e-12
anhaptoglobinemia B-Disease 0 1.062301998899784e-05
. O 0 7.510547739286721e-10

We O 0 1.2182717057385162e-08
have O 0 3.986794401555915e-12
found O 0 1.8931565841893983e-13
an O 0 7.710150436667212e-15
allelic O 0 3.895011424503991e-09
deletion O 0 2.7436175287220976e-07
of O 0 6.066383506642126e-12
the O 0 7.453138661794867e-10
haptoglobin O 0 1.5111656466615386e-05
( O 0 3.1349044454093145e-12
Hp O 0 5.43870615210551e-10
) O 0 1.3943994613477284e-12
gene O 0 3.744641749459099e-11
from O 0 1.609180020137324e-12
an O 0 2.3609570245011757e-13
individual O 0 6.487903096707992e-12
with O 0 1.1994064630371781e-09
anhaptoglobinemia B-Disease 0 8.203111065085977e-05
. O 0 3.2625266932484465e-09

The O 0 2.7249905110160455e-10
Hp O 0 2.144131538983629e-09
gene O 0 2.458535597327227e-09
cluster O 0 4.150450649831328e-09
consists O 0 4.882170622638737e-12
of O 0 1.8311937524054939e-13
coding O 0 1.4516761439153925e-05
regions O 0 3.661568617752131e-11
of O 0 6.553865252150598e-14
the O 0 2.0154171300607038e-12
alpha O 0 8.26025532696395e-12
chain O 0 1.1836622348937453e-08
and O 0 1.6816950609843673e-11
beta O 0 2.2624489087741395e-12
chain O 0 3.707672779906801e-10
of O 0 5.320168201925109e-15
the O 0 8.356488786533112e-13
haptoglobin O 0 7.525565948185431e-09
gene O 0 1.0360178270829579e-09
( O 0 7.399891246637202e-14
Hp O 0 1.778010204345204e-11
) O 0 2.31522998472497e-13
and O 0 2.549289989176029e-13
of O 0 2.2266929172363135e-16
the O 0 9.465435976251796e-14
alpha O 0 3.3035113273377492e-12
chain O 0 1.3245620600343955e-08
and O 0 1.7978368793691857e-11
beta O 0 3.985104889310531e-13
chain O 0 2.660003606269612e-10
of O 0 4.3063659023012246e-15
the O 0 8.078481460171982e-13
haptoglobin O 0 2.3988381059325548e-08
- O 0 4.743852866084808e-09
related O 0 1.2690691553185474e-10
gene O 0 9.624041119593585e-09
( O 0 8.275832276416484e-13
Hpr O 0 6.022303766783921e-10
) O 0 6.403993221132387e-12
, O 0 4.288043715678508e-13
in O 0 3.428332108219162e-13
tandem O 0 1.8073811247631966e-07
from O 0 1.8361015832746297e-12
the O 0 1.408556778159653e-11
5 O 0 1.1906151620166838e-09
side O 0 1.3038045665325626e-07
. O 0 4.930096331179357e-10

Southern O 0 3.7578985256914166e-08
blot O 0 0.00019314906967338175
and O 0 4.668612163527541e-10
PCR O 0 1.590163520859278e-07
analyses O 0 1.393275095296076e-08
have O 0 2.834963375164534e-10
indicated O 0 5.808183795030786e-11
that O 0 1.298837881864856e-13
the O 0 5.341859360451576e-14
individual O 0 4.630639404909487e-13
with O 0 7.656368594677332e-11
anhaptoglobinemia B-Disease 0 1.5952943499542016e-07
was O 0 2.84624523949617e-09
homozygous O 0 3.866907835603506e-11
for O 0 8.193299935605196e-16
the O 0 2.2773183824278086e-14
gene O 0 7.479198926851893e-10
deletion O 0 3.0087537794543096e-08
and O 0 1.79833842262056e-10
that O 0 9.367377750216233e-13
the O 0 1.3194099404614107e-13
gene O 0 2.5939785874840027e-09
deletion O 0 3.4616146393773306e-08
was O 0 2.8802313423170744e-08
included O 0 4.756872521750888e-13
at O 0 1.755546923110085e-11
least O 0 3.853992710227015e-15
from O 0 2.2064515826540143e-15
the O 0 6.238468807295491e-14
promoter O 0 7.455943418221977e-09
region O 0 1.2503161700427867e-11
of O 0 2.9008364449672336e-14
Hp O 0 2.6003664499452128e-11
to O 0 5.759659784700111e-13
Hpr O 0 4.453524788533558e-12
alpha O 0 3.911521578641927e-14
but O 0 4.342049994294356e-13
not O 0 1.686823559521669e-13
to O 0 7.296675416657017e-12
Hpr O 0 4.838311973287546e-09
beta O 0 1.0492817725804571e-10
( O 0 5.980491167394131e-13
Hpdel O 0 1.348137885770484e-07
) O 0 2.0514912685287712e-11
. O 0 2.714681084092785e-11

In O 0 6.714902939242151e-11
addition O 0 4.6477457299465286e-12
, O 0 1.6253871078925064e-12
we O 0 5.0865696203661326e-12
found O 0 1.962667658603201e-12
seven O 0 5.577727949651612e-13
individuals O 0 2.4974253994859957e-15
with O 0 1.0018572343256649e-12
hypohaptoglobinemia B-Disease 0 7.734436024975366e-08
in O 0 6.166708311529379e-13
three O 0 5.579081901324612e-12
families O 0 5.621573952868664e-12
, O 0 1.2307826470232125e-13
and O 0 1.5906965415007912e-12
the O 0 5.372385696034154e-12
genotypes O 0 7.970290205605579e-09
of O 0 3.0631242984788254e-13
six O 0 8.268740553374343e-11
of O 0 6.010610168220507e-14
the O 0 8.720292717090405e-12
seven O 0 9.411048329521776e-11
individuals O 0 9.809281039079975e-15
were O 0 1.9803902441550836e-12
found O 0 4.322007161883246e-12
to O 0 1.4598305203561424e-12
be O 0 1.5538584308139036e-10
Hp2 O 0 2.1086430024297442e-06
/ O 0 1.1766598362328295e-07
Hpdel O 0 3.7669012726837536e-06
. O 0 3.2208213873730074e-10

The O 0 8.376592197656407e-10
phenotypes O 0 3.582776741950511e-07
and O 0 8.192641232085407e-09
genotypes O 0 1.4630954581207334e-07
in O 0 2.2413310790669883e-11
one O 0 3.876981374828503e-11
of O 0 2.4497759845546786e-14
these O 0 2.599174998493825e-12
three O 0 5.848303091804397e-11
families O 0 6.803029667379334e-11
showed O 0 3.515569169110222e-09
the O 0 1.3464442505817936e-13
father O 0 1.2824066253358524e-09
to O 0 1.3288003510025792e-12
be O 0 6.291270282510197e-11
hypohaptoglobinemic B-Disease 0 9.885383178698248e-08
( O 0 2.4528056520004178e-14
Hp2 O 0 4.383875484847977e-09
) O 0 6.871605064476261e-13
and O 0 1.1153148717080175e-11
Hp2 O 0 6.857416678940353e-08
/ O 0 6.733699819960748e-09
Hpdel O 0 2.2943379462958546e-07
, O 0 3.1165183281278708e-12
the O 0 3.65168941092453e-13
mother O 0 3.628360389917873e-10
to O 0 6.01431407389226e-14
be O 0 4.059559763000542e-13
Hp2 O 0 1.2892589218438388e-09
- O 0 4.2814143896841017e-10
1 O 0 4.6234309783455e-12
and O 0 1.0873905942343498e-10
Hp1 O 0 6.931913532071121e-08
/ O 0 7.321692141459835e-10
Hp2 O 0 1.0838653530242937e-08
, O 0 4.9256683665654596e-14
one O 0 1.5479184909761648e-14
of O 0 2.682238882972701e-16
the O 0 9.18209193574715e-14
two O 0 6.387683351011253e-12
children O 0 3.129378266936156e-12
to O 0 3.8638593735131066e-13
be O 0 5.1391349509266604e-11
hypohaptoglobinemic B-Disease 0 8.54130917105067e-08
( O 0 2.256598262472074e-14
Hp2 O 0 2.25269514153581e-09
) O 0 1.0512017688604769e-12
and O 0 2.8158740963957207e-11
Hp2 O 0 6.048070844144604e-08
/ O 0 1.3342297267016079e-09
Hpdel O 0 7.1097112197549e-08
, O 0 1.9669923242288112e-12
and O 0 4.3401873349620257e-13
the O 0 3.988728123564388e-15
other O 0 1.3061634293685259e-14
child O 0 8.03015553357822e-12
to O 0 6.823656087872818e-14
be O 0 1.866852375811967e-12
Hp1 O 0 2.6579368039847395e-08
and O 0 5.635941713322268e-11
Hp1 O 0 1.0286193230513163e-07
/ O 0 1.784242531499558e-09
Hpdel O 0 4.8336382008074e-08
, O 0 5.288708381824547e-13
showing O 0 2.3661335477737078e-12
an O 0 3.3864811335612395e-15
anomalous O 0 5.6132518772011863e-11
inheritance O 0 2.054219727654072e-08
of O 0 7.216238023799448e-11
Hp O 0 1.0489750223996452e-07
phenotypes O 0 1.702238172640591e-08
in O 0 4.372920428541427e-12
the O 0 5.341144540538245e-11
child O 0 4.4434622736844176e-07
with O 0 7.500240983837614e-10
Hp1 O 0 2.1064315660623834e-05
. O 0 1.8149727276650651e-09

The O 0 1.4767879363830616e-08
Hp2 O 0 0.00010346989438403398
/ O 0 1.2011983926640823e-05
Hpdel O 0 4.241322130837943e-06
individuals O 0 3.181060883455933e-12
had O 0 1.6486877141286271e-10
an O 0 8.672513526547174e-14
extremely O 0 6.623094295221676e-10
low O 0 2.7990734174920817e-09
level O 0 1.6558730775440011e-10
of O 0 1.2042131885842827e-13
Hp O 0 3.318595676038427e-10
( O 0 4.595992301472361e-15
mean O 0 1.095654708453686e-12
+ O 0 2.1651180848181184e-10
/ O 0 2.087817918550172e-09
- O 0 2.550795272782125e-07
SD O 0 0.00031055451836436987
= O 0 1.0101753211699815e-08
0 O 0 1.5859938416826896e-13
. O 0 7.160216836761199e-15
049 O 0 1.6401118310693796e-11
+ O 0 9.101288472868063e-11
/ O 0 6.169459387805887e-10
- O 0 3.18581983016486e-09
0 O 0 1.4840388033038332e-12
. O 0 1.3158505216697997e-14
043 O 0 1.091577262607446e-11
mg O 0 1.904525648299682e-09
/ O 0 2.4831631195709747e-10
ml O 0 1.2211565092457022e-08
; O 0 7.30568557039124e-12
n O 0 6.8212790971244885e-09
= O 0 6.4051270953768835e-09
6 O 0 1.3205599114218813e-10
) O 0 1.389641548533993e-12
, O 0 7.795564730848567e-14
compared O 0 1.4257278083823488e-12
with O 0 3.1593575412075525e-13
the O 0 3.814653020545178e-12
level O 0 1.631196427931414e-10
( O 0 8.023250130510015e-16
1 O 0 1.839212105097382e-14
. O 0 2.938660531820285e-14
64 O 0 1.090850283366751e-12
+ O 0 3.3698259460646085e-11
/ O 0 3.1578729214887247e-11
- O 0 4.24768865914249e-11
1 O 0 4.0400167477909477e-13
. O 0 9.246715806238148e-14
07 O 0 2.1920293271499025e-12
mg O 0 1.1608759509229571e-09
/ O 0 2.638995966197655e-10
ml O 0 1.2336595078821233e-09
) O 0 1.0827241338738636e-13
obtained O 0 1.3143487491949768e-13
from O 0 1.1625769452488187e-14
52 O 0 3.1589176261760665e-13
healthy O 0 1.7119073899337506e-13
volunteers O 0 5.036825177859999e-14
having O 0 2.5529359442416633e-12
phenotype O 0 1.367493202009129e-10
Hp2 O 0 1.3487790440080971e-08
, O 0 4.139216638714138e-13
whereas O 0 5.06791548830765e-13
the O 0 1.391922926745337e-12
serum O 0 1.650261538088671e-06
Hp O 0 2.2564103918654155e-09
level O 0 2.447649895265247e-11
of O 0 8.3560181411463e-15
an O 0 4.0300117301432514e-13
individual O 0 4.6004107641384184e-12
with O 0 1.9467694123420642e-09
Hp1 O 0 4.548071592580527e-05
/ O 0 9.406502954334428e-08
Hpdel O 0 1.1259543271080474e-06
was O 0 3.2011222117489524e-08
0 O 0 2.0184496435371457e-11
. O 0 9.326592449732107e-12

50 O 0 4.54466242416629e-09
mg O 0 1.7688565776552423e-06
/ O 0 8.185536444216268e-07
ml O 0 5.594257800112246e-06
, O 0 1.9528897943210666e-10
which O 0 5.352563878235905e-12
was O 0 3.504599041526113e-11
approximately O 0 3.021734982188145e-15
half O 0 3.3004675381587134e-13
the O 0 3.1152255661149805e-14
level O 0 3.4718768658625887e-12
of O 0 2.5212135574799802e-14
Hp O 0 1.6864015739415095e-10
in O 0 8.529728572764794e-13
control O 0 1.4643572399108962e-07
sera O 0 4.989976787328487e-07
from O 0 6.204092822164123e-14
the O 0 1.7286849035569318e-12
Hp1 O 0 1.2550589190141181e-07
phenotype O 0 5.085120102776841e-10
( O 0 9.641994149579619e-16
1 O 0 5.8398529847352495e-15
. O 0 2.161128162547505e-14
26 O 0 6.357026450382053e-13
+ O 0 4.9991805833871084e-11
/ O 0 1.227380697077507e-10
- O 0 1.068772070844659e-09
0 O 0 2.837057845594959e-13
. O 0 2.5481986719267866e-15
33 O 0 1.731512069141905e-13
mg O 0 1.3458405223598646e-10
/ O 0 3.7056632068432904e-11
ml O 0 4.755611904272428e-09
; O 0 3.125363899972311e-12
n O 0 9.361752262293521e-09
= O 0 1.2384436587353775e-08
9 O 0 1.3987107305712954e-10
) O 0 6.47389477095861e-13
, O 0 2.255234370020405e-14
showing O 0 9.216381997856349e-13
a O 0 1.969467984693201e-14
gene O 0 2.257265763194738e-10
- O 0 1.2063684096119687e-07
dosage O 0 7.6305741458782e-07
effect O 0 1.348271605472462e-09
. O 0 1.1337911859365946e-10

The O 0 1.2143445103640627e-11
other O 0 2.6117278912468622e-12
allele O 0 1.3347144545150513e-07
( O 0 1.238437043887819e-11
Hp2 O 0 4.5373715806817927e-07
) O 0 9.845247013473557e-12
of O 0 6.308367660168811e-15
individuals O 0 3.5616573302839696e-14
with O 0 1.0351595448876427e-11
Hp2 O 0 1.9085466647084104e-06
/ O 0 3.637212486751196e-08
Hpdel O 0 4.281149301732512e-07
was O 0 2.0117036925171305e-08
found O 0 2.108417086754688e-11
to O 0 5.109710397854794e-13
have O 0 3.1987476903361234e-12
, O 0 1.0890322931639274e-14
in O 0 2.5552557269268358e-15
all O 0 3.9449299133343524e-14
exons O 0 5.0738282908469046e-08
, O 0 1.7533183238604977e-11
no O 0 7.048515417162893e-13
mutation O 0 1.1701732248112218e-12
, O 0 3.5602565071958005e-15
by O 0 7.941763972797375e-16
DNA O 0 4.061881664352285e-10
sequencing O 0 4.802860686936583e-08
. O 0 2.3927226866504725e-09

On O 0 3.1036031522546637e-09
the O 0 7.232641677408502e-13
basis O 0 1.047824695933619e-12
of O 0 1.3844027107415974e-13
the O 0 4.242666547943363e-12
present O 0 1.0150307244022327e-12
study O 0 2.61956780458995e-14
, O 0 1.77893605472464e-15
the O 0 5.752185392331785e-16
mechanism O 0 1.0855458025538223e-11
of O 0 2.597999127027656e-13
anhaptoglobinemia B-Disease 0 1.1889528650499415e-07
and O 0 5.475711572534847e-13
the O 0 2.3553951266486314e-15
mechanism O 0 4.77995572810419e-13
of O 0 1.0031520249824638e-15
anomalous O 0 2.3892544193104825e-11
inheritance O 0 8.605943180306497e-10
of O 0 2.6504896367962605e-12
Hp O 0 7.469308727081625e-09
phenotypes O 0 3.7124441298885813e-09
were O 0 1.9023062292067294e-10
well O 0 6.881607089725961e-11
explained O 0 1.1907725472326547e-08
. O 0 9.749128587754896e-11

However O 0 7.526628209575392e-09
, O 0 1.098789679035428e-12
the O 0 5.1894313770218387e-14
mechanism O 0 1.5048796930816621e-10
of O 0 1.1587090661957511e-11
hypohaptoglobinemia B-Disease 0 4.937742050969973e-05
remains O 0 5.049490141573187e-07
unknown O 0 1.2459477716220135e-07

ATM O 0 1.4869148799334653e-05
mutations O 0 1.417309158568969e-05
and O 0 8.653916694356667e-08
phenotypes O 0 3.625989847932942e-05
in O 0 4.8064352995425e-06
ataxia B-Disease 1 0.9999992847442627
- I-Disease 1 0.999996542930603
telangiectasia I-Disease 1 0.9999994039535522
families O 0 6.952469266252592e-05
in O 0 1.1661727139511413e-10
the O 0 3.3024122325642224e-10
British O 0 1.2297600733290892e-06
Isles O 0 3.712293255375698e-05
: O 0 1.0216658248574095e-12
expression O 0 2.371905704614749e-14
of O 0 2.108021616092516e-16
mutant O 0 2.4907620410630216e-10
ATM O 0 2.0653541810133902e-07
and O 0 3.074284993243026e-10
the O 0 2.4822100971877425e-11
risk O 0 3.530259462536378e-08
of O 0 8.581254457018517e-11
leukemia B-Disease 1 0.9886600971221924
, O 0 1.6369118384318426e-05
lymphoma B-Disease 1 0.9999998807907104
, O 0 5.044907425144629e-08
and O 0 4.27154901672111e-07
breast B-Disease 0 0.021633530035614967
cancer I-Disease 0 0.00931922160089016
. O 0 3.253666847058412e-08

We O 0 5.095520450026925e-09
report O 0 1.088249022146437e-11
the O 0 4.1169318117355996e-14
spectrum O 0 1.1380088711654412e-11
of O 0 1.5184625814222176e-14
59 O 0 3.3965842291538983e-12
ATM O 0 3.822716010404292e-08
mutations O 0 1.1634433860763238e-08
observed O 0 5.7940958697599854e-08
in O 0 1.6546519532312232e-07
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999983310699463
telangiectasia I-Disease 1 0.9999996423721313
( O 0 7.026519597275183e-05
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999992847442627
T I-Disease 1 0.9999998807907104
) O 0 6.344807701452737e-08
patients O 0 4.9615634517552465e-11
in O 0 2.1691355038110788e-14
the O 0 5.635756184646512e-12
British O 0 5.005160801374586e-07
Isles O 0 1.1628105312411208e-05
. O 0 1.5442008782784455e-09

Of O 0 7.274430363635176e-11
51 O 0 2.8405451324431397e-09
ATM O 0 4.128608907194575e-06
mutations O 0 2.514898937988619e-07
identified O 0 4.9712518546130013e-08
in O 0 1.0939178382574077e-11
families O 0 2.92120667932938e-11
native O 0 9.824378046112067e-14
to O 0 4.185774556825228e-12
the O 0 3.951736507468162e-11
British O 0 9.469370070291916e-07
Isles O 0 3.912435659003677e-06
, O 0 2.971795335857119e-12
11 O 0 6.243066502133188e-13
were O 0 1.0000568081980354e-12
founder O 0 2.4628979411467355e-11
mutations O 0 7.265154450264433e-11
, O 0 4.162588242845322e-13
and O 0 2.893456741565048e-12
2 O 0 3.0561052820343715e-12
of O 0 2.72468730384964e-15
these O 0 1.905589943652919e-13
11 O 0 8.755754368067192e-13
conferred O 0 1.147225456993306e-11
a O 0 1.1072618516516641e-12
milder O 0 1.310113267871671e-10
clinical O 0 3.0178315402196176e-10
phenotype O 0 3.212766719329352e-09
with O 0 3.2670424525427233e-12
respect O 0 3.387919014340851e-13
to O 0 6.910491623379755e-11
both O 0 3.6244265366747186e-09
cerebellar B-Disease 0 0.04137762263417244
degeneration I-Disease 0 0.0024962411262094975
and O 0 3.4388025760279106e-10
cellular O 0 2.3949982619342336e-07
features O 0 1.3880396920740168e-07
. O 0 2.3383400105103647e-08

We O 0 5.544729564377349e-09
report O 0 1.984361286400116e-11
, O 0 3.1517963830192744e-14
in O 0 9.00383740953586e-15
two O 0 1.1603114025149353e-09
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999983310699463
T I-Disease 1 0.9999998807907104
families O 0 7.30224769540655e-11
, O 0 9.526099925362733e-16
an O 0 3.257528572973449e-16
ATM O 0 4.353322680117344e-08
mutation O 0 4.84188245053474e-10
( O 0 1.6926981057053744e-14
7271T O 0 4.196384559285171e-11
- O 0 9.18023431495385e-07
- O 0 6.22637671767734e-05
> O 0 4.359753802418709e-08
G O 0 2.5429369998164475e-05
) O 0 1.7600598062328388e-11
that O 0 2.9298560105806004e-11
may O 0 2.0715327023190788e-11
be O 0 3.0533304292042207e-13
associated O 0 5.032062481004178e-14
with O 0 7.006607411776632e-15
an O 0 1.0216126040832677e-13
increased O 0 8.87343254429851e-11
risk O 0 1.0131855354700292e-08
of O 0 3.833165382327586e-11
breast B-Disease 0 0.0014174476964399219
cancer I-Disease 0 6.257289896893781e-06
in O 0 1.8369179875105113e-12
both O 0 6.000870633737776e-11
homozygotes O 0 1.4173640749959304e-07
and O 0 1.2095238144382847e-09
heterozygotes O 0 1.9054593458633917e-09
( O 0 1.9789241588723944e-13
relative O 0 1.428405033143676e-10
risk O 0 7.610143071268283e-11
12 O 0 3.35613400135118e-13
. O 0 1.8497108413093738e-13
7 O 0 6.767775229121753e-11
; O 0 1.4648322485544263e-11
P O 0 1.9298804545542225e-06
= O 0 7.09003211696313e-09
. O 0 1.5799349675771346e-12
0025 O 0 6.726212364860373e-10
) O 0 1.0498011964940601e-12
, O 0 4.2927551839816794e-14
although O 0 1.4340918318318796e-13
there O 0 1.0776963665275283e-14
is O 0 5.2809444778300144e-14
a O 0 8.238537890087327e-13
less O 0 1.0073920864162034e-10
severe O 0 3.5922648748965003e-06
A B-Disease 1 0.9999982118606567
- I-Disease 1 0.9999991655349731
T I-Disease 1 0.9999998807907104
phenotype O 0 2.9820879717590287e-05
in O 0 2.065436146767019e-12
terms O 0 8.857288004166658e-14
of O 0 2.002600398403058e-15
the O 0 2.095070861588e-12
degree O 0 3.222914990441694e-11
of O 0 4.196144126611401e-11
cerebellar B-Disease 0 0.03632644563913345
degeneration I-Disease 0 0.0466802641749382
. O 0 5.259589386241714e-08

This O 0 7.478610092315208e-11
mutation O 0 6.728573254122239e-10
( O 0 6.834066190557209e-13
7271T O 0 4.182658386309157e-10
- O 0 4.503246771037084e-07
- O 0 2.143787241948303e-05
> O 0 6.384504303014182e-08
G O 0 2.011264086831943e-06
) O 0 7.738947286825559e-13
also O 0 9.722225195046841e-14
allows O 0 5.786918507729539e-15
expression O 0 5.921285461734857e-14
of O 0 4.141818317352289e-15
full O 0 7.1886216597427666e-12
- O 0 2.891890282796794e-08
length O 0 2.3696675177653503e-10
ATM O 0 4.040242629343993e-08
protein O 0 2.397385623353898e-10
at O 0 6.677350512795943e-12
a O 0 3.3724715728378207e-13
level O 0 5.596540158386842e-12
comparable O 0 1.6194092941623772e-11
with O 0 3.898045081163204e-12
that O 0 5.1457949012956306e-11
in O 0 2.7121024610138322e-12
unaffected O 0 1.5586540058620812e-08
individuals O 0 5.409234258429985e-13
. O 0 5.049742221596709e-11

In O 0 1.5791014329469277e-11
addition O 0 1.1278629939714957e-12
, O 0 3.568906577059751e-14
we O 0 1.3308440720977144e-13
have O 0 2.2414129946068777e-14
studied O 0 1.123898825568237e-12
18 O 0 4.955986177002103e-10
A B-Disease 1 0.9999963045120239
- I-Disease 1 0.9999979734420776
T I-Disease 1 0.9999998807907104
patients O 0 7.523312639534652e-09
, O 0 6.244171033096407e-14
in O 0 1.2346655053457325e-15
15 O 0 1.9184779904025256e-13
families O 0 5.523839306971479e-13
, O 0 1.6259941255838267e-13
who O 0 4.312525336835904e-10
developed O 0 3.093262535003305e-08
leukemia B-Disease 0 0.44744667410850525
, O 0 1.889882526029396e-07
lymphoma B-Disease 1 0.9999994039535522
, O 0 2.426622902618192e-09
preleukemic O 0 3.799283877015114e-05
T O 0 0.007418303284794092
- O 0 1.4932091971786576e-06
cell O 0 0.0005263549392111599
proliferation O 0 0.0031086523085832596
, O 0 3.834588202522582e-09
or O 0 1.4070482393435668e-05
Hodgkin B-Disease 1 0.9999960660934448
lymphoma I-Disease 1 0.9999998807907104
, O 0 7.701916615587834e-08
mostly O 0 9.443486270743762e-11
in O 0 1.4936672732002165e-10
childhood O 0 3.6654707855632296e-06
. O 0 4.00771371644737e-09

A O 0 6.754113268669926e-09
wide O 0 4.085759230942898e-10
variety O 0 9.050990209050203e-13
of O 0 8.839263143049086e-14
ATM O 0 3.0889698336977744e-06
mutation O 0 4.702502831577249e-09
types O 0 1.212530631455877e-10
, O 0 1.4527363687011352e-12
including O 0 1.9687855133069393e-13
missense O 0 2.0553523327748735e-08
mutations O 0 6.459269741299067e-08
and O 0 4.54679494055199e-09
in O 0 6.118094919571604e-11
- O 0 0.0001315225090365857
frame O 0 0.004914393648505211
deletions O 0 5.323425398273685e-07
, O 0 1.2718559538882346e-10
were O 0 7.980169997034992e-11
seen O 0 6.156493648212802e-10
in O 0 5.915889523047668e-14
these O 0 2.3213067752714256e-12
patients O 0 2.4899343004092245e-11
. O 0 4.7278781584170204e-11

We O 0 4.746876225425467e-09
also O 0 1.1706157744539869e-11
show O 0 2.2504982252757877e-11
that O 0 1.1189679282978815e-13
25 O 0 7.342753114520859e-14
% O 0 3.90468927324652e-16
of O 0 7.261077179076386e-16
all O 0 3.223648292749459e-10
A B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999959468841553
T I-Disease 1 0.9999998807907104
patients O 0 1.4014780447269004e-09
carried O 0 6.873018265629582e-10
in O 0 2.0299335671582208e-13
- O 0 6.248096440231166e-08
frame O 0 4.855435690842569e-06
deletions O 0 1.1371731112319594e-08
or O 0 1.4190155717130892e-09
missense O 0 3.203834353371349e-08
mutations O 0 5.7178613843689163e-08
, O 0 1.506852281840665e-11
many O 0 1.2082992755218375e-13
of O 0 7.471231207485662e-13
which O 0 3.485844501938118e-08
were O 0 2.0066146078079328e-08
also O 0 8.289024577834425e-09
associated O 0 2.606976440278075e-11
with O 0 6.46496094505733e-13
expression O 0 1.3434692811356563e-12
of O 0 1.632341587202643e-14
mutant O 0 4.802436670559018e-09
ATM O 0 3.705372648710181e-07
protein O 0 1.5100683370405932e-08
. O 0 1.580394703992738e-10

The O 0 2.9622115871319465e-10
DMPK O 0 1.3549075674745836e-06
gene O 0 2.6331111513400174e-08
of O 0 6.826208487353824e-10
severely O 1 0.8315842747688293
affected O 0 0.00013832910917699337
myotonic B-Disease 1 0.9999910593032837
dystrophy I-Disease 1 0.999992847442627
patients O 0 1.9355484255356714e-06
is O 0 1.2852692243825459e-09
hypermethylated O 0 7.613131401740247e-06
proximal O 0 2.5879862732836045e-06
to O 0 5.821095827585054e-10
the O 0 1.3978619477217347e-11
largely O 0 2.943275831390757e-11
expanded O 0 3.2701990421157845e-11
CTG O 0 2.3910395157145103e-06
repeat O 0 3.532284381435602e-06
. O 0 1.1011033196339781e-09

Using O 0 8.872755308253488e-11
methylation O 0 1.7820632081111398e-08
- O 0 5.2396938343690636e-08
sensitive O 0 2.4249539265497333e-08
restriction O 0 2.8178312461157873e-10
enzymes O 0 2.3514252767142807e-09
, O 0 9.19815330673035e-13
we O 0 1.1718103700916749e-12
characterized O 0 7.631720776168915e-13
the O 0 2.066769878069502e-14
methylation O 0 3.249999602772391e-09
pattern O 0 2.3833003126583208e-08
on O 0 5.520690571358955e-09
the O 0 4.715522070042333e-11
5 O 0 1.3512677088378666e-10
side O 0 4.3936840277147837e-10
of O 0 2.7877590711680895e-15
the O 0 8.080623301563727e-13
CTG O 0 1.1512121922407914e-08
repeat O 0 3.8693759307761866e-09
in O 0 4.6856859755098346e-14
the O 0 5.931370845868589e-13
DMPK O 0 9.482702978402813e-08
gene O 0 1.508834585051133e-10
of O 0 5.0805822222887986e-14
normal O 0 4.889514574474285e-12
individuals O 0 1.3610658180205921e-14
and O 0 4.668284530641442e-13
of O 0 5.86425642746212e-14
patients O 0 4.7349076048863736e-11
affected O 0 2.1384401194257663e-11
with O 0 8.702479590283474e-07
myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999994039535522
, O 0 7.718174432902458e-10
showing O 0 3.9422978770353723e-10
expansions O 0 1.3377481067333719e-10
of O 0 2.3076767208837605e-14
the O 0 1.4544442039632344e-12
repetitive O 0 4.822835464324271e-08
sequence O 0 8.405661944266285e-09
. O 0 4.706944611854169e-09

The O 0 3.7693136806238314e-11
gene O 0 8.99486651828596e-10
segment O 0 3.560376216071859e-09
analyzed O 0 3.5362399120053567e-10
corresponds O 0 1.1824238636826134e-11
to O 0 2.0309986602674163e-13
the O 0 8.161770277638133e-14
genomic O 0 2.875357196785444e-08
SacI O 0 2.7541467716218904e-05
- O 0 7.705662596890761e-07
HindIII O 0 6.722979719597788e-07
fragment O 0 6.052812029366805e-09
carrying O 0 7.379521993478022e-11
exons O 0 7.216261366238541e-08
11 O 0 1.1951998279968734e-09
- O 0 6.123450191353186e-08
15 O 0 2.4912039098268224e-10
. O 0 3.98078618679687e-11

There O 0 1.3586461122816473e-10
is O 0 5.640592160016666e-13
constitutive O 0 7.181015764662346e-12
methylation O 0 6.906054061950329e-10
in O 0 1.798961045233749e-12
intron O 0 7.8450557339238e-07
12 O 0 1.508402847072432e-10
at O 0 3.7826720922229384e-12
restriction O 0 5.66543170612676e-14
sites O 0 5.302246055410853e-12
of O 0 3.7662703359676863e-13
SacII O 0 4.752694735543628e-07
and O 0 1.5083971571794308e-10
HhaI O 0 6.491626347582269e-09
, O 0 6.920224450716796e-15
localized O 0 1.1963925672636017e-13
1 O 0 4.2123463462988286e-13
, O 0 1.1873336515366706e-13
159 O 0 4.3460959657515286e-12
- O 0 1.802016758034597e-09
1 O 0 1.2608846258754802e-11
, O 0 7.107344362567228e-14
232 O 0 7.229028573668694e-13
bp O 0 9.688050361944534e-11
upstream O 0 8.25490023559361e-12
of O 0 3.2136518957287617e-15
the O 0 1.629739420673515e-12
CTG O 0 1.7703650101452695e-08
repeat O 0 1.8161337322908366e-08
, O 0 5.352142882532329e-13
whereas O 0 1.2169957966726153e-13
most O 0 1.1030517048805227e-13
, O 0 2.611831107293683e-13
if O 0 6.186102411570582e-12
not O 0 2.3557403857482617e-12
all O 0 9.1760176930758e-14
, O 0 3.524113103116691e-14
of O 0 1.4309366976308284e-16
the O 0 5.490598007176252e-15
other O 0 5.514272366293773e-16
sites O 0 7.749330691031453e-13
of O 0 1.8343811373860118e-14
SacII O 0 8.492619940625445e-09
, O 0 3.541202433284679e-13
HhaI O 0 6.501511551348926e-10
, O 0 3.4463548009323886e-13
and O 0 2.1057435309335126e-12
HpaII O 0 1.3975387957998464e-08
in O 0 1.0795979046721374e-13
this O 0 1.0307058754665394e-13
region O 0 7.406644741969615e-13
are O 0 2.6291685842338985e-14
unmethylated O 0 5.659157586990204e-10
, O 0 1.916635686965984e-12
in O 0 6.842058386871686e-14
normal O 0 1.488271832161825e-11
individuals O 0 1.5838594541808804e-13
and O 0 9.287928065537798e-12
most O 0 7.228913919288954e-14
of O 0 6.9479724030359e-15
the O 0 7.0580069566617e-11
patients O 0 1.6491499832405054e-10
. O 0 3.9260129869322924e-11

In O 0 2.3126814699403475e-11
a O 0 1.2318236708441788e-12
number O 0 6.245945736527495e-14
of O 0 6.185733891252154e-13
young O 0 8.086622038661062e-09
and O 0 8.63172466836204e-09
severely O 0 0.00043037653085775673
affected O 0 2.9959961594938633e-11
patients O 0 2.0179212033982763e-12
, O 0 4.989951052185304e-14
however O 0 3.740449790179401e-12
, O 0 6.4296278804582e-14
complete O 0 1.5401951632479371e-12
methylation O 0 8.447863519833732e-10
of O 0 4.61069238886537e-14
these O 0 5.4715011411606354e-14
restriction O 0 5.716996429212806e-13
sites O 0 6.137171881803738e-10
was O 0 6.313180023198584e-08
found O 0 7.916965000243081e-11
in O 0 5.861725493015724e-15
the O 0 8.848001134932962e-14
mutated O 0 5.8483426990108e-09
allele O 0 3.785574449466367e-07
. O 0 2.1196084887264988e-09

In O 0 1.0141822104348108e-10
most O 0 1.4848798189290302e-12
of O 0 2.2095271169338473e-14
these O 0 4.676190858143858e-12
patients O 0 2.674918012784966e-12
, O 0 1.0296998036131086e-13
the O 0 5.5028941473023174e-12
onset O 0 1.9494901692951316e-08
of O 0 3.1933344857293378e-12
the O 0 6.202560598467244e-08
disease O 0 0.0004042696673423052
was O 0 0.0045666685327887535
congenital O 1 0.9998084902763367
. O 0 1.0954421014730542e-07

Preliminary O 0 1.6944501357585295e-09
in O 0 1.0838829139769857e-10
vivo O 0 2.992015311065188e-07
footprinting O 0 3.5775672131421743e-06
data O 0 5.50166134871688e-10
gave O 0 1.8952358779578127e-11
evidence O 0 2.0051556172840518e-13
for O 0 2.328948852211221e-15
protein O 0 3.2659850518479416e-11
- O 0 3.758886091276281e-09
DNA O 0 3.0647862558907946e-07
contact O 0 7.120334544197249e-09
in O 0 1.1909603078036346e-13
normal O 0 3.6911703619850467e-13
genes O 0 3.009730659142562e-11
at O 0 5.5724806713453034e-11
an O 0 1.955152890715378e-13
Sp1 O 0 9.48695344504813e-08
consensus O 0 4.288379005200349e-13
binding O 0 5.327955091005698e-12
site O 0 3.0851576848789364e-10
upstream O 0 2.439815849353266e-10
of O 0 1.1263403675455114e-13
the O 0 5.466520465458036e-12
CTG O 0 2.2872765015335972e-08
repeat O 0 9.164182301901747e-09
and O 0 7.113192955661429e-13
for O 0 2.0001028688185196e-16
a O 0 4.239181790023855e-15
significant O 0 9.280228495389675e-15
reduction O 0 1.357647284525032e-12
of O 0 9.46528190095869e-16
this O 0 4.821172198851654e-15
interaction O 0 8.163946644092809e-15
in O 0 1.450348426968763e-14
cells O 0 2.1208033593178577e-11
with O 0 9.205963899180936e-13
a O 0 3.428786768400194e-11
hypermethylated O 0 9.339602229374577e-07
DMPK O 0 1.6151926729435218e-07
gene O 0 4.974993750295198e-10
. O 0 5.678495434285891e-12
. O 0 1.542300835655208e-11

The O 0 2.29152092856566e-08
hemochromatosis B-Disease 1 0.9998255372047424
gene O 0 2.1938998884252214e-07
product O 0 1.1071478844826288e-08
complexes O 0 7.551774761083152e-10
with O 0 1.989434875518392e-12
the O 0 3.762500565013954e-13
transferrin O 0 4.3015608852670084e-09
receptor O 0 3.761006783786769e-10
and O 0 6.13878781141608e-10
lowers O 0 1.6499075172760058e-07
its O 0 7.250455661203525e-14
affinity O 0 5.859292136764851e-14
for O 0 9.878478072216935e-17
ligand O 0 7.049590945717998e-13
binding O 0 3.3913183372646927e-10
. O 0 3.249258501147878e-11

We O 0 6.48442455286613e-09
recently O 0 6.337448343884944e-10
reported O 0 3.148508884165402e-11
the O 0 2.4265323416908366e-15
positional O 0 1.6441020420088215e-11
cloning O 0 1.178062314366457e-09
of O 0 1.1852490526315009e-14
a O 0 7.411845117689941e-13
candidate O 0 1.1042316366838278e-11
gene O 0 1.7672114438482822e-07
for O 0 1.001546223733385e-07
hereditary B-Disease 1 0.9999995231628418
hemochromatosis I-Disease 1 0.9999998807907104
called O 0 0.0011892295442521572
HFE O 0 0.3112173080444336
. O 0 5.7308543688350255e-08

The O 0 5.295396413029785e-11
gene O 0 2.5393274150076195e-09
product O 0 6.722419509941346e-09
, O 0 3.716384838758913e-12
a O 0 5.5084544781439093e-14
member O 0 3.639461287544129e-15
of O 0 2.1987958871184932e-16
the O 0 5.288403449963536e-14
major O 0 5.221652645860664e-13
histocompatibility O 0 2.2600630256164322e-09
complex O 0 2.794324771571155e-10
class O 0 4.0501123288461116e-11
I O 0 1.017341588749332e-07
- O 0 8.616414248763249e-08
like O 0 4.3678899386279113e-10
family O 0 1.4928334124419962e-09
, O 0 3.246498664517816e-13
was O 0 8.481020746797796e-11
found O 0 2.2277000123055446e-12
to O 0 3.933922550778193e-14
have O 0 3.068894896779244e-14
a O 0 2.8526731351468174e-14
mutation O 0 8.712994735426971e-12
, O 0 1.9887405524471324e-12
Cys O 0 6.333321778129175e-08
- O 0 2.513901975476074e-09
282 O 0 5.9998925827642324e-09
- O 0 8.95182665772154e-07
- O 0 1.1903104677912779e-05
> O 0 1.26564214664171e-09
Tyr O 0 4.007728815480505e-09
( O 0 6.090701537954726e-14
C282Y O 0 8.386112117231281e-12
) O 0 1.5545765087547625e-13
, O 0 2.4094507788149748e-14
in O 0 2.533674936793396e-14
85 O 0 1.8770746675750294e-12
% O 0 5.539913535914818e-15
of O 0 3.857964024200217e-15
patient O 0 7.922755229650136e-10
chromosomes O 0 3.5168656609130267e-07
. O 0 1.7922818784654737e-09

This O 0 1.866112993298419e-11
mutation O 0 3.2725713805525913e-10
eliminates O 0 1.3522591046921661e-08
the O 0 4.340895351506724e-11
ability O 0 3.897409339703728e-10
of O 0 1.6424329344483235e-13
HFE O 0 1.7302890853443387e-07
to O 0 9.063311733059631e-12
associate O 0 8.934707834695743e-11
with O 0 7.118168554587356e-11
beta2 O 0 4.5466062147170305e-05
- O 0 0.0003829763736575842
microglobulin O 0 0.003037175163626671
( O 0 2.732226988058639e-12
beta2m O 0 5.187863649780411e-08
) O 0 1.6412564666709595e-12
and O 0 1.5373482651834247e-12
prevents O 0 2.752397268435125e-11
cell O 0 4.345779416325968e-06
- O 0 3.3292846637777984e-05
surface O 0 2.0533854694804177e-05
expression O 0 3.165892792367231e-08
. O 0 2.7732149909809323e-09

A O 0 5.0161204079302024e-09
second O 0 2.6669697561487737e-09
mutation O 0 1.287551065765058e-09
that O 0 4.3824435747019663e-10
has O 0 1.500242707841437e-10
no O 0 5.374117817424917e-12
effect O 0 9.097137106117703e-12
on O 0 4.74561083763092e-08
beta2m O 0 2.3537979359389283e-05
association O 0 6.191390716087097e-12
, O 0 3.227451671802134e-13
H63D O 0 2.3760613032663969e-07
, O 0 2.3064690348600925e-12
was O 0 2.0483927887227082e-09
found O 0 1.5607198866618432e-10
in O 0 4.8744709847279785e-14
eight O 0 1.1192700412332446e-11
out O 0 6.380331679656237e-11
of O 0 1.3154497565011358e-13
nine O 0 2.1590478016531023e-10
patients O 0 5.533941360713612e-13
heterozygous O 0 8.238631673575247e-13
for O 0 5.945565661167902e-16
the O 0 4.2510398955315776e-13
C282Y O 0 5.198895980385032e-09
mutant O 0 2.673266408237396e-07
. O 0 1.0628360413988958e-09

In O 0 7.597975026918391e-11
this O 0 2.275123665851364e-12
report O 0 4.917722912917144e-12
, O 0 9.745836577264733e-15
we O 0 5.826605474143487e-14
demonstrate O 0 1.0707750062056293e-14
in O 0 4.69053653085811e-16
cultured O 0 4.1025776525982494e-11
293 O 0 6.444247913073298e-11
cells O 0 6.860860490842668e-11
overexpressing O 0 2.5295156191873502e-08
wild O 0 4.529034036693247e-09
- O 0 1.4025117707205936e-06
type O 0 1.879539723859125e-08
or O 0 8.060086487127194e-10
mutant O 0 8.793751504754255e-08
HFE O 0 4.4976928847972886e-07
proteins O 0 7.582010574935794e-10
that O 0 6.35494521589175e-12
both O 0 4.712781204239784e-14
the O 0 2.280075000332671e-13
wild O 0 5.09106179436003e-09
- O 0 6.336514616123168e-06
type O 0 7.598521989393703e-08
and O 0 1.659282844457266e-08
H63D O 0 3.613597073126584e-05
HFE O 0 3.4655206491152057e-06
proteins O 0 2.1039291198121646e-08
form O 0 2.4113025812178002e-11
stable O 0 5.840658512390462e-10
complexes O 0 1.4721854291188663e-10
with O 0 3.96947188660568e-12
the O 0 1.3885507327282554e-11
transferrin O 0 3.7271473729560967e-07
receptor O 0 1.7654283368528922e-08
( O 0 7.257409083416544e-12
TfR O 0 4.2113811105082277e-07
) O 0 1.7845129887672506e-11
. O 0 5.225005497710988e-11

The O 0 4.74182415555191e-10
C282Y O 0 9.195368733116993e-08
mutation O 0 9.88881510011197e-08
nearly O 0 4.578795564924576e-09
completely O 0 3.8542532365681836e-07
prevents O 0 3.863898356826212e-08
the O 0 4.599248204506523e-10
association O 0 6.930243596874053e-13
of O 0 2.464782020248236e-15
the O 0 6.720828320955219e-13
mutant O 0 2.5889878685347867e-08
HFE O 0 1.7354948056436115e-07
protein O 0 6.984102740581477e-10
with O 0 4.874838380186652e-12
the O 0 4.21364436398175e-11
TfR O 0 1.1065177204727661e-05
. O 0 3.239489232420567e-10

Studies O 0 3.4210949628743492e-09
on O 0 2.41608377749003e-09
cell O 0 3.5507148368196795e-06
- O 0 1.059158967109397e-05
associated O 0 3.748339860720762e-09
transferrin O 0 5.5840011725649674e-08
at O 0 2.485939787355562e-10
37 O 0 2.0086399991209314e-12
degrees O 0 5.082887236107503e-11
C O 0 3.211406918168791e-09
suggest O 0 1.3850611196158935e-12
that O 0 1.2073271527489327e-13
the O 0 3.492184568864437e-13
overexpressed O 0 5.654189649817454e-08
wild O 0 1.1899278895555199e-08
- O 0 1.5935472674755147e-06
type O 0 1.0172577447065123e-08
HFE O 0 1.1322363207000308e-06
protein O 0 5.552232895666975e-09
decreases O 0 2.2420333645190027e-10
the O 0 1.310473048300861e-14
affinity O 0 2.893524482516785e-11
of O 0 6.044536887076651e-14
the O 0 3.002237347615733e-11
TfR O 0 4.3642845071190095e-07
for O 0 1.1393897977884926e-12
transferrin O 0 3.155292347400973e-07
. O 0 1.69872713118302e-10

The O 0 5.650205858742652e-10
overexpressed O 0 3.956135515181813e-06
H63D O 0 9.596596100891475e-06
protein O 0 2.3145030780824527e-08
does O 0 1.436821078781847e-10
not O 0 8.537851415441056e-13
have O 0 5.232839443876369e-13
this O 0 1.1649609194788659e-14
effect O 0 1.1600751826171263e-12
, O 0 1.1169097568206662e-14
providing O 0 2.802300773987874e-16
the O 0 9.461098828748675e-15
first O 0 2.325222805098226e-13
direct O 0 1.5357993129734397e-14
evidence O 0 9.433543356196505e-12
for O 0 1.0948471743468281e-14
a O 0 3.2548208919735977e-12
functional O 0 1.15316194093662e-11
consequence O 0 3.3516210640183175e-11
of O 0 6.7734696398578844e-15
the O 0 1.1810263704503665e-11
H63D O 0 1.5020305909274612e-05
mutation O 0 1.0450046161736282e-08
. O 0 2.8931232409767915e-10

Addition O 0 4.1391102351129305e-11
of O 0 2.690020244316277e-13
soluble O 0 1.17162657353731e-09
wild O 0 1.0561678642773131e-08
- O 0 0.00011251109390286729
type O 0 6.842358743597288e-06
HFE O 0 0.303823322057724
/ O 0 7.446548261214048e-05
beta2m O 0 1.5325917047448456e-05
heterodimers O 0 4.118672336517193e-08
to O 0 4.4490249158368744e-12
cultured O 0 5.799927760286039e-10
cells O 0 1.4289998073735433e-09
also O 0 2.558432077304218e-10
decreased O 0 9.421842472878694e-11
the O 0 5.87128761407596e-13
apparent O 0 2.6173920808503226e-09
affinity O 0 2.0260378097436416e-10
of O 0 1.680087004848202e-13
the O 0 3.950174822658914e-12
TfR O 0 5.334532371392697e-09
for O 0 3.093710283392099e-16
its O 0 5.002031944298813e-15
ligand O 0 1.65954123815433e-13
under O 0 1.7617281331677725e-12
steady O 0 2.2344610606239712e-09
- O 0 1.1552638845557794e-08
state O 0 5.915141987333783e-11
conditions O 0 3.088177769061673e-10
, O 0 3.845034913293327e-15
both O 0 3.4881068760233896e-15
in O 0 5.986351568127617e-15
293 O 0 8.136706586281406e-12
cells O 0 3.208171228674672e-11
and O 0 5.922680314934814e-12
in O 0 1.1286327775139604e-13
HeLa O 0 9.022818971970992e-07
cells O 0 6.538324548444052e-09
. O 0 2.221270112290341e-10

Furthermore O 0 1.4857263197498582e-09
, O 0 2.263566721213972e-12
at O 0 7.91993727544682e-12
4 O 0 5.262468846106705e-12
degrees O 0 3.165170625596403e-10
C O 0 1.4644601087354658e-08
, O 0 1.2143624864360825e-12
the O 0 5.603490219573126e-13
added O 0 2.1472774947017825e-10
soluble O 0 1.905592905693254e-10
complex O 0 7.72595789427788e-12
of O 0 9.740420275905493e-13
HFE O 0 0.00013562498497776687
/ O 0 3.1070493378138053e-07
beta2m O 0 2.9770093945558074e-08
inhibited O 0 6.094661580968719e-11
binding O 0 9.82378349674573e-13
of O 0 7.911620611303436e-15
transferrin O 0 3.880854748672391e-09
to O 0 8.462596075287099e-12
HeLa O 0 4.2752250806188385e-07
cell O 0 5.0751141316141e-06
TfR O 0 3.054263743251795e-06
in O 0 4.755947155196671e-13
a O 0 1.0405279936287481e-11
concentration O 0 8.401095215049281e-07
- O 0 1.0515888106965576e-06
dependent O 0 1.3999505554807001e-08
manner O 0 7.968709248018513e-09
. O 0 5.632634358931909e-10

Scatchard O 0 1.722618253552355e-05
plots O 0 6.951203204152989e-07
of O 0 9.410828019640327e-12
these O 0 2.368783988404566e-12
data O 0 4.096715189305655e-10
indicate O 0 1.195504806261738e-10
that O 0 1.3975786673781077e-12
the O 0 5.642228221094947e-13
added O 0 3.0341767986996615e-10
heterodimer O 0 6.677417646594463e-11
substantially O 0 2.406465859916551e-10
reduced O 0 1.1016183625034426e-12
the O 0 8.354699988473782e-14
affinity O 0 1.188135007046398e-10
of O 0 1.575018652825999e-12
TfR O 0 3.103782830748969e-07
for O 0 6.09151726456425e-13
transferrin O 0 3.7182434198257397e-07
. O 0 1.7613771552404955e-10

These O 0 4.60971677496147e-10
results O 0 8.26076013149546e-12
establish O 0 1.2802321052232668e-12
a O 0 1.1717500884508847e-12
molecular O 0 3.9223249648223657e-10
link O 0 1.4049854257791594e-07
between O 0 3.815822768871158e-09
HFE O 0 4.5158139982959256e-05
and O 0 1.7801997376221124e-10
a O 0 1.5303028484160708e-13
key O 0 1.6511224679160996e-11
protein O 0 2.820570816838841e-12
involved O 0 5.94044805750718e-14
in O 0 1.3171092634513965e-13
iron O 0 1.8640276877590622e-08
transport O 0 2.5073484954951653e-11
, O 0 1.5340727548950744e-13
the O 0 4.4538111805374203e-13
TfR O 0 1.703936334251921e-07
, O 0 3.3358138842344565e-13
and O 0 7.192773937222952e-13
raise O 0 9.496087049294319e-14
the O 0 3.732340567792931e-15
possibility O 0 1.2495059884497488e-14
that O 0 4.71470735716184e-13
alterations O 0 2.933701458845972e-12
in O 0 2.7157126509603016e-14
this O 0 2.0639650131679642e-14
regulatory O 0 1.0274957100431248e-11
mechanism O 0 4.788890173301752e-09
may O 0 4.621901195100975e-10
play O 0 1.1065313162278434e-12
a O 0 6.241753262251765e-14
role O 0 1.897198977779402e-12
in O 0 5.243486648023356e-14
the O 0 4.770364875686384e-13
pathogenesis O 0 4.2376768760732375e-08
of O 0 3.981883711645651e-09
hereditary B-Disease 1 0.9999996423721313
hemochromatosis I-Disease 1 0.9999998807907104
. O 0 2.1230006552741543e-07
. O 0 1.6994150531246532e-09

Genomic O 0 2.7425651083490266e-08
organization O 0 5.0988113037275795e-11
of O 0 2.758211953106382e-13
the O 0 1.6626415522136284e-11
UBE3A O 0 2.2770660507376306e-05
/ O 0 1.8430354487009026e-07
E6 O 0 1.8753178665065207e-05
- O 0 4.680865094996989e-05
AP O 0 5.456363965095079e-07
gene O 0 2.1141323414131108e-10
and O 0 1.2759494849579056e-11
related O 0 3.845570736848991e-11
pseudogenes O 0 3.555112115805059e-08
. O 0 7.803689361374211e-10

The O 0 3.232216924664577e-11
UBE3A O 0 3.865416786652531e-08
gene O 0 1.1662083798658074e-10
encodes O 0 1.9059791522835212e-09
the O 0 7.378227195875553e-11
E6 O 0 2.4412101993220858e-05
- O 0 3.898308568750508e-05
AP O 0 1.1224250329178176e-06
ubiquitin O 0 1.3062315673550984e-09
- O 0 7.351877440164856e-10
protein O 0 1.6840678851437474e-10
ligase O 0 1.831450789635536e-11
and O 0 2.096359197345521e-11
has O 0 5.657576403889086e-12
recently O 0 3.9097505614982264e-12
been O 0 3.9132922163148676e-13
shown O 0 4.000051429409873e-14
to O 0 2.2305270648116193e-16
be O 0 1.6566792154695115e-13
mutated O 0 1.260994395124726e-06
in O 0 2.5102646759478375e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.2037276064802427e-07
who O 0 8.553120434129369e-10
lack O 0 6.892637502420307e-12
15q11 O 0 1.2221856859895297e-09
- O 0 3.3737930493771273e-07
q13 O 0 1.3858677050393453e-07
deletions O 0 6.820942530794127e-07
or O 0 5.591291341033866e-08
chromosome O 0 0.0015244960086420178
15 O 0 2.6633722782776204e-08
paternal O 0 0.0002962699218187481
uniparental B-Disease 1 0.5036643147468567
disomy I-Disease 0 0.06321967393159866
. O 0 1.3684110911071912e-07

Previous O 0 8.28995716517511e-09
UBE3A O 0 4.7009362447170133e-07
cDNA O 0 2.343175253827212e-08
analysis O 0 1.435172869435064e-09
has O 0 1.2504956792280808e-10
shown O 0 1.7379096425851337e-11
a O 0 5.003935633907108e-13
coding O 0 8.79603157954989e-06
region O 0 1.2796644299761795e-10
of O 0 6.024934511798113e-14
approximately O 0 1.3843506419322638e-12
2 O 0 1.2835879581452048e-10
. O 0 1.55437426818672e-10

6 O 0 4.050814084166632e-08
kb O 0 7.824994099792093e-06
and O 0 6.815137343352262e-10
a O 0 2.692610197307932e-11
3 O 0 4.3402952343285506e-09
- O 0 0.002986675826832652
untranslated O 1 0.9874862432479858
region O 0 2.621030716909445e-07
( O 0 5.441520172823344e-13
UTR O 0 5.40168016982534e-08
) O 0 9.40942311046522e-13
of O 0 2.958748553439131e-15
< O 0 5.558953471151984e-12
50 O 0 3.580961888778253e-14
bp O 0 6.270428620780422e-10
, O 0 3.867898026605615e-14
whereas O 0 6.153511402685885e-14
Northern O 0 5.755944630430818e-14
analysis O 0 1.9305999941071628e-12
has O 0 1.8227174977680782e-11
indicated O 0 3.1978265521703797e-12
mRNA O 0 1.4796833463365244e-12
sizes O 0 1.3223966192910108e-11
of O 0 7.121728337264321e-14
5 O 0 1.8804334825373026e-11
- O 0 5.775493505666418e-08
8 O 0 3.9255976247432045e-09
kb O 0 8.217987669922877e-06
. O 0 3.846577500965509e-10

We O 0 4.3620618228601415e-10
have O 0 2.6449030682620944e-13
analyzed O 0 1.7721512191731792e-13
additional O 0 8.591390809496377e-15
cDNA O 0 7.057915918373681e-10
clones O 0 5.769513791165082e-07
and O 0 1.2055294262847127e-10
provide O 0 5.752802561712978e-15
evidence O 0 3.1935930543949484e-14
for O 0 5.269948491985128e-17
an O 0 4.708822913398146e-16
additional O 0 3.4827701025875665e-14
0 O 0 2.0148801030406283e-11
. O 0 3.860069555661205e-11

5 O 0 1.3132568810192424e-08
kb O 0 1.2121835197831388e-06
of O 0 2.1034070752518064e-12
5 O 0 3.1096455965773373e-10
- O 0 2.4737281023590185e-07
UTR O 0 1.2045550647599157e-05
and O 0 5.568233651942478e-10
> O 0 1.7933501905709193e-11
2 O 0 1.3912281916772518e-11
kb O 0 1.1768170082859797e-07
of O 0 4.4526814418736904e-13
3 O 0 1.5891370441778463e-09
- O 0 2.7050434709963156e-06
UTR O 0 0.00012166282249381766
. O 0 2.4086574956783124e-09

We O 0 5.6704951845176765e-09
have O 0 1.3045763471233873e-12
established O 0 1.5990237156289847e-14
the O 0 8.94625102758383e-15
genomic O 0 1.1759171761327458e-11
organization O 0 2.888674271572106e-13
of O 0 5.819349705214012e-15
UBE3A O 0 6.526739326773168e-08
and O 0 1.4621099470035759e-12
the O 0 2.3189843566197212e-15
sequence O 0 4.707456213032257e-13
of O 0 4.574732790935815e-14
intron O 0 1.3126782505423762e-05
- O 0 1.7879043525681482e-06
exon O 0 1.1295572903691209e-06
borders O 0 7.85737256592256e-07
. O 0 1.2141564198486776e-08

We O 0 6.2619935903285295e-09
have O 0 2.5830745528643284e-11
also O 0 1.3283822826448688e-12
mapped O 0 1.0260319260879669e-09
two O 0 8.707108384992113e-13
highly O 0 2.861731576535298e-13
homologous O 0 9.01952286729707e-13
processed O 0 2.1662116544973742e-11
pseudogenes O 0 5.622147747352813e-10
, O 0 8.666784304112163e-12
UBE3AP1 O 0 7.456528692273423e-07
and O 0 1.208181332756908e-10
UBE3AP2 O 0 7.570081805852169e-08
, O 0 9.628791362327471e-14
to O 0 1.2734026344236177e-13
chromosomes O 0 7.233949550489172e-10
2 O 0 4.1897221803033347e-11
and O 0 6.096358834417615e-11
21 O 0 4.912971765524965e-11
, O 0 2.5129679153551576e-12
respectively O 0 3.264727030383163e-11
, O 0 1.1824660174630797e-12
and O 0 7.312488288502283e-12
determined O 0 5.449439857696525e-11
their O 0 2.9244386860055593e-12
genomic O 0 6.839384614210076e-10
organization O 0 7.148399927547899e-11
. O 0 2.2140286826122235e-10

These O 0 6.03233196727615e-09
results O 0 1.7080132863611652e-09
will O 0 6.797698515192963e-11
form O 0 3.575876980589296e-14
the O 0 1.4773159231302666e-14
basis O 0 1.4357586571468045e-13
for O 0 1.3140304003320807e-13
studies O 0 2.7743484593001355e-12
of O 0 1.787779925726922e-15
mutation O 0 1.5444498110972482e-11
and O 0 3.225127413394868e-12
imprinting O 0 3.5817791399495036e-07
of O 0 5.172925976459908e-11
UBE3A O 0 0.00015243497909978032
. O 0 6.814205200100787e-09

Mutation O 0 1.0543869422008356e-07
spectrum O 0 5.859991247803009e-08
and O 0 1.944691074839966e-09
genotype O 0 6.538865818583872e-06
- O 0 0.00022465271467808634
phenotype O 0 1.0649760042724665e-05
analyses O 0 1.325204408431091e-07
in O 0 1.8298252912885005e-09
Cowden B-Disease 1 0.9726521968841553
disease I-Disease 0 0.0031612783204764128
and O 0 1.9197280209937162e-07
Bannayan B-Disease 1 0.966436505317688
- I-Disease 1 0.999927282333374
Zonana I-Disease 1 0.9998865127563477
syndrome I-Disease 1 0.9999815225601196
, O 0 2.8796845463752163e-10
two O 0 3.2504399172239573e-09
hamartoma B-Disease 1 0.5807782411575317
syndromes I-Disease 0 0.0801602378487587
with O 0 8.528521777684261e-10
germline O 0 4.238156179781072e-06
PTEN O 0 0.0007857508608140051
mutation O 0 2.7722868253476918e-05
. O 0 9.901894770791841e-08

The O 0 7.768855425638321e-08
tumour B-Disease 1 0.9997543692588806
suppressor O 0 0.00039918950642459095
gene O 0 7.26867529010633e-06
PTEN O 0 0.00016478016914334148
, O 0 1.0920984949702728e-10
which O 0 5.869140676934004e-12
maps O 0 1.2862182430239955e-09
to O 0 3.744293763929818e-10
10q23 O 0 1.5468789626993384e-07
. O 0 1.823769690822985e-09

3 O 0 2.8448232658462302e-09
and O 0 1.4101985638254044e-12
encodes O 0 1.8183735767118847e-11
a O 0 4.881284178942513e-13
403 O 0 5.136565218305522e-12
amino O 0 7.811879476626871e-10
acid O 0 3.0056535038625043e-10
dual O 0 8.777388260661212e-10
specificity O 0 1.7930384288433743e-08
phosphatase O 0 0.0001281856675632298
( O 0 4.2149744523649335e-13
protein O 0 1.6692837390142046e-10
tyrosine O 0 3.588617403238459e-07
phosphatase O 0 0.0005204143817536533
; O 0 8.81362427485044e-10
PTPase O 0 1.0761867770270328e-06
) O 0 3.9743073415587915e-11
, O 0 1.0415183255771399e-12
was O 0 2.7653290768370198e-09
shown O 0 3.8391090306788556e-10
recently O 0 1.6034706895595718e-10
to O 0 7.753160093104672e-13
play O 0 2.338005006610744e-12
a O 0 2.6207437912526e-13
broad O 0 1.562046607513079e-12
role O 0 3.2802205396365025e-10
in O 0 1.6216967005378002e-11
human O 0 4.1002032880044226e-09
malignancy B-Disease 0 0.0001370534737361595
. O 0 2.655189401679081e-09

Somatic O 0 4.042895511702227e-07
PTEN O 0 1.3919815501139965e-05
deletions O 0 1.3536379128709086e-06
and O 0 1.4831392114444952e-08
mutations O 0 2.134360421734982e-08
were O 0 8.727535361074956e-11
observed O 0 8.165897957823631e-10
in O 0 9.184203744738717e-12
sporadic B-Disease 0 7.627358513673244e-07
breast I-Disease 0 0.42943131923675537
, I-Disease 0 3.332933829369722e-06
brain I-Disease 1 0.9438573718070984
, I-Disease 0 1.724662865854043e-06
prostate I-Disease 1 0.9972565770149231
and I-Disease 0 0.0907176285982132
kidney I-Disease 1 0.9707599878311157
cancer I-Disease 0 0.00910474918782711
cell O 0 0.02824164368212223
lines O 0 0.00015556838479824364
and O 0 1.1768254815081036e-08
in O 0 5.266746674198464e-12
several O 0 4.2764683461093966e-10
primary O 0 6.33561285212636e-05
tumours B-Disease 1 0.9999995231628418
such O 0 5.679433034977421e-10
as O 0 2.31934706107495e-07
endometrial B-Disease 1 0.9993858337402344
carcinomas I-Disease 1 0.9999997615814209
, O 1 0.9880631566047668
malignant B-Disease 1 0.9999998807907104
melanoma I-Disease 1 0.9999998807907104
and O 1 0.9998834133148193
thyroid B-Disease 1 0.9999783039093018
tumours I-Disease 1 0.9999934434890747
. O 0 7.107862620614469e-05

In O 0 1.7299203736165225e-10
addition O 0 1.594904937285424e-11
, O 0 4.217686963570166e-12
PTEN O 0 3.305844131773483e-08
was O 0 8.648364802077424e-10
identified O 0 4.420536419552645e-12
as O 0 1.7560600665115535e-14
the O 0 2.990522326301592e-14
susceptibility O 0 2.466754300822771e-10
gene O 0 4.0823006086654345e-10
for O 0 2.495295853624513e-12
two O 0 1.836088330264829e-07
hamartoma B-Disease 1 0.9997959733009338
syndromes I-Disease 1 0.9999579191207886
Cowden B-Disease 1 0.9997785687446594
disease I-Disease 1 0.7292680144309998
( O 0 5.1289802266429874e-11
CD B-Disease 0 6.570845926034963e-06
; O 0 7.340990038073869e-10
MIM O 0 7.933836968732066e-06
158350 O 0 2.900110303016845e-07
) O 0 1.3201796600359472e-10
and O 0 1.4174628137908485e-09
Bannayan B-Disease 0 1.0564082003838848e-05
- I-Disease 0 0.00010311923688277602
Zonana I-Disease 0 0.00034808219061233103
( I-Disease 0 1.951484113194013e-12
BZS I-Disease 0 2.8764142179227292e-09
) I-Disease 0 1.4705638508132057e-13
or I-Disease 0 1.6000596030421588e-12
Ruvalcaba I-Disease 0 3.22709723832304e-07
- I-Disease 0 3.790500704781152e-05
Riley I-Disease 0 0.013324026018381119
- I-Disease 1 0.9996484518051147
Smith I-Disease 1 0.9998252987861633
syndrome I-Disease 1 0.9999427795410156
( O 0 1.3244665780787201e-11
MIM O 0 2.607473561511142e-06
153480 O 0 2.714453160024277e-07
) O 0 1.2580410324591895e-10
. O 0 5.960307247754315e-11

Constitutive O 0 1.0144192152949927e-08
DNA O 0 3.096592138263077e-08
from O 0 2.50421784003807e-11
37 O 0 1.3813418291153123e-11
CD B-Disease 0 9.795666500167499e-08
families O 0 9.755844049275098e-11
and O 0 7.47819254437454e-12
seven O 0 1.6103906402831214e-11
BZS B-Disease 0 3.838966122771126e-08
families O 0 3.5276588507965334e-13
was O 0 1.7819553124742704e-11
screened O 0 2.1433525093650374e-11
for O 0 7.881592107477145e-14
germline O 0 8.271824114558513e-09
PTEN O 0 6.335052603390068e-06
mutations O 0 6.088971531426068e-07
. O 0 6.731195600906403e-09

PTEN O 0 6.571282574441284e-05
mutations O 0 6.646308179369953e-07
were O 0 5.097530175746101e-10
identified O 0 1.0797086835712122e-10
in O 0 4.755783982769712e-13
30 O 0 8.924955501206366e-13
of O 0 4.081033200178247e-13
37 O 0 4.754666105277749e-10
( O 0 3.5902099977842827e-13
81 O 0 1.2118046843756503e-10
% O 0 2.126605776241533e-13
) O 0 4.857729886745266e-13
CD B-Disease 0 5.015654025442018e-08
families O 0 7.772308838194242e-12
, O 0 2.951473429806811e-14
including O 0 1.5436965399538705e-14
missense O 0 7.036466964649435e-09
and O 0 2.17023754522927e-09
nonsense O 0 3.640051318143378e-07
point O 0 5.5738922810633085e-08
mutations O 0 3.2977938158040843e-09
, O 0 1.3792376529070394e-12
deletions O 0 6.13148587458312e-10
, O 0 6.748874462753074e-12
insertions O 0 5.2198142697079675e-08
, O 0 8.046503047198783e-11
a O 0 1.3853662661489352e-10
deletion O 0 2.2777524009143235e-06
/ O 0 5.321780918166041e-07
insertion O 0 2.5905587008878683e-08
and O 0 2.838503432300854e-09
splice O 0 0.00041109102312475443
site O 0 6.337566446745768e-06
mutations O 0 6.291570571193006e-06
. O 0 2.3602515497600507e-08

These O 0 1.7466801616183858e-10
mutations O 0 2.480172733854147e-09
were O 0 1.8496149056801414e-10
scattered O 0 9.609926049369832e-11
over O 0 4.953573315424897e-11
the O 0 1.0029857153148747e-11
entire O 0 1.6020683668571678e-09
length O 0 1.32961943677401e-08
of O 0 1.3949713779937145e-12
PTEN O 0 6.78758908634336e-07
, O 0 2.3318638686653514e-12
with O 0 5.0865480447429e-13
the O 0 5.2107415604574214e-12
exception O 0 1.917235467607803e-12
of O 0 5.8638951679101155e-15
the O 0 1.0443669583651283e-12
first O 0 2.4708038393050913e-10
, O 0 6.84969051964468e-12
fourth O 0 9.195908923231855e-09
and O 0 6.145743636221113e-11
last O 0 1.6244968703560403e-09
exons O 0 3.870806722261477e-06
. O 0 1.005636462991788e-08

A O 0 8.965542197536536e-10
hot O 0 6.148191289412352e-08
spot O 0 3.2444948061538526e-08
for O 0 2.7709796263097886e-12
PTEN O 0 8.075964501585986e-07
mutation O 0 7.514664446262032e-09
in O 0 7.074297744824598e-12
CD B-Disease 0 4.183687849490525e-07
was O 0 1.3830101508460757e-08
identified O 0 3.748085869448303e-11
in O 0 3.885822599022232e-14
exon O 0 5.351589171809223e-10
5 O 0 3.5860339697713073e-10
that O 0 3.41613577703459e-11
contains O 0 1.2173377540378172e-12
the O 0 4.31372212256198e-12
PTPase O 0 2.0881022066987498e-07
core O 0 5.86534465440991e-09
motif O 0 1.857695686169336e-08
, O 0 1.775202570662368e-13
with O 0 5.2324870781703114e-14
13 O 0 1.432703782000555e-12
of O 0 2.099244782454053e-14
30 O 0 8.003884881258028e-12
( O 0 1.5947931248706283e-14
43 O 0 2.8818260278118402e-11
% O 0 1.309431892342755e-13
) O 0 1.0066535278963062e-12
CD B-Disease 0 9.163259306887994e-08
mutations O 0 2.440099788891814e-10
identified O 0 1.8683707359024027e-11
in O 0 6.923498656574408e-15
this O 0 3.033898883530485e-14
exon O 0 4.440683198936313e-08
. O 0 3.248680968681583e-08

Seven O 0 9.75404823577719e-09
of O 0 2.538228958612332e-12
30 O 0 1.238702335149e-10
( O 0 4.4340280145466204e-13
23 O 0 5.832161836805128e-11
% O 0 8.23721380818418e-14
) O 0 1.3707660223918894e-13
were O 0 1.9234685730024764e-13
within O 0 2.6353413156611906e-16
the O 0 8.170819977646598e-14
core O 0 2.3260613435382993e-09
motif O 0 3.605405396456263e-08
, O 0 3.814259671997e-12
the O 0 5.699013309878875e-12
majority O 0 6.193138883670013e-12
( O 0 6.310028268261903e-15
five O 0 1.967532690591578e-12
of O 0 1.1703555876166338e-13
seven O 0 4.0056483130435083e-10
) O 0 2.172726652456894e-13
of O 0 1.747525637820727e-15
which O 0 2.5703848771652105e-11
were O 0 6.877732324633845e-12
missense O 0 4.4921757980098675e-10
mutations O 0 1.5437356948311276e-09
, O 0 6.922901488182198e-12
possibly O 0 8.00396485201027e-11
pointing O 0 5.814463133191339e-09
to O 0 1.3218796716951697e-11
the O 0 3.912033023911743e-12
functional O 0 3.019471131460172e-11
significance O 0 2.5375625212209485e-11
of O 0 1.1948374147724428e-13
this O 0 9.277605593493998e-12
region O 0 3.267631720760278e-10
. O 0 4.23453772047111e-10

Germline O 0 1.3265261259221006e-05
PTEN O 0 3.017155540874228e-05
mutations O 0 8.965411097960896e-07
were O 0 4.7959075599735e-10
identified O 0 4.288721044964916e-10
in O 0 1.5766538465425417e-12
four O 0 3.7361235633026624e-11
of O 0 1.2627299379730506e-12
seven O 0 6.022697451868453e-09
( O 0 4.990857987302588e-13
57 O 0 3.5029035228006933e-10
% O 0 1.102448644527132e-12
) O 0 5.141968795197016e-11
BZS B-Disease 0 6.363131177522519e-08
families O 0 8.110428127705571e-12
studied O 0 2.7369330760085298e-11
. O 0 5.385726239981459e-11

Interestingly O 0 1.090494720301649e-06
, O 0 7.99367128045958e-10
none O 0 1.1145391554112649e-10
of O 0 1.4282279921446275e-14
these O 0 8.73618722935926e-13
mutations O 0 4.199485204026132e-10
was O 0 3.484428390265748e-08
observed O 0 3.103672596704854e-10
in O 0 3.048471306117684e-13
the O 0 2.2161486187832757e-11
PTPase O 0 2.7704943477147026e-06
core O 0 3.369856216295375e-08
motif O 0 3.376831898549426e-07
. O 0 2.486637284970783e-10

It O 0 9.507147957776851e-09
is O 0 8.811905372052564e-11
also O 0 8.713027695173015e-12
worthy O 0 3.410367474532272e-11
of O 0 2.1955809566265305e-13
note O 0 9.17981315962102e-11
that O 0 1.661774423579107e-13
a O 0 3.792870694168532e-13
single O 0 1.879415928440764e-10
nonsense O 0 1.79588994342339e-07
point O 0 3.97039467969762e-09
mutation O 0 4.8442999611708615e-11
, O 0 5.315325545159066e-13
R233X O 0 9.394261757389444e-11
, O 0 7.639847955653867e-13
was O 0 4.797115482624292e-10
observed O 0 1.699611111571908e-11
in O 0 1.3438727432572243e-14
the O 0 2.5359147290751616e-13
germline O 0 2.5632320918567153e-11
DNA O 0 4.845896839356101e-08
from O 0 1.7533443230285939e-12
two O 0 3.398307893767716e-12
unrelated O 0 2.177783370305164e-10
CD B-Disease 0 6.915259973538923e-07
families O 0 8.202952900271399e-11
and O 0 8.537855318568877e-12
one O 0 5.3316989712115515e-11
BZS B-Disease 0 6.924030344634957e-07
family O 0 3.832716366503064e-09
. O 0 6.445242950459118e-11

Genotype O 0 0.002899360377341509
- O 0 0.008183210156857967
phenotype O 0 3.5424967791186646e-05
studies O 0 1.8116844913151908e-08
were O 0 2.575298307938567e-10
not O 0 1.3852652532009291e-11
performed O 0 1.7270257446355686e-10
on O 0 5.022081639438625e-10
this O 0 2.398040804558327e-13
small O 0 3.5507388045433186e-13
group O 0 1.7408656113881982e-11
of O 0 1.7456550799061638e-13
BZS B-Disease 0 1.9155729091835383e-07
families O 0 5.474962063573008e-12
. O 0 2.8080740857583386e-12

However O 0 3.2604968724925243e-10
, O 0 2.1870138078999846e-12
genotype O 0 4.589070812244245e-08
- O 0 4.441852183845185e-07
phenotype O 0 1.216184983832136e-07
analysis O 0 6.957441567312372e-11
inthe O 0 4.240264317445508e-08
group O 0 8.41934411077716e-10
of O 0 1.7065804336097862e-13
CD B-Disease 0 1.4592410479963291e-05
families O 0 2.922110886593998e-10
revealed O 0 6.771949667694344e-10
two O 0 8.778508519061146e-14
possible O 0 3.360111668071486e-13
associations O 0 7.2827141063184055e-16
worthy O 0 1.6496233632562474e-12
of O 0 3.5642126592792464e-14
follow O 0 6.117185230580802e-11
- O 0 1.3037771395829623e-07
up O 0 1.0405573291905057e-08
in O 0 7.034802428085296e-13
independent O 0 9.768816831845495e-12
analyses O 0 1.4301286821449821e-09
. O 0 3.480922841636591e-11

The O 0 2.7904965005376425e-09
first O 0 2.2304798008576654e-09
was O 0 6.974630650802283e-08
an O 0 1.1699149461696923e-11
association O 0 1.2121085385397024e-12
noted O 0 3.207967311930071e-12
in O 0 8.118669853150046e-14
the O 0 8.463172654002427e-13
group O 0 4.382315690887317e-11
of O 0 3.6562034866696735e-14
CD B-Disease 0 3.251910129620228e-06
families O 0 1.717525566213851e-10
with O 0 1.1348108008846225e-09
breast B-Disease 0 0.00028381438460201025
disease I-Disease 0 2.2235364667722024e-05
. O 0 1.090885271004538e-09

A O 0 2.8199669266371075e-09
correlation O 0 3.1150371171406732e-09
was O 0 5.537363012564356e-09
observed O 0 1.2255629844304394e-10
between O 0 3.5913624504835262e-12
the O 0 2.120474585851073e-12
presence O 0 2.4596927272746427e-10
/ O 0 6.154782461464947e-09
absence O 0 1.4516015126031512e-11
of O 0 1.5540561128877931e-15
a O 0 1.4358607618863983e-12
PTEN O 0 1.574034484974618e-07
mutation O 0 1.2714442831907036e-09
and O 0 9.12017822374267e-11
the O 0 8.441397754410662e-12
type O 0 1.992281895013548e-09
of O 0 8.268914025721941e-11
breast O 0 0.00023159675765782595
involvement O 0 1.8700994814935257e-06
( O 0 5.260624921787915e-11
unaffected O 0 7.323221211663622e-07
versus O 0 5.908312346036837e-07
benign O 0 0.06444264203310013
versus O 0 2.021504769800231e-05
malignant O 1 0.8645914793014526
) O 0 2.433822743341807e-08
. O 0 3.3974316693274886e-09

Specifically O 0 2.065486670588257e-09
and O 0 1.2667573934255216e-10
more O 0 2.6504970432523513e-14
directly O 0 7.408460650504267e-11
, O 0 1.3946501939421374e-11
an O 0 2.632579917949407e-11
association O 0 1.4135951090232801e-11
was O 0 7.98636392573826e-08
also O 0 1.3374987783976167e-09
observed O 0 1.115315340083356e-10
between O 0 7.539860120801822e-13
the O 0 1.1757971983203386e-13
presence O 0 3.402671211200775e-13
of O 0 4.76940493324726e-15
a O 0 2.4277359636504237e-11
PTEN O 0 7.545579865109175e-05
mutation O 0 4.3100812945340294e-06
and O 0 3.8649823181913234e-06
malignant B-Disease 1 0.9998551607131958
breast I-Disease 1 0.9975919723510742
disease I-Disease 0 0.1327359676361084
. O 0 3.16287476209709e-08

Secondly O 0 1.5202866961772088e-05
, O 0 2.0151426360914826e-10
there O 0 2.220687609494343e-12
appeared O 0 2.2703446067584565e-10
to O 0 5.867962366012947e-13
be O 0 6.1374468875163846e-12
an O 0 1.246851059899523e-11
interdependent O 0 0.0024771669413894415
association O 0 1.3821535929658957e-11
between O 0 1.9596499770124787e-11
mutations O 0 2.309739066674865e-09
upstream O 0 2.621650097012207e-08
and O 0 5.00979757678266e-10
within O 0 7.330956317257858e-14
the O 0 1.7750148573192348e-11
PTPase O 0 7.188826884885202e-07
core O 0 2.103868901315309e-08
motif O 0 3.7074642023071647e-08
, O 0 4.361939141047516e-13
the O 0 4.0356247803154804e-14
core O 0 5.003342185005977e-10
motif O 0 2.445557090169359e-09
containing O 0 7.431642801147831e-11
the O 0 1.2832200579904196e-11
majority O 0 6.982413779110797e-13
of O 0 4.019185903688348e-14
missense O 0 1.8794466427607404e-08
mutations O 0 1.7859049350477108e-08
, O 0 1.9299603581934832e-11
and O 0 1.6069664696138908e-11
the O 0 2.38787266869378e-12
involvement O 0 4.100498829373578e-10
of O 0 6.775569688644012e-13
all O 0 3.828261058852478e-12
major O 0 5.3487086287828944e-11
organ O 0 1.6925367162912153e-05
systems O 0 3.864603058900684e-05
( O 0 1.711193361488006e-12
central O 0 2.5051877239334885e-11
nervous O 0 7.831923198864388e-08
system O 0 6.628028614841242e-08
, O 0 1.54392110207624e-09
thyroid O 0 0.08932285010814667
, O 0 1.836181429126782e-09
breast O 0 0.012092681601643562
, O 0 1.4557288068317575e-06
skin O 1 0.9995618462562561
and O 0 0.12463963776826859
gastrointestinal O 1 0.9995648264884949
tract O 1 0.946182906627655
) O 0 1.0657094406951728e-07
. O 0 3.4951515459624716e-08

However O 0 6.433839683239739e-09
, O 0 1.1090331127408537e-12
these O 0 1.342934993081319e-14
observations O 0 1.6368616531647895e-11
would O 0 1.5740674388919906e-11
need O 0 1.6440345721076277e-13
to O 0 9.035944871027893e-14
be O 0 1.491798004571443e-12
confirmed O 0 6.566058460832913e-12
by O 0 9.969490968306021e-16
studying O 0 4.64894414265349e-15
a O 0 3.009645958558342e-14
larger O 0 2.6927895253637006e-15
number O 0 2.382629311133578e-14
of O 0 5.240907263292377e-14
CD B-Disease 0 6.404264240700286e-06
families O 0 2.816584465659133e-10
. O 0 5.247357062754254e-11

Molecular O 0 0.013727049343287945
defects O 1 0.9599997997283936
leading O 0 4.262675545874117e-09
to O 0 1.3190481693015066e-12
human O 0 6.567858778540325e-13
complement B-Disease 0 4.733654579425206e-10
component I-Disease 0 2.4653450964251533e-05
C6 I-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999997615814209
in O 0 2.1475387440572646e-11
an O 0 1.1024387999714058e-11
African O 0 1.676753874635395e-10
- O 0 2.0176469206489855e-07
American O 0 6.255237217089871e-09
family O 0 2.240548013787702e-08
. O 0 9.109642207238977e-11

Complement B-Disease 0 1.6117674306315166e-07
component I-Disease 0 0.00023621146101504564
C6 I-Disease 1 0.9999799728393555
deficiency I-Disease 1 0.9999980926513672
( O 0 1.2417645578466363e-08
C6D B-Disease 0 0.0003737758088391274
) O 0 2.0590433802425423e-09
was O 0 1.2298820593059645e-06
diagnosed O 0 2.7718895125872223e-06
in O 0 1.7746168304386828e-13
a O 0 2.716015997175636e-12
16 O 0 2.338684454428197e-11
- O 0 1.5586390844646303e-08
year O 0 6.45170417090668e-10
- O 0 4.726289049017396e-08
old O 0 2.5703920982778072e-06
African O 0 1.097014493134374e-11
- O 0 3.2721597653662116e-10
American O 0 1.2828627916905422e-11
male O 0 2.085822764508194e-10
with O 0 3.6218122945186337e-10
meningococcal B-Disease 1 0.9999669790267944
meningitis I-Disease 1 0.9999325275421143
. O 0 5.236551192666639e-10

The O 0 6.064958313345414e-09
patients O 0 2.1215468493096523e-08
father O 0 2.0410000445281185e-07
and O 0 1.931331067295261e-10
two O 0 1.0282490831015068e-10
brothers O 0 4.639097710423812e-07
also O 0 1.3780872276658584e-10
had O 0 1.5303058820137494e-09
C6D B-Disease 0 1.9752586410959339e-07
, O 0 1.2817805356609563e-13
but O 0 9.14361360064564e-13
gave O 0 1.0266260064284438e-11
no O 0 1.4149493209048014e-11
history O 0 7.62702817569405e-11
of O 0 7.302428800537442e-11
meningitis B-Disease 1 0.9999957084655762
or O 0 1.0839821401598115e-10
other O 0 3.029214032390648e-11
neisserial B-Disease 0 0.0003196104080416262
infection I-Disease 0 0.00016987774870358407
. O 0 3.2732163646187473e-09

By O 0 1.410992308235881e-12
using O 0 1.1783706605969502e-12
exon O 0 4.788823226853367e-10
- O 0 2.5123871871812753e-09
specific O 0 4.54452491263635e-12
polymerase O 0 4.863954018219374e-06
chain O 0 2.2945969249121845e-06
reaction O 0 3.7573263944601365e-11
( O 0 2.088245382007598e-15
PCR O 0 8.770175696781735e-10
) O 0 6.711055322572435e-13
/ O 0 2.462362605482049e-11
single O 0 7.320138939448384e-11
- O 0 1.4721173613452265e-07
strand O 0 1.0773276244435692e-06
conformation O 0 1.5994944257968768e-09
polymorphism O 0 2.20281466678518e-11
as O 0 1.4152540943706518e-15
a O 0 1.1298932472427695e-16
screening O 0 1.2991023086103299e-14
step O 0 1.8910526898736901e-13
and O 0 2.7995333585305164e-16
nucleotide O 0 7.897053338676557e-16
sequencing O 0 4.04716624796686e-13
of O 0 3.3254176813607298e-15
target O 0 2.576570901080544e-10
exons O 0 1.215778588914418e-08
, O 0 6.9018597260994685e-12
we O 0 1.5477400177460465e-12
determined O 0 3.1050667679416444e-12
that O 0 2.3185101841877165e-12
the O 0 5.48370984038149e-12
proband O 0 1.3449689504341222e-06
was O 0 6.5672458582355375e-09
a O 0 3.7089542591697833e-13
compound O 0 8.735129980452783e-11
heterozygote O 0 5.6208156185011404e-11
for O 0 3.978850025333509e-15
two O 0 2.6831757302114845e-12
C6 O 0 1.440509890926478e-06
gene O 0 3.920077418229084e-08
mutations O 0 4.430480089467892e-07
. O 0 5.2452207022213315e-09

The O 0 4.0884934326967937e-11
first O 0 3.5638103579316294e-11
, O 0 7.479757915471175e-13
1195delC O 0 2.083345579384499e-10
located O 0 5.152706820249486e-12
in O 0 1.9978489077931288e-13
exon O 0 7.955128777936693e-10
7 O 0 4.393577057726361e-09
, O 0 5.292737602358155e-12
is O 0 3.986511370578788e-13
a O 0 5.761703505795246e-13
novel O 0 2.075820244862303e-11
mutation O 0 3.391816272291237e-10
, O 0 1.9230439723266768e-12
while O 0 8.21457810627757e-13
the O 0 1.0686761263249689e-13
second O 0 6.925365281240659e-10
, O 0 9.961066260028018e-13
1936delG O 0 4.23507062752293e-10
in O 0 1.3394770318961302e-13
exon O 0 1.3185772473889301e-09
12 O 0 2.850667701892462e-09
, O 0 5.783903737899276e-12
has O 0 1.7092509352334417e-10
been O 0 2.3665780446435747e-10
described O 0 3.134321691078412e-10
before O 0 4.446363069399162e-11
to O 0 2.6821943971411244e-11
cause O 0 1.6958630055796675e-09
C6D B-Disease 0 8.877320283318113e-07
in O 0 4.4985393990622236e-13
an O 0 5.857574082897277e-13
unrelated O 0 7.800046830652718e-09
African O 0 2.0264395717006778e-10
- O 0 4.6864240488275755e-08
American O 0 4.89044249540882e-10
individual O 0 3.575630069807545e-11
. O 0 2.140416177631721e-10

Both O 0 2.0481114582082682e-09
mutations O 0 1.5787489360263862e-07
result O 0 3.1663982547058822e-09
in O 0 2.674899017562904e-11
premature O 0 5.621188847726444e-08
termination O 0 7.533388357572335e-10
codons O 0 5.804667857489676e-09
and O 0 2.9730811146322367e-09
C6 O 0 0.00034940146724693477
null O 0 0.00012474419781938195
alleles O 0 5.38675067218719e-07
. O 0 4.016616017565866e-08

Allele O 0 2.0252676335985598e-07
- O 0 3.2552667228458176e-09
specific O 0 3.960850310930075e-12
PCR O 0 3.249806468375027e-07
indicated O 0 1.7126565055036735e-08
that O 0 2.9360637185393834e-12
the O 0 1.0451998424740316e-12
probands O 0 1.9589434430145047e-07
two O 0 4.728502589479433e-10
brothers O 0 1.0701534165491466e-06
also O 0 6.287554366046777e-10
inherited O 0 2.764048900871785e-08
the O 0 6.076315665903831e-13
1195delC O 0 1.9330798295413842e-08
mutation O 0 1.1167933244848882e-09
from O 0 9.539351730411538e-13
their O 0 1.383987785485985e-10
heterozygous O 0 1.3909702722969541e-08
mother O 0 1.399941851332187e-07
and O 0 3.71623773420815e-11
the O 0 7.17716814799263e-12
1936delG O 0 3.912921897608612e-07
mutation O 0 2.8926445683197244e-09
from O 0 7.435208048203745e-13
their O 0 2.1279589201839144e-11
homozygous O 0 3.876541754266327e-09
father O 0 3.686458427409889e-08
. O 0 1.951748441683665e-12
. O 0 5.319712378937247e-11

PAX6 O 0 0.00019709909975063056
mutations O 0 1.0006848469856777e-06
reviewed O 0 2.7817995373879967e-07
. O 0 2.655180431077042e-08

Mutations O 0 2.191454314015573e-06
in O 0 5.7450072477038816e-11
PAX6 O 0 6.316890477364723e-08
are O 0 4.777439836962938e-13
responsible O 0 2.6890263019746508e-12
for O 0 2.309303789860273e-12
human O 0 9.979041948326994e-08
aniridia B-Disease 1 0.9999994039535522
and O 0 6.585813139281527e-08
have O 0 2.4026730605086755e-10
also O 0 1.2109306612995141e-11
been O 0 3.043913385236685e-11
found O 0 4.519744301045847e-11
in O 0 1.370946271003065e-13
patients O 0 6.0155361594760315e-12
with O 0 2.0060701988455776e-09
Peters B-Disease 1 0.9999996423721313
anomaly I-Disease 1 0.9999997615814209
, O 0 1.8204625007456343e-07
with O 0 1.736436752253212e-05
congenital B-Disease 1 0.9999982118606567
cataracts I-Disease 1 0.999962568283081
, O 0 1.0722501997406653e-07
with O 0 8.345184454583432e-08
autosomal B-Disease 1 0.9832664728164673
dominant I-Disease 0 0.026155799627304077
keratitis I-Disease 1 0.933422863483429
, O 0 7.2345462953649076e-09
and O 0 1.3928598274759452e-09
with O 0 2.8915538408114116e-08
isolated B-Disease 1 0.9896456003189087
foveal I-Disease 1 0.9999874830245972
hypoplasia I-Disease 1 0.9999772310256958
. O 0 2.4353284970857203e-06

No O 0 1.7538286378737666e-09
locus O 0 3.9180743982569766e-08
other O 0 3.049571879742974e-12
than O 0 5.206737384993998e-12
chromosome O 0 5.903248734284716e-07
11p13 O 0 3.346031007822603e-08
has O 0 2.8342728164432174e-09
been O 0 8.561277381469168e-11
implicated O 0 6.744756575471911e-08
in O 0 9.998942784861242e-10
aniridia B-Disease 1 0.9999973773956299
, O 0 3.600398867931176e-10
and O 0 1.6754143905561847e-10
PAX6 O 0 4.821451398129284e-07
is O 0 2.914296304279418e-10
clearly O 0 1.1493554996633293e-09
the O 0 3.4239990942368237e-13
major O 0 1.0937822696177602e-11
, O 0 7.359390007122268e-12
if O 0 4.043418811577881e-12
not O 0 2.835748671471683e-13
only O 0 1.2400661450657786e-14
, O 0 3.230490910720177e-15
gene O 0 4.683566381946669e-11
responsible O 0 9.741735196300283e-10
. O 0 4.4181294733824927e-10

Twenty O 0 5.608765718534414e-08
- O 0 1.1586930668272544e-06
eight O 0 2.2692169920901506e-08
percent O 0 1.1375587138928722e-09
of O 0 2.2315580627271054e-15
identified O 0 8.086501954163161e-12
PAX6 O 0 1.1426123380786635e-09
mutations O 0 3.565681916395391e-10
are O 0 1.1150121624614595e-12
C O 0 1.693898354915291e-08
- O 0 6.654923254245659e-06
T O 0 4.1431235331401695e-06
changes O 0 3.607280760990067e-13
at O 0 7.627086462402843e-11
CpG O 0 1.652032288745886e-08
dinucleotides O 0 1.0440363240604711e-08
, O 0 3.513408300729291e-14
20 O 0 1.1674299358168175e-14
% O 0 4.2788845403673794e-17
are O 0 3.2668224434638496e-17
splicing O 0 2.367589457819008e-10
errors O 0 1.4405813999474049e-06
, O 0 1.7445907999485977e-12
and O 0 4.561674388919856e-13
more O 0 2.822159196738455e-15
than O 0 5.224090609970769e-14
30 O 0 1.433534714545548e-12
% O 0 2.353918621166625e-14
are O 0 7.870055518735541e-14
deletion O 0 8.234873338786031e-10
or O 0 5.737910840908356e-11
insertion O 0 2.0249841803376967e-09
events O 0 9.960213098736403e-09
. O 0 9.72792602027539e-09

There O 0 4.753351601216593e-10
is O 0 3.381877677205436e-12
a O 0 1.304638580328088e-12
noticeably O 0 9.1864990281465e-08
elevated O 0 7.927143883534882e-07
level O 0 1.9425039354814544e-09
of O 0 1.4763842546509226e-13
mutation O 0 4.0509182119841114e-10
in O 0 1.8449762117372925e-12
the O 0 1.0786728281420022e-11
paired O 0 2.51416554242212e-09
domain O 0 3.3130320709062744e-09
compared O 0 7.335306806410813e-10
with O 0 9.840741936606445e-12
the O 0 6.833705042813554e-12
rest O 0 1.2344797059582469e-11
of O 0 1.1232456267935994e-15
the O 0 2.940702694374797e-13
gene O 0 2.2992820980505257e-09
. O 0 6.120350892757642e-10

Increased O 0 2.8462234791248875e-09
mutation O 0 1.1831384760796482e-08
in O 0 8.362695952390808e-12
the O 0 2.140423255303503e-11
homeodomain O 0 1.0449452503280554e-07
is O 0 7.919453287597022e-12
accounted O 0 4.806049221789399e-12
for O 0 4.466973831133362e-16
by O 0 2.7666250909143264e-14
the O 0 1.6985902268062958e-11
hypermutable O 0 3.989377091784263e-06
CpG O 0 1.4780891888221959e-06
dinucleotide O 0 2.8429409937302808e-09
in O 0 6.469065056856002e-14
codon O 0 2.004408097833199e-11
240 O 0 8.244184848682501e-12
. O 0 2.6049483750623104e-11

Very O 0 1.4044368445986777e-10
nearly O 0 7.628391841818516e-12
all O 0 2.470828446357598e-13
mutations O 0 2.436366663971512e-09
appear O 0 3.996111441750827e-09
to O 0 1.2223099865593667e-08
cause O 0 2.298438403158798e-06
loss O 0 1.0761225865962842e-07
of O 0 9.393691607992999e-14
function O 0 1.4115313085039105e-11
of O 0 1.2467159466247879e-14
the O 0 2.0884799965814604e-12
mutant O 0 3.7419198406496434e-08
allele O 0 2.821254163620779e-08
, O 0 1.7470417473797184e-12
and O 0 2.0623212610305225e-13
more O 0 6.74842319324493e-16
than O 0 1.2733923175623201e-14
80 O 0 8.702223376578708e-14
% O 0 5.538011946948232e-15
of O 0 9.411854874294152e-15
exonic O 0 1.2552527550724335e-07
substitutions O 0 2.1968544761108433e-09
result O 0 8.080307256630448e-11
in O 0 1.916394560402823e-12
nonsense O 0 6.522532913777468e-08
codons O 0 6.359877513517631e-09
. O 0 9.057532501799415e-10

In O 0 3.129206962992903e-11
a O 0 8.68431953952864e-13
gene O 0 1.4113187181419296e-11
with O 0 1.5456130299240645e-12
such O 0 1.0641863604254117e-14
extraordinarily O 0 4.0074746299190167e-10
high O 0 3.6476138082219833e-11
sequence O 0 3.9779607559353725e-12
conservation O 0 3.5127865785460066e-13
throughout O 0 7.135648646126088e-15
evolution O 0 6.145793238470504e-14
, O 0 1.03272879343249e-13
there O 0 1.1135472562486329e-13
are O 0 3.3408250666756845e-13
presumed O 0 7.727409865765367e-06
undiscovered O 0 0.0006170859560370445
missense O 0 7.503402343900234e-07
mutations O 0 2.41587827076728e-07
, O 0 1.3612003017804408e-11
these O 0 1.0338448847013737e-12
are O 0 8.850667594650918e-14
hypothesized O 0 1.1168922557647232e-11
to O 0 2.1208841974318382e-11
exist O 0 9.285701374484034e-11
in O 0 2.078568654001467e-12
as O 0 4.4700390611218666e-10
- O 0 1.0556970664765686e-05
yet O 0 2.123073095106065e-08
unidentified O 0 6.764815339010966e-07
phenotypes O 0 5.721818574500048e-09
. O 0 1.1593523883968171e-11
. O 0 4.0909528542520945e-10

Genetic O 0 5.905005195927515e-07
heterogeneity O 0 4.541017915471457e-06
and O 0 4.3316884301702885e-08
penetrance O 0 1.0572924793450511e-06
analysis O 0 3.466551698472209e-11
of O 0 5.006310307715395e-14
the O 0 9.813451266882378e-12
BRCA1 O 0 1.9156987036694773e-06
and O 0 2.268869536692364e-09
BRCA2 O 0 4.523435109149432e-06
genes O 0 2.509386604288011e-06
in O 0 4.19409431628992e-08
breast B-Disease 1 0.5829268097877502
cancer I-Disease 0 0.04406404495239258
families O 0 2.3393571524366052e-08
. O 0 1.4894461219938648e-09

The O 0 2.9888184144510888e-05
Breast B-Disease 1 0.999885082244873
Cancer I-Disease 1 0.9998587369918823
Linkage O 0 0.0010206140577793121
Consortium O 0 4.350894755589252e-07
. O 0 1.4954124605282004e-09

The O 0 5.526919200082858e-12
contribution O 0 2.680207672554197e-13
of O 0 3.6746677884802806e-14
BRCA1 O 0 1.9861975886215077e-07
and O 0 2.2482749884034092e-08
BRCA2 O 0 0.11545497924089432
to O 0 0.07536160200834274
inherited B-Disease 1 1.0
breast I-Disease 1 0.9999984502792358
cancer I-Disease 1 0.9999996423721313
was O 0 1.410203481100325e-06
assessed O 0 2.9201718820814904e-10
by O 0 4.52714227867565e-13
linkage O 0 4.8835310906270024e-08
and O 0 9.765325215127518e-10
mutation O 0 1.1647345588006175e-10
analysis O 0 1.3124586487056611e-11
in O 0 2.7713478755776733e-13
237 O 0 3.6282565840650705e-10
families O 0 3.867778319843751e-11
, O 0 1.4357451046196484e-13
each O 0 3.7868474767619245e-14
with O 0 2.9352911160712702e-12
at O 0 1.6226381349682129e-10
least O 0 1.703408837323405e-14
four O 0 2.8004896578809335e-12
cases O 0 4.820510657310706e-11
of O 0 2.085643602267595e-10
breast B-Disease 0 0.10372689366340637
cancer I-Disease 0 0.00017191757797263563
, O 0 6.943875596049365e-12
collected O 0 6.588477159674699e-12
by O 0 1.2551210938627211e-11
the O 0 3.7931593510620587e-07
Breast B-Disease 1 0.9999979734420776
Cancer I-Disease 1 0.9999947547912598
Linkage O 0 0.0001515488838776946
Consortium O 0 2.438846102847947e-08
. O 0 1.8048192107489314e-10

Families O 0 8.095079273573447e-09
were O 0 1.580418088065194e-11
included O 0 4.435370460124065e-14
without O 0 5.90047352340764e-14
regard O 0 1.2480769591644361e-14
to O 0 1.262982231818588e-13
the O 0 1.6050633044883966e-12
occurrence O 0 1.825622142348493e-08
of O 0 1.2317526998373296e-09
ovarian B-Disease 0 0.2250141054391861
or I-Disease 0 3.442585949642307e-08
other I-Disease 0 1.9225296910008183e-09
cancers I-Disease 0 0.0003858822165057063
. O 0 7.722270822796418e-09

Overall O 0 1.3072888577880803e-05
, O 0 2.0574887571456202e-07
disease O 0 4.00623230234487e-06
was O 0 2.2198873850243217e-08
linked O 0 4.7972115169159224e-08
to O 0 6.886439335440642e-11
BRCA1 O 0 3.6455954699476933e-08
in O 0 4.133591255742197e-13
an O 0 2.4820418073265293e-13
estimated O 0 2.1124584720366713e-11
52 O 0 2.756911920975824e-10
% O 0 1.3202657825513164e-13
of O 0 1.0886003910641224e-14
families O 0 3.955384197257272e-12
, O 0 3.332778524727312e-14
to O 0 4.605016997068223e-13
BRCA2 O 0 8.845998600293115e-09
in O 0 7.876340205048571e-12
32 O 0 3.3801916821118994e-10
% O 0 1.6347757566051446e-13
of O 0 5.954787308864659e-14
families O 0 1.461778788292012e-11
, O 0 8.579936349069339e-13
and O 0 2.5176601255172404e-12
to O 0 2.6840764853763854e-12
neither O 0 5.868446787543613e-12
gene O 0 9.867186061274236e-12
in O 0 4.64644924098867e-13
16 O 0 8.048544469785313e-11
% O 0 2.843460127186122e-14
( O 0 1.5354002122245172e-15
95 O 0 3.5973129856869956e-12
% O 0 9.543901042727287e-13
confidence O 0 5.858546980874735e-09
interval O 0 6.090112414369742e-09
[ O 0 1.2157581365246362e-11
CI O 0 1.295216094376883e-07
] O 0 5.739996922216051e-09
6 O 0 8.063514855827236e-10
% O 0 2.4919426331454497e-12
- O 0 5.312227813192294e-07
28 O 0 1.6230860921950807e-07
% O 0 4.80275021141896e-12
) O 0 1.883037996364134e-12
, O 0 1.3332779704496728e-13
suggesting O 0 6.112668097385532e-12
other O 0 1.217065592187469e-13
predisposition O 0 4.131305963994691e-09
genes O 0 1.667916649239487e-08
. O 0 7.171431892771807e-09

The O 0 1.0499254798901347e-08
majority O 0 2.5338893205884006e-09
( O 0 5.2419327559172224e-12
81 O 0 3.5189684499670193e-10
% O 0 6.584026401336429e-13
) O 0 1.4747940011144295e-13
of O 0 4.1723951903086323e-14
the O 0 1.1621087736557456e-07
breast B-Disease 1 0.9999783039093018
- I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 5.612872389093582e-09
were O 0 6.126266161032845e-12
due O 0 1.2677591181703418e-12
to O 0 2.692418770572358e-12
BRCA1 O 0 1.1777970598814136e-07
, O 0 1.1596022753135315e-11
with O 0 1.3635103462972253e-11
most O 0 3.2145047040854635e-11
others O 0 1.2266089255419388e-09
( O 0 5.562150268362612e-14
14 O 0 1.3691610345478722e-10
% O 0 3.9944574883009343e-13
) O 0 6.012103250137291e-13
due O 0 2.1485536873949718e-12
to O 0 1.810389685386049e-11
BRCA2 O 0 4.105181687918957e-06
. O 0 3.828128036786893e-09

Conversely O 0 9.867183052847395e-07
, O 0 4.497608882547688e-11
the O 0 1.3458391302442752e-12
majority O 0 4.009295879233571e-13
of O 0 5.5437005355186975e-14
families O 0 1.1581677457350725e-11
with O 0 2.2754588144269228e-11
male B-Disease 0 2.175589486341778e-08
and I-Disease 0 4.3832422136347304e-08
female I-Disease 0 7.305615099539864e-07
breast I-Disease 0 1.7534368453198113e-05
cancer I-Disease 0 1.2767056887241779e-06
were O 0 4.4311072172620314e-11
due O 0 4.389583314889922e-12
to O 0 3.3717029168656154e-11
BRCA2 O 0 7.5915622801403515e-06
( O 0 2.0204102280096947e-11
76 O 0 1.5095960037569967e-08
% O 0 2.7597132478546227e-12
) O 0 2.679545821338003e-11
. O 0 3.3191907555796263e-10

The O 0 5.113403034329167e-10
largest O 0 7.999253481827395e-10
proportion O 0 3.0229529990322135e-10
( O 0 3.764218103885497e-12
67 O 0 2.187984904367113e-09
% O 0 1.769757192356114e-12
) O 0 1.450300057999343e-12
of O 0 1.164663797261628e-13
families O 0 6.316239198334017e-12
due O 0 5.092955137481203e-13
to O 0 2.693489555742959e-14
other O 0 1.2040609767636611e-14
genes O 0 2.0822255031305303e-10
was O 0 1.183987734520997e-07
found O 0 1.8510558641438024e-09
in O 0 4.4157049978316154e-13
families O 0 6.918067464375954e-13
with O 0 9.292206896516567e-14
four O 0 3.1154367280405992e-12
or O 0 8.138864582285521e-12
five O 0 7.332040356800018e-12
cases O 0 6.465519526016594e-12
of O 0 1.019824502623834e-11
female O 0 1.6343143443009467e-06
breast B-Disease 0 2.5639468731242232e-05
cancer I-Disease 0 2.9222317721178115e-07
only O 0 1.9626949371298608e-11
. O 0 2.2711371672201608e-10

These O 0 2.509646379600383e-10
estimates O 0 2.1796575655486095e-10
were O 0 2.406937323062852e-11
not O 0 4.14906737439269e-12
substantially O 0 3.138902679444833e-11
affected O 0 8.728021967273e-14
either O 0 8.060772948919551e-15
by O 0 9.059029229346004e-15
changing O 0 1.903720020166033e-12
the O 0 4.0053672726615697e-13
assumed O 0 1.872650479128879e-09
penetrance O 0 4.753489601938554e-09
model O 0 2.8382461311760032e-11
for O 0 1.228287355723237e-13
BRCA1 O 0 1.3248425467793368e-08
or O 0 3.326173017570433e-11
by O 0 6.375626480752128e-14
including O 0 2.1109529800707703e-14
or O 0 3.984462759731855e-11
excluding O 0 8.418215430294751e-11
BRCA1 O 0 9.745647133740931e-08
mutation O 0 2.1608286271401766e-09
data O 0 7.58815232870802e-08
. O 0 4.732854108624451e-09

Among O 0 1.912868752285135e-10
those O 0 1.6180879552907257e-11
families O 0 3.427831976599016e-11
with O 0 7.046375150032702e-10
disease O 0 9.583617810449141e-08
due O 0 1.2131036626616964e-11
to O 0 9.797535178990291e-12
BRCA1 O 0 9.958716162827841e-08
that O 0 3.97954513786658e-09
were O 0 9.420247915059576e-10
tested O 0 8.284340990982741e-10
by O 0 6.073227925879228e-15
one O 0 3.8161498700645113e-13
of O 0 6.035578793681432e-16
the O 0 3.245791290362905e-14
standard O 0 9.214655270371394e-14
screening O 0 2.115402782955876e-14
methods O 0 1.3369559365844497e-12
, O 0 1.6599933165789386e-14
mutations O 0 6.051876122632749e-13
were O 0 1.799914248678744e-13
detected O 0 4.581245452439653e-11
in O 0 2.564464033854674e-15
the O 0 3.01237374346168e-14
coding O 0 6.524349771552806e-08
sequence O 0 1.4255669977814023e-09
or O 0 4.3364267038326076e-11
splice O 0 2.2657404485926236e-07
sites O 0 2.3846584706888052e-09
in O 0 4.592255395396982e-13
an O 0 1.6345639306056953e-13
estimated O 0 4.620559490575715e-11
63 O 0 7.743742869159576e-10
% O 0 5.135543683018606e-13
( O 0 2.5682933427542687e-14
95 O 0 3.0505278858505847e-11
% O 0 2.946239823289898e-12
CI O 0 9.938476978277322e-06
51 O 0 9.912192666661213e-08
% O 0 1.589842840710176e-10
- O 0 1.8788225133903325e-05
77 O 0 2.759404083008121e-07
% O 0 4.427058546141449e-12
) O 0 1.4205496154384711e-11
. O 0 8.731465550582129e-11

The O 0 3.437038431641781e-10
estimated O 0 1.4359745337255703e-10
sensitivity O 0 3.723604480310172e-10
was O 0 1.118266146349356e-09
identical O 0 2.0417284182783213e-11
for O 0 1.708202874398275e-16
direct O 0 6.23118464158646e-16
sequencing O 0 7.903688120647345e-11
and O 0 1.0092706184683387e-11
other O 0 5.059134331624783e-14
techniques O 0 3.0000807393903983e-10
. O 0 2.0246508636301286e-10

The O 0 6.578400046919342e-10
penetrance O 0 3.3142077882075682e-06
of O 0 1.85585470602323e-11
BRCA2 O 0 4.730789555651427e-07
was O 0 1.0649388926253778e-08
estimated O 0 4.846510427139114e-14
by O 0 1.3279570788816107e-15
maximizing O 0 2.710923282731037e-12
the O 0 5.238686567876627e-11
LOD O 0 2.488441350578796e-05
score O 0 4.6888377625009525e-08
in O 0 9.862086841616602e-12
BRCA2 O 0 5.83622704652953e-06
- O 0 2.3883570975158364e-05
mutation O 0 4.6855484470142983e-07
families O 0 7.764833220846867e-10
, O 0 8.100046647958534e-14
over O 0 5.748289214416169e-13
all O 0 4.7649879105372134e-14
possible O 0 1.2307673977196565e-11
penetrance O 0 2.277030404229663e-07
functions O 0 1.327297022291063e-10
. O 0 2.40437025844642e-09

The O 0 8.518340893770571e-11
estimated O 0 1.2359198386935333e-10
cumulative O 0 7.927022593889888e-09
risk O 0 1.5024555466425227e-07
of O 0 1.777749891740399e-10
breast B-Disease 0 0.0018675073515623808
cancer I-Disease 0 0.0001049959464580752
reached O 0 5.955782356181771e-08
28 O 0 5.1006061596581276e-09
% O 0 8.565939841123638e-13
( O 0 3.105578877285291e-14
95 O 0 7.450302527689523e-12
% O 0 3.298579671125873e-13
CI O 0 4.6360415240087605e-07
9 O 0 1.4899099731735532e-08
% O 0 7.152105730573455e-12
- O 0 1.7228597926077782e-07
44 O 0 3.6035334716189027e-09
% O 0 2.834083065884202e-13
) O 0 1.5471627681806245e-14
by O 0 5.599211347936776e-15
age O 0 1.4208840809666612e-13
50 O 0 3.0537756974839333e-15
years O 0 1.772084432319354e-12
and O 0 8.47283614796579e-12
84 O 0 1.5751755802484446e-11
% O 0 4.681368987390858e-15
( O 0 2.2267352688836763e-16
95 O 0 6.655375577903355e-13
% O 0 1.2027693023410752e-13
CI O 0 8.153035224722771e-08
43 O 0 1.6738915809000332e-09
% O 0 1.7224741598320659e-12
- O 0 5.799225988312173e-08
95 O 0 3.385472879813278e-08
% O 0 1.2655950072659738e-11
) O 0 3.801868542208098e-12
by O 0 1.884831266757425e-12
age O 0 2.3320562494988373e-11
70 O 0 2.7217048059746674e-12
years O 0 3.8807471125501536e-11
. O 0 1.9870011885858574e-11

The O 0 9.749427363203722e-07
corresponding O 0 0.4249785840511322
ovarian B-Disease 1 0.9999969005584717
cancer I-Disease 1 0.9999953508377075
risks O 0 0.002312421565875411
were O 0 6.038006539199614e-09
0 O 0 6.687401188365527e-10
. O 0 3.084210387083175e-10

4 O 0 3.0245015381069607e-08
% O 0 3.174685861417892e-11
( O 0 1.317189629937432e-13
95 O 0 1.6908807687343597e-11
% O 0 7.964833762148793e-13
CI O 0 9.8845123375213e-07
0 O 0 1.0709779729722868e-09
% O 0 1.6988420219188338e-12
- O 0 6.382190775866547e-08
1 O 0 1.7088932491304831e-09
% O 0 5.182114503135549e-13
) O 0 3.749002383491781e-14
by O 0 1.6098969081662987e-14
age O 0 1.5460102273899545e-13
50 O 0 6.011065024913182e-15
years O 0 1.616921006808436e-12
and O 0 2.0397657087695142e-12
27 O 0 2.011209601637809e-11
% O 0 1.67744054357813e-15
( O 0 9.307873003810095e-17
95 O 0 3.072949338565889e-13
% O 0 1.9421284716612634e-14
CI O 0 9.377966136980831e-08
0 O 0 1.5133422293089893e-10
% O 0 7.88550539969346e-13
- O 0 1.9575502108182263e-07
47 O 0 7.227915688190478e-08
% O 0 2.730330718458962e-12
) O 0 4.227494005901167e-13
by O 0 2.899587850640345e-13
age O 0 1.0740986225443727e-11
70 O 0 5.922067307026491e-13
years O 0 3.6707151207515665e-11
. O 0 1.9592015509939387e-11

The O 0 3.6394101066150597e-09
lifetime O 0 1.0153077028007829e-06
risk O 0 9.163763365904742e-07
of O 0 6.982717737358257e-10
breast B-Disease 0 0.0018757880898192525
cancer I-Disease 0 4.1627496102591977e-05
appears O 0 3.664942482828337e-08
similar O 0 9.20118907281331e-13
to O 0 2.5821376287149533e-12
the O 0 3.0284151922299607e-12
risk O 0 9.08511210706564e-10
in O 0 2.6367834781923505e-13
BRCA1 O 0 4.892201488360115e-08
carriers O 0 3.6423039584398964e-10
, O 0 2.569981553957046e-12
but O 0 6.270086880255654e-12
there O 0 6.045689529511275e-14
was O 0 8.62746887819732e-11
some O 0 3.8801454348086426e-16
suggestion O 0 3.3398631082981467e-13
of O 0 2.0617605675710875e-15
a O 0 4.117000837466911e-11
lower O 0 6.112968797822305e-09
risk O 0 1.1126195520461124e-09
in O 0 7.34727830333827e-14
BRCA2 O 0 5.16413045659192e-08
carriers O 0 7.937998175444605e-11
< O 0 3.016126931543184e-11
50 O 0 7.070234155082122e-13
years O 0 3.715649662949794e-11
of O 0 5.935716870276997e-13
age O 0 2.4267882148265585e-10
. O 0 1.1240993552652512e-10

Eye B-Disease 0 0.007903791032731533
movement I-Disease 0 8.437756946477748e-07
abnormalities I-Disease 0 0.0008825609693303704
correlate O 0 1.5284783216884534e-07
with O 0 5.8027529448168025e-09
genotype O 0 0.0012547916267067194
in O 0 3.306165652361415e-08
autosomal O 1 0.9998359680175781
dominant O 1 0.9997709393501282
cerebellar B-Disease 1 0.9998656511306763
ataxia I-Disease 1 0.9997226595878601
type I-Disease 0 0.00011689615348586813
I I-Disease 0 0.01435481570661068
. O 0 3.576106166747195e-08

We O 0 4.489182359179722e-08
compared O 0 1.1498910268414875e-08
horizontal O 0 5.9235255321254954e-05
eye O 0 0.00038305946509353817
movements O 0 2.0742224933201214e-06
( O 0 5.0422447467335374e-11
visually O 0 2.3108687230433134e-07
guided O 0 7.489940117011429e-07
saccades O 0 1.2318222616158891e-05
, O 0 1.740056432275594e-10
antisaccades O 0 1.24529128697759e-06
, O 0 2.3350649538955714e-11
and O 0 1.5353161797460047e-10
smooth O 0 1.0840576436521587e-08
pursuit O 0 2.587463256986666e-07
) O 0 2.1078099335380962e-11
in O 0 1.0220374758096104e-13
control O 0 3.628978006986472e-09
subjects O 0 2.7666005042448205e-09
( O 0 2.341869103153482e-13
n O 0 3.3661432752296605e-08
= O 0 4.3498030066757565e-08
14 O 0 1.9214912994058864e-10
) O 0 8.984602992145874e-12
and O 0 2.7263042517988723e-11
patients O 0 9.423467865407598e-13
with O 0 3.170572054141292e-14
three O 0 2.725621811583423e-12
forms O 0 4.633804191050972e-12
of O 0 9.283009083649318e-11
autosomal O 0 0.4877619445323944
dominant O 0 0.05737847834825516
cerebellar B-Disease 0 0.37415358424186707
ataxias I-Disease 0 0.004701452329754829
type I-Disease 0 8.599861871516623e-07
I I-Disease 0 0.00010844779171748087
spinocerebellar B-Disease 0 0.0021342167165130377
ataxias I-Disease 0 1.8370345060247928e-05
1 I-Disease 0 1.986302233802917e-09
and I-Disease 0 8.645527627137994e-10
2 I-Disease 0 3.781240320854806e-10
( O 0 1.9617083836260402e-13
SCA1 B-Disease 0 4.624948530818074e-07
, O 0 9.356168617635774e-12
n O 0 4.455077640130867e-09
= O 0 7.671506097040037e-09
11 O 0 2.464337067742406e-10
; O 0 1.2663260197387505e-12
SCA2 B-Disease 0 1.7309656641373294e-07
, O 0 6.910935799325779e-12
n O 0 6.619056414081115e-09
= O 0 3.957654204356231e-09
10 O 0 1.029765769183788e-11
) O 0 2.6356230566071392e-12
and O 0 1.3656642483539372e-09
SCA3 B-Disease 1 0.9999977350234985
/ O 0 1.0034552360593807e-05
Machado B-Disease 0 0.0001618643436813727
- I-Disease 0 0.0005252242553979158
Joseph I-Disease 0 0.0017579557606950402
disease I-Disease 0 0.28757795691490173
( O 0 8.807838486335484e-11
MJD B-Disease 1 0.9999948740005493
) O 0 6.60611232383701e-10
( O 0 4.675323713246304e-13
n O 0 7.354660880309893e-08
= O 0 3.4197955756098963e-07
16 O 0 3.225653355531932e-10
) O 0 4.016816740337603e-11
. O 0 4.800499581181228e-11

In O 0 5.461002761109057e-10
SCA1 B-Disease 0 4.335701362379041e-07
, O 0 5.400956374843058e-13
saccade O 0 8.364219872269985e-10
amplitude O 0 1.1029613888879908e-09
was O 0 3.0218478830335016e-09
significantly O 0 9.794232785909074e-11
increased O 0 2.2538691833023927e-12
, O 0 2.0010265146253037e-12
resulting O 0 3.673138529447506e-11
in O 0 8.726498690325712e-12
hypermetria B-Disease 0 4.050563438795507e-05
. O 0 4.4617274319591615e-09

The O 0 4.3531020454956604e-10
smooth O 0 5.2150070928291825e-08
pursuit O 0 6.036052013769222e-07
gain O 0 1.5101949912832424e-08
was O 0 3.8686177816771306e-08
decreased O 0 1.0494549229633776e-08
. O 0 1.3356167560818477e-10

In O 0 6.784373618451411e-10
SCA2 B-Disease 0 1.6821294366309303e-06
, O 0 1.6165176836002715e-11
saccade O 0 1.3250573083212203e-08
velocity O 0 4.86042992520197e-08
was O 0 2.8184361511307543e-08
markedly O 0 1.3615455429771828e-07
decreased O 0 5.313940221185476e-08
. O 0 8.786500416135823e-10

The O 0 1.9447939092476219e-10
percentage O 0 5.341771469602463e-09
of O 0 2.7185231062792914e-13
errors O 0 8.670471629557142e-08
in O 0 6.1837553307075854e-12
antisaccades O 0 1.0595580590688769e-07
was O 0 1.1051262127637074e-09
greatly O 0 1.3150546623874604e-11
increased O 0 2.4471155895926244e-13
and O 0 1.7297668289048551e-12
was O 0 2.781875285684521e-10
significantly O 0 2.8225578124763118e-11
correlated O 0 2.1619581680454303e-09
with O 0 1.9678798868216774e-10
age O 0 6.672023489251444e-10
at O 0 1.6361086707661343e-08
disease O 0 3.76349390762698e-07
onset O 0 6.779102079690347e-08
. O 0 3.9124117279243364e-09

In O 0 6.762923554504141e-11
addition O 0 4.0624643406206307e-13
, O 0 2.2379272846223368e-14
a O 0 1.3067339907617964e-14
correlation O 0 5.3919754078313176e-11
between O 0 1.2277739935839804e-10
smooth O 0 1.0941746353410053e-07
pursuit O 0 2.6015270577772753e-06
gain O 0 1.1397767174514684e-08
and O 0 5.1935261646818276e-12
the O 0 8.449071656072352e-14
number O 0 2.2510282754548833e-13
of O 0 2.341579838013863e-12
trinucleotide O 0 5.819330908707343e-06
repeats O 0 3.464228484517662e-06
was O 0 2.0127866662278393e-07
found O 0 7.3223942465006076e-09
. O 0 3.5439917667190457e-10

In O 0 6.273520369859398e-08
SCA3 B-Disease 1 0.9996713399887085
, O 0 2.096562212727804e-08
gaze B-Disease 0 0.00038982994738034904
- I-Disease 0 0.008149408735334873
evoked I-Disease 0 0.00015800654364284128
nystagmus I-Disease 0 1.8468992493581027e-05
was O 0 3.3130658039226546e-07
often O 0 1.1941715671870412e-10
present O 0 1.2672429430685486e-14
as O 0 3.045296897681918e-14
was O 0 4.1132827699463803e-10
saccade O 0 1.1428156199144723e-08
hypometria O 0 1.1971783351327758e-06
and O 0 9.713473081429669e-11
smooth O 0 1.1499255991864743e-09
pursuit O 0 5.264085700673604e-08
gain O 0 1.40159028827469e-09
was O 0 1.0493548252554774e-08
markedly O 0 1.7716622835450835e-08
decreased O 0 7.607771301820776e-09
. O 0 2.5649402046745706e-10

Three O 0 1.5209382364655966e-10
major O 0 6.215884144206152e-12
criteria O 0 1.2476147719098218e-11
, O 0 4.650099072077071e-14
saccade O 0 4.4891583506068145e-11
amplitude O 0 1.1023572332735654e-10
, O 0 2.77095159968363e-13
saccade O 0 1.0315576171038288e-09
velocity O 0 5.978795059036202e-08
, O 0 5.355934445949728e-12
and O 0 3.960819953269246e-12
presence O 0 4.492728238048027e-12
of O 0 5.557362729724513e-12
gaze B-Disease 0 0.0002990019565913826
- I-Disease 0 1.5990757674444467e-05
evoked I-Disease 0 8.006768439372536e-07
nystagmus I-Disease 0 3.025736461381712e-08
, O 0 5.859962986859077e-14
permitted O 0 1.132241646089032e-14
the O 0 1.3508937993570152e-14
correct O 0 1.4365724165799065e-09
assignment O 0 7.48426112751055e-11
of O 0 1.6354051359662725e-14
90 O 0 6.924271811308003e-13
% O 0 3.7867518467421795e-15
of O 0 6.175574281621255e-16
the O 0 4.542020839298777e-12
SCA1 B-Disease 0 6.174727786856238e-07
, O 0 9.800614096319715e-13
90 O 0 4.19312987923106e-14
% O 0 7.118381244221599e-16
of O 0 8.48543259938814e-16
the O 0 1.081346644171699e-11
SCA2 B-Disease 0 4.147005711274687e-06
, O 0 3.66903382675865e-12
and O 0 9.970613744358925e-12
93 O 0 1.644142808010507e-11
% O 0 1.4118037691874825e-14
of O 0 3.706631000261395e-15
the O 0 2.984036975850479e-11
patients O 0 6.310511141416342e-11
with O 0 3.161207129398491e-10
SCA3 B-Disease 1 0.9999992847442627
to O 0 5.889316812002221e-11
their O 0 1.3468404993707828e-12
genetically O 0 2.7982312647556462e-12
confirmed O 0 6.578462774520233e-10
patient O 0 2.6585325607619836e-10
group O 0 5.1788000970942605e-11
and O 0 4.6792448388233154e-11
, O 0 5.626805987292427e-13
therefore O 0 5.211493671504475e-13
, O 0 6.858210288736288e-13
may O 0 9.613166165878262e-12
help O 0 9.292340334698945e-12
orient O 0 1.6027728122480767e-07
diagnoses O 0 2.7003193281416316e-07
of O 0 1.076058404707314e-12
SCA1 B-Disease 0 5.212927135289647e-06
, O 0 2.935901305053945e-12
SCA2 B-Disease 0 2.3321493358707812e-07
, O 0 9.992736672848057e-12
and O 0 2.325706516259629e-09
SCA3 B-Disease 1 0.9999979734420776
at O 0 2.7985609385439147e-09
early O 0 1.1592971374541072e-11
clinical O 0 1.6181071760268395e-10
stages O 0 1.1263319166232577e-09
of O 0 5.58491349954976e-13
the O 0 4.931131059038307e-10
diseases O 0 2.2208746486285236e-07
. O 0 1.1077334362286084e-11
. O 0 1.2565398721520182e-10

Genetic O 0 8.05597100139721e-09
basis O 0 4.8498281779441044e-11
and O 0 3.7466422325715953e-11
molecular O 0 2.1114827220003463e-08
mechanism O 0 4.355658347776625e-06
for O 0 3.1988154660211876e-05
idiopathic B-Disease 1 0.9999990463256836
ventricular I-Disease 1 0.9999837875366211
fibrillation I-Disease 1 0.9999887943267822
. O 0 0.00017158691480290145

Ventricular B-Disease 1 0.9972776770591736
fibrillation I-Disease 1 0.8307055234909058
causes O 0 3.094499447797716e-07
more O 0 1.9084779871898772e-13
than O 0 2.901080051642864e-14
300 O 0 6.357581290843822e-14
, O 0 5.24868031524274e-14
000 O 0 4.0176724794283025e-12
sudden O 0 1.517273751083792e-09
deaths O 0 2.5494071298481913e-09
each O 0 6.409308847543649e-12
year O 0 1.9372710380327618e-10
in O 0 3.292038516788942e-12
the O 0 3.714872021109983e-10
USA O 0 3.0816022444923874e-06
alone O 0 4.751407445269251e-08
. O 0 2.6423542173747983e-11

In O 0 1.6924198154022463e-11
approximately O 0 5.387305618970162e-12
5 O 0 1.174852992669173e-10
- O 0 5.740163260270492e-07
12 O 0 1.3538437038107531e-08
% O 0 1.4741360259210023e-13
of O 0 1.4896090817003577e-15
these O 0 7.487975896888072e-14
cases O 0 1.852415383628639e-13
, O 0 2.6569353406844312e-14
there O 0 3.006396909579264e-15
are O 0 2.0840038645242222e-15
no O 0 1.468417618402662e-12
demonstrable O 0 6.504171778942691e-08
cardiac O 0 0.0031923723872750998
or O 0 3.746333376852817e-08
non O 0 1.0019819285389531e-07
- O 1 0.966741681098938
cardiac O 1 0.9893320798873901
causes O 0 1.6511793887730164e-07
to O 0 1.229995359036673e-11
account O 0 8.763022317330449e-13
for O 0 3.1606458444390084e-14
the O 0 8.252444734513364e-12
episode O 0 9.552671826895676e-07
, O 0 1.710029340351582e-11
which O 0 3.2297275964765504e-11
is O 0 8.033797151835165e-13
therefore O 0 1.407404032725823e-12
classified O 0 1.2141099432483315e-06
as O 0 0.008846798911690712
idiopathic B-Disease 1 0.9999998807907104
ventricular I-Disease 1 0.9999980926513672
fibrillation I-Disease 1 0.9999995231628418
( O 0 1.2324732779234182e-05
IVF B-Disease 1 0.9999799728393555
) O 0 6.214592076503322e-07
. O 0 1.1746300820902889e-08

A O 0 2.8425832798717465e-09
distinct O 0 9.933717043386636e-11
group O 0 3.946799331799866e-09
of O 0 1.2800208115670841e-10
IVF B-Disease 1 0.9999990463256836
patients O 0 2.4307382773258723e-07
has O 0 1.0734361177711094e-09
been O 0 1.5702449063237367e-10
found O 0 1.5093575694846706e-11
to O 0 7.822766956780414e-13
present O 0 5.935000619216799e-14
with O 0 7.90267048848825e-13
a O 0 2.8261833845411033e-11
characteristic O 0 2.535543863757539e-08
electrocardiographic O 0 7.908298357506283e-06
pattern O 0 1.1246481790294638e-06
. O 0 2.2357655726779058e-09

Because O 0 5.738825414880466e-09
of O 0 5.612162142887116e-14
the O 0 2.1465701395204095e-13
small O 0 6.364803432565291e-13
size O 0 3.5636132933447584e-11
of O 0 1.295351307906709e-14
most O 0 6.97893891114798e-13
pedigrees O 0 6.015097753220289e-09
and O 0 1.4622055302671022e-11
the O 0 5.775173308325554e-12
high O 0 7.309294858259818e-08
incidence O 0 3.806607651313243e-07
of O 0 2.7928937374605e-12
sudden B-Disease 0 3.193048669913878e-08
death I-Disease 0 8.496832570870083e-09
, O 0 1.9006096609736067e-13
however O 0 2.8806251546435735e-13
, O 0 4.08252389346212e-15
molecular O 0 2.306549395925117e-11
genetic O 0 1.1001403343868787e-08
studies O 0 1.808320937435326e-09
of O 0 1.1343747122194436e-11
IVF B-Disease 1 0.9999991655349731
have O 0 4.5823420613544386e-09
not O 0 1.7456560285830647e-12
yet O 0 5.63435582912053e-13
been O 0 3.5553712751656974e-11
done O 0 7.379933886220158e-10
. O 0 1.1397864596585094e-10

Because O 0 9.631662578613032e-07
IVF B-Disease 1 0.9998533725738525
causes O 0 0.00025195241323672235
cardiac O 0 0.14779740571975708
rhythm O 0 0.1089666411280632
disturbance O 0 4.860321132582612e-05
, O 0 1.1867308524760034e-10
we O 0 6.266978255786704e-12
investigated O 0 2.4603251727595143e-11
whether O 0 1.0040347026007979e-11
malfunction O 0 1.7296650867137942e-06
of O 0 3.4470613534653407e-15
ion O 0 1.0072048084452945e-08
channels O 0 4.6046792704146355e-05
could O 0 0.00011953039211221039
cause O 0 1.1864303672837195e-07
the O 0 2.413969468761934e-09
disorder O 0 2.641527771629626e-06
by O 0 5.392563769113755e-14
studying O 0 4.984902464769125e-13
mutations O 0 5.59808310818255e-10
in O 0 1.612595826186794e-13
the O 0 1.95554922081953e-12
cardiac O 0 7.844212035479359e-08
sodium O 0 8.115496608063211e-10
channel O 0 9.92632294583018e-07
gene O 0 7.134726729418617e-07
SCN5A O 0 0.0005938029498793185
. O 0 1.4195651321102787e-09

We O 0 2.0199701467049636e-08
have O 0 3.618716784559162e-11
now O 0 4.639187796938449e-13
identified O 0 1.4116652725243428e-12
a O 0 7.052119305184235e-13
missense O 0 4.930136299208243e-09
mutation O 0 2.8543565289140815e-09
, O 0 1.202639116765214e-12
a O 0 2.238091656447949e-12
splice O 0 0.0008363226661458611
- O 0 2.633377334859688e-05
donor O 0 5.0875863522037434e-09
mutation O 0 1.689854833841764e-08
, O 0 5.202171159124358e-12
and O 0 2.7601712148522806e-12
a O 0 1.2545132467567388e-11
frameshift O 0 5.059381464889157e-07
mutation O 0 1.252592141121056e-09
in O 0 6.666759158613367e-13
the O 0 1.1273904552966396e-11
coding O 0 0.004786639008671045
region O 0 7.775938115628378e-09
of O 0 4.976668816630836e-12
SCN5A O 0 2.0737632439704612e-05
in O 0 2.767313938764615e-12
three O 0 7.182543448891465e-10
IVF B-Disease 1 0.9999817609786987
families O 0 3.759531352898193e-09
. O 0 7.794328377164206e-11

We O 0 3.4485694855312943e-10
show O 0 1.0202057948438537e-11
that O 0 4.424308463942808e-15
sodium O 0 7.686132817447816e-14
channels O 0 2.7578307693065796e-11
with O 0 1.0467979564762753e-12
the O 0 3.497919185205256e-12
missense O 0 9.937843969964888e-08
mutation O 0 5.3222375839823144e-08
recover O 0 5.7293679134318154e-08
from O 0 2.3017872330388656e-13
inactivation O 0 1.5431623978656717e-08
more O 0 3.114207898380502e-15
rapidly O 0 3.90501042960012e-12
than O 0 2.5582023004404493e-14
normal O 0 3.9950842113667395e-12
and O 0 3.071962129119754e-11
that O 0 4.589466653937002e-11
the O 0 1.8931235745700548e-10
frameshift O 0 9.632540241000243e-06
mutation O 0 8.668814110990297e-09
causes O 0 5.4497933943409294e-11
the O 0 9.08128214012309e-14
sodium O 0 1.3526188502588354e-10
channel O 0 6.921970339135441e-07
to O 0 1.370828173197225e-10
be O 0 5.1109529802806364e-11
non O 0 5.5361722151037185e-12
- O 0 8.602538770219326e-08
functional O 0 4.977957601681737e-09
. O 0 8.730121070499308e-10

Our O 0 6.294531118555824e-08
results O 0 4.691034227732871e-10
indicate O 0 1.3430632994637648e-10
that O 0 2.150152451918519e-12
mutations O 0 4.871274494888667e-10
in O 0 4.016982926846602e-12
cardiac O 0 2.580142393071583e-07
ion O 0 8.415456136390276e-07
- O 0 3.779654434765689e-06
channel O 0 4.256939519109437e-06
genes O 0 2.528843801030689e-09
contribute O 0 2.8252855784061115e-13
to O 0 7.953934277708796e-13
the O 0 4.146235438318158e-12
risk O 0 1.070613875331361e-10
of O 0 1.5216113417003407e-14
developing O 0 2.5085539548386215e-11
IVF B-Disease 1 0.9996001124382019
. O 0 4.873985590125862e-11
. O 0 3.848395560557272e-11

Molecular O 0 4.393361408006058e-08
heterogeneity O 0 3.616970047914947e-07
in O 0 9.475353834886846e-10
mucopolysaccharidosis B-Disease 0 3.7028385122539476e-05
IVA I-Disease 0 0.00301056238822639
in O 0 8.420162900257822e-10
Australia O 0 1.1681368095040057e-09
and O 0 8.85061329780612e-11
Northern O 0 3.498648246114122e-11
Ireland O 0 1.1058309823397394e-08
: O 0 2.1839030150266892e-13
nine O 0 5.076099588406657e-13
novel O 0 1.862023122495282e-12
mutations O 0 3.656056013490172e-11
including O 0 5.978801031732497e-14
T312S O 0 7.61988874775632e-11
, O 0 5.4224023681532715e-14
a O 0 3.4606205298300455e-14
common O 0 8.560092196706337e-13
allele O 0 5.775292244436514e-09
that O 0 5.272116077037481e-11
confers O 0 9.166769565638333e-09
a O 0 2.2992205916949615e-09
mild O 0 5.405874503594532e-07
phenotype O 0 1.272728013645974e-06
. O 0 1.217279876897237e-08

Mucopolysaccharidosis B-Disease 0 0.07844114303588867
IVA I-Disease 1 0.9945297837257385
( O 0 8.843099749356043e-06
MPS B-Disease 1 0.9999572038650513
IVA I-Disease 1 0.9999892711639404
) O 0 6.528009066641971e-07
is O 0 2.240521101981585e-09
an O 0 3.736070564031024e-09
autosomal B-Disease 1 0.9999667406082153
recessive I-Disease 1 0.9999871253967285
lysosomal I-Disease 1 0.9999889135360718
storage I-Disease 1 0.9999831914901733
disorder I-Disease 1 0.9999829530715942
caused O 0 1.4184257679517032e-06
by O 0 3.484071017800794e-11
a O 0 8.070104584589899e-09
genetic B-Disease 1 0.9999978542327881
defect I-Disease 1 0.9999982118606567
in O 0 2.745981886320692e-09
N O 0 5.702869202650618e-06
- O 0 2.361581937293522e-05
acetylgalactosamine O 0 0.0013844378991052508
- O 0 2.960945676022675e-05
6 O 0 6.404811756510753e-07
- O 0 0.00013690874038729817
sulfate O 0 0.00021610264957416803
sulfatase O 0 4.037959661218338e-05
( O 0 3.323355696541186e-12
GALNS O 0 2.0075913198525086e-07
) O 0 7.57503608450616e-12
. O 0 8.350741105556114e-12

Previous O 0 4.11581382309123e-08
studies O 0 8.123953176841781e-10
of O 0 2.390473615495464e-13
patients O 0 8.971897010046082e-12
from O 0 2.0069463126971832e-13
a O 0 2.752580975651231e-11
British O 0 1.7469143642756535e-07
- O 0 2.756853609753307e-05
Irish O 0 1.4999945960880723e-06
population O 0 6.9243014100273115e-12
showed O 0 3.9657224726319384e-10
that O 0 1.2063235881130258e-13
the O 0 4.65109281113079e-14
I113F O 0 8.175477655969488e-11
mutation O 0 1.1523753479236731e-10
is O 0 3.229810353628376e-13
the O 0 7.151836292781065e-15
most O 0 2.8278074665406307e-14
common O 0 4.2902118489729357e-13
single O 0 1.7290165132965996e-10
mutation O 0 7.005268543025522e-08
among O 0 1.89828490704258e-08
MPS B-Disease 1 0.999996542930603
IVA I-Disease 1 0.9999991655349731
patients O 0 4.267983968020417e-06
and O 0 9.547338475357492e-10
produces O 0 2.167432899824462e-09
a O 0 1.2289460560310772e-09
severe O 0 4.1669684947009955e-07
clinical O 0 3.429871142657248e-08
phenotype O 0 6.516280336654745e-06
. O 0 5.481493303705065e-08

We O 0 3.2881024569775263e-09
studied O 0 2.2140286826122235e-10
mutations O 0 1.2280719774437898e-09
in O 0 1.1243726219176131e-12
the O 0 1.5792510528467307e-12
GALNS O 0 5.0324040046234586e-08
gene O 0 3.594317898869548e-11
from O 0 1.1004040831753131e-13
23 O 0 1.5084733592449218e-12
additional O 0 9.826224035835995e-12
MPS B-Disease 1 0.9999880790710449
IVA I-Disease 1 0.9999983310699463
patients O 0 7.246259769999597e-07
( O 0 8.618020034580065e-13
15 O 0 9.448453304472526e-12
from O 0 2.2104735576677914e-12
Australia O 0 1.7822746750661977e-11
, O 0 1.5948668167370394e-13
8 O 0 2.457017662244043e-12
from O 0 5.626913323307503e-13
Northern O 0 3.336123044483941e-11
Ireland O 0 7.176179650514314e-09
) O 0 1.1435895633238324e-12
, O 0 4.030361063471358e-15
with O 0 6.133248257005194e-15
various O 0 3.288088049990638e-14
clinical O 0 4.682097376473848e-09
phenotypes O 0 2.2411084898976696e-07
( O 0 1.0584329419860428e-11
severe O 0 6.804048879871516e-09
, O 0 4.664296835051041e-13
16 O 0 1.819475993480868e-12
cases O 0 2.0618266208943803e-12
; O 0 2.0589254043010263e-13
intermediate O 0 4.027895031399886e-11
, O 0 1.4122415259790189e-12
4 O 0 9.46870082341178e-11
cases O 0 1.3847276658651708e-09
; O 0 8.699004849788139e-10
mild O 0 4.3638448410376895e-09
, O 0 2.461506692919002e-12
3 O 0 4.0161422798501434e-11
cases O 0 2.6356698074048168e-11
) O 0 1.1994676085702594e-10
. O 0 4.1623565705251053e-10

We O 0 2.1745481859625215e-08
found O 0 1.468276195071283e-10
two O 0 2.8577949468672204e-12
common O 0 7.875514476674006e-12
mutations O 0 1.9069418266681737e-10
that O 0 4.364822739355567e-11
together O 0 8.373010618178967e-11
accounted O 0 9.375265321021065e-12
for O 0 1.3996473217350782e-14
32 O 0 2.4234243084508833e-11
% O 0 1.7567434526933982e-14
of O 0 2.2964306220914178e-15
the O 0 3.9050251747496656e-12
44 O 0 6.795102241302642e-12
unrelated O 0 1.6442180950093643e-11
alleles O 0 5.827414245596074e-11
in O 0 9.076265130095185e-13
these O 0 2.6695779267726927e-11
patients O 0 1.0990192783610908e-10
. O 0 1.2743400779058334e-10

One O 0 3.9312450517137165e-10
is O 0 2.004831630569859e-12
the O 0 6.936773611033661e-14
T312S O 0 3.787917479680658e-10
mutation O 0 1.2389178571936554e-09
, O 0 2.114347976214792e-12
a O 0 2.7299766180294283e-12
novel O 0 3.71918967845275e-10
mutation O 0 4.644606477199886e-09
found O 0 2.9148355951136296e-10
exclusively O 0 1.3465740675289162e-11
in O 0 1.459863913783055e-12
milder O 0 3.5066087811230773e-09
patients O 0 3.9762426684575303e-10
. O 0 2.6746505010777355e-10

The O 0 2.8769833737563033e-10
other O 0 1.5332084560282233e-11
is O 0 1.4992972141580907e-12
the O 0 1.0261257311515101e-13
previously O 0 1.1923304010785785e-10
described O 0 1.719311915060473e-10
I113F O 0 1.0599163907665243e-10
that O 0 1.477869801362608e-12
produces O 0 1.694868551060935e-11
a O 0 6.780618427848495e-11
severe O 0 6.859038848006094e-08
phenotype O 0 7.342858765468918e-08
. O 0 2.5861781605129863e-09

The O 0 5.4201663990394167e-11
I113F O 0 4.88112616991998e-09
and O 0 8.958118968838136e-11
T312S O 0 1.8193457851367612e-10
mutations O 0 5.055527108055458e-10
accounted O 0 1.6380617695599398e-10
for O 0 3.3378188451019253e-13
8 O 0 2.4675542165120135e-10
( O 0 3.0753828303420327e-13
18 O 0 1.3054986258698165e-10
% O 0 2.371545071867126e-13
) O 0 1.5640319985313345e-12
and O 0 1.484694450715196e-10
6 O 0 1.9592547029212426e-10
( O 0 6.423657992245951e-14
14 O 0 4.882108259329776e-11
% O 0 9.388873684589016e-14
) O 0 1.4474417487069652e-13
of O 0 1.8780134985649753e-15
44 O 0 2.1399067684935852e-13
unrelated O 0 3.3789375377540898e-12
alleles O 0 8.071220081173891e-11
, O 0 1.154436095329725e-11
respectively O 0 4.788567875557703e-10
. O 0 1.0372595005136986e-09

The O 0 1.5702089628533145e-10
relatively O 0 2.336424942406268e-10
high O 0 9.120605604096e-09
residual O 0 7.832550608100064e-08
GALNS O 0 1.1713153753589722e-06
activity O 0 2.0723162075242385e-10
seen O 0 5.883468018330618e-11
when O 0 4.807128545052108e-13
the O 0 1.3370565844273742e-14
T312S O 0 7.503338228520562e-12
mutant O 0 7.440408011927246e-11
cDNA O 0 6.159900367563864e-10
is O 0 6.639720023793316e-12
overexpressed O 0 1.9553283436835045e-09
in O 0 2.2851951450922336e-13
mutant O 0 1.4087409017093933e-09
cells O 0 1.8998939574355056e-11
provides O 0 2.3830416467723013e-15
an O 0 6.281232959703519e-15
explanation O 0 2.3860503416822665e-13
for O 0 2.8810097753642627e-13
the O 0 9.706144776799874e-10
mild O 0 1.2134025837440277e-06
phenotype O 0 3.2537170113755565e-07
in O 0 3.2741309663464335e-11
patients O 0 2.341237100023097e-11
with O 0 5.334765290111732e-13
this O 0 1.0560549830451738e-12
mutation O 0 1.730275123179581e-08
. O 0 5.595469865227187e-09

The O 0 7.826860687343284e-12
distribution O 0 2.323859681074847e-11
and O 0 4.407519921950653e-12
relative O 0 1.3651379289145171e-13
frequencies O 0 5.9557016436617705e-12
of O 0 5.5488594743872445e-15
the O 0 3.1378700094016054e-13
I113F O 0 1.7482233716226148e-10
and O 0 4.026763731485028e-12
T312S O 0 1.4666773004434752e-11
mutations O 0 1.7877775648766914e-10
in O 0 3.959360508724863e-13
Australia O 0 4.180330669296961e-13
corresponded O 0 1.5053403402270904e-12
to O 0 1.3472484575432347e-13
those O 0 2.7857739986342223e-13
observed O 0 3.485719698992362e-11
in O 0 2.1096509955631504e-12
Northern O 0 1.4069491405255263e-10
Ireland O 0 8.484819602472271e-08
and O 0 1.5191088664767705e-10
are O 0 2.521654776942205e-15
unique O 0 5.909837811452715e-16
to O 0 6.150319782540631e-14
these O 0 3.0041629448841756e-14
two O 0 4.28389311871169e-12
populations O 0 1.9017964286716094e-12
, O 0 2.9497414168362657e-13
suggesting O 0 1.775895229483293e-11
that O 0 2.553525099702192e-12
both O 0 4.8572823145359365e-14
mutations O 0 8.514421806493644e-12
were O 0 1.5413001821021344e-12
probably O 0 1.3755596054570995e-12
introduced O 0 2.2065464418737774e-13
to O 0 8.204044214810136e-12
Australia O 0 3.0911995185789465e-11
by O 0 7.051124007589893e-13
Irish O 0 4.3284048567571176e-10
migrants O 0 2.007031476777832e-12
during O 0 3.1803539294293637e-14
the O 0 3.1436733370551057e-14
19th O 0 2.4514905730410597e-11
century O 0 1.835280677431328e-10
. O 0 2.2666452048625274e-10

Haplotype O 0 2.6125660497200442e-06
analysis O 0 1.4825353444880562e-10
using O 0 5.898433824702565e-11
6 O 0 4.0586367600070616e-10
RFLPs O 0 4.165336520145502e-09
provides O 0 1.260570102213374e-14
additional O 0 9.263847936980961e-16
data O 0 1.009840475130197e-11
that O 0 2.2865825986123633e-12
the O 0 2.0984143242475106e-12
I113F O 0 3.684397009706686e-09
mutation O 0 1.921437231544587e-09
originated O 0 5.928043611547196e-10
from O 0 1.3447786449943128e-13
a O 0 1.1864829865121385e-12
common O 0 1.0676543850396403e-11
ancestor O 0 7.902355214639556e-09
. O 0 8.828957120954328e-09

The O 0 7.631423271092785e-11
other O 0 1.563704721263548e-11
9 O 0 3.5480904325702056e-10
novel O 0 1.1458614612713802e-10
mutations O 0 9.058240824089125e-10
identified O 0 1.1502019336973035e-09
in O 0 1.1136370688460961e-12
these O 0 8.775955656625811e-12
23 O 0 4.564211508739646e-11
patients O 0 3.667207596619315e-12
were O 0 2.8155919978324617e-13
each O 0 6.204882256870964e-15
limited O 0 1.8348053653673146e-13
to O 0 2.1932297557952785e-12
a O 0 1.8361270837097265e-11
single O 0 2.407124632952673e-08
family O 0 2.352019691898022e-06
. O 0 2.054790781969018e-09

These O 0 1.1077101909340303e-11
data O 0 3.3158779541575534e-12
provide O 0 3.4870554963776102e-15
further O 0 1.2954939059033792e-15
evidence O 0 9.334514836979203e-15
for O 0 1.4907908250106754e-16
extensive O 0 5.0179736125859076e-14
allelic O 0 1.2630450019202044e-09
heterogeneity O 0 5.978487394031617e-08
in O 0 3.5285407928853374e-09
MPS B-Disease 1 0.9999920129776001
IVA I-Disease 1 0.9999966621398926
in O 0 2.4762320194327003e-08
British O 0 7.533572352258489e-05
- O 0 0.08921493589878082
Irish O 0 4.925514440401457e-05
patients O 0 4.0110612054000683e-10
and O 0 7.37652668982014e-14
provide O 0 6.509255632002696e-17
evidence O 0 2.8767471667605e-14
for O 0 4.300142751237747e-16
their O 0 4.066978091105122e-12
transmission O 0 8.131510043085655e-08
to O 0 1.5138583095430924e-11
Australia O 0 2.2677196492154605e-12
by O 0 2.6858764236130372e-14
British O 0 1.463281051883314e-09
- O 0 2.722894976159296e-07
Irish O 0 1.5009742782012836e-08
migrants O 0 2.2093956872359932e-11
. O 0 2.726867058436104e-14
. O 0 2.571004932387655e-13

Identification O 0 4.308957080034759e-10
of O 0 1.4262527790742663e-12
constitutional O 0 6.919657902226817e-11
WT1 O 0 5.076450179331005e-06
mutations O 0 1.8849866023629147e-07
, O 0 3.737548812110525e-11
in O 0 4.92965640096904e-13
patients O 0 1.0460101534937039e-11
with O 0 3.2053942833343285e-11
isolated O 0 3.50077280018013e-05
diffuse B-Disease 1 0.9623076319694519
mesangial I-Disease 1 0.9999973773956299
sclerosis I-Disease 1 0.9999994039535522
, O 0 2.3503011092884663e-08
and O 0 7.579259442280772e-11
analysis O 0 9.246037095678172e-12
of O 0 7.182943476125025e-13
genotype O 0 2.42125697695883e-05
/ O 0 5.440700078906957e-06
phenotype O 0 1.3058664194431913e-07
correlations O 0 8.677051965833016e-09
by O 0 2.7686639330996854e-13
use O 0 1.970254336200114e-13
of O 0 4.646553053346686e-14
a O 0 2.9097499149727257e-12
computerized O 0 2.455017700242479e-08
mutation O 0 7.546968383564945e-09
database O 0 1.1451612103030584e-08
. O 0 8.719790223210566e-09

Constitutional O 0 1.4228668243632114e-09
mutations O 0 6.760802584437897e-09
of O 0 2.1182421051577083e-13
the O 0 1.8316304148304624e-13
WT1 O 0 2.2728545712169534e-09
gene O 0 2.0565178032727616e-11
, O 0 1.4749284760651356e-14
encoding O 0 6.59980837341978e-12
a O 0 9.99061278150748e-10
zinc O 0 0.00014674116391688585
- O 0 1.6047984900069423e-05
finger O 0 0.0007060283096507192
transcription O 0 1.7353153580756953e-08
factor O 0 9.480338736267413e-11
involved O 0 1.0044254490637616e-11
in O 0 8.45350178746429e-11
renal O 0 0.03154272213578224
and O 0 6.01966760882533e-08
gonadal O 0 3.484060289338231e-05
development O 0 1.4711019902247102e-10
, O 0 7.997964270034519e-12
are O 0 3.702972580258909e-14
found O 0 1.5759742686208278e-12
in O 0 5.314509174804503e-15
most O 0 1.218517338896427e-13
patients O 0 6.034842764401915e-12
with O 0 9.82960823847634e-10
Denys B-Disease 1 0.9999750852584839
- I-Disease 1 0.9999960660934448
Drash I-Disease 1 0.9999940395355225
syndrome I-Disease 1 0.9999978542327881
( O 0 3.8094652432540954e-10
DDS B-Disease 1 0.999995231628418
) O 0 2.3178846342286619e-10
, O 0 3.3884375340298423e-12
or O 0 8.756523506292524e-09
diffuse B-Disease 1 0.8087764382362366
mesangial I-Disease 1 0.9999971389770508
sclerosis I-Disease 1 0.9999991655349731
( O 0 2.0409311218827497e-06
DMS B-Disease 1 0.707417368888855
) O 0 1.7496788462523227e-09
associated O 0 1.7999729484685645e-09
with O 0 1.0217768853237885e-08
pseudohermaphroditism B-Disease 1 0.9999979734420776
and O 0 2.974035169245326e-06
/ O 0 6.064681201678468e-06
or O 0 3.036565772163158e-07
Wilms B-Disease 0 0.1274488866329193
tumor I-Disease 1 0.9214329123497009
( O 0 1.2919403324929135e-08
WT B-Disease 1 0.9999436140060425
) O 0 5.165152305863785e-09
. O 0 1.2072512989291795e-09

Most O 0 5.011470127769257e-10
mutations O 0 2.500800292182248e-06
in O 0 7.100970123019579e-08
DDS B-Disease 1 0.9999946355819702
patients O 0 2.4669794584042393e-05
lie O 0 2.700432332858327e-06
in O 0 9.442755822056115e-13
exon O 0 1.2692951134596342e-09
8 O 0 1.01041375266675e-09
or O 0 5.683406523182555e-11
exon O 0 2.5692210581240715e-09
9 O 0 9.858147631547354e-10
, O 0 5.153883504867285e-13
encoding O 0 4.378151174933009e-09
zinc O 0 0.04235171154141426
finger O 0 0.3997323513031006
2 O 0 1.840737979819096e-07
or O 0 1.8295442316684785e-07
zinc O 0 0.000766598794143647
finger O 0 0.001703572110272944
3 O 0 7.221680475844039e-10
, O 0 6.532356253141636e-12
respectively O 0 3.6773022127345456e-11
, O 0 2.3902684302343213e-13
with O 0 2.068388862963566e-12
a O 0 1.219977174837794e-10
hot O 0 5.2587893151212484e-05
spot O 0 0.004716197494417429
( O 0 1.5865665985853594e-12
R394W O 0 8.229530945591534e-11
) O 0 1.5232670539429977e-13
in O 0 1.7034706707285546e-14
exon O 0 1.831375606720087e-09
9 O 0 1.7267705487711282e-08
. O 0 1.215258671471986e-09

We O 0 3.0614816237672926e-10
analyzed O 0 1.0831223418161784e-10
a O 0 2.4905934519620088e-12
series O 0 4.5417394844982084e-10
of O 0 3.6903254974421373e-13
24 O 0 5.084544937861146e-11
patients O 0 2.193150175355818e-12
, O 0 4.103362005107407e-14
10 O 0 4.812807053930501e-13
with O 0 1.2326875631352152e-10
isolated B-Disease 0 5.675681313732639e-05
DMS I-Disease 0 0.4080089330673218
( O 0 2.7772443633028443e-12
IDMS B-Disease 0 4.5602769205288496e-07
) O 0 3.1467419815689457e-12
, O 0 1.165108320152347e-13
10 O 0 1.860315720914052e-12
with O 0 5.771104705232233e-10
DDS B-Disease 1 0.9999996423721313
, O 0 1.6071512176640823e-10
and O 0 2.640877967696742e-11
4 O 0 1.362705087659677e-10
with O 0 6.01909189157368e-09
urogenital B-Disease 0 0.06744594126939774
abnormalities I-Disease 1 0.9904822111129761
and O 0 2.1541700334637426e-07
/ O 0 8.527148565917742e-06
or O 0 6.762727025488857e-06
WT B-Disease 1 0.9999690055847168
. O 0 6.629507964817094e-08

We O 0 2.7314548400880767e-09
report O 0 4.243561058103751e-10
WT1 O 0 1.335054776063771e-06
heterozygous O 0 1.7364873983183315e-08
mutations O 0 2.6335078118222555e-08
in O 0 4.8407715336207247e-11
16 O 0 6.2365418385113e-10
patients O 0 2.398872211983871e-10
, O 0 1.1437029708710744e-12
4 O 0 3.232100004302296e-11
of O 0 1.1061958640756764e-12
whom O 0 1.379931724443395e-09
presented O 0 3.343552379408976e-10
with O 0 8.18048961903628e-10
IDMS B-Disease 0 0.0003174979065079242
. O 0 2.169654234052132e-09

One O 0 2.2127981225139592e-08
male O 0 1.4203376252908129e-08
and O 0 1.9608810408744404e-10
two O 0 4.3783660030882743e-10
female O 0 5.979547523793372e-08
IDMS B-Disease 0 9.990287071559578e-05
patients O 0 1.8143661573155612e-10
with O 0 1.1360808994942406e-11
WT1 O 0 0.00015886127948760986
mutations O 0 8.01186433818657e-06
underwent O 0 2.4777207840998017e-07
normal O 0 5.1012996493682294e-08
puberty O 0 7.379162070719758e-06
. O 0 8.468066248212835e-09

Two O 0 7.904679932835279e-08
mutations O 0 6.659710379608441e-06
associated O 0 2.1589063692317723e-07
with O 0 5.021337123878311e-09
IDMS B-Disease 0 0.00013705843593925238
are O 0 1.9440280548538302e-12
different O 0 3.365703373013444e-14
from O 0 7.955268930583126e-13
those O 0 1.2924042044892836e-11
described O 0 3.971009832071104e-08
in O 0 5.286981963337212e-10
DDS B-Disease 1 0.9999936819076538
patients O 0 4.8026311816329326e-08
. O 0 6.714804268170838e-10

No O 0 6.3827236829183676e-09
WT1 O 0 9.304768354922999e-06
mutations O 0 1.8026163672857365e-07
were O 0 1.726519371914037e-09
detected O 0 2.5274950132825325e-08
in O 0 1.283339320229393e-12
the O 0 1.2065340913858247e-11
six O 0 7.846014948853508e-10
other O 0 1.1242515945975029e-10
IDMS B-Disease 0 7.778056169627234e-05
patients O 0 2.724122594166545e-10
, O 0 5.588184537504148e-13
suggesting O 0 7.636927201737365e-11
genetic O 0 5.775093736559711e-09
heterogeneity O 0 3.995000952272676e-08
of O 0 8.651605473697366e-12
this O 0 1.3500986995040876e-09
disease O 0 6.355942332447739e-06
. O 0 3.9783918381886e-09

We O 0 2.8997706458255834e-09
analyzed O 0 1.6221941123717443e-08
genotype O 0 1.674119266681373e-05
/ O 0 1.2899262401333544e-05
phenotype O 0 5.69125234051171e-07
correlations O 0 3.641790726760519e-07
, O 0 4.291705879566621e-11
on O 0 3.553427274649579e-10
the O 0 1.6329099530865143e-12
basis O 0 2.6745506850889278e-12
of O 0 6.175922539217518e-14
the O 0 6.8349952433988115e-12
constitution O 0 3.149646613399143e-13
of O 0 5.07417522272412e-16
a O 0 1.5289322542397232e-12
WT1 O 0 4.0364298570239043e-08
mutation O 0 1.1464948782013984e-11
database O 0 6.3008855945290154e-12
of O 0 1.374646110916672e-13
84 O 0 5.504117162047351e-10
germ O 0 3.332708001835272e-05
- O 0 0.0008140315185301006
line O 0 0.00045085418969392776
mutations O 0 5.886103338070825e-08
, O 0 8.502294463093307e-13
to O 0 2.835997224819725e-13
compare O 0 5.688988776592074e-12
the O 0 2.165412218025492e-13
distribution O 0 1.5616645754334968e-09
and O 0 3.1202760375492744e-09
type O 0 1.635851315517911e-10
of O 0 5.246170793789251e-13
mutations O 0 3.4464144871293456e-09
, O 0 1.1234872624235615e-12
according O 0 1.1948093441005708e-14
to O 0 4.1267987291315755e-14
the O 0 3.957201049047815e-13
different O 0 1.3541677501560656e-10
symptoms O 0 9.901157227432122e-08
. O 0 7.289778503061228e-11

This O 0 2.8106612592893043e-09
demonstrated O 0 1.0327590338476966e-08
( O 0 3.837902218251088e-13
1 O 0 1.425655253572966e-11
) O 0 4.925936394895025e-12
the O 0 5.258696256227324e-12
association O 0 7.202077205014507e-14
between O 0 1.0939669038267236e-13
mutations O 0 3.421887426191539e-11
in O 0 2.676558722380061e-14
exons O 0 1.5604356917719997e-08
8 O 0 7.230142595737732e-10
and O 0 1.719439729486183e-10
9 O 0 1.469593891023635e-09
and O 0 2.674998667018258e-09
DMS B-Disease 0 0.0007433195132762194
; O 0 2.129132287143065e-11
( O 0 2.3306385982376984e-14
2 O 0 4.191944708020756e-11
) O 0 2.2731805587178355e-12
among O 0 1.290215764088165e-13
patients O 0 1.1701173883993388e-12
with O 0 3.539272824468198e-12
DMS B-Disease 0 1.3822000255458988e-06
, O 0 1.2165032978357637e-14
a O 0 4.158488772787201e-15
higher O 0 1.0912820973751295e-14
frequency O 0 8.565981257646627e-11
of O 0 1.8953161793917178e-14
exon O 0 1.8245350785761616e-09
8 O 0 3.362854439359353e-10
mutations O 0 1.4128849201711091e-09
among O 0 4.922893256237293e-12
46 O 0 2.2332370674948976e-10
, O 0 7.617825120709298e-11
XY O 0 0.00013769190991297364
patients O 0 3.114584146146626e-10
with O 0 1.1856102904994614e-11
female O 0 6.906502036940765e-10
phenotype O 0 3.1854796578301148e-09
than O 0 1.3986258169413485e-13
among O 0 8.526719911736147e-13
46 O 0 4.3782158454241937e-10
, O 0 1.8438980897705903e-10
XY O 0 0.0009469750802963972
patients O 0 2.1810132866395548e-10
with O 0 6.429928638140847e-12
sexual O 0 6.982131539601255e-10
ambiguity O 0 5.709252093311079e-08
or O 0 2.172790125598567e-08
male O 0 1.1464511118219889e-07
phenotype O 0 6.967948706915195e-07
; O 0 9.827322289268636e-10
and O 0 5.0986899147176246e-09
( O 0 6.858603312023814e-13
3 O 0 2.0862674435240258e-11
) O 0 1.438573788087663e-13
statistically O 0 5.0282440564779554e-14
significant O 0 1.3398776276582047e-14
evidence O 0 1.167596574980223e-11
that O 0 8.333302797813857e-12
mutations O 0 1.4048923135945302e-10
in O 0 3.4351850791009e-13
exons O 0 1.536531328838464e-07
8 O 0 1.0353803148177576e-08
and O 0 2.90075380382504e-10
9 O 0 4.708655340635026e-11
preferentially O 0 1.7392908224778125e-09
affect O 0 2.208030633332747e-11
amino O 0 4.6928839286808355e-11
acids O 0 1.6773982376705465e-12
with O 0 8.94734285305284e-15
different O 0 4.965792063167012e-16
functions O 0 5.851633197093142e-13
. O 0 5.168504946945207e-12
. O 0 4.3338884564425584e-11

The O 0 7.166109372569451e-10
185delAG O 0 4.714598276223114e-07
BRCA1 O 0 5.253268682281487e-07
mutation O 0 3.3092615314700424e-09
originated O 0 5.345784370724971e-10
before O 0 3.7807260794275876e-11
the O 0 1.9144946045157596e-12
dispersion O 0 1.3804931420224875e-08
of O 0 8.285261040609504e-13
Jews O 0 1.3545455868069212e-09
in O 0 2.580665282164718e-12
the O 0 2.2391647563901884e-11
diaspora O 0 1.965251739122209e-09
and O 0 4.571872325165316e-10
is O 0 7.385400342500847e-13
not O 0 5.179673964045284e-13
limited O 0 2.970511681142478e-14
to O 0 3.3253483300299536e-11
Ashkenazim O 0 1.391436740050267e-06
. O 0 5.534784297545059e-10

The O 0 1.3157702705157703e-10
185delAG O 0 1.4254798941237823e-07
mutation O 0 3.0909269810308615e-08
in O 0 2.0156104216240145e-11
BRCA1 O 0 1.0152718914469006e-06
is O 0 1.539428029495582e-09
detected O 0 4.9109932120927624e-08
in O 0 4.278144678793172e-12
Ashkenazi O 0 9.987103339881287e-07
Jews O 0 2.15144391191302e-09
both O 0 1.5336822090095126e-11
in O 0 1.8877077678780552e-10
familial B-Disease 1 0.9880239367485046
breast I-Disease 1 0.999997615814209
and I-Disease 1 0.9999985694885254
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
and O 0 2.0389417443311686e-07
in O 0 1.0592221544314384e-12
the O 0 7.482868491504036e-13
general O 0 7.914240009870843e-13
population O 0 2.2481458968742762e-12
. O 0 2.361937867512154e-10

All O 0 9.529728117740888e-10
tested O 0 7.904905885425251e-08
Ashkenazi O 0 8.17924671991932e-07
mutation O 0 3.21885309517711e-08
carriers O 0 1.7607960922649823e-10
share O 0 2.7297906990408904e-11
the O 0 7.311020278760738e-13
same O 0 7.660236160667022e-12
allelic O 0 3.1979108250368427e-09
pattern O 0 1.6188967322250392e-07
at O 0 6.692965071053436e-10
the O 0 2.709806554493377e-12
BRCA1 O 0 1.9320202682138188e-06
locus O 0 2.0838679120060988e-05
. O 0 1.4527759617521951e-07

Our O 0 1.2059722109825088e-08
previous O 0 5.134885294744151e-10
study O 0 2.1750290370853298e-12
showed O 0 6.29374261040816e-11
that O 0 4.937416713543877e-14
this O 0 1.561705307445444e-14
Ashkenazi O 0 8.71926246759358e-08
mutation O 0 3.1234872466257e-08
also O 0 3.789402569509548e-08
occurs O 0 4.609813364364612e-10
in O 0 7.088337620857199e-14
Iraqi O 0 1.351943140770473e-10
Jews O 0 1.3573062812577419e-11
with O 0 6.257858407897679e-14
a O 0 1.5595272469248744e-13
similar O 0 2.6402068465519735e-12
allelic O 0 1.9114233396066993e-07
pattern O 0 1.1590905160119291e-05
. O 0 3.6720566587433723e-09

We O 0 1.0122077620522418e-09
extended O 0 1.23403249424614e-11
our O 0 2.3225822307071375e-12
analysis O 0 9.360193826621344e-14
to O 0 6.040652732793722e-14
other O 0 7.828939184223102e-15
non O 0 4.392258854801073e-14
- O 0 1.6276441305862477e-10
Ashkenazi O 0 1.876373367792894e-08
subsets O 0 5.765053989748026e-10
354 O 0 3.24154703079671e-10
of O 0 1.8057246575276832e-14
Moroccan O 0 2.7825559634209185e-09
origin O 0 2.83816351497046e-12
, O 0 2.0834089932853656e-14
200 O 0 7.0951240488306005e-15
Yemenites O 0 1.8583812266825817e-10
and O 0 8.435453399159576e-13
150 O 0 2.8114316091647738e-14
Iranian O 0 3.58640131481458e-11
Jews O 0 3.691962707774721e-11
. O 0 1.9290107705627335e-11

Heteroduplex O 0 5.004520517104538e-06
analysis O 0 1.3305567758692405e-10
complemented O 0 1.0690753143860476e-10
by O 0 3.6324571721032834e-15
direct O 0 7.263934327086594e-15
DNA O 0 6.411073061318717e-11
sequencing O 0 4.968460087795279e-10
of O 0 8.624729077623405e-13
abnormally O 0 8.49918269096861e-09
migrating O 0 4.0305367550452775e-12
bands O 0 9.067208095459023e-11
were O 0 9.244944219888307e-12
employed O 0 5.580755649270408e-11
. O 0 3.1770117786544816e-11

Four O 0 2.6490127869038815e-09
of O 0 8.727543427539119e-13
Moroccan O 0 8.106964344278822e-08
origin O 0 2.181208824669767e-10
( O 0 1.969238777577674e-14
1 O 0 6.700474458045877e-14
. O 0 2.6020989358989562e-14
1 O 0 2.007031476777832e-12
% O 0 5.442347961182037e-14
) O 0 8.388970941519691e-13
and O 0 2.5634570854915495e-11
none O 0 1.723022982971778e-12
of O 0 1.8705555322830788e-16
the O 0 5.035607889870841e-13
Yemenites O 0 2.7285076420469068e-09
or O 0 6.849063417108114e-12
Iranians O 0 7.15133230411169e-11
was O 0 1.0253349558286828e-10
a O 0 4.939200090592344e-13
carrier O 0 9.900540109963885e-11
of O 0 7.292197275437628e-15
the O 0 2.3348365341818722e-12
185delAG O 0 9.242528875574862e-08
mutation O 0 1.0543176331978543e-09
. O 0 1.214803813098797e-10

BRCA1 O 0 0.00011338045442244038
allelic O 0 5.432456418930087e-06
patterns O 0 2.522742306609871e-06
were O 0 6.283885634061903e-10
determined O 0 3.229229939005762e-10
for O 0 1.8029585528538117e-13
four O 0 1.8533325915615073e-11
of O 0 4.653257827343972e-14
these O 0 2.5237082389162335e-12
individuals O 0 1.6129917971489764e-14
and O 0 3.1651840436824896e-13
for O 0 7.189553187614641e-16
12 O 0 1.1161175269050992e-14
additional O 0 8.674373886185052e-16
non O 0 8.605930638255765e-13
- O 0 4.8077641423560635e-08
Ashkenazi O 0 1.1742438800865784e-05
185delAG O 0 3.00574015454913e-07
mutation O 0 4.7866524077733175e-09
carriers O 0 1.3254401742823774e-10
who O 0 2.202746429702529e-08
had O 0 9.205347305396572e-05
breast B-Disease 1 0.9997881054878235
/ I-Disease 1 0.9999618530273438
ovarian I-Disease 1 0.9999984502792358
cancer I-Disease 1 0.9999850988388062
. O 0 1.24527582556766e-06

Six O 0 2.2933747345632582e-08
non O 0 3.32739458208664e-09
- O 0 1.8487249690224417e-05
Ashkenazi O 0 0.0017966065788641572
individuals O 0 5.7866982039467274e-11
shared O 0 1.8158477499419234e-10
the O 0 2.3448380823826165e-12
common O 0 2.821083124049384e-11
Ashkenazi O 0 6.932282872185169e-07
haplotype O 0 3.220446524210274e-05
, O 0 4.865514588447972e-11
four O 0 1.62982110446519e-11
had O 0 1.975470009796254e-09
a O 0 3.9163759583439595e-13
closely O 0 5.405330696928168e-11
related O 0 3.609067211751693e-11
pattern O 0 3.711936358286039e-08
, O 0 7.432149513875164e-12
and O 0 1.2739700787356423e-11
the O 0 2.037721207048815e-11
rest O 0 3.8305967287044496e-09
( O 0 1.6769336028295279e-13
n O 0 1.2228106527345517e-07
= O 0 2.622390979922784e-07
6 O 0 1.097723023590902e-09
) O 0 3.218349415093358e-12
displayed O 0 8.882949237287718e-11
a O 0 2.36330893006384e-13
distinct O 0 1.5586575433101935e-11
BRCA1 O 0 2.092812110277009e-06
allelic O 0 9.117605259234551e-06
pattern O 0 0.00010175016359426081
. O 0 6.174020228399968e-08

We O 0 1.0293715185794028e-10
conclude O 0 2.0992960841903496e-11
that O 0 8.120357820407334e-14
the O 0 1.038882928251425e-13
185delAG O 0 5.5325838133057914e-08
BRCA1 O 0 1.2363240102786222e-06
mutation O 0 7.18186470294313e-08
occurs O 0 7.156029102617367e-10
in O 0 3.5175855284119706e-14
some O 0 4.183405517480107e-15
non O 0 2.484567673127769e-12
- O 0 4.4964363610233704e-07
Ashkenazi O 0 0.0008502412238158286
populations O 0 6.427461229918663e-09
at O 0 4.314773871527677e-09
rates O 0 1.029548779563072e-09
comparable O 0 4.913831494479659e-12
with O 0 1.1979436539966137e-12
that O 0 2.5284071711317857e-11
of O 0 9.645913408296014e-12
Ashkenazim O 0 8.495436304656323e-06
. O 0 4.5544568116895334e-10

The O 0 2.0435695358145267e-09
majority O 0 2.1336245270564547e-11
of O 0 6.146496614629904e-14
Jewish O 0 3.3305425084506624e-10
185delAG O 0 5.086657495212421e-08
mutation O 0 1.2063765542080773e-09
carriers O 0 9.896702381217981e-12
have O 0 6.549832291119495e-13
a O 0 9.844241985164717e-14
common O 0 6.590173719234205e-12
allelic O 0 9.262823397193642e-08
pattern O 0 8.22291895019589e-06
, O 0 2.102100785106309e-11
supporting O 0 1.2362156654247003e-12
the O 0 1.120326704670549e-12
founder O 0 1.0146993245641056e-09
effect O 0 5.6533046473294934e-12
notion O 0 6.385795104507652e-12
, O 0 1.7380346294115778e-12
but O 0 6.8761324759081255e-12
dating O 0 1.291934670355488e-09
the O 0 6.552343845452058e-13
mutations O 0 9.750430324251269e-11
origin O 0 5.832578886012796e-13
to O 0 1.295481191938841e-12
an O 0 1.0139524446841144e-13
earlier O 0 2.2875532024180245e-10
date O 0 1.0105963982320887e-10
than O 0 4.3132758107376767e-13
currently O 0 4.559771830947579e-12
estimated O 0 5.163105620126229e-12
. O 0 2.823263151041644e-11

However O 0 1.0718403942178156e-09
, O 0 8.607091412206683e-14
the O 0 1.3618208208381272e-15
different O 0 1.2261145806882583e-14
allelic O 0 2.9383988575659714e-09
pattern O 0 1.59482738126826e-07
at O 0 1.1838466873470566e-09
the O 0 2.27602658942061e-12
BRCA1 O 0 2.0832094094203057e-07
locus O 0 2.9339119009819115e-06
even O 0 1.8487103403685978e-08
in O 0 1.2542918093050304e-13
some O 0 3.4824959180225403e-15
Jewish O 0 2.0220651542057766e-10
mutation O 0 7.962358772317657e-09
carriers O 0 2.1869243915784153e-10
, O 0 1.1664991889093201e-11
might O 0 1.2764320156399833e-10
suggest O 0 6.5420819803097e-12
that O 0 2.3446949676958484e-12
the O 0 8.847380835765029e-13
mutation O 0 1.5224649319023342e-10
arose O 0 3.142795268820664e-12
independently O 0 1.8285815570062702e-11
. O 0 1.774862548598044e-11
. O 0 3.146577165491493e-10

Crystal O 0 0.0001844683865783736
structure O 0 1.705389607309371e-09
of O 0 1.8023784504814233e-12
the O 0 5.180096351864449e-10
hemochromatosis B-Disease 1 0.9999867677688599
protein O 0 6.347168124420932e-08
HFE O 0 4.967615950590698e-06
and O 0 3.0844105047833636e-10
characterization O 0 4.4864215120732354e-10
of O 0 1.1976476668035252e-14
its O 0 7.528708559356723e-13
interaction O 0 1.4297411995642384e-13
with O 0 7.826513417387437e-13
transferrin O 0 6.434870858385011e-09
receptor O 0 1.8100110299457128e-10
. O 0 8.432903680910542e-11

HFE O 0 0.0004741120501421392
is O 0 2.6853812506999475e-09
an O 0 7.101985666224664e-12
MHC O 0 6.446703082474414e-08
- O 0 2.1206271583196212e-07
related O 0 8.037840393271267e-10
protein O 0 7.235592125454104e-10
that O 0 4.393771371041799e-12
is O 0 3.4760473714917986e-14
mutated O 0 6.91902438121339e-11
in O 0 7.578254430234965e-13
the O 0 7.610930774504254e-10
iron B-Disease 1 0.9283437728881836
- I-Disease 1 0.9971722960472107
overload I-Disease 1 0.9999116659164429
disease I-Disease 1 0.9988778233528137
hereditary B-Disease 1 0.9999979734420776
hemochromatosis I-Disease 1 0.9999995231628418
. O 0 7.877032476244494e-05

HFE O 0 2.6699475711211562e-05
binds O 0 2.6383503382021445e-07
to O 0 1.646576652802878e-09
transferrin O 0 7.75586954659957e-07
receptor O 0 5.035947481246694e-08
( O 0 3.276548476982555e-11
TfR O 0 7.80138748268655e-07
) O 0 6.646169291996129e-12
and O 0 7.864147158996582e-13
reduces O 0 1.122450656726448e-12
its O 0 2.696121287110078e-14
affinity O 0 3.829349164152784e-12
for O 0 2.0077846720270576e-13
iron O 0 1.822425303998898e-07
- O 0 1.70328409154763e-08
loaded O 0 2.372148166784882e-08
transferrin O 0 8.263895523441533e-08
, O 0 5.597956993785846e-13
implicating O 0 2.661940001758012e-08
HFE O 0 1.0314429346180987e-06
in O 0 1.9148974073068814e-11
iron O 0 3.798654461206752e-06
metabolism O 0 1.6293390672217356e-06
. O 0 2.9140237445268724e-10

The O 0 1.0935142791268504e-09
2 O 0 1.0926455296100812e-08
. O 0 3.1134987921177526e-09

6 O 0 1.3686737929674564e-06
A O 0 3.8105233102214697e-07
crystal O 0 9.41372782108374e-05
structure O 0 3.055066644108706e-09
of O 0 1.2746645102271192e-12
HFE O 0 5.728749670197431e-07
reveals O 0 8.179291910437314e-09
the O 0 9.34171631109676e-14
locations O 0 1.1979083003321733e-10
of O 0 6.407921970819075e-10
hemochromatosis B-Disease 1 0.999998927116394
mutations O 0 1.8809418179444037e-05
and O 0 2.956286770938732e-09
a O 0 7.426474990523957e-10
patch O 0 0.2484549731016159
of O 0 4.4089959461146577e-10
histidines O 0 1.1735298357962165e-05
that O 0 2.895049477924516e-10
could O 0 1.9284747410086567e-10
be O 0 1.7815125459910708e-12
involved O 0 8.194938326024082e-13
in O 0 1.4350702050303088e-11
pH O 0 0.0001321848394582048
- O 0 1.0960301551676821e-05
dependent O 0 1.560906071063073e-08
interactions O 0 6.75199673949578e-10
. O 0 1.0299489039411469e-10

We O 0 2.207304339307825e-09
also O 0 6.445448775399543e-12
demonstrate O 0 1.8606281879801623e-12
that O 0 5.5690777510386535e-12
soluble O 0 8.231188175500392e-09
TfR O 0 1.5155763321672566e-05
and O 0 8.44767544805336e-09
HFE O 0 8.49717889650492e-06
bind O 0 5.480185905071266e-07
tightly O 0 5.718406725918612e-08
at O 0 7.921058947646387e-11
the O 0 1.688027294983671e-13
basic O 0 1.2711035349277644e-11
pH O 0 8.887775493349181e-08
of O 0 2.3348488940866385e-13
the O 0 3.8593260531794016e-11
cell O 0 0.00012147966481279582
surface O 0 1.299541963817319e-06
, O 0 1.794623130657591e-11
but O 0 1.2002518770537485e-11
not O 0 1.6532528818169467e-11
at O 0 1.0815946749342942e-10
the O 0 2.7091362139741726e-11
acidic O 0 4.1524256744196464e-07
pH O 0 1.8750318986349157e-06
of O 0 1.2677663823248975e-12
intracellular O 0 3.773884373003966e-06
vesicles O 0 2.079343857985805e-06
. O 0 2.3242177960014487e-08

TfR O 0 0.01754482463002205
HFE O 0 0.0006440685247071087
stoichiometry O 0 1.954166236828314e-06
( O 0 1.5650782059228874e-10
2 O 0 2.6761048932399945e-10
1 O 0 7.039560601107553e-11
) O 0 8.025485657980891e-12
differs O 0 1.985411002269899e-10
from O 0 7.974840406099748e-12
TfR O 0 6.248406521081051e-07
transferrin O 0 3.2368181024367004e-08
stoichiometry O 0 4.777702122815697e-10
( O 0 4.9843199771519575e-14
2 O 0 5.2534430798611975e-12
2 O 0 5.991938195615276e-11
) O 0 1.5494826558978825e-12
, O 0 1.6454580617974654e-14
implying O 0 1.9039986059142533e-13
a O 0 4.1693995100599017e-16
different O 0 2.4405205614191493e-16
mode O 0 1.8919700875419387e-12
of O 0 2.741377399861016e-16
binding O 0 6.062007991934626e-13
for O 0 2.559959554992823e-14
HFE O 0 2.102497376199608e-07
and O 0 1.198351695652633e-10
transferrin O 0 2.085860550948837e-08
to O 0 5.3727369775380396e-11
TfR O 0 5.637793378809874e-07
, O 0 1.2867733137703063e-12
consistent O 0 5.065618063904154e-12
with O 0 1.7453555690560146e-13
our O 0 7.38289724494523e-12
demonstration O 0 4.223692576243998e-12
that O 0 2.6064415382942574e-13
HFE O 0 1.1667300903184241e-08
, O 0 3.6051986049279172e-12
transferrin O 0 8.568183318402589e-08
, O 0 2.0695896385536372e-11
and O 0 2.707577217986312e-10
TfR O 0 9.727333463160903e-07
form O 0 9.016065346569013e-13
a O 0 1.8425086109608024e-11
ternary O 0 5.903189492784122e-09
complex O 0 3.529545722358307e-08
. O 0 3.4265801307498123e-09

Identification O 0 1.4942463932854366e-09
of O 0 1.5965506911311267e-12
three O 0 2.7839015814823398e-11
novel O 0 4.2256464993783993e-10
mutations O 0 7.722860573267099e-09
and O 0 1.0135808165001592e-10
a O 0 4.377259839316583e-12
high O 0 7.847942434802135e-11
frequency O 0 2.7928659385167975e-09
of O 0 1.0300102242476183e-13
the O 0 4.522555593911015e-11
Arg778Leu O 0 3.081837576246471e-06
mutation O 0 2.8652181072175154e-08
in O 0 2.7237939334567862e-11
Korean O 0 3.0679789375653854e-08
patients O 0 4.677933040930782e-11
with O 0 9.485275759280043e-11
Wilson B-Disease 0 2.8884230687253876e-06
disease I-Disease 0 2.6812735995918047e-06
. O 0 5.062802954647339e-10

Four O 0 6.820247699934612e-10
mutations O 0 1.3126408404673384e-08
- O 0 1.4295997061708476e-06
- O 0 8.777561220085772e-07
R778L O 0 1.1397767174514684e-08
, O 0 6.476549982079027e-13
A874V O 0 2.5393476384139024e-12
, O 0 6.596048424660104e-15
L1083F O 0 6.101727196422546e-13
, O 0 1.5947626316845272e-14
and O 0 2.5964682335601064e-13
2304delC O 0 1.3975274271160743e-09
- O 0 2.4350763183633717e-08
- O 0 6.589482381968992e-08
in O 0 8.755420975899153e-13
the O 0 7.470319393458602e-13
copper O 0 8.163852927012272e-11
- O 0 2.59277625411225e-13
transporting O 0 2.5399471480051783e-13
enzyme O 0 5.7406805004101e-11
, O 0 1.3020257615126152e-12
P O 0 1.2186278297576791e-07
- O 0 1.2933671200698882e-07
type O 0 7.042549654556751e-09
ATPase O 0 4.761477612191811e-06
( O 0 6.1929497988111315e-12
ATP7B O 0 2.6382420514892146e-07
) O 0 1.2173308151439133e-12
, O 0 1.0289532626547165e-14
were O 0 1.349050943654992e-13
identified O 0 2.2594358675687154e-11
in O 0 6.079445757575797e-13
Korean O 0 1.0193203614505819e-08
Patients O 0 2.1467605471059414e-11
with O 0 5.1576257154017924e-11
Wilson B-Disease 0 1.7020196310113533e-06
disease I-Disease 0 1.0401762438050355e-06
. O 0 2.54003346134013e-10

Arg778Leu O 0 2.8302387363510206e-05
, O 0 9.076066287416751e-11
the O 0 4.009387765367689e-13
most O 0 8.314500888999266e-13
frequently O 0 5.225080812465421e-09
reported O 0 4.746212867168254e-10
mutation O 0 1.6651298395675695e-11
of O 0 1.5494870265878903e-14
this O 0 2.1479420618444184e-13
enzyme O 0 3.577610152571964e-10
, O 0 6.031862509470187e-12
was O 0 5.660261592765892e-09
found O 0 3.4908045898340845e-10
in O 0 3.0278188810350937e-13
six O 0 2.3138727045513008e-11
of O 0 1.2342618517947185e-13
eight O 0 6.375538291747418e-11
unrelated O 0 3.0610960988219915e-10
patients O 0 3.1975886782137364e-12
studied O 0 6.107269095827206e-13
, O 0 2.1334979054564223e-15
an O 0 1.025297066113717e-15
allele O 0 1.2433873930461914e-09
frequency O 0 3.583951979635458e-08
of O 0 4.658582113820087e-12
37 O 0 3.2991589460351634e-09
. O 0 1.9601416045844644e-09

5 O 0 7.865607187795831e-08
% O 0 5.926559243363272e-11
, O 0 1.9403719082877746e-12
which O 0 7.73582326668576e-12
is O 0 2.3341455179272386e-13
considerably O 0 1.6026444060734946e-11
higher O 0 8.601532572143078e-13
than O 0 2.962409302782222e-14
those O 0 2.9706204401729053e-13
in O 0 2.807214401526984e-14
other O 0 1.5300320689234925e-12
Asian O 0 2.9901730397297044e-11
populations O 0 3.2255472598441415e-11
. O 0 9.442154003114211e-11

The O 0 2.0382731960588707e-11
novel O 0 7.707133542478317e-12
single O 0 1.7073527921324105e-12
nucleotide O 0 5.113266476897138e-10
deletion O 0 4.6832161615384393e-07
, O 0 3.4296845918824204e-10
2304delC O 0 1.6641058664390584e-07
, O 0 6.106506966752079e-11
was O 0 6.516040151893776e-09
found O 0 1.993892828622279e-10
in O 0 1.3482354880960112e-13
one O 0 2.345044818052866e-11
patient O 0 4.611680370913973e-09
. O 0 2.9149299640707227e-10

Since O 0 9.377510989949656e-10
a O 0 2.339379124444152e-12
mutation O 0 2.643675035829407e-11
at O 0 2.3960175857262733e-11
cDNA O 0 4.6427264810411373e-10
nucleotide O 0 6.863655421796011e-09
2302 O 0 2.3559350665891543e-06
( O 0 7.282854007362172e-12
2302insC O 0 5.235228428546179e-08
) O 0 1.0552728135770906e-10
had O 0 6.410492137121082e-09
been O 0 4.846890666598824e-10
previously O 0 2.1420416829176503e-10
described O 0 1.4219715405161537e-09
, O 0 1.945340047902755e-13
this O 0 4.0994504069569865e-14
region O 0 1.3050715022555615e-12
of O 0 4.236338385123217e-14
the O 0 1.2270154337024053e-10
ATP7B O 0 1.445873476768611e-05
gene O 0 3.359588163220906e-08
may O 0 8.013867902612049e-10
be O 0 1.8874897304843596e-12
susceptible O 0 4.880972015453011e-11
to O 0 1.5849272849005613e-12
gene O 0 7.450734642588941e-07
rearrangements O 0 0.18826702237129211
causing O 0 0.025570843368768692
Wilson B-Disease 0 0.0011375703616067767
disease I-Disease 0 0.00022229147725738585
. O 0 1.0712890130548658e-08

Disruption O 0 1.4455686425662861e-07
of O 0 3.4744318424921594e-13
splicing O 0 1.007753880344353e-09
regulated O 0 1.4601772568845206e-10
by O 0 2.308101626491421e-12
a O 0 9.490411061185977e-12
CUG O 0 9.294384426539182e-07
- O 0 1.6941527070102325e-09
binding O 0 6.319680334598843e-10
protein O 0 4.5662300607318684e-08
in O 0 2.552087874363451e-09
myotonic B-Disease 1 0.9999351501464844
dystrophy I-Disease 1 0.9998965263366699
. O 0 2.250965280836681e-08

Myotonic B-Disease 1 0.9998658895492554
dystrophy I-Disease 1 0.9999666213989258
( O 0 3.4374901588307694e-05
DM B-Disease 1 0.9999939203262329
) O 0 1.1212116987735499e-05
is O 0 6.027708110423191e-09
caused O 0 2.0451136339971754e-09
by O 0 1.0822327192391845e-13
a O 0 8.991284279613598e-13
CTG O 0 3.0980198406638237e-09
expansion O 0 9.910623537112695e-12
in O 0 1.5253605128127956e-13
the O 0 2.598966831676708e-12
3 O 0 3.753782562565533e-10
untranslated O 0 2.5479546820861287e-05
region O 0 2.75521383485966e-10
of O 0 1.1594485137614297e-13
the O 0 6.47987052904142e-10
DM B-Disease 1 0.9999814033508301
gene O 0 1.622357217456738e-07
. O 0 2.825571776554625e-09

One O 0 9.32414284671168e-11
model O 0 6.433292787377809e-11
of O 0 4.370994018121355e-12
DM B-Disease 1 0.99998939037323
pathogenesis O 0 1.053278992912965e-06
suggests O 0 2.1275472494863834e-09
that O 0 6.3453764811982616e-12
RNAs O 0 1.2855910114240032e-08
from O 0 1.498512414415537e-14
the O 0 1.2229601982289477e-16
expanded O 0 1.5035218096172464e-15
allele O 0 3.172761012248948e-11
create O 0 4.5166693600278904e-14
a O 0 1.4935630857082494e-12
gain O 0 1.6629882193530676e-10
- O 0 1.1809745359414592e-07
of O 0 3.821616634258618e-11
- O 0 7.893724500718236e-07
function O 0 8.02256983067906e-10
mutation O 0 1.8601783308147546e-11
by O 0 1.6137642911968723e-14
the O 0 4.481092959803673e-14
inappropriate O 0 1.4906902101596842e-10
binding O 0 1.7900833593209597e-11
of O 0 1.117186164847179e-15
proteins O 0 1.4958344350494979e-13
to O 0 1.0235825994306738e-13
the O 0 4.405822061348541e-12
CUG O 0 1.1050445209548343e-05
repeats O 0 3.3625517517066328e-06
. O 0 2.435561752278659e-10

Data O 0 2.3469278076504452e-08
presented O 0 2.546520327939561e-09
here O 0 1.391583809989827e-11
indicate O 0 3.956380362213352e-12
that O 0 2.6080117340905595e-14
the O 0 9.988643653792862e-15
conserved O 0 7.706431326415242e-11
heterogeneous O 0 4.83415174556967e-09
nuclear O 0 2.555655782998656e-06
ribonucleoprotein O 0 7.665509116350222e-09
, O 0 2.3975282479812843e-13
CUG O 0 8.449061006388092e-09
- O 0 3.616621446766999e-10
binding O 0 1.1018842782650751e-10
protein O 0 1.186672538011635e-09
( O 0 1.799144566780233e-14
CUG O 0 4.113616114409524e-08
- O 0 8.61440980770567e-08
BP O 0 7.075322514538129e-07
) O 0 1.0096936307879556e-12
, O 0 8.6179822230293e-14
may O 0 1.0937546441464052e-12
mediate O 0 4.997431357622872e-09
the O 0 3.185549393713849e-11
trans O 0 1.5536468112031798e-08
- O 0 2.5321426164737204e-06
dominant O 0 1.4088966793224245e-07
effect O 0 1.7836145754790422e-11
of O 0 1.2643596217402713e-15
the O 0 6.584689119914361e-14
RNA O 0 9.512407750378316e-09
. O 0 8.923739525101837e-11

CUG O 0 0.018919266760349274
- O 0 0.0013303187442943454
BP O 0 7.089287100825459e-05
was O 0 2.6605137648516575e-08
found O 0 2.157523465440292e-11
to O 0 3.230554184081337e-14
bind O 0 3.9376668592439046e-11
to O 0 1.1719953078772466e-13
the O 0 2.4760084932871906e-13
human O 0 3.053957919885164e-10
cardiac O 0 1.687379517534282e-05
troponin O 0 0.0004176896472927183
T O 0 0.00013645492435898632
( O 0 3.0537090868129613e-13
cTNT O 0 5.722721740930581e-10
) O 0 9.671940982489136e-13
pre O 0 8.724905520285375e-11
- O 0 1.7148039432868245e-08
messenger O 0 1.809926999385425e-07
RNA O 0 1.4304540663090393e-08
and O 0 3.5489918837929013e-13
regulate O 0 4.819409438585123e-14
its O 0 2.7720114581292112e-15
alternative O 0 1.9450310841649145e-14
splicing O 0 2.229509910023353e-09
. O 0 4.8773707295168833e-11

Splicing O 0 2.5552209237389434e-08
of O 0 4.568453254583105e-11
cTNT O 0 1.469481674121198e-07
was O 0 3.0226392055965334e-08
disrupted O 0 4.020520009362372e-06
in O 0 1.0837158948007186e-09
DM B-Disease 1 0.9999979734420776
striated O 1 0.9965699911117554
muscle O 0 0.0010200163815170527
and O 0 2.4724171598933253e-09
in O 0 3.6955871305852095e-13
normal O 0 2.7626165244321044e-11
cells O 0 2.9902658127411996e-10
expressing O 0 7.966113879653847e-12
transcripts O 0 1.2864169729454034e-09
that O 0 3.138094645249723e-11
contain O 0 2.189053827095222e-09
CUG O 0 5.196365964366123e-05
repeats O 0 4.885685120825656e-05
. O 0 2.0342321160882193e-09

Altered O 0 1.1083695738989263e-07
expression O 0 1.88982968163387e-10
of O 0 8.092712020261669e-14
genes O 0 1.7325024748160445e-10
regulated O 0 1.0911225256649004e-09
posttranscriptionally O 0 9.702854413262685e-07
by O 0 6.998741863828428e-11
CUG O 0 0.00011480040848255157
- O 0 2.629488335514907e-06
BP O 0 1.395072104060091e-06
therefore O 0 8.078208241224516e-12
may O 0 3.5200171228343125e-13
contribute O 0 6.321231549538762e-15
to O 0 1.9447558147200894e-11
DM B-Disease 1 0.9999904632568359
pathogenesis O 0 4.844390844027657e-08
. O 0 9.096477911196832e-12
. O 0 3.026274716932953e-11

Identification O 0 9.51654088865439e-10
of O 0 5.044240307568171e-13
a O 0 4.1443400794483054e-11
novel O 0 1.6110619505127488e-09
nonsense O 0 1.7139872454663418e-07
mutation O 0 7.380370203868836e-10
and O 0 2.9507390454652782e-12
a O 0 8.910373930663337e-14
missense O 0 1.7889875345011852e-11
substitution O 0 4.2465827404004897e-13
in O 0 2.8057156614301124e-14
the O 0 5.505389980703379e-13
vasopressin O 0 2.2185201231650353e-08
- O 0 6.4658115661586635e-06
neurophysin O 0 1.5657116819056682e-05
II O 0 6.974783559599018e-07
gene O 0 6.748289149705045e-10
in O 0 2.436947399517969e-13
two O 0 2.3683560321230424e-11
Spanish O 0 8.552961894281452e-09
kindreds O 0 1.5436649846378714e-05
with O 0 5.496849642128154e-09
familial B-Disease 1 0.9076647162437439
neurohypophyseal I-Disease 1 0.9997863173484802
diabetes I-Disease 1 0.9998132586479187
insipidus I-Disease 1 0.9629806280136108
. O 0 3.611834529237967e-07

Familial B-Disease 1 0.9980126619338989
neurohypophyseal I-Disease 1 0.9991372227668762
diabetes I-Disease 1 0.9999496936798096
insipidus I-Disease 1 0.999681830406189
( O 0 0.00015137586160562932
FNDI B-Disease 1 0.9999940395355225
) O 0 2.4175952262339706e-07
is O 0 3.1390601229475124e-10
an O 0 1.389603154766661e-10
autosomal B-Disease 1 0.9959681034088135
dominant I-Disease 1 0.9987529516220093
disease I-Disease 1 0.9998584985733032
caused O 0 0.0002929949259851128
by O 0 8.026067632727063e-08
deficiency O 1 0.887649655342102
in O 0 9.748063467540646e-12
the O 0 2.0322341032219526e-10
antidiuretic O 0 3.6189643992656784e-07
hormone O 0 1.8963236314561982e-08
arginine O 0 8.51292369929979e-09
vasopressin O 0 1.044267428085277e-08
( O 0 1.139211554951336e-12
AVP O 0 5.393459567848424e-10
) O 0 3.116229808377245e-14
encoded O 0 5.36810179641023e-13
by O 0 5.777238361098433e-14
the O 0 6.365640978743536e-13
AVP O 0 2.0950108137185453e-06
- O 0 0.0001635233056731522
neurophysin O 0 0.0032894425094127655
II O 0 0.0012222984805703163
( O 0 1.7951734933643881e-12
AVP O 0 7.767492604671133e-08
- O 0 9.95660457192571e-07
NPII O 0 1.0486651262908708e-05
) O 0 6.306425108688896e-13
gene O 0 4.1096006805907415e-12
on O 0 1.024182183506639e-09
chromosome O 0 5.5214372878253926e-06
20p13 O 0 4.315154455980519e-08
. O 0 1.8948646818284232e-10

In O 0 1.6634925381620036e-10
this O 0 7.306155463612796e-13
study O 0 2.052573334822977e-13
, O 0 1.4081739788986136e-13
we O 0 2.6390275056388524e-13
analyzed O 0 1.5128616675380568e-12
two O 0 4.1074301078414255e-12
families O 0 1.6486733853127156e-12
with O 0 2.570967093731835e-12
FNDI B-Disease 1 0.9643056988716125
using O 0 4.294718352243531e-15
direct O 0 1.0562346268748251e-15
automated O 0 6.124913770610974e-11
fluorescent O 0 5.032927408166188e-10
, O 0 1.2971871840572469e-12
solid O 0 1.8331561962847687e-11
phase O 0 1.5704718775433335e-11
, O 0 7.618369910616929e-13
single O 0 8.905015613791534e-12
- O 0 2.3791248970894685e-09
stranded O 0 4.8580403588793786e-11
DNA O 0 1.4430761273442894e-12
sequencing O 0 4.0873429857715693e-13
of O 0 4.306595871746404e-15
PCR O 0 4.269431386205724e-08
- O 0 3.27465379257319e-08
amplified O 0 1.0459825716679916e-06
AVP O 0 2.2414726572606014e-06
- O 0 9.647253591538174e-07
NPII O 0 6.81218079989776e-06
DNA O 0 1.3267546705719724e-07
. O 0 2.155303574502554e-10

In O 0 1.924513465256794e-10
one O 0 2.0698897457149812e-11
of O 0 8.763051184213291e-14
the O 0 7.616790011211183e-12
families O 0 5.7342127574022683e-11
, O 0 1.5563772330379894e-13
affected O 0 2.3982907809217205e-14
individuals O 0 2.3093080110489657e-16
presented O 0 5.008443204439217e-13
a O 0 1.5019075393085668e-12
novel O 0 3.2731273247321724e-10
nonsense O 0 4.2274404421505096e-08
mutation O 0 9.057130739842378e-11
in O 0 2.405319595843308e-13
exon O 0 7.015477643257384e-10
3 O 0 9.17538878209001e-10
of O 0 1.5687456758964324e-13
the O 0 3.894165805790051e-12
gene O 0 7.067521012871225e-10
, O 0 7.985094790247116e-13
consisting O 0 3.8998684381667814e-15
in O 0 4.353458647179606e-14
a O 0 3.0212801011009205e-11
G O 0 9.084571956918808e-07
to O 0 6.178040717896849e-11
T O 0 6.893242954220113e-08
transition O 0 2.8568139607415555e-12
at O 0 4.66225961916894e-13
nucleotide O 0 1.2414542050614985e-12
2101 O 0 2.800127063551372e-08
, O 0 3.856283239782321e-13
which O 0 2.6871587637325445e-13
produces O 0 6.222520870964587e-14
a O 0 3.100992024469319e-14
stop O 0 1.2672164706462041e-10
signal O 0 1.1791019005613634e-07
in O 0 1.3600941119878973e-12
codon O 0 8.882513613528431e-10
82 O 0 1.3018836009237589e-09
( O 0 4.939783933462227e-13
Glu O 0 4.428875115536357e-07
) O 0 1.9261210681964513e-11
of O 0 1.2143023132155095e-12
NPII O 0 5.566515028476715e-05
. O 0 9.654114174750816e-10

The O 0 1.7147563924346798e-10
premature O 0 2.1755560908331972e-08
termination O 0 2.0075503759375835e-10
eliminates O 0 2.0867260697166046e-10
part O 0 2.6549609407656993e-13
of O 0 3.826132864855579e-14
the O 0 3.875968296318533e-11
C O 0 1.3635128937039553e-07
- O 0 1.2293686957320915e-08
terminal O 0 5.997143892599865e-10
domain O 0 9.901654496324852e-11
of O 0 6.391649633608748e-14
NPII O 0 5.0953193664327046e-08
, O 0 4.0351607756669745e-15
including O 0 1.3918131060649893e-17
a O 0 1.1516384888229187e-15
cysteine O 0 3.541584039923329e-11
residue O 0 9.796259803351859e-09
in O 0 2.1885638985222507e-14
position O 0 3.164017936541086e-10
85 O 0 8.516755551669919e-13
, O 0 4.557621641199106e-13
which O 0 4.704005240885323e-11
could O 0 2.0925809696148434e-10
be O 0 7.5697022434984e-13
involved O 0 2.13592571364149e-14
in O 0 2.555924798251872e-14
the O 0 2.3525656249467897e-12
correct O 0 3.381085207365686e-07
folding O 0 1.1409615296997799e-07
of O 0 9.053956179618308e-14
the O 0 1.1489515588936072e-10
prohormone O 0 1.6098699688882334e-06
. O 0 7.633785270577675e-10

In O 0 1.7480900060817817e-10
the O 0 1.1204148719912155e-11
second O 0 5.001996594700131e-10
family O 0 1.9221438329886098e-10
, O 0 4.523874645793709e-15
a O 0 1.5905022200724716e-16
G279A O 0 9.72778461109285e-15
substitution O 0 6.675175701493759e-15
at O 0 6.639162743876659e-12
position O 0 6.621272280460389e-11
- O 0 4.876414827492681e-10
1 O 0 6.481122604741485e-13
of O 0 5.322073708419076e-16
the O 0 8.254388248222708e-14
signal O 0 1.6336141328565645e-08
peptide O 0 1.5833787059271742e-10
was O 0 9.737797235231938e-10
observed O 0 1.4045139183627153e-11
in O 0 2.467077267777058e-15
all O 0 6.966686071346179e-14
affected O 0 4.217821025168794e-13
individuals O 0 5.963948139595804e-14
. O 0 3.8672766378144985e-11

This O 0 8.284068570008074e-11
missense O 0 1.4357588895563822e-07
mutation O 0 5.2087248292309596e-08
, O 0 2.01545766187472e-10
which O 0 1.5205582626354186e-10
replaces O 0 1.764811514703979e-07
Ala O 0 6.901977371853718e-07
with O 0 7.730255324744917e-10
Thr O 0 0.0005728336982429028
, O 0 5.3567639907159403e-11
is O 0 1.483891677069027e-12
frequent O 0 2.6083255000308725e-10
among O 0 3.24148707875338e-09
FNDI B-Disease 1 0.9999991655349731
patients O 0 3.360088030035513e-08
and O 0 5.298083499694073e-11
is O 0 7.886182483950177e-13
thought O 0 1.3552283210579996e-12
to O 0 2.968942637310984e-14
reduce O 0 1.3724828565320202e-12
the O 0 1.2837181404684594e-13
efficiency O 0 9.126368931411388e-12
of O 0 1.7370840509216864e-15
cleavage O 0 2.3786621561328047e-09
by O 0 3.274727223331192e-13
signal O 0 9.631592945424927e-08
peptidases O 0 2.5557179483826076e-08
. O 0 1.189957203953651e-12
. O 0 7.394128712090442e-12

Genetic O 0 1.6653791590215405e-07
heterogeneity O 0 5.486597274284577e-07
of O 0 1.9816477347944783e-09
Saethre B-Disease 1 0.9910213351249695
- I-Disease 1 0.9999557733535767
Chotzen I-Disease 1 0.9999816417694092
syndrome I-Disease 1 0.9999929666519165
, O 0 3.21946219683511e-11
due O 0 5.478263242347792e-12
to O 0 1.997987062254958e-12
TWIST O 0 6.802454777243838e-07
and O 0 1.699285379075377e-09
FGFR O 0 1.4249976629798766e-05
mutations O 0 1.7632520155075326e-07
. O 0 9.513601018085183e-10

Thirty O 0 7.221727571504744e-08
- O 0 3.296953252629464e-07
two O 0 3.450556507189617e-10
unrelated O 0 2.8014663921993588e-09
patients O 0 3.3761111961627677e-11
with O 0 1.3073954896122841e-13
features O 0 1.2712933483705058e-10
of O 0 4.44929856846521e-11
Saethre B-Disease 1 0.922057569026947
- I-Disease 1 0.9999122619628906
Chotzen I-Disease 1 0.9999788999557495
syndrome I-Disease 1 0.9999798536300659
, O 0 3.0252456355989166e-12
a O 0 8.334446847946264e-12
common O 0 6.796422091781551e-09
autosomal B-Disease 0 0.44393211603164673
dominant I-Disease 0 0.031053684651851654
condition I-Disease 0 0.0006161220953799784
of O 0 7.040008020986477e-10
craniosynostosis B-Disease 1 0.993963897228241
and O 0 2.154033791157417e-05
limb B-Disease 0 0.07125934213399887
anomalies I-Disease 0 0.01791650429368019
, O 0 6.088561599337794e-11
were O 0 5.070934991358023e-12
screened O 0 2.3162052831260382e-10
for O 0 1.6662813164848578e-13
mutations O 0 1.0107954473426162e-09
in O 0 1.4585064059269293e-11
TWIST O 0 1.4369780956258182e-06
, O 0 6.336780405957754e-11
FGFR2 O 0 3.2954078506008955e-06
, O 0 1.572753038914243e-11
and O 0 1.8554947855964343e-10
FGFR3 O 0 3.498730075079948e-05
. O 0 6.921905271184414e-10

Nine O 0 1.1933417809473212e-08
novel O 0 4.7662362945288805e-09
and O 0 4.5961001671201984e-10
three O 0 2.8115820782659284e-10
recurrent O 0 5.821960439789109e-05
TWIST O 0 0.0002467536542098969
mutations O 0 1.5282174103958823e-07
were O 0 1.2167453711242615e-09
found O 0 2.7386365397674695e-10
in O 0 2.7600222996838897e-13
12 O 0 8.514587646057947e-11
families O 0 1.4861216424133517e-11
. O 0 4.386447108317704e-11

Seven O 0 1.1972219660094652e-08
families O 0 6.380867362265619e-11
were O 0 1.9388735408853996e-12
found O 0 2.5531391779388957e-13
to O 0 3.9890494878645766e-14
have O 0 2.2742764160636753e-13
the O 0 2.255041856372153e-13
FGFR3 O 0 3.498467435747443e-07
P250R O 0 2.1204403510832748e-10
mutation O 0 4.6232151440506186e-10
, O 0 8.744944005045774e-12
and O 0 1.86493875897753e-11
one O 0 2.6110766326858936e-11
individual O 0 2.764175390315704e-12
was O 0 3.538861648166858e-08
found O 0 7.199397328294665e-11
to O 0 2.336336961568375e-13
have O 0 4.4022083070874296e-13
an O 0 7.80586126335539e-14
FGFR2 O 0 1.522111460872111e-06
VV269 O 0 4.211422766076112e-09
- O 0 1.774983715563394e-08
270 O 0 1.1161458424169268e-09
deletion O 0 1.7089112702706188e-07
. O 0 1.2300810370291515e-09

To O 0 3.858744573870254e-11
date O 0 1.4867567246779068e-11
, O 0 2.2695649816418216e-14
our O 0 3.127949017422277e-14
detection O 0 5.2925662984149024e-12
rate O 0 2.1706702407753298e-11
for O 0 4.6102326193816e-15
TWIST O 0 2.915605890052575e-08
or O 0 6.65349095263501e-11
FGFR O 0 4.429314230947057e-07
mutations O 0 1.9927683947429387e-09
is O 0 1.41098218178759e-11
68 O 0 1.5041221046452335e-10
% O 0 4.772018622812603e-14
in O 0 2.650973787276384e-13
our O 0 1.8575259730368998e-07
Saethre B-Disease 1 0.5462393164634705
- I-Disease 1 0.9998688697814941
Chotzen I-Disease 1 0.9999856948852539
syndrome I-Disease 1 0.9999934434890747
patients O 0 2.9506421750369327e-09
, O 0 4.0631906205509244e-14
including O 0 1.2395552994952895e-14
our O 0 6.026713156304098e-11
five O 0 4.8083342862881295e-11
patients O 0 5.855409906940778e-12
elsewhere O 0 6.708354574960773e-13
reported O 0 2.251863626123729e-11
with O 0 2.174527051479469e-12
TWIST O 0 7.060305051709292e-07
mutations O 0 3.626226714459335e-07
. O 0 1.3850711688689898e-09

More O 0 1.3521783248215263e-13
than O 0 1.5696338746449233e-14
35 O 0 8.094841799904245e-14
different O 0 1.8727002641747564e-13
TWIST O 0 4.458557043562905e-07
mutations O 0 2.251690922605576e-08
are O 0 3.168146994747545e-11
now O 0 3.7543107511694984e-11
known O 0 5.412044076780198e-12
in O 0 3.594142670114431e-13
the O 0 2.5950202056646e-11
literature O 0 1.9395189621018716e-10
. O 0 5.332677632807759e-10

The O 0 2.1328799837405654e-11
most O 0 3.087572244316744e-13
common O 0 3.5773863255386673e-13
phenotypic O 0 1.9055463045154764e-13
features O 0 3.414842852933475e-09
, O 0 2.5732986921878087e-11
present O 0 7.632579464289524e-13
in O 0 4.210783739917734e-15
more O 0 5.635443605772053e-16
than O 0 1.0880564265053957e-14
a O 0 5.265581373703476e-12
third O 0 1.6547254233501008e-08
of O 0 3.1026869441730387e-12
our O 0 2.3740933663418673e-09
patients O 0 3.6232716588320557e-13
with O 0 1.0776167962524633e-13
TWIST O 0 7.06636527070259e-09
mutations O 0 5.14992104516665e-10
, O 0 1.408378079957584e-13
are O 0 6.219056167397138e-14
coronal B-Disease 0 6.750116199327749e-07
synostosis I-Disease 0 6.944153028598521e-06
, O 0 5.739487010658628e-11
brachycephaly B-Disease 0 3.0911155590729322e-06
, O 0 1.9160575348564635e-09
low B-Disease 0 0.0002852667821571231
frontal I-Disease 1 0.9999271631240845
hairline I-Disease 1 0.9999910593032837
, O 0 1.6984977264655754e-06
facial B-Disease 0 0.00955917313694954
asymmetry I-Disease 0 0.0003713899932336062
, O 0 5.8859122020749055e-08
ptosis B-Disease 0 0.2672211229801178
, O 0 2.0535223299589234e-08
hypertelorism B-Disease 0 0.0004295033577363938
, O 0 2.250633457379081e-09
broad B-Disease 0 1.3463399284319166e-08
great I-Disease 0 4.38317238149466e-06
toes I-Disease 1 0.9967944025993347
, O 0 2.3493620937564685e-10
and O 0 1.020302176080179e-09
clinodactyly B-Disease 0 9.790986950974911e-06
. O 0 1.6517857082121168e-09

Significant O 0 5.104951877887842e-11
intra O 0 6.76378419939283e-08
- O 0 0.00017761248454917222
and O 0 2.162034036246041e-07
interfamilial O 0 1.4691886462969705e-05
phenotypic O 0 1.439295793659312e-09
variability O 0 7.494155624954146e-07
is O 0 2.051643924194657e-11
present O 0 1.528179438461258e-13
for O 0 7.840146277148224e-15
either O 0 9.985154196534562e-12
TWIST O 0 2.77848016594362e-07
mutations O 0 6.804103236390802e-08
or O 0 1.9426669162214694e-09
FGFR O 0 0.00010328377538826317
mutations O 0 8.391357937398425e-07
. O 0 1.1959347290257938e-08

The O 0 6.604571750612465e-11
overlap O 0 9.342554507796308e-10
in O 0 2.250110904891689e-12
clinical O 0 5.179461720627998e-11
features O 0 7.043902683356862e-10
and O 0 3.082034627510666e-10
the O 0 8.142338799727034e-13
presence O 0 5.054075213895004e-12
, O 0 4.4945598349881155e-13
in O 0 1.889785138949442e-15
the O 0 2.2166565932508868e-14
same O 0 5.696902368249046e-13
genes O 0 1.295017981739477e-10
, O 0 2.2347804216980155e-13
of O 0 5.337016428399826e-16
mutations O 0 1.9445471708540163e-12
for O 0 1.7693316540148417e-16
more O 0 4.667261653654338e-16
than O 0 2.881761262995067e-14
one O 0 8.578014687454782e-11
craniosynostotic B-Disease 0 2.623311502247816e-06
condition I-Disease 0 4.2369392438956766e-09
- O 0 4.9420318531945284e-11
such O 0 1.145129337084801e-14
as O 0 6.858724092145829e-12
Saethre B-Disease 0 5.205993502954698e-08
- I-Disease 0 2.723507286361837e-08
Chotzen I-Disease 0 1.2607475241566135e-07
, I-Disease 0 4.174339368091806e-13
Crouzon I-Disease 0 5.835283367616739e-09
, I-Disease 0 1.5639962198596424e-12
and I-Disease 0 1.3786471964039038e-10
Pfeiffer I-Disease 0 9.807845344766974e-05
syndromes I-Disease 0 3.281973840785213e-05
- O 0 1.3735141912718518e-09
support O 0 9.854109715712323e-13
the O 0 3.6378135204705175e-13
hypothesis O 0 2.7170224403683108e-11
that O 0 5.588294150343787e-12
TWIST O 0 3.470321274789967e-08
and O 0 2.323306685925175e-10
FGFRs O 0 3.130148940044819e-08
are O 0 2.466048334504381e-14
components O 0 2.244195931519477e-12
of O 0 4.576866826918951e-16
the O 0 5.2583696945329716e-14
same O 0 3.2732036482283067e-13
molecular O 0 1.893721074050503e-12
pathway O 0 1.8162548288264135e-12
involved O 0 8.39791154368455e-15
in O 0 1.8725768175930236e-15
the O 0 3.9485908574950213e-13
modulation O 0 3.88836944864579e-08
of O 0 6.227531823554955e-10
craniofacial O 0 0.037322066724300385
and O 0 4.332250114202907e-08
limb O 0 2.1793216831156315e-07
development O 0 5.192235530415701e-13
in O 0 1.1298303465761064e-13
humans O 0 3.9787045186256975e-12
. O 0 6.084016211833909e-13
. O 0 2.925472364356807e-11

Mutation O 0 1.0793601035175016e-07
analysis O 0 5.934638891424981e-10
of O 0 1.3311812763205921e-10
UBE3A O 1 0.9874811768531799
in O 0 0.006038359832018614
Angelman B-Disease 1 0.9999970197677612
syndrome I-Disease 1 0.9999984502792358
patients O 0 1.2471341506170575e-05
. O 0 1.267604599064498e-08

Angelman B-Disease 1 0.9999924898147583
syndrome I-Disease 1 0.9999991655349731
( O 0 5.821260856464505e-05
AS B-Disease 1 0.999980092048645
) O 0 1.6061996177541005e-08
is O 0 3.36191158245569e-10
caused O 0 4.859998514739061e-10
by O 0 2.5301847205935757e-13
chromosome O 0 1.102139776776312e-06
15q11 O 0 3.477397569895402e-08
- O 0 3.571280728920101e-07
q13 O 0 1.22139400815513e-08
deletions O 0 2.2361250628932794e-08
of O 0 5.464758853768181e-12
maternal O 0 6.676255281945487e-08
origin O 0 9.026794589583886e-11
, O 0 2.4770155544751038e-12
by O 0 9.871910580661059e-12
paternal O 0 4.757093392981915e-06
uniparental B-Disease 0 0.16232611238956451
disomy I-Disease 1 0.5363484025001526
( O 0 2.2965647161754532e-09
UPD B-Disease 1 0.99994957447052
) O 0 1.3348729066553489e-10
15 O 0 1.634895018844118e-12
, O 0 5.971028657408492e-14
by O 0 1.2702352190918642e-12
imprinting O 0 0.30563539266586304
defects O 1 0.9998782873153687
, O 0 9.78282455044166e-11
and O 0 2.912438692992403e-11
by O 0 8.163206438940862e-13
mutations O 0 1.1058979287881243e-09
in O 0 1.1251557411467994e-12
the O 0 5.873612013429508e-11
UBE3A O 0 5.059374871052569e-06
gene O 0 1.372926021758758e-07
. O 0 4.964995081735424e-09

UBE3A O 0 5.17633725394262e-06
encodes O 0 4.184856905453671e-08
a O 0 7.605528706822184e-11
ubiquitin O 0 3.042229224092807e-08
- O 0 4.824132915359769e-08
protein O 0 3.0573983345050237e-09
ligase O 0 7.525647882644648e-10
and O 0 2.5305604833825157e-10
shows O 0 5.139277448051871e-09
brain O 0 7.633631753378722e-07
- O 0 2.079087346729125e-09
specific O 0 2.030520369900035e-11
imprinting O 0 0.0003462174499873072
. O 0 4.053828206451726e-08

Here O 0 1.9332770107016728e-10
we O 0 6.9587122522585254e-12
describe O 0 8.547957480731228e-12
UBE3A O 0 3.441946319071576e-07
coding O 0 7.779101724736392e-05
- O 0 0.00011338401964167133
region O 0 9.80037206943507e-09
mutations O 0 9.115701082862415e-09
detected O 0 2.1703877806089622e-08
by O 0 5.621766940855366e-12
SSCP O 0 4.6484200311169843e-07
analysis O 0 1.7703893906428902e-11
in O 0 2.730778710796633e-12
13 O 0 3.2066799215968445e-10
AS B-Disease 1 0.9898617267608643
individuals O 0 9.399234862650374e-13
or O 0 4.431259179038527e-11
families O 0 4.554202501227955e-11
. O 0 2.0656194810175776e-10

Two O 0 8.654371108640646e-10
identical O 0 3.9670126739110856e-08
de O 0 1.6989103457376586e-08
novo O 0 2.813360566733536e-08
5 O 0 7.979032434768385e-10
- O 0 1.8742593255183237e-08
bp O 0 1.6965916671551895e-08
duplications O 0 1.2227220347327261e-09
in O 0 3.791178525627825e-13
exon O 0 5.539061431747427e-10
16 O 0 5.856856666319743e-10
were O 0 1.1620251288979588e-10
found O 0 1.488974499253004e-09
. O 0 2.1765625413117107e-10

Among O 0 1.3391164566112224e-10
the O 0 8.552715827225832e-13
other O 0 1.3824974964739972e-13
11 O 0 8.170933547824166e-13
unique O 0 3.29521362995612e-14
mutations O 0 4.975968942444453e-11
, O 0 2.1036147270728917e-13
8 O 0 2.775532353862381e-13
were O 0 1.888108132298491e-13
small O 0 8.08627372282959e-15
deletions O 0 2.620752781457014e-10
or O 0 4.392753660820148e-10
insertions O 0 3.237823875679169e-06
predicted O 0 5.513760243047727e-06
to O 0 2.291397294129638e-09
cause O 0 1.7614796732345894e-08
frameshifts O 0 5.025099653721554e-06
, O 0 1.1992701970386932e-11
1 O 0 7.2379168630787305e-12
was O 0 3.2445428566063583e-09
a O 0 1.4809200957546786e-12
mutation O 0 1.235150957207276e-11
to O 0 6.211874547731866e-13
a O 0 6.767432751339508e-13
stop O 0 2.5823418403625453e-10
codon O 0 2.1524965837516064e-11
, O 0 2.473370087300447e-13
1 O 0 1.2380461239525076e-13
was O 0 2.3658017211936055e-10
a O 0 2.6002065084407278e-12
missense O 0 3.533147330259112e-09
mutation O 0 9.119904831322856e-10
, O 0 4.879824842818348e-12
and O 0 1.7297940857474714e-11
1 O 0 1.8150401320804477e-11
was O 0 4.149662231611728e-07
predicted O 0 1.0156776752978658e-08
to O 0 1.4810789747410347e-11
cause O 0 7.916724220624616e-11
insertion O 0 3.3427488554949036e-10
of O 0 4.1947101174499846e-12
an O 0 5.719742457443999e-10
isoleucine O 0 0.008444692008197308
in O 0 9.816451124189385e-11
the O 0 8.324156641759117e-11
hect O 0 2.275758248515558e-07
domain O 0 1.6175702444165552e-10
of O 0 1.4403414103233113e-14
the O 0 1.1078596807295726e-12
UBE3A O 0 4.266858510959537e-08
protein O 0 2.7187657680727284e-10
, O 0 3.0690233069740475e-14
which O 0 7.252389268015517e-15
functions O 0 5.930459675586568e-15
in O 0 3.1151838920939756e-14
E2 O 0 2.5097445899291415e-08
binding O 0 5.97834212689996e-11
and O 0 1.397831828585383e-12
ubiquitin O 0 2.921273639655553e-11
transfer O 0 2.3763504185259077e-12
. O 0 1.257877222521353e-11

Eight O 0 5.563459026802775e-09
of O 0 1.7207723689970783e-13
the O 0 9.558056386291258e-13
cases O 0 4.691941713624859e-12
were O 0 4.527284797051223e-11
familial O 0 7.263044921046458e-08
, O 0 2.357567474575717e-10
and O 0 2.858406913941458e-11
five O 0 1.1518737352833597e-11
were O 0 3.443349425036324e-11
sporadic O 0 2.7201882968341806e-09
. O 0 1.7258905415928893e-09

In O 0 8.368124942981225e-11
two O 0 5.579691569890244e-11
familial O 0 7.300196784854052e-07
cases O 0 2.4233388629113506e-09
and O 0 7.934637669126943e-11
one O 0 1.4561041174893097e-12
sporadic O 0 7.343269048387668e-11
case O 0 6.499053378794528e-11
, O 0 5.262205059718139e-13
mosaicism O 0 6.714961031661915e-09
for O 0 5.603318915629873e-13
UBE3A O 0 1.9284454992885003e-06
mutations O 0 3.97592074818931e-08
was O 0 3.286950445158254e-08
detected O 0 5.253794199688855e-08
in O 0 2.5048901754892716e-12
the O 0 1.2296980100856558e-10
mother O 0 3.184698300628952e-07
of O 0 8.137681067194036e-13
three O 0 5.789011492396412e-09
AS B-Disease 1 0.9999991655349731
sons O 0 1.8360464309807867e-05
, O 0 3.319995916638979e-13
in O 0 1.4409018073212147e-14
the O 0 7.072139315139614e-12
maternal O 0 2.86465052568019e-07
grandfather O 0 8.920142136048526e-07
of O 0 4.020888439912329e-14
two O 0 1.277511013642041e-10
AS B-Disease 1 0.9955379962921143
first O 0 2.788680675269717e-10
cousins O 0 5.080559617454128e-07
, O 0 1.4816475824019903e-10
and O 0 1.8743574747848157e-10
in O 0 1.9254884145447626e-12
the O 0 2.0464978323087024e-10
mother O 0 5.553739015340398e-07
of O 0 7.904957341920565e-14
an O 0 2.9058026818074012e-11
AS B-Disease 1 0.999993085861206
daughter O 0 0.0003555410949047655
. O 0 1.9079213764428005e-09

The O 0 3.5375385346730903e-12
frequencies O 0 2.3730972742441736e-09
with O 0 4.945181070192817e-11
which O 0 1.014445333291647e-10
we O 0 2.233435008117124e-12
detected O 0 3.151116173549795e-11
mutations O 0 1.2311360264583016e-11
were O 0 1.1193874820125682e-11
5 O 0 5.369886393186141e-12
( O 0 2.50470607118412e-14
14 O 0 3.308115933964295e-11
% O 0 1.6662304945080225e-13
) O 0 3.1014606030957403e-13
of O 0 3.4862044400238565e-15
35 O 0 1.7277355761347035e-12
in O 0 3.870746767813821e-14
sporadic O 0 1.2136829041775599e-10
cases O 0 4.963910879562938e-11
and O 0 2.2474794247884233e-10
8 O 0 5.706437544716891e-10
( O 0 7.718982788021411e-14
80 O 0 2.7801274737199178e-12
% O 0 1.3103338130249914e-13
) O 0 5.483131852203338e-13
of O 0 3.5158213281894293e-14
10 O 0 3.279324728433508e-11
in O 0 7.643302223775406e-13
familial O 0 1.3515801811081474e-07
cases O 0 3.1372704434318166e-10
. O 0 1.1498191287984127e-11
. O 0 1.743551414357114e-10

The O 0 9.930602118402021e-09
hemochromatosis B-Disease 1 0.9995421171188354
845 O 0 7.493279099435313e-06
G O 0 0.00016021396731957793
- O 0 2.0422708075784612e-06
- O 0 7.282916385520366e-07
> O 0 7.72395758463773e-11
A O 0 9.280521229976246e-13
and O 0 9.396864254600235e-14
187 O 0 2.2377534395802423e-13
C O 0 3.5800676312369717e-10
- O 0 4.2324586502218153e-08
- O 0 3.7971913116052747e-06
> O 0 9.055424743387164e-10
G O 0 5.407813432611874e-07
mutations O 0 6.000910879322419e-09
: O 0 1.85287223931907e-12
prevalence O 0 3.25480109530929e-09
in O 0 6.476673581126691e-13
non O 0 1.0057410460007077e-10
- O 0 1.4628955796069931e-05
Caucasian O 0 3.219988866476342e-05
populations O 0 2.374941310279155e-08
. O 0 7.688112924064683e-10

Hemochromatosis B-Disease 0 0.07958856970071793
, O 0 3.257765257558276e-08
the O 0 2.2625606561632594e-06
inherited B-Disease 1 0.9999996423721313
disorder I-Disease 1 0.9999996423721313
of I-Disease 0 1.201247634696756e-08
iron I-Disease 0 0.029239311814308167
metabolism I-Disease 0 2.4865054001566023e-05
, O 0 2.3015846173368715e-10
leads O 0 2.9194955786238097e-08
, O 0 5.71890257372587e-10
if O 0 5.045225037747514e-08
untreated O 0 6.324898549792124e-06
, O 0 9.601328412878196e-12
to O 0 2.754331207555083e-10
progressive O 0 2.398615151832928e-06
iron B-Disease 1 0.9981268048286438
overload I-Disease 0 0.4907841086387634
and O 0 5.1635687725593016e-08
premature B-Disease 0 1.1204122074559564e-06
death I-Disease 0 7.073663965684318e-08
. O 0 4.2351355755698705e-10

The O 0 3.4305188023608935e-08
hemochromatosis B-Disease 1 0.9997982382774353
gene O 0 4.734359890790074e-07
, O 0 9.851774951386005e-10
HFE O 0 9.723412404127885e-06
, O 0 9.675664713881815e-10
recently O 0 5.15201703521484e-09
has O 0 1.1021197149352346e-10
been O 0 2.5176806819904307e-11
identified O 0 9.212262203073251e-11
, O 0 4.524940806164418e-13
and O 0 4.0145321962559155e-12
characterization O 0 2.7500163257698773e-10
of O 0 6.098524734255567e-14
this O 0 8.435871359097069e-13
gene O 0 9.810410261934521e-10
has O 0 3.32955458759443e-08
shown O 0 1.8192496398228286e-09
that O 0 2.2272455147548387e-12
it O 0 1.8361015832746297e-12
contains O 0 5.636911090353171e-14
two O 0 2.5911362899061485e-12
mutations O 0 1.8429804904407376e-10
that O 0 2.5780934678754086e-11
result O 0 3.864008939202801e-12
in O 0 2.0772983281972836e-14
amino O 0 1.0725836885328022e-11
acid O 0 2.0862493319267345e-13
substitutions O 0 3.1036073233972616e-14
- O 0 3.0445565773334904e-12
cDNA O 0 2.8330485526972815e-11
nucleotides O 0 5.3885725742608415e-11
845 O 0 7.76570752147876e-10
G O 0 4.0029686942943954e-07
- O 0 6.863827906045117e-08
- O 0 6.298639050328347e-07
> O 0 4.75626260598716e-10
A O 0 1.0489135254809767e-10
( O 0 6.035581970054984e-15
C282Y O 0 4.1594294198157855e-13
) O 0 3.7861737467556784e-15
and O 0 5.7677670927921195e-15
187 O 0 7.923222082768799e-14
C O 0 3.5487401905953675e-10
- O 0 1.6817527637158491e-07
- O 0 7.150535384425893e-05
> O 0 2.7233667765358405e-08
G O 0 3.504771302687004e-05
( O 0 1.6591150111752717e-12
H63D O 0 1.338541153472761e-07
) O 0 1.598638105573813e-12
. O 0 2.5659407324601924e-12

Although O 0 5.212340511207003e-06
hemochromatosis B-Disease 1 0.9999654293060303
is O 0 4.865343239401909e-09
common O 0 2.192473633200187e-11
in O 0 1.1805257292551996e-12
Caucasians O 0 1.3268364185137216e-10
, O 0 2.653665048119036e-13
affecting O 0 6.036911422147018e-13
> O 0 6.777977051147799e-12
= O 0 9.82147585482096e-10
1 O 0 2.068563549617597e-11
/ O 0 2.1684047890602187e-09
300 O 0 3.787564608736388e-13
individuals O 0 4.9838232770316876e-15
of O 0 1.2926463081896523e-14
northern O 0 5.0903382203815184e-11
European O 0 9.895203545440268e-10
origin O 0 1.3783869878825072e-10
, O 0 9.293741123905797e-12
it O 0 5.027580435301715e-11
has O 0 1.259198162406605e-10
not O 0 7.290647577838649e-13
been O 0 5.115007809669558e-12
recognized O 0 6.554381061334158e-13
in O 0 1.104242717907657e-14
other O 0 2.2138774103883097e-13
populations O 0 5.369466590104954e-12
. O 0 5.936968278108523e-11

The O 0 2.1277967235389106e-11
present O 0 1.5448369851140537e-13
study O 0 7.422105024492125e-16
used O 0 1.5414751113464013e-14
PCR O 0 1.7162328225239776e-09
and O 0 5.0352651735641185e-12
restriction O 0 3.87465103404705e-12
- O 0 3.4780572866210946e-10
enzyme O 0 4.077989057549303e-10
digestion O 0 4.962323330026663e-10
to O 0 1.8412469746982183e-15
analyze O 0 4.6500795903192844e-15
the O 0 1.4127452092506642e-16
frequency O 0 3.699411436908218e-12
of O 0 1.2423516940673549e-16
the O 0 4.2376478980596724e-14
845 O 0 2.111698038653742e-10
G O 0 1.4984347274094034e-07
- O 0 2.6687152487880894e-09
- O 0 2.1907913261287604e-09
> O 0 2.724305698566243e-13
A O 0 6.998196374610396e-14
and O 0 2.25498906927888e-14
187 O 0 3.847516381015603e-14
C O 0 4.631235672736267e-11
- O 0 1.6302953431690526e-09
- O 0 9.37354869279261e-08
> O 0 3.457498523595781e-11
G O 0 1.0947879047762399e-08
mutations O 0 2.8986948258369338e-11
in O 0 2.7169771017439628e-14
HLA O 0 8.712106036590228e-10
- O 0 9.618402740940724e-10
typed O 0 8.331280554330078e-09
samples O 0 5.166667094158583e-10
from O 0 2.4336029068663945e-13
non O 0 2.2887948047251028e-12
- O 0 3.277453970440547e-07
Caucasian O 0 2.1025446130806813e-06
populations O 0 1.2068046562063728e-09
, O 0 2.9348303843580725e-13
comprising O 0 1.653842417425862e-15
Australian O 0 1.2509906305302465e-12
Aboriginal O 0 5.70464682436711e-12
, O 0 1.201656589039585e-14
Chinese O 0 2.12742594977403e-16
, O 0 1.7048836699153406e-15
and O 0 2.0511135921229967e-13
Pacific O 0 4.0690653971275914e-12
Islanders O 0 3.887320187967447e-10
. O 0 3.1973753072261912e-12

Results O 0 9.22924314750162e-09
showed O 0 7.092111342643648e-10
that O 0 2.3625908832937935e-14
the O 0 2.1116778708670306e-14
845 O 0 3.3167099622311014e-10
G O 0 2.4582614059909247e-06
- O 0 2.894217061566451e-07
- O 0 1.2920507970193285e-06
> O 0 1.2900232271295664e-10
A O 0 4.727183575137239e-11
mutation O 0 2.2638628471849387e-10
was O 0 8.94677310014913e-09
present O 0 2.966843892955595e-13
in O 0 5.0382256621349895e-15
these O 0 2.1434023040603142e-14
populations O 0 1.0408504841439431e-13
( O 0 9.788450381324624e-17
allele O 0 2.8401345945200385e-12
frequency O 0 5.15994025285238e-10
0 O 0 5.702446436058051e-13
. O 0 2.367929257621887e-13
32 O 0 8.87090661344514e-12
% O 0 4.525464950152179e-14
) O 0 1.910557622481976e-13
, O 0 4.035865608723044e-13
and O 0 7.556838835243163e-12
, O 0 5.62974742778638e-13
furthermore O 0 4.493233909941274e-12
, O 0 2.283134347812882e-13
it O 0 2.1158659893605325e-11
was O 0 3.4661404413327546e-08
always O 0 7.426375625563253e-10
seen O 0 2.0502825132107105e-11
in O 0 3.331472431686381e-16
conjunction O 0 1.1491559114874816e-13
with O 0 8.22463104566129e-12
HLA O 0 1.4276819726433132e-08
haplotypes O 0 4.6436081646561433e-08
common O 0 3.4318373143271685e-10
in O 0 9.809402639129883e-13
Caucasians O 0 2.676736263196311e-11
, O 0 1.164640995134688e-14
suggesting O 0 1.0027838070547981e-13
that O 0 1.3296109276517837e-13
845 O 0 3.404734272294263e-10
G O 0 5.482975211634766e-06
- O 0 1.1860371387228952e-06
- O 0 4.156140857958235e-05
> O 0 1.6278840497818692e-09
A O 0 2.9477957852463987e-09
may O 0 8.376305205004542e-10
have O 0 4.724258636200351e-13
been O 0 4.775635724547922e-13
introduced O 0 6.991005403701386e-14
into O 0 8.304685064630668e-14
these O 0 1.453284378689218e-13
populations O 0 3.3599962005401163e-13
by O 0 7.486979786142101e-13
Caucasian O 0 1.2585202568971e-07
admixture O 0 2.480728369391727e-07
. O 0 1.5545708054176544e-09

187 O 0 1.0455070587056525e-08
C O 0 8.84246617260942e-07
- O 0 1.127129598899046e-05
- O 0 0.0004521018418017775
> O 0 4.796379471372347e-07
G O 0 1.3724217751587275e-05
was O 0 9.85700587818883e-09
present O 0 3.0753049033108854e-14
at O 0 2.1059822519231032e-14
an O 0 2.696776880023341e-16
allele O 0 3.3829501699944586e-11
frequency O 0 1.9090133918098218e-09
of O 0 1.1423818705239008e-12
2 O 0 3.091479738870362e-09
. O 0 3.963484263014294e-10

68 O 0 4.056237230543047e-06
% O 0 5.775950273623209e-10
in O 0 4.0083322945527744e-13
the O 0 6.489112632651617e-13
two O 0 1.1436365049410924e-10
populations O 0 7.574794264053608e-11
analyzed O 0 3.8246998457225345e-08
( O 0 1.4860158459653605e-12
Australian O 0 3.1578623049810517e-10
Aboriginal O 0 8.259507522367926e-10
and O 0 3.2053942833343285e-11
Chinese O 0 5.6657667923606936e-14
) O 0 8.950830257103276e-14
. O 0 2.2725302542547787e-12

In O 0 1.8127705933568272e-11
the O 0 1.155874332879614e-12
Australian O 0 5.568387331095215e-12
Aboriginal O 0 4.760285048088786e-13
samples O 0 1.038053540694528e-12
, O 0 2.7137334737757472e-15
187 O 0 2.1396524892028194e-14
C O 0 1.701068036430442e-10
- O 0 2.3450350994380642e-08
- O 0 5.468290510179941e-06
> O 0 2.1952126783020276e-09
G O 0 5.90049069160159e-07
was O 0 4.331785152800194e-09
found O 0 2.23143378774715e-12
to O 0 1.3947757811455345e-14
be O 0 1.620356274286902e-13
associated O 0 7.839716153817608e-14
with O 0 3.62205545504507e-13
HLA O 0 4.75234784858003e-09
haplotypes O 0 8.041942578529415e-08
common O 0 1.9247052840398737e-09
in O 0 1.297081452661386e-11
Caucasians O 0 1.044338615585616e-09
, O 0 7.644993037063397e-13
suggesting O 0 1.0935466074335487e-11
that O 0 6.884579711874395e-13
it O 0 4.509581076617142e-12
was O 0 1.0537863637249956e-10
introduced O 0 2.515527391423744e-13
by O 0 1.5222644041026738e-14
recent O 0 8.436841503201009e-12
admixture O 0 1.3479843907759914e-08
. O 0 6.809744435010145e-10

In O 0 2.8950260591575905e-11
the O 0 1.1946048534064446e-13
Chinese O 0 1.3515168767930155e-15
samples O 0 3.2334761089361855e-14
analyzed O 0 1.8532635007780657e-13
, O 0 9.028562301266214e-16
187 O 0 3.156513001282765e-14
C O 0 1.3402637333292944e-10
- O 0 4.990604551835531e-08
- O 0 2.554310867708409e-06
> O 0 3.14807790946503e-10
G O 0 1.196539187731105e-06
was O 0 3.483850363750207e-08
present O 0 3.3947577821741293e-12
in O 0 6.359197565232455e-13
association O 0 8.620510108157085e-15
with O 0 2.216567654791425e-14
a O 0 1.5423961749732457e-13
wide O 0 4.849472602999616e-13
variety O 0 8.262563810229606e-14
of O 0 2.027306409769017e-13
HLA O 0 3.1510428044612127e-08
haplotypes O 0 1.3023318956584262e-07
, O 0 1.5626165292270677e-11
showing O 0 8.285743618996477e-11
this O 0 4.623276249142959e-14
mutation O 0 2.3466679988093375e-12
to O 0 6.203365078560896e-12
be O 0 9.801745526338834e-11
widespread O 0 7.561596314376029e-12
and O 0 3.9202679991134914e-10
likely O 0 2.977313118268654e-10
to O 0 5.268786275325343e-12
predate O 0 6.103109684296726e-10
the O 0 1.4020572998766061e-14
more O 0 4.189789578333783e-17
genetically O 0 1.410624868731494e-14
restricted O 0 4.4223363171317157e-14
845 O 0 4.0855896443758866e-09
G O 0 1.753761353029404e-05
- O 0 2.2940412236494012e-06
- O 0 3.1352271889772965e-06
> O 0 1.2680288763444736e-10
A O 0 5.0984029498213346e-11
mutation O 0 3.388313629670847e-09
. O 0 3.455970787324958e-10

Genotype O 0 0.007076709996908903
- O 0 0.0009966675424948335
phenotype O 0 0.0006711347959935665
correlations O 0 0.00013327543274499476
in O 0 1.8581638983050652e-07
attenuated B-Disease 1 0.9986829161643982
adenomatous I-Disease 1 0.9998881816864014
polyposis I-Disease 1 0.9996069073677063
coli I-Disease 1 0.9998735189437866
. O 0 7.065806858008727e-05

Germ O 0 0.010454433970153332
- O 0 0.03911184147000313
line O 0 0.0005206947098486125
mutations O 0 1.7258230400329921e-07
of O 0 3.388048034399377e-13
the O 0 3.221549112544797e-12
tumor B-Disease 0 4.366282837509061e-07
suppressor O 0 7.613298748765374e-06
APC O 0 2.563329644544865e-06
are O 0 3.891806668598896e-11
implicated O 0 1.6572545291637653e-06
in O 0 2.7177573969083824e-08
attenuated B-Disease 1 0.9998468160629272
adenomatous I-Disease 1 0.9999949932098389
polyposis I-Disease 1 0.9999860525131226
coli I-Disease 1 0.9999979734420776
( O 0 9.785845031728968e-05
AAPC B-Disease 1 0.9999773502349854
) O 0 7.382992439630698e-09
, O 0 3.2405038396556007e-13
a O 0 2.9445545394329864e-12
variant O 0 9.126808436121792e-06
of O 0 5.226885150477756e-06
familial B-Disease 1 0.9999992847442627
adenomatous I-Disease 1 0.999976396560669
polyposis I-Disease 1 0.999992847442627
( O 0 6.327055075416865e-07
FAP B-Disease 0 1.6844196579768322e-05
) O 0 5.836106709011801e-09
. O 0 7.894396247820623e-10

AAPC B-Disease 1 0.9995561242103577
is O 0 6.845103595054525e-09
recognized O 0 3.463939204917388e-12
by O 0 8.834173491475625e-14
the O 0 1.4012239719224384e-13
occurrence O 0 5.7342127574022683e-11
of O 0 2.9925833946314873e-13
< O 0 5.948158632307354e-10
100 O 0 1.3980005521274652e-11
colonic B-Disease 0 2.7228791168454336e-06
adenomas I-Disease 0 2.4457740437355824e-06
and O 0 8.11742756345879e-11
a O 0 3.4771783976456083e-12
later O 0 8.151432950853632e-08
onset O 0 2.1949848814983852e-05
of O 0 2.321707142982632e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
( O 0 2.6869273472840405e-10
age O 0 3.2688474149722424e-10
> O 0 4.2815102158089147e-11
40 O 0 2.8330485526972815e-11
years O 0 1.0625178514800382e-09
) O 0 1.927635134846284e-11
. O 0 8.036119686360976e-11

The O 0 2.1211239709106877e-10
aim O 0 2.4406130449960983e-09
of O 0 4.423045114301978e-14
this O 0 1.5920456888029143e-14
study O 0 3.712220570680326e-15
was O 0 3.9482618563457805e-12
to O 0 2.5620063254065684e-14
assess O 0 1.5883355394819e-11
genotype O 0 1.28464535009698e-07
- O 0 1.489116698394355e-06
phenotype O 0 1.4324983794722357e-06
correlations O 0 4.763076503877528e-06
in O 0 5.809962733138718e-09
AAPC B-Disease 1 0.9999566078186035
families O 0 3.620544930527103e-08
. O 0 2.4206675552918e-10

By O 0 9.81245900505412e-12
protein O 0 9.096243758222045e-10
- O 0 1.0892021862218826e-07
truncation O 0 8.462190521640878e-07
test O 0 1.0476793477209867e-07
( O 0 1.2349442215370265e-14
PTT O 0 5.7893925764496146e-11
) O 0 4.825020184827736e-14
assay O 0 2.7298217505911104e-11
, O 0 7.8759080081813e-15
the O 0 4.383368396986692e-15
entire O 0 2.5454432398680504e-12
coding O 0 3.999330601800466e-06
region O 0 4.281322171784119e-11
of O 0 7.925062177143415e-15
the O 0 1.0356250362483777e-12
APC B-Disease 0 3.057134545514373e-10
gene O 0 3.236827195163272e-10
was O 0 1.2596871101777651e-08
screened O 0 2.689805045363869e-09
in O 0 4.500152691894882e-13
affected O 0 5.0448854078608e-13
individuals O 0 2.0375238632798845e-14
from O 0 1.258615824409337e-12
11 O 0 1.0429501173803146e-07
AAPC B-Disease 1 0.9999936819076538
kindreds O 0 0.00021962393657304347
, O 0 5.342183639900355e-11
and O 0 9.662707266266946e-12
their O 0 7.569980232935425e-12
phenotypic O 0 5.2369159356246975e-12
differences O 0 2.243477226215873e-08
were O 0 8.349921309935837e-10
examined O 0 1.7540928354264906e-07
. O 0 3.7863787105685276e-10

Five O 0 1.4898637878957288e-09
novel O 0 3.864339070958067e-09
germ O 0 8.034755592234433e-05
- O 0 0.001686032279394567
line O 0 0.00012992462143301964
APC B-Disease 0 4.5126787995286577e-07
mutations O 0 1.494634815912832e-08
were O 0 2.5741627579511928e-11
identified O 0 5.1458639432899744e-11
in O 0 5.001416490159338e-13
seven O 0 7.136864432766288e-10
kindreds O 0 8.953909855335951e-06
. O 0 2.0744053141896757e-09

Mutations O 0 8.144639878082671e-07
were O 0 2.211353988812448e-09
located O 0 8.868982631637934e-11
in O 0 1.8537726692233192e-13
three O 0 4.938785383261368e-13
different O 0 7.97900089641139e-14
regions O 0 5.568607098875578e-13
of O 0 2.2055145524561143e-14
the O 0 8.924467068127662e-12
APC B-Disease 0 3.0825124675004645e-09
gene O 0 2.8174671484748615e-09
( O 0 4.208055616201217e-14
1 O 0 2.9152036145306537e-13
) O 0 9.501141464297175e-14
at O 0 1.6379164734584006e-12
the O 0 1.1804255388100666e-14
5 O 0 9.156022294509736e-13
end O 0 3.4916552288377645e-11
spanning O 0 1.8455967656927363e-11
exons O 0 5.722692097975823e-09
4 O 0 1.799968507576466e-10
and O 0 1.1669737398634084e-10
5 O 0 1.3737145101999637e-11
, O 0 1.12476954833296e-12
( O 0 3.065692815777091e-15
2 O 0 1.8262314403771907e-12
) O 0 3.5618341907633563e-14
within O 0 3.9732362085964624e-16
exon O 0 7.139665247901661e-11
9 O 0 4.540520404106019e-09
, O 0 6.654772566339062e-11
and O 0 3.723022168333756e-10
( O 0 2.6810805230656834e-14
3 O 0 7.430944748421098e-12
) O 0 5.475784214080404e-13
at O 0 1.3069777898833124e-11
the O 0 2.323387521870751e-13
3 O 0 1.4121648295173372e-10
distal O 0 1.2694124507106608e-07
end O 0 3.0913382964570246e-09
of O 0 6.8529467412987554e-15
the O 0 6.377478298062733e-13
gene O 0 7.793563128188907e-09
. O 0 8.51144266178494e-10

Variability O 0 3.82495181838749e-06
in O 0 1.8887285398866416e-12
the O 0 8.827502937609408e-14
number O 0 5.24563335477235e-12
of O 0 4.723738911138753e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.999998927116394
was O 0 0.00022176222410053015
most O 0 4.1454468330259786e-11
apparent O 0 4.4493052797633936e-08
in O 0 2.0625189924017295e-12
individuals O 0 1.1291409295196772e-13
with O 0 5.3378824797778446e-12
mutations O 0 2.135255083857146e-09
in O 0 5.378260770766419e-12
region O 0 2.2767874391371734e-11
1 O 0 1.0048799986561718e-10
, O 0 9.314721910458346e-11
and O 0 8.343052115833416e-08
upper O 0 0.00020081872935406864
- O 1 0.9972872734069824
gastrointestinal O 1 0.5700412392616272
manifestations O 0 1.6574979326833272e-06
were O 0 1.8419165082050881e-09
more O 0 8.908395722484475e-12
severe O 0 4.190213953592092e-09
in O 0 1.7326651181523434e-13
them O 0 2.6063349395366586e-11
. O 0 3.364978296005461e-10

In O 0 3.353925193128049e-10
individuals O 0 1.8112799671579638e-12
with O 0 5.75294326066178e-12
mutations O 0 9.482802321159056e-10
in O 0 5.075627852041409e-12
either O 0 1.579321950995194e-10
region O 0 2.1358975699214966e-10
2 O 0 1.0203196065816655e-09
or O 0 1.476483046936039e-09
region O 0 4.0931671246857704e-11
3 O 0 3.8525013040802136e-11
, O 0 4.502316217330077e-13
the O 0 1.324889633766424e-13
average O 0 7.4027789107034e-12
number O 0 8.206101271591992e-14
of O 0 1.01155769958311e-12
adenomas B-Disease 0 1.999678715947084e-07
tended O 0 4.151210930558591e-09
to O 0 2.068082337325361e-11
be O 0 2.0491851271398076e-10
lower O 0 2.7404550850818055e-10
than O 0 1.1337296119268148e-12
those O 0 9.356061932142001e-12
in O 0 3.4916915279264993e-13
individuals O 0 2.0537706328345798e-14
with O 0 2.8444714032099805e-12
mutations O 0 2.7594595497504315e-09
in O 0 1.075291591878802e-11
region O 0 7.715844629885282e-11
1 O 0 5.576223163772376e-11
, O 0 1.729038787146031e-11
although O 0 4.207131518163543e-11
age O 0 3.284275629233946e-11
at O 0 1.7649620653870102e-10
diagnosis O 0 1.319100495500436e-09
was O 0 1.1998823046255325e-09
similar O 0 3.033237896965524e-11
. O 0 9.294725544783944e-10

In O 0 8.261382689056518e-10
all O 0 3.4931639802948666e-09
AAPC B-Disease 1 0.9999333620071411
kindreds O 0 2.8062440833309665e-05
, O 0 2.607924943706652e-12
a O 0 1.0009021606319224e-12
predominance O 0 2.9696256120814724e-08
of O 0 1.038361618910244e-10
right O 0 0.21202293038368225
- O 1 0.9999473094940186
sided O 1 0.9999953508377075
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.999998927116394
and O 0 0.004727397579699755
rectal B-Disease 1 0.9999219179153442
polyp I-Disease 1 0.600807249546051
sparing O 0 7.116643985227711e-08
was O 0 1.4095256517521193e-07
observed O 0 8.388635563960634e-09
. O 0 4.0223080421952773e-10

No O 0 5.5200285714818165e-05
desmoid B-Disease 1 0.9980818033218384
tumors I-Disease 1 0.9999973773956299
were O 0 2.5471780418229173e-07
found O 0 2.77834510953312e-09
in O 0 5.650078386924828e-13
these O 0 3.449488611417806e-11
kindreds O 0 5.524555490410421e-06
. O 0 1.7334587099071541e-09

Our O 0 2.3614301625229928e-09
data O 0 2.2639015662129225e-10
suggest O 0 7.733007983956597e-11
that O 0 1.4296117241408002e-11
, O 0 5.593157013927819e-12
in O 0 5.992806945132045e-11
AAPC B-Disease 1 0.9999970197677612
families O 0 5.354774956778385e-10
, O 0 1.5157136206951985e-14
the O 0 2.4141230972553242e-15
location O 0 1.3317189365147364e-11
of O 0 5.3350478603029355e-14
the O 0 5.415702261646338e-11
APC B-Disease 0 1.5724006061645923e-06
mutation O 0 2.7102058197669976e-07
may O 0 1.228238932782233e-08
partially O 0 2.515068686648192e-08
predict O 0 7.428454379398985e-11
specific O 0 1.8587080930377448e-13
phenotypic O 0 7.146314096040385e-11
expression O 0 2.112167507561935e-08
. O 0 2.1239721093024855e-08

This O 0 9.097071707042659e-11
should O 0 1.5353798094031035e-11
help O 0 1.8044112211346164e-12
in O 0 4.143983333565471e-15
the O 0 2.2701192800025048e-14
design O 0 2.2782513722785502e-11
of O 0 5.139438476035353e-15
tailored O 0 8.558893177523785e-11
clinical O 0 6.880228331507254e-11
- O 0 1.220141321311985e-08
management O 0 1.770122590172285e-11
protocols O 0 2.637792068105327e-11
in O 0 2.1705208685479606e-15
this O 0 3.282876828013422e-16
subset O 0 1.6634004219059743e-14
of O 0 2.2617173907921e-14
FAP B-Disease 0 1.1551487544281258e-09
patients O 0 3.308341448016172e-12
. O 0 2.0890883153153877e-13
. O 0 1.571071051031936e-11

Wilms B-Disease 0 0.0019128869753330946
' I-Disease 0 5.631248427562241e-07
tumor I-Disease 0 1.4801923953200458e-06
1 O 0 1.0255525317859338e-09
and O 0 5.524184998328963e-10
Dax O 0 0.00010951401054626331
- O 0 1.4333167541735747e-07
1 O 0 4.094898465450969e-12
modulate O 0 1.6905665756183907e-09
the O 0 2.9502888847232622e-12
orphan O 0 5.401719072040123e-09
nuclear O 0 2.434020984765084e-09
receptor O 0 1.323615522741406e-11
SF O 0 3.22048035741318e-05
- O 0 3.186050037129462e-07
1 O 0 1.1430847240978537e-10
in O 0 1.4101359782549977e-13
sex O 0 4.015489329933786e-12
- O 0 2.606085052619944e-12
specific O 0 3.0825809163278e-14
gene O 0 2.2079980899203377e-10
expression O 0 1.9177566479289254e-10
. O 0 4.824567481631625e-11

Products O 0 1.9720742816531356e-09
of O 0 1.6127473705454531e-12
steroidogenic O 0 1.1967060231654614e-08
factor O 0 1.1172763408895392e-10
1 O 0 3.773910350890475e-11
( O 0 7.628068641150898e-13
SF O 0 0.000860990840010345
- O 0 2.9719130907324143e-05
1 O 0 3.2606604083440516e-09
) O 0 7.615690023055066e-11
and O 0 4.3228690072005804e-10
Wilms B-Disease 0 9.89797285910754e-07
tumor I-Disease 0 4.271844773029443e-06
1 O 0 2.3369464696720854e-10
( O 0 9.186577144609451e-14
WT1 O 0 6.763100657281029e-08
) O 0 1.6854254537151947e-12
genes O 0 1.0937905962904448e-11
are O 0 3.0882761964585483e-15
essential O 0 2.388576160049661e-14
for O 0 2.2732475420833044e-14
mammalian O 0 4.093819505612828e-09
gonadogenesis O 0 1.5536917885583534e-07
prior O 0 1.9249521681502513e-12
to O 0 5.048177045656466e-13
sexual O 0 7.958035272426223e-12
differentiation O 0 1.202164034985742e-09
. O 0 1.3264677134472436e-09

In O 0 7.282871528069279e-11
males O 0 6.367784771699192e-11
, O 0 2.4965826281309056e-11
SF O 0 0.00034950338886119425
- O 0 4.227184945193585e-06
1 O 0 6.734711122113879e-10
participates O 0 8.54263326743876e-11
in O 0 1.0962231556527202e-12
sexual O 0 4.730364971256007e-12
development O 0 1.2293461807886229e-14
by O 0 1.1563626033279928e-14
regulating O 0 6.1209167075138016e-12
expression O 0 2.172421097179633e-12
of O 0 4.829050028777593e-15
the O 0 1.3341309394038214e-12
polypeptide O 0 1.7945272645647492e-07
hormone O 0 7.110545485744524e-10
Mullerian O 0 3.994909292259763e-08
inhibiting O 0 9.838489489766289e-08
substance O 0 2.687304743176355e-07
( O 0 7.097973467665164e-13
MIS O 0 1.7339624491796712e-06
) O 0 4.0554948288473724e-10
. O 0 1.5231271799365231e-10

Here O 0 2.407311683327862e-09
, O 0 1.7022736302149677e-12
we O 0 2.462416392751826e-13
show O 0 2.456497678882119e-12
that O 0 2.508235860763236e-13
WT1 O 0 1.0890359902759883e-07
- O 0 1.1328005911082073e-07
KTS O 0 2.18035165744368e-06
isoforms O 0 1.2350725910742488e-12
associate O 0 3.072114437840945e-11
and O 0 6.93579742250261e-13
synergize O 0 1.0449528353717596e-08
with O 0 3.125999181730066e-10
SF O 0 0.12520265579223633
- O 0 2.8420913622539956e-06
1 O 0 9.948868118225818e-11
to O 0 2.6547700669732333e-12
promote O 0 4.489575378130439e-12
MIS O 0 1.240375786437653e-05
expression O 0 3.568520812180509e-09
. O 0 3.0629185299169137e-10

In O 0 4.890564064830016e-10
contrast O 0 5.663045032910929e-10
, O 0 1.5635199732133565e-11
WT1 O 0 3.580332077035564e-06
missense O 0 6.373408041326911e-07
mutations O 0 3.2941622407633986e-07
, O 0 3.690835831404726e-11
associated O 0 1.412533978673025e-10
with O 0 3.900815503943278e-10
male B-Disease 0 2.12522581932717e-06
pseudohermaphroditism I-Disease 1 0.9999964237213135
in O 0 1.0830824948016016e-07
Denys B-Disease 1 0.9999786615371704
- I-Disease 1 0.9999933242797852
Drash I-Disease 1 0.9999899864196777
syndrome I-Disease 1 0.9999949932098389
, O 0 6.144981745670464e-11
fail O 0 1.7808018393239422e-09
to O 0 1.5342219682190628e-13
synergize O 0 6.258986218199425e-08
with O 0 1.924305159661799e-09
SF O 1 0.6230404376983643
- O 0 6.032290912116878e-05
1 O 0 8.634458481537877e-09
. O 0 8.571117149358543e-10

Additionally O 0 1.7418612330288852e-08
, O 0 7.789840300587159e-11
the O 0 1.2386732264890732e-11
X O 0 0.00014532434579450637
- O 0 3.481888825263013e-06
linked O 0 2.2020572032488417e-06
, O 0 9.785334435102877e-13
candidate O 0 1.1004465567954202e-12
dosage O 0 2.588793845959003e-09
- O 0 7.027168846818199e-10
sensitive O 0 6.53702780795129e-09
sex O 0 3.758812150422841e-10
- O 0 5.540244374380165e-10
reversal O 0 5.829482035979439e-11
gene O 0 1.5631470076660214e-11
, O 0 2.1783284540315834e-13
Dax O 0 2.962148073493154e-07
- O 0 9.38200073186124e-10
1 O 0 1.6634115959646145e-12
, O 0 6.076973505571986e-14
antagonizes O 0 6.255543860689272e-10
synergy O 0 1.902479562776449e-11
between O 0 5.049469956747155e-12
SF O 0 0.0002035356155829504
- O 0 7.984868943822221e-07
1 O 0 1.860172016421302e-10
and O 0 7.480165098439073e-11
WT1 O 0 6.028101040556066e-08
, O 0 4.4722661988669254e-13
most O 0 8.843778675690899e-15
likely O 0 7.48658025764154e-13
through O 0 4.037562961105388e-15
a O 0 1.800136611768057e-14
direct O 0 4.770241801799148e-15
interaction O 0 1.2978478968611595e-12
with O 0 3.103246271063398e-10
SF O 0 0.08193666487932205
- O 0 2.0536050215014257e-05
1 O 0 4.544055354216425e-09
. O 0 6.511290395749825e-10

We O 0 2.7896528836945933e-11
propose O 0 1.5573758645540114e-12
that O 0 1.9379036407269484e-13
WT1 O 0 2.8576263133572866e-08
and O 0 1.7832209320278736e-10
Dax O 0 2.7221389245823957e-05
- O 0 8.221447700407225e-08
1 O 0 7.0394098536374905e-12
functionally O 0 1.629274770653666e-10
oppose O 0 2.411198953174154e-13
each O 0 2.6740584505263558e-14
other O 0 1.2996110535391098e-13
in O 0 7.894790507098626e-13
testis O 0 4.032897749084441e-08
development O 0 1.044685103940117e-13
by O 0 3.3800702037636854e-13
modulating O 0 4.006691867175505e-08
SF O 0 0.08236393332481384
- O 0 2.8541865049191983e-06
1 O 0 6.710297317802372e-10
- O 0 1.3611920479661421e-08
mediated O 0 2.137400088031427e-07
transactivation O 0 3.5534249036572874e-06
. O 0 1.2133744529962964e-11
. O 0 7.899299270253124e-12

A O 0 1.910957780903999e-10
mouse O 0 8.92079157210901e-08
model O 0 1.990303033494456e-09
for O 0 2.957799694058849e-08
Prader B-Disease 1 0.9999911785125732
- I-Disease 1 0.9999970197677612
Willi I-Disease 1 0.9999995231628418
syndrome I-Disease 1 0.999988317489624
imprinting O 0 0.2817763388156891
- O 0 0.0043271263130009174
centre O 0 4.86179715153412e-06
mutations O 0 3.974188075517304e-06
. O 0 3.1319329352186287e-09

Imprinting O 0 2.931310746134841e-06
in O 0 4.343098103376519e-11
the O 0 4.196550659057996e-12
15q11 O 0 2.658675946065614e-09
- O 0 6.159729082355625e-08
q13 O 0 4.628732064304586e-09
region O 0 5.381965272749367e-12
involves O 0 1.0707061593676764e-13
an O 0 3.6573476587748247e-14
imprinting O 0 2.345908569623134e-06
centre O 0 3.5402194953348953e-07
( O 0 5.992606042469484e-13
IC O 0 2.5949384863110936e-09
) O 0 9.046641474136363e-13
, O 0 2.4881645341637802e-14
mapping O 0 5.728870156040955e-10
in O 0 3.651313463821221e-13
part O 0 1.3770552081439347e-13
to O 0 2.1996141887081766e-12
the O 0 1.9693225999581343e-13
promoter O 0 1.98507876802978e-09
and O 0 4.8252456717745584e-12
first O 0 6.931023680337156e-13
exon O 0 2.2813018141221164e-09
of O 0 4.569986750135868e-11
SNRPN O 0 0.000441935466369614
. O 0 2.894532169506192e-09

Deletion O 0 1.210975028698158e-06
of O 0 4.671225645874744e-12
this O 0 1.2426961369660372e-11
IC O 0 1.227260497671523e-07
abolishes O 0 1.0857341692371847e-07
local O 0 2.3456655454806574e-12
paternally O 0 3.0720958221763794e-08
derived O 0 5.312568961135522e-13
gene O 0 5.457095539340706e-11
expression O 0 1.1486667172988518e-10
and O 0 1.9562002018247426e-10
results O 0 4.684920007491655e-09
in O 0 4.084248530489276e-07
Prader B-Disease 1 0.9999988079071045
- I-Disease 1 0.9999995231628418
Willi I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999979734420776
( O 0 2.1648173742505605e-07
PWS B-Disease 1 0.9999243021011353
) O 0 9.984749915759039e-09
. O 0 1.2011874828132818e-09

We O 0 6.4261622689798514e-09
have O 0 1.5901929295916717e-12
created O 0 1.1258421088846185e-13
two O 0 1.6436998246868728e-12
deletion O 0 6.630833215837129e-09
mutations O 0 7.011708991200294e-09
in O 0 5.186252816091752e-11
mice O 0 7.074357881720061e-07
to O 0 2.6812612130555635e-09
understand O 0 7.322836950152123e-07
PWS B-Disease 1 0.9999985694885254
and O 0 3.2667965554900036e-10
the O 0 6.091282263743364e-14
mechanism O 0 7.381207624279629e-12
of O 0 2.939714240806669e-14
this O 0 8.996396834957954e-13
IC O 0 9.292730140941785e-08
. O 0 2.2039420288777478e-10

Mice O 0 4.907837865175679e-05
harbouring O 0 1.936180160555523e-05
an O 0 2.269924526121514e-10
intragenic O 0 3.809525878750719e-05
deletion O 0 8.884180715540424e-06
in O 0 5.162696936622524e-10
Snrpn O 0 4.030578566016629e-06
are O 0 1.9637284853768477e-11
phenotypically O 0 6.657772666507356e-10
normal O 0 1.7724368847615857e-11
, O 0 2.4553685907396927e-12
suggesting O 0 2.0122772892428031e-10
that O 0 2.535525782387804e-11
mutations O 0 2.662588594048998e-09
of O 0 1.6536052041549176e-12
SNRPN O 0 1.3384329804466688e-06
are O 0 4.011336279959553e-14
not O 0 2.2896920091278888e-14
sufficient O 0 2.993501510583675e-14
to O 0 1.4419102196960853e-11
induce O 0 2.1124601801147946e-07
PWS B-Disease 1 0.999920129776001
. O 0 3.4845747620693146e-08

Mice O 0 6.194029538164614e-06
with O 0 1.325060373924547e-11
a O 0 3.2415194660406765e-12
larger O 0 2.195707591440277e-12
deletion O 0 3.996690978169681e-09
involving O 0 2.054573004783844e-11
both O 0 2.0391316673390447e-12
Snrpn O 0 3.602758624765556e-08
and O 0 3.44433249283016e-12
the O 0 2.9676432752173687e-12
putative O 0 2.7191757908440195e-05
PWS O 1 0.9999938011169434
- O 0 0.0007537194760516286
IC O 0 7.757663843221962e-05
lack O 0 1.5915115059161877e-10
expression O 0 1.4680423760307648e-12
of O 0 5.2108425064559434e-15
the O 0 7.07399742082282e-13
imprinted O 0 3.2085913517221343e-06
genes O 0 2.5921897517378056e-08
Zfp127 O 0 3.741813543456374e-07
( O 0 5.843644388910454e-14
mouse O 0 1.9590689070980716e-09
homologue O 0 1.6651958034685777e-08
of O 0 6.998163767230059e-12
ZNF127 O 0 1.573238660057541e-05
) O 0 3.354498970264963e-11
, O 0 4.746569890606844e-12
Ndn O 0 4.7773518474514276e-08
and O 0 4.64073474093496e-10
Ipw O 0 6.924619100345808e-08
, O 0 5.0475085916490414e-11
and O 0 1.8739527291034008e-11
manifest O 0 2.7148341352756233e-09
several O 0 7.064397352686547e-13
phenotypes O 0 6.467995472547727e-09
common O 0 2.32229768748482e-09
to O 0 1.0730497024269425e-06
PWS B-Disease 1 0.9999948740005493
infants O 0 0.0013078020419925451
. O 0 1.1574247116286074e-09

These O 0 3.0399217865184625e-11
data O 0 1.781657044119811e-10
demonstrate O 0 1.4428740147121033e-10
that O 0 2.994691951016537e-12
both O 0 1.1278968075267501e-13
the O 0 1.5548640933810143e-13
position O 0 5.849410400493582e-10
of O 0 1.9097260732969974e-14
the O 0 4.3060034704556216e-12
IC O 0 6.362537163795423e-08
and O 0 3.76698498782968e-11
its O 0 4.539437673412722e-13
role O 0 4.33613518355247e-12
in O 0 1.0360428437199403e-14
the O 0 1.2803918590252508e-14
coordinate O 0 3.810108045038119e-12
expression O 0 1.1408988987923752e-12
of O 0 7.390997739504211e-16
genes O 0 1.9274071921815406e-11
is O 0 2.9636538991135997e-13
conserved O 0 8.500936933553138e-12
between O 0 2.716307387351513e-11
mouse O 0 5.666071047016885e-06
and O 0 8.48173753453807e-10
human O 0 8.896548081560596e-11
, O 0 3.4464815983764607e-12
and O 0 9.851483344369694e-12
indicate O 0 1.582445112446873e-11
that O 0 5.973514326414187e-13
the O 0 5.16493477761143e-13
mouse O 0 6.111304742262291e-07
is O 0 9.590543420187614e-13
a O 0 6.842292845591486e-14
suitable O 0 4.5467296594381423e-11
model O 0 7.437985227731758e-10
system O 0 5.454957374695368e-09
in O 0 1.187712471775737e-12
which O 0 2.741299158157129e-12
to O 0 1.6210447087851125e-14
investigate O 0 1.9514569810346466e-13
the O 0 1.1971817139792406e-14
molecular O 0 2.322281039343621e-12
mechanisms O 0 2.385910479602016e-12
of O 0 1.3461919194668066e-14
imprinting O 0 2.986564311413531e-07
in O 0 1.7878960464901006e-11
this O 0 3.494665060804758e-12
region O 0 4.8218048477599584e-12
of O 0 8.276613037505945e-15
the O 0 9.275159850233305e-13
genome O 0 3.285273442177328e-10
. O 0 7.125594819051839e-12
. O 0 5.437188893564482e-11

Mutations O 0 1.7241680438928597e-07
of O 0 7.491708533917396e-13
the O 0 1.8218815399460159e-13
ATM O 0 1.8849787508656846e-08
gene O 0 3.3132276922032133e-09
detected O 0 3.5212823945585114e-07
in O 0 1.5534643016401617e-10
Japanese O 0 0.0002523021539673209
ataxia B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999977350234985
telangiectasia I-Disease 1 0.9999997615814209
patients O 0 6.579854380106553e-05
: O 0 6.346707881466074e-12
possible O 0 5.740382127972232e-12
preponderance O 0 1.4517137492120469e-09
of O 0 1.0366640407427977e-13
the O 0 2.8364264062497035e-12
two O 0 2.5870883560430435e-11
founder O 0 1.0755619506142011e-08
mutations O 0 1.5864236591056624e-09
4612del165 O 0 4.005442089116684e-10
and O 0 2.3264761644936627e-11
7883del5 O 0 1.7233018345663709e-09
. O 0 1.1482505918314345e-10

The O 0 1.966266732766897e-10
ATM O 0 5.686614167643711e-05
( O 0 3.695004835435611e-08
A O 1 0.9999840259552002
- O 1 0.9999924898147583
T O 1 0.9999995231628418
, O 0 2.838068946520167e-10
mutated O 0 1.1827001600295262e-09
) O 0 5.601181953147905e-13
gene O 0 2.093837603300841e-11
on O 0 1.678962857631916e-09
human O 0 1.735638743838308e-09
chromosome O 0 2.110386594722513e-05
11q22 O 0 1.8653226163678482e-07
. O 0 3.988669949883672e-10

3 O 0 7.879448844505532e-07
has O 0 2.3371672597249926e-08
recently O 0 3.5607157222727892e-09
been O 0 8.66577642977262e-12
identified O 0 1.520228929720313e-12
as O 0 3.078151272826839e-14
the O 0 3.74420580531807e-15
gene O 0 3.2926036029612415e-12
responsible O 0 2.4968668625724444e-12
for O 0 6.058649641824034e-15
the O 0 8.103424181671315e-12
human O 0 6.845132105581797e-08
recessive B-Disease 1 0.9998852014541626
disease I-Disease 1 0.9999871253967285
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.999997615814209
telangiectasia I-Disease 1 0.9999996423721313
( O 0 0.00034664763370528817
A B-Disease 1 0.9999982118606567
- I-Disease 1 0.9999940395355225
T I-Disease 1 0.9999972581863403
) O 0 2.423423417496906e-08
. O 0 2.1063359390005587e-10

In O 0 5.321698810789588e-12
order O 0 2.063656320480667e-12
to O 0 1.1905469557253745e-13
define O 0 5.8927190384194805e-12
the O 0 4.639046308554939e-13
types O 0 2.900167328512282e-10
of O 0 6.875715968801543e-11
disease O 0 1.6874606671990477e-06
- O 0 3.8942559399401944e-07
causing O 0 1.6516541023747777e-08
ATM O 0 3.30581286789311e-07
mutations O 0 1.6465964591816373e-08
in O 0 7.0010338672210626e-12
Japanese O 0 1.7722472875902895e-06
A B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999990463256836
T I-Disease 1 0.9999998807907104
patients O 0 2.164314061303685e-09
as O 0 2.0504213290358647e-13
well O 0 1.8514183580870848e-14
as O 0 7.101948169770155e-15
to O 0 3.2122196477182494e-14
look O 0 1.0003291055736552e-13
for O 0 6.678709205312349e-17
possible O 0 7.773116324867255e-14
mutational O 0 3.611177579188052e-09
hotspots O 0 9.137094636457732e-09
, O 0 4.0438585639790414e-12
reverse O 0 5.131552143211593e-07
- O 0 1.9482976654217055e-07
transcribed O 0 1.944644054674427e-06
RNA O 0 1.0129789416168933e-06
derived O 0 7.003972922470236e-12
from O 0 4.088034774520251e-14
ten O 0 4.212716059239646e-13
patients O 0 2.2161788666686354e-14
belonging O 0 2.35864095690251e-15
to O 0 2.372204368431951e-14
eight O 0 2.7477418127266895e-13
unrelated O 0 2.036951857187219e-11
Japanese O 0 4.199986136654843e-08
A B-Disease 1 0.9999927282333374
- I-Disease 1 0.9999966621398926
T I-Disease 1 0.9999998807907104
families O 0 9.86932313651323e-10
was O 0 5.62527968650528e-10
analyzed O 0 6.129834140278234e-11
for O 0 6.435488670826842e-15
mutations O 0 3.6363030642139194e-12
by O 0 2.026840363771108e-15
the O 0 4.6491923233070356e-15
restriction O 0 5.368705697020304e-13
endonuclease O 0 4.960317157021166e-10
fingerprinting O 0 3.4754180089358044e-10
method O 0 1.1076537603793568e-10
. O 0 8.281920288455424e-11

As O 0 6.277407926802425e-09
has O 0 1.2238513535933748e-09
been O 0 3.5674030396393164e-10
reported O 0 1.0182059362318086e-10
by O 0 1.3700497713316911e-13
others O 0 2.6715988362541188e-12
, O 0 2.937836538169196e-14
mutations O 0 3.192366293189308e-12
that O 0 6.291266986535593e-12
lead O 0 9.691690505686523e-11
to O 0 5.051750576016978e-13
exon O 0 1.3221124195439415e-10
skipping O 0 4.434960843013869e-08
or O 0 1.2978028651744467e-09
premature O 0 2.559267908708307e-09
protein O 0 1.7554131759300873e-11
truncation O 0 4.2459107341130675e-09
were O 0 7.557610093300582e-10
also O 0 2.014873545785889e-10
predominant O 0 1.7504999672013355e-09
in O 0 1.0236143530018005e-12
our O 0 7.709581861803372e-10
mutants O 0 1.187615623621241e-07
. O 0 7.76782180245128e-11

Six O 0 1.7626012871474472e-09
different O 0 2.1566008527595937e-12
mutations O 0 4.886069882026334e-10
were O 0 1.6093772148284557e-11
identified O 0 2.581045620286826e-11
on O 0 1.046176811847488e-09
12 O 0 2.44276682215272e-11
of O 0 1.9880632377974536e-14
the O 0 4.486827576144492e-12
16 O 0 2.274456664674851e-11
alleles O 0 1.3816192634408253e-10
examined O 0 5.501373223637529e-08
. O 0 7.304744586988932e-10

Four O 0 1.8751085406609747e-10
were O 0 2.8547713238485928e-12
deletions O 0 3.0662619665555724e-10
involving O 0 3.060226516637954e-10
a O 0 2.5171404960389054e-09
loss O 0 4.798264185978951e-08
of O 0 2.447934323169111e-15
a O 0 7.34575432165957e-13
single O 0 1.3276812808882266e-11
exon O 0 1.446826547457647e-09
exon O 0 3.304526074998648e-08
7 O 0 2.676938226642278e-09
, O 0 2.370840719925771e-12
exon O 0 2.8647781369350866e-10
16 O 0 2.2772793373260214e-10
, O 0 1.5056649503575326e-12
exon O 0 2.616209027195282e-09
33 O 0 2.595671233507346e-09
or O 0 6.311127731528643e-10
exon O 0 4.797266797140765e-07
35 O 0 2.5143330617538595e-07
. O 0 5.726188945232025e-08

The O 0 3.544571233748961e-11
others O 0 5.0673575578696894e-12
were O 0 4.536959526059599e-14
minute O 0 1.282876908002828e-12
deletions O 0 1.6600906413422045e-11
, O 0 4.0541739887087203e-13
4649delA O 0 2.7012894698863477e-10
in O 0 3.985596642758389e-14
exon O 0 7.187956896359537e-10
33 O 0 7.001241808524128e-10
and O 0 1.894531233281871e-11
7883del5 O 0 1.2076098454549822e-10
in O 0 1.5069742057959717e-13
exon O 0 2.1419008788825522e-08
55 O 0 2.322644476748792e-08
. O 0 4.129730335478143e-09

The O 0 7.176802208075372e-11
mutations O 0 3.747646637464186e-09
4612del165 O 0 9.24559362402988e-09
and O 0 1.5969756073097585e-10
7883del5 O 0 5.546387793486929e-10
were O 0 2.7420432244240622e-11
found O 0 7.048707104106988e-12
in O 0 7.21496682301023e-16
more O 0 2.541721675676929e-16
than O 0 9.68926388199233e-16
two O 0 5.6083843759423616e-14
unrelated O 0 5.413203219006846e-11
families O 0 8.217010405431324e-12
; O 0 1.2223884827532866e-13
44 O 0 2.3249136990588504e-12
% O 0 7.51845891859386e-14
( O 0 8.309609205966236e-15
7 O 0 3.951676139091198e-11
of O 0 6.597212468158198e-13
16 O 0 2.347444738592941e-10
) O 0 1.6977462187831027e-13
of O 0 1.9151189944293116e-16
the O 0 7.538019687614028e-13
mutant O 0 1.981731756472982e-08
alleles O 0 7.52398254810771e-10
had O 0 5.870876762514854e-08
one O 0 6.604014644168155e-12
of O 0 1.5328194087133517e-15
the O 0 3.876629648801727e-13
two O 0 1.854203318663039e-10
mutations O 0 4.7038600570203926e-08
. O 0 1.5271918174519783e-09

The O 0 4.4662207265844245e-10
4612del165 O 0 4.2905070607446305e-09
mutations O 0 7.633003562546037e-09
in O 0 7.632667284665495e-13
three O 0 4.702852148506798e-13
different O 0 6.823239347662768e-14
families O 0 3.2713200637940476e-12
were O 0 9.517034512893097e-13
all O 0 2.246496547543119e-15
ascribed O 0 1.714663025280394e-12
to O 0 2.4112957182180483e-13
the O 0 3.5456224544913595e-13
same O 0 8.095873277325083e-11
T O 0 3.447604512984981e-06
- O 0 1.185410880566451e-08
- O 0 1.5267060504697838e-08
> O 0 1.827791661513506e-13
A O 0 8.519395550078603e-15
substitution O 0 1.4347479435528228e-14
at O 0 1.7286782899236797e-12
the O 0 1.5411625773646882e-15
splice O 0 5.533132707569166e-08
donor O 0 3.2944896810604973e-11
site O 0 3.913305512970311e-10
in O 0 3.833848928429251e-13
intron O 0 1.323877222603187e-05
33 O 0 1.34227837733647e-08
. O 0 1.8232816645369354e-10

Microsatellite O 0 6.94565023877658e-05
genotyping O 0 9.114728527492844e-07
around O 0 9.195742084466829e-11
the O 0 6.465836438311612e-13
ATM O 0 3.700354909597081e-06
locus O 0 1.0911460776696913e-05
also O 0 5.295586191778057e-08
indicated O 0 3.827324679406274e-09
that O 0 5.362967014921338e-12
a O 0 4.579155197387275e-12
common O 0 1.74465580871086e-10
haplotype O 0 1.1644417099887505e-05
was O 0 1.2680257555075514e-07
shared O 0 4.115988452846331e-11
by O 0 1.813684226133032e-14
the O 0 6.943179890620335e-14
mutant O 0 4.059458991179099e-09
alleles O 0 2.390823650166851e-10
in O 0 1.6695875367997437e-12
both O 0 3.2168597646764496e-11
mutations O 0 6.717218070662057e-08
. O 0 4.825685628873089e-09

This O 0 6.279656239449594e-10
suggests O 0 2.2896572138275673e-10
that O 0 8.0422598918925e-13
these O 0 1.2464122344912204e-13
two O 0 1.1353660199497906e-11
founder O 0 4.3676774197365376e-08
mutations O 0 4.324101965380578e-08
may O 0 5.061788765914343e-10
be O 0 8.4884242647007e-13
predominant O 0 2.083110246797748e-11
among O 0 2.60893703288214e-14
Japanese O 0 8.294736425495941e-12
ATM O 0 6.775392336066943e-08
mutant O 0 2.564748058375699e-07
alleles O 0 1.2606845345430884e-08
. O 0 9.702817216350468e-09

W474C O 0 4.728489244598677e-08
amino O 0 3.2634290825228618e-09
acid O 0 3.9120422179461656e-11
substitution O 0 8.973603652685791e-13
affects O 0 1.394391438251652e-12
early O 0 1.5349910741351697e-14
processing O 0 1.556715775166348e-13
of O 0 1.1007003890645481e-16
the O 0 1.5473775757360482e-15
alpha O 0 5.4916457869320055e-15
- O 0 1.0965493920864211e-12
subunit O 0 5.617805754008082e-14
of O 0 1.0875294873089088e-14
beta O 0 4.311287438163447e-12
- O 0 2.05145909148996e-08
hexosaminidase O 0 3.5051129998464603e-07
A O 0 1.8600125606393902e-10
and O 0 1.0025382433942465e-11
is O 0 6.18247803212818e-13
associated O 0 2.1230526017768092e-12
with O 0 2.6899255392565102e-11
subacute O 0 3.684438297568704e-06
G B-Disease 0 0.0007728013442829251
( I-Disease 0 7.234673797540392e-12
M2 I-Disease 0 1.0561159797362052e-05
) I-Disease 0 8.794384775967501e-09
gangliosidosis I-Disease 0 8.877608706825413e-06
. O 0 5.61968194201512e-10

Mutations O 0 3.78413773205466e-07
in O 0 2.9156291964094194e-11
the O 0 6.31573352644077e-12
HEXA O 0 5.938404257221919e-08
gene O 0 8.001339868446422e-11
, O 0 4.4473061707904146e-14
encoding O 0 1.658785142664293e-13
the O 0 4.67579398593862e-14
alpha O 0 1.2565714798979527e-13
- O 0 6.919469771465847e-12
subunit O 0 2.621038694243516e-13
of O 0 2.727529031625042e-13
beta O 0 1.0231040320496376e-10
- O 0 1.7553406905790325e-06
hexosaminidase O 0 7.528276910306886e-06
A O 0 3.127646586165156e-09
( O 0 7.760168918048704e-14
Hex O 0 2.0967341640698578e-08
A O 0 4.329187355822661e-11
) O 0 2.5465393682644333e-13
, O 0 1.0876367852075022e-15
that O 0 2.075103242314474e-15
abolish O 0 1.536967168119796e-12
Hex O 0 1.00563790628172e-09
A O 0 2.058964706629779e-13
enzyme O 0 2.993855441335569e-10
activity O 0 1.6405772740313296e-08
cause O 0 0.0004505495890043676
Tay B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999990463256836
Sachs I-Disease 1 0.9999996423721313
disease I-Disease 1 0.983029305934906
( O 0 9.23849278328115e-12
TSD B-Disease 0 2.439907405005215e-07
) O 0 1.1354439957700357e-11
, O 0 3.948824232012649e-13
the O 0 5.947066450406879e-11
fatal O 0 0.03079465590417385
infantile B-Disease 0 0.024693157523870468
form I-Disease 0 2.7334614571827842e-09
of I-Disease 0 3.746429833029197e-10
G I-Disease 0 0.0968523696064949
( I-Disease 0 7.2079941841607376e-12
M2 I-Disease 0 5.047596914664609e-06
) I-Disease 0 3.2971081420640758e-09
gangliosidosis I-Disease 0 1.2932218851346988e-06
, I-Disease 0 1.2042620589972075e-12
Type I-Disease 0 1.3361255678245865e-11
1 I-Disease 0 4.6191498542791365e-11
. O 0 7.587406813946984e-10

Less O 0 3.611330967601134e-08
severe O 0 3.0207656891434453e-06
, O 0 1.5974570277688116e-10
subacute O 0 1.696394247119315e-05
( O 0 1.7295112564319481e-10
juvenile O 0 0.0007942098309285939
- O 1 0.5113427042961121
onset O 0 0.05553088337182999
) O 0 3.6053782537237566e-07
and O 0 2.483046228007879e-05
chronic O 0 0.22954806685447693
( O 0 1.1206387380557903e-12
adult O 0 8.552149921570162e-08
- O 0 0.00144521938636899
onset O 0 1.3964197933091782e-05
) O 0 7.504372817601634e-11
variants O 0 2.50947401747581e-10
are O 0 5.115612360800936e-12
characterized O 0 4.231628936146592e-11
by O 0 4.3562663919931646e-14
a O 0 3.3290781156075644e-12
broad O 0 2.217873627807787e-11
spectrum O 0 2.116571451438176e-08
of O 0 5.272415316837087e-12
clinical O 0 5.4128159732158565e-09
manifestations O 0 2.2095001384059287e-08
and O 0 7.624705311570779e-10
are O 0 9.702631493385683e-13
associated O 0 1.8846237070935246e-11
with O 0 2.6804709493677414e-11
residual O 0 1.7150631492768298e-07
levels O 0 6.043315292636464e-10
of O 0 3.3230606851300526e-14
Hex O 0 3.7179523815211724e-07
A O 0 1.9979689777627208e-11
enzyme O 0 1.5427546740109932e-10
activity O 0 1.2930803650057499e-10
. O 0 4.936774947172928e-11

We O 0 2.526580160366887e-11
identified O 0 4.920565691013401e-12
a O 0 6.201670036884432e-13
1422 O 0 5.969679506279135e-08
G O 0 8.402077583014034e-06
- O 0 1.3376801462072763e-06
- O 0 1.725235597405117e-05
> O 0 3.5368759032650132e-09
C O 0 4.160209243764257e-08
( O 0 1.0462500142508283e-14
amino O 0 1.1459651587039654e-12
acid O 0 1.1162868589556507e-12
W474C O 0 2.2247264794272859e-13
) O 0 2.3404097373831635e-16
substitution O 0 1.0534781699062228e-15
in O 0 1.1334424211708835e-15
the O 0 3.839523693422017e-15
first O 0 1.1958496530257295e-13
position O 0 1.4077993978900416e-11
of O 0 5.233589470375339e-16
exon O 0 1.6138998470971444e-10
13 O 0 3.834306136485388e-11
of O 0 4.0674885334879285e-13
HEXA O 0 8.67313428898342e-06
of O 0 3.394477624332759e-13
a O 0 2.2576650618444383e-11
non O 0 2.7542615757547573e-11
- O 0 1.0656276572262868e-06
Jewish O 0 1.2933625157529605e-06
proband O 0 0.0007776871789246798
who O 0 5.0672590568012765e-09
manifested O 0 5.689027582356232e-10
a O 0 1.630553873345486e-12
subacute O 0 3.612681354070446e-08
variant O 0 1.5802854136381939e-07
of O 0 2.0986417048618478e-09
G B-Disease 0 0.20996259152889252
( I-Disease 0 2.0525206534394158e-11
M2 I-Disease 0 1.9285507733002305e-05
) I-Disease 0 1.0668276040348701e-08
gangliosidosis I-Disease 0 2.22624385060044e-05
. O 0 1.929807647016446e-09

On O 0 8.695691278148843e-09
the O 0 1.4361881128799325e-10
second O 0 5.4053494125128054e-08
maternally O 0 9.214832243742421e-05
inherited O 0 2.7937636332353577e-05
allele O 0 1.345152043086273e-07
, O 0 6.640644631406012e-12
we O 0 1.821875549729013e-12
identified O 0 1.7224522155800948e-11
the O 0 2.6681016770946364e-11
common O 0 1.2248425207417313e-07
infantile O 1 0.9860255122184753
disease O 0 0.3294757306575775
- O 0 5.856841744389385e-05
causing O 0 4.163816356594907e-06
4 O 0 1.3137047005784552e-09
- O 0 7.698685777768333e-08
bp O 0 2.7619410758461527e-08
insertion O 0 6.642881245078058e-10
, O 0 6.117823261875266e-12
+ O 0 3.896249989310263e-10
TATC O 0 3.35573332677086e-07
1278 O 0 1.0079488532710457e-07
, O 0 6.533549200792022e-13
in O 0 1.1245709157186971e-14
exon O 0 1.6987378170796319e-09
11 O 0 6.992370682468163e-09
. O 0 8.69454286345217e-10

Pulse O 0 0.0007164077833294868
- O 0 8.095203725133615e-07
chase O 0 2.015990929749023e-07
analysis O 0 2.1508990335344924e-12
using O 0 4.39725079265374e-12
proband O 0 1.7800309137783188e-07
fibroblasts O 0 2.2658726006596908e-09
revealed O 0 4.360036598427541e-08
that O 0 3.1568777539986437e-12
the O 0 4.931534577944964e-14
W474C O 0 2.543338456506561e-11
- O 0 2.878518950977238e-11
containing O 0 1.2985338715756911e-12
alpha O 0 3.921868255499228e-14
- O 0 8.326783815411354e-13
subunit O 0 1.3302343269603039e-14
precursor O 0 2.354024527390086e-12
was O 0 1.4295942207809276e-09
normally O 0 2.8346129696960043e-13
synthesized O 0 5.611686029055596e-12
, O 0 4.206049842182119e-14
but O 0 6.410696355273887e-14
not O 0 1.1043943368052155e-14
phosphorylated O 0 4.0214314517283967e-11
or O 0 3.547939719794613e-11
secreted O 0 1.068024690908942e-08
, O 0 1.3394067972793966e-11
and O 0 2.114284615439832e-11
the O 0 1.1443014938383733e-11
mature O 0 2.943243704311982e-10
lysosomal O 0 2.0974301406795348e-08
alpha O 0 2.915014421251555e-13
- O 0 1.2068800125941692e-10
subunit O 0 7.010107338362159e-12
was O 0 2.7166743521434e-08
not O 0 3.163793185767538e-11
detected O 0 6.294084808899925e-09
. O 0 3.975725304528055e-11

When O 0 3.334027054435751e-09
the O 0 1.6170382090632818e-12
W474C O 0 7.679066410526403e-11
- O 0 2.5155925953423974e-11
containing O 0 9.420969863602191e-13
alpha O 0 8.228372817093918e-14
- O 0 6.756215812503408e-12
subunit O 0 1.7419042553853958e-12
was O 0 2.9975669946225025e-08
transiently O 0 3.529788017431201e-08
co O 0 6.531021057298858e-09
- O 0 1.6059384932987086e-09
expressed O 0 1.0932624163600968e-12
with O 0 5.973963711274023e-15
the O 0 1.3012442008240518e-15
beta O 0 4.293538858864479e-15
- O 0 1.172728770646933e-13
subunit O 0 3.897206213613561e-15
to O 0 1.572688377096676e-13
produce O 0 2.4896754037724567e-13
Hex O 0 2.3744840760286934e-08
A O 0 1.6079421127912497e-10
( O 0 5.5578449692983076e-14
alphabeta O 0 1.2177024721893304e-08
) O 0 1.2149647607428982e-12
in O 0 2.785380704296153e-13
COS O 0 1.340759467893804e-06
- O 0 2.346945926490207e-08
7 O 0 1.2675452354393713e-10
cells O 0 1.1340030997564199e-10
, O 0 4.793629821428849e-14
the O 0 6.53603529331419e-15
mature O 0 5.036594784898346e-14
alpha O 0 2.452140265268702e-15
- O 0 5.492376952548339e-12
subunit O 0 3.5868972180462533e-13
was O 0 8.635939963141936e-09
present O 0 5.679562248566035e-14
, O 0 3.728299373601581e-15
but O 0 6.52034985249364e-14
its O 0 1.0796494042753305e-13
level O 0 2.162293131005577e-12
was O 0 3.9903211290770457e-10
much O 0 1.2899279084113702e-13
lower O 0 7.595388077166754e-13
than O 0 7.264045288402684e-15
that O 0 5.895028795622689e-14
from O 0 7.1741292470407325e-16
normal O 0 4.987360910135895e-15
alpha O 0 2.2416085321627513e-15
- O 0 1.509702302407434e-12
subunit O 0 5.159529487680503e-13
transfections O 0 8.906437365396869e-09
, O 0 1.6064369479833543e-14
although O 0 6.6340264173996716e-15
higher O 0 6.954442040687028e-15
than O 0 6.702858114638569e-16
in O 0 2.5344907142248966e-15
those O 0 1.7478473366989294e-13
cells O 0 7.702782856000567e-12
transfected O 0 2.0472015194172855e-09
with O 0 1.1685755986999558e-13
an O 0 2.0587830350032518e-14
alpha O 0 1.5532553541974803e-12
- O 0 6.528302343156156e-10
subunit O 0 8.636343029611027e-11
associated O 0 7.972525750687964e-09
with O 0 9.839175030279534e-10
infantile O 0 0.008489239029586315
TSD B-Disease 0 0.0003400926070753485
. O 0 5.641023648195187e-09

Furthermore O 0 3.1093520647118567e-08
, O 0 4.440699544194793e-12
the O 0 1.2804358200352133e-14
precursor O 0 1.880532838824389e-12
level O 0 3.531034839521219e-11
of O 0 1.4148384129517868e-15
the O 0 2.455211564383799e-14
W474C O 0 1.0113840103950777e-12
alpha O 0 7.581094802757652e-15
- O 0 1.0062714550507224e-12
subunit O 0 1.6826524982388458e-13
was O 0 5.286460602604848e-09
found O 0 2.5401195036245383e-11
to O 0 1.5256231607890802e-12
accumulate O 0 1.4823465788182943e-09
in O 0 1.1938252612224507e-14
comparison O 0 7.691441342334848e-14
to O 0 6.493801807047617e-14
the O 0 2.5283599744559647e-14
normal O 0 2.621623621315572e-13
alpha O 0 2.7601737491748587e-14
- O 0 4.355273953982053e-12
subunit O 0 1.2306300455674352e-13
precursor O 0 1.3073468523028264e-11
levels O 0 9.487338692437675e-11
. O 0 4.211078968169302e-12

We O 0 1.1294226665015117e-10
conclude O 0 8.798230373419091e-12
that O 0 7.420328457588554e-14
the O 0 1.131236285743277e-13
1422 O 0 1.0825864649177674e-08
G O 0 1.6240629747699131e-06
- O 0 2.8208785352035193e-07
- O 0 1.5002454347268213e-05
> O 0 3.232281775567003e-09
C O 0 4.08130809148588e-08
mutation O 0 5.365908828380839e-10
is O 0 7.447006553085167e-12
the O 0 4.903380761318854e-13
cause O 0 3.690540581469115e-11
of O 0 2.13971398379479e-14
Hex B-Disease 0 0.0004554367915261537
A I-Disease 0 1.9765316210396122e-06
enzyme I-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999996423721313
in O 0 5.44729669357813e-12
the O 0 6.890420178873313e-11
proband O 0 3.0257648177212104e-05
. O 0 1.1561781532165583e-09

The O 0 2.5890381852300415e-11
resulting O 0 1.6516234560559617e-11
W474C O 0 3.9913846533456976e-11
substitution O 0 7.01624695842451e-12
clearly O 0 2.258794817855403e-10
interferes O 0 2.3738611076851157e-10
with O 0 1.6016947493248564e-14
alpha O 0 1.094529791101492e-14
- O 0 1.794535928276858e-13
subunit O 0 3.2716041112107117e-14
processing O 0 1.2947753112724225e-11
, O 0 3.9962994122667156e-14
but O 0 1.0526633242109642e-14
because O 0 2.7467473240488124e-16
the O 0 6.397152806667059e-17
base O 0 9.727710919226439e-15
substitution O 0 3.735972035207036e-12
falls O 0 1.1669019528426361e-07
at O 0 1.3150395702932194e-11
the O 0 4.504186466077614e-14
first O 0 1.0418858701136124e-12
position O 0 1.613595229654763e-10
of O 0 5.160734578395221e-15
exon O 0 8.573827064983774e-11
13 O 0 3.07506312080541e-11
, O 0 6.91806366966835e-14
aberrant O 0 6.1154234454186e-11
splicing O 0 3.5727929059703456e-08
may O 0 1.461019194515245e-09
also O 0 1.3333550843291908e-12
contribute O 0 1.3797835520890176e-14
to O 0 5.7350443838366516e-11
Hex B-Disease 0 0.05162620171904564
A I-Disease 0 4.7047851694514975e-05
deficiency I-Disease 0 0.05360911041498184
in O 0 9.564931312266989e-13
this O 0 2.3541682925981577e-12
proband O 0 1.1259312771016994e-07
. O 0 4.154198686434629e-12
. O 0 5.016641269062205e-11

Two O 0 1.6467212038406842e-09
frequent O 0 1.8046786465220066e-07
missense O 0 6.0029324231436476e-05
mutations O 0 0.0012573411222547293
in O 0 0.00024372477491851896
Pendred B-Disease 1 0.9999903440475464
syndrome I-Disease 1 0.9999966621398926
. O 0 5.110949587106006e-06

Pendred B-Disease 1 0.999966025352478
syndrome I-Disease 1 0.9999979734420776
is O 0 0.0001638388930587098
an O 0 0.002320880303159356
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.3951354920864105
by O 0 5.423750337740785e-09
early O 0 4.7271551011363044e-06
childhood O 1 0.9990405440330505
deafness B-Disease 1 0.999998927116394
and O 1 0.6460925340652466
goiter B-Disease 1 0.9999740123748779
. O 0 2.6954460281558568e-06

A O 0 3.23571169857928e-09
century O 0 1.1995567039679855e-10
after O 0 2.2836199944920033e-11
its O 0 1.790924992941395e-13
recognition O 0 5.632884024671381e-13
as O 0 4.373039430571879e-11
a O 0 1.9624543767804425e-08
syndrome O 0 0.027667339891195297
by O 0 3.69173528552702e-12
Vaughan O 0 1.3638160112350306e-07
Pendred O 0 1.5269878304025042e-06
, O 0 9.820509856706128e-12
the O 0 1.3889161522284699e-11
disease O 0 4.121343977203651e-08
gene O 0 3.713125806825701e-08
( O 0 1.6269013913827735e-11
PDS O 0 1.791232307368773e-06
) O 0 1.1119502887901866e-11
was O 0 7.94215138100185e-10
mapped O 0 8.676195761836425e-08
to O 0 8.6384405184603e-10
chromosome O 0 4.603770139510743e-05
7q22 O 0 4.3556732975957857e-07
- O 0 8.243481715908274e-06
q31 O 0 1.2969964018338942e-06
. O 0 1.7290568976591203e-09

1 O 0 2.242737018320895e-08
and O 0 4.591476088222635e-09
, O 0 1.1408841753268728e-11
recently O 0 4.259861074995541e-10
, O 0 1.1787521913414478e-13
found O 0 3.384261526074607e-14
to O 0 1.6451338599369038e-15
encode O 0 7.194547475136703e-12
a O 0 2.79457750343437e-12
putative O 0 1.591483425045226e-07
sulfate O 0 9.529533144814195e-07
transporter O 0 6.975273572606966e-05
. O 0 5.882542453150563e-09

We O 0 4.567273226285806e-09
performed O 0 2.1165046104609786e-10
mutation O 0 3.3641357061187094e-11
analysis O 0 2.7507425590794776e-12
of O 0 4.2541850305086865e-14
the O 0 9.487586931367087e-12
PDS B-Disease 0 9.318071647612669e-07
gene O 0 6.0324816253398694e-09
in O 0 1.2455983293413464e-11
patients O 0 6.405425495570327e-11
from O 0 1.1620484305710499e-12
14 O 0 7.02701785648685e-11
Pendred B-Disease 0 3.799995624831354e-07
families O 0 6.9110546278838836e-12
originating O 0 8.328027503723412e-12
from O 0 4.762591688210749e-13
seven O 0 1.460733617397736e-11
countries O 0 1.6776021489941367e-13
and O 0 3.1180863013097193e-13
identified O 0 2.8385802822855632e-12
all O 0 4.457939144783887e-14
mutations O 0 1.3868951542761465e-09
. O 0 1.7397611129510437e-10

The O 0 1.1030155955271681e-10
mutations O 0 1.3519386721227988e-09
include O 0 7.66204374252899e-13
three O 0 1.0988692594748883e-12
single O 0 7.58403201350788e-11
base O 0 7.941723667581613e-11
deletions O 0 6.572584254627145e-09
, O 0 2.242741149044436e-12
one O 0 3.6828651022932646e-13
splice O 0 4.8172782953770366e-06
site O 0 3.928161618205195e-07
mutation O 0 6.02961875983965e-08
and O 0 1.9994235156417517e-09
10 O 0 9.978000370391982e-11
missense O 0 1.7564246945767081e-07
mutations O 0 6.689211886623525e-07
. O 0 1.4053199492991553e-08

One O 0 1.4815983107041575e-08
missense O 0 3.952937277063029e-06
mutation O 0 7.617297796969069e-07
( O 0 4.0215486496464337e-10
L236P O 0 1.0863883126432938e-08
) O 0 2.666439291587608e-10
was O 0 1.3897397899143016e-08
found O 0 3.553088379071312e-10
in O 0 3.65752180874878e-14
a O 0 5.63390425891569e-13
homozygous O 0 5.395929258966703e-10
state O 0 3.1599258799863694e-12
in O 0 1.2271025937992536e-13
two O 0 3.551040364535574e-11
consanguineous O 0 1.5872635117375467e-07
families O 0 3.0916669224723137e-10
and O 0 2.270689886119115e-11
in O 0 1.1460105054598296e-13
a O 0 6.5420819803097e-12
heterozygous O 0 3.945532789373374e-10
state O 0 4.284135979998327e-13
in O 0 9.980873820567698e-15
five O 0 9.13768098188307e-14
additional O 0 2.312100096340912e-14
non O 0 3.1195646760240336e-11
- O 0 1.2788211734005017e-06
consanguineous O 0 7.4123404374404345e-06
families O 0 1.917907610504699e-09
. O 0 8.532943102101953e-11

Another O 0 4.807449549559806e-09
missense O 0 2.230546215287177e-06
mutation O 0 9.30693488498946e-07
( O 0 1.4780741908193562e-10
T416P O 0 3.052063135555727e-08
) O 0 1.8496715270543973e-10
was O 0 2.2174710068156855e-08
found O 0 1.3271805876513554e-10
in O 0 1.1265890564188252e-14
a O 0 1.0325619482706716e-12
homozygous O 0 8.568321607782536e-10
state O 0 3.0263883846887163e-12
in O 0 5.499449637000331e-13
one O 0 2.6955920828797275e-10
family O 0 1.1479801997893446e-08
and O 0 1.3530136733219678e-10
in O 0 9.315613466167813e-14
a O 0 4.9496986370689555e-12
heterozygous O 0 3.9900166504125423e-10
state O 0 8.102229824558105e-13
in O 0 7.754783143756883e-14
four O 0 2.3872955695614095e-11
families O 0 1.0095266636533928e-11
. O 0 4.25328279540782e-11

Pendred B-Disease 0 0.0008795789326541126
patients O 0 6.789687034824965e-08
in O 0 2.560733959947048e-12
three O 0 2.1258009241797993e-11
non O 0 3.660802494476201e-10
- O 0 2.9892707971157506e-06
consanguineous O 0 2.67900895778439e-06
families O 0 3.882510979380527e-10
were O 0 1.3417874450416534e-11
shown O 0 5.377706526615844e-12
to O 0 1.472766678577153e-14
be O 0 1.956070396803844e-13
compound O 0 8.194973345754253e-12
heterozygotes O 0 1.3350905667466884e-12
for O 0 7.0480243582820516e-15
L236P O 0 3.899149614294828e-10
and O 0 2.712191755904758e-11
T416P O 0 3.0832474351427663e-09
. O 0 5.871136909973984e-11

In O 0 1.1794196175252125e-10
total O 0 1.9996540881472846e-11
, O 0 1.5123633248514956e-11
one O 0 2.452163992694434e-11
or O 0 9.611172274714974e-11
both O 0 3.817272886674772e-12
of O 0 3.9671591071889153e-14
these O 0 2.644304046561796e-12
mutations O 0 2.1413512629742115e-10
were O 0 4.7762328814204835e-11
found O 0 3.9875289181701135e-10
in O 0 3.3146432105134183e-13
nine O 0 3.715578886231974e-11
of O 0 2.91622533955295e-14
the O 0 1.909077063100284e-11
14 O 0 7.490959241795991e-11
families O 0 8.547643929462945e-13
analyzed O 0 5.451043505466657e-10
. O 0 1.5586731905159468e-10

The O 0 3.690102043374388e-12
identification O 0 9.674251850999571e-12
of O 0 5.509999127426522e-14
two O 0 5.7766964822736355e-11
frequent O 0 1.004170258056547e-08
PDS B-Disease 0 4.602711214829469e-06
mutations O 0 1.3886447547406533e-09
will O 0 1.9769473872614102e-13
facilitate O 0 1.2437946146930026e-14
the O 0 2.462347166443113e-12
molecular O 0 5.825978064422088e-07
diagnosis O 0 0.0005876538925804198
of O 0 1.8084965631715022e-06
Pendred B-Disease 1 0.9999969005584717
syndrome I-Disease 1 0.9999974966049194
. O 0 4.549434606815339e-07

Insertional O 0 3.888191258738516e-06
mutation O 0 2.1203847566653167e-09
by O 0 3.0353835764329595e-12
transposable O 0 2.1134398675570765e-09
element O 0 8.869494583230164e-10
, O 0 2.2648549702353193e-11
L1 O 0 7.184101559687406e-05
, O 0 5.681474388175012e-12
in O 0 1.164508349775148e-13
the O 0 9.160835284793833e-11
DMD B-Disease 1 0.9999924898147583
gene O 0 5.055339258319691e-08
results O 0 8.12942868577693e-09
in O 0 1.1002887490008106e-09
X B-Disease 1 0.9999055862426758
- I-Disease 1 0.9999746084213257
linked I-Disease 1 0.9999885559082031
dilated I-Disease 1 0.999963641166687
cardiomyopathy I-Disease 1 0.9999933242797852
. O 0 2.411707100691274e-07

X B-Disease 1 0.9992004036903381
- I-Disease 1 0.9997621178627014
linked I-Disease 1 0.9999526739120483
dilated I-Disease 1 0.999982476234436
cardiomyopathy I-Disease 1 0.9999988079071045
( O 0 2.98406746424007e-07
XLDCM B-Disease 0 0.0008830307051539421
) O 0 1.1631449275961714e-10
is O 0 1.5801278471436198e-12
a O 0 5.619887693229797e-13
clinical O 0 3.0244642901244845e-10
phenotype O 0 3.077197519019137e-08
of O 0 1.2558874946944076e-11
dystrophinopathy B-Disease 0 0.001483761239796877
which O 0 8.7025107120553e-09
is O 0 2.3130565171558537e-11
characterized O 0 1.0535693151236813e-10
by O 0 1.5520027754276078e-12
preferential O 0 3.770395995417175e-09
myocardial B-Disease 0 0.02439211867749691
involvement I-Disease 0 2.847015956319865e-09
without O 0 3.495251397339638e-12
any O 0 4.628543777635344e-14
overt O 0 3.354424238377618e-10
clinical O 0 1.5773066408542036e-08
signs O 0 1.2142564287387358e-07
of O 0 7.652507960642652e-09
skeletal B-Disease 1 0.9999940395355225
myopathy I-Disease 1 0.9999982118606567
. O 0 1.1548732800292782e-05

To O 0 2.2681058420293e-11
date O 0 2.6116097132100613e-11
, O 0 1.4910995208743463e-14
several O 0 6.647427325658182e-15
mutations O 0 1.4617433652386325e-10
in O 0 1.3346507926614848e-11
the O 0 4.51317816896335e-07
Duchenne B-Disease 1 0.9998986721038818
muscular I-Disease 0 0.005788492504507303
dystrophy I-Disease 0 8.502876880811527e-06
gene O 0 6.185159122651385e-07
, O 0 1.4623951472003682e-07
DMD O 1 0.9999988079071045
, O 0 3.8186895312541935e-10
have O 0 3.326236508449654e-11
been O 0 1.1886971962304926e-10
identified O 0 5.218613874369282e-10
in O 0 5.211148786793407e-12
patients O 0 6.714032801946601e-11
with O 0 2.961374201415623e-11
XLDCM B-Disease 0 1.266471554117743e-05
, O 0 1.8058538605453256e-12
but O 0 4.5091998169231873e-13
a O 0 3.017589772350872e-14
pathogenic O 0 7.844675430079828e-12
correlation O 0 1.4876048309853118e-11
of O 0 2.2637199460859986e-14
these O 0 1.0492492291680477e-11
cardiospecific O 0 2.405973305030784e-07
mutations O 0 1.3070197368847403e-08
in O 0 6.838601906977715e-10
DMD O 1 0.9999979734420776
with O 0 4.482298976427046e-10
the O 0 6.302718902340132e-10
XLDCM B-Disease 0 0.3664277195930481
phenotype O 0 7.483238005079329e-05
has O 0 1.0221106094832066e-07
remained O 0 7.622964481868166e-09
to O 0 8.287583943764054e-13
be O 0 2.2482328498885096e-11
elucidated O 0 5.972094072603795e-07
. O 0 5.118047652352686e-10

We O 0 3.157335726200472e-08
report O 0 6.445747408045932e-11
here O 0 2.9897240824521e-14
the O 0 1.1065101748148755e-16
identification O 0 8.890224033287694e-14
of O 0 8.675565026267128e-16
a O 0 2.351196223392832e-13
unique O 0 1.4790682784440734e-12
de O 0 3.6811501069600183e-10
novo O 0 3.67533603551351e-09
L1 O 0 1.0864080195460701e-06
insertion O 0 2.8886608383071888e-11
in O 0 7.843290632855021e-14
the O 0 2.750342542687939e-13
muscle O 0 5.0681143309860843e-11
exon O 0 2.4068410459099354e-11
1 O 0 7.809864560615054e-11
in O 0 4.724814983703141e-10
DMD O 1 0.9999988079071045
in O 0 1.0228991265126552e-10
three O 0 1.0091003588286185e-09
XLDCM B-Disease 0 0.0015611685812473297
patients O 0 1.4919644686361977e-10
from O 0 2.9426988460996145e-14
two O 0 8.571872053310392e-13
unrelated O 0 4.634834183114833e-10
Japanese O 0 1.1021475954109405e-09
families O 0 8.476035845417229e-12
. O 0 9.972192342722064e-12

The O 0 1.842403139773463e-11
insertion O 0 7.889459086030115e-10
was O 0 6.472389291189984e-09
a O 0 2.8357611397966664e-12
5 O 0 9.65517249484904e-12
- O 0 8.400756534854281e-09
truncated O 0 1.2955727157759611e-08
form O 0 7.085965494924018e-12
of O 0 5.667150166570149e-14
human O 0 4.620160590912414e-12
L1 O 0 1.2655722514409717e-07
inversely O 0 1.5614642911998544e-10
integrated O 0 1.504689428610817e-11
in O 0 5.093032657936536e-13
the O 0 3.4443589473631686e-12
5 O 0 1.605113819636017e-10
- O 0 7.544740014964191e-07
untranslated O 0 0.02861708216369152
region O 0 1.4739619524917202e-09
in O 0 1.6932456955651154e-12
the O 0 2.006951245817068e-12
muscle O 0 2.1637887315240079e-10
exon O 0 9.474878520654428e-11
1 O 0 6.050612788577325e-11
, O 0 4.543918193100627e-12
which O 0 1.257860395703636e-11
affected O 0 1.1516874896789174e-14
the O 0 1.320370797696117e-14
transcription O 0 3.5531173558922546e-09
or O 0 4.996533187195951e-10
the O 0 8.8415018362209e-11
stability O 0 4.423361943395321e-08
of O 0 2.621043573153292e-13
the O 0 5.598520536054252e-10
muscle O 0 2.138296473219725e-08
form O 0 5.933913706538882e-14
of O 0 7.92726954500396e-15
dystrophin O 0 6.647352113198224e-11
transcripts O 0 4.311129675471648e-09
but O 0 1.4012868990165295e-11
not O 0 4.170694551438453e-13
that O 0 3.2737839674411295e-13
of O 0 1.12640863840106e-14
the O 0 2.278257027477082e-10
brain O 0 0.0001862415374489501
or O 0 2.2348574102437624e-09
Purkinje O 0 2.0783347281394526e-05
cell O 0 0.0001456981262890622
form O 0 1.7568552168611973e-09
, O 0 8.53154824564939e-10
probably O 0 2.1466737720743367e-08
due O 0 3.1671196915050714e-11
to O 0 6.996224888485003e-13
its O 0 9.212849667178391e-13
unique O 0 2.0437640566462606e-13
site O 0 4.128389574642455e-10
of O 0 8.260719311283665e-14
integration O 0 2.5227339661704207e-10
. O 0 4.356325022936147e-10

We O 0 7.975209381783088e-11
speculate O 0 4.2777448250319594e-12
that O 0 1.9399366892069482e-14
this O 0 7.6733184530355e-17
insertion O 0 2.524968352891205e-13
of O 0 2.4793232466119872e-15
an O 0 2.0365847409106047e-13
L1 O 0 0.0004026391252409667
sequence O 0 2.45451730052082e-07
in O 0 1.323196414659833e-07
DMD O 1 0.9999996423721313
is O 0 1.1581174907959735e-10
responsible O 0 7.200652834410404e-13
for O 0 2.217674557446897e-15
some O 0 9.947987978148787e-16
of O 0 1.0660751380186704e-15
the O 0 2.4560947893548235e-12
population O 0 7.958603665415148e-14
of O 0 1.193115024096178e-14
Japanese O 0 2.767487128352286e-09
patients O 0 6.437631460895488e-13
with O 0 2.210691753355004e-13
XLDCM B-Disease 0 2.454746663715923e-07
. O 0 2.1316058727155474e-12
. O 0 1.8167476203978516e-11

Severe O 0 1.7056112483260222e-05
early O 0 2.7384254863704882e-08
- O 0 0.27514293789863586
onset O 1 0.9991284012794495
obesity B-Disease 1 0.9999980926513672
, O 0 0.007280466612428427
adrenal B-Disease 1 0.9999955892562866
insufficiency I-Disease 1 0.9999963045120239
and O 0 2.4368933736695908e-05
red O 0 0.00018628100224304944
hair O 1 0.9555383324623108
pigmentation O 0 0.0021989713422954082
caused O 0 1.8947564512927784e-06
by O 0 4.761397873198625e-11
POMC O 0 1.732358032313641e-05
mutations O 0 2.368599751889633e-07
in O 0 2.0756934365762092e-11
humans O 0 6.596442836404037e-10
. O 0 8.912534599225808e-10

Sequential O 0 1.7218701131582748e-08
cleavage O 0 3.225464979550452e-06
of O 0 5.322924176084931e-13
the O 0 1.1081909587033756e-13
precursor O 0 1.377560283725987e-12
protein O 0 3.37224345670073e-11
pre O 0 5.0626121073094055e-09
- O 0 8.99626229511341e-06
pro O 0 5.670454811479431e-06
- O 0 0.00044500772492028773
opiomelanocortin O 0 9.232221054844558e-05
( O 0 4.349900160124237e-13
POMC O 0 5.202645425583796e-09
) O 0 3.80597856290861e-14
generates O 0 2.4117176083884168e-14
the O 0 7.987406173753583e-14
melanocortin O 0 1.2367999602247437e-07
peptides O 0 1.1048996384488419e-07
adrenocorticotrophin O 0 6.0084203141741455e-06
( O 0 8.934221635073514e-13
ACTH O 0 1.1949794043175643e-08
) O 0 1.0097302768213856e-12
, O 0 2.927417423054246e-13
melanocyte O 0 4.913944451345742e-08
- O 0 1.4268511222326197e-05
stimulating O 0 7.540625688307045e-07
hormones O 0 2.390858639955695e-07
( O 0 5.1460327969363173e-14
MSH O 0 6.722211121079624e-10
) O 0 2.0050858895318338e-14
alpha O 0 1.552608173591933e-14
, O 0 1.8139947484114953e-15
beta O 0 9.112231368763046e-15
and O 0 8.294728022929104e-14
gamma O 0 9.235294413977371e-14
as O 0 1.3344330523391845e-13
well O 0 5.518647604868532e-13
as O 0 6.01845708144387e-14
the O 0 3.1203931447195896e-14
opioid O 0 3.461286118833229e-11
- O 0 1.3681480948157798e-10
receptor O 0 4.0018890978821275e-11
ligand O 0 1.830906676270061e-10
beta O 0 3.9953096386824427e-10
- O 0 5.151975415174093e-07
endorphin O 0 9.322234836872667e-05
. O 0 1.300920593472199e-09

While O 0 4.3044390274360467e-10
a O 0 7.753278271141473e-13
few O 0 5.780504113567231e-13
cases O 0 3.5188488949934593e-13
of O 0 1.5776974995537763e-12
isolated O 0 0.00013341238081920892
ACTH B-Disease 1 0.9796993136405945
deficiency I-Disease 0 0.2648971676826477
have O 0 1.3058847059266299e-10
been O 0 4.322475266604897e-09
reported O 0 8.969723808149865e-08
( O 0 1.8058469216514217e-12
OMIM O 0 9.865274478215724e-06
201400 O 0 3.417575271669193e-07
) O 0 1.2080245137546797e-10
, O 0 2.724036708007249e-12
an O 0 7.050243722162008e-11
inherited O 1 0.7538068294525146
POMC O 1 0.9796780347824097
defect O 0 0.09406901150941849
has O 0 2.0694033153745295e-08
not O 0 5.94760005134809e-11
been O 0 8.512741622723752e-10
described O 0 2.062915394063225e-09
so O 0 1.6705990757426292e-10
far O 0 7.991716316491093e-11
. O 0 1.361998291926625e-10

Recent O 0 2.0547867851661294e-09
studies O 0 1.2418911732314797e-10
in O 0 7.573641421041583e-14
animal O 0 3.1556855652897786e-12
models O 0 4.284383178093654e-12
elucidated O 0 6.437076982557244e-10
a O 0 1.4467959707879785e-13
central O 0 1.49802096589954e-14
role O 0 1.0517105307299157e-13
of O 0 2.954992174076295e-15
alpha O 0 4.511428123438188e-13
- O 0 6.410785680088793e-09
MSH O 0 1.0110662884699195e-07
in O 0 9.23792021611386e-14
the O 0 1.9212967127630806e-14
regulation O 0 1.2816784309213625e-12
of O 0 1.1434525506624164e-15
food O 0 4.836134205772613e-13
intake O 0 2.7310689517182074e-13
by O 0 9.5748412451724e-17
activation O 0 3.9914415089076227e-13
of O 0 1.2214135478309969e-14
the O 0 9.65544831588172e-12
brain O 0 4.2567955915728817e-07
melanocortin O 0 1.0117676696452804e-09
- O 0 3.795918246396468e-09
4 O 0 3.238042126096907e-11
- O 0 8.033594900425101e-10
receptor O 0 1.519625425494553e-09
( O 0 2.384671778619951e-13
MC4 O 0 1.7863021639641374e-06
- O 0 2.305991301909671e-06
R O 0 7.80130812927382e-06
; O 0 2.244495604999952e-12
refs O 0 1.3891957584277748e-09
3 O 0 2.5417172706820867e-12
- O 0 2.4107993379374193e-09
5 O 0 3.373620133251265e-11
) O 0 1.452910193414439e-13
and O 0 5.911444971766835e-14
the O 0 4.149791269078204e-14
linkage O 0 1.2095337176276644e-08
of O 0 1.2503511680889146e-12
human O 0 7.78058240058499e-09
obesity B-Disease 1 0.9999972581863403
to O 0 2.0725938743026973e-09
chromosome O 0 2.5394701879122294e-06
2 O 0 1.1876094552221161e-10
in O 0 4.417539738958004e-14
close O 0 5.104961592339308e-11
proximity O 0 2.4932325301540992e-11
to O 0 4.659880120660986e-12
the O 0 7.2646242320340004e-12
POMC O 0 3.094762064392853e-07
locus O 0 1.1267798782910177e-07
, O 0 1.6559828161510914e-11
led O 0 3.936831763362569e-12
to O 0 3.388528173331462e-12
the O 0 1.2545580893585928e-12
proposal O 0 2.6582727338797518e-11
of O 0 2.90510156078852e-13
an O 0 2.1899034668981798e-11
association O 0 6.683934547328796e-13
of O 0 3.4610891084564666e-14
POMC O 0 2.5237723093596287e-06
with O 0 7.427211068389283e-10
human O 0 1.41301697453855e-07
obesity B-Disease 1 0.9999891519546509
. O 0 3.2396904714460106e-08

The O 0 1.4145445231816822e-11
dual O 0 9.321564353736989e-11
role O 0 2.834598441386893e-12
of O 0 1.9705425306900878e-14
alpha O 0 7.038604508263768e-12
- O 0 4.2834933822177845e-08
MSH O 0 1.2729061893423932e-07
in O 0 1.1459771323617078e-14
regulating O 0 1.3762287750379576e-12
food O 0 3.645678377239836e-12
intake O 0 9.180600030189723e-11
and O 0 1.2361661173854177e-12
influencing O 0 7.190754658381593e-10
hair O 0 6.31745278951712e-05
pigmentation O 0 1.2765867474229253e-08
predicts O 0 5.456203266973603e-10
that O 0 9.142532651079671e-13
the O 0 4.204337832741656e-12
phenotype O 0 3.8673711344472395e-08
associated O 0 1.7466636470508945e-10
with O 0 2.6202415237541743e-11
a O 0 2.0182131521551128e-09
defect O 0 3.1150652830547187e-06
in O 0 5.137387910914004e-12
POMC O 0 1.3225455575138767e-07
function O 0 1.6060662522132674e-10
would O 0 1.5135731556981113e-10
include O 0 1.2542603067267066e-10
obesity B-Disease 1 0.9999977350234985
, O 0 2.7820279066559372e-11
alteration O 0 1.3828378442326539e-09
in O 0 3.315204777365466e-10
pigmentation O 0 0.002546431729570031
and O 0 7.414323044940829e-05
ACTH B-Disease 1 0.9948945045471191
deficiency I-Disease 1 0.6342132091522217
. O 0 9.090416197565787e-10

The O 0 1.5256268470764667e-11
observation O 0 5.166758132446603e-09
of O 0 8.896487604763414e-13
these O 0 3.8619787923188653e-10
symptoms O 0 2.4039485957416673e-09
in O 0 1.3187449179538624e-14
two O 0 1.0210486969808308e-11
probands O 0 4.1449004584137583e-07
prompted O 0 1.3341238704056568e-11
us O 0 1.545797859289419e-13
to O 0 3.109412209591385e-15
search O 0 4.435728314603621e-13
for O 0 1.0255015017507016e-13
mutations O 0 8.659782613218425e-11
within O 0 3.42781392734335e-14
their O 0 2.2495453416704336e-11
POMC O 0 4.6851371848788403e-07
genes O 0 1.5440573264413615e-08
. O 0 6.008077368946374e-10

Patient O 0 9.439966675017786e-07
1 O 0 2.2829038659466505e-09
was O 0 1.6848085593323958e-08
found O 0 4.5159868899968814e-11
to O 0 1.8447607807656197e-13
be O 0 2.908993846587743e-13
a O 0 2.719859893676648e-14
compound O 0 2.5887269758384512e-11
heterozygote O 0 2.6199115793490435e-11
for O 0 4.427836779684596e-15
two O 0 2.3465189752207294e-13
mutations O 0 1.4796672567762847e-11
in O 0 7.452568564440126e-14
exon O 0 4.0867723094528685e-10
3 O 0 2.93427127040502e-09
( O 0 6.237983762348576e-13
G7013T O 0 1.160466389649173e-09
, O 0 3.114487487354545e-11
C7133delta O 0 3.524080796069029e-07
) O 0 8.216744125377762e-12
which O 0 8.853036034296713e-13
interfere O 0 2.0309997173645344e-12
with O 0 9.953036294514423e-16
appropriate O 0 2.0056431525078324e-15
synthesis O 0 2.06887527942623e-11
of O 0 2.9214825003620604e-13
ACTH O 0 6.502224181303973e-08
and O 0 3.7589519170933006e-12
alpha O 0 2.86091463019833e-12
- O 0 2.777767349471105e-07
MSH O 0 9.906426384986844e-06
. O 0 1.261672016861226e-10

Patient O 0 4.763448941957904e-07
2 O 0 9.134846656877471e-09
was O 0 7.054578587961657e-10
homozygous O 0 1.1178625386465413e-10
for O 0 1.7051317023381203e-14
a O 0 2.835878504681838e-13
mutation O 0 5.85896539617714e-11
in O 0 5.81543016867081e-12
exon O 0 1.1114116915678096e-07
2 O 0 2.906467670982238e-07
( O 0 1.4094760081295732e-11
C3804A O 0 1.0347109835606716e-08
) O 0 2.1344752354490737e-11
which O 0 5.6303007395230864e-11
abolishes O 0 9.063352877092257e-07
POMC O 0 1.1823503882624209e-05
translation O 0 2.8913001770547453e-08
. O 0 9.689404834034576e-10

These O 0 1.4015628935215574e-10
findings O 0 2.3149763356267172e-11
represent O 0 1.0822651775417233e-14
the O 0 3.55066250381543e-14
first O 0 1.2674424227157588e-12
examples O 0 1.645493366130707e-13
of O 0 4.476539649492413e-14
a O 0 3.437448725662762e-08
genetic B-Disease 1 0.9999991655349731
defect I-Disease 1 0.999997615814209
within O 0 2.8278735689918344e-13
the O 0 9.884303662013871e-13
POMC O 0 1.013425645624011e-07
gene O 0 1.9161818798352215e-09
and O 0 1.8873754989434666e-11
define O 0 1.276580507969527e-10
a O 0 2.3466915910486108e-11
new O 0 2.0079815143958513e-08
monogenic B-Disease 1 0.9790897369384766
endocrine I-Disease 1 0.9995006322860718
disorder I-Disease 1 0.693719744682312
resulting O 0 1.1638734420671426e-09
in O 0 1.4019036582643696e-12
early O 0 2.5377453027886077e-08
- O 1 0.9478402733802795
onset O 1 0.9998354911804199
obesity B-Disease 1 0.9999996423721313
, O 0 0.0013202695408836007
adrenal B-Disease 1 0.9999986886978149
insufficiency I-Disease 1 0.999996542930603
and O 0 4.917788828606717e-06
red O 0 5.699172106687911e-06
hair O 0 0.03372415155172348
pigmentation O 0 1.4051022390049184e-06
. O 0 9.974879949803395e-11
. O 0 3.648937818567788e-10

A O 0 5.631651944781879e-08
European O 0 1.649022784988574e-08
multicenter O 0 2.7280594849798945e-07
study O 0 3.5103878137654476e-10
of O 0 2.175829072470492e-09
phenylalanine B-Disease 1 0.9999942779541016
hydroxylase I-Disease 1 0.9999915361404419
deficiency I-Disease 1 0.9999996423721313
: O 0 2.1602188926550525e-09
classification O 0 2.958300271416192e-09
of O 0 3.7040056894040163e-13
105 O 0 1.6556361837061218e-10
mutations O 0 1.1290570700595026e-09
and O 0 6.525606877777479e-12
a O 0 3.227831820188862e-14
general O 0 2.8974949423419627e-15
system O 0 1.0043525906777706e-11
for O 0 1.0608956882473056e-13
genotype O 0 8.186989930436539e-08
- O 0 2.9847189608744884e-08
based O 0 1.611927952227532e-10
prediction O 0 2.865393753381795e-07
of O 0 6.647991076906556e-13
metabolic O 0 3.6560097214533016e-05
phenotype O 0 1.7333809410047252e-07
. O 0 4.979313072972502e-10

Phenylketonuria B-Disease 0 0.04387114197015762
( O 0 4.977397605188116e-09
PKU B-Disease 0 2.541158664826071e-06
) O 0 6.188106915772096e-09
and O 0 2.552191915583535e-07
mild B-Disease 0 4.121581878280267e-05
hyperphenylalaninemia I-Disease 1 0.9999978542327881
( O 0 4.10867642131052e-08
MHP B-Disease 1 0.9999970197677612
) O 0 3.6957654714342425e-08
are O 0 9.73490066336069e-10
allelic B-Disease 0 0.15999498963356018
disorders I-Disease 1 0.9999485015869141
caused O 0 2.3744982513562718e-07
by O 0 6.5494228963791645e-12
mutations O 0 4.1024250663213024e-09
in O 0 4.0049089261931514e-13
the O 0 1.952400047189329e-12
gene O 0 3.087438926741015e-08
encoding O 0 1.1372228527761763e-06
phenylalanine O 1 0.7279127836227417
hydroxylase O 1 0.9928950667381287
( O 0 2.396467913001743e-09
PAH O 0 8.272899094663444e-07
) O 0 1.138064420480589e-09
. O 0 9.548595247821368e-10

Previous O 0 1.933615294547053e-07
studies O 0 1.856238940334265e-09
have O 0 2.899721912238973e-12
suggested O 0 1.3729489550459717e-12
that O 0 1.6424134865718545e-14
the O 0 1.017656384237186e-14
highly O 0 1.2464372416143288e-11
variable O 0 4.644367113115777e-09
metabolic O 0 0.017440572381019592
phenotypes O 0 2.950139059976209e-05
of O 0 3.070449849928991e-08
PAH B-Disease 1 0.8848944306373596
deficiency I-Disease 1 0.9969478249549866
correlate O 0 2.5867818749247817e-06
with O 0 7.91443994785368e-08
PAH O 0 0.000447682075900957
genotypes O 0 0.0003674625186249614
. O 0 7.127443524268529e-08

We O 0 8.659786776554768e-10
identified O 0 4.925243893283415e-11
both O 0 5.098874339241888e-13
causative O 0 5.367928324062632e-09
mutations O 0 2.740427476055629e-07
in O 0 1.7731817403277006e-10
686 O 0 5.207073627389036e-06
patients O 0 2.997429859874501e-08
from O 0 1.487613331130344e-11
seven O 0 9.276500123611697e-10
European O 0 2.0485646512469202e-09
centers O 0 2.2566557511538576e-09
. O 0 3.049487884432267e-10

On O 0 5.762459398539477e-10
the O 0 2.6476387813938185e-13
basis O 0 5.892083831471676e-14
of O 0 1.0072242417555072e-15
the O 0 2.5878393056385195e-14
phenotypic O 0 1.531131992027479e-13
characteristics O 0 6.406134650527306e-11
of O 0 9.297755978760619e-14
297 O 0 9.108036991278823e-09
functionally O 0 1.8694486243475694e-06
hemizygous O 0 0.00011036379873985425
patients O 0 1.289362172585129e-09
, O 0 2.997410804804479e-13
105 O 0 2.886005020033555e-12
of O 0 2.1859731635497787e-14
the O 0 2.6104032130325194e-12
mutations O 0 3.724321961939836e-10
were O 0 1.2533692616764625e-12
assigned O 0 1.2373456209288647e-12
to O 0 9.44172908259877e-13
one O 0 1.1644662014156926e-13
of O 0 2.9420784156415744e-16
four O 0 8.239512045739306e-13
arbitrary O 0 2.1418374018811193e-10
phenotype O 0 2.4627608397054246e-08
categories O 0 1.3570979895405344e-09
. O 0 2.1938981742408714e-09

We O 0 3.9593664458159594e-10
proposed O 0 1.59529670289843e-12
and O 0 2.2496698948160088e-11
tested O 0 6.420226156267361e-11
a O 0 1.150438793708075e-13
simple O 0 2.567295605705039e-13
model O 0 4.0307113115950477e-13
for O 0 4.3333729125497175e-16
correlation O 0 5.0901704726213914e-12
between O 0 2.5255765360998605e-12
genotype O 0 5.731900731831274e-09
and O 0 6.672360147036427e-12
phenotypic O 0 2.132972401133748e-12
outcome O 0 1.871638954931143e-10
. O 0 2.3881074895371057e-10

The O 0 9.309268633739265e-11
observed O 0 5.356082799501394e-10
phenotype O 0 2.7898896526323824e-09
matched O 0 1.4363403799677599e-08
the O 0 7.817808206356247e-11
predicted O 0 1.445498298835446e-07
phenotype O 0 3.86832290644179e-08
in O 0 1.71028149975605e-10
79 O 0 8.1435082677217e-08
% O 0 2.9057899749579397e-12
of O 0 1.7703529004635225e-14
the O 0 1.962013537748497e-11
cases O 0 8.921050703714073e-11
, O 0 1.867982504788479e-11
and O 0 1.733063519082645e-11
in O 0 3.272796055974088e-14
only O 0 2.987502010099591e-13
5 O 0 4.262276295796674e-13
of O 0 1.2710482385840886e-14
184 O 0 6.233506766317731e-11
patients O 0 3.0797866427262344e-12
was O 0 6.022062848387577e-10
the O 0 5.379809445149597e-12
observed O 0 5.561737737025396e-10
phenotype O 0 6.023655879650036e-11
more O 0 1.1908323550066224e-14
than O 0 1.297641871343333e-13
one O 0 5.6171074735988924e-11
category O 0 1.6286170190227267e-09
away O 0 1.246252026021466e-07
from O 0 1.2252486351893577e-12
that O 0 2.5274620937820735e-11
expected O 0 1.2885403855023014e-10
. O 0 6.46389469727282e-11

Among O 0 7.178311278721594e-10
the O 0 2.1157194919629863e-12
seven O 0 6.547012498109295e-12
contributing O 0 1.6297021241187815e-12
centers O 0 1.0556763796465418e-12
, O 0 1.4225843810236616e-13
the O 0 1.5133860419187795e-13
proportion O 0 1.0882982882931547e-12
of O 0 1.6543417433482685e-14
patients O 0 4.1427787849518394e-13
for O 0 3.4858588505813767e-15
whom O 0 2.8777817802361216e-12
the O 0 2.663329626284572e-13
observed O 0 5.644981149188766e-10
phenotype O 0 3.8112821232338945e-10
did O 0 1.1346090039721091e-10
not O 0 2.047311539049579e-12
match O 0 3.546223037442786e-10
the O 0 1.2226134167570013e-11
predicted O 0 2.2679015998505747e-08
phenotype O 0 2.6730592739276915e-10
was O 0 7.222138442841697e-09
4 O 0 1.435826596507539e-10
% O 0 3.067181383008266e-13
- O 0 6.3624035817611e-08
23 O 0 2.041536717456438e-08
% O 0 5.44567320924505e-13
( O 0 9.177925888899374e-14
P O 0 2.0144995005466626e-07
< O 0 4.3133375343673563e-11
. O 0 1.6196927696623953e-12
0001 O 0 1.0204622924447904e-08
) O 0 4.247322112072016e-12
, O 0 9.665333718924737e-14
suggesting O 0 4.699572762195681e-12
that O 0 2.2026623146959023e-12
differences O 0 1.9146262266594993e-12
in O 0 2.8451278185922353e-16
methods O 0 9.660775834635562e-15
used O 0 1.0761933065626256e-13
for O 0 1.4073877258592807e-16
mutation O 0 2.818860379491528e-12
detection O 0 5.8567590777158784e-09
or O 0 7.552570124857994e-09
phenotype O 0 2.039067567238817e-06
classification O 0 6.648110684182029e-06
may O 0 1.2262118431749514e-08
account O 0 4.6994296475089126e-12
for O 0 8.747316022558738e-15
a O 0 6.391116477190428e-13
considerable O 0 1.8613405359125396e-13
proportion O 0 2.9346962143392274e-13
of O 0 3.463012483110456e-13
genotype O 0 1.7603968444745988e-05
- O 0 0.0008501241100020707
phenotype O 0 5.660546594299376e-05
inconsistencies O 0 0.00010035450395662338
. O 0 1.6993251250596586e-08

Our O 0 3.2615874445696136e-09
data O 0 2.4316821889414086e-09
indicate O 0 7.966395876302101e-10
that O 0 3.892814456202265e-12
the O 0 2.401407024621438e-11
PAH O 0 1.5023724131424387e-07
- O 0 7.473468031093944e-06
mutation O 0 2.530172764636518e-07
genotype O 0 6.677248052255891e-07
is O 0 6.358752066559781e-12
the O 0 1.1735119711912823e-13
main O 0 2.2229229568182518e-10
determinant O 0 5.051423723756443e-09
of O 0 2.744877892688069e-12
metabolic O 0 0.03798519819974899
phenotype O 0 1.8723197570125194e-07
in O 0 6.682663537121991e-12
most O 0 1.6256924972868347e-10
patients O 0 5.887649923153049e-09
with O 0 1.1989432380232756e-07
PAH B-Disease 1 0.7665494084358215
deficiency I-Disease 1 0.9991329312324524
. O 0 2.0930061239710085e-08

In O 0 1.9291515607200438e-10
the O 0 5.132158586995672e-12
present O 0 6.13924709680358e-13
study O 0 7.348483123002444e-14
, O 0 4.493880107988603e-14
the O 0 9.156873393215137e-14
classification O 0 2.656956044067016e-10
of O 0 1.8581905220256545e-13
105 O 0 1.2667192850202014e-09
PAH O 0 1.1242205388839466e-08
mutations O 0 1.0727674748522986e-08
may O 0 3.537978937595554e-11
allow O 0 3.875134737293777e-14
the O 0 8.992708379167158e-13
prediction O 0 1.1231039209746996e-08
of O 0 1.6844941045672719e-15
the O 0 6.552730905627635e-13
biochemical O 0 9.613345675063556e-09
phenotype O 0 5.362317812007689e-10
in O 0 3.5726131254743e-13
> O 0 2.2673518878385535e-12
10 O 0 9.39002456519511e-13
, O 0 2.344139422502667e-13
000 O 0 3.841558581657578e-12
genotypes O 0 5.679858361418155e-09
, O 0 2.0053231297723073e-10
which O 0 6.296638765945772e-10
may O 0 1.6256234205980213e-11
be O 0 3.118899656226991e-14
useful O 0 6.097523880125091e-14
for O 0 2.313311776971959e-15
the O 0 3.2878842877448466e-12
management O 0 2.7028730364975218e-09
of O 0 1.0062777000552359e-11
hyperphenylalaninemia B-Disease 1 0.9999986886978149
in O 0 8.550102847948438e-10
newborns O 0 2.2736411153800873e-07
. O 0 1.2511248113911133e-11

Somatic O 0 4.541749603959033e-06
instability O 0 3.374417428858578e-05
of O 0 2.5432494651922433e-12
the O 0 9.867976227817543e-12
CTG O 0 2.5803217340580886e-07
repeat O 0 4.0566050074630766e-08
in O 0 3.4074381771026507e-13
mice O 0 1.5797887997770488e-10
transgenic O 0 2.6920864842905345e-11
for O 0 1.5440277095074562e-12
the O 0 4.268299562681932e-07
myotonic B-Disease 1 0.9999988079071045
dystrophy I-Disease 1 0.9999986886978149
region O 0 5.229774160397938e-07
is O 0 1.5833463429260064e-09
age O 0 3.767049866487682e-11
dependent O 0 1.7152428782862827e-11
but O 0 3.678577407961736e-12
not O 0 1.4528353834645374e-13
correlated O 0 4.416592092049143e-12
to O 0 5.49494098226605e-13
the O 0 7.73900637584396e-13
relative O 0 1.6175208394919594e-10
intertissue O 0 2.5794157920699945e-08
transcription O 0 8.704270193504726e-09
levels O 0 9.694617331135191e-10
and O 0 3.0736267697673014e-11
proliferative O 0 5.480089384946041e-06
capacities O 0 4.266695796673048e-08
. O 0 7.900481935330106e-10

A O 0 8.565536546711883e-08
( O 0 2.4879405827182843e-11
CTG O 0 7.18409864930436e-08
) O 0 1.2926981707295226e-10
nexpansion O 0 2.940289611785829e-08
in O 0 1.801057810920173e-13
the O 0 2.6301745070095306e-12
3 O 0 5.833447502823219e-09
- O 0 9.639729978516698e-05
untranslated O 1 0.9501698613166809
region O 0 3.063298663619207e-07
( O 0 1.890480176916509e-12
UTR O 0 5.416185899775883e-08
) O 0 5.05305161862396e-13
of O 0 1.6104119677257003e-15
the O 0 3.439299192664613e-11
DM O 1 0.9999938011169434
protein O 0 1.0719329424091484e-08
kinase O 0 1.5328298559325049e-06
gene O 0 1.5032668443382136e-07
( O 0 6.236523884123324e-12
DMPK O 0 4.6157217070685874e-07
) O 0 1.0897461318742918e-12
is O 0 1.7870103115910467e-14
responsible O 0 4.061559682327909e-12
for O 0 4.751898874388871e-11
causing O 0 0.4699377119541168
myotonic B-Disease 1 0.999997615814209
dystrophy I-Disease 1 0.9999973773956299
( O 0 2.649773023222224e-07
DM B-Disease 1 0.9999945163726807
) O 0 9.51836369722514e-08
. O 0 1.5637182659844484e-09

Major O 0 2.638873581872758e-07
instability O 0 2.2652769985143095e-05
, O 0 1.654609262102813e-11
with O 0 6.106523706833622e-13
very O 0 8.125454925870731e-14
large O 0 1.970102920590463e-14
expansions O 0 1.5079858195488072e-10
between O 0 1.1348015582779425e-10
generations O 0 1.0643358194784014e-08
and O 0 9.580240767359527e-11
high O 0 7.534265433761789e-10
levels O 0 3.4566923975964947e-12
of O 0 9.272867779078035e-15
somatic O 0 6.505554983604611e-10
mosaicism O 0 2.4019734610192245e-06
, O 0 8.924892942741014e-12
is O 0 7.94974817312083e-13
observed O 0 1.5531533004153886e-10
in O 0 4.670958498459443e-12
patients O 0 2.0113717635883432e-10
. O 0 3.0193689215529673e-10

There O 0 4.68959371335842e-10
is O 0 3.311295898936195e-12
a O 0 4.968755983915385e-13
good O 0 2.4715379048911856e-11
correlation O 0 2.738688997805383e-10
between O 0 2.7533963997683486e-10
repeat O 0 1.4698912309540901e-06
size O 0 7.4981709730082e-09
( O 0 1.8184446190592368e-13
at O 0 4.6664373754001787e-11
least O 0 8.053830497477266e-14
in O 0 3.2834330957257074e-13
leucocytes O 0 1.087792043108493e-06
) O 0 8.345678315091476e-12
, O 0 4.3524065644964804e-13
clinical O 0 2.3155027895072067e-10
severity O 0 3.1899384111966356e-07
and O 0 4.0508102427949666e-10
age O 0 6.678526481840308e-11
of O 0 2.1142029099641135e-12
onset O 0 1.843840635729066e-07
. O 0 3.1686335777436625e-09

The O 0 9.428701375213677e-09
trinucleotide O 0 0.00032194776576943696
repeat O 0 2.3305057766265236e-05
instability O 0 1.0686608931109731e-07
mechanisms O 0 1.855190445709809e-10
involved O 0 7.646153155072e-11
in O 0 1.0663545046973866e-10
DM B-Disease 1 0.9999982118606567
and O 0 1.0674626516049557e-08
other O 0 8.019598179975773e-11
human O 0 2.0466565331389575e-07
genetic B-Disease 1 0.9999988079071045
diseases I-Disease 1 0.9999988079071045
are O 0 2.2073780303610846e-11
unknown O 0 3.851813978883456e-09
. O 0 6.813811181949347e-10

We O 0 1.1009269051953652e-09
studied O 0 4.2736286731681616e-11
somatic O 0 7.31859683966718e-09
instability O 0 1.8059337492104532e-07
by O 0 2.6897650773349824e-12
measuring O 0 6.017544507130879e-08
the O 0 2.673186672019767e-10
CTG O 0 1.2312044418649748e-05
repeat O 0 4.2361625673947856e-05
length O 0 4.666550879051101e-08
at O 0 4.018320676202336e-10
several O 0 9.714704084576309e-13
ages O 0 9.576747381223605e-12
in O 0 1.2525841908833657e-14
various O 0 2.085898084304167e-14
tissues O 0 2.602238147186853e-10
of O 0 2.1902926927675967e-14
transgenic O 0 1.8334482820847597e-09
mice O 0 2.7725235440811957e-08
carrying O 0 1.7189873136036482e-10
a O 0 5.87024109877099e-11
( O 0 1.4019135245041392e-13
CTG O 0 1.537146054886307e-08
) O 0 9.903518977116832e-12
55expansion O 0 4.04855660107728e-09
surrounded O 0 7.903492443839255e-11
by O 0 4.714705324282767e-14
45 O 0 5.4418285605787806e-14
kb O 0 2.430245116258334e-09
of O 0 4.686836585065385e-15
the O 0 4.376199489591892e-12
human O 0 1.3445487390129074e-08
DM B-Disease 1 0.9999997615814209
region O 0 1.763230117468595e-09
, O 0 9.066242223111642e-14
using O 0 2.6020109461163954e-13
small O 0 1.814351446860485e-11
- O 0 7.925813747533539e-07
pool O 0 1.730186127701927e-08
PCR O 0 1.2127859463362256e-06
. O 0 2.1162382957129466e-10

These O 0 3.5300622425182837e-09
mice O 0 1.7796659790292324e-07
have O 0 5.271291736441697e-11
been O 0 4.5721666036557806e-11
shown O 0 1.9536898140937176e-11
to O 0 9.224859374643013e-13
reproduce O 0 1.8373236265745163e-09
the O 0 6.138474060654597e-13
intergenerational O 0 1.1146699563369111e-08
and O 0 1.8285789549210563e-10
somatic O 0 2.595681225514568e-09
instability O 0 1.0306417053129735e-08
of O 0 1.3663642632155519e-14
the O 0 3.379968830860558e-12
55 O 0 2.8400656826299553e-11
CTG O 0 1.4013825655467826e-08
repeat O 0 3.063511755385662e-08
suggesting O 0 2.336750237752483e-10
that O 0 1.0013222889737605e-12
surrounding O 0 9.442864242273363e-13
sequences O 0 6.295954868562603e-10
and O 0 1.0686043716567895e-10
the O 0 1.1150781903737639e-12
chromatin O 0 1.0245065906744344e-09
environment O 0 5.405756398069173e-10
are O 0 6.158944272009574e-15
involved O 0 3.394728481610418e-14
in O 0 1.9571601555124635e-13
instability O 0 2.576537871945561e-09
mechanisms O 0 4.863884295325249e-10
. O 0 3.445374263666423e-10

As O 0 4.0596664918624015e-10
observed O 0 2.1540706718337077e-10
in O 0 4.744745855976909e-14
some O 0 4.3750972261358723e-16
of O 0 6.307501568980243e-15
the O 0 1.351359822654441e-11
tissues O 0 1.052719085237186e-07
of O 0 1.0776703973647273e-09
DM B-Disease 1 0.9999996423721313
patients O 0 5.41884848104246e-09
, O 0 9.008949185609905e-13
there O 0 5.516087261438207e-14
is O 0 2.9442049384424684e-13
a O 0 1.2999513574959987e-12
tendency O 0 4.3836978491640366e-10
for O 0 1.1330075332799394e-12
repeat O 0 7.007499789324356e-07
length O 0 1.3498831386016263e-08
and O 0 3.587557681483666e-11
somatic O 0 7.538573931764603e-11
mosaicism O 0 8.850238231161711e-08
to O 0 3.758925115615597e-11
increase O 0 6.831016871947093e-13
with O 0 1.4670830522645062e-11
the O 0 7.089997339226883e-11
age O 0 7.808374780093885e-11
of O 0 8.078626709381777e-15
the O 0 6.12829925694669e-12
mouse O 0 2.4918017516029067e-06
. O 0 1.1117902154467174e-09

Furthermore O 0 5.503724409550159e-08
, O 0 5.561098109785334e-11
we O 0 4.719460065805148e-12
observed O 0 2.3514441262195707e-12
no O 0 4.0903532731034753e-13
correlation O 0 1.309687948369831e-11
between O 0 5.784044575761482e-13
the O 0 4.3904349556964095e-13
somatic O 0 3.904785383923581e-09
mutation O 0 1.9684719632095948e-07
rate O 0 3.5872693615601747e-07
and O 0 3.955345384554221e-09
tissue O 0 1.2334834309513099e-06
proliferation O 0 2.8104162993258797e-05
capacity O 0 6.360626469970043e-10
. O 0 8.77027131473973e-11

The O 0 3.011034130362411e-11
somatic O 0 5.538303593510818e-09
mutation O 0 6.747162046849553e-07
rates O 0 3.5626376302388962e-06
in O 0 3.2332205489316035e-12
different O 0 5.4090200200807015e-12
tissues O 0 1.2957679373926112e-08
were O 0 2.225990503035291e-10
also O 0 3.2881477488727606e-12
not O 0 1.923497710935862e-13
correlated O 0 6.594624585992692e-12
to O 0 2.845524163519464e-12
the O 0 1.5231177430408138e-11
relative O 0 9.420472224519472e-08
inter O 0 1.902970780065516e-06
- O 0 4.6182278310880065e-05
tissue O 0 1.4243944860936608e-05
difference O 0 1.7976045652012829e-10
in O 0 1.7135553814710933e-15
transcriptional O 0 7.400188795081419e-10
levels O 0 1.311743630383333e-10
of O 0 1.8419705525934103e-15
the O 0 1.5877613622743841e-13
three O 0 6.170382781112149e-12
genes O 0 9.049761495738551e-10
( O 0 1.0503974941364e-13
DMAHP O 0 3.9234890891748364e-07
, O 0 1.6420337312084143e-11
DMPK O 0 4.034501216665376e-06
and O 0 1.3832283096704145e-09
59 O 0 3.8955366710169415e-10
) O 0 1.0852678348008404e-12
surrounding O 0 1.0287286430696319e-12
the O 0 6.974830435435564e-12
repeat O 0 2.887765333525749e-07
. O 0 8.266181142357887e-12
. O 0 3.42731537594787e-11

A O 0 2.0428922553605844e-08
novel O 0 8.859625033608154e-09
missense O 0 9.007628136714629e-07
mutation O 0 1.2525083548098337e-07
in O 0 9.906017672811629e-11
patients O 0 1.4591165775623693e-10
from O 0 5.631648576295833e-13
a O 0 2.976909829754959e-10
retinoblastoma B-Disease 0 3.8253328966675326e-05
pedigree O 0 0.0052136522717773914
showing O 0 9.407432912666991e-07
only O 0 1.5377553674866817e-09
mild O 0 8.618727953546568e-09
expression O 0 1.666283083734399e-11
of O 0 8.155996901069648e-14
the O 0 1.0037747022462185e-10
tumor B-Disease 0 0.0010087437694892287
phenotype O 0 4.66866185888648e-06
. O 0 6.328790380649707e-09

We O 0 5.258360413762375e-10
have O 0 2.7103273510069303e-13
used O 0 3.4346348464983634e-13
single O 0 9.939284638382784e-12
strand O 0 3.0099309356046433e-07
conformation O 0 1.0909670500325319e-08
polymorphism O 0 1.6072592146088027e-09
analysis O 0 1.8384636261276066e-12
to O 0 2.270990741379958e-13
study O 0 3.5838316364035505e-14
the O 0 5.3796607468216406e-14
27 O 0 1.0566902387820765e-11
exons O 0 1.371961433349611e-09
of O 0 3.173730470595014e-14
the O 0 6.231149277113879e-12
RB1 O 0 8.402985827160592e-07
gene O 0 2.8863451628780012e-09
in O 0 1.7156739353860195e-12
individuals O 0 1.9235050293005262e-13
from O 0 3.4317928815537357e-13
a O 0 5.888567411460599e-10
family O 0 1.8883831671701046e-06
showing O 0 3.963023846154101e-05
mild O 0 1.704382412981431e-08
expression O 0 4.636704215021936e-12
of O 0 1.695176354702451e-14
the O 0 4.920098356508973e-11
retinoblastoma B-Disease 0 1.8168173482990824e-05
phenotype O 0 9.257751116820145e-07
. O 0 2.184744829492047e-09

In O 0 1.5899609406844206e-10
this O 0 5.6012490652623814e-12
family O 0 2.1262967775381725e-10
affected O 0 6.089344523410589e-13
individuals O 0 1.9052327329184028e-14
developed O 0 3.3037036994976177e-10
unilateral B-Disease 0 2.205404598498717e-05
tumors I-Disease 1 0.9999998807907104
and O 0 5.5045848768031647e-08
, O 0 1.6875130849983155e-12
as O 0 9.885057182523749e-13
a O 0 3.002613565769585e-12
result O 0 6.6905582636611616e-12
of O 0 3.001225095809919e-14
linkage O 0 4.88631677342255e-08
analysis O 0 4.859692648295777e-10
, O 0 4.550796371682875e-12
unaffected O 0 7.009726687989826e-10
mutation O 0 2.3290525064112444e-10
carriers O 0 8.279314039905117e-11
were O 0 2.2904828034242541e-10
also O 0 8.381623173292496e-11
identified O 0 4.485195548298293e-11
within O 0 6.508794290214018e-14
the O 0 7.171219867929679e-11
pedigree O 0 0.000351564260199666
. O 0 1.3166270296238736e-09

A O 0 3.441538443116343e-10
single O 0 6.241429595377213e-11
band O 0 2.7164070992569123e-10
shift O 0 6.5628908557657795e-12
using O 0 1.470780528617377e-12
SSCP O 0 7.249274602827427e-08
was O 0 1.9958026897803904e-10
identified O 0 2.6831961132123272e-12
in O 0 8.413463915629086e-15
exon O 0 3.9300607213021976e-10
21 O 0 1.1068687078008566e-09
which O 0 1.2507246627269097e-10
resulted O 0 2.0199132297338274e-11
in O 0 2.056749986523252e-14
a O 0 1.0405671550112183e-12
missense O 0 1.8288728309556745e-09
mutation O 0 2.8291226999987984e-11
converting O 0 6.070437208460788e-11
a O 0 2.152998612725554e-10
cys O 0 0.000119429336336907
- O 0 5.683963081537513e-06
- O 0 1.0898390428337734e-05
> O 0 4.085821680988033e-10
arg O 0 3.7144115561105195e-10
at O 0 9.828698618874476e-12
nucleotide O 0 2.9922197532228356e-12
position O 0 9.725547034378224e-10
28 O 0 4.101759622059109e-13
in O 0 1.1245103528629685e-15
the O 0 2.6791955698261816e-13
exon O 0 1.0312988507621412e-07
. O 0 5.749880571670474e-09

The O 0 6.108513139757576e-10
mutation O 0 7.276079116991241e-08
destroyed O 0 1.4796476079936838e-06
an O 0 9.908776577027822e-11
NdeI O 0 7.59759302582097e-07
restriction O 0 1.577217662029895e-10
enzyme O 0 9.539566914185116e-10
site O 0 1.2858975217966417e-08
. O 0 1.0080153378666523e-09

Analysis O 0 2.660781150964908e-09
of O 0 2.5226108094772437e-12
all O 0 1.6595233217134298e-12
family O 0 2.1217055889977132e-11
members O 0 8.405086759780741e-16
demonstrated O 0 5.427730883017859e-14
that O 0 2.3502163672091186e-15
the O 0 1.713432117001444e-14
missense O 0 5.436769257016749e-09
mutation O 0 2.3432542572976445e-09
co O 0 5.1219785746070556e-08
- O 0 1.1495839835617971e-08
segregated O 0 5.167221317492476e-09
with O 0 8.295646947154012e-10
patients O 0 1.033862773169858e-08
with O 0 1.829969988875746e-07
tumors B-Disease 1 0.9999998807907104
or O 0 5.672163183589873e-07
who O 0 5.023073512688825e-08
, O 0 3.222759949531029e-12
as O 0 2.8171833355711273e-12
a O 0 2.630150611193649e-11
result O 0 4.098901426607959e-11
of O 0 3.431332841019423e-14
linkage O 0 9.244114806961079e-08
analysis O 0 2.9639693477356843e-10
had O 0 5.398857894078901e-08
been O 0 8.063038570149672e-10
predicted O 0 6.782933936744229e-11
to O 0 2.543014322069822e-14
carry O 0 1.615783353468847e-12
the O 0 7.392587518702254e-13
predisposing O 0 3.61078704713691e-08
mutation O 0 6.489598547432252e-08
. O 0 2.1957695661711796e-09

These O 0 1.7430917820249192e-11
observations O 0 1.8244644683917954e-10
point O 0 8.223854930378138e-10
to O 0 7.410728389452281e-13
another O 0 1.027075885277895e-12
region O 0 2.3445698507651436e-12
of O 0 9.19642474965423e-15
the O 0 1.0079642849547543e-11
RB1 O 0 1.0061548749717986e-07
gene O 0 1.0359244018154357e-10
where O 0 3.0610991172408397e-12
mutations O 0 8.230673087528118e-12
only O 0 2.4237393776022076e-14
modify O 0 1.172633691537417e-11
the O 0 2.1361970352351545e-12
function O 0 6.682960435044905e-11
of O 0 1.2732934010547398e-13
the O 0 7.689894727935798e-12
gene O 0 2.798972165152236e-09
and O 0 9.282194457505e-11
raise O 0 4.594348989792052e-13
important O 0 1.748967012611246e-14
questions O 0 8.485348383137359e-13
for O 0 1.166280935623867e-15
genetic O 0 1.4821366356443377e-10
counseling O 0 3.730414865898979e-10
in O 0 1.6628746177336368e-13
families O 0 1.2507329156738467e-12
with O 0 2.4183934477402247e-13
these O 0 2.0499765079895482e-12
distinctive O 0 2.962098899494947e-10
phenotypes O 0 1.9978871890202754e-09
. O 0 2.01051918169437e-11
. O 0 3.1630284502703887e-10

Maternal B-Disease 0 0.0016191548202186823
disomy I-Disease 0 0.11669503897428513
and O 0 0.0028880031313747168
Prader B-Disease 1 0.9999834299087524
- I-Disease 1 0.9999961853027344
Willi I-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.9999943971633911
consistent O 0 8.452126820657213e-08
with O 0 5.1621134450341444e-11
gamete O 0 1.9485348445869022e-08
complementation O 0 1.789735870261211e-05
in O 0 1.3755123342423792e-12
a O 0 1.0222329710138367e-12
case O 0 6.356039305988048e-11
of O 0 2.5454321267957825e-13
familial O 0 4.279181666788645e-07
translocation O 0 4.540584995993413e-06
( O 0 4.18124215806337e-12
3 O 0 2.0974240400040145e-10
; O 0 4.437854597694191e-12
15 O 0 9.44578703448995e-12
) O 0 8.177138436857301e-13
( O 0 7.968012994437194e-16
p25 O 0 1.2901597108358476e-12
; O 0 4.6712654089894196e-14
q11 O 0 5.24266264081974e-12
. O 0 1.824120824008013e-13
2 O 0 1.484110404015304e-11
) O 0 8.572890661251442e-12
. O 0 2.736296085548151e-11

Maternal B-Disease 0 0.0338963083922863
uniparental I-Disease 1 0.6612914204597473
disomy I-Disease 1 0.8279773592948914
( I-Disease 0 5.390430146690051e-07
UPD I-Disease 1 0.9998971223831177
) I-Disease 0 3.3235127983033408e-09
for I-Disease 0 6.720460559578312e-12
chromosome I-Disease 0 1.6098545074783033e-06
15 I-Disease 0 2.5708665751800197e-10
is O 0 2.0821636515649944e-12
responsible O 0 5.714554263819283e-13
for O 0 3.2540274152255324e-15
an O 0 6.027991961924523e-14
estimated O 0 3.0711637660080227e-12
30 O 0 1.3781279719835005e-12
% O 0 2.5539692956381933e-15
of O 0 2.0599682458546974e-15
cases O 0 1.7451375414201387e-11
of O 0 1.655189585392236e-08
Prader B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999996423721313
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999990463256836
( O 0 1.0359475766108517e-07
PWS B-Disease 1 0.9999488592147827
) O 0 4.401553788113688e-09
. O 0 5.846176320822849e-10

We O 0 1.002079041967363e-08
report O 0 7.147905097676377e-12
on O 0 1.3243977312407673e-12
an O 0 2.746926789154512e-15
unusual O 0 8.59975610688346e-14
case O 0 9.483476287250325e-13
of O 0 5.962125578803197e-15
maternal B-Disease 0 1.1956839074400705e-08
disomy I-Disease 0 6.362803901538427e-07
15 I-Disease 0 1.1013799594561391e-10
in O 0 7.106949057034129e-11
PWS B-Disease 1 0.9999983310699463
that O 0 1.7918204697764395e-09
is O 0 1.3488226377825208e-12
most O 0 3.4142285353089274e-14
consistent O 0 2.1781893996819512e-11
with O 0 2.728789633490991e-12
adjacent O 0 1.160027629509841e-10
- O 0 1.775275677573518e-07
1 O 0 2.690229705670788e-10
segregation O 0 1.9825627806113744e-09
of O 0 3.9588747861515894e-14
a O 0 6.536322871841804e-11
paternal O 0 2.6415125375933712e-06
t O 0 2.6335289931012085e-06
( O 0 1.503826529720021e-14
3 O 0 3.774491569991101e-12
; O 0 2.399381149494062e-13
15 O 0 3.6496424372228775e-13
) O 0 5.2609179084514915e-14
( O 0 4.4215702181825715e-17
p25 O 0 1.280297347088996e-13
; O 0 9.425579349138513e-15
q11 O 0 4.977274018283517e-13
. O 0 4.918383544405894e-14
2 O 0 8.003209098043917e-13
) O 0 1.7698160509815528e-14
with O 0 8.673121018576944e-15
simultaneous O 0 6.737149033098078e-11
maternal O 0 1.1958786672039423e-06
meiotic O 0 5.944664735579863e-06
nondisjunction O 0 2.3465038339054445e-06
for O 0 4.925803146448027e-13
chromosome O 0 8.396658017773007e-07
15 O 0 2.2061541482543134e-10
. O 0 2.8865804191369193e-10

The O 0 1.0578609099809455e-09
patient O 0 4.46384049723747e-08
( O 0 1.4196475592309632e-11
J O 0 1.7216785863638506e-06
. O 0 7.326900197668351e-11
B O 0 3.419111660463159e-09
. O 0 7.898285432801633e-13
) O 0 1.0890322931639274e-14
, O 0 2.080500959770852e-15
a O 0 1.135832218752443e-14
17 O 0 6.452924674639482e-13
- O 0 4.2147477175014103e-10
year O 0 1.1213006217980492e-10
- O 0 1.813424006513742e-07
old O 0 0.0010666187154129148
white O 0 7.790815175212629e-07
male O 0 1.89237336911674e-09
with O 0 3.974597317935036e-10
PWS B-Disease 1 0.9999959468841553
, O 0 5.69354806356781e-12
was O 0 1.194274124038941e-10
found O 0 5.394914983497534e-12
to O 0 9.28719666275224e-13
have O 0 1.0251232154812051e-11
47 O 0 2.567287094717985e-12
chromosomes O 0 1.4375756141049578e-09
with O 0 2.221149262779387e-12
a O 0 5.981923290043767e-11
supernumerary O 0 0.0003956246073357761
, O 0 1.0382516180129642e-08
paternal O 0 0.0014420842053368688
der O 1 0.5911980867385864
( O 0 8.141861317090271e-12
15 O 0 1.4447043387988412e-11
) O 0 3.3831146434640247e-13
consisting O 0 2.139473087624591e-14
of O 0 4.2750732018011564e-14
the O 0 4.749155513295023e-10
short O 0 4.4681696635962e-06
arm O 0 0.002483072690665722
and O 0 2.1082371959302293e-10
the O 0 1.9986016314144095e-11
proximal O 0 5.0902013754239306e-05
long O 0 0.0001650756603339687
arm O 0 0.0025422279722988605
of O 0 2.4936925354518413e-12
chromosome O 0 8.91936849711783e-07
15 O 0 1.6916324244165004e-11
, O 0 3.7463597762216194e-13
and O 0 2.2897087004203343e-11
distal O 0 8.61414082464762e-05
chromosome O 1 0.7543230652809143
arm O 1 0.7639594078063965
3p O 0 0.01639285869896412
. O 0 5.737350505796712e-08

The O 0 2.1240492031893154e-08
t O 0 2.148510475308285e-06
( O 0 7.725069499017745e-13
3 O 0 1.3416569071000861e-11
; O 0 5.165585298914921e-13
15 O 0 1.0844855829333921e-12
) O 0 5.946833195151491e-13
was O 0 5.911772738009802e-10
present O 0 1.0062843570565749e-13
in O 0 3.3921700185932362e-15
the O 0 2.180985020404716e-13
balanced O 0 3.198163608941762e-11
state O 0 5.3366204684490715e-12
in O 0 4.602005083433058e-13
the O 0 5.8079398929100634e-11
patients O 0 8.769468484715048e-11
father O 0 8.098198556183434e-09
and O 0 3.4882118894741243e-12
a O 0 6.726000398998844e-12
sister O 0 1.1667365242828964e-06
. O 0 4.1657877147827094e-10

Fluorescent O 0 4.903858208393785e-09
in O 0 1.0169743736368475e-12
situ O 0 2.6046253695510835e-11
hybridization O 0 2.398006272719133e-11
analysis O 0 3.2544299286701994e-12
demonstrated O 0 3.5865244801813745e-11
that O 0 3.6613507364835485e-12
the O 0 2.794191267252444e-10
PWS B-Disease 1 0.999998927116394
critical O 0 7.052970119048041e-08
region O 0 2.2666322985198661e-10
resided O 0 9.59172852255108e-10
on O 0 9.407032930397463e-10
the O 0 4.871966111791304e-12
derivative O 0 3.6745018139328067e-09
chromosome O 0 8.980557026916358e-07
3 O 0 3.445045637651134e-10
and O 0 2.912060870219335e-11
that O 0 3.263069285261433e-12
there O 0 7.116242951897903e-14
was O 0 1.703509694417349e-10
no O 0 2.5499478830542932e-12
deletion O 0 2.0747842333079802e-10
of O 0 2.7848920001669053e-13
the O 0 1.5412444653861712e-08
PWS B-Disease 1 0.9999991655349731
region O 0 2.629566564493757e-09
on O 0 1.7914240091343459e-09
the O 0 1.1105259073440621e-11
normal O 0 3.5860522884512136e-11
pair O 0 6.79767631073247e-10
of O 0 2.960675256932603e-14
15s O 0 2.7630298765103645e-13
present O 0 2.1742439933972874e-13
in O 0 3.88389971225922e-12
J O 0 5.2167277317494154e-05
. O 0 1.0740792699692747e-09

B O 0 0.00014801816723775119
. O 0 4.3779532887811e-08

Methylation O 0 6.716626366198852e-09
analysis O 0 1.1731064730735596e-10
at O 0 2.5282527807424238e-11
exon O 0 1.7101248195316998e-10
alpha O 0 2.77146187943611e-11
of O 0 4.6686734881708214e-14
the O 0 2.3622733543587904e-12
small O 0 3.397123901627275e-11
nuclear O 0 3.4057557058986276e-06
ribonucleoprotein O 0 2.4403631115887947e-08
- O 0 2.225309359005223e-08
associated O 0 5.552484028115146e-10
polypeptide O 0 6.979607292123546e-07
N O 0 4.799500402441481e-06
( O 0 6.556669270019189e-13
SNRPN O 0 1.9102279225080565e-07
) O 0 1.001087342362983e-12
gene O 0 1.991072862139731e-10
showed O 0 3.1818014889495316e-08
a O 0 1.5604422268222784e-11
pattern O 0 3.381794897450163e-07
characteristic O 0 8.80934347691209e-09
of O 0 8.8179111365147e-14
only O 0 2.7909022749100787e-12
the O 0 1.0318398913078397e-11
maternal O 0 1.0196177981924848e-06
chromosome O 0 3.187968104612082e-05
15 O 0 6.123398454960238e-10
in O 0 7.783661215565729e-11
J O 0 0.00157668418250978
. O 0 4.716083967792883e-09

B O 0 0.0001775203854776919
. O 0 8.356621350458227e-08

Maternal B-Disease 0 0.0017640154110267758
disomy I-Disease 0 0.00013402121840044856
was O 0 2.4986061220033662e-08
confirmed O 0 5.404310332579598e-11
by O 0 1.5116112707250565e-14
polymerase O 0 4.746106618824797e-09
chain O 0 3.25114832833151e-08
reaction O 0 7.43013723464303e-12
analysis O 0 1.4725594604369369e-13
of O 0 7.405564165098143e-15
microsatellite O 0 1.8826743541922042e-07
repeats O 0 3.384143667517492e-07
at O 0 3.385132105182542e-11
the O 0 8.543988135262595e-14
gamma O 0 2.409160544669664e-11
- O 0 8.221978760047932e-07
aminobutyric O 0 4.674578121921513e-06
acid O 0 3.3622321593540505e-10
receptor O 0 1.0239512709953047e-10
beta3 O 0 3.168284834487167e-08
subunit O 0 2.524038200668599e-10
( O 0 8.687638282378618e-12
GABRB3 O 0 7.825456123100594e-07
) O 0 2.207083300842516e-11
locus O 0 1.1882239903115988e-07
. O 0 5.3725170978680126e-09

A O 0 1.6740719388508296e-07
niece O 0 2.3804346710676327e-05
( O 0 1.7931449727837112e-11
B O 0 4.795489338960124e-09
. O 0 3.4551565167989517e-12
B O 0 8.951838714743587e-10
. O 0 1.875330945221021e-13
) O 0 1.0097908362889825e-14
with O 0 9.874876117548295e-14
45 O 0 4.914032505562438e-14
chromosomes O 0 1.6465319385705612e-10
and O 0 1.0787915699639328e-12
the O 0 2.4109723888014224e-14
derivative O 0 3.419877922516967e-11
3 O 0 1.0125503734081942e-11
but O 0 4.19164911114045e-11
without O 0 6.709419912015457e-12
the O 0 1.1001077132588577e-10
der O 0 6.0518403188325465e-05
( O 0 4.929315351623158e-14
15 O 0 5.746853730739798e-13
) O 0 2.338530302563313e-13
demonstrated O 0 2.4014197748389865e-12
a O 0 2.233443681734504e-12
phenotype O 0 7.58910045917105e-10
consistent O 0 1.9326355793491956e-10
with O 0 6.918229010499655e-12
that O 0 6.784939970971848e-11
reported O 0 6.94996504790879e-10
for O 0 4.4067925849232414e-14
haploinsufficiency O 0 1.9485129598706408e-07
of O 0 4.188159964235022e-13
distal O 0 8.172229399860953e-07
3 O 0 4.97793202214325e-08
p O 0 4.7133803491306026e-06
. O 0 1.5979637613128261e-09

Uniparental B-Disease 1 0.9994340538978577
disomy I-Disease 1 0.9998514652252197
associated O 0 1.2131330322517897e-06
with O 0 2.7999799701028394e-10
unbalanced O 0 1.5088156033016276e-05
segregation O 0 1.861083092080662e-07
of O 0 3.0021438893884644e-12
non O 0 9.640106768404877e-11
- O 0 1.9901008272427134e-06
Robertsonian O 0 1.998095103772357e-05
translocations O 0 1.0268878440911067e-06
has O 0 1.4442355755761582e-08
been O 0 1.972567220676069e-09
reported O 0 8.412762708687183e-10
previously O 0 8.719681920954514e-11
but O 0 3.261241970919926e-11
has O 0 4.622410787469278e-11
not O 0 6.50164123927599e-12
, O 0 4.116924019032485e-14
to O 0 3.665583190714389e-13
our O 0 1.6206577746480377e-11
knowledge O 0 4.70933296699283e-13
, O 0 2.3335221016780594e-13
been O 0 4.2025275620583e-11
observed O 0 7.089236749718841e-12
in O 0 6.802600373463381e-15
a O 0 5.85413390940398e-13
case O 0 2.2436920377177927e-11
of O 0 1.5501043157395422e-11
PWS B-Disease 1 0.9999723434448242
. O 0 5.457069907066625e-09

Furthermore O 0 3.06713417330684e-07
, O 0 1.7361312387720318e-10
our O 0 1.4776288526086034e-10
findings O 0 1.5070677344963812e-11
are O 0 4.078953564886148e-14
best O 0 3.14794089233128e-13
interpreted O 0 1.7480083136164892e-12
as O 0 2.2197505335566636e-13
true O 0 4.1503519371266506e-11
gamete O 0 3.2199629629303672e-09
complementation O 0 3.320823816466145e-05
resulting O 0 1.1230011587315403e-08
in O 0 6.285992559806886e-11
maternal B-Disease 0 0.0003001324075739831
UPD I-Disease 1 0.9999756813049316
15 I-Disease 0 1.0493347417650511e-06
and O 0 2.065684611807228e-06
PWS B-Disease 1 0.9997856020927429

Schwartz B-Disease 1 0.6696239709854126
- I-Disease 1 0.9987059831619263
Jampel I-Disease 1 0.9991884827613831
syndrome I-Disease 1 0.9998027682304382
type I-Disease 0 1.525565096471837e-08
2 I-Disease 0 1.0991482390920737e-08
and O 0 7.642125865459093e-08
Stuve B-Disease 1 0.9895135164260864
- I-Disease 1 0.9999948740005493
Wiedemann I-Disease 1 0.999997615814209
syndrome I-Disease 1 0.9999940395355225
: O 0 2.5587320890557708e-12
a O 0 6.003598090669957e-14
case O 0 5.594786244532413e-13
for O 0 5.964517345736359e-14
" O 0 4.1525236027517565e-10
lumping O 0 3.400836945388619e-08
" O 0 3.979626628236588e-10
. O 0 2.6184028903419865e-11

Recent O 0 9.428701375213677e-09
studies O 0 1.7834735910327026e-09
demonstrated O 0 2.960663936235619e-10
the O 0 2.702816269406494e-13
existence O 0 1.5171497955504543e-12
of O 0 4.064420681796927e-15
a O 0 1.9036764352386992e-12
genetically O 0 2.285720397676716e-11
distinct O 0 6.3070898330408465e-12
, O 0 2.960265713114474e-12
usually O 0 1.1812375079814363e-12
lethal O 0 2.313695025499274e-12
form O 0 5.453362438814953e-14
of O 0 4.28933384850113e-14
the O 0 2.374609620048318e-09
Schwartz B-Disease 1 0.9982004165649414
- I-Disease 1 0.9999908208847046
Jampel I-Disease 1 0.9999935626983643
syndrome I-Disease 1 0.9999921321868896
( O 0 5.106607151028619e-11
SJS B-Disease 0 0.0037580211646854877
) O 0 4.892306004755653e-11
of O 0 3.2194789369166532e-12
myotonia B-Disease 0 0.010272575542330742
and O 0 1.0991319498998564e-07
skeletal B-Disease 0 0.15613789856433868
dysplasia I-Disease 0 0.013598487712442875
, O 0 7.634014254076504e-11
which O 0 2.625664616284773e-11
we O 0 2.391041531435434e-11
called O 0 6.046289580119435e-10
SJS B-Disease 0 0.22884361445903778
type I-Disease 0 3.17574877506388e-09
2 I-Disease 0 6.046174116924874e-10
. O 0 2.547621835713443e-10

This O 0 1.5427863786499074e-07
disorder O 0 0.008917029947042465
is O 0 5.585007456510027e-10
reminiscent O 0 2.588266845293674e-08
of O 0 4.736538310005922e-13
another O 0 2.3644745883455442e-11
rare O 0 2.0384297028108733e-10
condition O 0 9.603298156690698e-10
, O 0 1.4639507596621304e-13
the O 0 6.730867946336261e-11
Stuve B-Disease 1 0.9897516965866089
- I-Disease 1 0.9999943971633911
Wiedemann I-Disease 1 0.9999964237213135
syndrome I-Disease 1 0.9999953508377075
( O 0 1.5386640572767618e-10
SWS B-Disease 0 0.0007114966865628958
) O 0 2.838946022709621e-10
, O 0 2.5669444868314795e-12
which O 0 2.1152687240677537e-11
comprises O 0 1.765152152048699e-12
campomelia B-Disease 0 9.510031873105618e-07
at O 0 5.549099402202273e-09
birth O 0 2.8117781880609982e-08
with O 0 9.958371016693945e-09
skeletal B-Disease 0 0.3831760287284851
dysplasia I-Disease 0 0.1648825705051422
, O 0 6.02360217261122e-10
contractures B-Disease 0 1.111821438826155e-05
, O 0 1.3815289190421964e-11
and O 0 5.747338802791768e-12
early B-Disease 0 4.303175038522511e-10
death I-Disease 0 8.394399628741667e-07
. O 0 1.801813920287998e-09

To O 0 2.6374963324471423e-10
test O 0 8.680553498230381e-11
for O 0 3.831418011633267e-15
possible O 0 4.216576740545541e-12
nosologic O 0 5.258978035271866e-07
identity O 0 6.182150968925271e-08
between O 0 1.7630787940703385e-09
these O 0 4.367358474866023e-09
disorders O 0 1.0318619388272054e-05
, O 0 2.0534974816497492e-13
we O 0 1.3531328293091283e-13
reviewed O 0 2.9836582423475866e-13
the O 0 6.70603926122143e-13
literature O 0 4.652934721544044e-12
and O 0 1.7188280963462144e-12
obtained O 0 2.653913059365992e-13
a O 0 1.4040812512227524e-13
follow O 0 1.229258882184947e-11
- O 0 3.170882667546948e-09
up O 0 5.373449685208698e-09
of O 0 9.562769040440556e-15
the O 0 1.6175247447881846e-13
only O 0 1.9305474645119058e-13
two O 0 2.0024507225990806e-12
surviving O 0 1.334972909994292e-09
patients O 0 4.1660194716706955e-13
, O 0 2.4341158276676043e-15
one O 0 2.210733766189188e-13
with O 0 8.311495935942048e-11
SJS B-Disease 0 0.06648029386997223
type I-Disease 0 2.3592061637600636e-09
2 I-Disease 0 2.6122287666296984e-10
at O 0 2.192229286990255e-09
age O 0 2.4630000729913837e-12
10 O 0 4.752492344974046e-13
years O 0 5.588656707550266e-12
and O 0 5.797641013105537e-13
another O 0 2.1913480145047126e-12
with O 0 4.932598218765349e-10
SWS B-Disease 0 0.0034608093556016684
at O 0 4.8321634693593296e-08
age O 0 1.4859806440892243e-10
7 O 0 1.0012545653692584e-10
years O 0 2.6825283661047195e-10
. O 0 7.784997646531622e-11

Patients O 0 1.468911534630024e-07
reported O 0 2.002431820358197e-08
as O 0 3.734397339971718e-12
having O 0 1.5446802170693275e-10
either O 0 1.6749454045950074e-09
neonatal O 1 0.5903545022010803
SJS B-Disease 1 0.9995150566101074
or O 0 2.8265120022297197e-07
SWS B-Disease 0 0.0013774583349004388
presented O 0 2.746588234625591e-10
a O 0 1.3170922685823427e-12
combination O 0 1.484506788329565e-11
of O 0 1.8314452873095105e-13
a O 0 3.0653030114180524e-10
severe O 0 3.2460965027070188e-09
, O 0 9.750453076233859e-14
prenatal O 0 1.283704733623381e-07
- O 1 0.8142167329788208
onset O 1 0.7386321425437927
neuromuscular B-Disease 1 0.9999910593032837
disorder I-Disease 1 0.9999746084213257
( O 0 5.396824653836063e-10
with O 0 1.7207275604391725e-08
congenital B-Disease 1 0.9998711347579956
joint I-Disease 0 2.78476181847509e-05
contractures I-Disease 1 0.9996181726455688
, O 0 1.0443310429764097e-06
respiratory O 0 0.21320012211799622
and O 0 1.4457375741017131e-08
feeding O 0 0.0001249738852493465
difficulties O 0 1.1514337074913783e-06
, O 0 1.3329793865923811e-11
tendency O 0 2.0136143863425104e-09
to O 0 3.719012320324566e-10
hyperthermia B-Disease 0 0.00019906256056856364
, O 0 1.232758062297279e-10
and O 0 2.1677626360627755e-10
frequent O 0 3.827151573432275e-08
death O 0 2.4132074031513184e-05
in O 0 1.3834235979004461e-09
infancy O 0 5.5403532314812765e-05
) O 0 7.729844867486457e-13
with O 0 1.0215756056841316e-13
a O 0 7.175881416854324e-12
distinct O 0 4.1487394075723216e-10
campomelic B-Disease 0 0.0027954024262726307
- I-Disease 0 0.009343933314085007
metaphyseal I-Disease 1 0.7662968039512634
skeletal I-Disease 1 0.9849290251731873
dysplasia I-Disease 1 0.9015549421310425
. O 0 1.5696027588774086e-08

The O 0 5.653889856294114e-11
similarity O 0 7.306873162082894e-11
of O 0 4.6150210660390184e-14
the O 0 1.4320645363996576e-12
clinical O 0 2.355679540322342e-10
and O 0 5.561228144657093e-10
radiographic O 0 1.5818837084680126e-07
findings O 0 2.882399041670425e-10
is O 0 1.931380836511787e-12
so O 0 9.235791385148184e-13
extensive O 0 7.591680105736853e-13
that O 0 8.906948067988196e-09
these O 0 4.393520569578868e-08
disorders O 0 0.002140008844435215
appear O 0 1.4571557849230032e-10
to O 0 6.738764060654212e-12
be O 0 1.292695117616205e-11
a O 0 6.690277672138922e-12
single O 0 2.0155894731033186e-09
entity O 0 1.4224691824438196e-07
. O 0 7.630182352613701e-08

The O 0 1.0625336027692e-10
follow O 0 3.1135566347373356e-10
- O 0 6.852631173615009e-08
up O 0 3.664590852991978e-09
observation O 0 2.080594585507356e-09
of O 0 2.2378076835701845e-14
an O 0 1.120336869065916e-13
identical O 0 7.160384507542972e-10
and O 0 1.1498235523432765e-11
unique O 0 1.4968399783543695e-12
pattern O 0 4.6143046006363875e-07
of O 0 2.490657680098707e-10
progressive O 0 0.00014121380809228867
bone B-Disease 1 0.9999607801437378
dysplasia I-Disease 0 0.4652639627456665
in O 0 2.1460317897736836e-11
the O 0 3.4236891099936884e-11
two O 0 3.619122779241479e-08
patients O 0 1.331799115433796e-09
( O 0 4.582461797172921e-14
one O 0 3.182743651963804e-11
with O 0 5.667953661969705e-09
SJS B-Disease 0 0.28539881110191345
type I-Disease 0 9.689903324172633e-10
2 I-Disease 0 6.146939207640756e-11
, O 0 3.5390280658277595e-13
one O 0 8.587832701911768e-12
with O 0 6.346084768793503e-10
SWS B-Disease 0 0.033792197704315186
) O 0 2.6907068240156207e-10
surviving O 0 4.4627849860034985e-08
beyond O 0 6.1863247857729675e-09
infancy O 0 1.0730988151408383e-06
adds O 0 2.3695715528626593e-11
to O 0 2.709288414275146e-13
the O 0 9.638143283691517e-14
evidence O 0 2.6635966002275246e-11
in O 0 1.1629767786812406e-13
favor O 0 2.520690633219663e-13
of O 0 1.6327215661827814e-14
identity O 0 3.179605201353297e-08
. O 0 2.061349146931235e-10

The O 0 3.1737915073826173e-10
hypothesis O 0 2.299204382438802e-08
that O 0 9.387017385620311e-09
SWS B-Disease 0 0.1875504106283188
and O 0 1.2685909496212844e-06
SJS B-Disease 1 0.8300194144248962
type I-Disease 0 2.927246001149797e-08
2 I-Disease 0 1.4894488975514264e-09
are O 0 1.7600388377628229e-12
the O 0 2.2454430675944437e-11
same O 0 3.359524214374687e-08
disorder O 0 1.7624764950596727e-05
should O 0 1.6291177391478118e-12
be O 0 5.860029394242142e-14
testable O 0 2.9427957466687804e-13
by O 0 2.2082619038205336e-15
molecular O 0 2.6211300924866565e-12
methods O 0 1.387868292512806e-10
. O 0 5.287513829554946e-11
. O 0 2.5415405890960585e-10

A O 0 7.495822296199606e-10
mouse O 0 6.139970878393797e-07
model O 0 7.647546595990207e-09
of O 0 1.6647091483079635e-09
severe O 1 0.7459841966629028
von B-Disease 1 0.9999994039535522
Willebrand I-Disease 1 0.9999953508377075
disease I-Disease 1 0.9999997615814209
: O 0 0.013028261251747608
defects O 1 0.9998362064361572
in O 0 5.98328995238262e-08
hemostasis O 1 0.9952558875083923
and O 0 0.00035170509363524616
thrombosis B-Disease 1 0.671960175037384
. O 0 5.934044793320936e-07

von B-Disease 1 0.966731071472168
Willebrand I-Disease 1 0.7135170102119446
factor I-Disease 0 2.62013818428386e-05
( I-Disease 0 1.7857031409107549e-09
vWf I-Disease 0 1.103465911000967e-05
) I-Disease 0 1.427324787073303e-05
deficiency I-Disease 1 0.9997950196266174
causes O 0 0.040697552263736725
severe O 1 0.9999428987503052
von B-Disease 1 0.9999996423721313
Willebrand I-Disease 1 0.9999954700469971
disease I-Disease 1 0.9999994039535522
in O 0 1.0167750730261105e-07
humans O 0 1.3349817606922443e-07
. O 0 8.970695297705333e-09

We O 0 1.1590191306698472e-10
generated O 0 1.1299775134684942e-12
a O 0 2.7649700562980273e-13
mouse O 0 2.1079900491827175e-08
model O 0 2.545071930981635e-10
for O 0 9.02148364692601e-13
this O 0 9.440779755176543e-12
disease O 0 6.332877972026196e-11
by O 0 1.438308266552105e-16
using O 0 1.5928110677740533e-14
gene O 0 8.087461950134767e-11
targeting O 0 2.1220650125997054e-08
. O 0 5.613008391414098e-10

vWf B-Disease 0 0.00031752241193316877
- I-Disease 1 0.7530168890953064
deficient I-Disease 1 0.9924523234367371
mice O 0 0.010178440250456333
appeared O 0 1.9455769688647706e-06
normal O 0 9.38121358373678e-10
at O 0 3.261680703303682e-09
birth O 0 9.702428194202639e-09
; O 0 9.80214715819161e-13
they O 0 4.786049486414645e-13
were O 0 8.732039071847331e-13
viable O 0 3.9416945402104275e-11
and O 0 3.558405514691998e-10
fertile O 0 2.1124336058164772e-08
. O 0 5.3525517351715735e-09

Neither O 0 1.4185108909714472e-07
vWf O 0 6.458875532189268e-07
nor O 0 9.24767746823818e-08
vWf O 0 3.867884515784681e-06
propolypeptide O 0 0.0016777247656136751
( O 0 6.686562858959633e-09
von B-Disease 0 0.19515040516853333
Willebrand I-Disease 0 0.07178909331560135
antigen O 0 0.000458661699667573
II O 0 0.039945490658283234
) O 0 5.316104223496154e-10
were O 0 3.683536115017816e-11
detectable O 0 6.773899774437098e-10
in O 0 2.736648527148361e-13
plasma O 0 3.6132539094069216e-07
, O 0 5.659848700823034e-10
platelets O 0 2.4687724362593144e-06
, O 0 4.319907626060271e-11
or O 0 7.458766243528814e-11
endothelial O 0 1.510252545244839e-08
cells O 0 1.171020641566045e-10
of O 0 9.625572298314726e-15
the O 0 3.556033722693086e-12
homozygous O 0 2.7106244715469074e-07
mutant O 0 1.730386611598078e-05
mice O 0 1.2669595889747143e-05
. O 0 3.933069869788142e-09

The O 0 7.844174754190192e-10
mutant O 0 0.00033591710962355137
mice O 0 0.07879599183797836
exhibited O 0 8.003898983588442e-05
defects O 1 0.8220380544662476
in O 0 2.604274018658259e-10
hemostasis O 0 4.4319047447061166e-05
with O 0 8.333453926923085e-10
a O 0 2.018182287955028e-09
highly O 0 2.4166547518689185e-07
prolonged O 0 0.00019263116701040417
bleeding O 1 0.837915301322937
time O 0 1.385042054380392e-07
and O 0 3.741827114822627e-08
spontaneous O 0 6.617771219907809e-08
bleeding O 1 0.9129796028137207
events O 0 6.7481251697643074e-09
in O 0 6.412806050071218e-12
approximately O 0 4.4490925700524375e-12
10 O 0 6.412760600316147e-11
% O 0 3.5889433785962765e-13
of O 0 4.1832765550198214e-12
neonates O 0 1.3373000001593027e-05
. O 0 1.786663816893963e-09

As O 0 1.8682801972147445e-09
in O 0 8.840284407285459e-12
the O 0 2.6875305800255767e-11
human O 0 2.2481150274700212e-09
disease O 0 6.316034983910868e-08
, O 0 7.179967612212096e-14
the O 0 2.688100732132527e-14
factor O 0 7.713221554517258e-12
VIII O 0 3.4671396065277804e-07
level O 0 8.784238336723149e-10
in O 0 6.082252214899275e-13
these O 0 1.5901209168833752e-11
mice O 0 5.1676649626131166e-09
was O 0 1.057576359819734e-09
reduced O 0 2.3212935480049213e-12
strongly O 0 4.147168719548233e-12
as O 0 3.1760468820890564e-12
a O 0 1.3496699417803182e-11
result O 0 3.382324281764326e-11
of O 0 1.323230533391978e-13
the O 0 7.074395236283948e-11
lack O 0 1.483714193173391e-11
of O 0 3.1031320955622046e-15
protection O 0 2.3797554638688156e-13
provided O 0 3.9678553682715584e-14
by O 0 2.2231909781005033e-13
vWf O 0 2.127693354836424e-09
. O 0 4.105444872948283e-10

Defective O 0 0.11211477965116501
thrombosis B-Disease 0 0.112637460231781
in O 0 1.0355712953824536e-09
mutant O 0 2.962340477097314e-05
mice O 0 8.793965389486402e-05
was O 0 1.834199792938307e-06
also O 0 1.2808842875244864e-08
evident O 0 7.050250605544761e-09
in O 0 7.099581475012232e-14
an O 0 2.9782114816835625e-13
in O 0 7.020276287378335e-12
vivo O 0 1.276723651244538e-07
model O 0 1.0867691191407403e-09
of O 0 5.109890635623948e-11
vascular B-Disease 0 0.13561254739761353
injury I-Disease 0 0.03384493291378021
. O 0 5.1522723865105036e-09

In O 0 7.511901690959721e-12
this O 0 5.213211318796235e-14
model O 0 2.966732111711612e-12
, O 0 6.493839754123654e-14
the O 0 2.321473905036314e-13
exteriorized O 0 1.2249756764504127e-07
mesentery O 0 1.7594088319583534e-07
was O 0 2.075150362657041e-08
superfused O 0 6.530176221986039e-08
with O 0 6.567398968398974e-12
ferric O 0 2.3370379409470843e-08
chloride O 0 3.5949952348346415e-08
and O 0 1.6957327209077278e-10
the O 0 5.441543916850922e-12
accumulation O 0 1.269867144770842e-08
of O 0 2.7666963772071673e-12
fluorescently O 0 0.00012624372902791947
labeled O 0 1.0106253284902778e-05
platelets O 0 2.9941268167021917e-06
was O 0 1.7687147746414666e-08
observed O 0 1.076650227305187e-11
by O 0 1.2324693945530568e-13
intravital O 0 1.2657925374526258e-08
microscopy O 0 2.6621163051743224e-09
. O 0 2.7729649132446355e-10

We O 0 1.6779000411304423e-09
conclude O 0 1.0647855513967741e-10
that O 0 4.1210351103826426e-13
these O 0 1.0839556520165355e-13
mice O 0 7.062979645588996e-10
very O 0 8.459654417952711e-13
closely O 0 2.1058952359709338e-09
mimic O 0 3.943393676308915e-05
severe O 0 9.882537415251136e-05
human O 0 0.003062607254832983
von B-Disease 1 0.9999998807907104
Willebrand I-Disease 1 0.9999992847442627
disease I-Disease 1 1.0
and O 0 4.2601212044246495e-05
will O 0 1.9270305351426487e-09
be O 0 2.245925884505895e-12
very O 0 6.353650888561973e-15
useful O 0 1.8745718342936916e-14
for O 0 3.7210938231379664e-16
investigating O 0 3.420069945563736e-13
the O 0 1.9490827815648107e-14
role O 0 1.0788944607501016e-12
of O 0 7.120286009561737e-15
vWf O 0 3.605131471129397e-11
in O 0 4.0493132393189246e-13
normal O 0 5.308927603087099e-11
physiology O 0 3.823839023198161e-08
and O 0 3.9607184199041967e-10
in O 0 1.6818938602947142e-11
disease O 0 2.199769610911062e-08
models O 0 1.766843962802689e-11
. O 0 2.493597342501097e-12
. O 0 1.206109101481445e-10

Oral O 0 1.6448893802589737e-05
contraceptives O 0 0.00047819013707339764
and O 0 3.946221482920009e-08
the O 0 8.831529396680082e-10
risk O 0 9.932724651662284e-07
of O 0 9.02561581028749e-09
hereditary B-Disease 1 0.9999892711639404
ovarian I-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999891519546509
. O 0 1.3580330460172263e-06

Hereditary B-Disease 1 0.9996198415756226
Ovarian I-Disease 1 0.9996423721313477
Cancer I-Disease 0 0.0819636732339859
Clinical O 0 4.2334440308877674e-07
Study O 0 1.384405590165727e-09
Group O 0 1.5299301381332953e-08
. O 0 1.749658751215577e-09

BACKGROUND O 0 3.54068879460101e-06
Women O 0 7.485977393528742e-10
with O 0 2.1233856686841968e-11
mutations O 0 6.575263666874775e-10
in O 0 4.324412735453448e-13
either O 0 1.917835248249622e-12
the O 0 2.7792898191214555e-12
BRCA1 O 0 2.6489340143598383e-07
or O 0 5.638439160016162e-10
the O 0 1.081691160254028e-11
BRCA2 O 0 8.199742751457961e-08
gene O 0 7.0115886430244245e-09
have O 0 8.734279965949554e-11
a O 0 1.1712389738627316e-11
high O 0 1.2059290099841746e-07
lifetime O 0 1.5378315083580674e-06
risk O 0 4.0915449062595144e-05
of O 0 7.644931088179874e-07
ovarian B-Disease 1 0.9999984502792358
cancer I-Disease 1 0.9999884366989136
. O 0 7.189410098362714e-07

Oral O 0 5.858338772668503e-05
contraceptives O 0 0.08648491650819778
protect O 0 0.1462440937757492
against O 1 0.9782962799072266
ovarian B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999983310699463
in O 0 5.607804845486619e-11
general O 0 9.817134084821877e-13
, O 0 4.191289329491532e-11
but O 0 2.150835620717828e-10
it O 0 2.695088319182304e-10
is O 0 4.943773255355888e-12
not O 0 7.622512647117996e-13
known O 0 2.5217054464531097e-13
whether O 0 2.756472784401498e-12
they O 0 1.6394956572907127e-11
also O 0 4.935230696334614e-11
protect O 0 8.783098692788371e-10
against O 0 1.0102138681133965e-08
hereditary B-Disease 0 0.1094064712524414
forms I-Disease 0 6.301931421148765e-08
of I-Disease 0 1.837255149439443e-05
ovarian I-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999872446060181
. O 0 8.020863617730356e-08

METHODS O 0 2.0702066449995726e-10
We O 0 1.480163908107457e-11
enrolled O 0 3.908497657467702e-12
207 O 0 5.6011323579241434e-08
women O 0 1.2350602762722929e-09
with O 0 8.652198175695958e-07
hereditary B-Disease 1 0.9999991655349731
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
and O 0 4.2912539299777563e-08
161 O 0 1.4107844892308208e-09
of O 0 2.9227603410425518e-12
their O 0 3.8808325442118985e-09
sisters O 0 3.654959712662276e-08
as O 0 7.66605355584371e-12
controls O 0 5.128474311888453e-10
in O 0 1.5421374572298363e-13
a O 0 4.468516702493819e-12
case O 0 2.0264821765092478e-10
- O 0 1.4531181591337372e-07
control O 0 4.245670766067633e-07
study O 0 2.84202730793659e-11
. O 0 2.4098497503066696e-11

All O 0 3.449225627338848e-11
the O 0 2.8360690532136523e-12
patients O 0 2.6524520427284592e-12
carried O 0 2.1752417575515715e-11
a O 0 7.548806415028086e-14
pathogenic O 0 5.49686511586156e-11
mutation O 0 2.7769292421098157e-10
in O 0 3.990636380374335e-12
either O 0 2.148285438430264e-10
BRCA1 O 0 9.579804327586317e-07
( O 0 6.110255530711317e-12
179 O 0 3.878967813619738e-09
women O 0 1.6344478548369068e-10
) O 0 4.570562331385197e-11
or O 0 3.185461450172511e-09
BRCA2 O 0 0.00016091440920718014
( O 0 1.8249657340874137e-10
28 O 0 1.2415822148170719e-08
women O 0 1.318652131931941e-10
) O 0 1.479610704790968e-11
. O 0 1.5027629141073362e-10

The O 0 6.217253933904487e-10
control O 0 9.974339718610281e-07
women O 0 6.14730280568132e-11
were O 0 2.942915008907754e-12
enrolled O 0 2.2469702422485416e-13
regardless O 0 5.166531265310415e-13
of O 0 5.811141532438644e-15
whether O 0 7.793388330512574e-12
or O 0 8.207956883610201e-12
not O 0 1.831580026534496e-11
they O 0 1.902445865772928e-12
had O 0 2.3919183300691316e-10
either O 0 2.4290502335239106e-12
mutation O 0 5.082404497258608e-10
. O 0 4.70468997093576e-10

Lifetime O 0 1.9581229935283773e-06
histories O 0 9.554378976872613e-08
of O 0 1.5895227842288584e-12
oral O 0 2.2658077636350527e-09
- O 0 3.1627660490585185e-08
contraceptive O 0 1.373383383906912e-06
use O 0 9.389993990693846e-12
were O 0 5.420515165194262e-12
obtained O 0 7.196643454776552e-13
by O 0 3.8224146612676757e-13
interview O 0 4.4535144461121945e-09
or O 0 4.992126937525265e-12
by O 0 4.903471698776071e-14
written O 0 1.2678347087458075e-11
questionnaire O 0 1.1607712707695228e-10
and O 0 1.8052727715489603e-11
were O 0 3.184115818233302e-11
compared O 0 8.932283732110413e-12
between O 0 8.237662288412828e-12
patients O 0 1.671962568394747e-11
and O 0 2.101479407157214e-11
control O 0 6.703715627054407e-08
women O 0 1.1469278651810022e-11
, O 0 1.0724700885396746e-13
after O 0 2.8407536739605277e-11
adjustment O 0 1.957243395134256e-12
for O 0 1.1331095372226125e-15
year O 0 1.7768929773745445e-13
of O 0 1.19813208494606e-14
birth O 0 2.4038475654464264e-09
and O 0 7.114245303974087e-11
parity O 0 4.824654897817027e-09
. O 0 9.074889451010648e-11

RESULTS O 0 3.3794067544334894e-09
The O 0 1.5354268204093025e-11
adjusted O 0 2.53647328918305e-07
odds O 0 0.0001375063875457272
ratio O 0 2.4265456886496395e-05
for O 0 4.1766586946323514e-05
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999997615814209
associated O 0 1.8269220447564294e-07
with O 0 6.180772040009774e-12
any O 0 1.5275768931038991e-12
past O 0 4.275016451948943e-10
use O 0 5.2858268977107326e-12
of O 0 6.150932627818628e-13
oral O 0 8.838746623496263e-09
contraceptives O 0 3.439486590650631e-06
was O 0 6.523995352836209e-07
0 O 0 2.1413870676667557e-11
. O 0 2.118874520284919e-11

5 O 0 1.6354098519855143e-08
( O 0 7.534616160154162e-12
95 O 0 7.515090216791975e-10
percent O 0 4.3582407016629077e-08
confidence O 0 3.3707419078155e-09
interval O 0 2.5069157860713176e-09
, O 0 1.0764231574231925e-13
0 O 0 1.8948174463923745e-14
. O 0 3.921858684026924e-15
3 O 0 3.498315528861935e-14
to O 0 4.701865524529836e-13
0 O 0 3.33985036892262e-13
. O 0 1.131281618946614e-13
8 O 0 6.072113298283277e-12
) O 0 1.6899802954620236e-12
. O 0 1.0086990270830043e-11

The O 0 1.0890723878276276e-09
risk O 0 5.842647965437209e-08
decreased O 0 4.08005879082296e-10
with O 0 3.1562556387920715e-13
increasing O 0 2.642079263703856e-13
duration O 0 1.7745138691793727e-11
of O 0 5.574106138413106e-15
use O 0 2.1929116508778712e-12
( O 0 2.021510671530724e-13
P O 0 2.4943906939967064e-09
for O 0 1.617986750438935e-14
trend O 0 2.4241917501166554e-11
, O 0 4.755182318326619e-14
< O 0 1.0244634459331825e-13
0 O 0 8.028550121540103e-15
. O 0 6.450039002794776e-15
001 O 0 1.1103776752230399e-11
) O 0 4.715874568563157e-14
; O 0 1.4944064645553692e-16
use O 0 9.205580540539338e-16
for O 0 1.6185947506884742e-14
six O 0 6.474268170186814e-12
or O 0 3.353467243477626e-12
more O 0 1.0023990338681784e-14
years O 0 1.8519156694263295e-11
was O 0 1.5417670473638623e-09
associated O 0 2.4668117483590823e-13
with O 0 5.927836414548922e-15
a O 0 8.178885086557175e-13
60 O 0 6.7696954812734855e-12
percent O 0 2.0735339834043742e-10
reduction O 0 1.3441543017522761e-11
in O 0 1.3110669234289718e-12
risk O 0 3.049628993778697e-09
. O 0 1.1621980461340442e-10

Oral O 0 1.3942405985289952e-07
- O 0 2.5846441076282645e-07
contraceptive O 0 1.5859874110901728e-05
use O 0 7.684715974676237e-09
protected O 0 0.0002316590107511729
against O 1 0.7941011190414429
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999998927116394
both O 0 1.7076369832058624e-11
for O 0 3.6418384855105984e-14
carriers O 0 5.481803704542043e-13
of O 0 6.210897037829417e-15
the O 0 9.088452213035225e-11
BRCA1 O 0 1.5409294064738788e-05
mutation O 0 9.122104671632769e-08
( O 0 2.9506828837927435e-12
odds O 0 2.2149770018131676e-08
ratio O 0 1.6526726168142325e-11
, O 0 5.2280083067584096e-14
0 O 0 1.3248663403603745e-14
. O 0 1.1083023774172574e-14
5 O 0 6.046096240851229e-13
; O 0 2.029860112461035e-13
95 O 0 4.50109290117684e-11
percent O 0 1.5018962074009323e-08
confidence O 0 1.4037574436187583e-09
interval O 0 9.190556093940927e-10
, O 0 2.9152147276029217e-13
0 O 0 7.229489732286497e-15
. O 0 3.316246220366097e-15
3 O 0 5.928653970749612e-14
to O 0 8.353221543286327e-13
0 O 0 5.013097142264611e-13
. O 0 1.238350784762976e-13
9 O 0 4.669052037359345e-12
) O 0 3.526426180689053e-14
and O 0 2.1677831310074926e-14
for O 0 1.5216908516243083e-16
carriers O 0 8.104308748342528e-15
of O 0 9.260101933771729e-16
the O 0 1.965497035960606e-11
BRCA2 O 0 1.6467209889015066e-06
mutation O 0 1.6842623296042802e-08
( O 0 1.9874503247568204e-13
odds O 0 7.601287599356965e-09
ratio O 0 5.937395540500656e-12
, O 0 1.279664342426854e-14
0 O 0 7.61448399450547e-15
. O 0 1.4724744522103504e-14
4 O 0 2.194041389541601e-12
; O 0 1.830380194200315e-13
95 O 0 2.4183452115855708e-11
percent O 0 1.2129620863277069e-08
confidence O 0 2.404278776069191e-09
interval O 0 8.032920439937641e-10
, O 0 4.659128443294802e-14
0 O 0 3.547026064317925e-15
. O 0 2.878326374987361e-15
2 O 0 8.215827242705545e-14
to O 0 1.9599544155615017e-13
1 O 0 2.926546266608654e-13
. O 0 1.053780747015641e-13
1 O 0 1.885744598667527e-12
) O 0 5.993786630215103e-12
. O 0 1.967023419147118e-11

CONCLUSIONS O 0 1.1936654686905968e-07
Oral O 0 2.568443235873019e-08
- O 0 4.75307508907008e-08
contraceptive O 0 1.264855654881103e-06
use O 0 2.1757738666305926e-10
may O 0 4.1939060557716346e-10
reduce O 0 4.26279289644782e-11
the O 0 4.1183834120772644e-11
risk O 0 2.847251153070829e-06
of O 0 3.0667979444842786e-07
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999995231628418
in O 0 1.4985447327475754e-09
women O 0 1.0915106492259685e-11
with O 0 7.07537381548079e-13
pathogenic O 0 3.5657157781976423e-10
mutations O 0 3.3020171041897584e-09
in O 0 3.4968368803865724e-13
the O 0 4.2031668943953715e-12
BRCA1 O 0 3.140754415653646e-06
or O 0 3.214215027469436e-08
BRCA2 O 0 0.0004145128186792135
gene O 0 0.0006128690438345075

A O 0 7.680612590377223e-09
Japanese O 0 6.171545940958367e-09
family O 0 2.7464637231133793e-09
with O 0 1.0802297945033956e-10
adrenoleukodystrophy B-Disease 1 0.9999357461929321
with O 0 1.3002588372321155e-12
a O 0 3.863549833792862e-13
codon O 0 9.128183625639608e-11
291 O 0 1.930882786993493e-09
deletion O 0 1.1423366430562965e-07
: O 0 1.3859516832803731e-12
a O 0 6.242042473181275e-13
clinical O 0 3.001666137869563e-10
, O 0 1.0238804595830153e-11
biochemical O 0 3.073836651878992e-08
, O 0 8.893460273773357e-11
pathological O 0 5.471465414075283e-08
, O 0 6.545430170090683e-11
and O 0 5.612569298207859e-10
genetic O 0 1.4269474490902212e-07
report O 0 8.588275335341677e-08
. O 0 5.131644553735271e-10

We O 0 1.262291160486484e-09
report O 0 6.1429160369552704e-12
a O 0 1.2766030637115233e-13
Japanese O 0 1.6389244128500735e-10
family O 0 6.886656134241775e-09
with O 0 2.469986348785369e-08
adrenoleukodystrophy B-Disease 1 0.9999990463256836
( O 0 1.6606783725947594e-09
ALD B-Disease 1 0.9999984502792358
) O 0 6.248183220813885e-11
with O 0 1.987010545250606e-13
a O 0 2.667106715602968e-13
three O 0 8.263513571332703e-13
base O 0 1.022715731546775e-10
pair O 0 2.1936571670266858e-07
deletion O 0 1.7895266068990168e-07
( O 0 1.2144869528454838e-13
delGAG O 0 3.5085754301888983e-09
291 O 0 1.7612470371020095e-09
) O 0 8.236247621418169e-12
in O 0 1.938868716185732e-13
the O 0 1.375320302088312e-09
ALD B-Disease 1 0.999982476234436
gene O 0 3.187753463862464e-06
. O 0 9.845562587429413e-09

A O 0 1.2697938256422958e-09
variety O 0 2.3292645590089478e-11
of O 0 5.5374394306029195e-12
phenotypes O 0 1.5545360554369836e-08
were O 0 1.405980748492297e-10
observed O 0 1.2286406614325784e-10
within O 0 3.650058093230754e-14
this O 0 2.3450080852832622e-12
family O 0 3.1238446496217875e-08
. O 0 1.8188298644972178e-09

While O 0 4.066606607011636e-08
the O 0 8.542669904798572e-10
proband O 0 3.596180977183394e-05
( O 0 3.5757987282974968e-12
patient O 0 8.874452284146628e-10
1 O 0 2.3093589540668091e-10
) O 0 2.7168357841222956e-11
was O 0 2.917267538649071e-09
classified O 0 2.905216622828277e-10
as O 0 1.2589855373501546e-12
having O 0 2.6614621964626828e-12
a O 0 6.901879241738573e-14
rare O 0 4.2721351629915194e-12
intermediate O 0 5.826780724582648e-11
type O 0 2.363256985937756e-11
of O 0 1.266161763109619e-12
adult O 0 1.4880213711876422e-05
cerebral O 0 0.025782447308301926
and O 0 7.252053535466985e-08
cerebello O 1 0.5475339293479919
- O 1 0.9842819571495056
brain O 1 0.999498724937439
stem O 0 1.6318459529429674e-05
forms O 0 4.252684593364364e-10
, O 0 3.8049990935817846e-10
his O 0 5.980563173579867e-07
younger O 0 2.656130959621805e-07
brother O 0 1.0246711781292106e-06
( O 0 1.1298260097674165e-13
patient O 0 1.033142182915725e-10
2 O 0 2.712881308486459e-10
) O 0 1.503433905147844e-10
and O 0 6.406703167982641e-09
nephew O 0 7.234104486997239e-06
( O 0 9.266300834281926e-13
patient O 0 3.1864502703093933e-10
3 O 0 7.206269470039217e-10
) O 0 8.554813107908288e-11
had O 0 3.106868575741828e-07
a O 0 2.469228199686313e-08
childhood O 0 0.0028122689109295607
ALD B-Disease 1 0.999994158744812
type O 0 5.812647145830852e-07
. O 0 9.491963659513658e-09

Another O 0 1.6740112585011957e-07
nephew O 0 0.00013793082325719297
( O 0 2.2377526220918043e-10
patient O 0 9.186478244771479e-09
4 O 0 3.883031673979076e-09
) O 0 6.427797877295305e-11
of O 0 2.2231740374415582e-13
patient O 0 3.5598377023937644e-10
1 O 0 2.6815192427642742e-11
was O 0 1.2407323168872608e-08
classified O 0 2.496047146749447e-09
as O 0 2.9738721901706455e-11
having O 0 1.2571869933974966e-10
an O 0 8.12836169900022e-12
adolescent O 0 5.4649021876684856e-06
form O 0 1.0654768178852692e-09
. O 0 1.1231124474875287e-08

The O 0 2.4455592065319998e-11
tau O 0 9.203603851259956e-11
level O 0 6.419849651884135e-10
in O 0 2.2247374081851845e-11
the O 0 3.260798919768604e-08
cerebrospinal O 1 0.9909060001373291
fluid O 0 0.004740356467664242
( O 0 8.900935988265246e-09
CSF O 1 0.5552619695663452
) O 0 4.890881033503547e-10
in O 0 8.837311850189156e-13
patient O 0 2.4486690453073834e-10
1 O 0 7.801955262398685e-12
was O 0 1.6342623254672617e-08
as O 0 6.928581840204284e-12
high O 0 6.885667591660649e-10
as O 0 2.9500638043522542e-12
that O 0 6.6056023498295424e-12
of O 0 2.822926625529326e-13
patients O 0 1.0013653101159647e-10
with O 0 8.547481833431902e-09
Alzheimers B-Disease 1 0.999650239944458
disease I-Disease 0 0.004675911273807287
( O 0 1.4826949347110374e-12
AD B-Disease 0 1.799473210439828e-07
) O 0 6.0236599042085e-10
. O 0 3.0051547361686914e-10

His O 0 3.53508426087501e-07
brain O 0 7.350156374741346e-05
magnetic O 0 3.229244612157345e-06
resonance O 0 1.3144419426680543e-05
image O 0 5.980825153528713e-05
( O 0 8.175259774700905e-11
MRI O 0 9.818542821449228e-06
) O 0 8.906306447897805e-08
showed O 0 2.7813701308332384e-05
abnormalities B-Disease 0 8.442292892141268e-05
in I-Disease 0 3.136350229006324e-13
the I-Disease 0 4.5232949330564765e-12
bilateral I-Disease 0 1.6375844325011712e-06
cerebellar I-Disease 1 0.9655454754829407
hemispheres I-Disease 0 0.1149115115404129
and O 0 5.698204859072575e-06
brain O 0 0.007715489249676466
stem O 0 1.0043349902844056e-06
, O 0 7.623537912060385e-11
but O 0 1.2866616105888795e-10
not O 0 3.174540491590605e-11
in O 0 1.4102019899042695e-11
the O 0 1.2080815281478863e-07
cerebral O 0 0.03350792080163956
white O 0 7.342551100464334e-08
matter O 0 1.6761198332049254e-11
, O 0 1.4798033200831735e-14
where O 0 2.7869218976843413e-13
marked O 0 9.794078742464407e-12
reductions O 0 3.8047433259524865e-11
of O 0 1.3165289442385736e-13
the O 0 2.5242718137974407e-08
cerebral O 0 0.02057594433426857
blood O 0 8.926595910452306e-05
flow O 0 4.1421736796110054e-07
and O 0 4.30250413074873e-09
oxygen O 0 1.457137788207774e-08
metabolism O 0 4.52019932595249e-08
were O 0 3.4635710965957855e-11
clearly O 0 6.724516082856624e-11
demonstrated O 0 4.1146418412220387e-13
by O 0 3.6078207953159185e-15
positron O 0 1.7838827304217375e-08
emission O 0 7.896131748452717e-09
tomography O 0 4.484356850298354e-06
( O 0 3.296626860382901e-11
PET O 0 1.4544296789154032e-07
) O 0 1.2032505547487915e-10
. O 0 6.751298131657535e-11

In O 0 7.291492409855493e-10
patients O 0 6.356721260480924e-10
2 O 0 3.242140722559128e-10
and O 0 4.225160846194065e-11
3 O 0 1.7819655473427787e-11
, O 0 1.142917412187e-13
the O 0 3.952592105612579e-13
autopsy O 0 1.1699667084030807e-06
findings O 0 5.371061817527334e-09
showed O 0 1.701907876849873e-07
massive O 0 7.664942103247085e-08
demyelination B-Disease 1 0.9999964237213135
of I-Disease 0 3.020924344010467e-10
the I-Disease 0 1.3221658434758865e-07
cerebral I-Disease 0 0.048130977898836136
white I-Disease 0 5.493980381743313e-08
matter I-Disease 0 1.2126311239868404e-12
with O 0 1.1271220942525324e-14
sparing O 0 2.145235757696623e-13
of O 0 1.5982402101527744e-14
the O 0 1.803628496555021e-10
U O 0 1.6156920537468977e-05
- O 0 5.624891855404712e-05
fibers O 0 1.7120086113209254e-06
, O 0 2.3812085658304893e-13
compatible O 0 6.070784847045374e-11
with O 0 2.2710396931080457e-12
the O 0 7.917611011265535e-12
findings O 0 4.179827040040607e-10
of O 0 3.414025312453717e-11
childhood O 0 0.00010378332081018016
ALD B-Disease 1 0.9999814033508301
. O 0 1.856161979674198e-08

Oleic O 0 0.0007664593285880983
and O 0 8.987328925513793e-08
erucic O 0 0.00013071032299194485
acids O 0 4.1200638634109055e-07
( O 0 1.543684763349873e-10
Lorenzos O 0 3.0749852157896385e-06
Oil O 0 3.3102352858804807e-08
) O 0 8.670698707635704e-13
were O 0 1.4889459565466112e-13
administered O 0 1.3262980123884827e-13
to O 0 1.0305019641429491e-12
patients O 0 2.1724780991088516e-13
1 O 0 5.3555707909885494e-14
and O 0 6.039137506047565e-12
4 O 0 1.3020289707510457e-11
, O 0 1.1599285442732976e-13
but O 0 3.1221984090994137e-13
sufficient O 0 1.1341436585720916e-14
effectiveness O 0 2.7496884977273872e-12
was O 0 6.569794708255472e-11
not O 0 2.505997796428683e-13
obtained O 0 7.301366976297796e-12
. O 0 5.0831391179562146e-11

The O 0 5.197316466087898e-10
findings O 0 1.2607025146049722e-10
in O 0 8.221772329793098e-13
this O 0 2.2500066859578588e-13
family O 0 6.947376701704755e-11
suggest O 0 3.6234327170647784e-12
that O 0 3.0028941572918244e-12
delGAG291 O 0 1.7909936866900011e-09
is O 0 4.801358095829489e-12
part O 0 1.0277926242290708e-13
of O 0 1.8790824541444102e-14
the O 0 3.067032391945723e-11
cause O 0 6.903183025208648e-10
of O 0 7.509032458330456e-13
Japanese O 0 8.88482361460774e-07
ALD B-Disease 1 0.99998939037323
with O 0 8.356110942076e-12
phenotypic O 0 7.680264410558912e-12
variations O 0 3.956695859841375e-09
. O 0 1.045847519698384e-09

Moreover O 0 2.0475267703545796e-08
, O 0 1.0007709938530951e-11
although O 0 4.279301522511214e-13
the O 0 2.1193736056499685e-13
scale O 0 1.0129377336909329e-09
of O 0 5.768275397263767e-14
the O 0 4.954383257815831e-12
study O 0 1.1897076206135448e-12
is O 0 4.013963098535578e-13
limited O 0 8.375009805669867e-14
, O 0 2.754726514172384e-13
there O 0 3.303949250147743e-14
is O 0 2.963392538627395e-14
a O 0 1.98496394424345e-14
possibility O 0 1.5197034169273094e-13
that O 0 5.795885906628717e-12
PET O 0 4.0475548246377e-08
can O 0 1.0895975788294265e-10
detect O 0 3.3085562733958795e-08
an O 0 4.795530292311945e-11
insidious B-Disease 0 0.0009517786093056202
lesion I-Disease 1 0.9918465614318848
which O 0 1.749367925185652e-06
is O 0 2.6539323516594493e-10
undetectable O 0 1.2920240877178912e-08
by O 0 8.628743336167033e-13
computed O 0 1.0420269980215835e-08
tomogram O 0 6.188202678458765e-05
( O 0 5.411507179864383e-12
CT O 0 6.165925015011453e-07
) O 0 6.816953945776305e-11
or O 0 2.965081999373176e-11
MRI O 0 6.972287192041904e-09
analysis O 0 1.4575637571900835e-11
, O 0 5.140560828571783e-13
and O 0 2.6016450278831815e-12
that O 0 6.774819962841738e-13
the O 0 6.738426548517917e-13
higher O 0 1.6554110512934095e-11
level O 0 8.163366684021955e-12
of O 0 1.1564508641610967e-14
tau O 0 1.0895335333807946e-13
reflects O 0 4.702131967213724e-14
the O 0 2.2499357130672084e-15
process O 0 1.0215892259739234e-13
of O 0 2.2390374060030083e-14
neuronal B-Disease 0 8.878149628799292e-07
degeneration I-Disease 0 0.018182119354605675
in O 0 3.428151273965341e-08
ALD B-Disease 1 0.9999730587005615
. O 0 2.7513576128512796e-07

Lorenzos O 0 0.00016910104022827
Oil O 0 7.929625667202345e-08
should O 0 8.536455396723763e-12
be O 0 7.146902834083077e-14
given O 0 1.8986728439067445e-15
in O 0 4.556224104598772e-16
the O 0 2.2009002557726517e-14
early O 0 8.021506202327e-12
stage O 0 1.2011096561792556e-09
. O 0 1.2956245234660435e-12
. O 0 7.46770180415357e-12

Nonsense O 0 2.125651690221275e-06
mutation O 0 1.4823191563095861e-08
in O 0 8.770149537151717e-12
exon O 0 1.1496739560357128e-08
4 O 0 5.7440048273349475e-09
of O 0 1.6982524327774362e-12
human O 0 6.524614876157742e-11
complement O 0 1.3599112114182077e-10
C9 O 0 2.9824431635461224e-07
gene O 0 2.1717916354191402e-08
is O 0 2.5706103912170875e-11
the O 0 3.911225184873024e-13
major O 0 2.244775025583845e-11
cause O 0 4.5041184670857604e-10
of O 0 7.853800617664553e-14
Japanese O 0 7.925313738610384e-09
complement B-Disease 0 1.1283515455318138e-08
C9 I-Disease 0 0.0030573937110602856
deficiency I-Disease 0 0.01582452468574047
. O 0 2.273087412740793e-10

Deficiency B-Disease 1 0.9994165897369385
of I-Disease 0 1.115297199212606e-12
the I-Disease 0 1.4992285841605724e-12
ninth I-Disease 0 2.5951614190944383e-09
component I-Disease 0 6.409862224332485e-11
of I-Disease 0 5.028838673606928e-14
human I-Disease 0 7.446111435771563e-12
complement I-Disease 0 2.507756224900959e-10
( O 0 6.139060071928826e-13
C9 O 0 4.0578047588724075e-08
) O 0 5.629822779837368e-13
is O 0 1.269642926221299e-14
the O 0 1.8444034429761615e-15
most O 0 3.87804968259714e-13
common O 0 4.6459622815575585e-09
complement B-Disease 1 0.9999979734420776
deficiency I-Disease 1 0.9999998807907104
in O 0 7.670060767073217e-12
Japan O 0 4.736834258167733e-10
but O 0 4.365039232845369e-11
is O 0 6.608849752176571e-13
rare O 0 1.28722987130514e-12
in O 0 5.397150367819842e-15
other O 0 2.904734490590498e-14
countries O 0 2.818665439940915e-13
. O 0 3.1211105748496504e-12

We O 0 2.7550300929490845e-10
studied O 0 1.3540269166306684e-12
the O 0 4.504484791081637e-15
molecular O 0 2.2936064939665934e-12
basis O 0 9.665892218568839e-13
of O 0 2.418617216226604e-11
C9 B-Disease 0 0.10779640823602676
deficiency I-Disease 0 0.08033386617898941
in O 0 1.2381995385599143e-13
four O 0 1.2552312488034456e-11
Japanese O 0 6.977515454309469e-09
C9 B-Disease 0 3.168400871800259e-05
- I-Disease 0 0.003946174867451191
deficient I-Disease 0 0.12186216562986374
patients O 0 2.4570086409880787e-08
who O 0 9.40700530804861e-08
had O 0 2.0959836547262967e-05
suffered O 0 0.00014007335994392633
from O 0 4.6781782891969215e-09
meningococcal B-Disease 1 0.9999798536300659
meningitis I-Disease 1 0.9999799728393555
. O 0 4.029991274023814e-08

Direct O 0 8.535575891921443e-12
sequencing O 0 9.561261782309316e-10
of O 0 5.3834332824909126e-12
amplified O 0 1.4260128011756024e-07
C9 O 0 2.1382072645792505e-07
cDNA O 0 1.1106928710091779e-08
and O 0 1.9153696684259813e-10
DNA O 0 2.7022133419762895e-09
revealed O 0 1.1305526514959752e-09
a O 0 6.550503547789535e-14
nonsense O 0 2.140019238205948e-11
substitution O 0 2.3129038289639026e-13
( O 0 1.6733630328491663e-15
CGA O 0 1.809562222288008e-10
- O 0 5.994507290552065e-08
- O 0 2.1358321191655705e-06
> O 0 3.8587466555384253e-10
TGA O 0 2.5747263876496618e-08
) O 0 1.0678427814301422e-13
at O 0 9.082338559614905e-14
codon O 0 1.6458724303152622e-14
95 O 0 7.630185444248722e-15
in O 0 2.9222486331925224e-15
exon O 0 4.852881985151214e-11
4 O 0 1.347880140833979e-10
in O 0 3.8392786129090584e-13
the O 0 3.2743664550582974e-12
four O 0 3.9310146249249556e-09
C9 B-Disease 0 0.00010816327267093584
- I-Disease 0 0.0019327611662447453
deficient I-Disease 0 0.002557460218667984
individuals O 0 6.37205869666313e-12
. O 0 2.374711365049631e-11

An O 0 6.393570568807849e-12
allele O 0 8.148662189455536e-09
- O 0 5.132946845343156e-10
specific O 0 1.4886684550005636e-12
polymerase O 0 7.140886850720563e-07
chain O 0 9.480673952566576e-07
reaction O 0 3.6288586025001734e-10
system O 0 1.3263512510519604e-09
designed O 0 1.0542799522283985e-08
to O 0 1.1806030111860544e-11
detect O 0 3.6203360309627897e-09
exclusively O 0 2.035583724149803e-12
only O 0 1.5162986155298902e-13
one O 0 9.48168003530106e-14
of O 0 4.791504446357599e-16
the O 0 1.2392085242066836e-13
normal O 0 2.4594042080661183e-12
and O 0 8.101754510325687e-12
mutant O 0 2.5529347524866353e-09
alleles O 0 3.184542629597331e-10
indicated O 0 8.989051725194486e-10
that O 0 3.3979774289455422e-12
all O 0 2.2872085085265392e-14
the O 0 2.86004537110654e-13
four O 0 1.678445750441515e-11
patients O 0 2.5033797192326734e-13
were O 0 1.1600916658782798e-14
homozygous O 0 1.0905029049906867e-12
for O 0 7.330599525804651e-16
the O 0 8.576970242975962e-14
mutation O 0 1.5251263793536474e-11
in O 0 6.514212455045743e-13
exon O 0 7.455214223739404e-10
4 O 0 1.3441050050744252e-08
and O 0 5.336343811279676e-09
that O 0 9.375650256160384e-10
the O 0 1.5119745733205292e-10
parents O 0 1.569202962015126e-10
of O 0 2.1867571772457572e-14
patient O 0 1.867588028670042e-10
2 O 0 7.463216676606432e-12
were O 0 2.9245630223107e-11
heterozygous O 0 3.308308738070309e-09
. O 0 1.1255259918518945e-10

The O 0 4.977212045287338e-11
common O 0 1.530964244267352e-11
mutation O 0 2.0297303768290753e-11
at O 0 2.0849068999018172e-11
codon O 0 2.4171031929448583e-12
95 O 0 1.9934648549935208e-12
in O 0 7.261185468003528e-13
exon O 0 6.131758212291061e-09
4 O 0 8.552276220541444e-09
might O 0 6.213590753034737e-10
be O 0 1.8835185689770884e-13
responsible O 0 1.3978924896969336e-13
for O 0 7.098806101052315e-15
most O 0 2.965440664293856e-13
Japanese O 0 5.3259544330330755e-08
C9 B-Disease 0 0.0007752306992188096
deficiency I-Disease 0 0.00033700515632517636
. O 0 9.972301847141485e-13
. O 0 1.568451098166168e-11

BRCA1 O 0 1.10323662738665e-06
required O 0 3.566979350777544e-11
for O 0 3.042695828907489e-14
transcription O 0 1.2274958294256066e-07
- O 0 0.0023804178927093744
coupled O 0 0.00017034131451509893
repair O 0 7.694478881603573e-06
of O 0 1.435748546961546e-12
oxidative O 0 7.007697977456928e-09
DNA O 0 3.363350515428465e-06
damage O 0 1.2185840205347631e-05
. O 0 4.499174810490558e-09

The O 0 7.761462939015473e-07
breast B-Disease 1 0.9991700649261475
and I-Disease 1 0.9852494597434998
ovarian I-Disease 1 0.9999974966049194
cancer I-Disease 1 0.9999847412109375
susceptibility O 0 1.7207139535457827e-05
gene O 0 4.928784846924827e-07
BRCA1 O 0 1.2862999028584454e-05
encodes O 0 7.777076461934485e-06
a O 0 7.471903700206894e-07
zinc O 0 0.49598434567451477
finger O 0 0.08072150498628616
protein O 0 1.2140592531295624e-08
of O 0 2.2038881136721145e-13
unknown O 0 4.6535869602237767e-10
function O 0 2.0699064684492896e-10
. O 0 6.519517148362297e-10

Association O 0 5.544357195574889e-10
of O 0 1.946438615754026e-13
the O 0 1.0409006555994749e-12
BRCA1 O 0 3.356557032319074e-09
protein O 0 7.269188029290774e-11
with O 0 9.61328388312914e-14
the O 0 6.417694202670923e-14
DNA O 0 2.2494759832625277e-08
repair O 0 1.9018952457372507e-07
protein O 0 2.4906290918558227e-10
Rad51 O 0 1.7513524852574847e-08
and O 0 8.462978581813552e-13
changes O 0 1.7483255545602903e-15
in O 0 1.8410495366121693e-16
the O 0 3.3827224248577986e-16
phosphorylation O 0 1.158390917910257e-11
and O 0 6.128346094480541e-12
cellular O 0 1.8746482144393894e-09
localization O 0 4.023305577582903e-10
of O 0 1.1754461497505138e-15
the O 0 3.144279135018982e-14
protein O 0 5.260311717464328e-12
after O 0 2.702019857858673e-11
exposure O 0 2.4837300618973934e-11
to O 0 2.0356603230332893e-13
DNA O 0 2.6451115076042697e-08
- O 0 6.793546845074161e-07
damaging O 0 1.9883336221937498e-07
agents O 0 7.232073828689067e-10
are O 0 2.5518670022147555e-14
consistent O 0 1.3519906765305234e-12
with O 0 1.1363008651414999e-13
a O 0 6.245612344359455e-14
role O 0 1.032099319203672e-12
for O 0 1.606887400104704e-14
BRCA1 O 0 9.397354006068781e-09
in O 0 1.8573304786523304e-12
DNA O 0 7.601883567076584e-07
repair O 0 9.625759412301704e-05
. O 0 8.140627616448626e-10

Here O 0 1.1150505407897526e-08
, O 0 3.905837025336423e-12
it O 0 3.6534032635086866e-13
is O 0 5.240027704279948e-14
shown O 0 1.8294213800090775e-12
that O 0 1.1583389683631623e-13
mouse O 0 4.1843519760220715e-09
embryonic O 0 1.3636496376534524e-09
stem O 0 2.5783236878851312e-08
cells O 0 6.50382503408764e-08
deficient B-Disease 0 3.3986583730438724e-05
in I-Disease 0 4.083123769649255e-11
BRCA1 I-Disease 0 8.136255473800702e-07
are O 0 4.1720033677750124e-11
defective O 0 3.569302862160839e-07
in O 0 4.3747475260424995e-12
the O 0 1.505932097772833e-12
ability O 0 4.687168014827492e-11
to O 0 1.4814674010113493e-13
carry O 0 3.547849947854731e-12
out O 0 1.4693234476337302e-11
transcription O 0 4.448490642516845e-08
- O 0 4.930336217512377e-06
coupled O 0 4.342585270933341e-06
repair O 0 2.352560386498226e-06
of O 0 3.2516112198621716e-13
oxidative O 0 3.0558418018244993e-09
DNA O 0 1.3854404642188456e-05
damage O 0 2.4098037101794034e-05
, O 0 8.872531181980392e-12
and O 0 1.0783045463480523e-11
are O 0 1.5604138532514245e-13
hypersensitive O 0 9.280314117177113e-08
to O 0 1.0832133107152586e-10
ionizing O 0 1.1718596759635602e-08
radiation O 0 3.1751122264722653e-07
and O 0 1.4345181986730182e-10
hydrogen O 0 2.225970296976243e-09
peroxide O 0 9.279795449401718e-06
. O 0 9.166122083570372e-09

These O 0 9.578529081011311e-10
results O 0 7.444581756610447e-11
suggest O 0 2.8267870683107432e-11
that O 0 7.178044183347998e-12
BRCA1 O 0 5.91999027577117e-09
participates O 0 1.1024477164500723e-10
, O 0 1.5420125246135008e-11
directly O 0 6.333034791028425e-11
or O 0 3.802575754274784e-10
indirectly O 0 5.183073970016494e-09
, O 0 1.6971708326901647e-12
in O 0 5.599598272587082e-14
transcription O 0 2.071830294880783e-06
- O 0 0.011476784013211727
coupled O 0 0.00020904427219647914
repair O 0 4.353855729277711e-06
of O 0 1.0084401575512908e-13
oxidative O 0 9.492556740653413e-10
DNA O 0 2.2117023945611436e-06
damage O 0 3.3040080325008603e-06
. O 0 2.354506173363191e-11
. O 0 3.8956407544255e-10

Truncation O 0 9.181521818391047e-07
mutations O 0 8.198989576158056e-07
in O 0 1.0929502095025079e-11
the O 0 6.757323867123688e-12
transactivation O 0 6.828337973274756e-06
region O 0 2.6772599692748145e-09
of O 0 9.326356961020243e-13
PAX6 O 0 3.871460592108633e-07
result O 0 1.6269705027660564e-10
in O 0 8.076570553842977e-13
dominant O 0 2.6384601170548194e-08
- O 0 6.9534712565655354e-06
negative O 0 1.1284875256478699e-07
mutants O 0 1.5957829191393103e-06
. O 0 1.4433748640740873e-10

PAX6 O 0 4.976846321369521e-05
is O 0 3.061592646069755e-10
a O 0 2.2079778597920013e-13
transcription O 0 8.866753997693877e-10
factor O 0 3.1466895061837974e-11
with O 0 1.5086105379247955e-13
two O 0 1.2838216817759318e-12
DNA O 0 5.769988575821117e-08
- O 0 1.0488670199038097e-07
binding O 0 3.865267661495864e-09
domains O 0 4.86673776833868e-08
( O 0 2.5689804558810814e-13
paired O 0 1.9530175254800497e-09
box O 0 1.2964967481821077e-06
and O 0 6.172175270879876e-11
homeobox O 0 1.670047988788781e-10
) O 0 7.213735766500515e-14
and O 0 7.143986330239091e-14
a O 0 3.5927017654271975e-14
proline O 0 1.659389736730077e-09
- O 0 1.008496064436315e-09
serine O 0 2.5783236878851312e-08
- O 0 2.211211658220691e-08
threonine O 0 3.280136695593683e-07
( O 0 2.0616250677105152e-13
PST O 0 1.0336935929444735e-07
) O 0 8.940392371738215e-13
- O 0 2.4426982658809493e-10
rich O 0 3.187967034454231e-12
transactivation O 0 3.230810463605849e-08
domain O 0 1.048877984466401e-09
. O 0 6.763555687738787e-11

PAX6 O 0 0.00012828409671783447
regulates O 0 1.4970491974963807e-06
eye O 0 9.53418293647701e-06
development O 0 6.387503720395316e-11
in O 0 4.479952433328327e-12
animals O 0 1.4785386456828142e-11
ranging O 0 1.018305882324877e-12
from O 0 4.336229658219275e-14
jellyfish O 0 2.9660263828334976e-11
to O 0 1.1065413450979389e-13
Drosophila O 0 2.151276552730952e-12
to O 0 3.3714681437271854e-13
humans O 0 4.8059481741469234e-12
. O 0 1.3344192070774419e-11

Heterozygous O 0 1.6112306866489234e-06
mutations O 0 3.4635669976523786e-07
in O 0 4.6406791603947894e-11
the O 0 1.590651742267024e-11
human O 0 1.4292934891191322e-10
PAX6 O 0 2.7521136303221283e-07
gene O 0 6.342593650288109e-08
result O 0 8.491854441849966e-10
in O 0 4.2244131776654134e-14
various O 0 2.532158070191453e-14
phenotypes O 0 2.200649884542827e-09
, O 0 5.485132313631791e-12
including O 0 9.005161200059675e-11
aniridia B-Disease 1 0.9999978542327881
, O 0 7.005120096437167e-06
Peters B-Disease 1 0.999998927116394
anomaly I-Disease 1 0.9999985694885254
, O 0 8.033143217289762e-08
autosomal B-Disease 0 0.05308208987116814
dominant I-Disease 0 0.002759442897513509
keratitis I-Disease 1 0.9948840737342834
, O 0 8.098865578176628e-08
and O 0 2.4498680772921944e-07
familial B-Disease 1 0.9098782539367676
foveal I-Disease 1 0.9991957545280457
dysplasia I-Disease 1 0.9989776611328125
. O 0 6.407121304619068e-07

It O 0 3.61669227899597e-09
is O 0 5.3461870347382145e-12
believed O 0 5.3502983293762796e-12
that O 0 3.003005897878226e-14
the O 0 1.330066783843337e-14
mutated O 0 5.465160546336278e-10
allele O 0 1.7374681249293644e-08
of O 0 1.4575378664422045e-12
PAX6 O 0 4.308723191570607e-07
produces O 0 4.0498424058732496e-11
an O 0 1.8964696688592887e-14
inactive O 0 4.346415172218343e-10
protein O 0 9.654878141418521e-08
and O 0 9.939092251443071e-07
aniridia B-Disease 1 0.9999990463256836
is O 0 6.553440243806108e-07
caused O 0 3.1586608884026646e-08
due O 0 2.6664226382422385e-11
to O 0 1.932855785147236e-11
genetic O 0 6.13995325693395e-07
haploinsufficiency O 0 0.00046527627273462713
. O 0 5.098126365510325e-09

However O 0 8.129439899029478e-10
, O 0 3.0365632426067324e-13
several O 0 1.2203517920316136e-14
truncation O 0 8.585585575815458e-09
mutations O 0 2.2817078004777613e-08
have O 0 6.005350661197895e-10
been O 0 2.0372716014183112e-10
found O 0 3.619683372479976e-11
to O 0 6.554971843097945e-12
occur O 0 4.63168349160159e-12
in O 0 8.873854274549058e-15
the O 0 1.008525814943928e-11
C O 0 1.5515907989538391e-06
- O 0 2.2634856122749625e-07
terminal O 0 2.677276533802342e-08
half O 0 3.140340071317027e-11
of O 0 2.640172473954974e-15
PAX6 O 0 1.2552182626635044e-09
in O 0 7.723812908699834e-14
patients O 0 1.4363429065925026e-12
with O 0 5.572055317148994e-11
Aniridia B-Disease 1 0.9999982118606567
resulting O 0 1.6690903104077393e-09
in O 0 1.0039378047421374e-13
mutant O 0 1.9405634876790145e-09
proteins O 0 6.920806289167913e-11
that O 0 2.3418435159822115e-12
retain O 0 1.0188460318472092e-12
the O 0 3.627378887711974e-13
DNA O 0 2.480708616303673e-08
- O 0 3.3757863171501867e-09
binding O 0 4.749101112366816e-10
domains O 0 6.732556290245384e-09
but O 0 1.0072888079193376e-09
have O 0 1.898380758147411e-10
lost O 0 7.647659727716416e-10
most O 0 1.7583089389865136e-14
of O 0 2.21651602813329e-15
the O 0 1.4078953931503935e-12
transactivation O 0 3.7205418834673765e-07
domain O 0 8.950955532327498e-09
. O 0 4.3431999663390286e-10

It O 0 7.817502201135085e-09
is O 0 1.5113453891157924e-11
not O 0 9.723727492682091e-14
clear O 0 1.0067047564489562e-13
whether O 0 8.537028234941596e-15
such O 0 1.0665348651507926e-15
mutants O 0 1.1680215017406681e-08
really O 0 1.3864323022971803e-09
behave O 0 1.3923272257354569e-11
as O 0 5.898498703360566e-12
loss O 0 4.336067505050778e-09
- O 0 7.755897257766264e-09
of O 0 4.8564260252126346e-12
- O 0 1.6472661457100912e-07
function O 0 9.096937647612435e-10
mutants O 0 1.917074676782704e-08
as O 0 2.2435881277815817e-12
predicted O 0 5.85890114201959e-10
by O 0 4.943999636769503e-12
haploinsufficiency O 0 3.153853185722255e-06
. O 0 1.5968212307981844e-09

Contrary O 0 1.2294249174260585e-08
to O 0 3.120279035151441e-11
this O 0 1.078387799522372e-13
theory O 0 1.8822768864390493e-12
, O 0 6.859440316100973e-13
our O 0 1.2796345580379231e-11
data O 0 3.5293065692165726e-10
showed O 0 1.5077815385122761e-10
that O 0 1.868874182470691e-14
these O 0 1.1140162075695507e-14
mutants O 0 9.895617658628453e-10
are O 0 1.8940876428050202e-14
dominant O 0 7.70981667397308e-10
- O 0 5.149985895513964e-07
negative O 0 3.4179641339449063e-09
in O 0 1.1179311599704422e-13
transient O 0 5.287450598884247e-12
transfection O 0 1.645095792923712e-08
assays O 0 3.45075590324484e-09
when O 0 1.5658424556974637e-10
they O 0 1.7097742492644397e-12
are O 0 5.95453404601343e-15
coexpressed O 0 1.2756344869302438e-09
with O 0 3.3494849688980866e-12
wild O 0 6.288564780021488e-09
- O 0 9.288596629630774e-06
type O 0 1.2457279296995694e-07
PAX6 O 0 2.8565980755956843e-05
. O 0 2.713721025671134e-09

We O 0 4.406266018719407e-09
found O 0 1.3888446816212596e-11
that O 0 3.0131737491397026e-13
the O 0 1.4588228628570343e-12
dominant O 0 7.908268173650868e-08
- O 0 2.3269039957085624e-05
negative O 0 2.3757665701396036e-07
effects O 0 2.0795482669200283e-08
result O 0 3.600841630077567e-12
from O 0 1.2862657995803988e-15
the O 0 1.5281311872294176e-15
enhanced O 0 8.2422469457194e-13
DNA O 0 7.59537044370262e-10
binding O 0 3.3533474608216096e-11
ability O 0 2.5460649213937536e-12
of O 0 8.477021032826312e-16
these O 0 3.4328600075420046e-13
mutants O 0 4.517076934718034e-09
. O 0 3.028549633299349e-11

Kinetic O 0 2.2989003412021702e-07
studies O 0 2.4033890433372562e-09
of O 0 2.5767883378262357e-13
binding O 0 3.989736985232639e-09
and O 0 6.9513599321169295e-09
dissociation O 0 4.11836609259808e-08
revealed O 0 2.644316710043171e-10
that O 0 5.408960548203409e-15
various O 0 3.317305607120206e-17
truncation O 0 4.9815620378756975e-11
mutants O 0 5.842098804720308e-09
have O 0 1.6968860127794527e-12
3 O 0 3.355077988435179e-13
- O 0 7.226947928984373e-09
5 O 0 6.454239365183412e-10
- O 0 1.5792473107012484e-07
fold O 0 5.6789836833104346e-08
higher O 0 7.14689266968771e-13
affinity O 0 1.0183753796841333e-13
to O 0 6.642078312596271e-15
various O 0 6.133031390100917e-17
DNA O 0 1.9210881496700694e-10
- O 0 3.091635975005502e-11
binding O 0 8.673891140932588e-13
sites O 0 6.774823757549342e-12
when O 0 8.928915246064761e-11
compared O 0 1.357644059023569e-13
with O 0 2.6712532891632864e-15
the O 0 9.19541271468885e-14
wild O 0 9.56118850758969e-10
- O 0 4.053937630033033e-07
type O 0 1.7277622887945654e-08
PAX6 O 0 7.533950793003896e-06
. O 0 7.308869620636926e-10

These O 0 1.3307598079048688e-10
results O 0 2.977707273463248e-12
provide O 0 1.84565717879304e-14
a O 0 8.677030583848291e-14
new O 0 2.3657849767752537e-13
insight O 0 8.895910809207652e-13
into O 0 3.212434116460494e-14
the O 0 2.6107839035203334e-14
role O 0 2.336167554978924e-13
of O 0 1.2829733613385977e-14
mutant O 0 9.866899297605869e-09
PAX6 O 0 3.813267994701164e-07
in O 0 4.552378612965313e-11
causing O 0 7.291985184565419e-07
aniridia B-Disease 1 0.9999517202377319
. O 0 7.264949752894267e-10
. O 0 2.8824376219205305e-10

Reversal O 0 2.00179529201705e-05
of O 0 4.807452214095065e-08
severe O 0 0.12044765055179596
hypertrophic B-Disease 1 0.9996780157089233
cardiomyopathy I-Disease 1 0.9999957084655762
and O 0 5.521229695659713e-07
excellent O 0 3.775514656467749e-08
neuropsychologic O 0 3.991679477621801e-06
outcome O 0 1.1996329485342017e-09
in O 0 2.9247845464985822e-12
very B-Disease 0 7.445891681001626e-10
- I-Disease 0 3.783935244427994e-05
long I-Disease 0 1.6028896425268613e-05
- I-Disease 0 4.5214856072561815e-06
chain I-Disease 0 1.746559064486064e-06
acyl I-Disease 0 9.298448677697024e-10
- I-Disease 0 7.871485685484458e-09
coenzyme I-Disease 0 4.751765092514404e-10
A I-Disease 0 2.667605691897279e-09
dehydrogenase I-Disease 0 0.00012021278234897181
deficiency I-Disease 0 0.04675467684864998
. O 0 1.617971312484201e-10

Very B-Disease 0 4.5066318676845185e-08
- I-Disease 0 2.281611341459211e-05
long I-Disease 0 2.7642395252769347e-06
- I-Disease 0 2.325881951037445e-06
chain I-Disease 0 2.421618091830169e-06
acyl I-Disease 0 2.020770883959244e-09
- I-Disease 0 1.7198342749935591e-09
coenzyme I-Disease 0 5.1418608953968103e-11
A I-Disease 0 4.7875793607321526e-11
dehydrogenase I-Disease 0 3.188301533896265e-08
( I-Disease 0 7.209094432525376e-12
VLCAD I-Disease 0 7.787875802023336e-05
) I-Disease 0 1.809664063046057e-08
deficiency I-Disease 0 0.0006183517398312688
is O 0 4.743103913101843e-12
a O 0 1.660465376307485e-10
disorder O 0 6.864677561679855e-05
of O 0 6.092377036887031e-13
fatty O 0 2.76030842627506e-08
acid O 0 3.6034628059233853e-10
beta O 0 1.0160519994806272e-11
oxidation O 0 4.683006205041806e-10
that O 0 2.740308813198311e-10
reportedly O 0 1.227753330113046e-07
has O 0 1.0688067098030274e-09
high O 0 1.5436943945346115e-09
rates O 0 3.1733873306905025e-09
of O 0 3.3163018772069952e-12
morbidity O 0 0.0009713767794892192
and O 0 1.876530753008865e-08
mortality O 0 8.681126359988411e-07
. O 0 3.912648538495489e-10

We O 0 4.538996289937813e-09
describe O 0 3.2980545378036297e-11
the O 0 7.946261378934116e-13
outcome O 0 2.5274172945483064e-12
of O 0 3.065014765902814e-15
a O 0 3.389696563802641e-13
5 O 0 1.4316166524822038e-12
- O 0 5.125083468726643e-09
year O 0 3.7333761082614103e-10
- O 0 1.1585179038320348e-07
old O 0 5.171418251848081e-06
girl O 0 6.852710157545516e-06
with O 0 1.26089190644052e-07
VLCAD B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999996423721313
who O 0 1.1544680766917281e-09
was O 0 3.3451980074872267e-10
first O 0 3.4686530991229203e-12
seen O 0 2.7539109881402624e-10
at O 0 1.8249648320312062e-11
5 O 0 1.004336696273922e-12
months O 0 7.491897727196495e-12
of O 0 1.6790139157479844e-13
age O 0 2.7641424704683004e-09
with O 0 3.287142362751183e-07
severe O 0 0.1665232926607132
hypertrophic B-Disease 1 0.9999538660049438
cardiomyopathy I-Disease 1 0.9999990463256836
, O 0 0.0011365164536982775
hepatomegaly B-Disease 1 0.9999978542327881
, O 0 1.1501932931423653e-05
encephalopathy B-Disease 1 0.9329507350921631
, O 0 4.249734786299086e-09
and O 0 7.135074042707856e-08
hypotonia B-Disease 0 0.0017268189694732428
. O 0 8.363139514244722e-09

Biochemical O 0 3.201811523467768e-06
studies O 0 2.9476282179530244e-06
indicated O 0 0.2912697196006775
VLCAD B-Disease 1 0.9999972581863403
deficiency I-Disease 1 0.9999996423721313
caused O 0 0.0004563711700029671
by O 0 5.2524238430828873e-11
a O 0 1.4503347134375844e-10
stable O 0 4.6711705614654875e-09
yet O 0 3.542070456385993e-11
inactive O 0 1.716625036563002e-10
enzyme O 0 6.879619096622491e-09
. O 0 9.244565668531379e-10

Molecular O 0 4.664824615474572e-08
genetic O 0 2.6416734044687473e-07
analysis O 0 4.278143173053195e-09
of O 0 2.9694965236748416e-11
her O 0 1.658133442106191e-06
VLCAD O 0 1.176278146886034e-05
gene O 0 3.116762314903099e-08
revealed O 0 3.382130273621442e-07
a O 0 5.40144561023137e-11
T1372C O 0 1.5849183299110337e-08
( O 0 1.155715605681562e-12
F458L O 0 1.1098452157298766e-09
) O 0 3.059577244335365e-11
missense O 0 1.5561795407847967e-08
mutation O 0 2.310841829000765e-08
and O 0 2.574145785416704e-09
a O 0 3.5744198711995523e-09
1668 O 0 0.002352209994569421
ACAG O 0 0.04237907752394676
1669 O 0 5.920240255363751e-06
splice O 0 8.070331386988983e-05
site O 0 1.0430211432321812e-06
mutation O 0 8.68238487328199e-07
. O 0 2.5594403041395708e-08

After O 0 1.9314637389467038e-10
initial O 0 8.705021078969644e-12
treatment O 0 2.619711739204611e-11
with O 0 1.455232310522414e-12
intravenous O 0 3.666646319899769e-09
glucose O 0 0.00028042183839716017
and O 0 1.2941550942002777e-08
carnitine O 0 2.2437602353875263e-07
, O 0 5.917768879093455e-12
the O 0 1.0859841671762016e-12
patient O 0 9.527365563144485e-10
has O 0 5.292086768804438e-10
thrived O 0 6.803513308284437e-10
on O 0 3.430122852421391e-10
a O 0 5.565024135956165e-11
low O 0 2.124681230952774e-08
- O 0 5.697699023698988e-08
fat O 0 1.436597862891631e-08
diet O 0 1.4651444120439283e-12
supplemented O 0 3.980812803960204e-13
with O 0 1.2760235576503298e-13
medium O 0 2.353761907603058e-10
- O 0 1.2419019590481639e-08
chain O 0 2.413658251043671e-07
triglyceride O 0 8.595240075237598e-08
oil O 0 2.4591065295176406e-10
and O 0 1.8297284260643254e-12
carnitine O 0 6.712550515430848e-10
and O 0 7.150710687638118e-13
avoidance O 0 5.741351283283791e-10
of O 0 1.9689093834051458e-13
fasting O 0 6.568648736049454e-09
. O 0 2.1623520682356734e-11

Her O 0 0.012666708789765835
ventricular O 0 0.03798054903745651
hypertrophy O 0 9.708218385640066e-06
resolved O 0 2.4054173763943254e-08
significantly O 0 1.7485102254966023e-10
over O 0 3.00122947327619e-11
1 O 0 1.4417782072395635e-11
year O 0 4.718319485119693e-11
, O 0 6.092961205017566e-12
and O 0 2.502089924139028e-10
cognitively O 0 3.802275898578955e-07
, O 0 9.922502056114446e-12
she O 0 2.1833088226230757e-08
is O 0 3.484468139372532e-12
in O 0 2.910946291412482e-14
the O 0 1.4297500900220528e-12
superior O 0 2.2606783112166795e-10
range O 0 5.691871418633809e-10
for O 0 4.865428806372085e-12
age O 0 4.94162877284765e-10
. O 0 7.807958446459651e-11

Clinical O 0 1.2409642202726445e-08
recognition O 0 1.3824193345612912e-08
of O 0 1.0912749530689325e-06
VLCAD B-Disease 1 0.9999990463256836
deficiency I-Disease 1 0.9999997615814209
is O 0 1.153990347724232e-09
important O 0 3.788462599185749e-12
because O 0 3.27074166361907e-11
it O 0 2.015691259737995e-11
is O 0 1.773639937176219e-12
one O 0 4.251728906012192e-13
of O 0 2.7294516524197085e-15
the O 0 1.482735462188245e-11
few O 0 7.146535585533798e-10
directly O 0 2.512686307909462e-07
treatable O 1 0.9753212928771973
causes O 0 1.296956838814367e-06
of O 0 1.930436894781451e-07
cardiomyopathy B-Disease 1 0.9999998807907104
in O 0 6.6271668153206065e-09
children O 0 5.466195496239834e-09
. O 0 5.1390763172731724e-11
. O 0 7.151854108933264e-10

Cloning O 0 1.37734289751279e-07
of O 0 6.982350895384792e-12
a O 0 6.015802439529594e-11
novel O 0 1.8347662278372923e-10
member O 0 8.918353252077016e-13
of O 0 1.4718793268616095e-14
the O 0 1.1077086470301367e-10
low O 0 3.71080460581652e-07
- O 0 7.065794761729194e-06
density O 0 3.832482331489473e-09
lipoprotein O 0 1.4569011455023428e-06
receptor O 0 4.8264798380159846e-08
family O 0 2.775995824322308e-07
. O 0 3.964769346165298e-10

A O 0 4.1800802402791604e-11
gene O 0 5.839041056221461e-11
encoding O 0 1.3624329442407657e-09
a O 0 1.100032731571332e-09
novel O 0 1.4521853053395262e-08
transmembrane O 0 3.1186064575194905e-07
protein O 0 1.014042005920146e-08
was O 0 7.700147186540107e-10
identified O 0 7.344690177227275e-13
by O 0 3.014514555708394e-16
DNA O 0 7.048976419926634e-12
sequence O 0 1.0102894215657798e-11
analysis O 0 6.529513258204944e-13
within O 0 4.775576415300955e-15
the O 0 8.406370217983739e-12
insulin B-Disease 0 0.07263562083244324
- I-Disease 1 0.9956513047218323
dependent I-Disease 1 0.9991133809089661
diabetes I-Disease 1 0.9999997615814209
mellitus I-Disease 1 0.9999994039535522
( O 0 1.4734482078893052e-08
IDDM B-Disease 0 0.0010988656431436539
) O 0 3.220925748337322e-10
locus O 0 1.2499339163696277e-06
IDDM4 O 0 0.0001959904475370422
on O 0 1.1003128008724161e-07
chromosome O 0 0.00022232497576624155
11q13 O 0 4.606684740338096e-07
. O 0 2.7663367152541696e-09

Based O 0 1.6435856842189622e-10
on O 0 1.8595168738144707e-09
its O 0 5.759327459387009e-10
chromosomal O 0 2.4882538127712905e-06
position O 0 8.599880629844847e-08
, O 0 4.352873964053039e-12
this O 0 2.281922853529083e-14
gene O 0 2.138505345028463e-11
is O 0 7.599952568312918e-13
a O 0 5.280531464564933e-14
candidate O 0 6.600544899060604e-14
for O 0 2.0680781628081837e-15
conferring O 0 2.52750798068746e-09
susceptibility O 0 1.9026839481739444e-06
to O 0 9.868089279052583e-08
diabetes B-Disease 0 0.20903784036636353
. O 0 1.7549604436339905e-08

The O 0 1.4497089292908605e-11
gene O 0 2.7460131946099864e-09
, O 0 5.390720855813491e-11
termed O 0 2.5620092714007114e-08
low O 0 5.47823219676502e-07
- O 0 9.37415097723715e-06
density O 0 5.424898308348247e-09
lipoprotein O 0 4.6658391283926903e-07
receptor O 0 1.240568980875878e-08
related O 0 1.8656023392793486e-09
protein O 0 3.4702217988069606e-08
5 O 0 6.2368393782819e-10
( O 0 3.271131466826144e-13
LRP5 O 0 1.518557724011771e-07
) O 0 5.683845321485803e-13
, O 0 8.991098034009156e-16
encodes O 0 1.1180212571709758e-12
a O 0 2.141736224134383e-13
protein O 0 3.448778415626741e-11
of O 0 3.988547705546623e-14
1615 O 0 1.3526170183908448e-09
amino O 0 3.7158835036743554e-11
acids O 0 2.4479290122725317e-12
that O 0 1.7050186403803208e-13
contains O 0 1.3132278535552162e-14
conserved O 0 3.492379345784724e-12
modules O 0 5.65182523004637e-09
which O 0 1.411892824876304e-10
are O 0 2.0892197748288016e-13
characteristic O 0 1.407071854864217e-11
of O 0 2.497683829238203e-14
the O 0 4.813778264889379e-10
low O 0 0.00011407625424908474
- O 0 0.13644103705883026
density O 0 2.8336583000054816e-06
lipoprotein O 0 0.0790829211473465
( O 0 5.293005478357315e-10
LDL O 0 3.906256824848242e-05
) O 0 7.868865975479977e-11
receptor O 0 2.7979631944674566e-09
family O 0 5.330679897497248e-08
. O 0 8.343155610823771e-10

These O 0 1.4925614563732204e-11
modules O 0 1.0959196883320033e-09
include O 0 1.9905826525957668e-14
a O 0 3.467372737672378e-14
putative O 0 9.934986860971051e-11
signal O 0 3.567534045956222e-09
peptide O 0 4.100901476039587e-12
for O 0 3.416752502909332e-16
protein O 0 2.4333012276119004e-13
export O 0 6.432942286499488e-13
, O 0 3.227185364643517e-14
four O 0 2.7816022055149325e-12
epidermal O 0 9.931836331134036e-08
growth O 0 6.344563097115952e-09
factor O 0 2.9370525456151597e-10
( O 0 2.0057485403471298e-13
EGF O 0 5.5002608689846966e-08
) O 0 4.7406009673345295e-11
repeats O 0 4.3225850276940037e-07
with O 0 6.079080988596886e-11
associated O 0 1.2335389654172246e-10
spacer O 0 4.998549343326886e-07
domains O 0 6.59257466395502e-08
, O 0 1.4368834247435736e-11
three O 0 4.969595221449019e-11
LDL O 0 7.9867742897477e-05
- O 0 1.8020053175860085e-05
receptor O 0 7.683560170335113e-07
( O 0 1.5766665750760467e-11
LDLR O 0 3.4936103929794626e-06
) O 0 2.7261691168400937e-11
repeats O 0 6.64936408156791e-07
, O 0 1.1874813198725631e-12
a O 0 8.157727965363293e-13
single O 0 6.7410370618858906e-09
transmembrane O 0 7.183316483860835e-07
spanning O 0 7.527244605398664e-09
domain O 0 1.0070399980577349e-07
, O 0 2.091671141846163e-10
and O 0 1.138067591555103e-11
a O 0 3.5700472526128957e-12
cytoplasmic O 0 7.358084275210786e-08
domain O 0 5.225431820576887e-08
. O 0 2.7287001547193768e-09

The O 0 2.76907750201838e-12
encoded O 0 2.1611543665756017e-09
protein O 0 1.637045166091866e-08
has O 0 2.6158472957171774e-11
a O 0 7.289976185643338e-14
unique O 0 2.4780860279375802e-14
organization O 0 2.076981368468421e-14
of O 0 1.2825531652341238e-13
EGF O 0 1.7695589349386864e-07
and O 0 1.5647892981363043e-09
LDLR O 0 1.9587823771871626e-06
repeats O 0 5.894545438422938e-07
; O 0 8.586911021644938e-13
therefore O 0 8.581474831952096e-13
, O 0 6.177468475990211e-13
LRP5 O 0 1.0210579830527422e-06
likely O 0 4.987287804958385e-10
represents O 0 5.183522729291677e-15
a O 0 3.674113828932776e-14
new O 0 2.05042337275696e-11
category O 0 1.1786691622717171e-09
of O 0 6.894027449605433e-13
the O 0 1.7359633730507085e-09
LDLR O 0 0.0009290346642956138
family O 0 3.712842300274133e-08
. O 0 6.578484285091335e-11

Both O 0 1.4820970839490855e-10
human O 0 9.208361850809865e-11
and O 0 2.1051793641646555e-10
mouse O 0 2.320507292097318e-06
LRP5 O 0 4.5325974497245625e-05
cDNAs O 0 3.3544793609507906e-07
have O 0 1.0808089839775548e-10
been O 0 1.0855090437633663e-10
isolated O 0 4.186483604229352e-09
and O 0 1.1220573081782703e-11
the O 0 6.569931857797412e-15
encoded O 0 9.077035650895127e-11
mature O 0 3.2355956022106502e-12
proteins O 0 8.452025971467103e-13
are O 0 1.1121903433484494e-14
95 O 0 1.671234765160401e-12
% O 0 9.971820732427444e-14
identical O 0 2.1516819437295e-09
, O 0 4.1245600684858275e-12
indicating O 0 2.2766280527442007e-10
a O 0 1.5247744039603717e-11
high O 0 1.0696556529410373e-08
degree O 0 4.417712289733755e-12
of O 0 3.4564496548944706e-15
evolutionary O 0 2.0309181853611635e-12
conservation O 0 1.2383867802751025e-12
. O 0 2.8885823854379877e-12
. O 0 5.490442128719408e-11

The O 0 1.346224867693202e-11
APC B-Disease 0 1.5711474343760301e-09
variants O 0 8.063557460635806e-11
I1307K O 0 2.9322793082542375e-09
and O 0 3.535172848900814e-11
E1317Q O 0 1.476155725432804e-10
are O 0 1.7169965536162346e-12
associated O 0 2.025857037679657e-09
with O 0 0.008829068392515182
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.3329988632904133e-06
but O 0 2.112259034348085e-09
not O 0 3.582417418268591e-10
always O 0 7.872023033428377e-10
with O 0 4.075955285093302e-12
a O 0 1.3495471407054538e-10
family O 0 3.1345638973334644e-08
history O 0 3.3241596142374874e-09
. O 0 1.6157325477550444e-10

Classical O 1 0.9186795353889465
familial B-Disease 1 0.999933123588562
adenomatous I-Disease 1 0.9993945360183716
polyposis I-Disease 1 0.9999732971191406
( O 0 9.86001396086067e-07
FAP B-Disease 0 2.566760485933628e-05
) O 0 2.5626285538038474e-09
is O 0 3.800492906491648e-11
a O 0 4.990446944574956e-10
high O 0 1.2707760106422938e-05
- O 1 0.9995076656341553
penetrance O 1 0.9999444484710693
autosomal B-Disease 1 0.9999819993972778
dominant I-Disease 1 0.9917309880256653
disease I-Disease 0 0.038257233798503876
that O 0 4.839811537649119e-11
predisposes O 0 2.3268123428010767e-08
to O 0 4.364928991168471e-12
hundreds O 0 1.6022430777973273e-12
or O 0 1.269787747171236e-11
thousands O 0 6.06262678948255e-11
of O 0 4.821621502060225e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999996423721313
and I-Disease 1 0.9679486751556396
carcinoma I-Disease 1 0.9999997615814209
and O 0 5.651468200085219e-06
that O 0 7.298759374663177e-09
results O 0 8.187387989799788e-10
from O 0 1.8482871483316288e-12
truncating O 0 1.516617587071778e-08
mutations O 0 8.715833388350802e-09
in O 0 4.729794572493062e-13
the O 0 3.5068153350810427e-13
APC B-Disease 0 5.2747264334129795e-09
gene O 0 4.1534303107937376e-08
. O 0 2.7168336469429732e-09

A O 0 1.033387042603806e-09
variant O 0 5.40230864487512e-08
of O 0 2.776589028141707e-11
FAP B-Disease 0 1.1167679986101575e-05
is O 0 1.3310967972302024e-07
attenuated B-Disease 1 0.9874846339225769
adenomatous I-Disease 1 0.9999874830245972
polyposis I-Disease 1 0.999977707862854
coli I-Disease 1 0.9999973773956299
, O 0 1.0927937665883292e-07
which O 0 1.0245807535724794e-09
results O 0 4.1254746147023624e-11
from O 0 6.714361705517646e-12
germ O 0 0.0002702263300307095
- O 0 0.0030316219199448824
line O 0 7.109191210474819e-05
mutations O 0 1.6879349473697403e-08
in O 0 6.690019089920785e-13
the O 0 2.4912394196163756e-12
5 O 0 3.6546751736032945e-11
and O 0 6.136467028960979e-11
3 O 0 1.1129772450879649e-11
regions O 0 5.392090447102829e-14
of O 0 3.652869819099165e-15
the O 0 3.506721822643666e-13
APC B-Disease 0 1.0202670930326008e-09
gene O 0 3.29780625030196e-09
. O 0 3.573559226310863e-10

Attenuated B-Disease 1 0.9952240586280823
adenomatous I-Disease 1 0.9997062087059021
polyposis I-Disease 1 0.9997888207435608
coli I-Disease 1 0.9999841451644897
patients O 0 3.421115252422169e-05
have O 0 8.616722446674885e-09
" O 0 4.10883105317339e-09
multiple O 0 1.363719638902694e-05
" O 1 0.9997972846031189
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999991655349731
( O 0 1.8999248840856353e-09
typically O 0 2.7679856670626002e-11
fewer O 0 1.0583249093710709e-13
than O 0 2.414907365061187e-14
100 O 0 6.652024851089289e-13
) O 0 1.152484141106469e-12
without O 0 1.5078892995346038e-12
the O 0 7.320889554296439e-12
florid O 0 2.480229886714369e-05
phenotype O 0 1.567500191868021e-07
of O 0 5.246590922131089e-13
classical O 0 7.876742813550663e-09
FAP B-Disease 0 1.8259272849263652e-07
. O 0 4.763762162518503e-10

Another O 0 3.880114451959571e-09
group O 0 6.535378904715117e-10
of O 0 4.2340141267159515e-13
patients O 0 5.1535449518969045e-11
with O 0 5.899758979965863e-12
multiple O 0 3.681210003492197e-08
adenomas B-Disease 0 0.00022777514823246747
has O 0 9.945372170250266e-08
no O 0 1.845273794875979e-10
mutations O 0 2.575323010400865e-10
in O 0 5.969356953183791e-13
the O 0 8.690450702814045e-13
APC B-Disease 0 8.046369126546438e-10
gene O 0 2.660192732761857e-09
, O 0 1.8508703250597058e-11
and O 0 1.57310709597569e-11
their O 0 4.4371564755785187e-10
phenotype O 0 4.219618077172527e-08
probably O 0 2.6647577477945106e-09
results O 0 3.425974131124332e-12
from O 0 2.551127373045213e-14
variation O 0 5.00524578381234e-12
at O 0 1.0329279653831236e-09
a O 0 1.3086766045833365e-11
locus O 0 1.3474411275637976e-07
, O 0 2.5868529540673535e-10
or O 0 1.352370472551545e-11
loci O 0 2.484271677261063e-10
, O 0 3.820275693011688e-11
elsewhere O 0 2.009069126340801e-12
in O 0 6.292072863846006e-15
the O 0 1.250866489381497e-12
genome O 0 1.5734971725578362e-07
. O 0 4.426432109738698e-09

Recently O 0 1.6928977686347935e-07
, O 0 1.6698654611846386e-11
however O 0 7.30930452882278e-13
, O 0 8.804058759695303e-15
a O 0 9.368624176138776e-14
missense O 0 2.300883483741245e-09
variant O 0 3.843340223852465e-08
of O 0 3.495533376640658e-11
APC B-Disease 0 3.7247702948661754e-06
( O 0 5.579816556716688e-12
I1307K O 0 1.4071377396618345e-09
) O 0 6.851023220955099e-12
was O 0 2.0256099020343754e-09
described O 0 8.645077709257265e-11
that O 0 1.2751770668041618e-13
confers O 0 3.645177909517017e-12
an O 0 1.0573679993098987e-14
increased O 0 3.3088164153038946e-11
risk O 0 1.151851165559492e-06
of O 0 1.0266469871567097e-05
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 6.456485834860359e-08
including O 0 5.538907874025334e-12
multiple O 0 2.3388624015296955e-07
adenomas B-Disease 0 0.008727475069463253
, O 0 1.0450246001880714e-08
in O 0 6.293745524743599e-10
Ashkenazim O 0 0.0004962866078130901
. O 0 4.175846868292865e-08

We O 0 4.300264588863456e-09
have O 0 1.6666254964645133e-12
studied O 0 1.2556659000333842e-13
a O 0 1.7662718957236513e-14
set O 0 8.939117675244024e-12
of O 0 2.5140918738660555e-14
164 O 0 2.4800546061243267e-09
patients O 0 1.191011438778089e-11
with O 0 1.4366374756491496e-10
multiple O 1 0.5547765493392944
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999995231628418
and I-Disease 0 0.0066681127063930035
/ I-Disease 0 0.005586936138570309
or I-Disease 0 0.00013030464469920844
carcinoma I-Disease 1 0.9999996423721313
and O 0 7.37960306196328e-08
analyzed O 0 1.3765255602038451e-08
codons O 0 3.629573308572276e-09
1263 O 0 1.6902229162951699e-06
- O 0 1.7233015796591644e-06
1377 O 0 4.014175829070155e-06
( O 0 2.4504701653244032e-12
exon O 0 1.1846733594111925e-09
15G O 0 3.576078810851868e-08
) O 0 1.1811412091444762e-11
of O 0 2.1134979752640906e-15
the O 0 1.412440043396801e-13
APC B-Disease 0 4.751626869747838e-11
gene O 0 7.090670498671736e-12
for O 0 1.664131072526276e-13
germ O 0 1.82960502570495e-06
- O 0 7.940876685097464e-07
line O 0 1.459484906263242e-06
variants O 0 1.552894168810326e-08
. O 0 2.0667201283686154e-09

Three O 0 3.109848822901995e-09
patients O 0 8.664061829088965e-11
with O 0 4.341288613318728e-13
the O 0 3.601210855127407e-13
I1307K O 0 2.5857427310427283e-10
allele O 0 1.3556989308938228e-08
were O 0 3.874009793514155e-11
detected O 0 2.6860780266702022e-09
, O 0 7.702452093022796e-14
each O 0 4.029556297468172e-14
of O 0 9.107480394843215e-13
Ashkenazi O 0 0.0010133832693099976
descent O 0 0.00018004806770477444
. O 0 4.46255512542848e-08

Four O 0 6.6795644571016055e-09
patients O 0 6.114015405067619e-10
had O 0 1.854641995535644e-10
a O 0 3.60178250072285e-12
germ O 0 8.473855814372655e-06
- O 0 3.749948155018501e-05
line O 0 9.608445907360874e-06
E1317Q O 0 1.679521055564237e-08
missense O 0 6.252231177228396e-09
variant O 0 2.579807922842292e-09
of O 0 1.4905257746371942e-13
APC O 0 4.822373167456817e-09
that O 0 2.287500883157989e-10
was O 0 2.7840902916409505e-09
not O 0 2.1508180653162512e-11
present O 0 1.1079611620529173e-12
in O 0 9.452072371324283e-13
controls O 0 1.6418358228520447e-08
; O 0 2.3343870239611597e-12
one O 0 2.2393642929580126e-12
of O 0 3.389345756637206e-14
these O 0 4.193509688804609e-12
individuals O 0 5.1042425630110425e-14
had O 0 3.3930586118557926e-10
an O 0 5.2483896135352426e-14
unusually O 0 4.369895764688714e-11
large O 0 1.5663926861315958e-13
number O 0 1.406268981471448e-12
of O 0 5.6968534056789366e-11
metaplastic B-Disease 0 0.020633595064282417
polyps I-Disease 0 4.728281783172861e-05
of I-Disease 0 1.515674846915005e-12
the I-Disease 0 3.254309044464776e-10
colorectum I-Disease 0 2.107815998897422e-05
. O 0 2.006758981210055e-09

There O 0 5.167494765423442e-10
is O 0 1.429859269180822e-12
increasing O 0 9.329637621268913e-15
evidence O 0 3.2898399174134674e-13
that O 0 1.0776172705909137e-12
there O 0 5.940528017417401e-14
exist O 0 6.201314960672943e-13
germ O 0 1.6647518918944115e-07
- O 0 3.317941263958346e-07
line O 0 4.822628625333891e-07
variants O 0 6.156596760176214e-11
of O 0 4.145250494854563e-14
the O 0 4.4040305798888346e-13
APC B-Disease 0 1.4516991775348487e-10
gene O 0 1.2755990708157583e-11
that O 0 1.5539872990841253e-12
predispose O 0 5.857848234258611e-11
to O 0 1.5634466377784095e-13
the O 0 2.408945438958643e-14
development O 0 3.383797013206333e-14
of O 0 1.5429474104627916e-12
multiple O 0 0.45890340209007263
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999998807907104
and I-Disease 1 0.8624186515808105
carcinoma I-Disease 1 0.9999996423721313
, O 0 3.4719216390755037e-09
but O 0 5.833229732576939e-11
without O 0 6.324328213902497e-12
the O 0 3.7185352019797335e-11
florid O 0 5.9099216741742566e-05
phenotype O 0 2.4293015599141654e-07
of O 0 1.9777554160355093e-12
classical O 0 5.096813193716798e-09
FAP B-Disease 0 2.2049279735369964e-08
, O 0 5.363038572264722e-12
and O 0 5.702490346246036e-13
possibly O 0 2.696230554360274e-13
with O 0 4.3173557312753755e-14
importance O 0 4.787752486135055e-11
for O 0 1.426663288839336e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
risk O 0 1.8781669496092945e-05
in O 0 1.7970293222230316e-13
the O 0 6.262550970425468e-14
general O 0 5.3708638014446364e-14
population O 0 2.2347718836059072e-13
. O 0 6.286252768328282e-12
. O 0 3.1869124006433935e-10

Genomic O 0 3.731817059815512e-07
structure O 0 2.9446841409708213e-08
of O 0 9.562199990154063e-12
the O 0 8.164500187035628e-09
human O 0 8.424599218415096e-05
congenital B-Disease 1 0.9999802112579346
chloride I-Disease 1 0.9999430179595947
diarrhea I-Disease 1 0.999998927116394
( O 0 2.14623163685701e-08
CLD B-Disease 0 0.00021608617680612952
) O 0 2.1489492130211119e-10
gene O 0 3.350852750827471e-08
. O 0 8.723999300741525e-09

Congenital B-Disease 1 0.999826967716217
chloride I-Disease 1 0.9998272061347961
diarrhea I-Disease 1 0.9999984502792358
( O 0 2.9478728720278013e-06
CLD B-Disease 1 0.6729708909988403
) O 0 3.198858564701368e-07
is O 0 2.212831873293908e-08
caused O 0 1.1857048676233717e-08
by O 0 5.060731347872327e-12
mutations O 0 1.7848151401267387e-08
in O 0 3.600704153242096e-12
a O 0 2.030194935775942e-11
gene O 0 9.081582597048055e-09
which O 0 2.9487728925303713e-10
encodes O 0 1.175903285854929e-08
an O 0 6.625254789227597e-10
intestinal O 0 0.16991420090198517
anion O 0 8.879285815055482e-06
transporter O 0 0.13921932876110077
. O 0 2.0583854620781494e-07

We O 0 2.9287985370274328e-08
report O 0 9.121813721035821e-11
here O 0 1.1587609940588023e-13
the O 0 3.627209379478569e-15
complete O 0 4.4056520042377867e-13
genomic O 0 1.1688940093623756e-10
organization O 0 4.200904760772589e-13
of O 0 1.7358993271141855e-14
the O 0 4.570822019489551e-12
human O 0 1.9220043612211413e-10
CLD B-Disease 0 6.834382020315388e-07
gene O 0 3.487167887783471e-08
which O 0 6.4832867963104945e-09
spans O 0 6.622266823796963e-08
approximately O 0 7.869612947408733e-12
39kb O 0 4.862822606810369e-07
, O 0 7.547663015416983e-12
and O 0 1.0991654635084114e-11
comprises O 0 3.744409296513318e-13
21 O 0 1.2066997574777805e-11
exons O 0 3.701773607645009e-07
. O 0 5.8181575113280815e-09

All O 0 7.531703732910344e-11
exon O 0 1.7513715988570766e-07
/ O 0 1.8855560028896434e-06
intron O 0 3.0298191632027738e-05
boundaries O 0 3.862275388399894e-09
conform O 0 5.08972863855206e-10
to O 0 6.017758990770061e-13
the O 0 3.5824136625922653e-12
GT O 0 1.5186735424776998e-07
/ O 0 7.704061744107094e-08
AG O 0 0.0002618845319375396
rule O 0 3.804246695437996e-09
. O 0 5.5723210767855136e-11

An O 0 1.0408614942170047e-11
analysis O 0 4.633442067525362e-12
of O 0 1.303908288849756e-14
the O 0 2.983829004189753e-13
putative O 0 2.1921999771024048e-09
promoter O 0 8.885381319601038e-09
region O 0 2.2424416924043955e-12
sequence O 0 8.167166595796083e-12
shows O 0 8.247900973312738e-11
a O 0 1.8835768448438595e-12
putative O 0 3.791253178064835e-08
TATA O 0 7.463809197361115e-06
box O 0 3.987270247307606e-05
and O 0 2.2050110626281594e-09
predicts O 0 3.284567284822515e-09
multiple O 0 6.666215756484517e-12
transcription O 0 6.592521639703364e-09
factor O 0 1.8365368253947523e-11
binding O 0 1.2266848127551189e-11
sites O 0 8.668578077575262e-10
. O 0 8.480119384479679e-10

The O 0 1.1942354050109572e-10
genomic O 0 2.8124324202849493e-08
structure O 0 8.681522167819367e-09
was O 0 2.6128579300177535e-09
determined O 0 8.117871826140988e-12
using O 0 3.5021630235589074e-13
DNA O 0 5.892143661867522e-09
from O 0 7.423612912544827e-14
several O 0 1.2191972014212113e-15
sources O 0 6.833160051650895e-15
including O 0 3.24594248574399e-16
multiple O 0 2.7864715743119994e-12
large O 0 1.3422558203801671e-11
- O 0 9.043192790159083e-07
insert O 0 1.3082127452435088e-06
libaries O 0 3.270538115884847e-07
and O 0 5.653625354332115e-13
genomic O 0 5.806323130630453e-11
DNA O 0 4.3489987433531496e-07
from O 0 8.281682978283911e-11
Finnish O 0 5.1076358431600966e-06
CLD B-Disease 0 9.005323227029294e-05
patients O 0 1.2667621118733763e-10
and O 0 2.1781051354891057e-12
controls O 0 1.4028668005039435e-08
. O 0 8.675261065071993e-10

Exon O 0 4.838563683051689e-08
- O 0 3.6366504474472094e-08
specific O 0 5.347811082856424e-11
primers O 0 5.693832008546451e-06
developed O 0 1.1157674784101346e-08
in O 0 1.3967285444546618e-12
this O 0 1.603981399469264e-14
study O 0 8.95392811070127e-16
will O 0 1.1478797801194778e-15
facilitate O 0 1.6093801757168262e-15
mutation O 0 4.412045381818608e-12
screening O 0 2.738750372321963e-11
studies O 0 1.706220754960075e-11
of O 0 2.9167095035856e-14
patients O 0 3.677602059687368e-12
with O 0 3.9022534118957064e-13
the O 0 3.4685573857551333e-10
disease O 0 1.9954886738560162e-06
. O 0 1.3359536810142458e-09

Genomic O 0 2.8833682108597714e-09
sequencing O 0 8.578378007939591e-10
of O 0 1.6665746473826237e-12
a O 0 5.732791671930748e-11
BAC O 0 7.942932001014924e-08
clone O 0 0.0008684922358952463
H O 1 0.9999974966049194
_ O 0 8.345005575449704e-09
RG364P16 O 0 1.4067431663988827e-09
revealed O 0 1.5151055521300805e-08
the O 0 1.7688416920416672e-13
presence O 0 2.1044856124679406e-13
of O 0 2.3453175521586734e-15
another O 0 2.323711156219238e-13
, O 0 9.223759349895073e-15
highly O 0 1.2445538950269213e-14
homologous O 0 1.2585844909665522e-12
gene O 0 3.199794318398119e-10
3 O 0 2.1140264885866067e-11
of O 0 3.3711772387317804e-14
the O 0 1.6991992882187112e-11
CLD B-Disease 0 1.0759050184105945e-07
gene O 0 1.1197516247563044e-09
, O 0 1.1144253922457104e-12
with O 0 4.566538255390898e-14
a O 0 1.404531195124334e-13
similar O 0 1.2974915196070635e-12
genomic O 0 1.3722709191199556e-08
structure O 0 5.4732272047886e-09
, O 0 1.7208357135090058e-12
recently O 0 8.215381500087382e-12
identified O 0 4.080770877462614e-12
as O 0 3.172700296927289e-11
the O 0 5.50304150692682e-07
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999998807907104
gene O 0 3.57962453563232e-05
( O 0 1.398905435934239e-10
PDS B-Disease 0 1.4481297512247693e-06
) O 0 2.2023818532779238e-11
. O 0 6.392168044877522e-12
. O 0 4.113973051111941e-10

The O 0 4.057135183366256e-10
APCI1307K O 0 2.987396510434337e-05
allele O 0 0.00011586806067498401
and O 0 4.0528034332965035e-06
cancer B-Disease 0 0.00021711961016990244
risk O 0 5.364542516872461e-07
in O 0 6.610202402806964e-12
a O 0 2.9774932519543995e-11
community O 0 9.41452645009111e-12
- O 0 2.788954667209964e-08
based O 0 5.705248426468579e-11
study O 0 7.664338456427056e-13
of O 0 3.7002613972013376e-14
Ashkenazi O 0 1.2399556226228015e-07
Jews O 0 3.6619498544609996e-09
. O 0 9.568901226941762e-11

Mutations O 0 3.056953346458613e-06
in O 0 1.0158317242936477e-10
APC O 0 7.78419064317859e-07
are O 0 7.792161915709528e-10
classically O 0 0.00015041959704831243
associated O 0 4.424714006745489e-06
with O 0 0.0002079189580399543
familial B-Disease 1 0.9999984502792358
adenomatous I-Disease 1 0.9999744892120361
polyposis I-Disease 1 0.9999972581863403
( O 0 7.179249195132797e-08
FAP B-Disease 0 6.929929554644332e-07
) O 0 1.0853620086015425e-10
, O 0 4.404408695396489e-13
a O 0 1.9772020826147596e-11
highly O 0 4.9336049414705485e-06
penetrant O 1 0.999968409538269
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999985694885254
disorder I-Disease 1 0.9999998807907104
characterized O 0 6.0600410506594926e-05
by O 0 7.106030763814886e-10
multiple O 0 2.100279562000651e-05
intestinal O 1 0.9999700784683228
polyps B-Disease 1 0.9995959401130676
and O 0 1.6726357898733113e-07
, O 0 4.933213993557617e-12
without O 0 9.623268978561916e-13
surgical O 0 1.6323106755145034e-10
intervention O 0 5.374100123245462e-11
, O 0 9.185771446870022e-14
the O 0 1.1833566624427222e-13
development O 0 5.065243710578038e-11
of O 0 3.0998949114291463e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
( O 0 8.488971747766527e-10
CRC B-Disease 0 2.022663238676614e-06
) O 0 3.15775842973931e-11
. O 0 1.3278668442584518e-10

APC B-Disease 0 4.571189492708072e-06
is O 0 1.48760914697732e-09
a O 0 1.7230257221001466e-09
tumour O 1 0.999992847442627
- O 0 7.053318768157624e-06
suppressor O 0 6.6110560510423966e-06
gene O 0 7.506158539172247e-08
, O 0 4.5293577916050154e-11
and O 0 2.755838092449725e-11
somatic O 0 6.640784278033607e-08
loss O 0 1.6844694982864894e-05
occurs O 0 5.0452442224013794e-08
in O 0 8.92245477501774e-09
tumours B-Disease 1 0.9999955892562866
. O 0 2.150687578250654e-06

The O 0 3.5272068599212503e-10
germline O 0 2.4275365717585373e-07
T O 0 3.7963320210110396e-05
- O 0 7.580600680512362e-08
to O 0 9.057445904403494e-10
- O 0 5.7895665150908826e-08
A O 0 4.5952849858643674e-10
transversion O 0 5.129973779105512e-09
responsible O 0 3.1076069452115607e-13
for O 0 9.268932649293549e-17
the O 0 3.3636667246434186e-15
APC O 0 2.4355698013955873e-11
I1307K O 0 9.533003726691636e-13
allele O 0 5.797422437947564e-12
converts O 0 1.2170777623568552e-12
the O 0 4.245892239141888e-14
wild O 0 1.4614693136238976e-11
- O 0 1.8782058130994983e-09
type O 0 1.1680710218509027e-11
sequence O 0 1.0491216229091549e-10
to O 0 8.408811841276176e-11
a O 0 1.139381122783334e-08
homopolymer O 1 0.8913561701774597
tract O 1 0.8657633662223816
( O 0 2.5916729873287636e-10
A8 O 0 0.06665055453777313
) O 0 9.779882459426403e-10
that O 0 4.834970201983424e-10
is O 0 1.1277952877142283e-10
genetically O 0 4.2007631151363967e-08
unstable O 0 0.10676855593919754
and O 0 8.093553560684086e-08
prone O 0 9.254371252609417e-05
to O 0 3.139920962125231e-11
somatic O 0 2.775126617393653e-08
mutation O 0 1.0103587300136496e-07
. O 0 1.4001695802789982e-08

The O 0 1.777370195465977e-10
I1307K O 0 3.447225083164085e-08
allele O 0 6.253389983612578e-07
was O 0 1.356609971026046e-07
found O 0 9.391794009161458e-10
in O 0 2.311842123986496e-12
6 O 0 6.7418309823708e-10
. O 0 2.4909996287902914e-10

1 O 0 4.675118958630264e-09
% O 0 4.874959377149102e-12
of O 0 3.893330021440336e-14
unselected O 0 4.193878311298249e-08
Ashkenazi O 0 1.6380469105570228e-06
Jews O 0 3.180739582830938e-08
and O 0 1.7137306018710774e-09
higher O 0 2.1326826971090895e-09
proportions O 0 2.2259020227011206e-07
of O 0 1.9255444461130367e-11
Ashkenazim O 0 0.00011070191249018535
with O 0 3.987629781931901e-09
family O 0 6.556484777320293e-08
or O 0 8.083071434406008e-10
personal O 0 1.0581705112144846e-07
histories O 0 4.7284082427268004e-08
of O 0 2.3235937479659796e-11
CRC B-Disease 0 2.2987866032053716e-05
( O 0 6.781336017898376e-13
ref O 0 3.6001901548843307e-07
. O 0 1.631830434667414e-11
2 O 0 8.6223361783766e-11
) O 0 7.054773432102479e-12
. O 0 9.611594159464332e-11

To O 0 8.23687645867821e-12
evaluate O 0 7.017063145819957e-12
the O 0 4.5951703407003455e-14
role O 0 8.364972126431724e-13
of O 0 1.15397261516402e-13
I1307K O 0 1.2875313037952196e-09
in O 0 5.634272562393683e-12
cancer B-Disease 0 2.5930042557575916e-09
, O 0 4.0381757725020673e-13
we O 0 2.8367887466157482e-12
genotyped O 0 1.1446212866417227e-09
5 O 0 1.2855908828809937e-12
, O 0 2.920501839497047e-13
081 O 0 4.601400149795154e-09
Ashkenazi O 0 4.370978103906964e-07
volunteers O 0 4.9834532334092074e-11
in O 0 7.420257984447343e-14
a O 0 1.667407531491527e-12
community O 0 1.2959290758562947e-11
survey O 0 2.1587029941372293e-09
. O 0 8.037591425757995e-11

Risk O 0 1.786257826097426e-06
of O 0 3.185002608874221e-11
developing O 0 1.0420751550554996e-07
colorectal B-Disease 1 0.9999980926513672
, I-Disease 0 2.1935495624347823e-06
breast I-Disease 0 0.0017527596792206168
and I-Disease 0 5.211318665487852e-08
other I-Disease 0 2.0470521111537465e-10
cancers I-Disease 0 1.6107576357171638e-06
were O 0 2.215874844724297e-10
compared O 0 1.5205574646626197e-11
between O 0 9.674232769041335e-12
genotyped O 0 5.194170853428659e-07
I1307K O 0 4.766472994077731e-09
carriers O 0 5.1432535314033245e-11
and O 0 1.8931946288436308e-11
non O 0 2.119209105075348e-12
- O 0 3.949640259293119e-08
carriers O 0 9.333839950942391e-11
and O 0 1.866974456976589e-11
their O 0 7.793730071037341e-12
first O 0 2.0984233448095857e-11
- O 0 4.013246268641524e-08
degree O 0 1.0705689806878027e-10
relatives O 0 2.463035331246033e-10
. O 0 1.906977180332614e-11

Sperm O 0 1.4780785484447279e-08
DNA O 0 5.5276552224370334e-09
analysis O 0 8.694405612130751e-11
in O 0 1.2532259301492599e-12
a O 0 3.2394151250336733e-10
Friedreich B-Disease 0 0.015939684584736824
ataxia I-Disease 1 0.8192407488822937
premutation O 0 0.0004962998791597784
carrier O 0 7.281909120138153e-07
suggests O 0 3.204906895426518e-10
both O 0 3.1757241151023075e-13
meiotic O 0 1.1528803867122406e-07
and O 0 1.9551409102813722e-10
mitotic O 0 1.042769071091243e-07
expansion O 0 1.384383718772142e-10
in O 0 5.362268788722258e-13
the O 0 5.086666764880787e-12
FRDA B-Disease 0 2.3006491574051324e-06
gene O 0 2.8046596156627857e-08
. O 0 2.209819216503206e-09

Friedreich B-Disease 1 0.987711489200592
ataxia I-Disease 1 0.9995519518852234
is O 0 4.0668743167771026e-05
usually O 0 1.3208405107434373e-06
caused O 0 9.37476052342845e-09
by O 0 8.38571969025495e-14
an O 0 2.00806710669299e-14
expansion O 0 4.109882573155588e-12
of O 0 3.67333089943897e-13
a O 0 4.166679445916088e-09
GAA O 0 2.395825958956266e-06
trinucleotide O 0 3.498671730994829e-06
repeat O 0 2.1768642000097316e-07
in O 0 2.994467738007267e-13
intron O 0 9.374010119245213e-07
1 O 0 6.108662187198632e-11
of O 0 1.5975331070484065e-14
the O 0 2.4429066408648836e-11
FRDA B-Disease 0 2.149484089386533e-06
gene O 0 1.420977202570839e-08
. O 0 1.0709003683828655e-09

Occasionally O 0 4.465373706352693e-07
, O 0 3.5554100896034724e-12
a O 0 1.0364524857938914e-13
fully O 0 4.5132785854960777e-13
expanded O 0 2.11380663407007e-13
allele O 0 4.567980838032781e-08
has O 0 2.3497841450392798e-09
been O 0 3.160248174260971e-10
found O 0 2.7308634520384345e-11
to O 0 2.3576923399715177e-11
arise O 0 3.0677699963677085e-11
from O 0 1.9055344460542148e-14
a O 0 1.6190502714549804e-12
premutation O 0 3.384865721045571e-08
of O 0 5.4871226309936676e-15
100 O 0 1.6832688671739038e-13
or O 0 1.5943201620016723e-12
less O 0 1.6314654705321119e-12
triplet O 0 5.1716775487875566e-05
repeats O 0 0.0002006644499488175
. O 0 6.0367750798207e-09

We O 0 6.017326370511e-08
have O 0 1.3458447897796155e-11
examined O 0 1.634138484252201e-11
the O 0 8.571835190436528e-14
sperm O 0 1.5160579736051005e-10
DNA O 0 1.000375005055787e-09
of O 0 5.776665766826089e-14
a O 0 7.935697238226069e-11
premutation O 0 5.826083452120656e-06
carrier O 0 1.838302949863646e-07
. O 0 5.920212653443002e-10

This O 0 4.53459630955777e-11
mans O 0 1.7209311309329678e-08
leucocyte O 0 6.093461593081884e-07
DNA O 0 1.7048009226527938e-07
showed O 0 1.098634783147645e-08
one O 0 4.45372607066688e-13
normal O 0 7.807175587438986e-13
allele O 0 1.6862351515101182e-09
and O 0 2.3309000563020987e-11
one O 0 4.120675588942246e-12
allele O 0 8.575531951215964e-10
of O 0 4.546783414181854e-14
approximately O 0 2.440515237817076e-13
100 O 0 3.532596090649598e-12
repeats O 0 6.36558411315491e-07
. O 0 2.1224038082579e-09

His O 0 6.433388222149006e-08
sperm O 0 5.9580770539469086e-08
showed O 0 4.2014799972456274e-10
an O 0 1.280205702359268e-15
expanded O 0 1.7430466250044352e-13
allele O 0 5.4414094563526305e-08
in O 0 2.3715383823397218e-11
a O 0 3.4046110375385297e-10
tight O 0 2.5313045171060367e-07
range O 0 1.9737403378350393e-10
centering O 0 6.549829012492125e-10
on O 0 5.213908194079409e-10
a O 0 2.6835953164522364e-12
size O 0 9.160795386153886e-12
of O 0 4.191122749959246e-14
approximately O 0 5.865601515782359e-13
320 O 0 5.566446609206466e-11
trinucleotide O 0 2.3289539967663586e-06
repeats O 0 1.893832813948393e-05
. O 0 1.6692781601435058e-09

His O 0 1.1211133141841856e-06
affected O 0 1.634592905475074e-08
son O 0 1.4641258303527138e-06
has O 0 2.186829384243083e-09
repeat O 0 3.375279078454696e-08
sizes O 0 1.1119041798401952e-10
of O 0 2.0767448091069118e-13
1040 O 0 1.992906106806913e-08
and O 0 4.202345693649079e-10
540 O 0 1.5811018272415822e-08
. O 0 7.824733638805981e-10

These O 0 1.6076900227757207e-11
data O 0 1.1778616970659073e-10
suggest O 0 1.4174613739703634e-11
that O 0 3.959043108538868e-13
expansion O 0 7.560226750191745e-12
occurs O 0 2.929956277597512e-11
in O 0 8.256829058363516e-14
two O 0 1.3866689047015157e-11
stages O 0 1.7502295168725368e-09
, O 0 5.125347303687466e-13
the O 0 2.0842873664516683e-14
first O 0 1.0566271165315944e-12
during O 0 6.18048928008319e-12
meiosis O 0 6.803480088329872e-12
followed O 0 2.669225084017679e-12
by O 0 1.8781066721891733e-15
a O 0 3.08754757871732e-14
second O 0 1.5160572450212406e-11
mitotic O 0 9.278168704440759e-07
expansion O 0 3.131126691258146e-09
. O 0 3.839848439213256e-10

We O 0 8.505199211583658e-09
also O 0 8.110525445692573e-11
show O 0 2.34069819082805e-10
that O 0 7.323241541174266e-14
in O 0 9.780691559527774e-16
all O 0 1.9251254710912595e-15
informative O 0 2.7077000364084114e-11
carrier O 0 2.2373396468822193e-09
father O 0 3.3930283027672203e-09
to O 0 1.4795732998160172e-12
affected O 0 1.8274360432009307e-13
child O 0 1.265974824971039e-10
transmissions O 0 2.107962302488886e-07
, O 0 3.3484738419520266e-13
with O 0 2.5777945113236202e-14
the O 0 1.3131910923253054e-13
notable O 0 5.424980668682078e-13
exception O 0 1.1318060339849181e-13
of O 0 4.905396072928938e-15
the O 0 1.2311031534484318e-11
premutation O 0 8.329749334734515e-07
carrier O 0 2.507045016031384e-09
, O 0 3.2602792807059217e-14
the O 0 9.855146814382611e-16
expansion O 0 5.872620098545944e-13
size O 0 1.2487462452970277e-10
decreases O 0 8.643071258696011e-10
. O 0 3.7563428929854314e-12
. O 0 1.6762326249253334e-10

The O 0 1.839766811118082e-10
R496H O 0 2.3583703878671258e-08
mutation O 0 9.838354131375127e-09
of O 0 3.0303160154787623e-12
arylsulfatase O 0 1.105487285713025e-06
A O 0 1.174996988595467e-09
does O 0 5.342389863827179e-10
not O 0 8.326320743989868e-10
cause O 0 1.9153042103425832e-06
metachromatic B-Disease 1 0.9999765157699585
leukodystrophy I-Disease 1 0.9999507665634155
. O 0 3.6334304809315654e-07

Deficiency B-Disease 1 0.9994768500328064
of I-Disease 0 8.535421813782307e-10
arylsulfatase I-Disease 0 0.00018607046513352543
A I-Disease 0 1.5178785872649314e-07
( O 0 4.3186884624013544e-11
ARSA O 0 7.381674367934465e-05
) O 0 1.3408177346185823e-11
enzyme O 0 4.6243555651415136e-09
activity O 0 1.5775029282849573e-07
causes O 0 0.00031480719917453825
metachromatic B-Disease 1 0.9999861717224121
leukodystrophy I-Disease 1 0.9999849796295166
( O 0 2.767866590147605e-06
MLD B-Disease 1 0.9999496936798096
) O 0 7.5523864495608e-08
. O 0 2.787607700227568e-09

A O 0 6.192660828574503e-10
number O 0 3.1256026412906923e-12
of O 0 1.494138688641622e-12
ARSA O 0 0.00027156571741215885
gene O 0 3.228137401833919e-08
mutations O 0 5.603173391932614e-08
responsible O 0 2.7659778911726107e-09
for O 0 5.491240795407748e-10
MLD B-Disease 1 0.9999942779541016
have O 0 5.419014126317734e-09
been O 0 1.7334775281874215e-10
identified O 0 2.310734936727954e-09
. O 0 2.945186594605076e-10

Recently O 0 7.241214294850806e-09
, O 0 8.071180442742465e-13
the O 0 1.1708536429896194e-13
R496H O 0 4.40826430914143e-10
mutation O 0 2.3231516710353617e-10
of O 0 1.1899117758826239e-12
ARSA O 0 8.802288357401267e-05
was O 0 2.0085471064135163e-09
proposed O 0 2.0425966588976958e-15
to O 0 3.138191678633655e-14
be O 0 1.2899679154715349e-12
a O 0 1.276950073458849e-11
cause O 0 4.367167072416578e-09
of O 0 4.1726022637078586e-10
MLD B-Disease 1 0.9999992847442627
( O 0 4.283650517633575e-11
Draghia O 0 1.5305612066640606e-07
et O 0 6.996986545715345e-09
al O 0 1.5020545163224597e-07
. O 0 7.815527391930033e-11
, O 0 3.2824203424763887e-12
1997 O 0 5.3039680286692814e-11
) O 0 1.0985136411623131e-11
. O 0 1.7777669614194025e-10

We O 0 3.6559339999797658e-09
have O 0 3.2211681239013856e-12
investigated O 0 2.607188987271969e-12
the O 0 3.3588108965150465e-13
R496H O 0 7.071552787785151e-10
mutation O 0 1.514474878838712e-09
and O 0 9.425491637182759e-11
found O 0 4.475086967659081e-11
this O 0 1.2100197688443004e-13
mutation O 0 1.717095562958626e-11
at O 0 7.690807712901204e-11
a O 0 8.9536684273403e-13
relatively O 0 1.5666773434119818e-12
high O 0 1.1079664269386669e-10
frequency O 0 7.259842060847177e-09
in O 0 1.2748784233157506e-12
an O 0 3.8890292895776835e-12
African O 0 1.545044994721856e-11
American O 0 5.4383920977674194e-11
population O 0 1.710507278353257e-13
( O 0 4.308518636536671e-15
f O 0 1.2471050858664512e-08
= O 0 1.3876705340365447e-09
0 O 0 9.489446988614203e-13
. O 0 1.9612482753290916e-13
09 O 0 6.119974665930172e-11
, O 0 3.316278154863461e-11
n O 0 1.7429454146622447e-07
= O 0 5.746977080889337e-07
61 O 0 4.936111075437566e-09
subjects O 0 5.164255689749098e-09
) O 0 1.531347548766604e-10
. O 0 2.1595790433703854e-10

The O 0 7.96338772701688e-10
ARSA O 0 2.4035700334934518e-05
enzyme O 0 6.052329126760014e-08
activity O 0 4.004466536144946e-09
in O 0 1.5551140019817722e-12
subjects O 0 2.44497283530265e-10
with O 0 3.372891375919007e-12
and O 0 1.694558209031083e-11
without O 0 9.291592018359496e-13
the O 0 1.913792746239401e-13
R496H O 0 3.282386029646034e-10
mutation O 0 4.258447483529437e-10
was O 0 6.585185019503115e-08
determined O 0 8.486677138819232e-09
and O 0 5.19739355719917e-11
found O 0 1.2902194937436384e-11
to O 0 1.6401477073192672e-13
be O 0 4.004009797331509e-12
normal O 0 2.148825214987049e-11
. O 0 1.5425193067297727e-10

It O 0 8.830472353338337e-09
is O 0 9.691316325832755e-12
therefore O 0 2.8831535141098097e-13
concluded O 0 2.041813116152036e-12
that O 0 5.172602187612611e-14
the O 0 5.837161537545349e-14
R496H O 0 1.1262948212964474e-10
mutation O 0 1.85382487138952e-10
of O 0 1.3241627846299897e-12
ARSA O 0 0.00022388974321074784
does O 0 7.315243411021299e-10
not O 0 1.6476548857918827e-12
negatively O 0 1.812392792267803e-12
influence O 0 1.013115914945406e-12
the O 0 3.0922874395648836e-13
activity O 0 6.033766819513176e-10
of O 0 2.1192333912040118e-12
ARSA O 0 0.03622228652238846
and O 0 7.066537355271407e-10
is O 0 3.246909035040102e-12
not O 0 9.064967743457886e-13
a O 0 2.4381770907799805e-11
cause O 0 1.5026470734369468e-08
of O 0 7.156497172644549e-09
MLD B-Disease 1 0.9999231100082397

Down O 0 4.718192576547153e-05
- O 0 7.245962478918955e-07
regulation O 0 6.726343926288791e-09
of O 0 3.366836757306979e-12
transmembrane O 0 1.3446299362840364e-07
carbonic O 0 6.222586534931906e-08
anhydrases O 0 2.821528869390022e-05
in O 0 5.716549900114387e-09
renal B-Disease 1 0.9654127955436707
cell I-Disease 1 0.9990202188491821
carcinoma I-Disease 1 0.9999994039535522
cell O 0 0.09836513549089432
lines O 0 2.5815302251430694e-07
by O 0 1.5403194345009474e-11
wild O 0 1.1425392187902617e-07
- O 0 0.3670443296432495
type O 0 0.017256001010537148
von B-Disease 1 0.9999599456787109
Hippel I-Disease 1 0.9998257756233215
- I-Disease 1 0.9979962110519409
Lindau I-Disease 1 0.9985276460647583
transgenes O 0 0.0016624934505671263
. O 0 3.2686696016526184e-08

To O 0 3.6815623466468494e-11
discover O 0 2.8489974268630647e-10
genes O 0 1.0563663138674073e-10
involved O 0 1.345755729076359e-10
in O 0 8.779230120659065e-10
von B-Disease 1 0.9996803998947144
Hippel I-Disease 1 0.9998364448547363
- I-Disease 1 0.999957799911499
Lindau I-Disease 1 0.999957799911499
( O 0 3.239591350734372e-08
VHL B-Disease 0 0.0008144721505232155
) O 0 1.9484001079206337e-09
- O 0 1.9279751484191365e-07
mediated O 0 5.8853561313299e-06
carcinogenesis O 0 0.00014121933782007545
, O 0 3.52022196115076e-11
we O 0 4.722794724743018e-11
used O 0 2.2111770192623226e-09
renal B-Disease 0 0.22455042600631714
cell I-Disease 1 0.9990236759185791
carcinoma I-Disease 1 0.9999995231628418
cell O 1 0.9737821221351624
lines O 0 0.00036236856249161065
stably O 0 0.07614079862833023
transfected O 0 0.0011446477146819234
with O 0 1.2693368134364391e-08
wild O 0 2.5456897674303036e-06
- O 0 0.10245152562856674
type O 0 0.00031017253058962524
VHL O 1 0.8211679458618164
- O 0 0.0004153610789217055
expressing O 0 8.495864278756926e-08
transgenes O 0 4.52200310974149e-06
. O 0 6.016704023892316e-09

Large O 0 1.0021487112377159e-10
- O 0 1.349363110136892e-08
scale O 0 3.694431649492458e-09
RNA O 0 1.4403104842131143e-07
differential O 0 9.485212615345517e-09
display O 0 2.3217164302202775e-10
technology O 0 3.419264871240557e-11
applied O 0 2.019418161337827e-13
to O 0 1.0215678129810168e-13
these O 0 1.419927814650529e-13
cell O 0 4.5519602309695983e-08
lines O 0 2.47735010283634e-09
identified O 0 4.3381558761934613e-11
several O 0 8.233239529595662e-14
differentially O 0 5.697696092710203e-09
expressed O 0 9.004773923043663e-13
genes O 0 1.8758695985443552e-11
, O 0 2.5474514194607188e-14
including O 0 2.7091708249262435e-16
an O 0 1.1114947598921641e-14
alpha O 0 2.745988115712694e-12
carbonic O 0 4.0562297964896743e-10
anhydrase O 0 9.451978089103363e-10
gene O 0 7.820332714736367e-10
, O 0 3.484109268453439e-12
termed O 0 1.5216274462659385e-08
CA12 O 0 0.00016691152995917946
. O 0 2.9516553645692056e-09

The O 0 9.648029770936706e-12
deduced O 0 2.4114601981928274e-10
protein O 0 6.06843464368012e-11
sequence O 0 2.976512369912143e-10
was O 0 7.876889140945309e-10
classified O 0 9.178044435564914e-11
as O 0 5.174953889887368e-13
a O 0 9.925039089198062e-12
one O 0 1.5506675943299797e-09
- O 0 0.07910297811031342
pass O 0 0.024490268900990486
transmembrane O 0 0.00206338451243937
CA O 0 8.173748824447102e-07
possessing O 0 1.80206665562066e-11
an O 0 6.969268369870496e-13
apparently O 0 5.824722748570821e-08
intact O 0 2.843682511688428e-10
catalytic O 0 8.733230111301893e-11
domain O 0 6.749756864543599e-10
in O 0 3.1396659903003277e-13
the O 0 3.0411380878836436e-12
extracellular O 0 4.682377493736567e-06
CA O 0 3.6950994399376214e-05
module O 0 1.1802458175225183e-05
. O 0 1.5336253378350762e-09

Reintroduced O 0 2.3269484472621116e-07
wild O 0 3.8516918721143156e-07
- O 0 7.155249477364123e-05
type O 0 1.3015363720114692e-06
VHL B-Disease 0 0.00011867587454617023
strongly O 0 1.1226707341549513e-09
inhibited O 0 1.1317177195380168e-09
the O 0 1.3657871491754014e-12
overexpression O 0 1.278330663545546e-09
of O 0 4.3356509653097106e-14
the O 0 2.9662002021257905e-12
CA12 O 0 1.35563226422164e-07
gene O 0 1.1528282495287812e-10
in O 0 1.5072386156007866e-13
the O 0 4.35010968219407e-12
parental O 0 8.775772585067898e-06
renal B-Disease 1 0.9439117312431335
cell I-Disease 1 0.9565771818161011
carcinoma I-Disease 1 0.9999972581863403
cell O 0 0.4278883635997772
lines O 0 0.0003323567216284573
. O 0 9.178547344390608e-08

Similar O 0 2.0982213744247247e-09
results O 0 1.3917118846240584e-10
were O 0 5.260883308849662e-12
obtained O 0 1.8484105305388576e-12
with O 0 5.71618100075888e-12
CA9 O 0 3.0749330193202695e-08
, O 0 1.1926878484402187e-13
encoding O 0 3.88394628958455e-11
another O 0 1.0626076019093489e-08
transmembrane O 0 0.00019503897055983543
CA O 0 1.8725870177149773e-05
with O 0 3.2660022689784407e-12
an O 0 1.6251081426735259e-12
intact O 0 2.0946595569171222e-08
catalytic O 0 1.960631434982929e-09
domain O 0 2.2533706456329128e-08
. O 0 9.046620674801886e-10

Although O 0 1.401413873836077e-09
both O 0 1.8335994615009676e-12
domains O 0 1.992816744955661e-10
of O 0 1.6831942266305917e-14
the O 0 1.2624866430055448e-12
VHL B-Disease 0 2.9148218061436637e-08
protein O 0 1.2530567729263087e-11
contribute O 0 3.803806431618671e-15
to O 0 7.829002881100736e-14
regulation O 0 1.768054279371878e-11
of O 0 1.819707579064911e-13
CA12 O 0 1.0179912806052016e-06
expression O 0 2.6115349466282467e-11
, O 0 7.735918025955635e-14
the O 0 3.331780719915446e-14
elongin O 0 1.993072373807081e-09
binding O 0 1.2470603542868997e-11
domain O 0 7.91533893984564e-10
alone O 0 3.815866733702933e-09
could O 0 1.8144239583017807e-11
effectively O 0 2.3387525249773944e-10
regulate O 0 1.3934982945329466e-08
CA9 O 0 6.785483856219798e-05
expression O 0 9.04196806317259e-09
. O 0 7.430102089145407e-10

We O 0 9.534677936073876e-09
mapped O 0 4.685973635787377e-06
CA12 O 0 0.000358124787453562
and O 0 6.442632205505561e-09
CA9 O 0 3.5330756986695633e-07
loci O 0 1.4846244233979178e-09
to O 0 1.0553632967535975e-10
chromosome O 0 5.392528237280203e-07
bands O 0 2.1584682929898236e-09
15q22 O 0 1.2491237377787456e-08
and O 0 2.4006663323916655e-10
17q21 O 0 1.1418263667906103e-08
. O 0 2.700758783280577e-10

2 O 0 2.2611075678469206e-08
respectively O 0 9.62648272206934e-09
, O 0 5.5356785128024555e-11
regions O 0 1.191075710282874e-10
prone O 0 1.1179402463312726e-05
to O 0 6.411170205833372e-11
amplification O 0 1.2110870102333138e-06
in O 0 2.7066918584922606e-12
some O 0 1.1127383059026871e-13
human O 0 1.0525413873807565e-09
cancers B-Disease 0 0.00013044438674114645
. O 0 9.280203272510335e-09

Additional O 0 1.1468206592701868e-11
experiments O 0 4.021373900542358e-09
are O 0 6.092319032070803e-13
needed O 0 1.4819202722587965e-12
to O 0 1.0731105132104346e-13
define O 0 2.6081287737150793e-12
the O 0 1.0782808023204749e-13
role O 0 1.5402224634586403e-11
of O 0 1.5850299588462957e-12
CA O 0 7.933983425800761e-08
IX O 0 3.8291961601544244e-08
and O 0 2.266215126667248e-08
CA O 0 9.310755189062547e-08
XII O 0 3.21530491120825e-09
enzymes O 0 1.6996086482645723e-10
in O 0 1.4977758345646047e-13
the O 0 1.5632268699980467e-12
regulation O 0 1.8834997450589697e-10
of O 0 6.883844622801449e-13
pH O 0 2.366247002782984e-07
in O 0 7.289392749349269e-14
the O 0 7.926139264239143e-14
extracellular O 0 3.5439393641922834e-09
microenvironment O 0 1.9617813507011306e-07
and O 0 1.5726277224903384e-10
its O 0 4.366877519312862e-12
potential O 0 2.2945046904143673e-11
impact O 0 8.704688879423994e-12
on O 0 6.620950454561125e-09
cancer B-Disease 0 3.065055125262006e-07
cell O 0 1.6538219824724365e-06
growth O 0 6.702114418999372e-09
. O 0 7.168962645742738e-11

A O 0 6.139019154138836e-11
gene O 0 5.303583613947005e-11
encoding O 0 8.441646826007343e-10
a O 0 1.5905737837940137e-10
transmembrane O 0 2.7052985629438808e-08
protein O 0 1.6320406137637633e-09
is O 0 1.6544696385470403e-12
mutated O 0 2.8288396070053068e-09
in O 0 2.518674852014513e-11
patients O 0 6.557985443578218e-08
with O 0 2.1107489374116994e-05
diabetes B-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.9999997615814209
and O 1 0.7264788150787354
optic B-Disease 1 0.9999969005584717
atrophy I-Disease 1 0.9999336004257202
( O 0 4.51085579697974e-05
Wolfram B-Disease 1 0.9999972581863403
syndrome I-Disease 1 0.9999990463256836
) O 0 5.908903517592989e-07
. O 0 1.7878749147826056e-08

Wolfram B-Disease 1 0.9998629093170166
syndrome I-Disease 1 0.9999909400939941
( O 0 5.241880899120588e-06
WFS B-Disease 0 0.06176672875881195
; O 0 2.3329501175339828e-07
OMIM O 0 0.007111862767487764
222300 O 0 1.5191186321317218e-05
) O 0 3.8465284291078206e-09
is O 0 1.84397899727351e-10
an O 0 1.6484212883582927e-09
autosomal B-Disease 1 0.9999861717224121
recessive I-Disease 1 0.9999946355819702
neurodegenerative I-Disease 1 0.9999940395355225
disorder I-Disease 1 0.9999362230300903
defined O 0 1.1867750338012684e-08
by O 0 1.3836867762684335e-10
young O 0 9.098677367092023e-09
- O 0 4.4742177124135196e-05
onset O 0 0.0003968310193158686
non O 0 1.3198133252956268e-08
- O 0 0.0001371754624415189
immune O 0 0.0010663260472938418
insulin B-Disease 1 0.9792373180389404
- I-Disease 1 0.9930942058563232
dependent I-Disease 1 0.9870738983154297
diabetes I-Disease 1 0.9999996423721313
mellitus I-Disease 1 0.9999995231628418
and O 0 5.202618922339752e-05
progressive O 0 8.039837121032178e-05
optic B-Disease 1 0.9999521970748901
atrophy I-Disease 1 0.713198721408844
. O 0 8.646426152836284e-08

Linkage O 0 5.584000177805137e-07
to O 0 3.2347841072422057e-10
markers O 0 1.909409775180393e-06
on O 0 3.294885004834214e-07
chromosome O 0 0.008768749423325062
4p O 0 0.43818390369415283
was O 0 6.381642947417276e-07
confirmed O 0 1.0060643873543995e-08
in O 0 3.1665062282318357e-13
five O 0 3.692793640319714e-11
families O 0 8.055071887280718e-11
. O 0 9.067484263436398e-11

On O 0 1.052705630999462e-10
the O 0 5.432432932314657e-14
basis O 0 3.1683958570932064e-14
of O 0 3.8583191004117057e-14
meiotic O 0 7.478286988771288e-06
recombinants O 0 0.002549597527831793
and O 0 9.691323157312581e-07
disease O 0 8.770081876718905e-06
- O 0 3.4043594041577308e-06
associated O 0 2.7024826820820635e-08
haplotypes O 0 4.2398681898703217e-07
, O 0 8.6529099857513e-12
the O 0 2.087806707032347e-12
WFS B-Disease 0 3.612529653196361e-08
gene O 0 9.527177657897568e-11
was O 0 3.3317240633046197e-10
localized O 0 2.5969464426123245e-11
to O 0 4.72539628953994e-12
a O 0 1.5663621788508664e-10
BAC O 0 6.090893975851941e-07
/ O 0 5.70976851577143e-07
P1 O 0 0.00035200189449824393
contig O 0 2.2410699784813914e-07
of O 0 1.372609691245542e-14
less O 0 9.802099046720206e-15
than O 0 2.420947641711352e-15
250 O 0 1.491890920697625e-13
kb O 0 2.3028894702292746e-07
. O 0 3.678258253536626e-10

Mutations O 0 8.482924158670357e-07
in O 0 5.157458488058708e-11
a O 0 4.7049922985431536e-11
novel O 0 6.636625138334296e-10
gene O 0 1.5834912403533963e-07
( O 0 2.1607358263731058e-11
WFS1 O 0 2.499822358004167e-07
) O 0 1.59595318731387e-13
encoding O 0 2.40150672785322e-12
a O 0 1.4821867691527935e-11
putative O 0 1.3675175125626993e-07
transmembrane O 0 3.5777777185330706e-08
protein O 0 1.185527787050944e-09
were O 0 9.94196322490204e-11
found O 0 7.930869849737121e-11
in O 0 9.973114998770849e-14
all O 0 5.120461888698247e-13
affected O 0 3.018511818535935e-13
individuals O 0 3.5156386231827066e-15
in O 0 1.3796499749932356e-13
six O 0 7.289420733691543e-10
WFS B-Disease 0 4.442726549314102e-06
families O 0 1.4047771279557253e-10
, O 0 4.739737248515841e-13
and O 0 4.476142980575082e-12
these O 0 1.0651763759222943e-12
mutations O 0 8.368288839655236e-10
were O 0 8.381510763211253e-11
associated O 0 1.4212893882648014e-11
with O 0 3.4528833785241186e-12
the O 0 5.589216867107893e-10
disease O 0 8.41983546706615e-06
phenotype O 0 1.667783919856447e-07
. O 0 5.017354975933586e-09

WFS1 O 0 7.620653923368081e-05
appears O 0 9.590053906549656e-08
to O 0 6.739946708383959e-12
function O 0 7.364953785726769e-11
in O 0 1.8650135255593447e-11
survival O 0 4.551899621674238e-07
of O 0 2.7965078169822633e-12
islet O 0 7.210325566120446e-05
beta O 0 4.830649213971583e-09
- O 0 6.038395099494664e-07
cells O 0 1.3814150712221362e-08
and O 0 8.813703933352457e-11
neurons O 0 9.084067525977346e-11
. O 0 7.352935968429897e-12
. O 0 1.8667048462539526e-10

Stable O 0 1.6547514292142296e-07
interaction O 0 1.3314301050559862e-10
between O 0 1.802533990125088e-11
the O 0 3.8503887036210604e-13
products O 0 1.0654391431608179e-11
of O 0 2.0960668842425444e-15
the O 0 4.0467496432820826e-13
BRCA1 O 0 2.6297391286789207e-07
and O 0 2.666812104479277e-09
BRCA2 O 0 4.3628571688714146e-07
tumor B-Disease 0 2.4015307076297177e-07
suppressor O 0 9.473698980855261e-08
genes O 0 1.8861394668334697e-09
in O 0 5.617636889519717e-13
mitotic O 0 2.043835365839186e-06
and O 0 3.790593172681156e-09
meiotic O 0 2.358304845984094e-05
cells O 0 1.4517263480229303e-06
. O 0 1.4334665898729781e-08

BRCA1 O 0 0.0009941216558218002
and O 0 3.840519582354318e-07
BRCA2 O 0 1.3773340015177382e-06
account O 0 1.0748327922138756e-10
for O 0 7.612570377671032e-14
most O 0 1.9702280442974313e-13
cases O 0 2.3717722664323704e-12
of O 0 5.888308775032353e-14
familial O 0 5.379943956995703e-08
, O 0 8.383712994664005e-12
early O 0 2.0786738996747545e-10
onset O 0 3.6736281572302687e-07
breast B-Disease 0 0.006312096957117319
and I-Disease 0 0.00017178271082229912
/ I-Disease 1 0.5023281574249268
or I-Disease 1 0.954311728477478
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999996423721313
and O 0 1.2314120834133746e-09
encode O 0 5.614561038314037e-10
products O 0 5.383284928939247e-10
that O 0 6.9337211753423e-13
each O 0 1.676117266356282e-14
interact O 0 7.949399060021289e-13
with O 0 1.7725754891673162e-11
hRAD51 O 0 2.130928805854637e-06
. O 0 9.181025384386032e-10

Results O 0 7.885728181555862e-10
presented O 0 4.493201644084621e-11
here O 0 1.3440330662653488e-12
show O 0 1.2079848406287841e-11
that O 0 5.65379774247754e-13
BRCA1 O 0 2.4290367051094108e-08
and O 0 1.4157875982689916e-09
BRCA2 O 0 9.31355032207648e-07
coexist O 0 2.525955835608329e-07
in O 0 2.1408620861328165e-13
a O 0 2.3965556102123475e-12
biochemical O 0 4.744902692976893e-09
complex O 0 3.8220196452165567e-10
and O 0 3.3329652371349994e-09
colocalize O 0 1.9051898334510042e-06
in O 0 3.34347410868574e-11
subnuclear O 0 1.974384076675051e-06
foci O 0 2.216821258116397e-06
in O 0 1.3375724952548879e-13
somatic O 0 3.142671192724045e-11
cells O 0 8.166007314791557e-10
and O 0 1.2204420633821211e-11
on O 0 8.968856213265042e-11
the O 0 4.026602402201762e-12
axial O 0 4.396653707772202e-09
elements O 0 4.329847938522313e-11
of O 0 3.0177867583330853e-13
developing O 0 4.516934742904155e-11
synaptonemal O 0 1.7793706774682505e-07
complexes O 0 1.5185880331003432e-09
. O 0 7.55929277507228e-11

Like O 0 1.285873008072258e-08
BRCA1 O 0 3.287814251962118e-06
and O 0 8.828451747433519e-09
RAD51 O 0 1.0980462320731021e-05
, O 0 4.114722451653563e-12
BRCA2 O 0 2.939004151158997e-09
relocates O 0 1.4234911027699582e-09
to O 0 1.081388381618531e-10
PCNA O 0 2.427131221338641e-05
+ O 0 7.087865294685969e-10
replication O 0 1.0014746809616781e-09
sites O 0 9.62818602623372e-10
following O 0 6.136034041981375e-11
exposure O 0 1.1898364515872117e-09
of O 0 6.928495727446735e-14
S O 0 6.530674312443807e-08
phase O 0 1.2341965557188805e-12
cells O 0 4.70081916101317e-12
to O 0 9.033825255780684e-14
hydroxyurea O 0 8.848254351434548e-10
or O 0 3.810355243133445e-12
UV O 0 3.2377567293906395e-08
irradiation O 0 3.6768430522471363e-09
. O 0 6.957299181209464e-10

Thus O 0 7.600794660334032e-09
, O 0 4.786054538796769e-11
BRCA1 O 0 3.5990908031635627e-08
and O 0 7.66693819542752e-10
BRCA2 O 0 1.1017425194381758e-08
participate O 0 1.3315506466535232e-12
, O 0 3.395644876391657e-12
together O 0 5.5085887240569065e-11
, O 0 5.743774054468853e-13
in O 0 4.06581100167655e-14
a O 0 1.7597576174033236e-11
pathway O 0 7.512159072575741e-07
( O 0 1.3809360772942814e-11
s O 0 1.2195885574328713e-05
) O 0 9.917696004724252e-12
associated O 0 3.218476646218299e-13
with O 0 3.72299821790119e-15
the O 0 2.3423313375031283e-15
activation O 0 5.153630560500444e-12
of O 0 4.304356486040453e-14
double O 0 2.0279733803363342e-07
- O 0 2.3248101570061408e-05
strand O 0 0.056448277086019516
break O 0 0.003795032622292638
repair O 0 0.00034964701626449823
and O 0 3.3198746529627954e-10
/ O 0 1.3963703804353855e-10
or O 0 4.362671248564487e-13
homologous O 0 5.3617419532026034e-11
recombination O 0 1.9627799829891046e-08
. O 0 2.448646840846891e-09

Dysfunction O 0 0.005155214108526707
of O 0 1.6053979326469126e-11
this O 0 8.974840835784814e-12
pathway O 0 3.241167334522288e-08
may O 0 1.6612516917646758e-09
be O 0 3.4386594049626296e-13
a O 0 2.118891542259027e-14
general O 0 1.7135007266701717e-14
phenomenon O 0 4.343779780313639e-10
in O 0 6.81421715928443e-13
the O 0 1.0534823881303002e-11
majority O 0 1.7351794914105545e-12
of O 0 3.791364534063042e-14
cases O 0 1.829174485490359e-11
of O 0 8.36239324314425e-12
hereditary B-Disease 1 0.9544629454612732
breast I-Disease 1 0.9891701340675354
and I-Disease 0 0.006179206073284149
/ I-Disease 1 0.820364236831665
or I-Disease 1 0.637757420539856
ovarian I-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999964237213135
. O 0 7.13294889820304e-09
. O 0 1.1341940719944432e-09

A O 0 7.90086307489446e-09
novel O 0 4.512255014077482e-09
Arg362Ser O 0 4.4742358795701875e-07
mutation O 0 1.7195226353905468e-09
in O 0 3.7394420242600757e-13
the O 0 1.3908056564065907e-12
sterol O 0 1.6873788410975976e-07
27 O 0 1.964771900730966e-09
- O 0 2.291200189574738e-07
hydroxylase O 0 5.947547469986603e-05
gene O 0 9.187374416796956e-08
( O 0 3.725696400697087e-12
CYP27 O 0 1.9629769667517394e-06
) O 0 1.59230927054832e-11
: O 0 2.6206421811802473e-14
its O 0 6.097887494428689e-13
effects O 0 1.0091536634115883e-10
on O 0 3.6785789692128645e-11
pre O 0 5.2984273218870115e-11
- O 0 1.0956970573905433e-11
mRNA O 0 1.5597183917678836e-12
splicing O 0 4.020474786425865e-10
and O 0 6.512150302513675e-13
enzyme O 0 1.1351495264599887e-11
activity O 0 5.727840424185615e-11
. O 0 1.499509717783898e-11

A O 0 6.71307853750136e-09
novel O 0 1.569604890505616e-09
C O 0 1.9084756885945353e-08
to O 0 1.062791890084347e-12
A O 0 4.1416115328929415e-12
mutation O 0 1.285133024303553e-11
in O 0 7.059315561578836e-14
the O 0 1.2275994023397407e-12
sterol O 0 1.644003475576028e-07
27 O 0 1.4562367978143698e-09
- O 0 2.715527784857841e-07
hydroxylase O 0 0.0001682810252532363
gene O 0 2.838787338532711e-07
( O 0 4.843909561652593e-12
CYP27 O 0 5.058609531261027e-07
) O 0 8.555717983041444e-13
was O 0 4.751660870327967e-12
identified O 0 2.326725475427973e-14
by O 0 2.6476039704572687e-16
sequencing O 0 4.278914028654768e-11
amplified O 0 2.3972492613211216e-07
CYP27 O 0 2.2473837191228085e-07
gene O 0 2.188413894543828e-10
products O 0 2.164783491354072e-10
from O 0 1.3086877230766153e-13
a O 0 4.220873650595536e-12
patient O 0 8.373881144052575e-09
with O 0 8.465841716542855e-08
cerebrotendinous B-Disease 1 0.9999970197677612
xanthomatosis I-Disease 1 0.9999934434890747
( O 0 1.1087830653622177e-09
CTX B-Disease 0 5.1585357141448185e-05
) O 0 3.428474726341335e-10
. O 0 1.849438518997104e-10

The O 0 3.474024540262022e-11
mutation O 0 5.170758266004327e-10
changed O 0 1.1455991710818125e-10
the O 0 1.0112060928185729e-13
adrenodoxin O 0 4.6448522805775383e-10
cofactor O 0 2.5421537704767294e-12
binding O 0 2.800938300739908e-12
residue O 0 1.0113740955830508e-09
362Arg O 0 1.8684252756084874e-10
to O 0 1.6724464695083707e-12
362Ser O 0 1.3906572782218518e-08
( O 0 6.084999989780168e-14
CGT O 0 2.510038843439588e-10
362Arg O 0 4.112278573220607e-10
to O 0 2.323601380749274e-12
AGT O 0 4.979356305057081e-08
362Ser O 0 6.8452891355264e-08
) O 0 3.7161792740270094e-12
, O 0 7.212566861033304e-14
and O 0 2.913124927915456e-13
was O 0 7.077432390145688e-11
responsible O 0 7.368406232388658e-12
for O 0 9.873529945025883e-12
deficiency O 0 1.31222748223081e-06
in O 0 1.836427780744815e-15
the O 0 1.5863478336920062e-13
sterol O 0 1.7615066738585483e-08
27 O 0 2.663079756715092e-10
- O 0 9.000774348066898e-09
hydroxylase O 0 1.5281110563591938e-06
activity O 0 7.71148978007119e-11
, O 0 3.524744989695343e-14
as O 0 1.474970658305909e-14
confirmed O 0 1.4200746698347921e-12
by O 0 1.663104510945851e-15
expression O 0 1.9046006769331617e-14
of O 0 2.4272160560979484e-16
mutant O 0 1.10275261144821e-10
cDNA O 0 5.152249737960801e-10
into O 0 3.231669931658132e-10
COS O 0 1.8346165234106593e-05
- O 0 3.2658530102480654e-08
1 O 0 6.655467843508234e-12
cells O 0 1.723172715628607e-10
. O 0 7.492458736768626e-11

Quantitative O 0 9.990803739867715e-10
analysis O 0 8.402055051703883e-09
showed O 0 3.760615996384331e-08
that O 0 1.3310909449323893e-12
the O 0 4.513622819685842e-13
expression O 0 3.0222007622177083e-12
of O 0 2.044616917180192e-14
CYP27 O 0 2.8157602471878818e-08
gene O 0 7.706957468045506e-12
mRNA O 0 4.175245149617979e-10
in O 0 2.2890263903091457e-12
the O 0 3.735594299170142e-12
patient O 0 9.028177094805301e-10
represented O 0 6.940803834454279e-12
52 O 0 1.143678485249211e-09
. O 0 4.4642620156132296e-10

5 O 0 1.5809365550012444e-07
% O 0 2.815165114911089e-11
of O 0 1.3487465708357255e-14
the O 0 4.50168954847438e-13
normal O 0 3.642817991700298e-10
level O 0 4.288886579217888e-09
. O 0 1.6095386135006606e-09

As O 0 4.131341102553421e-11
the O 0 7.579917054266472e-13
mutation O 0 1.5770124789371565e-11
occurred O 0 5.042927880838377e-11
at O 0 5.038211601388065e-13
the O 0 2.5334467461174057e-15
penultimate O 0 3.432954961968271e-11
nucleotide O 0 3.807993850801772e-12
of O 0 4.105866850939027e-14
exon O 0 1.2900928103576348e-09
6 O 0 1.6996548612979723e-09
( O 0 1.6426772865129474e-13
- O 0 5.590477414330053e-09
2 O 0 1.4021885041959337e-10
position O 0 5.131879365904979e-10
of O 0 3.1039149657637044e-14
exon O 0 6.930941931493351e-10
6 O 0 9.684563151424186e-10
- O 0 5.651526535643825e-08
intron O 0 4.5491691707866266e-05
6 O 0 4.4844301605451165e-09
splice O 0 2.0675845007644966e-05
site O 0 1.2992669553568703e-06
) O 0 1.5442730427750462e-11
of O 0 5.508283631598448e-15
the O 0 2.6133511587395075e-13
gene O 0 4.785324220213383e-11
, O 0 8.181193895083483e-13
we O 0 6.208001777571748e-13
hypothesized O 0 8.709433998652094e-13
that O 0 2.8221366216163446e-12
the O 0 3.019448233110289e-11
mutation O 0 1.4806977333137183e-07
may O 0 3.059902908830736e-08
partially O 0 4.660722030536135e-09
affect O 0 1.7686966800010973e-13
the O 0 2.000393665817224e-15
normal O 0 7.412121047142839e-15
splicing O 0 1.139636440772307e-10
efficiency O 0 3.5969738299002074e-10
in O 0 5.763953496353696e-14
exon O 0 4.809299625208041e-10
6 O 0 5.186663543099712e-09
and O 0 2.4676624632569144e-10
cause O 0 8.710198361183696e-13
alternative O 0 7.75096471923066e-15
splicing O 0 2.1115230453006006e-08
elsewhere O 0 7.851179706364064e-10
, O 0 7.93821714091536e-13
which O 0 5.503523851924097e-12
resulted O 0 2.2780515321341177e-11
in O 0 8.572919392609013e-13
decreased O 0 5.112281709074296e-10
transcript O 0 1.2416738570664165e-07
in O 0 7.111772542395256e-12
the O 0 8.792414019076489e-11
patient O 0 1.743101734064112e-07
. O 0 1.7536981866683732e-09

Transfection O 0 2.1563295376836322e-05
of O 0 6.600973656567533e-10
constructed O 0 5.208685252000578e-07
minigenes O 0 3.91459179809317e-05
, O 0 5.3842676844828574e-11
with O 0 2.0482881883665538e-12
or O 0 1.8575653168428907e-11
without O 0 2.9036221669241635e-13
the O 0 6.198190018961297e-14
mutation O 0 5.817774387240071e-11
, O 0 1.9583523171162742e-12
into O 0 4.584348178848785e-11
COS O 0 0.00018918867863249034
- O 0 6.725525736328564e-08
1 O 0 8.82192409401572e-12
cells O 0 2.959668968238738e-11
confirmed O 0 2.890055209037179e-11
that O 0 6.277056917866966e-14
the O 0 1.848314524436484e-13
mutant O 0 6.907167460212804e-08
minigene O 0 2.646116286086908e-07
was O 0 3.761006783786769e-10
responsible O 0 3.526279745633132e-13
for O 0 5.957144072161276e-16
a O 0 1.2835656914786126e-14
mRNA O 0 7.980306693244898e-11
species O 0 3.0801140175722164e-13
alternatively O 0 3.706902007571955e-10
spliced O 0 8.24565995571902e-06
at O 0 5.78622649793914e-10
an O 0 4.1018359905496335e-14
activated O 0 6.480641356887418e-09
cryptic O 0 1.8239584065327108e-08
5 O 0 2.3177054893352977e-12
splice O 0 1.850871512942831e-06
site O 0 4.898172392131528e-07
88 O 0 4.362297190141362e-09
bp O 0 5.8683689019289886e-08
upstream O 0 5.9431375376561846e-09
from O 0 2.3445117375286983e-12
the O 0 5.278238241444855e-13
3 O 0 1.6642947436862343e-11
end O 0 5.363071792219287e-11
of O 0 3.36245008886963e-14
exon O 0 3.6695568805811263e-09
6 O 0 7.447245042868644e-09
. O 0 1.1895687768159746e-09

Our O 0 1.9485488778059334e-09
data O 0 6.070012270598113e-10
suggest O 0 1.200164967407602e-11
that O 0 2.6252963561748666e-13
the O 0 1.3038940586962422e-13
C O 0 1.6514896117314493e-09
to O 0 1.6034347244051061e-13
A O 0 1.0658572548866152e-12
mutation O 0 9.446682802324857e-13
at O 0 3.0396301795021508e-12
the O 0 9.531194193265757e-15
penultimate O 0 3.3532707860439714e-11
nucleotide O 0 1.083786706213008e-12
of O 0 1.2638153395441894e-14
exon O 0 3.968469164394861e-10
6 O 0 2.684995836776949e-10
of O 0 9.738892092943374e-14
the O 0 7.611823497899461e-12
CYP27 O 0 7.248292632766606e-08
gene O 0 1.0880046863448456e-10
not O 0 1.1332069831115898e-11
only O 0 1.3794059210842091e-12
causes O 0 4.0123773747957614e-10
the O 0 4.991944191345965e-09
deficiency B-Disease 0 0.0020627013873308897
in I-Disease 0 5.926596019500963e-14
the I-Disease 0 3.6432454275647785e-12
sterol I-Disease 0 1.1375260555723798e-07
27 I-Disease 0 7.467452767251359e-10
- I-Disease 0 1.1103496788678058e-08
hydroxylase I-Disease 0 4.4233597691345494e-06
activity I-Disease 0 2.301585588782018e-09
, O 0 1.792822726214005e-12
but O 0 3.3159999052179145e-11
also O 0 9.063265415942823e-11
partially O 0 2.616360106344473e-08
leads O 0 2.622963235499043e-10
to O 0 2.848808428740357e-13
alternative O 0 3.246479962030341e-13
pre O 0 5.628520982625673e-10
- O 0 2.517081543196298e-10
mRNA O 0 2.4115142174818693e-11
splicing O 0 1.3876705340365447e-09
of O 0 3.12014310059356e-14
the O 0 2.1637069035334439e-13
gene O 0 1.7642964866837474e-09
. O 0 3.59744012357055e-10

To O 0 3.7466871272151536e-10
our O 0 2.611898718141159e-11
knowledge O 0 5.036712691884604e-13
, O 0 4.550985239701322e-13
this O 0 1.0086940641475597e-13
is O 0 2.765508091626123e-13
the O 0 3.1542634173001294e-13
first O 0 1.7266955226746816e-11
report O 0 7.399940903096702e-12
regarding O 0 2.6632165982080902e-14
effects O 0 1.337991674919825e-12
on O 0 6.4948988028057375e-12
pre O 0 1.2396422430227538e-11
- O 0 1.4320433727732507e-11
mRNA O 0 2.371338151882507e-12
splicing O 0 2.8579069666356816e-10
of O 0 2.889086065109743e-14
a O 0 2.914981082034751e-13
mutation O 0 6.203447911606874e-12
at O 0 6.32679325596186e-11
the O 0 5.070625343217561e-12
- O 0 1.1143600175955726e-07
2 O 0 9.394661715234065e-10
position O 0 2.066294468860974e-09
of O 0 2.483336488716078e-15
a O 0 6.788945490845966e-13
5 O 0 1.2056615471614518e-12
splice O 0 3.6122930850979174e-06
site O 0 1.6810119518595457e-07
. O 0 5.746785269877819e-10

ATM O 0 1.3922694961365778e-05
germline O 0 4.9586465138418134e-06
mutations O 0 1.0297524568159133e-05
in O 0 2.030074242043156e-08
classical O 0 0.4590073525905609
ataxia B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999983310699463
telangiectasia I-Disease 1 0.9999994039535522
patients O 0 0.04211698845028877
in O 0 3.699168193982416e-10
the O 0 6.833829058194851e-10
Dutch O 0 1.527743847873353e-06
population O 0 3.2844258562869655e-11
. O 0 3.310099416786727e-10

Germline O 0 4.50641846327926e-06
mutations O 0 1.9931551378249424e-06
in O 0 4.066227909937936e-11
the O 0 7.487994057274461e-13
ATM O 0 3.536649160196248e-07
gene O 0 2.344497262996015e-09
are O 0 1.0363200776035766e-13
responsible O 0 2.529616490234976e-12
for O 0 4.851139889100464e-12
the O 0 5.6091113947331905e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999966621398926
telangiectasia I-Disease 1 0.9999994039535522
( O 0 0.012906687334179878
A B-Disease 1 0.9999977350234985
- I-Disease 1 0.9999963045120239
T I-Disease 1 0.9999984502792358
) O 0 2.0114352849986972e-08
. O 0 3.379572732775671e-10

In O 0 3.485561561600292e-10
our O 0 4.774641237936805e-10
study O 0 2.963621535678751e-12
, O 0 1.1766323592538042e-12
we O 0 7.860218010323494e-13
have O 0 1.2326191160968135e-14
determined O 0 6.10199147070209e-14
the O 0 2.7491491918498704e-15
ATM O 0 4.883680304601512e-08
mutation O 0 7.090714820856547e-11
spectrum O 0 1.6482035181120125e-10
in O 0 2.8998477881111984e-13
19 O 0 2.207769383977265e-11
classical O 0 4.468185110795275e-08
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999984502792358
T I-Disease 1 0.9999997615814209
patients O 0 3.7408121045245935e-09
, O 0 9.326434989695345e-15
including O 0 5.708441566910918e-17
some O 0 2.3032199617405754e-16
immigrant O 0 1.2004808605525774e-11
populations O 0 5.070905501058931e-12
, O 0 6.40956255085201e-13
as O 0 1.4424403511903439e-12
well O 0 3.0906791882723272e-12
as O 0 7.463629540793715e-12
12 O 0 4.833370249174296e-12
of O 0 4.4451862167300266e-14
Dutch O 0 3.9078176250484375e-09
ethnic O 0 1.7001127068649868e-12
origin O 0 3.830461642317928e-11
. O 0 6.363365390171793e-11

Both O 0 5.486649329311533e-12
the O 0 1.598338432093338e-13
protein O 0 4.710002873831165e-11
truncation O 0 7.61889751288436e-08
test O 0 1.1389883525225741e-07
( O 0 3.1798138612221943e-14
PTT O 0 7.758882425434876e-10
) O 0 7.402478153020753e-13
and O 0 4.3501884223768467e-14
the O 0 6.331512411936061e-15
restriction O 0 2.2313901215046533e-13
endonuclease O 0 1.4685150873106068e-09
fingerprinting O 0 1.5724253898952156e-08
( O 0 7.0744759266753825e-15
REF O 0 1.1775838082428436e-09
) O 0 2.40690489423706e-15
method O 0 3.843489586384356e-14
were O 0 1.4177554529676284e-12
used O 0 3.290150443757689e-11
and O 0 3.0213650591831565e-12
compared O 0 1.7393833769141498e-13
for O 0 4.665497178146089e-17
their O 0 1.8015860545473987e-14
detection O 0 8.09511312149791e-12
efficiency O 0 3.597414250169906e-13
, O 0 5.957030252108989e-16
identifying O 0 3.7423601544073204e-13
76 O 0 6.560916393505423e-11
% O 0 4.906072428737321e-14
and O 0 2.0173449716276437e-11
60 O 0 6.9474794840707066e-12
% O 0 8.108451586487549e-15
of O 0 2.0780185179606865e-15
the O 0 7.59458121390999e-12
mutations O 0 4.13344203309407e-09
, O 0 8.942460487382231e-12
respectively O 0 1.1414333367376628e-10
. O 0 4.0384515176405955e-10

Most O 0 1.3394900744145843e-09
patients O 0 1.2894901812998683e-09
were O 0 3.6542154718821607e-11
found O 0 5.2841134245973365e-12
to O 0 1.9582840665895163e-13
be O 0 4.343808732848453e-12
compound O 0 1.713426622806935e-09
heterozygote O 0 9.349264473712537e-08
. O 0 4.481256199451167e-10

Seventeen O 0 2.005248589398434e-08
mutations O 0 1.24906108567302e-07
were O 0 1.2417710193446396e-09
distinct O 0 6.20674137086219e-11
, O 0 2.5570989770073993e-11
of O 0 2.2156389678680555e-13
which O 0 2.6970217725796886e-10
10 O 0 2.3191648254594632e-12
were O 0 1.7422839213021568e-11
not O 0 9.042436938111464e-12
reported O 0 3.3121835829597046e-10
previously O 0 3.32465249774927e-10
. O 0 2.121508246855086e-10

Mutations O 0 5.089130809210474e-06
are O 0 3.2437167535315226e-11
small O 0 1.7300505646133946e-12
deletions O 0 2.314679647952289e-08
or O 0 5.2975561715129516e-08
point O 0 3.0377468647202477e-06
mutations O 0 9.117492822952045e-07
frequently O 0 2.3610196819845441e-07
affecting O 0 1.0643388254072406e-10
splice O 0 0.00017843267414718866
sites O 0 4.201078354526544e-06
. O 0 1.5338842729306634e-07

Moreover O 0 1.0545699780095674e-07
, O 0 1.9490782252051808e-11
a O 0 6.333225176929913e-12
16 O 0 1.421843337512385e-10
. O 0 1.0591665738912681e-10

7 O 0 3.608962373391478e-08
- O 0 6.435664658965834e-07
kb O 0 3.1158642741502263e-06
genomic O 0 9.530208444630262e-08
deletion O 0 3.917883532267297e-06
of O 0 3.5111273697513434e-12
the O 0 1.574010366489631e-11
3 O 0 9.940465117708186e-11
end O 0 3.701024209323833e-10
of O 0 8.025793876329738e-15
the O 0 1.4489859236511277e-13
gene O 0 7.929523704319763e-11
, O 0 2.1062164057110422e-13
most O 0 1.9627967532006262e-14
likely O 0 5.680629144161342e-12
a O 0 4.180171562628149e-13
result O 0 9.942692285810906e-13
of O 0 3.920811327787644e-15
recombination O 0 8.87799112003762e-10
between O 0 1.1562150542543392e-10
two O 0 1.0915195830518698e-10
LINE O 0 1.3645814078699914e-06
elements O 0 3.5163028738738333e-11
, O 0 1.013322672299699e-12
was O 0 2.562378087489492e-10
identified O 0 2.2116988795950476e-10
. O 0 3.3147352918039275e-11

The O 0 2.867866777389594e-10
most O 0 1.8021284117764047e-11
frequently O 0 6.754087511495754e-09
found O 0 1.1556770818099693e-10
mutation O 0 2.9578856725054337e-11
, O 0 1.7405350706718725e-13
identified O 0 2.1255239322087727e-12
in O 0 1.325609357661706e-14
three O 0 2.2757227959718795e-12
unrelated O 0 5.07583930442479e-09
Turkish O 0 4.491813888307661e-05
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999992847442627
T I-Disease 1 0.9999998807907104
individuals O 0 6.083662740241635e-11
, O 0 3.1546325881398607e-12
was O 0 6.367764093795358e-10
previously O 0 1.203787763914832e-10
described O 0 5.4758215323191806e-11
to O 0 1.775507366998108e-13
be O 0 2.00156492942416e-12
a O 0 2.7996738607982685e-11
Turkish O 0 4.73420641355915e-06
A B-Disease 1 0.9999983310699463
- I-Disease 1 0.9999896287918091
T I-Disease 1 0.999996542930603
founder O 0 8.897449674805102e-07
mutation O 0 8.868602741074483e-09
. O 0 1.579213565472415e-10

The O 0 6.949974623582378e-11
presence O 0 2.7928206622340745e-11
of O 0 5.368344725459502e-14
a O 0 1.1386228331716763e-12
founder O 0 2.1485815349109316e-09
mutation O 0 3.228330658355816e-10
among O 0 2.4185089152715944e-13
relatively O 0 1.0568967440593643e-13
small O 0 4.021946892283218e-14
ethnic O 0 1.0197067121893097e-13
population O 0 1.9007066970680442e-14
groups O 0 1.0698930755009481e-14
in O 0 2.5960424131568627e-13
Western O 0 1.7240175953503467e-10
Europe O 0 3.820412786126326e-08
could O 0 2.1882020639907296e-09
indicate O 0 5.469409647407275e-12
a O 0 4.4256967340026987e-13
high O 0 2.1512211456631292e-10
carrier O 0 2.0846693815634865e-10
frequency O 0 3.2553286732905917e-09
in O 0 1.4477235057465399e-13
such O 0 5.0492630096574814e-14
communities O 0 1.1962066753801182e-11
. O 0 4.099474371077605e-10

In O 0 1.947311645267291e-09
patients O 0 1.0615253120960233e-09
of O 0 6.483125126154066e-13
Dutch O 0 1.4921965885150712e-08
ethnic O 0 7.344665674258177e-12
origin O 0 7.551813341333258e-11
, O 0 3.543244473866447e-12
however O 0 9.33712916012519e-12
, O 0 7.072401881800736e-14
no O 0 9.388264498493351e-14
significant O 0 1.1551149237966872e-14
founder O 0 1.2805367877177787e-09
effect O 0 3.838953113732835e-11
could O 0 9.591357569282977e-11
be O 0 1.6912089133638841e-12
identified O 0 3.618001453986608e-10
. O 0 7.214902980612337e-11

The O 0 1.8643909333038167e-11
observed O 0 1.584868208892587e-10
genetic O 0 3.0894622971011643e-10
heterogeneity O 0 8.338017498665806e-10
including O 0 9.735628102303107e-13
the O 0 6.713887692327836e-12
relative O 0 1.6089491960968871e-09
high O 0 3.818370952757277e-09
percentage O 0 7.794778156267057e-10
of O 0 8.17398449273754e-14
splice O 0 0.059806209057569504
- O 0 0.0013507000403478742
site O 0 1.0577811735856812e-05
mutations O 0 1.5880144701441168e-06
had O 0 2.987900415973854e-07
no O 0 1.9815586671523278e-11
reflection O 0 6.8075432443914785e-12
on O 0 4.732427227871483e-10
the O 0 4.211147541788307e-10
phenotype O 0 3.4773054835568473e-07
. O 0 2.7443063377319277e-09

All O 0 1.8238835441941603e-10
patients O 0 2.882356575639733e-09
manifested O 0 5.554502635618519e-08
classical O 0 8.302966421069868e-07
A B-Disease 1 0.9999879598617554
- I-Disease 1 0.9999639987945557
T I-Disease 1 0.9999988079071045
and O 0 3.760648181749815e-10
increased O 0 1.9806535968627803e-13
cellular O 0 1.4122651936787634e-09
radioresistant O 0 1.2222283629625963e-08
DNA O 0 5.712209039110405e-10
synthesis O 0 2.466313375748541e-09
. O 0 3.3564209744874063e-10

Determination O 0 5.944932013335347e-08
of O 0 2.2410593075294222e-13
the O 0 2.4763296881807895e-13
genomic O 0 1.335472177288466e-09
structure O 0 2.436137958028439e-10
of O 0 2.6916252362260522e-14
the O 0 2.57954334975663e-12
COL4A4 O 0 3.112868398602586e-07
gene O 0 2.9893648667567163e-10
and O 0 1.0683022175217438e-11
of O 0 9.62264054787769e-14
novel O 0 2.7153637560672905e-08
mutations O 0 0.0023754462599754333
causing O 0 0.030650220811367035
autosomal B-Disease 1 0.9999731779098511
recessive I-Disease 1 0.9999845027923584
Alport I-Disease 1 0.9999874830245972
syndrome I-Disease 1 0.9999761581420898
. O 0 4.4183807403896935e-06

Autosomal B-Disease 1 0.9997082352638245
recessive I-Disease 1 0.9998997449874878
Alport I-Disease 1 0.9999678134918213
syndrome I-Disease 1 0.9999874830245972
is O 0 2.8436375032470096e-07
a O 0 1.626385959241361e-08
progressive O 0 0.00014210166409611702
hematuric B-Disease 1 0.999904990196228
glomerulonephritis I-Disease 1 0.9999967813491821
characterized O 0 0.01779997907578945
by O 0 5.171818884264212e-08
glomerular B-Disease 1 0.9995526671409607
basement I-Disease 1 0.9999138116836548
membrane I-Disease 1 0.9992262125015259
abnormalities I-Disease 1 0.9999655485153198
and O 0 9.687491342447174e-08
associated O 0 1.395444537699575e-09
with O 0 2.0051271407139915e-11
mutations O 0 3.763965583658546e-09
in O 0 5.2600202839203636e-12
either O 0 1.9766665734777256e-11
the O 0 9.634261444180225e-11
COL4A3 O 0 4.238109977450222e-05
or O 0 8.545256169334436e-11
the O 0 4.9541096051874955e-12
COL4A4 O 0 2.3684731331741204e-07
gene O 0 1.0509662584645696e-10
, O 0 7.253042161011261e-14
which O 0 4.474224115524504e-15
encode O 0 3.0216011984163238e-12
the O 0 1.1800360688596356e-10
alpha3 O 0 9.120039067056496e-06
and O 0 3.665345804648723e-09
alpha4 O 0 2.8222714263392845e-06
type O 0 1.0236476555292029e-08
IV O 0 0.00019675400108098984
collagen O 0 4.892892206953547e-07
chains O 0 1.4447942930928548e-06
, O 0 2.3728222078162053e-12
respectively O 0 4.464148842253657e-11
. O 0 3.501064715916158e-11

To O 0 9.352154467512364e-12
date O 0 1.4173802756478615e-11
, O 0 2.633776104653783e-14
mutation O 0 9.893106977078639e-14
screening O 0 2.6833036660678378e-12
in O 0 9.038599811097767e-14
the O 0 6.806134703139094e-14
two O 0 6.9113573371304415e-12
genes O 0 4.477917592282665e-09
has O 0 1.8747813967934235e-08
been O 0 8.119603656098207e-09
hampered O 0 6.175951483555764e-08
by O 0 2.7096242458980735e-13
the O 0 1.5655840339412475e-12
lack O 0 2.1418678462781227e-12
of O 0 9.661840131533787e-16
genomic O 0 1.1466812915861269e-10
structure O 0 3.7132550506635553e-11
information O 0 3.065899478738032e-10
. O 0 7.766992604629763e-11

We O 0 1.2368195356771139e-08
report O 0 1.8124109851802572e-11
here O 0 1.0179072753961627e-13
the O 0 2.3932907454340784e-15
complete O 0 3.8169651900982204e-13
characterization O 0 1.4640500617391083e-11
of O 0 1.6015532736468412e-15
the O 0 1.9639472611122227e-13
48 O 0 8.62466348339197e-13
exons O 0 9.3570173831381e-10
of O 0 7.15033839971714e-14
the O 0 4.447641907545652e-12
COL4A4 O 0 9.425684055486272e-08
gene O 0 1.8766148357496348e-10
, O 0 1.5422344933242738e-13
a O 0 2.5065700518878478e-14
comprehensive O 0 1.0095101973328982e-13
gene O 0 1.3119568764707878e-09
screen O 0 1.0185848623223137e-05
, O 0 3.75630221371992e-11
and O 0 2.384672971242341e-12
the O 0 1.7854499074956148e-14
subsequent O 0 1.6111978288005369e-12
detection O 0 4.644409301590713e-10
of O 0 5.5890347552952843e-14
10 O 0 1.1474093376817596e-11
novel O 0 1.6700098248723094e-10
mutations O 0 2.237669427529454e-08
in O 0 2.1868064650765184e-11
eight O 0 3.781698509897069e-08
patients O 0 1.7818993569562736e-07
diagnosed O 0 0.011759985238313675
with O 0 1.7313038824795512e-06
autosomal B-Disease 1 0.9999840259552002
recessive I-Disease 1 0.9999847412109375
Alport I-Disease 1 0.9999815225601196
syndrome I-Disease 1 0.9999547004699707
. O 0 4.107264885533368e-06

Furthermore O 0 1.2026914930629573e-07
, O 0 2.91634112692396e-11
we O 0 2.605442717042855e-13
identified O 0 1.8476612587462436e-14
a O 0 2.35092469851126e-15
glycine O 0 3.7831571209068215e-11
to O 0 1.1482050661822119e-13
alanine O 0 5.756579241067428e-11
substitution O 0 5.437380688928795e-13
in O 0 1.9607396489849244e-13
the O 0 1.412974446647619e-12
collagenous O 0 2.72066706941132e-08
domain O 0 5.472691744223823e-10
that O 0 1.8648685373712226e-10
is O 0 7.348715386212845e-12
apparently O 0 5.9804126095741594e-09
silent O 0 7.365646426116257e-10
in O 0 9.608623169040167e-15
the O 0 2.0462799477875132e-13
heterozygous O 0 3.098254708344683e-10
carriers O 0 7.6490523984174e-12
, O 0 2.8840444572450497e-13
in O 0 2.782131350385214e-13
11 O 0 6.09239769744363e-10
. O 0 3.1016014756524157e-10

5 O 0 6.43587938498058e-08
% O 0 2.1398110713888308e-11
of O 0 3.0415818111752604e-14
all O 0 1.8777084921650644e-12
control O 0 2.3902049228752276e-09
individuals O 0 9.280114654161564e-13
, O 0 2.5483725372976718e-12
and O 0 2.3884477728941533e-11
in O 0 1.9227825440778362e-13
one O 0 7.464555015768148e-12
control O 0 5.16169273989675e-10
individual O 0 1.1336893948024791e-14
homozygous O 0 4.7068390851556785e-12
for O 0 1.3993522948655936e-16
this O 0 3.713861749955191e-16
glycine O 0 3.254009214859188e-11
substitution O 0 1.7864881449169978e-11
. O 0 1.2495753043406665e-10

There O 0 5.396631141962871e-09
has O 0 2.1694916696457511e-10
been O 0 8.452404748338083e-11
no O 0 5.650649761469728e-13
previous O 0 2.2360351417671787e-12
finding O 0 1.2225306487631538e-13
of O 0 4.0493124727541074e-17
a O 0 1.2591276051041999e-15
glycine O 0 3.386880186029284e-12
substitution O 0 1.6089590597345715e-12
that O 0 2.7597356691555497e-11
is O 0 2.4938352164577404e-12
not O 0 2.337737642355009e-12
associated O 0 1.0483344877951217e-12
with O 0 1.5510253400640578e-13
any O 0 8.281895677066109e-13
obvious O 0 2.0842330084036575e-09
phenotype O 0 1.1325841597908948e-08
in O 0 1.5223529901964294e-12
homozygous O 0 5.024501348316335e-08
individuals O 0 1.5048559620645108e-11
. O 0 9.602473260983402e-10

Founder O 0 2.283937590163987e-07
BRCA1 O 0 2.292669887538068e-05
and O 0 1.4320400865130978e-08
BRCA2 O 0 4.257040927768685e-06
mutations O 0 4.58356879562416e-07
in O 0 3.460601250004913e-10
French O 0 6.693826890113996e-06
Canadian O 0 0.002309089759364724
breast B-Disease 1 0.9999828338623047
and I-Disease 1 0.9999384880065918
ovarian I-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999939203262329
families O 0 1.4566994366305153e-07
. O 0 9.604103068383552e-10

We O 0 1.3692981859492193e-08
have O 0 2.244967753362026e-11
identified O 0 3.786015598250536e-11
four O 0 5.1215776411539515e-12
mutations O 0 1.417586464880216e-10
in O 0 2.2191832247699106e-13
each O 0 1.4675104664449434e-12
of O 0 2.9973263454552423e-12
the O 0 3.949278593040617e-08
breast B-Disease 0 0.023976974189281464
cancer I-Disease 0 2.1205605662544258e-05
- O 0 1.790427859305055e-07
susceptibility O 0 7.479034280777341e-08
genes O 0 6.00287708429903e-10
, O 0 1.4567263411160991e-12
BRCA1 O 0 3.630419698197329e-08
and O 0 1.5790275753602145e-09
BRCA2 O 0 1.5940548792059417e-06
, O 0 7.10803360615131e-11
in O 0 1.3273243615330443e-11
French O 0 7.431904577970272e-06
Canadian O 0 4.0595656173536554e-05
breast B-Disease 1 0.9850510358810425
cancer I-Disease 1 0.5762811899185181
and O 0 0.00015747410361655056
breast B-Disease 1 0.999981164932251
/ I-Disease 1 0.9999943971633911
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.999998927116394
families O 0 6.588162477783044e-07
from O 0 1.5517497009565062e-10
Quebec O 0 8.176846222340828e-08
. O 0 1.9041779708572903e-08

To O 0 5.524616875085542e-10
identify O 0 3.4773162127521573e-09
founder O 0 2.3100250245988718e-07
effects O 0 3.23132809398885e-08
, O 0 3.944723887816526e-12
we O 0 2.8814507203878126e-12
examined O 0 2.598432927158889e-11
independently O 0 5.736039768167167e-11
ascertained O 0 4.2803654309864214e-07
French O 0 3.0299811442091595e-06
Canadian O 0 1.0931593124041683e-06
cancer B-Disease 0 9.760969260241836e-05
families O 0 1.7289825821054094e-11
for O 0 4.528623112496017e-15
the O 0 7.621287363137816e-14
distribution O 0 7.847923699788595e-12
of O 0 5.706575738616574e-15
these O 0 1.9846015835486147e-13
eight O 0 6.628117325824245e-12
mutations O 0 8.40203462360023e-10
. O 0 8.338076756819746e-11

Mutations O 0 1.936680291692028e-06
were O 0 7.680612590377223e-09
found O 0 1.0831373575825864e-09
in O 0 3.075265194406318e-13
41 O 0 1.0146401947797035e-11
of O 0 1.7939745826020537e-13
97 O 0 6.68337163389765e-10
families O 0 6.594023937989135e-11
. O 0 2.2835251745068064e-10

Six O 0 8.912368620883626e-09
of O 0 8.596874297508994e-13
eight O 0 1.4964560146601968e-10
mutations O 0 5.751105702778148e-10
were O 0 3.095311854051097e-11
observed O 0 1.2830634124605389e-11
at O 0 2.2252932135868875e-11
least O 0 4.0309341151414935e-13
twice O 0 9.647712850835433e-09
. O 0 8.741634083264671e-10

The O 0 3.2030306185149016e-10
BRCA1 O 0 2.0685115487140138e-06
C4446T O 0 8.35835862744716e-08
mutation O 0 3.266351455977201e-08
was O 0 3.978287566042127e-08
the O 0 4.558606530452591e-12
most O 0 1.3536989454734916e-12
common O 0 3.226027431302292e-11
mutation O 0 1.1584274650644488e-09
found O 0 6.980271027856588e-09
, O 0 1.4700934697006729e-12
followed O 0 2.042518064404586e-12
by O 0 8.174779348455244e-14
the O 0 5.31870554543179e-12
BRCA2 O 0 4.5869364839745685e-06
8765delAG O 0 1.765767251526995e-06
mutation O 0 3.743804555256247e-08
. O 0 1.2661974801986275e-09

Together O 0 2.147345412595314e-08
, O 0 5.5538238938335205e-12
these O 0 2.9838631565581863e-13
mutations O 0 9.715288296074931e-11
were O 0 2.5114707535855985e-10
found O 0 3.2449742892737277e-10
in O 0 6.95752754454465e-13
28 O 0 2.9013388913590177e-11
of O 0 8.953834852373777e-14
41 O 0 7.550401970313203e-11
families O 0 1.359240140146739e-13
identified O 0 1.8629681131088205e-12
to O 0 4.902763308181624e-13
have O 0 2.4713668611564543e-12
a O 0 1.4058425647570094e-12
mutation O 0 6.946787589612313e-09
. O 0 2.088722084181427e-09

The O 0 1.0407354977814975e-09
odds O 0 1.7160955678718892e-07
of O 0 7.386945872697726e-14
detection O 0 1.6720791418123326e-09
of O 0 7.146166931858502e-14
any O 0 4.694043005855353e-13
of O 0 1.9428657291385536e-14
the O 0 1.8258205277538186e-12
four O 0 4.1113275978110764e-11
BRCA1 O 0 2.7391202195303777e-08
mutations O 0 3.430117745395478e-09
was O 0 5.9017519760118375e-08
18 O 0 2.356974060369055e-10
. O 0 1.4219490862554807e-10

7x O 0 7.570546586066484e-05
greater O 0 1.0005996725626076e-10
if O 0 3.1678690920466934e-11
one O 0 1.5237233675323425e-13
or O 0 2.967194632358394e-13
more O 0 1.8742714764105953e-14
cases O 0 6.606175606549414e-10
of O 0 2.1753503460786305e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
were O 0 6.878125304865534e-07
also O 0 3.8008303171466196e-09
present O 0 1.4472390300057647e-11
in O 0 2.5120671601902567e-12
the O 0 5.991961093965159e-11
family O 0 3.117057190138439e-07
. O 0 1.259191528824033e-09

The O 0 1.16196352539788e-09
odds O 0 1.2238594138125336e-07
of O 0 6.614899735824312e-14
detection O 0 2.168065726948498e-09
of O 0 5.0760007904836896e-14
any O 0 4.0240513287000124e-13
of O 0 2.6153641494793163e-14
the O 0 4.357059851800571e-12
four O 0 4.164992795097078e-10
BRCA2 O 0 5.932358959626072e-08
mutations O 0 2.1741985989365276e-09
was O 0 2.5324508712287752e-08
5 O 0 1.0250650328558208e-10
. O 0 2.821601285951658e-10

3x O 0 3.096004729741253e-05
greater O 0 1.599432669641132e-10
if O 0 8.929187944595185e-11
there O 0 1.7491780593403838e-13
were O 0 7.109341327443675e-13
at O 0 2.346072771816643e-12
least O 0 1.1751144304725453e-15
five O 0 4.081788346991383e-13
cases O 0 2.2733724625023655e-11
of O 0 3.0707802967100406e-10
breast B-Disease 0 0.03273668512701988
cancer I-Disease 0 8.28882766654715e-05
in O 0 2.969960735677013e-11
the O 0 2.666891985025899e-10
family O 0 2.7615757858256984e-07
. O 0 3.2683440398528774e-09

Interestingly O 0 3.699976787174819e-07
, O 0 3.344214141720592e-11
the O 0 1.415925075754984e-13
presence O 0 1.4603261091691855e-12
of O 0 3.503318783074777e-13
a O 0 1.1201788385761802e-09
breast B-Disease 0 7.763426765450276e-06
cancer I-Disease 0 4.242238276219723e-07
case O 0 3.171606866025911e-10
< O 0 3.6240354467365066e-11
36 O 0 1.038660216862164e-11
years O 0 7.382337796624228e-11
of O 0 1.468951913233263e-13
age O 0 5.306811934335798e-11
was O 0 6.658762985445321e-10
strongly O 0 5.64778692563328e-12
predictive O 0 3.065957765446825e-10
of O 0 1.9146252779825984e-13
the O 0 2.0924123544929785e-11
presence O 0 1.1908047464759264e-11
of O 0 4.572246918642213e-14
any O 0 1.8336088127447053e-13
of O 0 8.344391766912287e-15
the O 0 1.3042130309753874e-12
eight O 0 2.7760170898116776e-11
mutations O 0 2.2327728554927262e-10
screened O 0 1.2018572803640382e-08
. O 0 2.4322008296273623e-10

Carriers O 0 1.2234272261935075e-08
of O 0 7.423305134653113e-13
the O 0 1.0034292190555516e-12
same O 0 1.9182239130444145e-11
mutation O 0 3.1081986984204946e-10
, O 0 1.5697253609794903e-12
from O 0 6.2861953022250085e-15
different O 0 2.4533904435472022e-14
families O 0 7.96650939660637e-12
, O 0 6.620807960038e-14
shared O 0 5.232742624622366e-12
similar O 0 2.231595550711285e-12
haplotypes O 0 2.0256146981978418e-08
, O 0 2.476727373537657e-12
indicating O 0 8.504666589026488e-12
that O 0 9.588343167403826e-14
the O 0 3.030903097402636e-14
mutant O 0 2.2148829437185213e-09
alleles O 0 1.2890394307518704e-10
were O 0 5.697041172147976e-10
likely O 0 5.850166184817596e-11
to O 0 6.635058171292063e-13
be O 0 1.0504946738876253e-11
identical O 0 2.4294199985064324e-09
by O 0 3.2962622215082504e-11
descent O 0 6.408734520846338e-08
for O 0 7.623152326399762e-13
a O 0 3.761729469586861e-11
mutation O 0 1.4702106199138143e-09
in O 0 5.675268414939705e-12
the O 0 4.006448645066385e-11
founder O 0 1.6898427190881193e-07
population O 0 3.778532608328389e-12
. O 0 6.531599566761415e-11

The O 0 2.177286996529748e-12
identification O 0 4.517277177318313e-12
of O 0 7.284027303848181e-14
common O 0 1.313485986642604e-10
BRCA1 O 0 2.17748402064899e-06
and O 0 1.9303534770642727e-08
BRCA2 O 0 6.151558409328572e-07
mutations O 0 2.9868130191346154e-09
will O 0 3.575476503411834e-13
facilitate O 0 3.300453714581014e-14
carrier O 0 1.1191431115165074e-09
detection O 0 1.414152794865231e-08
in O 0 9.6808967092743e-12
French O 0 1.6791308610208944e-07
Canadian O 0 2.3160259843280073e-06
breast B-Disease 1 0.806362509727478
cancer I-Disease 1 0.6270618438720703
and O 0 9.69743705354631e-05
breast B-Disease 1 0.9999589920043945
/ I-Disease 1 0.9999878406524658
ovarian I-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999949932098389
families O 0 4.915191311738454e-07
. O 0 1.595052534497654e-09

Are O 0 7.0493055837062e-10
Dp71 O 0 3.6345122680359054e-06
and O 0 1.2924645798051415e-09
Dp140 O 0 4.652429197449237e-08
brain O 0 1.2302164122957038e-06
dystrophin O 0 2.9400359924380837e-09
isoforms O 0 3.080916424758051e-11
related O 0 1.5671451636389833e-10
to O 0 3.460885189543461e-10
cognitive B-Disease 0 3.3276298836426577e-06
impairment I-Disease 0 0.0008765656384639442
in O 0 1.935590717039304e-06
Duchenne B-Disease 1 0.9998563528060913
muscular I-Disease 1 0.9981069564819336
dystrophy I-Disease 1 0.9598081707954407
? O 0 8.149246241373476e-06

Molecular O 0 6.849154488008935e-07
study O 0 2.3467578103009146e-08
and O 0 3.417757099555274e-08
neuropsychological O 0 3.028588579923053e-08
analysis O 0 3.2184534985019164e-12
were O 0 8.300208393860475e-13
performed O 0 5.119895393063123e-13
concurrently O 0 3.392789955231068e-12
on O 0 1.3021916878130924e-09
49 O 0 3.004848281307204e-08
patients O 0 4.82411222080259e-09
with O 0 1.1702200026775245e-06
Duchenne B-Disease 1 0.9999810457229614
muscular I-Disease 1 0.9988346695899963
dystrophy I-Disease 1 0.6569312214851379
( O 0 6.591264423150278e-09
DMD B-Disease 1 0.9999978542327881
) O 0 1.6713201933526989e-09
in O 0 2.6974960893461075e-13
order O 0 3.122414653222716e-12
to O 0 2.2066148821359155e-12
find O 0 5.633134150112573e-12
a O 0 1.1259488689172904e-14
molecular O 0 1.1423403455806946e-12
explanation O 0 2.580195002696139e-14
for O 0 8.389522529374943e-15
the O 0 3.248607979844387e-11
cognitive B-Disease 0 4.6216416649258463e-07
impairment I-Disease 0 2.6211601777959004e-08
observed O 0 2.050377506668255e-10
in O 0 4.556633282498668e-12
most O 0 4.4032582025010925e-09
DMD B-Disease 1 0.9999890327453613
patients O 0 2.5418097848728394e-08
. O 0 5.393182012092268e-10

Complete O 0 3.7207665837257764e-09
analysis O 0 3.284037625173042e-11
of O 0 7.112972727095143e-14
the O 0 2.9001866012901e-12
dystrophin O 0 7.186805595083001e-10
gene O 0 9.524040445185733e-10
was O 0 1.4701329043020905e-08
performed O 0 5.358572960356689e-11
to O 0 2.3538885684376565e-13
define O 0 2.549816477750988e-12
the O 0 3.9957528388465113e-13
localization O 0 4.703568090569377e-10
of O 0 1.702557738618004e-14
deletions O 0 2.1190464938314335e-09
and O 0 8.094627190757819e-10
duplications O 0 1.872226462751314e-08
in O 0 1.5048962076491534e-11
relation O 0 4.329426747662346e-11
to O 0 1.9912190386134343e-12
the O 0 9.95608977205631e-13
different O 0 5.072042785769781e-10
DMD B-Disease 1 0.9999779462814331
promoters O 0 5.0329994394360256e-08
. O 0 1.3885778638034196e-10

Qualitative O 0 8.539036699950486e-10
analysis O 0 5.945127029560737e-11
of O 0 3.484373163262222e-13
the O 0 1.4328001458896455e-11
Dp71 O 0 1.1879576788942359e-07
transcript O 0 8.232877917180303e-07
and O 0 3.931993272643375e-11
testing O 0 1.0971577785829842e-13
for O 0 2.3007600258605162e-17
the O 0 8.397229867450467e-17
specific O 0 1.308122425993112e-15
first O 0 7.347940615340387e-13
exon O 0 1.157424087128156e-10
of O 0 6.048667968404364e-13
Dp140 O 0 4.2933534505351645e-10
were O 0 3.1975783132409674e-11
also O 0 8.950088066506101e-12
carried O 0 1.4117966795623715e-09
out O 0 3.4856035835417742e-09
. O 0 1.8462137374442023e-10

Neuropsychological O 0 6.7149903770769015e-06
analysis O 0 2.807793164638639e-10
assessed O 0 4.865436054046768e-09
verbal O 0 8.03927058257159e-09
and O 0 2.5045202023399327e-10
visuospatial O 0 1.4887260135765246e-07
intelligence O 0 1.238311853057894e-07
, O 0 2.2546570513370945e-11
verbal O 0 3.2642446523567514e-09
memory O 0 3.4602530831762124e-06
, O 0 2.485625767711941e-11
and O 0 1.1381007247734942e-10
reading O 0 3.6323712926389362e-09
skills O 0 1.790884218699773e-09
. O 0 4.1586008941996155e-11

Comparison O 0 9.255645139205626e-10
of O 0 4.377700188028938e-13
molecular O 0 3.604578191485075e-09
and O 0 1.3186024494515891e-09
psychometric O 0 2.008885502391422e-08
findings O 0 5.043735915033487e-11
demonstrated O 0 2.3406923968516402e-11
that O 0 2.1356091266071242e-13
deletions O 0 6.873146496388927e-11
and O 0 8.136012003001625e-11
duplications O 0 2.121618658534885e-09
that O 0 7.961636905307046e-11
were O 0 4.003812906216986e-11
localized O 0 1.3229473072584597e-10
in O 0 2.7748418146567033e-11
the O 0 1.4629593370063532e-10
distal O 0 1.7553105635670363e-06
part O 0 5.479324216572934e-10
of O 0 1.6107307545046301e-12
the O 0 1.832132015544552e-11
gene O 0 4.770019934596803e-09
seemed O 0 3.659757163987365e-09
to O 0 3.2159282967745076e-14
be O 0 2.146054194811578e-13
preferentially O 0 6.934260943225468e-10
associated O 0 1.3455118963445756e-10
with O 0 3.023033767757255e-10
cognitive B-Disease 0 2.1968426153762266e-06
impairment I-Disease 0 1.2803661775251385e-06
. O 0 1.1291970691829079e-09

Two O 0 3.8029746018963806e-10
altered O 0 3.3574359292742884e-08
Dp71 O 0 6.109661399023025e-07
transcripts O 0 3.66636143667165e-08
and O 0 2.284064257174201e-11
two O 0 1.0747000213579341e-13
deleted O 0 4.091561256469589e-10
Dp140 O 0 1.482599633340076e-11
DNA O 0 1.840290697607827e-09
sequences O 0 2.332889159628593e-10
were O 0 7.112423497379616e-12
found O 0 2.7362634727468027e-12
in O 0 8.687491779560061e-15
four O 0 1.66628950221126e-11
patients O 0 8.575920529274583e-11
with O 0 1.3797087916600503e-08
severe O 0 0.0015560899628326297
cerebral B-Disease 1 0.816864013671875
dysfunction I-Disease 0 0.012505370192229748
. O 0 6.710303779300375e-08

These O 0 1.2915891967058002e-10
findings O 0 3.1344874612537765e-11
suggest O 0 5.032451885766953e-12
that O 0 1.4051843761112796e-14
some O 0 2.614772973421692e-16
sequences O 0 3.1355024913276575e-12
located O 0 2.6654059168129685e-11
in O 0 1.3152748204806053e-12
the O 0 8.143118991610354e-12
distal O 0 3.194389250893437e-07
part O 0 3.9185543698749825e-11
of O 0 5.766020934371355e-14
the O 0 7.574627231866915e-13
gene O 0 4.739147962951051e-10
and O 0 2.0559931535046871e-10
, O 0 1.3164611816027932e-13
in O 0 5.514840937159617e-16
particular O 0 1.870625168979255e-14
, O 0 2.550465670906818e-14
some O 0 3.6133730962851704e-14
DMD B-Disease 1 0.9997811913490295
isoforms O 0 4.72051633892967e-11
expressed O 0 3.894821618000144e-11
in O 0 3.424007822064312e-12
the O 0 7.468022866774504e-10
brain O 0 0.0034943956416100264
may O 0 1.6955752357716847e-09
be O 0 2.084419469710122e-13
related O 0 3.9457602766732047e-13
to O 0 1.7388172065396779e-12
the O 0 1.3124117070884012e-10
cognitive B-Disease 0 2.2388148863683455e-06
impairment I-Disease 0 3.672430182177777e-07
associated O 0 4.6223536109835095e-09
with O 0 1.5912032580445157e-08
DMD B-Disease 1 0.9999895095825195
. O 0 3.695967976113934e-09
. O 0 1.1239283947972467e-09

I1307K O 0 3.6132192349214165e-07
APC O 0 1.190212515211897e-06
and O 0 5.1074304785458935e-09
hMLH1 O 0 3.224408828828018e-07
mutations O 0 1.429348657211449e-07
in O 0 6.681010605857907e-11
a O 0 2.041600916102837e-10
non O 0 4.2528469634817156e-10
- O 0 3.4969802982232068e-06
Jewish O 0 1.0008412800743827e-06
family O 0 2.6281395548721775e-07
with O 0 2.6783975037858454e-10
hereditary B-Disease 1 0.573977530002594
non I-Disease 0 9.41583130043e-06
- I-Disease 1 0.9999281167984009
polyposis I-Disease 1 0.9999639987945557
colorectal I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999909400939941
. O 0 1.9694007278303616e-06

We O 0 3.2223284041066336e-09
describe O 0 1.1531514632068252e-10
a O 0 7.736531033863958e-12
French O 0 9.319422566989033e-09
Canadian O 0 3.758056266178755e-08
hereditary B-Disease 1 0.9988834261894226
non I-Disease 0 0.00042676946031861007
- I-Disease 1 0.9999730587005615
polyposis I-Disease 1 0.9999915361404419
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
( O 0 6.687903919555538e-07
HNPCC B-Disease 0 0.0730113685131073
) O 0 6.243507932879311e-09
kindred O 0 1.3781668712908868e-06
which O 0 2.407867460973989e-09
carries O 0 1.7234079052741436e-08
a O 0 9.003113358996284e-12
novel O 0 8.838488274598433e-10
truncating O 0 5.068779387329414e-07
mutation O 0 1.0949678852512079e-07
in O 0 1.9054836875032066e-10
hMLH1 O 0 7.45262832424487e-06
. O 0 4.05175448747741e-09

Interestingly O 0 2.9377501320482224e-08
, O 0 2.598203553347278e-12
the O 0 6.724441424695027e-14
I1307K O 0 1.2073243793597754e-10
APC O 0 7.317996431055462e-09
polymorphism O 0 1.0041628684120951e-07
, O 0 4.501030624604052e-12
associated O 0 4.831837512563053e-13
with O 0 2.4498788143544753e-14
an O 0 3.047878247529334e-13
increased O 0 2.098316242982179e-10
risk O 0 3.2517114050278906e-06
of O 0 3.525146667016088e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, O 0 7.105739285862e-08
is O 0 4.0048231397804557e-10
also O 0 1.9333877554483792e-10
present O 0 2.51888484029128e-12
in O 0 2.6219884553466133e-13
this O 0 3.4022706527081503e-12
family O 0 1.0564398245094253e-08
. O 0 3.4402392046217756e-10

The O 0 3.217757171825042e-10
I1307K O 0 1.617328848624311e-07
polymorphism O 0 6.24721451458754e-07
has O 0 2.3315247510424797e-09
previously O 0 3.8925637019238124e-11
only O 0 9.912410519133386e-14
been O 0 2.6595302349274874e-11
identified O 0 2.8773455840180873e-10
in O 0 1.6872717415947203e-12
individuals O 0 6.309746019943219e-13
of O 0 3.594919284130582e-12
self O 0 2.9392297165031778e-06
- O 0 0.007043146528303623
reported O 0 3.9245005609700456e-05
Ashkenazi O 0 1.141795473813545e-05
Jewish O 0 2.4976628765216446e-08
origins O 0 5.734353436537276e-08
. O 0 6.984209321991841e-10

In O 0 5.927938695471369e-11
addition O 0 8.176971252882304e-12
, O 0 5.031165588309516e-12
in O 0 1.2571779554881868e-13
this O 0 9.082898278986451e-13
family O 0 9.32729560254586e-10
, O 0 5.488206460471656e-13
there O 0 6.075640614526187e-14
appears O 0 5.5692502692883394e-11
to O 0 1.3609165877559448e-12
be O 0 1.7844484570539443e-11
no O 0 1.580833337497256e-12
relationship O 0 1.6692510221294476e-11
between O 0 5.586735501300621e-13
the O 0 1.0086138738443773e-12
I1307K O 0 6.090353221743783e-10
polymorphism O 0 1.638062685493935e-09
and O 0 1.4734487935319507e-11
the O 0 6.48579660030707e-13
presence O 0 3.2858233495192124e-11
or O 0 2.611317273526481e-10
absence O 0 2.6649291107183615e-10
of O 0 7.611427222005418e-13
cancer B-Disease 0 3.3274027089191804e-08
. O 0 3.051522923236405e-11
. O 0 2.2341616057186542e-10

Identification O 0 7.051416672787525e-10
of O 0 1.6281205984097769e-12
a O 0 2.1575935482687214e-11
novel O 0 1.9549059593337859e-10
mutation O 0 5.686586757036594e-10
of O 0 2.3328902828620435e-13
the O 0 7.105806828361372e-12
CPO O 0 8.956047281571955e-08
gene O 0 1.1792239407171223e-10
in O 0 1.7954431344446853e-13
a O 0 4.4482802857848114e-11
Japanese O 0 8.538474816077724e-08
hereditary B-Disease 0 0.22846610844135284
coproporphyria I-Disease 0 0.0019478709436953068
family O 0 1.4263243031109596e-07
. O 0 2.2412895150925038e-10

Hereditary B-Disease 1 0.9990901947021484
coproporphyria I-Disease 1 0.9795854091644287
( O 0 8.5557232409883e-08
HCP B-Disease 0 0.006175939459353685
) O 0 1.348856226712769e-08
is O 0 9.427132408035277e-10
an O 0 7.443108906990403e-10
autosomal B-Disease 1 0.9994730353355408
dominant I-Disease 1 0.9993502497673035
disease I-Disease 1 0.9858047366142273
characterized O 0 5.613067060039612e-07
by O 0 4.241074505473286e-11
a O 0 1.3365609063953343e-08
deficiency B-Disease 0 0.10215453803539276
of I-Disease 0 1.2368688972336228e-12
coproporphyrinogen I-Disease 0 1.9807623175438493e-05
oxidase I-Disease 0 1.5882204706940684e-06
( O 0 2.4234104306630755e-11
CPO O 0 1.6293999578920193e-05
) O 0 2.1821991436077326e-10
caused O 0 8.19118037287403e-11
by O 0 1.1393559605163157e-14
a O 0 2.535916138537986e-12
mutation O 0 2.7900212695719517e-10
in O 0 4.636003495157859e-13
the O 0 2.0346016538219658e-12
CPO O 0 5.323907998899813e-07
gene O 0 2.538339538560308e-09
. O 0 5.436756600474268e-10

Only O 0 5.016883020125817e-10
11 O 0 2.4994711855796936e-10
mutations O 0 1.6892546250701912e-09
of O 0 2.290995084613945e-13
the O 0 7.453713861405031e-12
gene O 0 1.577965491605937e-08
have O 0 7.165375404127872e-09
been O 0 6.097807148108814e-09
reported O 0 6.395838880735027e-08
in O 0 7.186058172126142e-12
HCP B-Disease 0 0.0003062462783418596
patients O 0 1.8594636941315912e-09
. O 0 2.0234502962068746e-10

We O 0 3.892575151098754e-09
report O 0 1.7510123559438817e-11
another O 0 3.570324374688183e-13
mutation O 0 1.148508996240416e-10
in O 0 7.409117265023968e-13
a O 0 7.574562504997218e-11
Japanese O 0 1.921680059524533e-08
family O 0 1.2548309946680547e-08
. O 0 1.2260188697599261e-10

Polymerase O 0 2.407158035566681e-06
chain O 0 3.496933686619741e-06
reaction O 0 2.7897619769845505e-09
- O 0 1.9587659494391119e-07
single O 0 2.7363094012855527e-09
strand O 0 1.133070099967881e-06
conformational O 0 3.3021016476730836e-11
polymorphism O 0 2.3214595523679549e-10
and O 0 4.806355644428398e-14
direct O 0 9.78636456269201e-16
sequence O 0 2.016341087152096e-11
analyses O 0 6.096533000654603e-11
demonstrated O 0 1.6117080543429085e-12
a O 0 2.602907852363584e-14
C O 0 2.1631686025758157e-11
to O 0 2.1767418596774224e-13
T O 0 5.853872248051672e-11
substitution O 0 2.913455160650602e-15
in O 0 7.86662473883763e-16
exon O 0 1.3302889605854018e-12
1 O 0 2.513802100506668e-12
of O 0 1.0912279719698e-14
the O 0 1.0582305431244832e-12
CPO O 0 2.3655504222119816e-09
gene O 0 2.3438800271328997e-13
at O 0 1.2090969772702437e-13
nucleotide O 0 7.534479360945048e-14
position O 0 5.880699260885081e-10
85 O 0 3.882233510360544e-12
, O 0 4.720702995175685e-12
which O 0 3.3281184474986958e-09
lies O 0 9.097085040821185e-08
in O 0 6.42232577882651e-13
the O 0 1.0632703485030648e-12
putative O 0 3.42741230952015e-08
presequence O 0 6.286166698288298e-09
for O 0 6.943543585392062e-16
targeting O 0 4.209136077876208e-12
to O 0 2.8252658459265723e-12
mitochondria O 0 1.3035815094042391e-08
. O 0 2.90658552781764e-10

This O 0 7.579559375969769e-12
mutation O 0 3.6951466192425286e-11
changes O 0 3.703438787193078e-14
the O 0 4.864140909716444e-15
codon O 0 1.8317143049735585e-13
for O 0 7.389390494486796e-16
glutamine O 0 1.021149918095654e-11
to O 0 2.0707631301960377e-14
a O 0 1.3662554703038066e-13
termination O 0 1.737803477508404e-11
codon O 0 5.748029222735207e-12
at O 0 2.804029404501751e-11
amino O 0 1.842891637904298e-11
acid O 0 3.5453692065479103e-11
position O 0 1.979018948716771e-09
29 O 0 2.1388544269029808e-09
. O 0 5.892362292536646e-11

MaeI O 0 1.1919678399863187e-05
restriction O 0 9.626814012619889e-09
analysis O 0 3.9199091195207814e-10
showed O 0 3.084447364187781e-09
two O 0 2.933828581550696e-13
other O 0 1.730432339303381e-13
carriers O 0 3.352079681537279e-12
in O 0 2.381599149663127e-13
the O 0 2.1562647500861232e-11
family O 0 2.3864753728730648e-08
. O 0 4.096809003151236e-10

The O 0 5.4322604192691415e-09
C O 0 0.0007995996274985373
- O 1 0.6221075057983398
T O 1 0.5199320912361145
mutation O 0 2.2995691040250676e-07
is O 0 7.736756374443488e-11
located O 0 5.086007136279047e-12
within O 0 4.756370874958206e-14
a O 0 7.167520158120333e-13
recently O 0 1.7074579597431416e-11
proposed O 0 2.111491354212045e-15
putative O 0 9.895606903342902e-12
alternative O 0 2.055330359303654e-14
translation O 0 8.33769078084634e-12
initiation O 0 5.59751116985252e-12
codon O 0 4.0716860438827496e-10
( O 0 7.048905187843901e-13
TIC O 0 5.568961469748501e-08
- O 0 1.0401485894817597e-08
1 O 0 2.7749793782283483e-11
) O 0 9.697377449657818e-13
, O 0 9.10705345635648e-15
supporting O 0 2.0351479019815183e-13
that O 0 1.2787390937796239e-11
TIC O 0 6.308329858484285e-08
- O 0 4.725772662084182e-09
1 O 0 1.672507965455594e-11
is O 0 3.7020304356760736e-12
the O 0 8.736903344894187e-13
real O 0 1.723150622190417e-09
TIC O 0 8.311508281622082e-08
rather O 0 1.997696441862623e-13
than O 0 2.2511559063793755e-14
TIC O 0 2.3228793111229606e-08
- O 0 5.997672580804192e-09
2 O 0 5.963912003137395e-11
. O 0 4.355855086346505e-12
. O 0 1.792327918026526e-11

Human B-Disease 0 1.871864885316654e-09
complement I-Disease 0 7.11216614490695e-08
factor I-Disease 0 0.00021996993746142834
H I-Disease 1 0.9999974966049194
deficiency I-Disease 1 0.9999051094055176
associated O 0 4.725730832433328e-06
with O 0 0.00020914514607284218
hemolytic B-Disease 1 0.9999759197235107
uremic I-Disease 1 0.999991774559021
syndrome I-Disease 1 0.9999291896820068
. O 0 7.930682386358967e-07

This O 0 2.378963692706293e-11
study O 0 2.4805843685561657e-13
reports O 0 6.000051800889028e-13
on O 0 1.6637932351293294e-11
six O 0 3.0314740301351506e-11
cases O 0 5.7399796721258056e-11
of O 0 1.1680827138871308e-10
deficiency B-Disease 0 0.0002598639403004199
in I-Disease 0 3.285053977973573e-14
the I-Disease 0 1.7521054390874126e-14
human I-Disease 0 3.4401663782197486e-14
complement I-Disease 0 2.5206365586363105e-14
regulatory I-Disease 0 5.685669816901662e-12
protein I-Disease 0 9.860743332978927e-10
Factor I-Disease 0 4.115419116601515e-09
H I-Disease 1 0.999997615814209
( O 0 1.0640093840719178e-11
FH O 0 2.800536265112896e-07
) O 0 2.73986714392771e-12
in O 0 2.734078569894085e-15
the O 0 1.2337952213440761e-14
context O 0 5.567089215834098e-13
of O 0 1.670322544557526e-13
an O 0 3.753886446133947e-08
acute B-Disease 1 0.9643074870109558
renal I-Disease 1 0.9999986886978149
disease I-Disease 1 0.9999905824661255
. O 0 3.210557792954205e-07

Five O 0 7.303184168527821e-10
of O 0 2.1661805107899695e-13
the O 0 3.332780557606385e-13
cases O 0 1.7200833585164638e-13
were O 0 8.736154161192999e-13
observed O 0 9.285235774703082e-12
in O 0 1.5198600841412335e-13
children O 0 4.018885571555053e-11
presenting O 0 6.730514812147703e-09
with O 0 2.1934070900897495e-05
idiopathic O 1 0.9999861717224121
hemolytic B-Disease 1 0.9999963045120239
uremic I-Disease 1 0.9999986886978149
syndrome I-Disease 1 0.9999969005584717
( O 0 5.178422952667461e-07
HUS B-Disease 1 0.9981516003608704
) O 0 1.285657589278344e-07
. O 0 1.280713313178694e-08

Two O 0 5.73130765069152e-10
of O 0 3.173320438885907e-13
the O 0 5.6876330901955985e-12
children O 0 2.196698378753581e-10
exhibited O 0 7.190589790262436e-10
a O 0 9.956860336224338e-11
homozygous O 0 0.0005210054805502295
deficiency O 1 0.94272381067276
characterized O 0 2.3864967779729795e-09
by O 0 1.9155649289004373e-12
the O 0 3.713515172448778e-12
absence O 0 2.948495614329971e-11
of O 0 1.9671956917572493e-15
the O 0 6.066399823884822e-14
150 O 0 1.3107154691303653e-14
- O 0 2.3448493147171234e-10
kD O 0 9.497790331991496e-10
form O 0 1.5625939127697497e-13
of O 0 3.92374629694988e-14
Factor O 0 1.782834213592821e-09
H O 1 0.9999985694885254
and O 0 2.8916983391136242e-11
the O 0 3.265731123567629e-14
presence O 0 1.2909961186018115e-13
, O 0 5.530812590413044e-15
upon O 0 2.716888840910859e-14
immunoblotting O 0 1.5937722253056563e-09
, O 0 1.845459057786677e-15
of O 0 3.4155650685964e-17
the O 0 1.0595604593905718e-14
42 O 0 7.039943172686136e-13
- O 0 8.982277421853979e-11
kD O 0 1.6310199857372254e-09
Factor O 0 1.588312925626667e-09
H O 1 0.9999649524688721
- O 0 7.731541629141248e-09
like O 0 1.5084186070352112e-12
protein O 0 1.0134275363338219e-11
1 O 0 3.6660583423164805e-13
( O 0 1.4936947451214388e-15
FHL O 0 4.946174025910466e-10
- O 0 5.283675719169878e-10
1 O 0 5.162475048142712e-12
) O 0 2.997216190514518e-13
and O 0 1.882527201615622e-13
other O 0 3.2247303243491954e-14
FH O 0 9.561101244059955e-09
- O 0 5.998127550199683e-10
related O 0 8.57351620253688e-11
protein O 0 9.82012693384604e-10
( O 0 8.474490776006274e-14
FHR O 0 2.6330456037726435e-08
) O 0 2.2538421866682978e-13
bands O 0 4.241034259888643e-11
. O 0 5.13142653368881e-11

Southern O 0 4.6351132709787635e-08
blot O 0 0.00016614171909168363
and O 0 7.520679218275816e-11
PCR O 0 7.383611944078439e-09
analysis O 0 2.2171620008698545e-12
of O 0 1.9579263190478699e-16
DNA O 0 1.0935638505848999e-10
of O 0 5.239525583148816e-15
one O 0 2.01791751711089e-12
patient O 0 2.742954752221749e-10
with O 0 2.1454231446949024e-10
homozygous O 0 0.00018496206030249596
deficiency O 0 0.0754295364022255
ruled O 0 4.665658970282038e-09
out O 0 3.0626379210474397e-10
the O 0 6.607261938094966e-13
presence O 0 1.275386805714429e-12
of O 0 3.4242310626797588e-15
a O 0 3.9205314342205533e-13
large O 0 2.6484127391146473e-12
deletion O 0 1.0606616918096279e-08
of O 0 1.9604404091853184e-13
the O 0 1.4555279204131466e-10
FH O 0 1.7372036609231145e-07
gene O 0 1.8827814307620372e-10
as O 0 1.7645102393104573e-11
the O 0 2.8833322882060308e-11
underlying O 0 1.36961219254772e-07
defect O 0 7.134257629104468e-08
for O 0 7.97845730454716e-13
the O 0 1.382870262744973e-08
deficiency O 0 0.02962474711239338
. O 0 1.712129660269568e-09

The O 0 1.770159713254671e-11
other O 0 8.839065005102065e-13
four O 0 3.2387939986194825e-12
children O 0 6.184227175493051e-12
presented O 0 9.041280744914726e-12
with O 0 9.141112172761368e-11
heterozygous O 0 5.594401500275126e-06
deficiency O 0 0.11890874803066254
and O 0 7.859431855328225e-11
exhibited O 0 9.470253747867474e-11
a O 0 2.4178963952542487e-12
normal O 0 1.798290405474745e-10
immunoblotting O 0 7.394533895421773e-06
pattern O 0 2.0869754280283814e-07
of O 0 6.852506030056299e-14
proteins O 0 3.504204565407676e-11
of O 0 1.2362315760915815e-13
the O 0 1.5479048043332e-09
FH O 0 0.00018537840514909476
family O 0 2.813076349639232e-08
. O 0 2.3281108985084842e-10

Factor B-Disease 0 0.1076003685593605
H I-Disease 1 0.9999959468841553
deficiency I-Disease 1 0.9995513558387756
is O 0 4.054533445096986e-11
the O 0 7.325872222220531e-13
only O 0 1.9185479871453026e-09
complement B-Disease 1 0.9999909400939941
deficiency I-Disease 1 0.9999992847442627
associated O 0 1.0365263314326967e-08
with O 0 1.1131587873691728e-09
HUS B-Disease 1 0.9032140970230103
. O 0 3.463814124415876e-08

These O 0 3.619075872318689e-11
observations O 0 1.5473725079040435e-10
suggest O 0 2.311877468977319e-12
a O 0 2.408467542969802e-14
role O 0 3.9534989865197545e-12
for O 0 2.0299152983516144e-12
FH O 0 3.7791135127918096e-06
and O 0 3.958319005903377e-09
/ O 0 4.5190006403572625e-08
or O 0 3.3032643287356223e-09
FH O 0 5.34576997779368e-07
receptors O 0 1.9616488433626955e-09
in O 0 2.6704460582942235e-13
the O 0 5.311092277776597e-12
pathogenesis O 0 1.6527137347566168e-07
of O 0 2.453381664491161e-10
idiopathic O 0 0.007205392699688673
HUS B-Disease 1 0.9906505346298218
. O 0 1.0095685176736424e-08
. O 0 2.1776431768927296e-09

Further O 0 4.901795636058637e-11
evidence O 0 5.567675660789195e-12
for O 0 2.7389327039565627e-15
a O 0 1.989573158729229e-14
major O 0 1.6763611440824555e-13
ancient O 0 8.067345680373705e-10
mutation O 0 0.00019295542733743787
underlying O 1 0.8990201950073242
myotonic B-Disease 1 0.9999963045120239
dystrophy I-Disease 1 0.9999943971633911
from O 0 1.2449797859304113e-09
linkage O 0 0.00015090531087480485
disequilibrium O 0 0.011896711774170399
studies O 0 1.2074492516944701e-09
in O 0 2.3199335247997555e-13
the O 0 1.8674079210051486e-12
Japanese O 0 2.9484426011805454e-09
population O 0 7.713585629606778e-13
. O 0 2.1375430939163387e-11

The O 0 0.00016395891725551337
myotonic B-Disease 1 0.9999328851699829
dystrophy I-Disease 1 0.9999791383743286
( O 0 6.216753718035761e-06
DM B-Disease 1 0.9999934434890747
) O 0 2.8021659659316356e-07
mutation O 0 3.0335263545566704e-07
is O 0 3.970916928608403e-09
an O 0 3.578606577736565e-10
unstable O 0 0.14209188520908356
( O 0 1.1670732956436947e-11
CTG O 0 8.62045794747246e-08
) O 0 2.0123311350594975e-10
n O 0 2.32227307606081e-07
repeat O 0 2.8199901862535626e-06
, O 0 1.6626892571092178e-11
present O 0 3.587827734560789e-13
at O 0 9.92481184042271e-12
a O 0 2.984653065603478e-14
copy O 0 3.1696398977709705e-11
number O 0 2.12458546713706e-14
of O 0 3.4474033430177946e-15
5 O 0 2.254523998046487e-11
- O 0 1.763974388779843e-08
37 O 0 3.7266578711836473e-11
repeats O 0 1.77446235483103e-08
on O 0 1.9456176947318937e-10
normal O 0 2.2772957131156346e-11
chromosomes O 0 1.5234183914358823e-09
but O 0 5.882836318776841e-12
amplified O 0 4.5737105075494e-11
to O 0 1.1873675328545608e-13
50 O 0 1.8641250381420255e-14
- O 0 1.0957059565219751e-10
3000 O 0 7.175762067879177e-11
copies O 0 1.1378321618238374e-09
on O 0 1.276461034649401e-06
DM B-Disease 1 0.9999918937683105
chromosomes O 0 3.421607834752649e-05
. O 0 4.0225325292908565e-09

Previous O 0 8.50072279234837e-09
findings O 0 5.299531369296062e-10
in O 0 1.010952519614472e-11
Caucasian O 0 1.1367810515139354e-07
populations O 0 5.673983505261049e-11
of O 0 2.749802338955498e-13
a O 0 3.6931091074166034e-08
DM B-Disease 1 0.9999983310699463
founder O 0 1.1162431292177644e-05
chromosome O 0 7.988358993316069e-05
raise O 0 3.5435793188653975e-10
a O 0 5.321171021172022e-12
question O 0 7.101281368493417e-12
about O 0 2.4861152226511932e-14
the O 0 2.1270508412333383e-14
molecular O 0 1.0737508798763784e-10
events O 0 9.708040794864647e-12
involved O 0 6.103845727467583e-13
in O 0 1.2329248102874776e-14
the O 0 8.796073949508126e-14
expansion O 0 3.0484281765552623e-11
mutation O 0 2.7203335140058016e-09
. O 0 3.1412999978996936e-10

To O 0 5.859222829140975e-11
investigate O 0 1.4524601139875859e-11
whether O 0 7.618646382170913e-13
a O 0 8.82635774906472e-14
founder O 0 6.351676129501271e-11
chromosome O 0 1.4979740114995366e-08
for O 0 1.0365612448243189e-13
the O 0 6.205880254128715e-10
DM B-Disease 1 0.9999994039535522
mutation O 0 4.808029885339238e-08
exists O 0 1.1969849590676152e-11
in O 0 6.765928929044953e-15
the O 0 1.8406905502848375e-13
Japanese O 0 5.745689479752514e-10
population O 0 4.530698936139853e-14
, O 0 3.782350409438362e-14
we O 0 3.2776656822691708e-12
genotyped O 0 3.7160006183256655e-09
families O 0 3.845535340358565e-14
using O 0 1.0743023902111751e-13
polymorphic O 0 4.4949119981652075e-09
markers O 0 9.967920050257817e-06
near O 0 6.350256143150546e-08
the O 0 4.720113189193853e-10
( O 0 1.2503774057814887e-12
CTG O 0 9.916750087768378e-08
) O 0 7.389859557616063e-11
n O 0 3.13592806833185e-07
repeat O 0 2.1755104171461426e-05
region O 0 2.408078625393273e-09
and O 0 4.45748937760726e-10
constructed O 0 1.168073211488263e-07
haplotypes O 0 1.1531146810739301e-05
. O 0 8.774915016829254e-09

Six O 0 1.593522258591662e-10
different O 0 7.530546824140172e-13
haplotypes O 0 2.1287011264803368e-08
were O 0 1.6752642328921041e-10
found O 0 1.1505179031701118e-09
and O 0 2.327925407996645e-09
DM B-Disease 1 0.9999972581863403
alleles O 0 9.656236699129295e-09
were O 0 2.2901813778730684e-10
always O 0 1.0210731149484786e-09
haplotype O 0 3.892406397199011e-08
A O 0 1.4792962410581367e-09
. O 0 1.5638316197552626e-09

To O 0 2.882360461420319e-10
find O 0 1.3368706142102837e-10
an O 0 1.0354231035937522e-13
origin O 0 3.3950945353689033e-12
of O 0 1.0996801749372717e-13
the O 0 4.42289989355249e-11
( O 0 3.647191056110888e-14
CTG O 0 9.406423417956944e-10
) O 0 4.888329758340193e-12
n O 0 1.8835592641153198e-08
repeat O 0 1.2084433365089353e-07
mutation O 0 4.09067357765025e-09
and O 0 3.0024146363549775e-11
to O 0 2.7918907962408424e-13
investigate O 0 2.27435149706412e-12
the O 0 1.5055377734427e-13
mechanism O 0 8.166575055090775e-12
of O 0 5.353678942900857e-15
the O 0 1.0005828766446526e-13
expansion O 0 2.6904578825232006e-12
mutation O 0 1.2272441743399476e-11
in O 0 4.4439481933743197e-14
the O 0 7.682457643133633e-13
Japanese O 0 9.619627316936885e-11
population O 0 1.027046930303626e-15
we O 0 9.422780752280785e-14
have O 0 1.0655431378003236e-14
studied O 0 9.3947803841434e-15
90 O 0 1.498120915787316e-14
Japanese O 0 6.078133552023246e-10
DM B-Disease 1 0.9999970197677612
families O 0 3.4559276013840234e-12
comprising O 0 1.0775971154419338e-15
190 O 0 1.1886886332017343e-13
affected O 0 3.470436625249186e-14
and O 0 1.1861231398110905e-12
130 O 0 7.421298818532929e-12
unaffected O 0 1.4619920829517241e-09
members O 0 3.678891230280562e-13
. O 0 3.155037342494893e-11

The O 0 2.77676126536619e-09
results O 0 7.218967645883367e-10
suggest O 0 3.044355045833669e-11
that O 0 5.617444443634101e-13
a O 0 4.5302951385932377e-13
few O 0 1.883724079498883e-12
common O 0 1.4875160565114287e-12
ancestral O 0 1.7335024082854034e-08
mutations O 0 2.1734408051088394e-08
in O 0 1.7483817128446932e-12
both O 0 6.38756478266167e-11
Caucasian O 0 2.3143910254930233e-07
and O 0 3.2042099529228096e-10
Japanese O 0 2.605113624820632e-10
populations O 0 7.847066095870159e-13
have O 0 2.26410231708718e-12
originated O 0 2.6000859451591474e-13
by O 0 1.7579291082371411e-15
expansion O 0 5.90387317484474e-14
of O 0 5.684303113147641e-16
an O 0 8.377629509169135e-14
ancestral O 0 3.780573365474993e-08
n O 0 5.151862865204748e-07
= O 0 4.753109017485713e-09
5 O 0 8.873715998114484e-12
repeat O 0 7.929955359031737e-09
to O 0 9.299312708765939e-11
n O 0 1.0706644104629959e-07
= O 0 2.6414310738687163e-08
19 O 0 2.719853509081105e-11
- O 0 1.5844891620986346e-08
37 O 0 4.9068096807936e-11
copies O 0 8.813960672426902e-10
. O 0 2.7755525655592805e-10

These O 0 2.2552753935201064e-12
data O 0 3.519803806056876e-12
support O 0 6.251881065795495e-14
multistep O 0 9.040958953709932e-11
models O 0 1.354198697622877e-10
of O 0 1.9983518420758906e-13
triplet O 0 3.572534478735179e-05
repeat O 0 4.142616205626837e-07
expansion O 0 3.542077395279897e-11
that O 0 4.4585901810834105e-12
have O 0 4.941119263962915e-14
been O 0 2.7589052326330507e-14
proposed O 0 4.332662198967412e-16
for O 0 8.499530086366648e-15
both O 0 5.099319300150285e-10
DM B-Disease 1 0.9999982118606567
and O 0 7.098992682585958e-08
Friedreichs B-Disease 0 1.710994001768995e-05
ataxia I-Disease 0 2.8198608561069705e-05
. O 0 7.613889380087002e-11
. O 0 1.054886386575582e-10

The O 0 4.824408234016531e-12
molecular O 0 7.281538566550338e-11
basis O 0 6.519314948993937e-11
of O 0 1.5953879994867748e-08
C6 B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999995231628418
in O 0 2.1903921385013625e-11
the O 0 4.0954609495380545e-12
western O 0 1.435876639810374e-09
Cape O 0 6.5380749703081165e-09
, O 0 1.3730850224186186e-12
South O 0 2.4652290625537532e-11
Africa O 0 1.9709440676751733e-11
. O 0 4.8896355714367346e-12

Deficiency B-Disease 1 0.9993446469306946
of I-Disease 0 1.5134158032684142e-12
the I-Disease 0 1.3520190826274425e-12
sixth I-Disease 0 4.742568116000712e-09
component I-Disease 0 9.273948275989596e-11
of I-Disease 0 6.821977607384538e-14
human I-Disease 0 1.1923388491819065e-11
complement I-Disease 0 5.771080141547813e-11
( O 0 1.2328666191240012e-13
C6 O 0 9.51309800711897e-07
) O 0 1.7490696391231353e-11
has O 0 2.5680635395985973e-10
been O 0 1.0684031437335761e-09
reported O 0 3.6812058956670057e-10
in O 0 3.0063166532075117e-15
a O 0 4.233850818763721e-14
number O 0 4.0323626870290147e-14
of O 0 2.2977549157528025e-14
families O 0 1.5665997145364319e-12
from O 0 2.6570455820225164e-15
the O 0 9.393423267955309e-14
western O 0 4.857790211754143e-11
Cape O 0 5.16226394964292e-10
, O 0 4.914935103871032e-13
South O 0 5.804260717889864e-12
Africa O 0 9.791444564866136e-12
. O 0 8.13687387867662e-13

Meningococcal B-Disease 1 0.8554601669311523
disease I-Disease 1 0.5722494125366211
is O 0 1.431217384606498e-07
endemic O 0 4.338958660810022e-06
in O 0 2.4421752814474118e-11
the O 0 5.20318843566514e-10
Cape O 0 6.411752018209427e-09
and O 0 2.1432369767815374e-12
almost O 0 1.3415730488054289e-14
all O 0 4.7950907838562734e-15
pedigrees O 0 1.0493623747720449e-09
of O 0 4.18412223271436e-12
total O 0 5.060963985670242e-07
C6 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
( O 0 2.2898669072013433e-10
C6Q0 O 0 2.1502821255126037e-05
) O 0 3.124143999055917e-11
have O 0 4.48669053298989e-12
been O 0 2.5873992184899386e-11
ascertained O 0 2.4240507379147402e-09
because O 0 2.9529927114690935e-11
of O 0 6.824847544745216e-12
recurrent O 0 0.43936532735824585
disease O 0 0.025975411757826805
. O 0 1.3152272160255052e-08

We O 0 3.824520977691037e-10
have O 0 1.1015847522360955e-12
sequenced O 0 5.185558146075797e-12
the O 0 2.0097427411505664e-13
expressed O 0 2.5436946928143744e-13
exons O 0 3.4652727354256285e-09
of O 0 6.129278399928662e-13
the O 0 2.820754914367729e-11
C6 O 0 1.0809535524458624e-05
gene O 0 6.840976118915876e-10
from O 0 2.6231190071619725e-13
selected O 0 1.8396270834789008e-13
cases O 0 2.4391389515793227e-12
and O 0 1.3930471359779872e-11
have O 0 1.8647217450706854e-11
found O 0 3.4817329574998723e-11
three O 0 6.365453303347479e-11
molecular O 0 4.898517545370851e-06
defects O 0 0.013263260945677757
leading O 0 1.5956611587597536e-09
to O 0 9.983335269581062e-10
total O 0 9.670262812733199e-09
deficiency O 0 0.004006820730865002
879delG O 0 1.1274828182195051e-07
, O 0 4.4041777169656626e-11
which O 0 5.441058367749996e-11
is O 0 2.2186128802170746e-12
the O 0 3.3990794120336565e-12
common O 0 4.357432192847455e-09
defect O 0 1.100562144529249e-06
in O 0 1.2419325550599991e-12
the O 0 9.219943558624877e-11
Cape O 0 4.651672380617811e-09
and O 0 8.357338258935254e-12
hitherto O 0 1.7196430390775674e-10
unreported O 0 1.0051459664595086e-11
, O 0 2.671668496243701e-13
and O 0 5.3694557480832295e-12
1195delC O 0 8.595776535003097e-09
and O 0 2.4182356117563586e-10
1936delG O 0 2.8584821620825096e-08
, O 0 3.2831278928141527e-12
which O 0 2.58182212588276e-12
have O 0 9.2634016776727e-13
been O 0 3.7130850477629096e-11
previously O 0 3.691992822574264e-10
reported O 0 9.372235210136637e-10
in O 0 1.3057357116114804e-13
African O 0 3.925277203969957e-12
- O 0 4.260360952912379e-08
Americans O 0 2.7039545602569603e-10
. O 0 1.1825793816422348e-11

We O 0 5.280111459171621e-09
also O 0 1.4856909105742666e-11
show O 0 3.0184459098858696e-11
that O 0 1.787907929345911e-13
the O 0 2.912580387374325e-13
879delG O 0 2.8724471690111386e-07
and O 0 1.0326035138064071e-08
1195delC O 0 5.192273965803906e-05
defects O 0 0.0042059593833982944
are O 0 7.289920620281998e-14
associated O 0 6.354262276943301e-13
with O 0 9.194808109347363e-12
characteristic O 0 1.985481787869503e-07
C6 O 0 0.2848660349845886
/ O 0 1.947192140505649e-05
C7 O 0 0.00266900472342968
region O 0 1.3064233028714511e-09
DNA O 0 3.316505114980828e-07
marker O 0 6.912662229296984e-06
haplotypes O 0 5.306354182721407e-07
, O 0 3.896805447767271e-11
although O 0 1.2553814324883783e-12
small O 0 7.628326545742678e-14
variations O 0 1.677232831787112e-11
were O 0 1.4829171224306492e-10
observed O 0 1.2232889146090997e-09
. O 0 2.454898229142799e-10

The O 0 2.7990787465626e-09
1936delG O 0 6.569004199263873e-06
defect O 0 2.9654706850124057e-06
was O 0 1.6250734091727281e-09
observed O 0 2.0983992321532696e-11
only O 0 1.322184224085421e-12
once O 0 6.888268289095834e-10
in O 0 9.927722706415398e-13
the O 0 1.3988761538019645e-10
Cape O 0 8.682532026682566e-09
, O 0 5.472766879434376e-13
but O 0 5.015488350156028e-13
its O 0 2.3298097392293604e-12
associated O 0 4.536689773848579e-11
haplotype O 0 8.370179926942001e-08
could O 0 4.757115812381585e-10
be O 0 3.133816340109008e-12
deduced O 0 3.1566655955828082e-09
. O 0 1.9800749928577943e-10

The O 0 6.079847042483877e-11
data O 0 2.5399666814251987e-09
from O 0 1.5096591511609692e-12
the O 0 1.1028672549859286e-12
haplotypes O 0 2.1284819240463548e-08
indicate O 0 5.20747778232078e-10
that O 0 3.3580438776881216e-12
these O 0 6.71998264326068e-13
three O 0 9.061242728369834e-11
molecular O 0 1.1114982044091448e-05
defects O 0 0.011291544884443283
account O 0 5.356447230209227e-11
for O 0 5.2237576243785444e-12
the O 0 1.1260210541763627e-08
defects O 0 0.4622502326965332
in O 0 1.3254742355778282e-12
all O 0 1.4503047200686847e-13
the O 0 2.086297931289116e-12
38 O 0 6.630396925944027e-11
unrelated O 0 9.000941658676709e-10
C6Q0 O 0 4.850113327847794e-06
individuals O 0 1.358155016402407e-12
we O 0 5.4163500941284415e-12
have O 0 2.9316414747182495e-13
studied O 0 9.24804286969727e-13
from O 0 2.788272271490172e-13
the O 0 3.4349006278189265e-11
Cape O 0 5.50968692891729e-09
. O 0 5.0272352253299957e-11

We O 0 8.178153265703259e-09
have O 0 6.012450086412269e-12
also O 0 2.926155682776016e-13
observed O 0 1.407820149519623e-12
the O 0 3.3326406955261345e-13
879delG O 0 6.013746656208241e-08
defect O 0 5.0058865497248917e-08
in O 0 5.742610298961962e-14
two O 0 4.1171524522987113e-10
Dutch O 0 0.004700744990259409
C6 B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999831914901733
deficient I-Disease 1 0.9999994039535522
kindreds O 0 3.132844722131267e-05
, O 0 2.4630657756430363e-12
but O 0 2.0159468170320716e-13
the O 0 1.2695758073305585e-13
879delG O 0 7.720993266957521e-08
defect O 0 7.779294719512109e-08
in O 0 4.3766563723873775e-13
the O 0 1.5194333291557172e-10
Cape O 0 1.93184881425168e-08
probably O 0 5.866058194747836e-10
did O 0 1.4313825298650773e-11
not O 0 2.6945661413951827e-12
come O 0 1.2138854374801888e-12
from O 0 1.1080740173346777e-14
The O 0 3.3907713876263346e-12
Netherlands O 0 7.898678155981997e-09
. O 0 5.771561180367701e-12
. O 0 1.2731077476957342e-11

Complement B-Disease 0 0.04513159766793251
C7 I-Disease 1 0.9999593496322632
deficiency I-Disease 1 0.9999971389770508
: O 0 4.783339502267836e-09
seven O 0 5.209769768366179e-11
further O 0 3.956774491387094e-11
molecular O 0 2.3924056222313084e-05
defects O 1 0.9747203588485718
and O 0 1.4399932357633816e-09
their O 0 8.565658737857973e-10
associated O 0 3.785217916885131e-09
marker O 0 7.570508842036361e-06
haplotypes O 0 2.7874722945853136e-05
. O 0 2.232068219143457e-08

Seven O 0 4.758764562962092e-11
further O 0 9.702162711471354e-14
molecular O 0 6.655788420406594e-11
bases O 0 3.662733760734227e-08
of O 0 5.477260174302501e-07
C7 B-Disease 1 0.9999991655349731
deficiency I-Disease 1 0.9999995231628418
are O 0 3.7023797916369006e-10
described O 0 6.745798231122535e-08
. O 0 1.043366948394464e-09

All O 0 1.197105348876848e-12
these O 0 9.615705042105571e-14
new O 0 7.82330417895688e-13
molecular O 0 2.895151851589617e-08
defects O 0 2.348703310417477e-05
involve O 0 5.136621379978057e-13
single O 0 4.685862808884167e-11
- O 0 2.8573960975109003e-09
nucleotide O 0 5.023442217755303e-10
events O 0 1.1439114239175652e-10
, O 0 1.694491850437116e-13
deletions O 0 2.221451148032294e-11
and O 0 2.8482192299117415e-11
substitutions O 0 1.0422148560840228e-10
, O 0 2.1195556160896745e-13
some O 0 4.577041527464322e-16
of O 0 1.462482173938181e-14
which O 0 3.7903674643402496e-10
alter O 0 5.600103936131973e-09
splice O 0 8.556564353057183e-06
sites O 0 8.873072943060833e-08
, O 0 3.3060974097276485e-11
and O 0 9.191388969376213e-12
others O 0 7.74487331905993e-12
codons O 0 1.1364245100509152e-09
. O 0 3.4821062699919025e-10

They O 0 1.7136710106502306e-10
are O 0 1.3311581857958742e-14
distributed O 0 3.70540322600435e-14
along O 0 8.97076770506322e-12
the O 0 1.6629080057395385e-11
C7 O 0 3.287419303887873e-06
gene O 0 6.084353465496406e-09
, O 0 5.554356627412993e-11
but O 0 3.1556372098728858e-12
predominantly O 0 4.5588516008011545e-15
towards O 0 2.5948543986263617e-13
the O 0 8.79584328549593e-13
3 O 0 7.009936381363602e-11
end O 0 5.5322013636782685e-09
. O 0 9.524852434550368e-11

All O 0 1.962235374186605e-10
were O 0 2.1964972896082458e-10
found O 0 6.993270545985197e-11
in O 0 1.256844698845419e-13
compound O 0 3.378826773925425e-09
heterozygous O 0 5.499041666467974e-09
individuals O 0 6.0785907557425745e-12
. O 0 3.000693027388479e-10

The O 0 3.2192215115856015e-08
C6 O 0 0.11769692599773407
/ O 0 0.0043107895180583
C7 O 0 0.4346991181373596
marker O 0 0.0021435574162751436
haplotypes O 0 5.1211085519753397e-05
associated O 0 7.238622146132911e-08
with O 0 7.370326016165052e-10
most O 0 1.1560971735491421e-08
C7 B-Disease 1 0.9997937083244324
defects I-Disease 1 0.9998239874839783
are O 0 1.0253041748953251e-09
tabulated O 0 5.538249752135016e-06
. O 0 1.1618699752302675e-10
. O 0 1.1733799487601004e-09

A O 0 1.0936400229866194e-08
genome O 0 6.79302942785398e-08
- O 0 1.921171275398592e-07
wide O 0 2.655785591443305e-10
search O 0 4.8468694335834783e-11
for O 0 2.418771834298422e-13
chromosomal O 0 5.647916054840607e-07
loci O 0 3.060258890741352e-08
linked O 0 2.4599905373179354e-05
to O 0 2.198389736918216e-08
mental O 0 5.03556248077075e-06
health O 0 3.9970776688491583e-10
wellness O 0 1.7796210727283324e-08
in O 0 1.5457515909617081e-12
relatives O 0 1.6180763673379062e-10
at O 0 1.1327649929171457e-09
high O 0 2.092942352760474e-08
risk O 0 1.369269995166178e-07
for O 0 1.5996561852915647e-09
bipolar B-Disease 1 0.9999877214431763
affective I-Disease 1 0.9998774528503418
disorder I-Disease 1 0.9824579358100891
among O 0 1.5831062155635678e-11
the O 0 3.3068335396346793e-12
Old O 0 3.856249577438575e-07
Order O 0 1.541073268995774e-09
Amish O 0 3.8618250641775376e-07
. O 0 3.325299202661114e-10

Bipolar B-Disease 1 0.9982783794403076
affective I-Disease 1 0.9985718727111816
disorder I-Disease 1 0.9993118047714233
( O 0 1.2642743740798323e-06
BPAD B-Disease 1 0.999984622001648
; O 0 0.0002988238411489874
manic B-Disease 1 0.9999232292175293
- I-Disease 1 0.999977707862854
depressive I-Disease 1 0.999995231628418
illness I-Disease 1 0.9999535083770752
) O 0 2.5329821795594398e-08
is O 0 8.129264622569465e-11
characterized O 0 1.3785789176878893e-10
by O 0 7.776753416580129e-13
episodes O 0 9.284115698449114e-09
of O 0 1.5108496051463582e-11
mania B-Disease 0 0.2146710902452469
and O 0 7.683751590548127e-08
/ O 0 7.890156439316343e-07
or O 0 2.9244221266822024e-08
hypomania B-Disease 0 0.006431770045310259
interspersed O 0 9.601329111319501e-06
with O 0 6.551654219144609e-10
periods O 0 3.6632352706789106e-09
of O 0 3.8153240983218595e-11
depression B-Disease 0 2.77506364909641e-06
. O 0 7.257568435115047e-10

Compelling O 0 1.0977355691110802e-09
evidence O 0 6.075534519922599e-11
supports O 0 3.697598650875822e-12
a O 0 1.3287389580545622e-13
significant O 0 5.276230061852186e-15
genetic O 0 3.1094897490202555e-11
component O 0 1.434736357497357e-11
in O 0 5.552292837735645e-14
the O 0 1.0360083017163513e-12
susceptibility O 0 6.930297669072161e-09
to O 0 2.4875809745417143e-10
develop O 0 2.859944459032704e-07
BPAD B-Disease 1 0.9999650716781616
. O 0 2.031119983314511e-08

To O 0 5.976585892852881e-11
date O 0 1.7543930197483348e-10
, O 0 1.945697292518589e-12
however O 0 1.2757394966811386e-12
, O 0 3.9402752978826006e-14
linkage O 0 4.949656795538715e-10
studies O 0 1.515646635974477e-11
have O 0 7.816428710880063e-13
attempted O 0 7.040219102139034e-11
only O 0 4.0816305278126505e-14
to O 0 1.2682011745011185e-13
identify O 0 5.051999374394711e-10
chromosomal O 0 8.092487178146257e-07
loci O 0 2.8670276819298124e-08
that O 0 5.871994002148995e-09
cause O 0 2.599862991559121e-09
or O 0 2.380912411670266e-10
increase O 0 3.7594823087960805e-12
the O 0 1.6394058333091266e-10
risk O 0 4.6383856755483066e-08
of O 0 2.068878271824226e-12
developing O 0 1.4938253301011173e-08
BPAD B-Disease 1 0.9999778270721436
. O 0 8.949196939056492e-09

To O 0 5.3126756466292946e-11
determine O 0 3.5925016433902e-11
whether O 0 2.294717801193391e-12
there O 0 2.3455524089839586e-13
could O 0 6.255370353647205e-12
be O 0 1.5536694381122068e-13
protective O 0 2.062597705479452e-12
alleles O 0 2.3492429789689906e-12
that O 0 4.480841045428896e-12
prevent O 0 3.50777074054065e-10
or O 0 8.334133383414155e-11
reduce O 0 2.0925809696148434e-10
the O 0 1.894701062710169e-11
risk O 0 1.6224254162366947e-09
of O 0 3.7395845968457575e-13
developing O 0 1.0450679210904923e-09
BPAD B-Disease 1 0.9999980926513672
, O 0 1.2947993371925648e-12
similar O 0 1.203730295101053e-14
to O 0 3.131460477208414e-13
what O 0 4.822565957685043e-13
is O 0 9.954831962010954e-14
observed O 0 1.845356333018966e-12
in O 0 1.6070813028869896e-13
other O 0 4.645501316957734e-09
genetic B-Disease 1 0.9999995231628418
disorders I-Disease 1 0.9999997615814209
, O 0 1.4287885111152754e-11
we O 0 4.619978011266568e-11
used O 0 9.569384396002079e-09
mental O 0 3.653883686638437e-05
health O 0 1.0607871026024895e-08
wellness O 0 1.0131335557161947e-06
( O 0 1.1483901503350769e-11
absence O 0 9.583091958864642e-11
of O 0 2.42753435625645e-13
any O 0 5.8447517936599525e-09
psychiatric B-Disease 0 0.04225242882966995
disorder I-Disease 0 0.0009503029868938029
) O 0 7.051419994782981e-13
as O 0 2.127023465128483e-13
the O 0 2.1029339294237337e-12
phenotype O 0 4.944874287815537e-09
in O 0 2.2023806389714906e-12
our O 0 5.542485359555371e-10
genome O 0 3.6629156596745815e-08
- O 0 2.3606896775163477e-06
wide O 0 3.5598208825149413e-08
linkage O 0 2.9396444460871862e-06
scan O 0 4.85258397020516e-07
of O 0 3.582410315118058e-14
several O 0 2.376136397017059e-13
large O 0 7.941912644020277e-13
multigeneration O 0 1.704968468629886e-07
Old O 0 3.022160655063999e-08
Order O 0 3.916865790043467e-11
Amish O 0 7.613635943926056e-09
pedigrees O 0 3.584763819119985e-09
exhibiting O 0 1.7782059462054245e-12
an O 0 3.893998499842309e-14
extremely O 0 1.7532733043168491e-09
high O 0 2.2348761774537707e-07
incidence O 0 3.842692603939213e-05
of O 0 3.399616144150741e-09
BPAD B-Disease 1 0.9999881982803345
. O 0 1.1035010771820453e-07

We O 0 1.4179305196648784e-07
have O 0 2.039876600967716e-10
found O 0 2.3740681295847388e-11
strong O 0 4.927491859094309e-14
evidence O 0 3.0511343099412155e-14
for O 0 4.729434930773988e-16
a O 0 1.218719407076324e-13
locus O 0 1.3599438020150956e-08
on O 0 9.291256333199271e-07
chromosome O 0 0.011463169939815998
4p O 0 0.00172565714456141
at O 0 4.0365746301063155e-09
D4S2949 O 0 2.5071394960107796e-10
( O 0 6.609448485885667e-15
maximum O 0 4.481702010374067e-13
GENEHUNTER O 0 5.859773182237404e-07
- O 0 7.794131562377515e-08
PLUS O 0 2.0300179592869227e-10
nonparametric O 0 4.3764042390037616e-10
linkage O 0 8.604486900765096e-09
score O 0 5.920600010256294e-09
= O 0 2.711577629099793e-10
4 O 0 4.09982204435666e-12
. O 0 1.2403086370460503e-12
05 O 0 2.692683576110966e-10
, O 0 1.7556005260654928e-11
P O 0 4.374822992758709e-07
= O 0 3.568798034869758e-10
5 O 0 1.2256201912738685e-12
. O 0 1.4074275057028574e-13
22 O 0 2.4873414959658557e-12
x O 0 2.0376232257035554e-08
10 O 0 6.736017993391741e-11
( O 0 3.073657254821886e-14
- O 0 2.622094097404215e-09
4 O 0 6.273048192007025e-10
) O 0 1.920866460683457e-12
; O 0 3.664329920765631e-14
SIBPAL O 0 6.100817073750875e-10
Pempirical O 0 7.931793416515731e-11
value O 0 2.5030440231350176e-14
< O 0 5.400018539963858e-13
3 O 0 7.055429374416833e-13
x O 0 2.4499518858078773e-08
10 O 0 8.973510129406392e-11
( O 0 6.080440242018509e-14
- O 0 1.2829625362087427e-08
5 O 0 3.555800098808959e-10
) O 0 1.884762745180124e-12
) O 0 1.1443003120580053e-13
and O 0 6.154476342619397e-13
suggestive O 0 4.701634914727748e-12
evidence O 0 1.485087958641093e-14
for O 0 1.204776518433766e-16
a O 0 1.3981297944474363e-13
locus O 0 1.8955534031306343e-08
on O 0 4.114282091904897e-06
chromosome O 1 0.597416877746582
4q O 0 0.00020970466721337289
at O 0 1.8787467137570957e-09
D4S397 O 0 2.725816794502123e-10
( O 0 9.178200835794053e-15
maximum O 0 2.494823466737961e-13
GENEHUNTER O 0 1.377939469193734e-07
- O 0 3.266288928216454e-08
PLUS O 0 9.1070193053433e-11
nonparametric O 0 2.492520634334028e-10
linkage O 0 6.743814839893503e-09
score O 0 1.6906730460064523e-09
= O 0 1.4317681762410217e-10
3 O 0 6.559908866110575e-13
. O 0 1.334730936886075e-13
29 O 0 3.7095385790886226e-11
, O 0 2.134026245645404e-12
P O 0 8.692362030160439e-08
= O 0 1.9714901933198803e-10
2 O 0 3.1155969731216926e-12
. O 0 8.166056806452326e-13
57 O 0 3.136006385129342e-11
x O 0 1.0181918241869425e-07
10 O 0 6.346154157732542e-11
( O 0 2.529565810559676e-14
- O 0 1.512333036579605e-09
3 O 0 3.830331885001925e-10
) O 0 1.5820278030306834e-12
; O 0 3.987710836994736e-14
SIBPAL O 0 1.0244107784274092e-09
Pempirical O 0 1.3384882091571626e-10
value O 0 2.041195751106232e-14
< O 0 3.9758804972270245e-13
1 O 0 6.67514437821537e-13
x O 0 8.015128827310036e-08
10 O 0 2.4872584547530607e-10
( O 0 6.70565545365237e-13
- O 0 7.074365271364513e-08
3 O 0 4.7619477250293585e-09
) O 0 7.47471268908173e-12
) O 0 1.0142116367659743e-13
that O 0 2.1857408732343236e-13
are O 0 6.074270199920824e-15
linked O 0 1.0632152935841077e-09
to O 0 3.092828770867584e-10
mental O 0 9.156879627880699e-07
health O 0 2.6104707284702044e-10
wellness O 0 3.038106299868559e-08
. O 0 3.4664476844525893e-10

These O 0 1.3438352652883623e-09
findings O 0 2.550694655489849e-10
are O 0 1.0396546904628545e-12
consistent O 0 8.945412119376606e-12
with O 0 1.6192448857449415e-12
the O 0 2.4234230074082763e-12
hypothesis O 0 4.1923683274935897e-11
that O 0 3.013921035487088e-13
certain O 0 1.5130390294609483e-14
alleles O 0 5.3032599145463877e-11
could O 0 3.0894167224460034e-09
prevent O 0 3.274650828277714e-10
or O 0 7.280368148621097e-12
modify O 0 1.2750475675282757e-10
the O 0 9.218536350941164e-11
clinical O 0 3.023994210593628e-08
manifestations O 0 1.9629453618108528e-07
of O 0 9.761395025620345e-10
BPAD B-Disease 1 0.9999994039535522
and O 0 1.7600221724478615e-08
perhaps O 0 7.557847576944443e-12
other O 0 2.7969506051495063e-12
related O 0 1.0350351686838621e-07
affective B-Disease 1 0.7170649170875549
disorders I-Disease 1 0.8374230861663818
. O 0 2.609074556403357e-08

Segregation O 0 0.00013651401968672872
distortion O 0 0.19475698471069336
in O 0 5.0412077143846545e-06
myotonic B-Disease 1 0.9998748302459717
dystrophy I-Disease 1 0.9998561143875122
. O 0 1.9233027614973253e-06

Myotonic B-Disease 1 0.9998966455459595
dystrophy I-Disease 1 0.9999707937240601
( O 0 1.925601281982381e-05
DM B-Disease 1 0.9999954700469971
) O 0 2.4141379526554374e-06
is O 0 3.6903751166050824e-09
an O 0 5.872707320442316e-10
autosomal B-Disease 1 0.9919994473457336
dominant I-Disease 1 0.9974023699760437
disease I-Disease 1 0.928958535194397
which O 0 2.410359201121537e-08
, O 0 6.18413263306361e-12
in O 0 1.5558608817533431e-13
the O 0 2.1291119908783962e-11
typical O 0 1.276581951259459e-08
pedigree O 0 6.879107968416065e-05
, O 0 2.330334276240409e-12
shows O 0 4.5189572570047964e-12
a O 0 7.059678769306618e-14
three O 0 5.653905620593702e-13
generation O 0 3.0831401320874363e-10
anticipation O 0 4.4746258781591663e-11
cascade O 0 3.914138630989328e-07
. O 0 1.085708301040711e-09

This O 0 1.0492557517283174e-10
results O 0 1.0319355370214112e-09
in O 0 1.6666534818909895e-09
infertility B-Disease 1 0.9982002973556519
and O 0 0.4799075424671173
congenital B-Disease 1 0.9999966621398926
myotonic I-Disease 1 0.9999983310699463
dystrophy I-Disease 1 0.9999966621398926
( O 0 5.111465029017381e-09
CDM B-Disease 0 1.450731247132353e-06
) O 0 8.936446027618672e-11
with O 0 1.0339573164666604e-12
the O 0 2.6088901004805987e-12
disappearance O 0 1.1731572158169001e-07
of O 0 8.724556493922009e-11
DM B-Disease 1 0.9999986886978149
in O 0 8.820380537066796e-11
that O 0 2.184510489167124e-10
pedigree O 0 6.232282885321183e-06
. O 0 3.5029301681532843e-10

The O 0 5.1346648287375896e-12
concept O 0 6.853271422579965e-12
of O 0 2.674836480781595e-12
segregation O 0 3.8386001932622094e-08
distortion O 0 1.4573289490726893e-06
, O 0 1.756165742342053e-12
where O 0 1.2577342867279434e-13
there O 0 4.620195209148969e-16
is O 0 1.026408479219633e-15
preferential O 0 2.3323595997799297e-14
transmission O 0 2.3946506999550365e-08
of O 0 6.714911393477998e-16
the O 0 7.316159837515452e-15
larger O 0 2.0783433550959586e-15
allele O 0 5.043687689720855e-11
at O 0 1.8452139816105273e-10
the O 0 1.1118066189919062e-10
DM B-Disease 1 0.9999988079071045
locus O 0 1.515089206804987e-05
, O 0 6.435088018008628e-10
has O 0 9.060603656241284e-11
been O 0 2.4956113564567062e-11
put O 0 9.131979894494435e-11
forward O 0 2.8687831190449264e-12
to O 0 3.620869446288588e-12
explain O 0 1.2065645704772976e-10
partially O 0 3.609633425494252e-10
the O 0 8.981771489752211e-13
maintenance O 0 4.678473164432262e-09
of O 0 4.408220316554079e-11
DM B-Disease 1 0.9999992847442627
in O 0 6.643317840282492e-12
the O 0 5.538464218496353e-12
population O 0 1.9350571492382507e-12
. O 0 8.758719444168506e-11

In O 0 1.3953294075719214e-10
a O 0 8.548060176361005e-11
survey O 0 1.2502386903534557e-09
of O 0 1.3165754944588492e-11
DM B-Disease 1 0.9999969005584717
in O 0 2.0620185559039328e-09
Northern O 0 2.596468595683632e-09
Ireland O 0 1.0658192195478478e-07
, O 0 1.204246511538054e-11
59 O 0 5.017196380574518e-11
pedigrees O 0 4.047043589139321e-09
were O 0 1.6151802118002934e-11
ascertained O 0 6.812203690031993e-09
. O 0 9.990474419963036e-11

Sibships O 0 4.259065099176951e-05
where O 0 2.2189337034461687e-09
the O 0 8.558199179713177e-13
status O 0 6.644872911458488e-13
of O 0 2.9180393453127895e-14
all O 0 1.704781335629818e-13
the O 0 2.8325161226944173e-13
members O 0 4.077685387157519e-14
had O 0 4.895612804034499e-10
been O 0 6.630886378172773e-12
identified O 0 2.9859313806224197e-12
were O 0 5.324718801730938e-14
examined O 0 3.8064739077761645e-13
to O 0 2.2943467092829354e-15
determine O 0 1.8141868216026147e-13
the O 0 1.4126286945748134e-13
transmission O 0 5.94278972698703e-08
of O 0 7.54998684014338e-14
the O 0 7.949107483362639e-10
DM B-Disease 1 0.9999991655349731
expansion O 0 9.991089067185044e-10
from O 0 8.522398932397923e-12
affected O 0 1.0905091933632871e-12
parents O 0 1.0450817186473393e-13
to O 0 3.957070267160759e-14
their O 0 5.0904714471444734e-12
offspring O 0 1.1686939194177626e-09
. O 0 6.526456458599839e-11

Where O 0 2.1298534047531348e-09
the O 0 5.9325166307244714e-12
transmitting O 0 1.5086788152984809e-05
parent O 0 7.944552748995193e-08
was O 0 2.832923939877219e-07
male O 0 2.3857595898846284e-09
, O 0 1.875768420797619e-12
58 O 0 1.88564219794074e-10
. O 0 5.8163650978881876e-11

3 O 0 1.5629996141797164e-07
% O 0 7.383379324599204e-11
of O 0 5.916148376316349e-14
the O 0 3.778950676686099e-12
offspring O 0 1.3574733559451602e-09
were O 0 2.6884755532918803e-10
affected O 0 2.3803376804354404e-12
, O 0 6.064367215861954e-13
and O 0 1.9738445253270065e-11
in O 0 3.0417918075835437e-13
the O 0 2.7514299432568334e-12
case O 0 3.228747824657319e-11
of O 0 1.024777644334637e-14
a O 0 2.196915219188078e-11
female O 0 8.330117151622574e-10
transmitting O 0 4.826728400075808e-06
parent O 0 8.781055327311549e-10
, O 0 9.130316945202277e-13
68 O 0 3.811267412778818e-10
. O 0 6.915541056473629e-11

7 O 0 2.961679115287552e-07
% O 0 1.263058824196861e-10
were O 0 3.166479578542436e-11
affected O 0 3.2959038276381136e-11
. O 0 6.226601872993953e-11

Studies O 0 1.4276477222630035e-10
on O 0 3.243586649270824e-11
meiotic O 0 4.2707668512775854e-07
drive O 0 1.6032206531235715e-06
in O 0 4.982987633628255e-11
DM B-Disease 1 0.999995231628418
have O 0 8.061884493315574e-10
shown O 0 2.944084212530562e-11
increased O 0 2.0251371922724165e-14
transmission O 0 9.580757298621734e-10
of O 0 5.126453566833063e-16
the O 0 2.041931822737396e-14
larger O 0 1.7054796634728524e-14
allele O 0 5.7295231059573126e-11
at O 0 1.0261214100637517e-10
the O 0 6.891602566394539e-11
DM B-Disease 1 0.9999958276748657
locus O 0 3.22259643326106e-06
in O 0 8.588639521800445e-11
non O 0 4.496720773516927e-09
- O 0 0.004120714962482452
DM O 1 0.9999903440475464
heterozygotes O 0 6.969869446038501e-07
for O 0 8.145728883079961e-12
CTGn O 0 1.6824021713546244e-06
. O 0 1.5848289347530908e-10

This O 0 5.846630124484165e-11
study O 0 1.2780892338394578e-13
provides O 0 2.1050253164509427e-15
further O 0 1.9283300084889593e-15
evidence O 0 2.213011946004123e-13
that O 0 1.2132881505033666e-12
the O 0 5.4670344640239676e-11
DM B-Disease 1 0.999998927116394
expansion O 0 2.9125306610922053e-09
tends O 0 4.6052087143699794e-10
to O 0 4.402239274611981e-14
be O 0 7.092262974822683e-13
transmitted O 0 2.3716143715546423e-08
preferentially O 0 2.792600994894201e-08
. O 0 7.325924866741218e-10

Diagnosis O 0 0.005800606682896614
of O 0 2.9042453775218746e-07
hemochromatosis B-Disease 1 0.9993670582771301
. O 0 3.1924143968353746e-06

If O 0 1.1266544788668398e-05
untreated O 0 0.11714035272598267
, O 0 1.4487942507912521e-06
hemochromatosis B-Disease 1 0.9999970197677612
can O 0 0.028609704226255417
cause O 0 0.00034840768785215914
serious O 0 0.0010255890665575862
illness O 0 0.12621502578258514
and O 0 4.058559321951094e-10
early B-Disease 0 2.628241235758111e-10
death I-Disease 0 3.246194921757706e-07
, O 0 1.106871712341917e-11
but O 0 2.582287994545851e-10
the O 0 3.772646084421183e-10
disease O 0 2.0259449229342863e-06
is O 0 1.8165259227376218e-11
still O 0 2.1592579113605126e-10
substantially O 0 3.716104923778829e-10
under O 0 3.2560037999118663e-10
- O 0 0.08905288577079773
diagnosed O 0 0.14220334589481354
. O 0 2.090647210906127e-09

The O 0 3.8752733660940564e-11
cornerstone O 0 1.9263874939667858e-09
of O 0 1.222583639144334e-14
screening O 0 1.5991931086659084e-12
and O 0 1.0801669888399479e-12
case O 0 2.098836343166887e-14
detection O 0 6.297906206959025e-12
is O 0 2.4919926148656013e-14
the O 0 8.624489468943286e-15
measurement O 0 1.1432117474896586e-09
of O 0 1.7699284691943123e-13
serum O 0 8.596895639811919e-08
transferrin O 0 6.709315325537091e-09
saturation O 0 8.868941137052389e-09
and O 0 2.262670259489674e-11
the O 0 2.9233345345131e-12
serum O 0 2.616884842154832e-07
ferritin O 0 6.018118483552826e-07
level O 0 2.1335928857002529e-10
. O 0 4.6253386537520313e-11

Once O 0 1.61517380092846e-06
the O 0 2.1199064725863082e-10
diagnosis O 0 2.7690205683938984e-07
is O 0 1.1355219715902809e-11
suspected O 0 1.3498059558969544e-08
, O 0 3.4048200999066414e-13
physicians O 0 6.466289499294439e-14
must O 0 2.6025258405043723e-14
use O 0 1.0360118253734119e-13
serum O 0 3.770485079712671e-07
ferritin O 0 0.00017089997709263116
levels O 0 5.357415844287061e-08
and O 0 4.592984836904179e-08
hepatic O 0 0.0505434051156044
iron O 0 0.0001020336858346127
stores O 0 3.034532980450422e-08
on O 0 4.4246448283047357e-07
liver O 0 0.0001291581429541111
biopsy O 0 2.262099224026315e-05
specimens O 0 1.4593481978408818e-09
to O 0 1.5733081504265556e-11
assess O 0 8.147566649130411e-11
patients O 0 2.770382230912749e-12
for O 0 4.115830923014053e-15
the O 0 4.793394956133235e-13
presence O 0 7.289806258636844e-11
of O 0 3.571969803273234e-11
iron B-Disease 0 0.004998768679797649
overload I-Disease 0 4.3297313823131844e-05
. O 0 5.029539562606544e-10

Liver O 1 0.9973427653312683
biopsy O 0 0.08892408013343811
is O 0 1.5770689643090918e-08
also O 0 1.0495138785815428e-10
used O 0 4.054292058325304e-12
to O 0 1.7838509803417418e-13
establish O 0 2.9393122050885845e-13
the O 0 1.2067981162988684e-12
presence O 0 2.4382424898550248e-11
or O 0 9.799165645585362e-11
absence O 0 2.9931990219722593e-10
of O 0 8.417794239434784e-12
cirrhosis B-Disease 0 0.0012902508024126291
, O 0 4.3616603384588615e-11
which O 0 9.880675444495779e-11
can O 0 3.140665227885364e-10
affect O 0 3.3037478308628465e-10
prognosis O 0 4.0078006691146584e-07
and O 0 4.865115948993193e-11
management O 0 8.392664896383906e-10
. O 0 1.492263396185578e-10

A O 0 6.163625720922994e-10
DNA O 0 5.9381295436367054e-09
- O 0 1.1845113334629787e-08
based O 0 7.998391012009609e-12
test O 0 1.4456727481793052e-10
for O 0 1.4587149313777963e-15
the O 0 2.6949078277098415e-14
HFE O 0 1.363951285249243e-09
gene O 0 5.910571945072496e-12
is O 0 8.706999795368275e-15
commercially O 0 5.137953864448042e-13
available O 0 9.823258742894247e-13
, O 0 1.4119203039803657e-13
but O 0 2.9767066090681527e-13
its O 0 3.0982145017913187e-13
place O 0 4.308420634147048e-11
in O 0 6.460064145945299e-14
the O 0 1.0714263677658042e-11
diagnosis O 0 1.3144770036888076e-06
of O 0 4.610235526669726e-10
hemochromatosis B-Disease 1 0.9999996423721313
is O 0 2.943269095112555e-08
still O 0 3.468610398904559e-10
being O 0 1.8188488909443024e-11
evaluated O 0 1.9962749508994904e-10
. O 0 6.48009007564454e-11

Currently O 0 9.666390354823307e-09
, O 0 1.835856553583648e-12
the O 0 2.240232103623463e-15
most O 0 3.29376517185258e-16
useful O 0 3.8445652335240745e-15
role O 0 1.188690937131351e-13
for O 0 1.3094511030499988e-14
this O 0 9.063856978332174e-14
test O 0 2.1805172251143645e-11
is O 0 3.904810451897537e-15
in O 0 7.638476943890276e-17
the O 0 1.195041854644592e-14
detection O 0 3.569500917066648e-09
of O 0 3.448534860450714e-11
hemochromatosis B-Disease 1 0.9999996423721313
in O 0 1.0167543196271112e-10
the O 0 2.803179216526175e-11
family O 0 1.1462335525180833e-09
members O 0 2.4215769024878674e-14
of O 0 3.1402994354196023e-14
patients O 0 6.842622714102464e-13
with O 0 1.4872712707659358e-13
a O 0 1.0670986663741111e-11
proven O 0 8.03141233518545e-08
case O 0 1.9755658914322183e-11
of O 0 8.632591847303542e-14
the O 0 1.3317507097099224e-09
disease O 0 1.0068918072647648e-06
. O 0 4.511942763851806e-10

It O 0 2.5951502058418896e-10
is O 0 1.5179283611305161e-12
crucial O 0 1.6994392004754388e-11
to O 0 9.155319280473861e-10
diagnose O 1 0.9185370802879333
hemochromatosis B-Disease 1 0.9999951124191284
before O 0 0.10342424362897873
hepatic B-Disease 1 0.9999512434005737
cirrhosis I-Disease 1 0.9998325109481812
develops O 0 4.042914952151477e-05
because O 0 8.128234973980852e-09
phlebotomy O 0 5.459729436552152e-05
therapy O 0 6.275953182921512e-06
can O 0 4.4869480575471243e-07
avert O 0 0.003087486606091261
serious O 1 0.7997432947158813
chronic O 1 0.9999715089797974
disease O 1 0.5795347690582275
and O 0 1.0554614959801256e-07
can O 0 1.7879431268852386e-08
even O 0 5.053967466750464e-09
lead O 0 8.87838922380979e-08
to O 0 1.8758669617646717e-10
normal O 0 7.250374189915476e-10
life O 0 1.1268116217877377e-08
expectancy O 0 2.3499961088191412e-08
. O 0 3.5057872403709833e-12
. O 0 8.392436745552345e-11

Prevalence O 0 2.0571467757690698e-05
of O 0 5.844427589454804e-13
the O 0 1.0723131367226801e-12
I1307K O 0 4.117073904019719e-10
APC B-Disease 0 7.830272541475836e-10
gene O 0 1.5918917295465462e-09
variant O 0 8.173307008974007e-08
in O 0 7.1128580456103485e-12
Israeli O 0 2.3392371417685354e-07
Jews O 0 1.65653735173521e-09
of O 0 1.9875401102492293e-14
differing O 0 4.1656877600160236e-12
ethnic O 0 9.174504038422793e-12
origin O 0 3.4886077360241075e-10
and O 0 5.613000730875228e-09
risk O 0 7.014039482555745e-08
for O 0 1.2041082797509262e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999958276748657
. O 0 2.7498626309352403e-07

BACKGROUND O 0 7.195122179837199e-06
& O 0 5.9083231462864205e-06
AIMS O 0 1.7556333276047553e-08
Israeli O 0 2.5629924493841827e-07
Jews O 0 7.57570077780656e-08
of O 0 5.4414814668057865e-12
European O 0 2.973381763027305e-09
birth O 0 2.480684990757709e-08
, O 0 7.989273305419875e-12
i O 0 3.6078162679586967e-10
. O 0 4.149078744962974e-14
e O 0 1.3121782306557694e-11
. O 0 2.1318283781063957e-13
, O 0 7.886343623498063e-14
Ashkenazim O 0 3.936032055840144e-10
, O 0 5.0052599868607994e-14
have O 0 3.4824085889256784e-12
the O 0 1.4832961248156806e-10
highest O 1 0.5256357789039612
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.1651715189218521
of O 0 4.871461849360881e-13
any O 0 1.3283745848094441e-12
Israeli O 0 5.981556228107365e-07
ethnic O 0 8.119336869505389e-10
group O 0 2.6367548144889952e-08
. O 0 8.318034594445578e-10

The O 0 8.656050876076904e-11
I1307K O 0 3.4792138059458466e-09
APC B-Disease 0 1.631041746108508e-09
gene O 0 2.343750526989652e-09
variant O 0 1.3693892242372385e-06
was O 0 8.357643309864216e-06
found O 0 1.2957852568717954e-08
in O 0 6.4020516318819e-12
6 O 0 3.42586137236367e-09
. O 0 5.864222996088131e-10

1 O 0 3.987395658100468e-08
% O 0 3.5632597567003543e-11
of O 0 2.635655501357151e-14
American O 0 3.182506688736986e-11
Jews O 0 2.1396162619424786e-10
, O 0 8.357301938162476e-13
28 O 0 2.179339391242263e-12
% O 0 2.2666394145453e-15
of O 0 8.970993707006075e-15
their O 0 2.098560116792214e-06
familial O 1 0.999993085861206
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cases O 0 3.0173805498634465e-07
, O 0 2.440522089974806e-11
but O 0 1.1825777856966369e-10
not O 0 1.0799578592513015e-10
in O 0 2.9284463309159348e-12
non O 0 1.2510371905083417e-10
- O 0 4.444506885192823e-06
Jews O 0 1.5236233252835518e-07
. O 0 1.7192143264566084e-09

We O 0 2.528572351501168e-10
assessed O 0 8.95302929015962e-11
the O 0 1.7191888104090003e-12
I1307K O 0 8.027288167511415e-09
prevalence O 0 1.1309348337817937e-06
in O 0 7.272370639715975e-13
Israeli O 0 4.640101991526535e-08
Jews O 0 1.1466468885501513e-09
of O 0 1.508946674479584e-14
differing O 0 2.032906612145502e-12
ethnic O 0 3.735437740376435e-12
origin O 0 1.9814426488462544e-10
and O 0 2.039433955047798e-09
risk O 0 8.440077436944193e-08
for O 0 1.4156525951491972e-09
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999959468841553
. O 0 2.215072640865401e-07

METHODS O 0 1.803958787904847e-10
DNA O 0 2.6593047763867617e-09
samples O 0 9.823666324848546e-10
from O 0 5.919774219431684e-13
500 O 0 8.038456510671421e-13
unrelated O 0 3.3836922846974815e-11
Jews O 0 1.6349225306910853e-09
of O 0 1.8904873326508476e-12
European O 0 4.465448011359285e-09
or O 0 1.8511264743281686e-09
non O 0 1.078163253120934e-10
- O 0 4.037493113173696e-07
European O 0 4.3886858591690725e-09
origin O 0 4.0586808219833514e-11
, O 0 9.485103674711226e-13
with O 0 1.6062139411490012e-13
or O 0 2.1552850650030653e-12
without O 0 3.048866768860098e-13
a O 0 4.156312609620433e-13
personal O 0 3.318529451235008e-08
and O 0 3.149732918927839e-08
/ O 0 1.0445865683550437e-07
or O 0 3.5515450580447805e-09
family O 0 3.6295180194656496e-09
history O 0 2.192972609060817e-10
of O 0 1.7311563424091125e-12
neoplasia B-Disease 0 4.1269103689955955e-07
, O 0 1.4482379054672756e-12
were O 0 4.454389060295355e-13
examined O 0 2.1551699227323473e-12
for O 0 1.2205420779832143e-15
the O 0 1.5089588378727065e-13
I1307K O 0 7.226912818181219e-11
variant O 0 7.43277731030112e-11
by O 0 2.1844434220470374e-14
the O 0 6.199822420857246e-14
allele O 0 1.5173142742241907e-09
- O 0 4.733537450896108e-10
specific O 0 7.1809884427676e-12
oligonucleotide O 0 7.763272878946736e-05
( O 0 4.031614972421771e-11
ASO O 0 5.324153335095616e-06
) O 0 7.963052960080486e-14
method O 0 2.748146762238113e-12
. O 0 5.7655349244845056e-11

RESULTS O 0 4.5197680265118834e-08
In O 0 8.316943596493875e-13
persons O 0 5.6124938409892605e-14
at O 0 6.229750049158156e-11
average O 0 7.281319436280853e-10
risk O 0 6.630393301065851e-08
for O 0 5.064455308456672e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
, O 0 6.726523782418781e-09
I1307K O 0 6.948576380949589e-09
was O 0 5.8344181042002674e-08
found O 0 6.235055249881327e-10
in O 0 2.1546273879652356e-12
5 O 0 1.9379915727757435e-10
. O 0 3.9892175673905683e-10

0 O 0 1.3917829733145481e-07
% O 0 3.400786596774452e-11
of O 0 5.957877285056243e-14
120 O 0 6.525656317396544e-12
European O 0 1.6082243869952606e-10
and O 0 5.060628305297854e-11
1 O 0 3.4904031054328044e-11
. O 0 7.877621471807927e-11

6 O 0 7.198033102895351e-08
% O 0 9.308039582156535e-12
of O 0 6.041793177953905e-14
188 O 0 6.243013050966084e-11
non O 0 4.5415813471061384e-11
- O 0 4.326917405705899e-06
European O 0 3.3017548162206367e-07
Jews O 0 4.8430511156993816e-08
( O 0 1.0559583806316053e-12
P O 0 2.421871272417775e-07
= O 0 1.8823156366920557e-09
0 O 0 1.0104372850580634e-12
. O 0 2.391955990915795e-13
08 O 0 5.587441967436213e-12
) O 0 2.7291539254209463e-12
. O 0 1.8183007183258937e-11

It O 0 4.099124595313697e-09
occurred O 0 1.9708596976641957e-09
in O 0 7.573254631916548e-13
15 O 0 3.38190517257253e-11
. O 0 5.5974929552560226e-11

4 O 0 5.1090797370534347e-08
% O 0 1.1920386552843887e-11
of O 0 5.042169616943995e-14
52 O 0 7.76178288308671e-10
Ashkenazi O 0 5.556088126468239e-06
Israelis O 0 4.171707041678019e-05
with O 0 5.606615616216004e-08
familial O 0 0.17687183618545532
cancer B-Disease 1 0.8728301525115967
( O 0 1.3820732336355945e-09
P O 0 0.0001884307712316513
= O 0 8.71663488055674e-08
0 O 0 4.282114593467945e-11
. O 0 2.008173662082502e-11
02 O 0 1.398760218762618e-08
) O 0 1.0212434196910092e-11
and O 0 2.5015732540989433e-11
was O 0 5.2392614691143535e-09
not O 0 1.3189934387758395e-11
detected O 0 1.5889765059284855e-09
in O 0 5.401996666827558e-13
51 O 0 2.3062732279477416e-10
non O 0 6.946144354147421e-11
- O 0 6.133188321655325e-07
European O 0 2.931581910559089e-08
Jews O 0 2.015958733281309e-09
at O 0 5.656394796993425e-10
increased O 0 2.000382672007195e-11
cancer B-Disease 0 6.260371776534157e-08
risk O 0 8.570238740901459e-09
. O 0 7.8392653479753e-11

Colorectal B-Disease 0 0.2630769908428192
neoplasia I-Disease 0 0.11529557406902313
occurred O 0 3.211433067917824e-05
personally O 0 1.9279050320619717e-06
or O 0 5.872285324670656e-09
in O 0 1.8633946382434763e-12
the O 0 4.069003380763325e-12
families O 0 1.0422024354639348e-11
of O 0 7.459262665822277e-15
13 O 0 1.0462749373482683e-12
of O 0 6.015354399758078e-15
20 O 0 3.577809706487023e-13
Ashkenazi O 0 8.232392545437506e-10
I1307K O 0 1.5729900021410614e-11
carriers O 0 4.13154997410195e-13
, O 0 8.191245668949867e-14
8 O 0 1.2217876450143494e-12
of O 0 8.50293820813322e-14
whom O 0 4.752018778475531e-10
also O 0 5.963687876864299e-10
had O 0 3.0499737846412245e-08
a O 0 6.230071319945907e-11
personal O 0 8.094084478216246e-07
or O 0 8.375850057973366e-08
family O 0 4.174079037966294e-08
history O 0 1.0571407083048712e-09
of O 0 3.409827628586548e-11
noncolonic O 0 0.0003254324255976826
neoplasia B-Disease 0 4.979828008799814e-05
. O 0 2.449642044766165e-09

CONCLUSIONS O 0 4.1314951459980875e-09
The O 0 1.8338521673433306e-11
I1307K O 0 2.2995145787518823e-09
APC O 0 4.837493605691634e-08
variant O 0 3.1670523981119914e-07
may O 0 1.919052916576902e-09
represent O 0 1.852922265084935e-15
a O 0 2.3586118952020896e-13
susceptibility O 0 7.858221295897749e-10
gene O 0 1.581976682984987e-08
for O 0 3.807244297604484e-09
colorectal B-Disease 1 0.9999997615814209
, I-Disease 0 2.1208833800301363e-08
or I-Disease 0 8.378925331342657e-10
other I-Disease 0 1.846460206955669e-10
, I-Disease 0 1.1799789589872489e-08
cancers I-Disease 0 0.00042388233123347163
in O 0 9.440928594450781e-11
Ashkenazi O 0 0.00017193560779560357
Jews O 0 7.04150409092108e-07
, O 0 2.701129875326558e-10
and O 0 2.516885033720939e-10
partially O 0 1.1059221804998742e-07
explains O 0 8.124479422555453e-10
the O 0 1.7233221143511668e-12
higher O 0 2.431515211398505e-09
incidence O 0 0.0013636791845783591
of O 0 2.5974341042456217e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
in O 0 3.970318740442735e-09
European O 0 1.5012346921139397e-08
Israelis O 0 5.306629191181855e-06
. O 0 2.481232552753454e-09

Systematic O 0 1.9541352980212423e-09
analysis O 0 1.7264394081006884e-10
of O 0 2.896272848287862e-12
coproporphyrinogen O 0 8.328785952471662e-06
oxidase O 0 3.157991386615322e-06
gene O 0 0.005338359158486128
defects O 1 0.9998216032981873
in O 0 4.8680908193432515e-09
hereditary B-Disease 1 0.7275809049606323
coproporphyria I-Disease 0 0.010267009027302265
and O 0 1.3104537455177478e-09
mutation O 0 1.2689924666631214e-09
update O 0 1.0843372422186803e-07
. O 0 7.206300889350814e-09

Hereditary B-Disease 1 0.9992088675498962
coproporphyria I-Disease 1 0.9939796924591064
( O 0 9.930018052273226e-08
HC B-Disease 0 0.05696142464876175
) O 0 2.2649620845527352e-08
is O 0 1.8202596097083301e-09
an O 0 2.7398620261465112e-08
acute O 1 0.9936239719390869
hepatic B-Disease 1 0.9999841451644897
porphyria I-Disease 1 0.9999746084213257
with O 0 0.0002079354162560776
autosomal O 1 0.9999394416809082
dominant O 1 0.5220099687576294
inheritance O 0 0.2557612955570221
caused O 0 0.00033544664620421827
by O 0 1.9504106663070786e-10
deficient B-Disease 0 6.668894002359593e-06
activity I-Disease 0 3.2524118953602965e-09
of I-Disease 0 9.035799018730639e-12
coproporphyrinogen I-Disease 0 7.591090979985893e-05
III I-Disease 0 0.004863289184868336
oxidase I-Disease 0 3.242483444410027e-06
( O 0 9.856069953240176e-12
CPO O 0 3.7805236274834897e-07
) O 0 1.261943240876695e-11
. O 0 1.5672728739812847e-11

Clinical O 0 4.058980721310945e-06
manifestations O 0 3.719499090948375e-06
of O 0 2.6738086744693135e-10
the O 0 5.541370740047569e-08
disease O 0 3.540564648574218e-05
are O 0 1.9191315203670456e-11
characterized O 0 5.59110668874041e-09
by O 0 3.938397385994108e-10
acute O 0 7.2185507633548696e-06
attacks O 0 0.0005655004060827196
of O 0 1.6927283752465883e-07
neurological B-Disease 1 0.9999268054962158
dysfunction I-Disease 0 0.12283427268266678
often O 0 7.02946820752004e-08
precipitated O 0 2.732097037494441e-08
by O 0 1.408142482825503e-12
drugs O 0 2.5631502476031187e-10
, O 0 1.2059099378791682e-12
fasting O 0 6.188696666242777e-09
, O 0 3.993857328188355e-12
cyclical O 0 2.991307468391824e-08
hormonal O 0 3.839626003809826e-07
changes O 0 7.160080861545737e-11
, O 0 3.0471142969945575e-11
or O 0 3.294160055844486e-09
infectious B-Disease 0 0.00018791544425766915
diseases I-Disease 0 4.9691167077980936e-05
. O 0 3.781083002252217e-09

Skin O 1 0.9997772574424744
photosensitivity O 1 0.9961579442024231
may O 0 9.717350621940568e-06
also O 0 5.009960224455767e-10
be O 0 1.403576647268645e-11
present O 0 7.939205716456232e-12
. O 0 1.5969452149544594e-10

The O 0 3.5087592553662006e-11
seven O 0 7.916282213082937e-12
exons O 0 4.425672273100645e-09
, O 0 1.195243665326473e-12
the O 0 1.7408238750255683e-13
exon O 0 3.8709044858364905e-09
/ O 0 3.6487611509983253e-07
intron O 0 8.074118522927165e-05
boundaries O 0 5.085464138687712e-08
and O 0 3.414157290215769e-10
part O 0 1.3001192733074624e-13
of O 0 3.063222147724892e-14
3 O 0 5.632016554513175e-12
noncoding O 0 6.895734538936438e-10
sequence O 0 5.869804642344434e-11
of O 0 3.0438569416715855e-14
the O 0 6.835734777700664e-13
CPO O 0 1.0144192152949927e-08
gene O 0 8.573005153000857e-12
were O 0 2.3341097392555465e-13
systematically O 0 3.33021193954508e-10
analyzed O 0 7.82026526868762e-12
by O 0 2.4275320523268334e-15
an O 0 7.729528009401548e-15
exon O 0 2.993644221405134e-10
- O 0 7.645796884503397e-09
by O 0 3.894464958853483e-11
- O 0 4.900578431943359e-08
exon O 0 6.286276743594499e-07
denaturing O 0 0.010387539863586426
gradient O 0 0.001219730474986136
gel O 0 0.019795788452029228
electrophoresis O 0 0.00022051823907531798
( O 0 8.151856273341807e-11
DGGE O 0 5.330364842848212e-07
) O 0 2.8983616721933725e-12
strategy O 0 7.915844195405253e-12
followed O 0 3.431084152146109e-14
by O 0 2.9239277486246397e-18
direct O 0 2.008765104193175e-17
sequencing O 0 6.8979774149602324e-12
in O 0 3.7368892702449585e-13
seven O 0 8.646772534093294e-12
unrelated O 0 1.2700192009162947e-09
heterozygous O 0 9.70489395513141e-08
HC B-Disease 0 0.00029701966559514403
patients O 0 1.5414325815754637e-08
from O 0 1.061524756984511e-10
France O 0 1.0431828911805496e-07
, O 0 1.1583119879921e-10
Holland O 0 6.75208013944939e-07
, O 0 1.6807787106554173e-10
and O 0 1.8659938039178314e-09
Czech O 0 3.79253407345459e-07
Republic O 0 5.059772045790112e-10
. O 0 2.926506259548489e-10

Seven O 0 2.4286057609401723e-08
novel O 0 5.516101353464364e-09
mutations O 0 4.472183690040765e-08
and O 0 1.3041895341459053e-10
two O 0 9.27339043228781e-13
new O 0 1.677887863371641e-12
polymorphisms O 0 1.433037422060579e-08
were O 0 4.189228963724645e-10
detected O 0 8.212091273662736e-08
. O 0 6.853984602095409e-10

Among O 0 1.3543588472941792e-10
these O 0 2.1674710637409333e-12
mutations O 0 4.2821815537941177e-10
two O 0 1.0129101724043466e-10
are O 0 5.29449487723932e-12
missense O 0 1.1249134068691546e-08
( O 0 4.526606682802442e-13
G197W O 0 2.2781657116333065e-10
, O 0 2.307745140817108e-12
W427R O 0 1.7029216925479318e-10
) O 0 4.268884724878408e-12
, O 0 1.0408901252858746e-13
two O 0 7.1253502230417265e-12
are O 0 1.1557955113816742e-11
nonsense O 0 4.679100129578728e-08
( O 0 1.1413483514148472e-14
Q306X O 0 6.285632431213273e-11
, O 0 1.6111700732249212e-12
Q385X O 0 4.684700891099958e-11
) O 0 1.0285344624605397e-12
, O 0 2.1191178694625334e-14
two O 0 2.0848886582002651e-13
are O 0 1.8876318964942268e-14
small O 0 2.861555800258084e-14
deletions O 0 3.1109639309079284e-09
( O 0 3.243948349957587e-13
662de14bp O 0 1.5516965490292023e-10
; O 0 4.82337585670789e-13
1168del3bp O 0 1.2481175815093337e-10
removing O 0 3.3543374241412627e-12
a O 0 9.349095662133239e-14
glycine O 0 6.69860944491063e-10
at O 0 3.812721527385321e-10
position O 0 3.0787561389189477e-10
390 O 0 9.191112454454142e-11
) O 0 1.92008258251275e-12
, O 0 2.38969868199268e-13
and O 0 5.116244342247278e-13
one O 0 8.347516471454708e-14
is O 0 8.225341286175695e-15
a O 0 5.064007227467042e-15
splicing O 0 1.3704268830849742e-08
mutation O 0 9.989816973643428e-09
( O 0 1.986017822636424e-13
IVS1 O 0 2.4502421069882985e-07
- O 0 3.502492518236977e-08
15c O 0 9.763243546956346e-09
- O 0 6.931409757271467e-07
- O 0 3.0314433388412e-05
> O 0 2.7211861208797927e-08
g O 0 1.5961238659656374e-06
) O 0 9.991555326160917e-12
which O 0 9.131030350231772e-13
creates O 0 4.495723590495007e-14
a O 0 4.2192091766440724e-15
new O 0 1.9463744784192598e-14
acceptor O 0 1.1749396594540329e-11
splice O 0 5.466622496896889e-06
site O 0 1.6130280755533022e-06
. O 0 1.0226343105657065e-09

The O 0 4.1985639964714494e-10
pathological O 0 7.062888940367884e-09
significance O 0 4.91299015359381e-11
of O 0 5.340178847084223e-14
the O 0 5.084804539229326e-12
point O 0 4.0062007045094106e-09
mutations O 0 6.816498754336209e-11
G197W O 0 7.65869104246697e-11
, O 0 5.33648537685838e-13
W427R O 0 5.7941977604780703e-11
, O 0 3.7429456235804626e-13
and O 0 8.677233736230361e-13
the O 0 4.82104861674465e-13
in O 0 4.889057474838365e-12
- O 0 1.1037816420866875e-06
frame O 0 0.0013823957415297627
deletion O 0 1.3000065735013777e-07
390delGly O 0 2.2798880561225587e-09
were O 0 1.019839594718075e-12
assessed O 0 1.200333777685858e-12
by O 0 9.740186867506547e-15
their O 0 5.3019121211417275e-12
respective O 0 3.508083060155265e-11
expression O 0 8.086937369755631e-11
in O 0 9.334734049105953e-14
a O 0 1.8823691791489822e-13
prokaryotic O 0 7.056626875716343e-13
system O 0 2.8223682072003875e-12
using O 0 2.551284379072316e-13
site O 0 3.28656613035605e-09
- O 0 5.0574321619478724e-08
directed O 0 1.736613164382561e-08
mutagenesis O 0 6.895846382803938e-08
. O 0 1.248553205268621e-10

These O 0 8.066541185014486e-11
mutations O 0 1.56144199792152e-08
resulted O 0 4.77515360586267e-09
in O 0 4.226109913407772e-12
the O 0 4.15916997023591e-12
absence O 0 8.902760473272764e-11
or O 0 8.901669332206374e-12
a O 0 2.970950742364753e-12
dramatic O 0 3.3384670028446806e-10
decrease O 0 1.5451753765383103e-10
of O 0 7.673549973609764e-14
CPO O 0 7.375169843726326e-07
activity O 0 5.325765939367955e-10
. O 0 4.267967229631964e-11

The O 0 1.7844075175799112e-11
two O 0 2.48050972123659e-12
polymorphisms O 0 1.6334334773659975e-08
were O 0 3.0302269027338014e-10
localized O 0 6.936261343071237e-09
in O 0 1.2582331010424497e-10
noncoding O 0 3.2322932952411065e-07
part O 0 7.872631366256932e-12
of O 0 2.391197388208234e-14
the O 0 7.381678005392162e-14
gene O 0 1.1333236432653493e-11
1 O 0 4.931414976892812e-13
) O 0 1.9620479760752534e-14
a O 0 3.3032325247490946e-13
C O 0 4.9224313514173446e-09
/ O 0 1.2833535345535552e-09
G O 0 3.2820676665323845e-07
polymorphism O 0 7.108701405300621e-10
in O 0 1.6864922002327032e-13
the O 0 3.641590338738371e-13
promotor O 0 2.4799427933430707e-07
region O 0 1.5284374460522443e-11
, O 0 8.941240488887642e-14
142 O 0 3.997584381576491e-12
bp O 0 2.247763530860425e-09
upstream O 0 9.700271835777485e-11
from O 0 6.122472303850225e-15
the O 0 2.1752444007178834e-16
transcriptional O 0 1.914418059842382e-12
initiation O 0 6.13117304322508e-13
site O 0 5.032111394243088e-10
( O 0 1.550708109284652e-14
- O 0 1.3817043065245116e-09
142C O 0 3.4516771663106738e-09
/ O 0 5.403511860180288e-09
G O 0 7.945340740889151e-08
) O 0 1.7292379550851167e-13
, O 0 1.4386746188897043e-14
and O 0 7.419762639579788e-14
2 O 0 2.2702892625743598e-13
) O 0 7.043347465863787e-15
a O 0 2.972166444708234e-14
6 O 0 2.639426220987784e-12
bp O 0 1.1612546479966568e-09
deletion O 0 1.0270612832430359e-10
polymorphism O 0 7.890538222810051e-11
in O 0 6.522937707554091e-14
the O 0 1.2908588043966662e-12
3 O 0 1.5364851058130569e-10
noncoding O 0 1.0078005097113873e-08
part O 0 6.660188351347018e-13
of O 0 7.062827106068268e-15
the O 0 1.5482882716796181e-13
CPO O 0 1.8642967170023894e-09
gene O 0 4.85192658619682e-12
, O 0 5.609454686774512e-14
574 O 0 7.15333764444992e-11
bp O 0 3.6011904569477338e-09
downstream O 0 5.877043851576502e-10
of O 0 2.6835055783936725e-14
the O 0 1.7280189865825912e-12
last O 0 1.4626413968876761e-10
base O 0 3.053056668155668e-13
of O 0 1.0764220689858553e-15
the O 0 8.069206517162184e-14
normal O 0 2.172611699921556e-12
termination O 0 4.446125759227648e-11
codon O 0 5.24689666714373e-11
( O 0 1.2690309957388846e-13
+ O 0 9.286874602665307e-10
574 O 0 2.700669021749036e-08
delATTCTT O 0 3.286963590198866e-07
) O 0 4.192696190230549e-11
. O 0 4.752669091612205e-11

Five O 0 1.8470821316896036e-08
intragenic O 0 2.1934989490546286e-05
dimorphisms O 0 3.6218840250512585e-05
are O 0 9.822256896718784e-11
now O 0 1.6339700426026837e-11
well O 0 3.884551534605318e-12
characterized O 0 5.273345649037253e-10
and O 0 1.3154057704189981e-11
the O 0 2.645679628068137e-13
high O 0 2.2961911538832425e-10
degree O 0 8.096421211419014e-13
of O 0 1.492117993290125e-14
allelic O 0 2.8273239305320885e-09
heterogeneity O 0 4.2043062364882644e-08
in O 0 7.480924768543673e-10
HC B-Disease 0 0.0007110893493518233
is O 0 6.499416005389946e-10
demonstrated O 0 1.684292844084112e-10
with O 0 5.379058201464282e-13
seven O 0 3.747874677707125e-13
new O 0 1.3628140093204302e-14
different O 0 4.879119416839215e-15
mutations O 0 2.613402333082049e-12
making O 0 1.0075423026272012e-13
a O 0 9.792835894409033e-14
total O 0 2.321383916255998e-14
of O 0 1.4707847908871675e-14
nineteen O 0 2.1260575244763658e-10
CPO O 0 0.00034328229958191514
gene B-Disease 0 0.00010581592505332083
defects I-Disease 1 0.8870345950126648
reported O 0 2.078227900881302e-08
so O 0 2.4155285410776273e-11
far O 0 8.690289807211649e-12
. O 0 2.8734597166957254e-12
. O 0 6.400992236255121e-11

Coincidence O 0 7.314842509487107e-09
of O 0 1.1554973557842407e-12
two O 0 1.5694176860869824e-11
novel O 0 3.5933531150611486e-10
arylsulfatase O 0 4.1733784428288345e-08
A O 0 1.7175540503733266e-11
alleles O 0 1.3310846869174497e-10
and O 0 6.432703675285367e-11
mutation O 0 1.9434849563015888e-10
459 O 0 3.576206664135384e-09
+ O 0 9.012387280904477e-09
1G O 0 6.35065907772514e-06
> O 0 1.3063218951003819e-08
A O 0 1.0474200673460388e-10
within O 0 4.4962660981570646e-13
a O 0 9.802829381566625e-11
family O 0 8.186239028873388e-07
with O 0 2.618912049001665e-06
metachromatic B-Disease 1 0.9999967813491821
leukodystrophy I-Disease 1 0.9999921321868896
: O 0 1.0464007048002766e-12
molecular O 0 1.7424825688241996e-12
basis O 0 1.0463503029517832e-13
of O 0 5.438176493323399e-14
phenotypic O 0 8.794678180157334e-11
heterogeneity O 0 1.318489580626192e-06
. O 0 1.1234900654244484e-07

In O 0 1.6215869758084978e-09
a O 0 1.990021203379655e-10
family O 0 1.1007421640840676e-09
with O 0 1.0203128272823214e-11
three O 0 7.619758296550927e-11
siblings O 0 4.835885469844925e-09
, O 0 6.420633068184717e-14
one O 0 1.8256419596560103e-13
developed O 0 1.9673648127271903e-11
classical O 0 4.685161147932604e-09
late O 0 1.7816946638049558e-05
infantile O 1 0.9998757839202881
metachromatic B-Disease 1 0.9999947547912598
leukodystrophy I-Disease 1 0.999984860420227
( O 0 2.4801323661449715e-07
MLD B-Disease 1 0.9999771118164062
) O 0 3.0428328301468355e-08
, O 0 1.3769048401446327e-10
fatal O 0 3.788531785176019e-06
at O 0 2.0626687913249953e-08
age O 0 4.013890955723021e-11
5 O 0 3.5951729874389438e-12
years O 0 3.888764310566728e-11
, O 0 2.351182941916219e-13
with O 0 5.925304691345445e-11
deficient O 0 4.4847944081993774e-05
arylsulfatase O 0 9.398337169841398e-06
A O 0 1.28625812223504e-08
( O 0 8.973757609394284e-13
ARSA O 0 2.3960428734426387e-05
) O 0 1.9755085154532503e-12
activity O 0 5.997972084281766e-12
and O 0 3.977672358157491e-12
increased O 0 4.8734905000458184e-12
galactosylsulfatide O 0 3.1802594548935303e-06
( O 0 5.769043576187016e-11
GS O 1 0.9999912977218628
) O 0 8.559370989758008e-10
excretion O 0 2.08847605875917e-08
. O 0 4.307099954470317e-10

The O 0 6.845919664488775e-11
two O 0 7.603237484055114e-11
other O 0 1.4206552600981581e-11
siblings O 0 3.9424826070444396e-08
, O 0 1.176992010798461e-11
apparently O 0 9.158852343205126e-09
healthy O 0 2.2848747199821773e-11
at O 0 1.1206976319177997e-10
12 O 0 3.731777040161255e-12
( O 0 2.2650577922745394e-15
1 O 0 4.579362605262871e-13
/ O 0 8.172686832841336e-11
2 O 0 1.832834405079975e-11
) O 0 3.763067602750164e-13
and O 0 7.613503469165728e-13
15 O 0 2.9949304212843753e-13
years O 0 2.3894170062682685e-12
, O 0 1.450857493770063e-14
respectively O 0 3.381772672225031e-13
, O 0 7.628122580208979e-14
and O 0 4.611268832055426e-12
their O 0 1.4402179449035657e-10
father O 0 1.2621526934708527e-07
, O 0 1.7172487390415547e-12
apparently O 0 3.9386455208401117e-10
healthy O 0 5.028061774987706e-14
as O 0 2.1275092554643923e-14
well O 0 1.8607688903170966e-13
, O 0 4.946079150088857e-14
presented O 0 2.2139221012018595e-11
ARSA O 0 0.0011340886121615767
and O 0 1.57085537466628e-07
GS O 1 0.9999969005584717
values O 0 7.680696634260187e-10
within O 0 1.520946759649925e-14
the O 0 6.67622641198351e-13
range O 0 1.8116629307840526e-09
of O 0 2.284300665289507e-10
MLD B-Disease 1 0.9999774694442749
patients O 0 5.0829598308155255e-09
. O 0 3.978296858608843e-11

Mutation O 0 5.98275118335323e-09
screening O 0 9.045498794435503e-10
and O 0 1.547386697942077e-11
sequence O 0 1.407080008064554e-11
analysis O 0 3.815744161611567e-12
disclosed O 0 3.8471428820407993e-10
the O 0 3.388242106588252e-13
involvement O 0 1.062460102535523e-11
of O 0 1.73560794778033e-14
three O 0 3.108788400318918e-12
different O 0 2.0889340604512974e-12
ARSA O 0 0.00010377916623838246
mutations O 0 1.6364201105290022e-09
being O 0 5.2105823995785006e-12
the O 0 8.681462599041505e-15
molecular O 0 4.89109057075221e-12
basis O 0 3.7263841643452034e-13
of O 0 6.209458403190482e-13
intrafamilial O 0 3.70281145478657e-06
phenotypic O 0 2.815939703637582e-10
heterogeneity O 0 9.522202049083717e-07
. O 0 3.356667477305564e-08

The O 0 2.985537372879321e-09
late O 0 3.1752649647387443e-06
infantile O 1 0.7835994362831116
patient O 0 0.002101106336340308
inherited O 1 0.5390246510505676
from O 0 2.1744350764407727e-09
his O 0 7.81517883297056e-07
mother O 0 3.4799595027834584e-07
the O 0 1.2921620154079938e-12
frequent O 0 5.116895795964638e-10
0 O 0 1.5290322827321567e-11
- O 0 6.665933582894468e-09
type O 0 2.232074525210237e-10
mutation O 0 1.0244591286401317e-10
459 O 0 1.6650575362930908e-10
+ O 0 2.5624075083996445e-10
1G O 0 3.1639433473173995e-07
> O 0 2.6275961406696524e-09
A O 0 3.2266767036048805e-09
, O 0 1.1370526742382481e-10
and O 0 2.7232394117504555e-10
from O 0 3.585332551681031e-12
his O 0 1.276679881812015e-07
father O 0 4.634812711401537e-08
a O 0 5.3645217608366824e-12
novel O 0 9.476433526778294e-11
, O 0 1.4874139246667806e-12
single O 0 1.9927749728143596e-10
basepair O 0 5.981532922305632e-07
microdeletion O 0 6.6431633527486156e-09
of O 0 5.810540139046094e-16
guanine O 0 2.4131407592650755e-13
at O 0 1.187496688438358e-13
nucleotide O 0 3.059719903657221e-13
7 O 0 4.508463047336875e-12
in O 0 1.0100591424453548e-13
exon O 0 6.644832462043837e-10
1 O 0 2.4923552111033587e-09
( O 0 4.561467956826215e-12
7delG O 0 1.5825763455268316e-07
) O 0 1.2776524282998025e-10
. O 0 1.2820464134755127e-10

The O 0 1.0927319465947605e-10
two O 0 5.168361849605674e-10
clinically O 0 1.7843929526861757e-05
unaffected O 0 1.6788345647000824e-06
siblings O 0 6.267504915058453e-08
carried O 0 5.782277434640548e-10
the O 0 3.7934857078508744e-13
maternal O 0 4.310964918374793e-09
mutation O 0 1.1044850450891985e-10
459 O 0 5.450346840518705e-10
+ O 0 9.12310560430285e-10
1G O 0 7.155762205002247e-07
> O 0 2.9433797621436497e-09
A O 0 4.877382386858642e-10
and O 0 7.244264077499452e-10
, O 0 9.866391557922238e-13
on O 0 8.214366686853936e-11
their O 0 7.592933226607812e-11
paternal O 0 5.2433102304405566e-09
allele O 0 3.997026265523118e-09
, O 0 1.1107111866533181e-13
a O 0 1.2023168512219698e-14
novel O 0 3.208302493031695e-13
cytosine O 0 5.963059213076605e-11
to O 0 1.1447063457716011e-13
thymidine O 0 7.439784205365285e-11
transition O 0 1.092591186795111e-12
at O 0 1.2478252209725121e-13
nucleotide O 0 2.4744361290865435e-13
2435 O 0 2.8858210265880757e-10
in O 0 8.431069495437767e-15
exon O 0 7.051184636175378e-11
8 O 0 2.934090748141216e-10
, O 0 1.0480844707741466e-12
resulting O 0 1.8763472492324546e-13
in O 0 4.612499385427571e-16
substitution O 0 4.7787769292921556e-14
of O 0 3.0096686590413285e-14
alanine O 0 2.6669356500974573e-08
464 O 0 1.5098089889420407e-08
by O 0 5.081038367826807e-10
valine O 0 2.4915996618801728e-05
( O 0 4.1674840661753976e-12
A464V O 0 3.544574855851579e-09
) O 0 6.00188926336287e-11
. O 0 1.5089295091197386e-10

The O 0 4.803488162785641e-10
fathers O 0 2.6340254422052567e-08
genotype O 0 2.4792043973320688e-08
thus O 0 1.2157543027857542e-10
was O 0 9.861142125089373e-09
7delG O 0 3.50752060285231e-07
/ O 0 1.9555201902221597e-07
A464V O 0 1.246221046358187e-07
. O 0 1.2571254037752055e-09

Mutation O 0 7.895741873653606e-07
A464V O 0 3.150952920805139e-07
was O 0 3.839507911607143e-08
not O 0 3.443532958780082e-11
found O 0 3.85389740953368e-11
in O 0 2.6078938271043017e-13
18 O 0 9.440496995249958e-11
unrelated O 0 2.011543074331712e-07
MLD B-Disease 1 0.9999961853027344
patients O 0 3.9738488055718335e-09
and O 0 1.0321391311074457e-11
50 O 0 2.9204030686791338e-12
controls O 0 6.997963453159173e-08
. O 0 3.943089854629989e-09

A464V O 0 1.4564798789251654e-07
, O 0 1.9227956032930038e-11
although O 0 8.98535260952793e-13
clearly O 0 1.8575795415753937e-11
modifying O 0 2.3206185584268013e-10
ARSA O 0 0.0013665100559592247
and O 0 3.2834671515047376e-07
GS O 1 0.9999920129776001
levels O 0 2.6877918912759924e-07
, O 0 3.7787578621717444e-11
apparently O 0 1.1946443834176534e-08
bears O 0 3.1776620224022167e-10
little O 0 2.1666174442654812e-14
significance O 0 1.4078294905989653e-14
for O 0 4.662121434213925e-15
clinical O 0 2.1022291546435312e-11
manifestation O 0 6.132082064347344e-10
of O 0 7.894843806477425e-11
MLD B-Disease 1 0.9999963045120239
, O 0 1.2719893194290677e-10
mimicking O 0 3.3710567670652836e-09
the O 0 4.0282790991774675e-11
frequent O 0 8.187690809791093e-07
ARSA O 0 0.46093493700027466
pseudodeficiency O 0 0.00031686192960478365
allele O 0 1.0692459909478202e-05
. O 0 8.250945704446622e-09

Our O 0 1.2593656606441073e-07
results O 0 4.610262172022317e-10
demonstrate O 0 1.2563091192352438e-11
that O 0 8.490233391550764e-14
in O 0 9.607078392702612e-16
certain O 0 1.9442706179848696e-14
genetic O 0 6.932531881886916e-09
conditions O 0 3.932832157715893e-07
MLD B-Disease 1 0.9999765157699585
- O 0 1.069269455911126e-05
like O 0 1.0519520365903645e-08
ARSA O 0 0.31457656621932983
and O 0 4.974050398232066e-07
GS O 1 0.9999977350234985
values O 0 2.585936353938223e-09
need O 0 7.019746925667619e-14
not O 0 3.6382629900336486e-14
be O 0 1.0388056788466354e-13
paralleled O 0 1.9280038676683375e-10
by O 0 4.740646070144905e-11
clinical O 0 3.8561900339573185e-08
disease O 0 1.5921193607937312e-06
, O 0 2.5232835027151623e-13
a O 0 3.533551218553449e-13
finding O 0 5.102605837858931e-11
with O 0 8.351701275000067e-11
serious O 0 1.960661411004594e-09
diagnostic O 0 4.769928896308784e-09
and O 0 3.552200755763124e-10
prognostic O 0 2.9099112452968257e-06
implications O 0 1.409031913368608e-08
. O 0 9.718796878388503e-10

Moreover O 0 1.0691986851441015e-08
, O 0 8.579122655338889e-12
further O 0 4.909203685926622e-12
ARSA O 0 8.457257536065299e-06
alleles O 0 1.6328999263848232e-09
functionally O 0 2.5185201479871466e-08
similar O 0 1.909608755845671e-11
to O 0 3.1077938833501406e-11
A464V O 0 4.087413518760741e-09
might O 0 1.068713006979749e-09
exist O 0 2.7189082148909582e-12
which O 0 2.1386685825075524e-11
, O 0 1.5151536980357455e-13
together O 0 1.3803330874140318e-11
with O 0 4.479271120683137e-11
0 O 0 4.259168365217114e-11
- O 0 6.549722542104064e-08
type O 0 3.4247311653246015e-09
mutations O 0 3.010826432614522e-08
, O 0 4.986419957497823e-11
may O 0 6.495921023308426e-10
cause O 0 3.0264377115507557e-10
pathological O 0 1.351344280919875e-07
ARSA O 1 0.8831166625022888
and O 0 3.6215176805853844e-05
GS O 1 0.9999994039535522
levels O 0 3.164510360420536e-07
, O 0 1.7395578033596593e-11
but O 0 6.658527462038988e-12
not O 0 3.3696439735719785e-12
clinical O 0 9.74689773336479e-11
outbreak O 0 1.4679970572473167e-09
of O 0 3.1786270664191374e-13
the O 0 4.439943968037596e-09
disease O 0 6.365329454638413e-07
. O 0 1.7973773511203994e-11
. O 0 6.356017934194824e-10

Human O 0 4.630143303074874e-05
MLH1 O 1 0.9948896169662476
deficiency O 1 0.9993125200271606
predisposes O 0 0.0012221651850268245
to O 0 1.2642527735806652e-06
hematological B-Disease 1 0.9826488494873047
malignancy I-Disease 1 0.9990461468696594
and O 0 8.127577530103736e-06
neurofibromatosis B-Disease 0 0.07651333510875702
type I-Disease 0 9.530717903771802e-08
1 I-Disease 0 1.6991242191011224e-08
. O 0 1.7905231075587835e-08

Heterozygous O 0 5.188910108699929e-06
germ O 0 0.0037414405960589647
- O 0 0.021937020123004913
line O 0 8.39100539451465e-05
mutations O 0 2.7088303156119764e-08
in O 0 6.010303474530965e-13
the O 0 2.7015340919173125e-12
DNA O 0 1.7020082623275812e-06
mismatch O 0 2.4244778614956886e-05
repair O 0 8.184225066543149e-07
genes O 0 6.752672732091014e-08
lead O 0 9.436437835574907e-07
to O 0 3.227767919611324e-08
hereditary B-Disease 1 0.9999608993530273
nonpolyposis I-Disease 1 0.9999650716781616
colorectal I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999943971633911
. O 0 2.4182869310607202e-05

The O 0 1.459388556668273e-07
disease O 0 0.00012429799244273454
susceptibility O 0 1.4087033832765883e-06
of O 0 1.3949428417925347e-11
individuals O 0 4.995215699410416e-11
who O 0 5.659441359995299e-09
constitutionally O 0 2.3693730781815248e-06
lack O 0 1.344181321805138e-09
both O 0 9.30278597210954e-12
wild O 0 8.998061851173134e-09
- O 0 0.00011678006558213383
type O 0 5.0854062294547475e-08
alleles O 0 5.599409824696977e-09
is O 0 5.517224455076075e-10
unknown O 0 7.121746747884572e-09
. O 0 2.328226222925167e-10

We O 0 5.150984971891148e-09
have O 0 2.933936513876967e-12
identified O 0 2.9186488295640522e-12
three O 0 2.0858445179405827e-12
offspring O 0 7.731316697956458e-10
in O 0 1.5120452633021753e-12
a O 0 6.623805504091251e-09
hereditary B-Disease 1 0.9999873638153076
nonpolyposis I-Disease 1 0.9999953508377075
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
family O 0 0.03539783135056496
who O 0 1.7165240251415526e-06
developed O 0 5.914327516620688e-07
hematological B-Disease 0 0.13327756524085999
malignancy I-Disease 0 0.09565068036317825
at O 0 3.130250192384665e-08
a O 0 1.2076000789618124e-11
very O 0 9.407615311762818e-12
early O 0 1.4779924506491682e-10
age O 0 1.3256861164379075e-09
, O 0 3.3598057062184106e-12
and O 0 1.7838017521421e-11
at O 0 3.690357394670052e-11
least O 0 3.8906256146463425e-15
two O 0 1.143434170047461e-13
of O 0 3.960438070159042e-14
them O 0 2.6881150083646332e-11
displayed O 0 5.272968905956077e-08
signs O 0 5.007354531016972e-09
of O 0 9.890262437153852e-13
neurofibromatosis B-Disease 0 4.790716411662288e-05
type I-Disease 0 6.232276472672993e-09
1 I-Disease 0 1.096379764753408e-09
( O 0 8.425649067334007e-12
NF1 B-Disease 0 1.2026757758576423e-06
) O 0 2.8846322552844583e-10
. O 0 2.174583152436682e-10

DNA O 0 6.492985593631317e-10
sequence O 0 1.30090507810543e-10
analysis O 0 9.318252766621349e-12
and O 0 9.469629941305513e-13
allele O 0 1.2329813559031066e-10
- O 0 3.964210071316643e-10
specific O 0 5.587996211586788e-12
amplification O 0 5.91234197599988e-07
in O 0 1.290130220536756e-12
two O 0 5.575010592062668e-11
siblings O 0 1.232557078623131e-08
revealed O 0 3.5579390544882017e-09
a O 0 2.068720411987912e-12
homozygous O 0 1.761866030847159e-08
MLH1 O 0 2.47027328441618e-05
mutation O 0 2.8392628692586186e-08
( O 0 2.8676930621807095e-13
C676T O 0 2.373513829923013e-09
- O 0 2.129085078195203e-05
- O 0 0.005031785927712917
> O 0 8.484204983005839e-08
Arg226Stop O 0 1.3069373380858451e-05
) O 0 1.6032750127514817e-10
. O 0 5.935066327289462e-11

Thus O 0 7.164732807041219e-09
, O 0 4.436212681924179e-12
a O 0 8.266650168217704e-13
homozygous O 0 4.998413682955061e-09
germ O 0 0.00013819926243741065
- O 0 0.0002645287604536861
line O 0 0.0002165882324334234
MLH1 O 0 0.0009439330315217376
mutation O 0 2.0693644842140202e-07
and O 0 7.566524073965297e-10
consequent O 0 9.65761955740163e-07
mismatch O 1 0.5439118146896362
repair O 1 0.9994850158691406
deficiency O 1 0.9988377690315247
results O 0 4.145575549507896e-10
in O 0 7.990199214075178e-13
a O 0 1.2540067595434579e-10
mutator O 0 0.00034324536682106555
phenotype O 0 6.735353963449597e-05
characterized O 0 6.924862532287079e-07
by O 0 5.532686309095425e-09
leukemia B-Disease 1 0.9874225854873657
and O 0 6.081872015784029e-06
/ O 1 0.8820695281028748
or O 1 0.9905285239219666
lymphoma B-Disease 1 1.0
associated O 0 0.00012400417472235858
with O 0 1.2717189967759168e-08
neurofibromatosis B-Disease 0 0.0038656543474644423
type I-Disease 0 9.953338597767925e-09
1 I-Disease 0 3.731681630370076e-10
. O 0 2.3033938645333762e-10
. O 0 1.3286352018582193e-09

Missense O 0 0.00016538241470698267
mutations O 0 2.8156691769254394e-05
in O 0 5.067817276938058e-10
the O 0 1.3759696507187336e-11
most O 0 1.0984816571982248e-12
ancient O 0 1.0823494878131612e-11
residues O 0 1.1559163404228912e-08
of O 0 1.7760551262644385e-14
the O 0 6.0408193204575245e-12
PAX6 O 0 1.337681112545397e-07
paired O 0 1.3158237832655573e-09
domain O 0 4.4533848830852207e-10
underlie O 0 3.977663087795236e-09
a O 0 7.020999233386949e-12
spectrum O 0 3.044986840450292e-08
of O 0 5.000136971133884e-10
human O 0 0.00011516749509610236
congenital B-Disease 1 0.9999579191207886
eye I-Disease 1 0.9885109663009644
malformations I-Disease 1 0.998083233833313
. O 0 3.757562296868855e-07

Mutations O 0 8.577190442338178e-07
of O 0 1.1089632901209456e-12
the O 0 3.9118387348824335e-12
human O 0 1.1742211369902833e-10
PAX6 O 0 1.6769410649430938e-05
gene O 0 0.0016293164808303118
underlie O 1 0.974062979221344
aniridia B-Disease 1 0.9999985694885254
( O 0 7.995239684532862e-06
congenital B-Disease 1 0.9997897744178772
absence I-Disease 0 5.930005997356602e-08
of I-Disease 0 1.6630658438918089e-12
the I-Disease 0 4.901462014039737e-10
iris I-Disease 0 5.350239734980278e-05
) O 0 2.532063003712892e-09
, O 0 8.712545442046693e-12
a O 0 2.1651429260582944e-10
rare O 0 4.1710995901667047e-07
dominant O 0 0.05594337359070778
malformation B-Disease 1 0.9993581175804138
of I-Disease 0 4.709741971420378e-11
the I-Disease 0 1.43140854724777e-09
eye I-Disease 0 0.0003804384614340961
. O 0 9.372743647872994e-08

The O 0 2.2854936693184058e-11
spectrum O 0 4.690434707299573e-10
of O 0 3.6389793088564826e-13
PAX6 O 0 1.9627727851911914e-06
mutations O 0 3.4635413612704724e-06
in O 0 3.624953492931127e-08
aniridia B-Disease 1 0.9999963045120239
patients O 0 1.2252830572379025e-07
is O 0 9.159817002113435e-12
highly O 0 1.0286874433870774e-12
biased O 0 3.5204137383004763e-09
, O 0 1.0674935761734172e-11
with O 0 6.58027582076115e-12
92 O 0 2.328520487537844e-09
% O 0 1.6994893448259163e-13
of O 0 2.5361264195493394e-14
all O 0 2.9641487181431003e-11
reported O 0 2.0433132519315222e-08
mutations O 0 5.899551402954728e-10
leading O 0 1.019806017410474e-09
to O 0 2.46083674271258e-11
premature O 0 2.971964008224859e-09
truncation O 0 3.1971789660190097e-09
of O 0 9.515800690820808e-13
the O 0 3.16350348694705e-11
protein O 0 1.0118761828437073e-08
( O 0 2.0138780915243334e-14
nonsense O 0 6.434888039086317e-11
, O 0 4.197214219163161e-16
splicing O 0 1.4646226939585283e-11
, O 0 2.868540908279593e-13
insertions O 0 7.273407431895862e-10
and O 0 1.4724438335278478e-10
deletions O 0 2.5749706811240003e-09
) O 0 6.007547237452115e-11
and O 0 2.2950615019556864e-10
just O 0 4.1311698506518724e-10
2 O 0 7.422930325962085e-11
% O 0 7.15418257404496e-15
leading O 0 4.480548419262542e-13
to O 0 3.7601219779134516e-15
substitution O 0 3.752751351316329e-14
of O 0 1.1132599765542421e-14
one O 0 9.205143591817233e-12
amino O 0 1.8227915010715634e-10
acid O 0 8.641628211625285e-12
by O 0 3.902310942373484e-14
another O 0 1.1802494745416503e-11
( O 0 3.1119906456454627e-13
missense O 0 7.10294489891794e-09
) O 0 5.732080782250293e-11
. O 0 6.755008358227954e-11

The O 0 1.625657594650498e-11
extraordinary O 0 2.560396773071405e-12
conservation O 0 1.9453362531951512e-13
of O 0 1.3846442294810127e-15
the O 0 3.419866047792673e-14
PAX6 O 0 5.8024507421095e-10
protein O 0 1.7427359902399964e-11
at O 0 8.166944225930506e-13
the O 0 3.906047120000528e-15
amino O 0 1.1657051192381918e-11
acid O 0 1.6854810949706867e-11
level O 0 2.9870422541683483e-12
amongst O 0 2.2470689046462378e-13
vertebrates O 0 3.054824795900579e-11
predicts O 0 8.55527826360003e-09
that O 0 9.588467519971999e-11
pathological O 0 2.0909658360324102e-07
missense O 0 1.801023245207034e-06
mutations O 0 2.7113171654491453e-06
should O 0 1.6888817455651406e-08
in O 0 5.968688650964671e-12
fact O 0 2.2600305307762802e-11
be O 0 6.37576666809303e-12
common O 0 1.2076462226062734e-11
even O 0 2.5369586986734305e-10
though O 0 8.057111401671424e-12
they O 0 4.747213039335563e-12
are O 0 1.426263078994905e-13
hardly O 0 1.5340603787272755e-10
ever O 0 2.1842978814579084e-10
seen O 0 1.297788720933113e-08
in O 0 3.1863409133414677e-10
aniridia B-Disease 1 0.9999948740005493
patients O 0 4.6412171883503106e-08
. O 0 2.1787430193320745e-10

This O 0 1.827564349854427e-10
indicates O 0 4.477940518388124e-10
that O 0 3.641091768369353e-12
there O 0 9.574472833485947e-14
is O 0 2.240226098159867e-13
a O 0 3.242743747133847e-12
heavy O 0 5.220192278443392e-08
ascertainment O 0 2.579431929916609e-05
bias O 0 1.4991193211244536e-06
in O 0 5.019527003248536e-13
the O 0 8.430976999439926e-14
selection O 0 4.704303420877305e-14
of O 0 3.0218517033282766e-14
patients O 0 2.130653509527236e-13
for O 0 3.1979618809302966e-15
PAX6 O 0 2.5404139236684387e-08
mutation O 0 9.286803548391731e-10
analysis O 0 3.807676396405668e-11
and O 0 1.7999915793986965e-11
that O 0 1.6245688605129316e-12
the O 0 4.369302229051408e-12
missing O 0 1.7901292892474885e-07
PAX6 O 0 3.2154413929674774e-05
missense O 0 4.654346867027925e-06
mutations O 0 8.412034731009044e-06
frequently O 0 5.21976198797347e-06
may O 0 6.882404335328829e-08
underlie O 0 2.964097518542985e-07
phenotypes O 0 3.508029351451114e-07
distinct O 0 9.847402893115031e-09
from O 0 2.2360566731549625e-08
textbook O 0 0.005146132316440344
aniridia B-Disease 1 0.9999358654022217
. O 0 1.3614953786600381e-06

Here O 0 1.8882955199472917e-09
we O 0 8.87046686104398e-12
present O 0 7.078906417209291e-14
four O 0 1.022158920005456e-12
novel O 0 2.45901271567206e-10
PAX6 O 0 6.589125860045897e-06
missense O 0 1.2012475281153456e-06
mutations O 0 4.7296302341237606e-07
, O 0 9.216567786740626e-11
two O 0 2.057612413786103e-11
in O 0 1.1580594989901716e-11
association O 0 3.9368896055484714e-13
with O 0 1.0921499815630398e-11
atypical O 0 7.55395674900683e-08
phenotypes O 0 7.064359124342445e-06
ectopia B-Disease 0 0.0038979833479970694
pupillae I-Disease 0 0.0017020116792991757
( O 0 4.170221112875794e-11
displaced B-Disease 0 3.6281042059549407e-10
pupils I-Disease 0 1.2794095560764163e-08
) O 0 2.680480370997884e-08
and O 0 0.00035461137304082513
congenital B-Disease 1 0.9999562501907349
nystagmus I-Disease 0 0.00017958685930352658
( O 0 2.0450804244509513e-11
searching B-Disease 0 4.444046908247401e-08
gaze I-Disease 0 8.382384839933366e-05
) O 0 7.962992487620113e-10
, O 0 9.537937280257314e-12
and O 0 1.1130966981465207e-10
two O 0 2.912823870993009e-10
in O 0 1.1872281803493312e-11
association O 0 2.8056301111024397e-14
with O 0 1.0103539099109993e-13
more O 0 3.0104738146796706e-13
recognizable O 0 1.330108534602914e-05
aniridia B-Disease 1 0.9999858140945435
phenotypes O 0 1.5756380889797583e-05
. O 0 3.743774179554293e-09

Strikingly O 0 8.343455988324422e-07
, O 0 1.3117359976000387e-10
all O 0 1.103868949373088e-12
four O 0 2.787876179910498e-11
mutations O 0 1.4667599357309768e-09
are O 0 5.039778273527307e-13
located O 0 1.4273958534247178e-12
within O 0 5.270730615738843e-14
the O 0 4.409126275889408e-12
PAX6 O 0 6.95686708240828e-08
paired O 0 6.279751718629711e-10
domain O 0 6.729394819160461e-10
and O 0 6.306624666940763e-11
affect O 0 1.3323763750280881e-12
amino O 0 1.1557073006929208e-11
acids O 0 2.367940565850546e-11
which O 0 1.8269673968118738e-11
are O 0 2.40718174695587e-14
highly O 0 1.346644692458432e-13
conserved O 0 2.7666660629144246e-11
in O 0 3.133934355515483e-13
all O 0 1.110204999764039e-13
known O 0 1.4491800771551655e-12
paired O 0 2.9279006302784794e-11
domain O 0 8.23760296086995e-11
proteins O 0 4.54559612173e-10
. O 0 6.88821222283309e-11

Our O 0 1.8105133392509742e-08
results O 0 1.0108874848313576e-10
support O 0 3.840128085311201e-13
the O 0 2.4264281989899716e-13
hypothesis O 0 1.474865889139476e-11
that O 0 1.6724010956474522e-13
the O 0 1.817736262346107e-14
under O 0 2.529021913763585e-13
- O 0 1.325187459766397e-10
representation O 0 7.280971208974488e-14
of O 0 1.6402572117386882e-13
missense O 0 3.082578459157048e-08
mutations O 0 1.9038218113109906e-08
is O 0 1.2402413818168867e-10
caused O 0 9.392278066400195e-10
by O 0 2.8474787631960208e-12
ascertainment O 0 1.1447218639659695e-05
bias O 0 3.6736666970682563e-06
and O 0 1.3192061887323803e-09
suggest O 0 1.0340703120170769e-11
that O 0 4.7798801050026596e-14
a O 0 6.537211229154863e-14
substantial O 0 2.0456244120489742e-13
burden O 0 1.843073604845813e-08
of O 0 4.760650641061348e-12
PAX6 B-Disease 0 0.0010823806514963508
- I-Disease 0 0.07409600168466568
related I-Disease 0 7.178691157605499e-05
disease I-Disease 0 0.0004811720282305032
remains O 0 3.40834227507969e-09
to O 0 3.1513548281320025e-12
be O 0 1.0995260257828932e-11
uncovered O 0 1.091464838509637e-07
. O 0 7.796137867221997e-12
. O 0 6.30704585780073e-11

The O 0 6.553575043755089e-11
chromosomal O 0 6.722075909237901e-07
order O 0 2.1992041868146295e-11
of O 0 1.4366510571787137e-14
genes O 0 2.0959523006069958e-10
controlling O 0 1.0283947027289742e-09
the O 0 2.607059533532574e-12
major O 0 3.842819291943744e-12
histocompatibility O 0 2.5719961715964246e-09
complex O 0 3.580625726473663e-11
, O 0 2.974107505410162e-13
properdin O 0 1.2821791406381067e-09
factor O 0 1.508494995583476e-10
B O 0 7.140683777606682e-08
, O 0 2.8568167276254997e-10
and O 0 1.333631587385753e-07
deficiency B-Disease 0 4.656080636777915e-05
of I-Disease 0 6.992559264467301e-16
the I-Disease 0 2.5193784775404127e-13
second I-Disease 0 5.503128161499227e-11
component I-Disease 0 3.1371474428637525e-12
of I-Disease 0 9.816992427031778e-15
complement I-Disease 0 2.251210849679719e-11
. O 0 6.913985356460373e-11

The O 0 9.651292265377975e-11
relationship O 0 2.9078373389723744e-11
of O 0 6.698870177643777e-16
the O 0 2.1598495239619772e-15
genes O 0 4.551193948619525e-13
coding O 0 6.99304725237937e-10
for O 0 7.14117638313987e-15
HLA O 0 2.6499450203609776e-11
to O 0 7.272296913968246e-14
those O 0 7.907155053605511e-15
coding O 0 3.3580602187832653e-10
for O 0 4.3889926957564607e-14
properdin O 0 3.2854130527226744e-09
Factor O 0 3.9794275513704847e-11
B O 0 4.573401213292527e-09
allotypes O 0 1.1241373698567259e-07
and O 0 4.4811704347225145e-10
for O 0 1.3801224052478744e-11
deficiency B-Disease 0 3.8470184335892554e-06
of I-Disease 0 2.4800502655785274e-16
the I-Disease 0 1.4314356720345617e-13
second I-Disease 0 1.9980565812982576e-11
component I-Disease 0 6.221340283218968e-12
of I-Disease 0 5.4986288959557594e-14
complement I-Disease 0 3.722738228795208e-10
( O 0 7.776738237749714e-13
C2 O 0 1.590893020875228e-06
) O 0 1.4303727473297112e-11
was O 0 1.4231082978710674e-09
studied O 0 3.0875271957164774e-12
in O 0 3.807350756283162e-14
families O 0 7.399584417422389e-13
of O 0 4.2459728766784666e-14
patients O 0 7.765096204925825e-11
with O 0 1.926993897782836e-09
connective O 0 0.0053163873963057995
tissue O 1 0.9981841444969177
disorders O 1 0.9916369318962097
. O 0 3.2960283391503253e-08

Patients O 0 6.073433667097561e-08
were O 0 3.529122827305997e-11
selected O 0 5.522680294849092e-13
because O 0 1.7143392825116899e-12
they O 0 1.1931680144773582e-13
were O 0 8.932682745614942e-14
heterozygous O 0 9.48228648378624e-12
or O 0 1.0667160731114844e-11
homozygous O 0 1.0517737791815307e-07
for O 0 1.8180786298671592e-07
C2 B-Disease 1 0.9999974966049194
deficiency I-Disease 1 0.9999945163726807
. O 0 7.187058770341537e-08

12 O 0 3.910994195166495e-09
families O 0 1.2187904331606436e-11
with O 0 1.4517355958858225e-13
15 O 0 9.25580345332265e-14
matings O 0 6.65837340818598e-09
informative O 0 4.265890396482064e-08
for O 0 5.572105692408513e-07
C2 B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999996423721313
were O 0 2.1073616185418587e-09
found O 0 2.1713888465058062e-09
. O 0 4.938661146702827e-10

Of O 0 5.589075383061193e-11
57 O 0 2.7796265289481425e-10
informative O 0 3.922362434849447e-10
meioses O 0 1.3654883446179156e-07
, O 0 2.600929183398798e-13
two O 0 8.934927891144934e-15
crossovers O 0 3.80792142609665e-12
were O 0 2.864731455526348e-12
noted O 0 5.227722009622238e-13
between O 0 7.860402433113034e-12
the O 0 1.4957818450511695e-07
C2 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999985694885254
gene O 0 1.6596705953997315e-10
and O 0 9.577989443232404e-12
the O 0 3.0714317265749524e-13
HLA O 0 2.152750333550557e-08
- O 0 4.062260813952889e-06
B O 0 2.8772609184102294e-08
gene O 0 1.0459687282970975e-10
, O 0 2.7286515874493794e-14
with O 0 4.647115504399486e-16
a O 0 6.11301719269738e-16
recombinant O 0 3.458977624725551e-14
fraction O 0 3.197806602850406e-13
of O 0 1.3786214737073615e-13
0 O 0 2.6152883678132177e-11
. O 0 3.210632107397693e-11

035 O 0 0.0023768909741193056
. O 0 7.314035883609904e-07

A O 0 1.1888869977383365e-07
lod O 0 5.3730487707071006e-05
score O 0 2.2710443303708416e-08
of O 0 7.486419389144197e-14
13 O 0 7.642368725704896e-13
was O 0 5.195725794049366e-12
calculated O 0 3.8497942897799953e-13
for O 0 1.932394707844596e-15
linkage O 0 3.349530857121863e-07
between O 0 6.631545602431288e-06
C2 B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999995231628418
and O 0 9.01523633523027e-10
HLA O 0 1.1074884298523102e-07
- O 0 2.0026952824991895e-06
B O 0 4.456558500010033e-08
at O 0 4.017166807535055e-12
a O 0 3.651434521770042e-15
maximum O 0 3.2402781646674638e-15
likelihood O 0 5.1236218298112736e-15
value O 0 3.4025641716472306e-15
of O 0 2.9173224219201894e-17
the O 0 9.120155150226373e-16
recombinant O 0 5.261660248126465e-14
fraction O 0 8.00436512861033e-14
of O 0 4.9710097014188034e-14
0 O 0 2.683934324787529e-11
. O 0 5.763413010728691e-11

04 O 0 0.000284872978227213
. O 0 1.568834164800137e-07

18 O 0 1.6049197526513126e-08
families O 0 2.9010068652857157e-11
with O 0 1.5256223476374509e-13
21 O 0 1.629853614267332e-13
informative O 0 2.7008076764617472e-12
matings O 0 1.8609112029110975e-09
for O 0 1.8185338285692416e-14
both O 0 2.1069798195657435e-13
properdin O 0 9.085723284840697e-09
Factor O 0 5.3718349213305316e-11
B O 0 3.884631727402166e-09
allotype O 0 1.8065085427565464e-08
and O 0 3.784081034630127e-11
HLA O 0 1.6717514483843843e-08
- O 0 1.7134558447651216e-06
B O 0 1.4151517291338678e-07
were O 0 6.618898484855862e-11
found O 0 1.482057393475955e-10
. O 0 7.288551706619018e-12

Of O 0 1.5856928617385968e-11
72 O 0 7.995074602362706e-10
informative O 0 1.0983010056975218e-09
meioses O 0 2.917808842539671e-06
, O 0 9.96300958400198e-12
three O 0 6.092844978544676e-12
recombinants O 0 2.440591799768299e-07
were O 0 1.3505462026497383e-10
found O 0 5.9884614628247235e-12
, O 0 1.9532274831823154e-15
giving O 0 1.1958112040826713e-16
a O 0 6.502582997611802e-16
recombinant O 0 9.981849602522935e-14
fraction O 0 2.530701071878222e-13
of O 0 9.257092298655192e-14
0 O 0 2.6343026718333995e-11
. O 0 7.434194926325688e-11

042 O 0 0.0002286666422151029
. O 0 2.3579461583267403e-07

A O 0 4.436458667100851e-08
lod O 0 6.7174178184359334e-06
score O 0 3.0756350799521215e-09
of O 0 2.8945246942574734e-14
16 O 0 4.188383580933097e-13
between O 0 1.744523443888632e-13
HLA O 0 6.151918974239834e-09
- O 0 7.972116122800799e-07
B O 0 2.2114274145224044e-07
and O 0 9.377648657604709e-11
Factor O 0 1.3907798523948856e-11
B O 0 1.0913681069979475e-09
allotypes O 0 9.378691157024832e-10
was O 0 4.249674223633093e-11
calculated O 0 3.193620715102874e-12
at O 0 1.03174840361802e-13
a O 0 2.8140751142898598e-15
maximum O 0 1.9036489507136267e-14
likelihood O 0 5.1422059020806224e-14
value O 0 1.0831820907071261e-14
of O 0 2.786130915024789e-16
the O 0 1.2806702787550132e-14
recombinant O 0 3.5178891050202665e-13
fraction O 0 3.266648290842916e-13
of O 0 8.307489082499259e-14
0 O 0 2.1932474933428203e-11
. O 0 3.115663976815952e-11

04 O 0 0.00041309805237688124
. O 0 1.9015905650121567e-07

A O 0 1.7760191095561595e-09
crossover O 0 7.886814756830063e-09
was O 0 2.1254109583423997e-08
shown O 0 1.1094383051135637e-10
to O 0 1.7782864482167315e-13
have O 0 3.1597191226320764e-13
occurred O 0 1.7368176124729628e-13
between O 0 1.2241743670192776e-15
genes O 0 8.844693640680523e-14
for O 0 9.564989325553546e-16
Factor O 0 3.829317776499891e-13
B O 0 2.8559710152364914e-11
and O 0 1.2316756772476345e-12
HLA O 0 1.8919295019514948e-09
- O 0 1.4187045280777966e-06
D O 0 5.669448341905081e-07
, O 0 1.6206251564256785e-13
in O 0 2.1576343210466704e-15
which O 0 9.326943514395558e-13
HLA O 0 2.417236188989591e-09
- O 0 3.874421508953674e-06
D O 0 6.082712843635818e-06
segregared O 0 5.280305970245536e-08
with O 0 1.5710491718320951e-12
HLA O 0 3.6258922531118287e-09
- O 0 3.5888223948177256e-08
A O 0 2.945514054886189e-09
and O 0 8.924425087819543e-10
B O 0 2.4365165884887574e-08
. O 0 4.941202308428316e-11

These O 0 4.4166301171877365e-10
studies O 0 2.6827777846460954e-11
suggest O 0 8.304499666059173e-13
that O 0 2.5553923109895805e-15
the O 0 1.1981582794399538e-16
genes O 0 7.189642761348813e-14
for O 0 4.091878525331596e-15
Factor O 0 2.0395536648454282e-10
B O 0 2.5653849661466666e-05
and O 0 0.0010913058649748564
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
are O 0 6.565842704600588e-13
located O 0 5.752706931693233e-14
outside O 0 2.9645358975809166e-13
those O 0 9.890289576089482e-15
for O 0 2.3728183826154155e-15
HLA O 0 1.2167958307607307e-10
, O 0 1.5816647579332266e-13
that O 0 7.554741066669729e-14
the O 0 8.53683257033078e-15
order O 0 3.739085321745328e-13
of O 0 2.0756970124104993e-15
genese O 0 2.3635480239647677e-09
is O 0 9.704106143865535e-14
HLA O 0 1.5442818898647737e-11
- O 0 1.2690433148776492e-09
A O 0 2.16655568485713e-10
, O 0 3.6494055390481894e-13
- O 0 6.188846657373404e-10
B O 0 3.1493285757022704e-09
, O 0 9.711073091500655e-13
- O 0 3.5196547898408426e-09
D O 0 3.0184088561924227e-09
, O 0 6.0684565892873445e-15
Factor O 0 9.28979657956186e-14
B O 0 4.787234497705128e-10
allotype O 0 1.7413251498510363e-06
, O 0 6.957438358767831e-08
C2 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999995231628418
, O 0 2.699445044395104e-14
that O 0 1.731961883870962e-16
the O 0 1.593271356065503e-16
genes O 0 3.8257005202657623e-11
coding O 0 1.1675909263431095e-05
for O 0 2.4908462137318566e-07
C2 B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999994039535522
and O 0 5.029769933884154e-10
Factor O 0 5.04195643569183e-11
B O 0 4.844268097770055e-09
allotypes O 0 8.677019103231487e-09
are O 0 3.240903910257248e-14
approximately O 0 1.398168486912467e-15
3 O 0 9.488958013434412e-13
- O 0 2.028371248741223e-08
- O 0 2.8141931807112996e-07
5 O 0 2.1615984002743005e-10
centimorgans O 0 7.455871475769982e-09
from O 0 2.6512944400688965e-15
the O 0 3.5090734825667753e-15
HLA O 0 1.6909614333759926e-11
- O 0 1.7674381402876804e-10
A O 0 5.356651580634697e-11
and O 0 8.314362219541405e-12
HLA O 0 1.166440277700076e-09
- O 0 2.0256802457652157e-08
B O 0 2.4132915110719466e-10
loci O 0 3.5980404853447334e-12
, O 0 2.829659521020461e-13
and O 0 5.934027547766993e-14
that O 0 3.15909245377638e-13
the O 0 1.5241253354877915e-12
apparent O 0 9.168206815957092e-08
lack O 0 1.6977740394108487e-11
of O 0 2.3476817481694022e-14
recombinants O 0 5.76505643223868e-09
between O 0 5.771335557895607e-14
the O 0 4.379576399888424e-14
Factor O 0 2.16289117692392e-12
B O 0 5.495096599972271e-10
gene O 0 1.0327358523909425e-07
and O 0 8.532468928024173e-05
C2 B-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.999998927116394
gene O 0 1.2329614662576205e-08
suggests O 0 9.5985552839295e-10
that O 0 3.0289004811223652e-12
these O 0 2.295080087349327e-13
two O 0 1.0290417129521501e-10
genes O 0 1.9614349184848834e-06
lie O 0 0.00030342087848111987
in O 0 1.4343826690646488e-12
close O 0 4.241384188308217e-10
proximity O 0 1.139238703373735e-10
to O 0 7.1186940890644035e-12
one O 0 8.686246166789147e-12
another O 0 8.647469545985942e-11
. O 0 9.621374807977645e-10

Distribution O 0 3.7022405141584613e-09
of O 0 2.570326070039375e-11
emerin O 0 2.778310954454355e-05
and O 0 2.746334004655182e-08
lamins O 0 8.168331078195479e-06
in O 0 3.649360674762292e-11
the O 0 5.63612712056738e-10
heart O 0 1.4621653008362046e-06
and O 0 4.318943813697018e-11
implications O 0 3.0249110508084875e-12
for O 0 1.0932269629490565e-12
Emery B-Disease 0 0.05861305817961693
- I-Disease 1 0.991178572177887
Dreifuss I-Disease 1 0.9997914433479309
muscular I-Disease 1 0.9898148775100708
dystrophy I-Disease 0 0.0070986393839120865
. O 0 3.0413340734725125e-09

Emerin O 0 0.00020047667203471065
is O 0 3.942508819410051e-10
a O 0 9.724571842228968e-12
nuclear O 0 1.874598964946017e-08
membrane O 0 6.488924397807239e-10
protein O 0 2.5778601475678897e-09
which O 0 3.2983896169902494e-10
is O 0 2.5065628826009823e-12
missing O 0 1.9372599358025155e-10
or O 0 1.1099414790050055e-11
defective O 0 2.2685944145450776e-07
in O 0 9.380832916017212e-11
Emery B-Disease 1 0.9390066266059875
- I-Disease 1 0.9999158382415771
Dreifuss I-Disease 1 0.9999527931213379
muscular I-Disease 1 0.9999388456344604
dystrophy I-Disease 1 0.9813355207443237
( O 0 1.9382079941010488e-08
EDMD B-Disease 1 0.9999649524688721
) O 0 3.6076478693303216e-08
. O 0 2.049510561263901e-09

It O 0 1.410903660570284e-08
is O 0 2.9859271305499036e-11
one O 0 2.3558121599320803e-12
member O 0 6.575137976401121e-14
of O 0 1.1498218149092951e-14
a O 0 3.7697379939860554e-11
family O 0 2.8974043164708974e-09
of O 0 9.783282040390362e-13
lamina O 0 1.8118663547284086e-06
- O 0 1.5742956804842834e-07
associated O 0 8.808678786387247e-11
proteins O 0 3.1393683225938718e-12
which O 0 2.167016349349793e-12
includes O 0 1.4908548977591793e-14
LAP1 O 0 6.040542643859226e-08
, O 0 4.0503093500648957e-13
LAP2 O 0 1.9805686690688162e-07
and O 0 2.0034689185433052e-10
lamin O 0 5.950967079115799e-07
B O 0 2.940369085990824e-07
receptor O 0 6.265341312428063e-08
( O 0 5.4125419424178034e-11
LBR O 0 9.118069499436388e-08
) O 0 1.659748900817437e-11
. O 0 4.383260421292334e-11

A O 0 7.010853675382123e-09
panel O 0 3.5852404378644565e-10
of O 0 1.708593119417734e-13
16 O 0 6.6429249254151834e-12
monoclonal O 0 1.0684963330787056e-10
antibodies O 0 9.008314094671732e-09
( O 0 1.252566409967737e-12
mAbs O 0 8.866703482546257e-10
) O 0 1.6021491425211032e-11
has O 0 2.106499696896691e-11
been O 0 2.3060598569601964e-12
mapped O 0 6.934194884955502e-10
to O 0 3.917601106798868e-13
six O 0 8.649134739576597e-15
specific O 0 9.585402687233477e-17
sites O 0 1.7581598069776883e-12
throughout O 0 5.6726548642877656e-14
the O 0 3.838720113264957e-14
emerin O 0 7.683169378491783e-11
molecule O 0 3.3947755088796494e-13
using O 0 1.7172223929287633e-12
phage O 0 7.330929197024716e-10
- O 0 9.022672387004604e-09
displayed O 0 1.4061504183260354e-09
peptide O 0 4.0393428185625524e-11
libraries O 0 4.122536730391535e-13
and O 0 3.326291932864711e-12
has O 0 1.5473237925320293e-12
been O 0 1.9813565664463656e-13
used O 0 1.9383065573592984e-13
to O 0 1.0292094867331292e-12
localize O 0 4.883689541657077e-08
emerin O 0 9.879962817649357e-06
in O 0 6.194650695179327e-12
human O 0 2.918212060887271e-10
and O 0 3.7745859771121104e-08
rabbit O 0 0.33742451667785645
heart O 0 0.001654264167882502
. O 0 7.461577133938135e-09

Several O 0 1.0448162474085976e-10
mAbs O 0 5.866060526216188e-09
against O 0 1.3596148512595718e-11
different O 0 1.493599352270919e-13
emerin O 0 2.2541831512512545e-08
epitopes O 0 3.626558253699841e-08
did O 0 2.2263939303268643e-10
not O 0 4.1348608564861777e-13
recognize O 0 1.0094649942338219e-11
intercalated O 0 7.401166790543812e-09
discs O 0 0.008165951818227768
in O 0 9.273952716881695e-10
the O 0 2.0304073089505437e-08
heart O 0 0.0003216492768842727
, O 0 7.391942960510711e-12
though O 0 1.759880977926509e-12
they O 0 6.345130584145542e-13
recognized O 0 6.4816572248327375e-12
cardiomyocyte O 0 2.1456632737226755e-07
nuclei O 0 6.9069798769305635e-09
strongly O 0 4.4966247392252967e-10
, O 0 1.3997528179945928e-12
both O 0 6.290783323946447e-13
at O 0 1.2041099228810026e-09
the O 0 2.400465104468452e-10
rim O 0 1.213326322613284e-05
and O 0 1.7719992140285967e-09
in O 0 2.7921694904092798e-12
intranuclear O 0 8.78810126891949e-08
spots O 0 1.7035659549691218e-09
or O 0 3.3812583809245123e-12
channels O 0 6.3457008536715875e-09
. O 0 2.2773674057674498e-09

A O 0 2.706391333262559e-09
polyclonal O 0 1.70290149981156e-07
rabbit O 0 6.104505246184999e-06
antiserum O 0 1.9271071778348414e-06
against O 0 2.3146220939906925e-08
emerin O 0 5.344318651623325e-06
did O 0 8.702489284750925e-10
recognize O 0 2.5371364731352486e-11
both O 0 2.3073874083102963e-13
nuclear O 0 9.688374547067724e-09
membrane O 0 6.117138046102255e-11
and O 0 1.81570140866949e-11
intercalated O 0 1.3341322491200458e-10
discs O 0 1.0260914962145762e-07
but O 0 1.6326609118474944e-12
, O 0 1.9822229297442674e-16
after O 0 4.939194381590279e-15
affinity O 0 6.74486576074558e-14
purification O 0 1.4725300839790734e-11
against O 0 3.648020470772839e-13
a O 0 6.060943847502331e-13
pure O 0 7.977126598168738e-11
- O 0 1.084996711142594e-06
emerin O 0 1.4229863154469058e-06
band O 0 6.968056132095057e-10
on O 0 2.842596470709058e-11
a O 0 1.8017596963015858e-12
western O 0 2.866793434586068e-11
blot O 0 0.009789837524294853
, O 0 1.2201005483714056e-10
it O 0 2.2495981466530424e-10
stained O 0 6.917489372426644e-07
only O 0 3.245737012491645e-13
the O 0 6.690069505321805e-13
nuclear O 0 3.0450507892965106e-08
membrane O 0 8.22059309513179e-10
. O 0 1.653903541898316e-10

These O 0 6.578236844134722e-10
results O 0 5.44332183494145e-11
would O 0 9.484217881536305e-13
not O 0 9.840750854169314e-14
be O 0 6.021283732032812e-13
expected O 0 1.0509692074944788e-12
if O 0 2.735689496116689e-12
immunostaining O 0 3.0153477492689262e-09
at O 0 2.5674304696132744e-11
intercalated O 0 1.7134454965983537e-10
discs O 0 5.251690708973911e-07
were O 0 9.99373292454031e-11
due O 0 5.787498301781935e-13
to O 0 2.833541371373774e-14
a O 0 2.4208719339065266e-13
product O 0 2.840157622974182e-11
of O 0 1.973841554613054e-14
the O 0 7.545604766012737e-12
emerin O 0 2.336864035612507e-08
gene O 0 6.270990393630882e-10
and O 0 2.1274974837393046e-10
, O 0 4.0207217438283094e-13
therefore O 0 6.011483628595715e-13
, O 0 1.5128665735528873e-13
cast O 0 9.140514733996241e-12
some O 0 4.205582534105119e-15
doubt O 0 1.3730398653981346e-13
upon O 0 8.283684174428742e-16
the O 0 7.905439811887321e-14
hypothesis O 0 3.8740782803969864e-10
that O 0 2.4951665178463145e-09
cardiac B-Disease 0 0.1613903045654297
defects I-Disease 1 0.9981670379638672
in O 0 1.5493972327362826e-08
EDMD B-Disease 1 0.9999996423721313
are O 0 2.3438545326825988e-08
caused O 0 2.2013477263271852e-08
by O 0 6.8365599639741426e-12
absence O 0 6.236482441579483e-10
of O 0 1.99280327482787e-12
emerin O 0 1.3869727808923926e-05
from O 0 2.079509481278663e-11
intercalated O 0 1.3369425744258479e-07
discs O 0 0.0001805750362109393
. O 0 3.009406501774947e-09

Although O 0 1.2843288210717674e-08
emerin O 0 1.0931875067399233e-06
was O 0 5.356248777843575e-09
abundant O 0 4.105965133865963e-12
in O 0 1.2088940959387173e-13
the O 0 7.150697135110962e-13
membranes O 0 4.086043503548353e-08
of O 0 9.188864946718667e-12
cardiomyocyte O 0 1.7922882307175314e-06
nuclei O 0 8.154104058633038e-09
, O 0 1.6097519150992667e-11
it O 0 9.69557420460454e-11
was O 0 2.1943096228937975e-08
absent O 0 5.22651311118949e-10
from O 0 3.812786674925461e-14
many O 0 4.587391528925941e-15
non O 0 2.7590501498059306e-12
- O 0 5.37846062798053e-07
myocyte O 0 2.7333297111908905e-05
cells O 0 2.755195893655582e-08
in O 0 4.265783906665099e-12
the O 0 3.3087613204862976e-10
heart O 0 2.4132305043167435e-05
. O 0 4.243644102785993e-09

This O 0 8.16447257023789e-12
distribution O 0 1.7354848461104133e-11
of O 0 3.999351847958077e-13
emerin O 0 1.0238920822303044e-07
was O 0 4.811887555078442e-10
similar O 0 6.8654317528314e-14
to O 0 1.621605410714877e-13
that O 0 3.389883859727938e-13
of O 0 4.1844588029500175e-15
lamin O 0 6.076884329075938e-09
A O 0 2.488995398675087e-10
, O 0 3.123193164592669e-13
a O 0 1.1327930645376946e-13
candidate O 0 1.318826775217885e-12
gene O 0 1.214444794728209e-10
for O 0 4.581835128317224e-13
an O 0 4.7525330892916884e-11
autosomal O 0 0.018522629514336586
form O 0 1.4744237830655038e-08
of O 0 9.118378940797811e-09
EDMD B-Disease 1 0.9999935626983643
. O 0 1.882406763797917e-07

In O 0 1.1427839924360583e-10
contrast O 0 3.940644199840193e-10
, O 0 2.3005300789358252e-11
lamin O 0 6.107125955168158e-06
B1 O 0 0.09637108445167542
was O 0 4.635572850020253e-07
absent O 0 3.1942775091664544e-09
from O 0 5.677495691462642e-13
cardiomyocyte O 0 1.337308042081986e-08
nuclei O 0 1.3547936106306224e-09
, O 0 3.512118764217864e-12
showing O 0 1.2070209276515698e-09
that O 0 6.329064494714487e-10
lamin O 0 5.493998287420254e-06
B1 O 0 5.296414747135714e-05
is O 0 5.919074366929344e-13
not O 0 5.6689094540015965e-15
essential O 0 5.7048342388770195e-15
for O 0 2.2142593206035677e-15
localization O 0 1.098661384091315e-09
of O 0 5.57336464577108e-14
emerin O 0 3.277428461956333e-08
to O 0 4.617878562179767e-12
the O 0 1.7787361861199003e-11
nuclear O 0 5.12811629960197e-06
lamina O 0 2.8905290605507616e-07
. O 0 2.281679289950489e-10

Lamin O 1 0.7054203748703003
B1 O 1 0.9955883026123047
is O 0 3.432783657331129e-08
also O 0 9.22283249771283e-10
almost O 0 2.978993093871729e-11
completely O 0 2.4231928819062887e-07
absent O 0 1.079211884302822e-07
from O 0 1.3969671253111215e-10
skeletal O 0 0.00038406666135415435
muscle O 0 1.6304021528412704e-06
nuclei O 0 3.4157378081545176e-07
. O 0 1.7865582346843212e-09

In O 0 7.210400809753992e-08
EDMD B-Disease 1 0.9997988343238831
, O 0 4.42428125385641e-12
the O 0 3.5707156700284966e-15
additional O 0 1.0362364754516826e-14
absence O 0 1.3314134950787038e-12
of O 0 8.811337483217649e-14
lamin O 0 2.660690552147571e-05
B1 O 1 0.603154182434082
from O 0 1.1596477111908143e-09
heart O 0 5.977335968054831e-05
and O 0 5.3084292517269205e-08
skeletal O 0 0.0012601561611518264
muscle O 0 7.310940475235839e-08
nuclei O 0 3.3755673811697307e-09
which O 0 2.2539112798369842e-09
already O 0 1.7798994278450664e-08
lack O 0 7.100364046719321e-11
emerin O 0 1.505631388454276e-07
may O 0 3.756989858105797e-11
offer O 0 1.5813013511527013e-15
an O 0 6.846776423915363e-16
alternative O 0 1.5309597394073254e-13
explanation O 0 3.560859506562819e-12
of O 0 2.1150889741895773e-13
why O 0 6.498102056440302e-10
these O 0 4.979384526232478e-12
tissues O 0 1.95701477245791e-09
are O 0 2.5083887332695565e-13
particularly O 0 9.556834490442867e-13
affected O 0 1.2823233143735568e-13
. O 0 3.5083874282311467e-13
. O 0 3.867859504902427e-11

Genetic O 0 3.58181999615681e-08
mapping O 0 2.1919842652096122e-07
of O 0 8.847924996835399e-12
the O 0 3.1842750658483965e-10
copper B-Disease 0 1.0870224969039555e-06
toxicosis I-Disease 0 1.7913757801579777e-06
locus O 0 6.319734069393235e-08
in O 0 2.6710803707752362e-11
Bedlington O 0 4.0885547036850767e-07
terriers O 0 1.290760610572761e-05
to O 0 1.6875929542692347e-09
dog O 0 4.78504898637766e-06
chromosome O 0 1.5263764225892373e-06
10 O 0 7.413210323381492e-11
, O 0 1.211050140378922e-12
in O 0 6.459337730489734e-14
a O 0 8.504411064258477e-11
region O 0 8.6744994520771e-10
syntenic O 0 1.1243298558838433e-06
to O 0 1.164889990024065e-10
human O 0 7.106112365207196e-10
chromosome O 0 3.972199192503467e-05
region O 0 1.4152907734654718e-09
2p13 O 0 1.693859452700508e-08
- O 0 2.396255069925246e-07
p16 O 0 5.4652286252121485e-08
. O 0 2.2238136332397573e-10

Abnormal O 1 0.9963310360908508
hepatic B-Disease 1 0.9998468160629272
copper I-Disease 1 0.6610701680183411
accumulation I-Disease 0 8.491153857903555e-05
is O 0 2.000772880705881e-10
recognized O 0 3.493313624480798e-11
as O 0 9.210315843333206e-10
an O 0 7.722634336460033e-07
inherited B-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999997615814209
in O 0 7.165685822485557e-10
man O 0 2.830973926393199e-07
, O 0 4.510415478609087e-12
mouse O 0 2.7498731469677296e-07
, O 0 2.2248063114016503e-10
rat O 0 0.0005161704611964524
and O 0 3.4930458525650465e-08
dog O 0 0.0001820398319978267
. O 0 6.968883692337613e-09

The O 0 1.1302350721997811e-10
major O 0 3.2565938834494546e-10
cause O 0 2.0584914750543248e-07
of O 0 2.0366663910920124e-09
hepatic B-Disease 1 0.9999499320983887
copper I-Disease 0 0.4245757460594177
accumulation I-Disease 0 2.512947321520187e-05
in O 0 1.727131215822908e-10
man O 0 2.3509809921051783e-07
is O 0 5.411507179864383e-12
a O 0 2.7043863676246005e-11
dysfunctional O 0 2.319639861525502e-06
ATP7B O 0 1.1262271073064767e-05
gene O 0 1.4347568821904133e-07
, O 0 1.4599328412856494e-09
causing O 0 1.475519729865482e-05
Wilson B-Disease 0 0.0027362224645912647
disease I-Disease 0 0.01306545827537775
( O 0 6.279512465567905e-10
WD B-Disease 0 0.04016781970858574
) O 0 6.141836372819398e-09
. O 0 1.929502113640069e-09

Mutations O 0 2.746795871644281e-06
in O 0 5.731742164227782e-11
the O 0 1.2271949949294036e-11
ATP7B O 0 1.7248602262043278e-06
genes O 0 1.3646806351630403e-08
have O 0 4.952130927549092e-10
also O 0 8.965738741706364e-12
been O 0 1.1425391882591285e-11
demonstrated O 0 3.168932477537467e-11
in O 0 7.147556743518357e-14
mouse O 0 6.031252723914804e-07
and O 0 1.349110956283539e-08
rat O 0 0.00023739341122563928
. O 0 1.5730515778855647e-09

The O 0 1.1075909078783752e-09
ATP7B O 0 3.977153482992435e-06
gene O 0 3.585565622188369e-08
has O 0 5.694350324603192e-09
been O 0 1.271984462203335e-10
excluded O 0 1.6235652145618618e-12
in O 0 2.676802413758986e-15
the O 0 1.7969358436669726e-14
much O 0 5.644940894930506e-13
rarer O 0 1.458969722811787e-09
human O 0 5.4586624109731474e-09
copper B-Disease 0 5.905409489059821e-05
overload I-Disease 0 0.19855563342571259
disease O 0 4.919669663649984e-05
non B-Disease 0 8.473894363980605e-10
- I-Disease 0 0.002836342202499509
Indian I-Disease 0 1.692798286967445e-05
childhood I-Disease 0 0.030980555340647697
cirrhosis I-Disease 0 0.20824463665485382
, O 0 1.1768370999920563e-11
indicating O 0 1.5745457715432565e-10
genetic O 0 8.621851677048653e-09
heterogeneity O 0 5.622399612548179e-07
. O 0 1.0253574878049676e-08

By O 0 5.650814451779729e-12
investigating O 0 6.675864028249379e-11
the O 0 4.067337092128476e-11
common O 0 2.1112654735588876e-08
autosomal O 1 0.8456820845603943
recessive O 1 0.9981645941734314
copper B-Disease 1 0.9447792172431946
toxicosis I-Disease 0 0.07136960327625275
( O 0 5.170065417448022e-11
CT B-Disease 0 8.073200206126785e-07
) O 0 3.100797119071075e-10
in O 0 5.902561425741304e-12
Bedlington O 0 8.733793038118165e-06
terriers O 0 0.0004580110835377127
, O 0 4.905508985131313e-11
we O 0 5.502327760087411e-12
have O 0 3.8146271081132554e-14
identified O 0 1.2703945154960566e-13
a O 0 1.1109436802566805e-14
new O 0 3.9216682201984043e-13
locus O 0 6.194131429992922e-08
involved O 0 1.103879099240146e-09
in O 0 2.0756560914492184e-09
progressive O 0 0.04716385528445244
liver B-Disease 1 0.9999992847442627
disease I-Disease 1 0.9999946355819702
. O 0 3.7830659493920393e-07

We O 0 3.7852954104522496e-10
examined O 0 6.195458035485046e-11
whether O 0 1.1830909515953003e-12
the O 0 1.487301254377016e-11
WD B-Disease 0 4.633756179828197e-05
gene O 0 1.270151130938757e-07
ATP7B O 0 0.00023527350276708603
was O 0 1.7427751686227566e-08
also O 0 3.3018420896729905e-12
causative O 0 8.054975089710759e-12
for O 0 7.009819021899441e-14
CT B-Disease 0 2.9542027490947476e-08
by O 0 4.972633632985279e-13
investigating O 0 1.4017387077458476e-11
the O 0 1.3452032890381993e-11
chromosomal O 0 1.1113063010270707e-05
co O 0 2.4878642079784186e-07
- O 0 9.942143996966024e-09
localization O 0 3.245503776838632e-08
of O 0 2.1419076636029072e-13
ATP7B O 0 1.9496117431572202e-07
and O 0 2.186304739679179e-12
C04107 O 0 5.295562707959001e-13
, O 0 1.1551446228894003e-16
using O 0 7.373565801449718e-16
fluorescence O 0 1.536340672736447e-11
in O 0 1.568476522707113e-13
situ O 0 2.2058670862135088e-11
hybridization O 0 3.7144540221412115e-10
( O 0 3.6547693582460183e-13
FISH O 0 3.448946239714701e-09
) O 0 1.7211319175425288e-11
. O 0 5.597984228944419e-11

C04107 O 0 7.372212621703511e-06
is O 0 1.1458970439193195e-09
an O 0 1.3653235443264466e-12
anonymous O 0 4.77142103605388e-09
microsatellite O 0 0.00037318497197702527
marker O 0 3.639709029812366e-05
closely O 0 1.1088597595687588e-08
linked O 0 4.559798227887768e-08
to O 0 2.46441114043483e-11
CT B-Disease 0 4.534682375378907e-06
. O 0 6.085235426667168e-09

However O 0 8.234092518932812e-09
, O 0 4.046190119066928e-11
BAC O 0 1.0844340536664276e-08
clones O 0 3.343593846238946e-08
containing O 0 3.136464199471334e-09
ATP7B O 0 2.83559393210453e-06
and O 0 1.4205359978591847e-11
C04107 O 0 6.124115971284372e-12
mapped O 0 5.6511006985005e-10
to O 0 3.8485973305815713e-13
the O 0 3.1690744321279107e-13
canine O 0 2.4162329737009713e-07
chromosome O 0 9.534255696053151e-06
regions O 0 1.1587516363098516e-10
CFA22q11 O 0 2.0785071228601737e-06
and O 0 1.0026520724792931e-09
CFA10q26 O 0 1.2282546890673984e-07
, O 0 1.2223681268574982e-12
respectively O 0 8.449172893450207e-13
, O 0 1.3469778813385638e-14
demonstrating O 0 4.710970762794586e-12
that O 0 9.476885248771438e-11
WD B-Disease 0 9.285717533202842e-05
cannot O 0 2.156660544594402e-10
be O 0 8.798322313763318e-14
homologous O 0 9.192633633470226e-12
to O 0 7.874346313885283e-11
CT B-Disease 0 5.627760856441455e-06
. O 0 5.214875198333857e-09

The O 0 1.015134434845244e-10
copper O 0 8.884144087062396e-09
transport O 0 3.752871624573828e-11
genes O 0 2.6397777297404446e-09
CTR1 O 0 4.657675526686944e-05
and O 0 1.7995814838300817e-09
CTR2 O 0 7.0329406298697e-07
were O 0 9.244860432744417e-11
also O 0 2.090265243878675e-12
excluded O 0 4.408678283551737e-13
as O 0 4.044702601817794e-14
candidate O 0 1.3585015274167334e-13
genes O 0 3.790703428235842e-12
for O 0 3.5484096672262766e-13
CT B-Disease 0 4.915463591714797e-07
since O 0 3.550046645539595e-10
they O 0 2.0901764477207485e-13
both O 0 4.254701974716396e-15
mapped O 0 4.080893400981722e-09
to O 0 8.824957431485814e-11
canine O 0 1.729677023831755e-05
chromosome O 0 0.02781112678349018
region O 0 6.367793758954576e-08
CFA11q22 O 0 0.00021249777637422085
. O 0 1.2834936669037234e-08

2 O 0 1.689401187832118e-07
- O 0 5.456668532133335e-06
22 O 0 2.1051612009159726e-08
. O 0 8.304242848922172e-10

5 O 0 6.735538704560895e-07
. O 0 3.257566305592263e-08

A O 0 4.81822415299149e-10
transcribed O 0 5.780052880766107e-09
sequence O 0 5.247779988337697e-10
identified O 0 8.804316165011983e-10
from O 0 7.12409623480903e-13
the O 0 6.910734462982349e-13
C04107 O 0 3.071250365138667e-09
- O 0 1.0180345100252453e-07
containing O 0 2.9972355264362704e-08
BAC O 0 9.928612598741893e-09
was O 0 4.16498702193735e-09
found O 0 9.66631614161828e-13
to O 0 1.2803478980152883e-14
be O 0 4.181572622885543e-14
homologous O 0 1.8627408643334675e-12
to O 0 2.084054933834678e-12
a O 0 3.5616523836115577e-13
gene O 0 3.110369184433637e-10
expressed O 0 2.319447802226482e-12
from O 0 2.0147041180544958e-14
human O 0 3.3542094882849094e-12
chromosome O 0 6.609483449437903e-08
2p13 O 0 1.005904581852235e-09
- O 0 1.0727285726375158e-08
p16 O 0 6.432928634225732e-10
, O 0 1.0956881018805986e-12
a O 0 7.42463989594766e-12
region O 0 8.128799716677904e-11
devoid O 0 1.8199948492725326e-10
of O 0 1.3046589082717891e-15
any O 0 1.443636199081541e-14
positional O 0 4.819400989397593e-10
candidate O 0 1.7095411197765031e-10
genes O 0 2.4964720068965107e-08
. O 0 4.5072745535890135e-09

Molecular O 0 9.293169789259537e-09
analysis O 0 6.411341596512798e-11
of O 0 4.474209292447927e-14
the O 0 2.0496667243238148e-13
APC B-Disease 0 1.2309864239057333e-10
gene O 0 3.86227161364161e-11
in O 0 1.2354159850073293e-13
205 O 0 2.8989809684742962e-12
families O 0 5.505075019972272e-13
: O 0 5.862103269710199e-16
extended O 0 6.769369136419567e-13
genotype O 0 1.1279603739922095e-07
- O 0 1.6635758584016003e-06
phenotype O 0 5.01375552630634e-07
correlations O 0 2.1684188311610342e-07
in O 0 9.843049986191232e-12
FAP B-Disease 0 5.473623776452996e-09
and O 0 5.1532302730583623e-11
evidence O 0 5.848263496741057e-13
for O 0 8.095775738431888e-16
the O 0 7.985148153322793e-15
role O 0 1.3639752305047437e-12
of O 0 1.3153787243181791e-14
APC B-Disease 0 5.164469407681338e-10
amino O 0 5.469975514205139e-11
acid O 0 2.812095521720348e-11
changes O 0 6.8699971926544645e-12
in O 0 5.36445128318519e-08
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999996542930603
predisposition O 0 0.014965483918786049
. O 0 3.498179523830913e-08

BACKGROUND O 0 3.5702183254215925e-07
/ O 0 5.511455825057965e-08
AIMS O 0 5.742796793661853e-10
The O 0 6.146077028389152e-13
development O 0 4.162574365057514e-12
of O 0 1.2413903682784166e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
and O 0 8.468191148303106e-10
a O 0 3.266916359830063e-13
variable O 0 5.385007023628319e-11
range O 0 1.9300321341120252e-09
of O 0 4.432239991691844e-11
extracolonic O 0 0.032324668020009995
manifestations O 0 5.5422297009499744e-05
in O 0 1.2283535397727974e-06
familial B-Disease 1 0.9999994039535522
adenomatous I-Disease 1 0.9999915361404419
polyposis I-Disease 1 0.999998927116394
( O 0 2.34116996011835e-07
FAP B-Disease 0 1.1329230801493395e-05
) O 0 3.061751741029184e-09
is O 0 6.126689433560983e-11
the O 0 5.5696727611909136e-12
result O 0 1.3288163104585582e-11
of O 0 2.3595420729034464e-14
the O 0 2.5176614265598474e-11
dominant O 0 3.289618007329409e-06
inheritance O 0 6.629958807025105e-05
of O 0 8.529520414413128e-07
adenomatous B-Disease 1 0.9999966621398926
polyposis I-Disease 1 0.9999744892120361
coli I-Disease 1 0.9999955892562866
( O 0 1.8753849584385307e-09
APC B-Disease 0 6.502310867517735e-08
) O 0 3.5940434656156484e-11
gene O 0 8.691164232743631e-09
mutations O 0 1.2686006130024907e-06
. O 0 7.070477536785802e-09

In O 0 1.0216492929426835e-10
this O 0 8.833026947678221e-14
study O 0 9.19105964296632e-15
, O 0 5.93477922598021e-16
direct O 0 1.7530405634611813e-15
mutation O 0 1.1337862940163923e-11
analysis O 0 1.0807688294658946e-12
of O 0 1.1320472520276372e-14
the O 0 1.52968501580808e-12
APC B-Disease 0 2.297909862392089e-09
gene O 0 2.5968335815029775e-10
was O 0 1.4954895100061094e-09
performed O 0 9.374067494460903e-12
to O 0 1.4551206105935938e-13
determine O 0 5.2069983741409587e-11
genotype O 0 8.606575363501179e-08
- O 0 1.221920456373482e-06
phenotype O 0 2.175697915163255e-07
correlations O 0 1.4215762789149267e-08
for O 0 8.67551690209023e-12
nine O 0 8.410729002150674e-09
extracolonic O 0 2.562221015978139e-05
manifestations O 0 3.358934819175374e-08
and O 0 1.5207460291044583e-11
to O 0 1.3007195147352046e-13
investigate O 0 2.8829749351699796e-11
the O 0 2.236962004520393e-11
incidence O 0 4.586384250160336e-07
of O 0 6.281431538107674e-13
APC B-Disease 0 5.073305686664753e-08
mutations O 0 5.97377702860058e-09
in O 0 6.203696410744808e-12
non O 0 4.378560625184491e-09
- O 0 0.34012848138809204
FAP O 1 0.9993588328361511
colorectal B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.999980092048645
. O 0 6.488367034762632e-07

METHODS O 0 6.121740336872961e-10
The O 0 1.747049206690665e-11
APC B-Disease 0 2.0278481116520197e-09
gene O 0 9.71346003630913e-10
was O 0 5.237513089895174e-09
analysed O 0 7.698854331827931e-10
in O 0 8.295945717494077e-14
190 O 0 9.255631200702497e-13
unrelated O 0 6.616408376042271e-12
FAP B-Disease 0 1.7211337910438829e-09
and O 0 7.458424849948742e-11
15 O 0 1.0974873787539252e-11
non O 0 3.106290225041164e-10
- O 0 0.07278169691562653
FAP O 1 0.9961090683937073
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999979734420776
patients O 0 1.6912696798598859e-09
using O 0 1.9277492796510032e-11
denaturing O 0 6.400346319423988e-05
gradient O 0 0.00020168357877992094
gel O 0 0.00043124568765051663
electrophoresis O 0 6.773751920263749e-06
, O 0 7.57330222839192e-12
the O 0 7.144283299990398e-15
protein O 0 5.401195549842308e-12
truncation O 0 4.2704142444449644e-09
test O 0 9.870965378411256e-09
, O 0 1.2272516377166524e-14
and O 0 2.187794834957791e-15
direct O 0 2.898865865167094e-15
sequencing O 0 1.2425463324916564e-08
. O 0 4.572345613240714e-09

RESULTS O 0 2.75517578529616e-07
Chain O 0 1.9648969384888915e-07
terminating O 0 1.0563995900270129e-08
signals O 0 9.471401654082001e-07
were O 0 8.118294231307388e-11
only O 0 1.4158116411026878e-13
identified O 0 3.081316105046916e-11
in O 0 5.833513468285478e-13
patients O 0 2.1989471875316635e-12
belonging O 0 5.368603239915004e-13
to O 0 6.439587144774217e-12
the O 0 2.4178008553588093e-11
FAP B-Disease 0 3.448454677368318e-08
group O 0 5.395766944360503e-09
( O 0 1.6745077004685915e-13
105 O 0 2.8219279343821846e-11
patients O 0 2.2243682590294966e-11
) O 0 3.835079389474805e-12
. O 0 3.397965936402514e-11

Amino O 0 2.8041523592037265e-07
acid O 0 4.934786446142425e-08
changes O 0 7.566238217557308e-13
were O 0 7.831724635129489e-13
identified O 0 5.094084442464064e-12
in O 0 1.4260780869992246e-13
four O 0 4.259550004381829e-11
patients O 0 5.852216714702374e-12
, O 0 4.31888750565719e-14
three O 0 2.277181698415176e-12
of O 0 1.5807489865682367e-12
whom O 0 2.939647414379465e-10
belonged O 0 2.9124680445136164e-10
to O 0 3.819399657656319e-12
the O 0 6.568673014371862e-13
non O 0 4.717732281223075e-12
- O 0 4.792657293251068e-08
FAP O 0 1.3273546528580482e-07
group O 0 1.6753073595054957e-08
of O 0 1.6254119827863178e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999983310699463
patients O 0 1.3883878580145392e-07
. O 0 2.2139694244582842e-10

Genotype O 0 0.003061895491555333
- O 0 0.001602462027221918
phenotype O 0 2.371046139160171e-05
correlations O 0 4.709731342700252e-07
identified O 0 1.8809240387440695e-08
significant O 0 3.328091413568046e-10
differences O 0 2.0530686128950038e-07
in O 0 2.862935583047843e-11
the O 0 1.2164401430592164e-11
nature O 0 5.6766896738835726e-11
of O 0 1.0051046773302749e-13
certain O 0 5.0438129367558204e-11
extracolonic O 0 5.688442342943745e-06
manifestations O 0 8.27864354846497e-09
in O 0 1.2850122441815381e-12
FAP B-Disease 0 1.0451600473970757e-08
patients O 0 1.7643083174978536e-11
belonging O 0 4.776774678930118e-13
to O 0 8.784739293421148e-14
three O 0 5.1280091284411355e-12
mutation O 0 2.9566700199268325e-09
subgroups O 0 1.914509439870926e-08
. O 0 8.726578570872334e-09

CONCLUSIONS O 0 6.5421916772834265e-09
Extended O 0 8.869815437684281e-10
genotype O 0 8.278224413516e-06
- O 0 3.714789272635244e-05
phenotype O 0 3.0732908271602355e-06
correlations O 0 4.2474036376916047e-07
made O 0 2.2096844354280165e-09
in O 0 3.072933183953519e-12
this O 0 1.7142543894815843e-12
study O 0 5.850788169919907e-12
may O 0 3.8998784757104943e-10
have O 0 3.813234016741829e-12
the O 0 1.8743405265364554e-13
potential O 0 4.220277773081538e-12
to O 0 2.1418096788315688e-13
determine O 0 5.080904772435113e-13
the O 0 2.9327010197616405e-15
most O 0 6.848314979854712e-17
appropriate O 0 8.077756171270237e-17
surveillance O 0 6.393061774412345e-11
and O 0 2.2734350751778265e-13
prophylactic O 0 3.4637210634402837e-12
treatment O 0 1.9382670381901113e-12
regimens O 0 4.76183112038675e-12
for O 0 1.791678183108423e-15
those O 0 4.340973923638164e-13
patients O 0 8.219013035264122e-13
with O 0 1.0687358116545642e-12
mutations O 0 7.165156024058206e-09
associated O 0 7.213818986606668e-10
with O 0 2.971446977362291e-10
life O 0 3.053746411296743e-07
threatening O 0 0.000582219276111573
conditions O 0 7.058299900108977e-08
. O 0 4.979493484214004e-10

This O 0 9.707212811349564e-11
study O 0 1.9772879080587336e-12
also O 0 1.775454132671439e-12
provided O 0 6.275533275001445e-15
evidence O 0 9.786430292448717e-14
for O 0 4.517821324836156e-15
the O 0 4.533069611952628e-13
pathological O 0 3.0415949758832994e-09
nature O 0 7.079885722821588e-12
of O 0 9.870087840297467e-15
amino O 0 1.1429125701400977e-10
acid O 0 2.3413623470580625e-11
changes O 0 3.4640811676393476e-14
in O 0 7.055748536431358e-14
APC O 0 1.914059355456743e-09
associated O 0 2.035538057554298e-11
with O 0 6.594595746214904e-13
both O 0 9.775410732618117e-13
FAP B-Disease 0 6.215206127535566e-09
and O 0 1.6678038117223792e-10
non O 0 7.0973615873271e-10
- O 0 0.190993532538414
FAP O 1 0.999651312828064
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999979734420776
patients O 0 9.784107390942154e-08
. O 0 2.709539190237642e-11
. O 0 1.4274545434567187e-10

Inherited B-Disease 1 0.9993694424629211
colorectal I-Disease 1 0.9999922513961792
polyposis I-Disease 1 0.9999207258224487
and O 0 0.18495109677314758
cancer B-Disease 0 0.4335983395576477
risk O 0 4.903752710561093e-07
of O 0 1.1909920207171798e-13
the O 0 1.0249707332876667e-11
APC O 0 1.280070307529968e-07
I1307K O 0 1.8519573430353375e-08
polymorphism O 0 5.971250516267901e-08
. O 0 8.432313181039319e-10

Germ O 0 0.0008300532936118543
- O 0 0.0003462146269157529
line O 0 1.5448340491275303e-05
and O 0 2.0589245586233318e-10
somatic O 0 4.818757615154823e-10
truncating O 0 1.8107971300196368e-07
mutations O 0 1.459405325476837e-07
of O 0 1.2419776578703745e-12
the O 0 1.0000745023774904e-11
APC B-Disease 0 4.541473419550357e-09
gene O 0 1.0357352753231908e-09
are O 0 2.5377727805482586e-13
thought O 0 2.7480001781043928e-12
to O 0 1.2762166540572495e-12
initiate O 0 8.10643854265436e-08
colorectal B-Disease 1 0.9999983310699463
tumor I-Disease 1 0.9972609281539917
formation O 0 6.799890252295882e-05
in O 0 2.7534220862435177e-05
familial B-Disease 1 0.9999984502792358
adenomatous I-Disease 1 0.9999899864196777
polyposis I-Disease 1 0.9999992847442627
syndrome I-Disease 1 0.9999960660934448
and O 0 6.522684543597279e-06
sporadic O 0 0.001245782827027142
colorectal O 1 0.9999959468841553
carcinogenesis O 1 0.9345198273658752
, O 0 7.764485587813397e-08
respectively O 0 2.18031672716279e-08
. O 0 2.7910658229046703e-09

Recently O 0 3.5859351044109644e-08
, O 0 3.117368559471534e-12
an O 0 2.0062190840899885e-13
isoleucine O 0 7.1304261837212835e-06
- O 0 1.4332242244563531e-05
- O 0 0.00010873203427763656
> O 0 1.6755398180023917e-09
lysine O 0 8.66145910549676e-09
polymorphism O 0 3.306048490525626e-10
at O 0 4.547727125436829e-11
codon O 0 5.329136784637534e-11
1307 O 0 1.5682111609294225e-08
( O 0 2.8133048733496036e-13
I1307K O 0 4.639741021938981e-11
) O 0 5.252599028469918e-13
of O 0 8.779303268899731e-16
the O 0 1.5611311885137952e-13
APC B-Disease 0 3.411358417970689e-10
gene O 0 1.4182301166787425e-10
has O 0 1.8660177569795877e-10
been O 0 9.01456968967207e-13
identified O 0 4.272371085384252e-12
in O 0 6.013534125954428e-14
6 O 0 1.8682934366243131e-10
% O 0 7.636103663451188e-13
- O 0 2.0732085204144823e-07
7 O 0 9.928049138352435e-08
% O 0 1.0167319460310797e-12
of O 0 3.705537396023195e-14
the O 0 1.2979531338608297e-10
Ashkenazi O 0 8.085520676104352e-06
Jewish O 0 4.674015485761629e-08
population O 0 2.9289449338110174e-11
. O 0 1.0650576948156854e-10

To O 0 2.9150412639289414e-10
assess O 0 2.3360285927864766e-10
the O 0 1.0992010253396689e-11
risk O 0 6.74533900957286e-11
of O 0 1.5152612098101581e-16
this O 0 1.9594815509483676e-15
common O 0 7.059382646588258e-14
APC B-Disease 0 6.873752678160372e-10
allelic O 0 1.0789234394792402e-08
variant O 0 5.040420091972919e-06
in O 0 8.998478051580605e-08
colorectal O 1 0.9999992847442627
carcinogenesis O 0 0.06658465415239334
, O 0 6.01938721089823e-10
we O 0 3.159746769787475e-11
have O 0 1.8457215194157134e-13
analyzed O 0 3.4876728241539645e-12
a O 0 7.022880269946102e-14
large O 0 3.3875249068511526e-13
cohort O 0 1.5666707930961365e-09
of O 0 2.393128555565338e-13
unselected O 0 3.146727749481215e-07
Ashkenazi O 0 5.906018486712128e-06
Jewish O 0 1.1841206237761526e-08
subjects O 0 1.4207062193349884e-08
with O 0 1.5779941242577422e-10
adenomatous B-Disease 0 3.134058351861313e-05
polyps I-Disease 0 0.028259629383683205
and O 0 1.9253123539897388e-08
. O 0 9.135020739847732e-09
or O 0 0.013408358208835125
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
, I-Disease 0 7.063676726870582e-11
for O 0 9.514519502666109e-15
the O 0 2.0802263991231973e-12
APC O 0 3.5541231113711547e-07
I1307K O 0 2.3799749726549635e-08
polymorphism O 0 6.174562372507353e-08
. O 0 7.855553429969575e-10

The O 0 8.150394942285644e-11
APC O 0 1.4301838824337665e-08
I1307K O 0 3.9615364322287405e-09
allele O 0 4.095539551940419e-08
was O 0 1.9582479637847428e-08
identified O 0 1.574762653611117e-09
in O 0 5.10888423579936e-12
48 O 0 3.1545318440739933e-11
( O 0 2.088237546952836e-15
10 O 0 5.016997153004313e-14
. O 0 1.4447967019819152e-13
1 O 0 1.5915006942521237e-12
% O 0 3.6880576853104766e-14
) O 0 3.5944151436729035e-14
of O 0 1.5937522060817475e-15
476 O 0 1.3551476607531754e-09
patients O 0 3.240878052035434e-11
. O 0 1.5681490828090006e-11

Compared O 0 4.276315745954662e-09
with O 0 2.6628536615308507e-12
the O 0 7.327950366734642e-14
frequency O 0 6.9733250285253234e-09
in O 0 1.763895968306603e-13
two O 0 1.2706060162348543e-12
separate O 0 3.9455665297449816e-12
population O 0 4.359026025335319e-14
control O 0 2.5774691408964046e-11
groups O 0 9.799219981732488e-15
, O 0 1.4233646465988486e-15
the O 0 1.3443598719051902e-14
APC O 0 4.013175569639316e-09
I1307K O 0 1.230465951351789e-09
allele O 0 8.262509254564065e-08
is O 0 7.381295574759861e-11
associated O 0 1.2722677945886662e-11
with O 0 6.753030209680211e-13
an O 0 2.0890535395307053e-12
estimated O 0 9.254122468327353e-11
relative O 0 1.39324507486549e-09
risk O 0 1.1495835394725873e-09
of O 0 1.0867192833542011e-13
1 O 0 2.4692020650363133e-10
. O 0 1.2284070427526217e-09

5 O 0 2.26866738728404e-08
- O 0 1.2613046465048683e-06
1 O 0 3.670410864131668e-09
. O 0 7.118022282703862e-10

7 O 0 6.542131814057939e-07
for O 0 2.1668057570423116e-08
colorectal B-Disease 1 0.9999790191650391
neoplasia I-Disease 1 0.7967960834503174
( O 0 3.8290628445736274e-09
both O 0 1.1448882730746845e-08
P O 0 0.14708608388900757
= O 0 4.708276719611604e-06
. O 0 4.897658389957371e-10
01 O 0 1.4405152626295603e-07
) O 0 1.177086900172597e-10
. O 0 7.097646359532916e-10

Furthermore O 0 1.683241102057309e-08
, O 0 1.2309059153892132e-11
compared O 0 3.226763908154018e-12
with O 0 7.113572968522885e-13
noncarriers O 0 5.895518384591014e-08
, O 0 1.641900591181633e-13
APC O 0 6.193733026460535e-11
I1307K O 0 1.3814129527778274e-11
carriers O 0 2.42542422777825e-13
had O 0 2.242062091539765e-11
increased O 0 1.2564652958476849e-14
numbers O 0 1.6574693278027103e-13
of O 0 9.407664534541449e-13
adenomas B-Disease 0 0.0009008903289213777
and O 0 0.0005515581578947604
colorectal B-Disease 1 0.9999994039535522
cancers I-Disease 1 0.96964430809021
per O 0 1.0646179937623401e-08
patient O 0 2.8882143965347495e-07
( O 0 4.7178160683669645e-11
P O 0 0.00032358733005821705
= O 0 1.292880369874183e-06
. O 0 1.106729374811266e-09
03 O 0 8.171261001166386e-09
) O 0 3.406993090426802e-11
, O 0 2.1688511717913445e-13
as O 0 3.424587002864854e-13
well O 0 7.192403682181048e-13
as O 0 6.782137785404929e-13
a O 0 1.801918683708159e-11
younger O 0 6.51194032030844e-09
age O 0 1.8809500831884485e-11
at O 0 1.7939123797550138e-10
diagnosis O 0 1.4348507271222388e-08
. O 0 3.2139543804099446e-10

We O 0 4.048011925661399e-11
conclude O 0 9.09292172807108e-12
that O 0 4.875196383744007e-14
the O 0 7.621312774126233e-15
APC O 0 7.402740226369886e-11
I1307K O 0 2.7092807164397215e-11
variant O 0 1.277750460992877e-09
leads O 0 3.79745346279492e-09
to O 0 7.29683480304999e-10
increased O 0 1.4351600796658204e-08
adenoma B-Disease 1 0.9999978542327881
formation O 0 3.897918787743038e-08
and O 0 4.706000034104818e-10
directly O 0 1.071504083377528e-11
contributes O 0 3.415241613818898e-12
to O 0 3.281494000140217e-12
3 O 0 8.117969491072685e-11
% O 0 7.182861618861003e-13
- O 0 3.7210309500324e-08
4 O 0 6.638299687722338e-09
% O 0 1.0854555779595335e-13
of O 0 5.209491065388599e-15
all O 0 3.937253995056622e-11
Ashkenazi O 0 0.011314169503748417
Jewish O 0 0.2378607541322708
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999957084655762
. O 0 2.6557992782727524e-07

The O 0 1.5577815426492947e-10
estimated O 0 6.070715458106335e-11
relative O 0 4.801939956777801e-10
risk O 0 1.3508785756677355e-10
for O 0 5.104612885815582e-14
carriers O 0 2.1373717032369122e-11
may O 0 6.17581116454935e-12
justify O 0 6.122533713738901e-14
specific O 0 2.15325886647851e-16
clinical O 0 2.1617835966420904e-14
screening O 0 1.3141875418844554e-14
for O 0 3.6986770961888813e-16
the O 0 2.319391355950877e-15
360 O 0 9.865488417512558e-13
, O 0 1.1459727277903821e-14
000 O 0 3.856560660013206e-14
Americans O 0 6.469632907743841e-14
expected O 0 1.0428873612128645e-13
to O 0 3.781696093427267e-13
harbor O 0 3.363611333906391e-10
this O 0 2.5072249777626648e-14
allele O 0 9.139158874127418e-11
, O 0 3.416106102421129e-13
and O 0 2.374102162690933e-13
genetic O 0 2.1392764296135347e-11
testing O 0 2.4620524369245445e-11
in O 0 1.3586017991770293e-14
the O 0 5.46127304891595e-14
setting O 0 4.405941930740731e-11
of O 0 1.3437357780296533e-12
long O 0 1.779770464338526e-08
- O 0 3.2665756322103334e-08
term O 0 1.8898773657127776e-09
- O 0 1.2198202448132633e-08
outcome O 0 6.948622233160506e-11
studies O 0 1.9324715438973072e-12
may O 0 7.919177466564342e-13
impact O 0 2.327947405157682e-13
significantly O 0 6.408630848220298e-10
on O 0 0.07491789758205414
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
prevention O 0 1.286987117055105e-05
in O 0 3.4168117554050914e-12
this O 0 1.3678727204743946e-12
population O 0 1.630448272053886e-12
. O 0 2.2400883925577375e-10

Localization O 0 2.0248427290425752e-07
of O 0 2.1781133754256166e-12
human O 0 3.208048757197268e-11
BRCA1 O 0 1.074382907972904e-06
and O 0 6.776565530941525e-09
its O 0 1.050025577598035e-08
loss O 0 6.105660190769413e-07
in O 0 3.060509528099442e-12
high O 0 2.3021444306436933e-08
- O 0 3.6413880479813088e-06
grade O 0 3.0436333418037975e-06
, O 0 7.295022919073801e-11
non B-Disease 0 1.5352760174280888e-09
- I-Disease 1 0.7880532741546631
inherited I-Disease 1 0.9998120665550232
breast I-Disease 1 0.9963147044181824
carcinomas I-Disease 1 0.9999812841415405
. O 0 3.7402688235488313e-07

Although O 0 2.935305332130156e-10
the O 0 3.4054630317949253e-13
link O 0 2.28152829961914e-09
between O 0 1.5109446679928418e-11
the O 0 7.218041442325074e-11
BRCA1 O 0 9.063923789653927e-05
tumour B-Disease 1 0.9999970197677612
- O 0 1.1297296396151069e-06
suppressor O 0 7.73761530581396e-06
gene O 0 6.890494660183322e-06
and O 0 4.004608854302205e-06
hereditary B-Disease 1 0.99998939037323
breast I-Disease 1 0.9999979734420776
and I-Disease 1 0.9999984502792358
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999996423721313
is O 0 3.1897005925429767e-08
established O 0 3.0494280711668154e-11
, O 0 2.225432295041574e-12
the O 0 1.112076332713749e-13
role O 0 6.69362551497521e-11
, O 0 6.440591332826373e-13
if O 0 2.0320138800766774e-13
any O 0 7.29962829548389e-15
, O 0 2.6742878270484723e-14
of O 0 1.4037378132439587e-14
BRCA1 O 0 1.3802767853121622e-06
in O 0 2.376593088992962e-10
non B-Disease 0 6.45442952418307e-08
- I-Disease 1 0.7529526948928833
familial I-Disease 1 0.9984018206596375
cancers I-Disease 1 0.9837774038314819
is O 0 2.030382972861844e-09
unclear O 0 3.9431200526962584e-09
. O 0 2.056063791444629e-10

BRCA1 O 0 0.0001470749848522246
mutations O 0 4.512120540312026e-06
are O 0 7.369282267744026e-11
rare O 0 5.577138056933606e-11
in O 0 3.607014426726396e-12
sporadic B-Disease 0 6.938089427421801e-07
cancers I-Disease 0 0.08955081552267075
, O 0 3.77870401635505e-09
but O 0 8.080331070914326e-09
loss O 0 1.1428897828125173e-08
of O 0 2.220512727683921e-13
BRCA1 O 0 5.501335908775218e-05
resulting O 0 8.8715502499781e-08
from O 0 6.973849275837551e-11
reduced O 0 3.8433287108396996e-10
expression O 0 6.164986576795428e-11
or O 0 4.8623789022927966e-11
incorrect O 0 7.430335102753816e-08
subcellular O 0 1.56635408643524e-07
localization O 0 1.2413720185122656e-07
is O 0 1.3805858366244816e-11
postulated O 0 2.7872648633575636e-11
to O 0 4.396420293789616e-12
be O 0 3.154987339090698e-12
important O 0 9.364841801334789e-13
in O 0 2.878358142111015e-12
non B-Disease 0 4.868406566771455e-09
- I-Disease 0 0.3157174289226532
familial I-Disease 1 0.9999499320983887
breast I-Disease 1 0.9999891519546509
and I-Disease 1 0.999559223651886
ovarian I-Disease 1 0.9999984502792358
cancers I-Disease 1 0.999992847442627
. O 0 1.3347682852327125e-06

Epigenetic O 0 0.00019155253539793193
loss O 0 0.0026387434918433428
, O 0 1.2276293315238718e-09
however O 0 1.262998594597775e-10
, O 0 4.68823601901952e-13
has O 0 2.916640019778871e-12
not O 0 6.609930701742539e-14
received O 0 1.6081651069539899e-15
general O 0 5.040859087568003e-15
acceptance O 0 5.930245877694418e-11
due O 0 3.5606441406432765e-11
to O 0 9.303632083484947e-13
controversy O 0 3.6564098103430975e-12
regarding O 0 8.85349922579359e-15
the O 0 5.7204810549951746e-15
subcellular O 0 2.0530463440415758e-10
localization O 0 4.578906420693585e-10
of O 0 2.3961405877851154e-15
BRCA1 O 0 2.108302643577531e-09
proteins O 0 1.889206152627665e-10
, O 0 1.4479976462658528e-12
reports O 0 3.964599048361661e-12
of O 0 3.426892016683558e-14
which O 0 4.319712365585815e-10
have O 0 4.248880067225791e-11
ranged O 0 2.3543219457300424e-11
from O 0 2.5632709879484664e-15
exclusively O 0 4.4681820092831726e-13
nuclear O 0 7.200117835282072e-09
, O 0 5.093588688479596e-16
to O 0 1.1292388084118972e-15
conditionally O 0 6.171574362667798e-11
nuclear O 0 5.0998569811611105e-09
, O 0 6.552483826116921e-16
to O 0 2.1407535896826027e-15
the O 0 2.457100820550673e-13
ER O 0 6.52828305192088e-07
/ O 0 6.101052996143608e-09
golgi O 0 1.2772525224136189e-06
, O 0 1.0360854969110322e-12
to O 0 4.0533082532739906e-13
cytoplasmic O 0 1.0273875972188762e-08
invaginations O 0 2.1168217401168476e-08
into O 0 3.722299432660364e-13
the O 0 7.232489889104354e-13
nucleus O 0 1.8831512738071154e-10
. O 0 2.7880890304810002e-11

In O 0 1.7224751139299777e-11
an O 0 6.682481716417665e-13
attempt O 0 1.7681504038691287e-09
to O 0 6.784629108524953e-11
resolve O 0 7.595080675493193e-10
this O 0 1.0672476222000835e-14
issue O 0 3.718029790295008e-12
, O 0 8.702721431951693e-14
we O 0 3.842452831609444e-12
have O 0 2.7769531465993147e-12
comprehensively O 0 2.798587104280159e-07
characterized O 0 3.2910998926105606e-10
19 O 0 5.5873990330301826e-12
anti O 0 1.6673475045081432e-08
- O 0 3.839237706415588e-06
BRCA1 O 0 3.2758373436081456e-06
antibodies O 0 4.713559675906254e-08
. O 0 5.75886671683179e-10

These O 0 5.7643664147510876e-12
reagents O 0 7.122907819123725e-11
detect O 0 3.2578877373623527e-09
a O 0 5.166531265310415e-13
220 O 0 3.8181905553935636e-12
- O 0 3.876786003331745e-09
kD O 0 5.304803263328495e-09
protein O 0 2.5431151975952027e-11
localized O 0 4.914928273397345e-12
in O 0 1.3430707724627639e-14
discrete O 0 2.9516089572467763e-10
nuclear O 0 1.2331317520875018e-05
foci O 0 3.906995971192373e-06
in O 0 9.459449282905874e-13
all O 0 8.495972480225544e-13
epithelial O 0 1.1801431831770515e-08
cell O 0 0.0014415577752515674
lines O 0 2.3761976990499534e-06
, O 0 2.2141415437215706e-11
including O 0 2.8532512181926595e-13
those O 0 1.4175370946500898e-11
derived O 0 4.384573606963649e-11
from O 0 2.655360098469117e-10
breast B-Disease 0 0.00022929236001800746
malignancies I-Disease 0 0.004607833456248045
. O 0 3.0312932608467236e-08

Immunohistochemical O 0 0.000634757976513356
staining O 0 0.00013056534226052463
of O 0 2.478922900284175e-10
human O 0 7.027564663530939e-08
breast O 0 3.710318196681328e-05
specimens O 0 4.557120547588056e-08
also O 0 1.502998836500069e-09
revealed O 0 2.8748644353981945e-07
BRCA1 O 0 1.748594149830751e-05
nuclear O 0 9.385529847349972e-05
foci O 0 8.04176161182113e-05
in O 0 8.096475573315942e-11
benign O 0 0.00015232249279506505
breast O 0 0.00033580054878257215
, O 0 8.168393961227594e-09
invasive B-Disease 0 6.734326598234475e-05
lobular I-Disease 1 0.9995067119598389
cancers I-Disease 1 0.9999459981918335
and O 0 1.0912553079833742e-05
low B-Disease 0 0.0019816444255411625
- I-Disease 1 0.9714884161949158
grade I-Disease 1 0.688323438167572
ductal I-Disease 1 0.977353572845459
carcinomas I-Disease 1 0.9999876022338867
. O 0 1.0630834367475472e-05

Conversely O 0 2.7744022190745454e-07
, O 0 3.045214427843668e-11
BRCA1 O 0 3.258678660245096e-08
expression O 0 5.796787494460887e-10
was O 0 9.381096077731854e-08
reduced O 0 7.848799388199268e-10
or O 0 3.036718654314541e-10
undetectable O 0 1.4027456529674964e-07
in O 0 2.3432642545090365e-12
the O 0 1.097043809961118e-11
majority O 0 1.0631696044371974e-11
of O 0 4.492905613523446e-13
high O 0 4.10952267770881e-08
- O 0 1.0986056622641627e-05
grade O 0 5.9031526689068414e-06
, O 0 1.6250972789677576e-10
ductal B-Disease 0 2.292602175657521e-06
carcinomas I-Disease 1 0.9999974966049194
, O 0 3.5089837702173554e-09
suggesting O 0 3.431014361510165e-09
that O 0 4.561618097143061e-11
absence O 0 1.020511869453955e-10
of O 0 3.6473179077650686e-13
BRCA1 O 0 8.238548616645858e-07
may O 0 5.43686984322278e-10
contribute O 0 1.8193525706160577e-14
to O 0 2.1738790238409744e-13
the O 0 1.5341407614763436e-12
pathogenesis O 0 7.325645645650525e-10
of O 0 7.125638410755437e-15
a O 0 5.587150750732683e-13
significant O 0 6.411457736249515e-13
percentage O 0 3.907295820226864e-09
of O 0 1.571846494109741e-12
sporadic B-Disease 0 3.2867110348888673e-06
breast I-Disease 0 0.06756573915481567
cancers I-Disease 0 0.011715767905116081
. O 0 6.399445418026062e-10
. O 0 7.050569572619736e-10

